02125000000000409000450099100020000070000020000270600020000470100020000609100090
00081300053000174210022000701510026000922300039001180350010001574800049001670300
02700216930000600243117000600249085000300255935001000258032000600268036000700274
04200020028120000020028306500090028512200030029404800140029704800140031104800240
03250430058003490430058004070430058004655400388005235400402009115400396013135410
00601709#1#0#i#1#20110411#Revista da Sociedade Brasileira de Medicina Tropical#R
ev Soc Bras Med Trop#Rev. Soc. Bras. Med. Trop#Jornal Brasileiro de Medicina Tro
pical#0037-8682#Sociedade Brasileira de Medicina Tropical - SBMT#Rev. Soc. Bras.
 Med. Trop.#RSBMT#other#nd#0037-8682#ahead#201150#1#0#20110000#20#^les^hSumario#
^lpt^hSumário#^len^hTable of Contents#^les^tRev. Soc. Bras. Med. Trop.^nno.ahead
^cUberaba^a2011#^lpt^tRev. Soc. Bras. Med. Trop.^nno.ahead^cUberaba^a2011#^len^t
Rev. Soc. Bras. Med. Trop.^nno.ahead^cUberaba^a2011#^t<a rel="license" href="htt
p://creativecommons.org/licenses/by-nc/3.0/"><img alt="Creative Commons License"
 style="border-width:0" src="http://i.creativecommons.org/l/by-nc/3.0/80x15.png"
 /></a> Todo el contenido de esta revista, excepto dónde está identificado, est&
#225; bajo una <a rel="license" href="http://creativecommons.org/licenses/by-nc/
3.0/">Licencia Creative Commons</a>^les#^t<a rel="license" href="http://creative
commons.org/licenses/by-nc/3.0/"><img alt="Creative Commons License" style="bord
er-width:0" src="http://i.creativecommons.org/l/by-nc/3.0/80x15.png" /></a> Todo
 o conteúdo deste periódico, exceto onde est&#225 identificado, est&#225; licenc
iado sob uma <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.
0/">Licen&#231;a Creative Commons</a>^lpt#^t<a rel="license" href="http://creati
vecommons.org/licenses/by-nc/3.0/"><img alt="Creative Commons License" style="bo
rder-width:0" src="http://i.creativecommons.org/l/by-nc/3.0/80x15.png" /></a> Al
l the contents of this journal, except where otherwise noted, is licensed under 
a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creativ
e Commons Attribution License</a>^len#BY-NC##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#o#1#
1#article#1#20110311#101239#aop01-11.htm#197##
04550000000000781000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201670
01860120144003530100033004970100045005300100037005750100039006120100031006510100
03300682010003500715010003700750070010900787070009400896070010300990070008301093
07000440117607001190122007000860133907001050142508309870153008500080251708500250
25250850024025500850024025740850025025980850029026230830921026520850008035730850
02403581085002303605085002403628085002503652085002903677117000603706072000303712
112000903715111001103724114000903735113001103744002001303755#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#h#2#1#article#1#tr#pt#br1.1#1#4.
0#GRA#TAB#04#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20
110318#Monitoramento da suscetibilidade de populações de Triatoma sordida Stål, 
1859 (Hemiptera: Reduviidae) ao inseticida deltametrina, na região Centro-Oeste 
do Brasil^lpt#Monitoring the susceptibility of Triatoma sordida Stål, 1859 (Hemi
ptera: Reduviidae) to deltamethrin insecticide, in Central-Western Brazil^len#^r
ND^1A01^nMarcos Takashi^sObara#^rND^1A02^nVanessa Camargo Garbeloto^sOtrera#^rND
^1A03^nRodrigo Gurgel^sGonçalves#^rND^1A04^nJanduhy Pereira dos^sSantos#^rND^1A0
5^nMarcelo^sSantalucia#^rND^1A06^nJoão Aristeu da^sRosa#^rND^1A07^nPaulo Silva d
e^sAlmeida#^rND^1A08^nJosé Maria Soares^sBarata#Ministério da Saúde^iA01^1Secret
aria de Vigilância em Saúde^2Laboratório de Entomologia Médica^cBrasília^sDF#Sup
erintendência de Controle de Endemias^iA02^1Laboratório do Núcleo de Pesquisa^cM
arília^sSP#Universidade de Brasília^iA03^1Laboratório de Parasitologia Médica e 
Biologia de Vetores^cBrasília^sDF#Núcleo de Geoprocessamento^iA04^1Departamento 
de Estradas de Rodagem^cBrasília^sDF#Secretaria de Estado da Saúde de Goiás^iA05
#Universidade Estadual Paulista^iA06^1Faculdade de Ciências Farmacêuticas^2Labor
atório de Parasitologia^cAraraquara^sSP#Secretaria de Estado de Saúde^iA07^1Labo
ratório Regional de Entomologia^cDourados^sMS#Universidade de São Paulo^iA08^1Fa
culdade de Saúde Pública^2Departamento de Epidemiologia^cSão Paulo^sSP#^lpt^aINT
RODUÇÃO: Populações de Triatoma sordida Stål, 1859 foram investigadas quanto à s
uscetibilidade à deltametrina. MÉTODOS: Análise por meio de bioensaios por aplic
ação tópica em 11 populações de T. sordida procedentes dos Estados de Goiás, Mat
o Grosso e Mato Grosso do Sul. RESULTADOS: As estimativas de DL50 e RR50 demonst
raram elevados níveis de suscetibilidade (DL50 < 1 e RR50 < 2). Entretanto, as a
nálises do coeficiente angular da curva dose resposta revelaram que as populaçõe
s de triatomíneos dos municípios de Firminópolis/GO, Posse/GO, Poxoréu/MT, Doura
dina/MS e Aparecida do Taboado/MS apresentam maiores probabilidades de evolução 
de resistência, portanto, mais propícias a tolerar o tratamento com deltametrina
. CONCLUSÕES: Detectaram-se pequenas alterações de suscetibilidade e baixos níve
is de resistência, porém as alterações temporais de suscetibilidade deverão ser 
continuamente monitoradas, a fim de nortear adequadamente as ações de controle d
os vetores da DC.#^dnd^i1#^tm^lpt^kTriatomíneos^i1#^tm^lpt^kResistência^i1#^tm^l
pt^kInseticidas^i1#^tm^lpt^kDeltametrina^i1#^tm^lpt^kTriatoma sordida^i1#^len^aI
NTRODUCTION: Triatoma sordida Stål, 1859 populations were investigated for susce
ptibility to deltamethrin. METHODS: This study aimed to analyze the resistance o
f 11 populations of insects from the States of Goiás, Mato Grosso and Mato Gross
o do Sul by topical application bioassays. RESULTS: The estimated LD50 and RR50 
showed high levels of susceptibility (LD50 < 1 and RR50 < 2). However, analysis 
of the slope of the dose response curve showed that the populations of insects i
n the towns of Firminópolis/GO, Posse/GO, Poxoréu/MT, Douradina/MS and Aparecida
 do Taboado/MS present great probability of evolving resistance and, thus, are m
ore likely to tolerate treatment with deltamethrin. CONCLUSIONS: Small changes i
n susceptibility and low levels of resistance were detected, but the temporal ch
anges of susceptibility should be continuously monitored to adequately guide the
 actions of vector-control of DC.#^dnd^i2#^tm^len^kTriatominae^i2#^tm^len^kResis
tance^i2#^tm^len^kInsecticide^i2#^tm^len^kDeltamethrin^i2#^tm^len^kTriatoma sord
ida^i2#other#24#20100729#29/07/2010#20101002#21/10/2010#aop01-11.htm##
04776000000000781000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201810
01860120158003670100033005250100045005580100037006030100039006400100031006790100
03300710010003500743010003700778070010900815070009400924070010301018070008301121
07000440120407001190124807000860136707001050145308310790155808500080263708500250
26450850024026700850024026940850025027180850036027430831006027790850008037850850
03103793085002303824085002403847085002503871085003603896117000603932072000303938
112000903941111001103950114000903961113001103970002001303981#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#f#3#1#article#1#tr#pt#br1.1#1#4.
0#GRA#TAB#04#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20
110318#<b>Monitoramento da suscetibilidade de populações de <i>Triatoma sordida<
/i> Stål, 1859 (Hemiptera: Reduviidae) ao inseticida deltametrina, na região Cen
tro-Oeste do Brasil</b>^lpt#<b>Monitoring the susceptibility of <i>Triatoma sord
ida</i> Stål, 1859 (Hemiptera: Reduviidae) to deltamethrin insecticide, in Centr
al-Western Brazil</b>^len#^rND^1A01^nMarcos Takashi^sObara#^rND^1A02^nVanessa Ca
margo Garbeloto^sOtrera#^rND^1A03^nRodrigo Gurgel^sGonçalves#^rND^1A04^nJanduhy 
Pereira dos^sSantos#^rND^1A05^nMarcelo^sSantalucia#^rND^1A06^nJoão Aristeu da^sR
osa#^rND^1A07^nPaulo Silva de^sAlmeida#^rND^1A08^nJosé Maria Soares^sBarata#Mini
stério da Saúde^iA01^1Secretaria de Vigilância em Saúde^2Laboratório de Entomolo
gia Médica^cBrasília^sDF#Superintendência de Controle de Endemias^iA02^1Laborató
rio do Núcleo de Pesquisa^cMarília^sSP#Universidade de Brasília^iA03^1Laboratóri
o de Parasitologia Médica e Biologia de Vetores^cBrasília^sDF#Núcleo de Geoproce
ssamento^iA04^1Departamento de Estradas de Rodagem^cBrasília^sDF#Secretaria de E
stado da Saúde de Goiás^iA05#Universidade Estadual Paulista^iA06^1Faculdade de C
iências Farmacêuticas^2Laboratório de Parasitologia^cAraraquara^sSP#Secretaria d
e Estado de Saúde^iA07^1Laboratório Regional de Entomologia^cDourados^sMS#Univer
sidade de São Paulo^iA08^1Faculdade de Saúde Pública^2Departamento de Epidemiolo
gia^cSão Paulo^sSP#^lpt^a<b>INTRODUÇÃO:</b> Populações de <i>Triatoma sordida</i
> Stål, 1859 foram investigadas quanto à suscetibilidade à deltametrina. <b>MÉTO
DOS: </b>Análise por meio de bioensaios por aplicação tópica em 11 populações de
 <i>T. sordida</i> procedentes dos Estados de Goiás, Mato Grosso e Mato Grosso d
o Sul. <b>RESULTADOS: </b>As estimativas de DL<sub>50</sub> e RR<sub>50</sub> de
monstraram elevados níveis de suscetibilidade (DL<sub>50</sub> &lt; 1 e RR<sub>5
0</sub> &lt; 2). Entretanto, as análises do coeficiente angular da curva dose re
sposta revelaram que as populações de triatomíneos dos municípios de Firminópoli
s/GO, Posse/GO, Poxoréu/MT, Douradina/MS e Aparecida do Taboado/MS apresentam ma
iores probabilidades de evolução de resistência, portanto, mais propícias a tole
rar o tratamento com deltametrina. <b>CONCLUSÕES:</b> Detectaram-se pequenas alt
erações de suscetibilidade e baixos níveis de resistência, porém as alterações t
emporais de suscetibilidade deverão ser continuamente monitoradas, a fim de nort
ear adequadamente as ações de controle dos vetores da DC.#^dnd^i1#^tm^lpt^kTriat
omíneos^i1#^tm^lpt^kResistência^i1#^tm^lpt^kInseticidas^i1#^tm^lpt^kDeltametrina
^i1#^tm^lpt^k<i>Triatoma sordida</i>^i1#^len^a<b>INTRODUCTION:</b> <i>Triatoma s
ordida</i> Stål, 1859 populations were investigated for susceptibility to deltam
ethrin. <b>METHODS:</b> This study aimed to analyze the resistance of 11 populat
ions of insects from the States of Goiás, Mato Grosso and Mato Grosso do Sul by 
topical application bioassays. <b>RESULTS:</b> The estimated LD<sub>50</sub> and
 RR<sub>50</sub> showed high levels of susceptibility (LD<sub>50</sub> &lt; 1 an
d RR<sub>50</sub> &lt; 2). However, analysis of the slope of the dose response c
urve showed that the populations of insects in the towns of Firminópolis/GO, Pos
se/GO, Poxoréu/MT, Douradina/MS and Aparecida do Taboado/MS present great probab
ility of evolving resistance and, thus, are more likely to tolerate treatment wi
th deltamethrin. <b>CONCLUSIONS:</b> Small changes in susceptibility and low lev
els of resistance were detected, but the temporal changes of susceptibility shou
ld be continuously monitored to adequately guide the actions of vector-control o
f DC.#^dnd^i2#^tm^len^k<i>Triatominae</i>^i2#^tm^len^kResistance^i2#^tm^len^kIns
ecticide^i2#^tm^len^kDeltamethrin^i2#^tm^len^k<i>Triatoma sordida</i>^i2#other#2
4#20100729#29/07/2010#20101002#21/10/2010#aop01-11.htm##
04685000000000805000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120167001920120144003590100033005030100045005360100037005810100039006180100
03100657010003300688010003500721010003700756070011100793070009600904070010501000
07000850110507000460119007001210123607000880135707001070144508309870155208500080
25390850025025470850024025720850024025960850025026200850029026450830921026740850
00803595085002403603085002303627085002403650085002503674085002903699117000603728
07200030373411200090373711100110374611400090375711300110376600200130377700800890
3790#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#l#4#1#ar
ticle#1#^a2011#tr#pt#br1.1#1#4.0#gra#tab#04#nd#nd#Rev. Soc. Bras. Med. Trop#ahea
d#20110000#^f0^l0#0037-8682#20110318#Monitoramento da suscetibilidade de populaç
ões de Triatoma sordida Stål, 1859 (Hemiptera: Reduviidae) ao inseticida deltame
trina, na região Centro-Oeste do Brasil^lpt#Monitoring the susceptibility of Tri
atoma sordida Stål, 1859 (Hemiptera: Reduviidae) to deltamethrin insecticide, in
 Central-Western Brazil^len#^rND^1A01^nMarcos Takashi^sObara#^rND^1A02^nVanessa 
Camargo Garbeloto^sOtrera#^rND^1A03^nRodrigo Gurgel^sGonçalves#^rND^1A04^nJanduh
y Pereira dos^sSantos#^rND^1A05^nMarcelo^sSantalucia#^rND^1A06^nJoão Aristeu da^
sRosa#^rND^1A07^nPaulo Silva de^sAlmeida#^rND^1A08^nJosé Maria Soares^sBarata#^i
A01^1Ministério da Saúde^2Secretaria de Vigilância em Saúde^3Laboratório de Ento
mologia Médica^cBrasília^sDF#^iA02^1Superintendência de Controle de Endemias^2La
boratório do Núcleo de Pesquisa^cMarília^sSP#^iA03^1Universidade de Brasília^2La
boratório de Parasitologia Médica e Biologia de Vetores^cBrasília^sDF#^iA04^1Núc
leo de Geoprocessamento^2Departamento de Estradas de Rodagem^cBrasília^sDF#^iA05
^1Secretaria de Estado da Saúde de Goiás#^iA06^1Universidade Estadual Paulista^2
Faculdade de Ciências Farmacêuticas^3Laboratório de Parasitologia^cAraraquara^sS
P#^iA07^1Secretaria de Estado de Saúde^2Laboratório Regional de Entomologia^cDou
rados^sMS#^iA08^1Universidade de São Paulo^2Faculdade de Saúde Pública^3Departam
ento de Epidemiologia^cSão Paulo^sSP#^lpt^aINTRODUÇÃO: Populações de Triatoma so
rdida Stål, 1859 foram investigadas quanto à suscetibilidade à deltametrina. MÉT
ODOS: Análise por meio de bioensaios por aplicação tópica em 11 populações de T.
 sordida procedentes dos Estados de Goiás, Mato Grosso e Mato Grosso do Sul. RES
ULTADOS: As estimativas de DL50 e RR50 demonstraram elevados níveis de suscetibi
lidade (DL50 < 1 e RR50 < 2). Entretanto, as análises do coeficiente angular da 
curva dose resposta revelaram que as populações de triatomíneos dos municípios d
e Firminópolis/GO, Posse/GO, Poxoréu/MT, Douradina/MS e Aparecida do Taboado/MS 
apresentam maiores probabilidades de evolução de resistência, portanto, mais pro
pícias a tolerar o tratamento com deltametrina. CONCLUSÕES: Detectaram-se pequen
as alterações de suscetibilidade e baixos níveis de resistência, porém as altera
ções temporais de suscetibilidade deverão ser continuamente monitoradas, a fim d
e nortear adequadamente as ações de controle dos vetores da DC.#^dnd^i1#^tm^lpt^
kTriatomíneos^i1#^tm^lpt^kResistência^i1#^tm^lpt^kInseticidas^i1#^tm^lpt^kDeltam
etrina^i1#^tm^lpt^kTriatoma sordida^i1#^len^aINTRODUCTION: Triatoma sordida Stål
, 1859 populations were investigated for susceptibility to deltamethrin. METHODS
: This study aimed to analyze the resistance of 11 populations of insects from t
he States of Goiás, Mato Grosso and Mato Grosso do Sul by topical application bi
oassays. RESULTS: The estimated LD50 and RR50 showed high levels of susceptibili
ty (LD50 < 1 and RR50 < 2). However, analysis of the slope of the dose response 
curve showed that the populations of insects in the towns of Firminópolis/GO, Po
sse/GO, Poxoréu/MT, Douradina/MS and Aparecida do Taboado/MS present great proba
bility of evolving resistance and, thus, are more likely to tolerate treatment w
ith deltamethrin. CONCLUSIONS: Small changes in susceptibility and low levels of
 resistance were detected, but the temporal changes of susceptibility should be 
continuously monitored to adequately guide the actions of vector-control of DC.#
^dnd^i2#^tm^len^kTriatominae^i2#^tm^len^kResistance^i2#^tm^len^kInsecticide^i2#^
tm^len^kDeltamethrin^i2#^tm^len^kTriatoma sordida^i2#other#24#20100729#29/07/201
0#20101002#21/10/2010#aop01-11.htm#Internet^ihttp://www.scielo.br/scielo.php?scr
ipt=sci_arttext&pid=S0037-86822011005000004##
00521000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704027700085002001300362#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#5#1#article#169#<p><font s
ize="4" face="Verdana"><B><a name="tx"></a>Monitoramento da suscetibilidade de p
opula&ccedil;&otilde;es de <I>Triatoma sordida</I> St&aring;l, 1859 (Hemiptera: 
Reduviidae) ao inseticida deltametrina, na regi&atilde;o Centro&#45;Oeste do Bra
sil</B></font></p>     ^cY#aop01-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#6#2#article#169#<p>&nbsp;<
/p>     ^cY#aop01-11.htm##
00460000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704021600085002001300301#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#7#3#article#169#<p><font s
ize="3" face="Verdana"><b>Monitoring the susceptibility of <I>Triatoma sordida</
I> St&aring;l, 1859 (Hemiptera: Reduviidae) to deltamethrin insecticide, in Cent
ral&#45;Western Brazil</b></font></p>     ^cY#aop01-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#8#4#article#169#<p>&nbsp;<
/p>     ^cY#aop01-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#9#5#article#169#<p>&nbsp;<
/p>     ^cY#aop01-11.htm##
00632000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704038700086002001300473#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#10#6#article#169#<p><font 
size="2" face="Verdana"><b>Marcos Takashi Obara<SUP>I</SUP>; Vanessa Camargo Gar
beloto Otrera<SUP>II</SUP>; Rodrigo Gurgel Gon&ccedil;alves<SUP>III</SUP>; Jandu
hy Pereira dos Santos<SUP>IV</SUP>; Marcelo Santalucia<SUP>V</SUP>; Jo&atilde;o 
Aristeu da Rosa<SUP>VI</SUP>; Paulo Silva de Almeida<SUP>VII</SUP>; Jos&eacute; 
Maria Soares Barata<SUP>VIII</SUP></b></font></p>     ^cY#aop01-11.htm##
00449000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704020400086002001300290#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#11#7#article#169#<p><font 
size="2" face="Verdana"><sup>I</sup>Laborat&oacute;rio de Entomologia M&eacute;d
ica, Secretaria de Vigil&acirc;ncia em Sa&uacute;de, Minist&eacute;rio da Sa&uac
ute;de, Bras&iacute;lia, DF    ^cY#aop01-11.htm##
00388000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704014300086002001300229#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#12#8#article#169#<br>   <s
up>II</sup>Laborat&oacute;rio do N&uacute;cleo de Pesquisa, Superintend&ecirc;nc
ia de Controle de Endemias, Mar&iacute;lia, SP    ^cY#aop01-11.htm##
00399000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704015400086002001300240#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#13#9#article#169#<br>   <s
up>III</sup>Laborat&oacute;rio de Parasitologia M&eacute;dica e Biologia de Veto
res, Universidade de Bras&iacute;lia, Bras&iacute;lia, DF    ^cY#aop01-11.htm##
00365000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011900087002001300206#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#14#10#article#169#<br>   <
sup>IV</sup>Departamento de Estradas de Rodagem, N&uacute;cleo de Geoprocessamen
to, Bras&iacute;lia, DF    ^cY#aop01-11.htm##
00418000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017200087002001300259#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#15#11#article#169#<br>   <
sup>V</sup>Laborat&oacute;rio de Sa&uacute;de P&uacute;blica Dr. Giovanni Cysnei
ros, Secretaria de Estado da Sa&uacute;de de Goi&aacute;s, Goi&acirc;nia, GO    
^cY#aop01-11.htm##
00406000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704016000087002001300247#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#16#12#article#169#<br>   <
sup>VI</sup>Laborat&oacute;rio de Parasitologia, Faculdade de Ci&ecirc;ncias Far
mac&ecirc;uticas, Universidade Estadual Paulista, Araraquara, SP    ^cY#aop01-11
.htm##
00369000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704012300087002001300210#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#17#13#article#169#<br>   <
sup>VII</sup>Laborat&oacute;rio Regional de Entomologia, Secretaria de Estado de
 Sa&uacute;de, Dourados, MS    ^cY#aop01-11.htm##
00415000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704016900087002001300256#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#18#14#article#169#<br>   <
sup>VIII</sup>Departamento de Epidemiologia, Faculdade de Sa&uacute;de P&uacute;
blica, Universidade de S&atilde;o Paulo, S&atilde;o Paulo, SP</font></p>     ^cY
#aop01-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011300087002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#19#15#article#169#<p><font
 size="2" face="Verdana"><a href="#nt">Endere&ccedil;o para correspond&ecirc;nci
a</a></font></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#20#16#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#21#17#article#169#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop01-11.htm##
00312000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006600087002001300153#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#22#18#article#169#<p><font
 size="2" face="Verdana"><B>RESUMO</B></font></p>     ^cY#aop01-11.htm##
00462000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021600087002001300303#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#23#19#article#169#<p><font
 size="2" face="Verdana"><B>INTRODU&Ccedil;&Atilde;O:</B> Popula&ccedil;&otilde;
es de <I>Triatoma sordida</I> St&aring;l, 1859 foram investigadas quanto &agrave
; suscetibilidade &agrave; deltametrina.    ^cY#aop01-11.htm##
00489000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704024300087002001300330#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#24#20#article#169#<br>  <B
>M&Eacute;TODOS: </B>An&aacute;lise por meio de bioensaios por aplica&ccedil;&at
ilde;o t&oacute;pica em 11 popula&ccedil;&otilde;es de <I>T. sordida</I> procede
ntes dos Estados de Goi&aacute;s, Mato Grosso e Mato Grosso do Sul.    ^cY#aop01
-11.htm##
00850000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060400087002001300691#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#25#21#article#169#<br>  <B
>RESULTADOS: </B>As estimativas de DL<SUB>50</SUB> e RR<SUB>50</SUB> demonstrara
m elevados n&iacute;veis de suscetibilidade (DL<SUB>50</SUB> &lt; 1 e RR<SUB>50<
/SUB> &lt; 2). Entretanto, as an&aacute;lises do coeficiente angular da curva do
se resposta revelaram que as popula&ccedil;&otilde;es de triatom&iacute;neos dos
 munic&iacute;pios de Firmin&oacute;polis/GO, Posse/GO, Poxor&eacute;u/MT, Doura
dina/MS e Aparecida do Taboado/MS apresentam maiores probabilidades de evolu&cce
dil;&atilde;o de resist&ecirc;ncia, portanto, mais prop&iacute;cias a tolerar o 
tratamento com deltametrina.    ^cY#aop01-11.htm##
00615000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036900087002001300456#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#26#22#article#169#<br>  <B
>CONCLUS&Otilde;ES:</B> Detectaram&#45;se pequenas altera&ccedil;&otilde;es de s
uscetibilidade e baixos n&iacute;veis de resist&ecirc;ncia, por&eacute;m as alte
ra&ccedil;&otilde;es temporais de suscetibilidade dever&atilde;o ser continuamen
te monitoradas, a fim de nortear adequadamente as a&ccedil;&otilde;es de control
e dos vetores da DC. </font></p>     ^cY#aop01-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019400087002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#27#23#article#169#<p><font
 size="2" face="Verdana"><B>Palavras&#45;chaves:</B> Triatom&iacute;neos. Resist
&ecirc;ncia. Inseticidas. Deltametrina. <I>Triatoma sordida</I>.</font></p> <hr 
size="1" noshade>     ^cY#aop01-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006800087002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#28#24#article#169#<p><font
 size="2" face="Verdana"><B>ABSTRACT</B></font></p>     ^cY#aop01-11.htm##
00414000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704016800087002001300255#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#29#25#article#169#<p><font
 size="2" face="Verdana"><B>INTRODUCTION:</B> <I>Triatoma sordida</I> St&aring;l
, 1859 populations were investigated for susceptibility to deltamethrin.    ^cY#
aop01-11.htm##
00449000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020300087002001300290#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#30#26#article#169#<br>  <B
>METHODS:</B> This study aimed to analyze the resistance of 11 populations of in
sects from the States of Goi&aacute;s, Mato Grosso and Mato Grosso do Sul by top
ical application bioassays.    ^cY#aop01-11.htm##
00740000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049400087002001300581#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#31#27#article#169#<br>  <B
>RESULTS:</B> The estimated LD<SUB>50</SUB> and RR<SUB>50</SUB> showed high leve
ls of susceptibility (LD<SUB>50</SUB> &lt; 1 and RR<SUB>50</SUB> &lt; 2). Howeve
r, analysis of the slope of the dose response curve showed that the populations 
of insects in the towns of  Firmin&oacute;polis/GO, Posse/GO, Poxor&eacute;u/MT,
 Douradina/MS and Aparecida do Taboado/MS present great probability of evolving 
resistance and, thus, are more likely to tolerate treatment with deltamethrin.  
  ^cY#aop01-11.htm##
00505000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025900087002001300346#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#32#28#article#169#<br>  <B
>CONCLUSIONS:</B> Small changes in susceptibility and low levels of resistance w
ere detected, but the temporal changes of susceptibility should be continuously 
monitored to adequately guide the actions of vector&#45;control of DC. </font></
p>     ^cY#aop01-11.htm##
00421000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017500087002001300262#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#33#29#article#169#<p><font
 size="2" face="Verdana"><B>Keywords:</B> <I>Triatominae</I>. Resistance. Insect
icide. Deltamethrin. <I>Triatoma sordida.</I></font></p> <hr size="1" noshade>  
   ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#34#30#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#35#31#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00330000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008400087002001300171#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#36#32#article#169#<p><font
 size="3" face="Verdana"><b>INTRODU&Ccedil;&Atilde;O</b></font></p>     ^cY#aop0
1-11.htm##
00879000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063300087002001300720#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#37#33#article#169#<p><font
 size="2" face="Verdana"><I>Triatoma sordida</I> St&aring;l, 1859 destaca&#45;se
, atualmente, como a esp&eacute;cie de triatom&iacute;neo mais capturada no Bras
il, predominantemente, em ambiente peridomiciliar, sendo potencial vetor de <I>T
rypanosoma cruzi</I>, agente etiol&oacute;gico da doen&ccedil;a de Chagas (DC)<S
UP>1&#45;3</SUP>. Nesse ambiente, pode ser encontrado habitando ec&oacute;topos,
 tais como: montes de madeira e de telhas, cercas de madeira, galinheiros e chiq
ueiros<SUP>4,5</SUP>. Em ambiente natural, vive, preferencialmente, em cascas de
 &aacute;rvores secas ou mortas<SUP>6</SUP>. </font></p>     ^cY#aop01-11.htm##
00930000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068400087002001300771#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#38#34#article#169#<p><font
 size="2" face="Verdana">Em maio de 2006, <I>T. sordida</I> foi incriminado como
 potencial vetor respons&aacute;vel pela ocorr&ecirc;ncia de sete casos agudos d
e DC, dos quais dois pacientes evolu&iacute;ram para &oacute;bito, na cidade de 
Maca&uacute;bas, Estado da Bahia, Brasil. A investiga&ccedil;&atilde;o entomol&o
acute;gica detectou a presen&ccedil;a de col&ocirc;nia intradomiciliar na pia da
 cozinha. Nesse local, eram armazenados alimentos que, provavelmente, foram cont
aminados e ingeridos pelos moradores da resid&ecirc;ncia. Essas evid&ecirc;ncias
 indicaram que a infec&ccedil;&atilde;o ocorreu por meio de transmiss&atilde;o o
ral<SUP>7</SUP>.</font></p>     ^cY#aop01-11.htm##
00787000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054100087002001300628#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#39#35#article#169#<p><font
 size="2" face="Verdana">Devido &agrave; inexist&ecirc;ncia de uma vacina sufici
entemente segura e eficaz, como tamb&eacute;m de expectativa de melhoria da prog
ress&atilde;o cl&iacute;nica da doen&ccedil;a entre os portadores cr&ocirc;nicos
, a estrat&eacute;gia b&aacute;sica de controle da transmiss&atilde;o da DC depe
nde do combate aos vetores por meio de aplica&ccedil;&atilde;o peri&oacute;dica 
e sistem&aacute;tica de inseticidas de a&ccedil;&atilde;o residual, no intra e p
eridomic&iacute;lio<SUP>8</SUP>. </font></p>     ^cY#aop01-11.htm##
01021000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704077500087002001300862#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#40#36#article#169#<p><font
 size="2" face="Verdana">Originalmente, as a&ccedil;&otilde;es de controle de po
pula&ccedil;&otilde;es triatom&iacute;nicas eram realizadas com inseticidas orga
noclorados. Por&eacute;m, a partir de 1983, o Programa Nacional de Controle da D
oen&ccedil;a de Chagas (PNCD) instituiu, no Brasil, o uso de piretr&oacute;ides 
de s&iacute;ntese em larga escala<SUP>9,10</SUP>. Certamente, a expans&atilde;o 
do uso de inseticidas vem acompanhada pelas constantes quest&otilde;es sobre o p
otencial de evolu&ccedil;&atilde;o de resist&ecirc;ncia dos vetores da DC. Nos d
ias atuais, os conhecimentos existentes sobre o perfil de resist&ecirc;ncia de t
riatom&iacute;neos, al&eacute;m de esparsos, s&atilde;o em geral isolados e, em 
alguns casos, inexistentes.</font></p>     ^cY#aop01-11.htm##
00876000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063000087002001300717#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#41#37#article#169#<p><font
 size="2" face="Verdana">Os estudos de monitoramento de suscetibilidade de triat
om&iacute;neos realizados pelo Centro de Investigaciones en Plagas e Insecticida
s (CIPEIN), Buenos Aires, Argentina, t&ecirc;m detectado elevados n&iacute;veis 
de resist&ecirc;ncia aos piretr&oacute;ides deltametrina, </font><font>&#946;</f
ont><font size="2" face="verdana">&#45;cipermetrina e </font><font>&#946;</font>
<font size="2" face="verdana">&#45;ciflutrina em popula&ccedil;&otilde;es de <I>
Triatoma infestans</I> (Klug, 1834) procedentes do norte da Argentina, sul do Br
asil e Bol&iacute;via<SUP>11&#45;16</SUP>.</font></p>     ^cY#aop01-11.htm##
00641000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039500087002001300482#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#42#38#article#169#<p><font
 size="2" face="Verdana">Recentemente, no Brasil, avalia&ccedil;&otilde;es de su
scetibilidade de <I>T. sordida</I> registraram n&iacute;veis de resist&ecirc;nci
a incipiente a deltametrina em cinco popula&ccedil;&otilde;es procedentes dos mu
nic&iacute;pios de Presidente Juscelino, Bocai&uacute;va e Cora&ccedil;&atilde;o
 de Jesus, Estado de Minas Gerais<SUP>17</SUP>.</font></p>     ^cY#aop01-11.htm#
#
00735000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048900087002001300576#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#43#39#article#169#<p><font
 size="2" face="Verdana">A detec&ccedil;&atilde;o de altera&ccedil;&otilde;es na
 suscetibilidade de popula&ccedil;&otilde;es de <I>T. sordida </I>evidencia a ne
cessidade de novos estudos sobre os n&iacute;veis de toler&acirc;ncia aos inseti
cidas piretr&oacute;ides, as quais v&ecirc;m sendo utilizadas, pelo menos nos &u
acute;ltimos vinte anos, nas a&ccedil;&otilde;es de controle dos vetores da DC n
o Brasil e em diversas &aacute;reas da Am&eacute;rica Latina.</font></p>     ^cY
#aop01-11.htm##
00851000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060500087002001300692#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#44#40#article#169#<p><font
 size="2" face="Verdana">Nesse contexto, o objetivo desta pesquisa foi analisar 
os n&iacute;veis de suscetibilidade de popula&ccedil;&otilde;es de <I>T. sordida
 </I>procedentes da regi&atilde;o Centro&#45;Oeste do Brasil ao piretr&oacute;id
e deltametrina, a fim de fornecer par&acirc;metros sobre o perfil de resist&ecir
c;ncia desse vetor. Outro intuito foi subsidiar a implanta&ccedil;&atilde;o de p
rograma de monitoramento de resist&ecirc;ncia dos vetores da DC, imprescind&iacu
te;veis n&atilde;o s&oacute; para o Brasil, como tamb&eacute;m para toda a Am&ea
cute;rica Latina.</font></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#45#41#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00320000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007400087002001300161#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#46#42#article#169#<p><font
 size="3" face="Verdana"><b>M&Eacute;TODOS</b></font></p>     ^cY#aop01-11.htm##
00375000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704012900087002001300216#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#47#43#article#169#<p><font
 size="2" face="Verdana"><B>Triatom&iacute;neos para avalia&ccedil;&atilde;o de 
resist&ecirc;ncia</B></font></p>     ^cY#aop01-11.htm##
00756000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051000087002001300597#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#48#44#article#169#<p><font
 size="2" face="Verdana">As popula&ccedil;&otilde;es de triatom&iacute;neos fora
m obtidas a partir de amostras peridomiciliares procedentes dos Estados de Goi&a
acute;s, Mato Grosso e Mato Grosso do Sul. Os insetos foram capturados em &aacut
e;reas end&ecirc;micas tratadas com inseticidas, nas quais os programas estaduai
s de controle da doen&ccedil;a de Chagas realizam aplica&ccedil;&otilde;es cont&
iacute;nuas e sistem&aacute;ticas com inseticidas de a&ccedil;&atilde;o residual
. </font></p>     ^cY#aop01-11.htm##
00774000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052800087002001300615#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#49#45#article#169#<p><font
 size="2" face="Verdana">A sele&ccedil;&atilde;o dos munic&iacute;pios,  para as
 atividades de captura,  obedeceu aos seguintes crit&eacute;rios: I) a realiza&c
cedil;&atilde;o de um programa espec&iacute;fico de controle de vetores; II) ant
ecedentes hist&oacute;ricos de controle de outros vetores dentro da mesma &aacut
e;rea geogr&aacute;fica;    III) uso de inseticidas com finalidades agr&iacute;c
olas na mesma &aacute;rea,    onde se localiza os vetores e IV) uso dom&eacute;s
tico de inseticidas.</font></p>     ^cY#aop01-11.htm##
00420000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017400087002001300261#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#50#46#article#169#<p><font
 size="2" face="Verdana">Ap&oacute;s o recebimento, cada popula&ccedil;&atilde;o
 foi identificada por meio de chave dicot&ocirc;mica<SUP>18</SUP>.</font></p>   
  ^cY#aop01-11.htm##
00349000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010300087002001300190#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#51#47#article#169#<p><font
 size="2" face="Verdana"><B>Popula&ccedil;&atilde;o de refer&ecirc;ncia</B></fon
t></p>     ^cY#aop01-11.htm##
00958000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071200087002001300799#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#52#48#article#169#<p><font
 size="2" face="Verdana">Neste trabalho, foi selecionada uma popula&ccedil;&atil
de;o de refer&ecirc;ncia de <I>T. sordida</I>, cuja cria&ccedil;&atilde;o inicio
u&#45;se em 08/03/1982, no inset&aacute;rio do Departamento de Ci&ecirc;ncias Bi
ol&oacute;gicas da Faculdade de Ci&ecirc;ncias Farmac&ecirc;uticas (UNESP&#45;Ar
araquara), a partir de exemplares procedentes do munic&iacute;pio de Cordeiros, 
Estado da Bahia. Os crit&eacute;rios estabelecidos para selecionar a popula&cced
il;&atilde;o de refer&ecirc;ncia, para monitoramento de resist&ecirc;ncia de tri
atom&iacute;neos, est&atilde;o estabelecidos no protocolo da Organiza&ccedil;&at
ilde;o Mundial da Sa&uacute;de<SUP>19</SUP>.</font></p>     ^cY#aop01-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#53#49#article#169#<p><font
 size="2" face="Verdana"><B>Inseticida</B></font></p>     ^cY#aop01-11.htm##
00670000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042400087002001300511#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#54#50#article#169#<p><font
 size="2" face="Verdana">O inseticida utilizado nos bioensaios foi o piretr&oacu
te;ide deltametrina &#91;(S) &#45; </font><font>&#940;</font><font size="2" face
="verdana"> &#45; ciano &#45; 3 &#45; fenoxibenzil (1R) &#45; cis &#45; 3 &#45; 
(2,2 &#45; dibromovinil) &#45; 2,2 dimetil ciclopropano carboxilato&#93; com gra
u de pureza de 98,2%, concedido pela <I>Bayer<SUP>&reg;</SUP></I> (Brasil). </fo
nt></p>     ^cY#aop01-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#55#51#article#169#<p><font
 size="2" face="Verdana"><B>Bioensaios</B></font></p>     ^cY#aop01-11.htm##
01155000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090900087002001300996#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#56#52#article#169#<p><font
 size="2" face="Verdana">Foram utilizadas, no m&iacute;nimo cinco concentra&cced
il;&otilde;es iniciais do piretr&oacute;ide deltametrina para estimar as taxas d
e mortalidade entre 0 e 100%. Os ensaios biol&oacute;gicos consistiam na aplica&
ccedil;&atilde;o t&oacute;pica de 0,2</font><font>&#181;</font><font size="2" fa
ce="verdana">l de solu&ccedil;&atilde;o de deltametrina no dorso do abd&ocirc;me
n de ninfas de 1º est&aacute;dio entre cinco a sete dias de idade, em jejum. As 
aplica&ccedil;&otilde;es foram realizadas utilizando microsseringa de 10</font><
font>&#181;</font><font size="2" face="verdana">l, modelo 1701N provida de dispe
nsador com 50 repeti&ccedil;&otilde;es, modelo PB600&#45;1, ambos da <I>Halmilto
n<SUP>&reg;</SUP></I>. Nos insetos do grupo controle, foi aplicado o mesmo volum
e de acetona PA (CH<SUB>3</SUB>)<SUB>2</SUB>CO, da Vetec<I><SUP>&reg;</SUP></I>.
 </font></p>     ^cY#aop01-11.htm##
00782000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053600087002001300623#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#57#53#article#169#<p><font
 size="2" face="Verdana">Para cada concentra&ccedil;&atilde;o, foram utilizadas 
20 ninfas, assim o n&uacute;mero total de ninfas utilizadas foi de 100 por linha
gem. Tamb&eacute;m foram utilizadas doses intermedi&aacute;rias, a fim de aprimo
rar os resultados atingidos. As concentra&ccedil;&otilde;es finais de deltametri
na variaram de    0,1 a 3,5</font><font>&#181;</font><font size="2" face="verdan
a">g/mL. Todos os ensaios foram repetidos em laborat&oacute;rio, pelo menos cinc
o vezes, em diferentes dias.</font></p>     ^cY#aop01-11.htm##
00738000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049200087002001300579#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#58#54#article#169#<p><font
 size="2" face="Verdana">As aplica&ccedil;&otilde;es t&oacute;picas foram execut
adas por um &uacute;nico pesquisador, sob microsc&oacute;pio estereosc&oacute;pi
co Leica<SUP>&reg;</SUP> (Zoom 2000), em amplia&ccedil;&atilde;o de 10,5X para a
umentar a confiabilidade na distribui&ccedil;&atilde;o do inseticida. Os ensaios
 biol&oacute;gicos de material capturado em campo foram realizados com ninfas ob
tidas da primeira e segunda gera&ccedil;&atilde;o    (F1 e F2). </font></p>     
^cY#aop01-11.htm##
00976000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704073000087002001300817#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#59#55#article#169#<p><font
 size="2" face="Verdana">A taxa de mortalidade foi observada ap&oacute;s 24h de 
exposi&ccedil;&atilde;o do inseticida, por uma &uacute;nica pessoa. As ninfas qu
e atingiram a borda do disco, no per&iacute;odo de at&eacute; 50 segundos, sem a
ltera&ccedil;&atilde;o nos movimentos de locomo&ccedil;&atilde;o foram considera
das vivas (normais). Por outro lado, os insetos foram considerados mortos (intox
icados) quando n&atilde;o apresentaram atividade locomotora pr&oacute;pria, ou s
eja, fortes sintomas de desequil&iacute;brio ou totalmente incapazes de andar so
zinhos, do centro at&eacute; a borda de um disco de papel, quando estimulados co
m a ponta da pin&ccedil;a, durante esse mesmo per&iacute;odo. </font></p>     ^c
Y#aop01-11.htm##
00339000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009300087002001300180#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#60#56#article#169#<p><font
 size="2" face="Verdana"><B>An&aacute;lise estat&iacute;stica</B></font></p>    
 ^cY#aop01-11.htm##
00789000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054300087002001300630#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#61#57#article#169#<p><font
 size="2" face="Verdana">Os dados de mortalidade das popula&ccedil;&otilde;es de
 <I>T. sordida</I> foram utilizados para estimar a concentra&ccedil;&atilde;o qu
e mata 50% (DL<SUB>50</SUB>) e 95% (DL<SUB>95</SUB>) das amostras estudadas. O c
&aacute;lculo da DL<SUB>50</SUB> e DL<SUB>95</SUB> de cada popula&ccedil;&atilde
;o foi baseado na an&aacute;lise <I>Probit</I><SUP>20</SUP> e foi realizado pelo
 programa <I>Basic Probit Analisys</I>. As doses letais foram expressas em nanog
rama por ninfa inseto (ng/inseto). </font></p>     ^cY#aop01-11.htm##
00933000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068700087002001300774#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#62#58#article#169#<p><font
 size="2" face="Verdana">As estimativas de varia&ccedil;&atilde;o das DL<SUB>50<
/SUB> e DL<SUB>95</SUB> entre as popula&ccedil;&otilde;es foram comparadas por a
n&aacute;lise de vari&acirc;ncia (Kruskal&#45;Wallis, H) e por testes de Mann&#4
5;Whitney. Na an&aacute;lise de vari&acirc;ncia, os resultados dos bioensaios fo
ram testados quanto &agrave; hip&oacute;tese de nulidade de que as estimativas d
e DL<SUB>50</SUB> e DL<SUB>95</SUB> de cada popula&ccedil;&atilde;o eram iguais 
contra a hip&oacute;tese alternativa de que pelo menos uma das m&eacute;dias de 
cada par&acirc;metro era diferente, estabelecendo&#45;se o n&iacute;vel de signi
fic&acirc;ncia 5%. </font></p>     ^cY#aop01-11.htm##
00516000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027000087002001300357#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#63#59#article#169#<p><font
 size="2" face="Verdana">O teste Mann&#45;Whitney foi aplicado para calcular os 
n&iacute;veis de signific&acirc;ncia descritivos para diferen&ccedil;as de DL<SU
B>50</SUB> e DL<SUB>95</SUB>, entre pares sucessivos das m&eacute;dias estudadas
. </font></p>     ^cY#aop01-11.htm##
00968000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072200087002001300809#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#64#60#article#169#<p><font
 size="2" face="Verdana">As RR<SUB>50</SUB> e RR<SUB>95</SUB> foram obtidas por 
meio do quociente da DL<SUB>50 </SUB>da popula&ccedil;&atilde;o de campo, pela D
L<SUB>50 </SUB>da linhagem suscept&iacute;vel. O intervalo de confian&ccedil;a d
e 95% (IC 95%) de cada popula&ccedil;&atilde;o foi calculado e comparado com a p
opula&ccedil;&atilde;o de refer&ecirc;ncia usando o programa Polo PC<SUP>21</SUP
>. Os valores da RR<SUB>50</SUB> e RR<SUB>95</SUB> foram considerados significan
temente diferentes quando n&atilde;o houve sobreposi&ccedil;&atilde;o dos limite
s dos intervalos de confian&ccedil;a, no n&iacute;vel de 95% da popula&ccedil;&a
tilde;o de refer&ecirc;ncia com as amostras de campo. </font></p>     ^cY#aop01-
11.htm##
00830000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058400087002001300671#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#65#61#article#169#<p><font
 size="2" face="Verdana">Ainda, o coeficiente angular da curva dose resposta foi
 caracterizado para cada popula&ccedil;&atilde;o. Esse par&acirc;metro represent
a a varia&ccedil;&atilde;o de homogeneidade da popula&ccedil;&atilde;o e indica 
a progress&atilde;o de resist&ecirc;ncia e varia&ccedil;&atilde;o genot&iacute;p
ica na toler&acirc;ncia a um inseticida. Os menores valores do coeficiente angul
ar da curva indicam popula&ccedil;&otilde;es menos homog&ecirc;neas, consequente
mente com maior probabilidade de sele&ccedil;&atilde;o de resist&ecirc;ncia.</fo
nt></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#66#62#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#67#63#article#169#<p><font
 size="3" face="Verdana"><b>RESULTADOS</b></font></p>     ^cY#aop01-11.htm##
01031000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704078500087002001300872#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#68#64#article#169#<p><font
 size="2" face="Verdana">A suscetibilidade para deltametrina de onze popula&cced
il;&otilde;es de <I>T. sordida</I> procedentes de diferentes munic&iacute;pios d
a regi&atilde;o central do brasil foi avaliada e comparada com a popula&ccedil;&
atilde;o de refer&ecirc;ncia (TsREF). As estimativas de DL<SUB>50</SUB> e DL<SUB
>95 </SUB>da popula&ccedil;&atilde;o de refer&ecirc;ncia (TsREF) foram de 0,58ng
/inseto e 1,35ng/inseto, respectivamente. Nas estimativas de DL<SUB>50</SUB> e D
L<SUB>95</SUB> das popula&ccedil;&otilde;es de campo observaram&#45;se varia&cce
dil;&otilde;es entre 0,61 a 0,86ng/inseto para os valores DL<SUB>50 </SUB>e 1,61
    a 3,20ng/inseto para DL<SUB>95 </SUB><B>(<a href="/img/revistas/rsbmt/2011na
head/a01tab01.jpg">Tabela 1</a>)</B>.</font></p>     ^cY#aop01-11.htm##
01260000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704101400087002001301101#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#69#65#article#169#<p><font
 size="2" face="Verdana">A an&aacute;lise de vari&acirc;ncia detectou diferen&cc
edil;a estatisticamente significativa da DL<SUB>50</SUB> (H<SUB>11,64</SUB> = 34
,88; p &lt; 0,01) e DL<SUB>95 </SUB>(H<SUB>11,64</SUB> = 38,03; p &lt; 0,01) ent
re as popula&ccedil;&otilde;es analisadas. Quanto &agrave;s estimativas de DL<SU
B>50</SUB>, pode se observar que as popula&ccedil;&otilde;es de triatom&iacute;n
eos dos munic&iacute;pios de Guarani do Goi&aacute;s/GO (TsG), Aparecida do Tabo
ado/MS (TsA), Douradina/MS (TsD) e Posse/GO (TsPs) apresentaram diferen&ccedil;a
s significativas com a popula&ccedil;&atilde;o de refer&ecirc;ncia (TsREF), conf
orme mostra a <B><a href="#fig01">Figura 1</a></B>. Esses resultados indicam que
 essas popula&ccedil;&otilde;es exibiram menor suscetibilidade em rela&ccedil;&a
tilde;o &agrave; popula&ccedil;&atilde;o de refer&ecirc;ncia e podem tolerar mai
ores doses de deltametrina. Resultados semelhantes foram obtidos comparando os v
alores de DL<SUB>95</SUB>.</font></p>     ^cY#aop01-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#70#66#article#169#<p><a na
me="fig01"></a></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#71#67#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#72#68#article#169#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a01fig01.jpg"></p>     ^cY#ao
p01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#73#69#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
01283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704103700087002001301124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#74#70#article#169#<p><font
 size="2" face="Verdana">Os resultados estimados para RR<SUB>50</SUB> confirmara
m as diferen&ccedil;as de DL<SUB>50</SUB> e DL<SUB>95 </SUB>das amostras estudad
as. As popula&ccedil;&otilde;es dos munic&iacute;pios de Guarani do Goi&aacute;s
/GO (TsG), Aparecida do Taboado/MS (TsA), Douradina/MS (TsD) e Posse/GO (TsPs), 
tamb&eacute;m, apresentaram diferen&ccedil;as significativas na RR<SUB>50</SUB>,
 quando os limites de confian&ccedil;a foram sobrepostos ao n&iacute;vel de 95% 
<B>(<a href="/img/revistas/rsbmt/2011nahead/a01tab01.jpg">Tabela 1</a>)</B>. Em 
rela&ccedil;&atilde;o a RR<SUB>95</SUB>, as popula&ccedil;&otilde;es de triatom&
iacute;neos que apresentaram diferen&ccedil;as significativas com a popula&ccedi
l;&atilde;o de refer&ecirc;ncia pertencem aos munic&iacute;pios de Aparecida do 
Taboado/MS (TsA), Posse/GO (TsPs) e Douradina/MS (TsD). Apesar das diferen&ccedi
l;as significativas, os resultados obtidos indicaram baixos n&iacute;veis de res
ist&ecirc;ncia, em todas as amostras analisadas. </font></p>     ^cY#aop01-11.ht
m##
00940000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704069400087002001300781#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#75#71#article#169#<p><font
 size="2" face="Verdana">Conforme mostram as <B><a href="#fig02">Figuras 2A</a> 
e <a href="#fig02">2B</a>, </B>as popula&ccedil;&otilde;es com menores taxas de 
varia&ccedil;&atilde;o na homogeneidade foram oriundas dos munic&iacute;pios de 
Guarani de Goi&aacute;s/GO (TsG) e S&atilde;o Luis dos Montes Belos/GO (TsSL). E
ntretanto, as popula&ccedil;&otilde;es de triatom&iacute;neos dos munic&iacute;p
ios de Firmin&oacute;polis/GO (TsF), e Posse/GO (TsPs), mostradas nas <B><a href
="#fig02">Figuras 2C</a> e <a href="#fig02">2D</a> </B>foram consideradas mais h
eterog&ecirc;neas e com maiores chances de tolerar a press&atilde;o de tratament
o com piretr&oacute;ides. </font></p>     ^cY#aop01-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#76#72#article#169#<p><a na
me="fig02"></a></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#77#73#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#78#74#article#169#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a01fig02.jpg"></p>     ^cY#ao
p01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#79#75#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00955000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070900087002001300796#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#80#76#article#169#<p><font
 size="2" face="Verdana">Como se pode ver na <B><a href="#fig03">Figura 3A</a>,<
/B> a popula&ccedil;&atilde;o de S&atilde;o Jos&eacute; do Povo/MT (TsSJ) mostro
u uma varia&ccedil;&atilde;o de inclina&ccedil;&atilde;o da reta no gr&aacute;fi
co muito pr&oacute;xima &agrave; popula&ccedil;&atilde;o de refer&ecirc;ncia, ao
 contr&aacute;rio da popula&ccedil;&atilde;o de <I>T. sordida</I> do munic&iacut
e;pio de Poxor&eacute;u/MT (TsPx), mostrada na <B><a href="#fig03">Figura 3B</a>
</B>, que apresentou um valor do coeficiente angular menor que a popula&ccedil;&
atilde;o de refer&ecirc;ncia, consequentemente possui maior probabilidade de evo
lu&ccedil;&atilde;o de resist&ecirc;ncia.</font></p>     ^cY#aop01-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#81#77#article#169#<p><a na
me="fig03"></a></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#82#78#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#83#79#article#169#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a01fig03.jpg"></p>     ^cY#ao
p01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#84#80#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00663000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041700087002001300504#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#85#81#article#169#<p><font
 size="2" face="Verdana">Nas popula&ccedil;&otilde;es de triatom&iacute;neos pro
cedentes dos munic&iacute;pios de Campo Grande/MS (TsC), Terenos/MS (TsT) e Roch
edo/MS (TsR), mostradas nas<B> <a href="#fig04">Figuras 4 A</a>, <a href="#fig04
">B</a> e <a href="#fig04">C</a>,</B> foram observados padr&otilde;es de coefici
ente angular similares a popula&ccedil;&atilde;o de refer&ecirc;ncia.</font></p>
     ^cY#aop01-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#86#82#article#169#<p><a na
me="fig04"></a></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#87#83#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#88#84#article#169#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a01fig04.jpg"></p>     ^cY#ao
p01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#89#85#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00838000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059200087002001300679#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#90#86#article#169#<p><font
 size="2" face="Verdana">Todavia, os valores do coeficiente angular das popula&c
cedil;&otilde;es de triatom&iacute;neos dos munic&iacute;pios de Douradina/MS (T
sD) e Aparecida do Taboado/MS (TsA), mostrados nas <B><a href="#fig04">Figuras 4
D</a> e <a href="#fig04">4E</a>,</B> quando comparados &agrave; popula&ccedil;&a
tilde;o de refer&ecirc;ncia, apontaram menor homogeneidade e maior frequ&ecirc;n
cia de indiv&iacute;duos com alelos de resist&ecirc;ncia, os quais podem ser sel
ecionados futuramente, mediante forte press&atilde;o de inseticidas qu&iacute;mi
cos.</font></p>     ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#91#87#article#169#<p>&nbsp
;</p>     ^cY#aop01-11.htm##
00322000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007600087002001300163#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#92#88#article#169#<p><font
 size="3" face="Verdana"><b>DISCUSS&Atilde;O</b></font></p>     ^cY#aop01-11.htm
##
00716000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047000087002001300557#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#93#89#article#169#<p><font
 size="2" face="Verdana">Os par&acirc;metros de RR <u>&lt;</u> 5 para monitorame
nto de resist&ecirc;ncia de triatom&iacute;neos consideram que as diferen&ccedil
;as de suscetibilidade s&atilde;o produzidas por varia&ccedil;&otilde;es individ
uais, ou seja, a resist&ecirc;ncia n&atilde;o est&aacute; estabelecida, portanto
 as a&ccedil;&otilde;es de controle devem prosseguir com o mesmo inseticida que 
est&aacute; sendo utilizado<SUP>22</SUP>. </font></p>     ^cY#aop01-11.htm##
01138000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089200087002001300979#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#94#90#article#169#<p><font
 size="2" face="Verdana">De acordo com Pessoa<SUP>17</SUP>, no Estado de Minas G
erais, h&aacute; registros de cinco popula&ccedil;&otilde;es de <I>T. sordida</I
> com n&iacute;veis de resist&ecirc;ncia incipiente para deltametrina que demons
traram    RR<SUB>50</SUB> <u>&gt;</u> 5: I) munic&iacute;pio de Cora&ccedil;&ati
lde;o de Jesus, Fazenda Domingada (RR<SUB>50</SUB>=5,4); II) munic&iacute;pio de
 Cora&ccedil;&atilde;o de Jesus, Fazenda Barriguda    (RR<SUB>50</SUB>= 6,8); II
I) munic&iacute;pio de Bocai&uacute;va, Fazenda Chaves (RR<SUB>50</SUB>=5,8); IV
) munic&iacute;pio de Bocai&uacute;va, Fazenda F&eacute;lix I (RR<SUB>50</SUB>= 
6,2); V) munic&iacute;pio de Presidente Juscelino (RR<SUB>50</SUB>= 5,5). Esse a
utor obteve um valor de DL<SUB>50</SUB> igual a 0,065ng i. a./ninfa para a popul
a&ccedil;&atilde;o de refer&ecirc;ncia procedente de Uberaba/MG.</font></p>     
^cY#aop01-11.htm##
00615000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036900087002001300456#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#95#91#article#169#<p><font
 size="2" face="Verdana">Por outro lado, os resultados deste trabalho apontaram 
para a DL<SUB>50</SUB> maior, cujo valor foi de 0,58ng/inseto. A popula&ccedil;&
atilde;o de refer&ecirc;ncia demonstrou baixo n&iacute;vel de suscetibilidade, p
odendo ser considerada, at&eacute; mesmo resistente, quando comparada com a util
izada por esse autor.</font></p>     ^cY#aop01-11.htm##
00734000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048800087002001300575#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#96#92#article#169#<p><font
 size="2" face="Verdana">Ressalta&#45;se que os par&acirc;metros de RR s&atilde;
o calculados a partir dos valores da DL<SUB>50</SUB> da popula&ccedil;&atilde;o 
de refer&ecirc;ncia, consequentemente a variabilidade desses valores poder&aacut
e; interferir nos resultados de monitoramento e nas tomadas de decis&otilde;es f
eitas pelo Programa Nacional de Controle da Doen&ccedil;a de Chagas para o manej
o de inseticidas, caso haja resist&ecirc;ncia estabelecida. </font></p>     ^cY#
aop01-11.htm##
00726000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048000087002001300567#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#97#93#article#169#<p><font
 size="2" face="Verdana">Por exemplo, nos resultados obtidos, neste trabalho, to
das as popula&ccedil;&otilde;es foram classificadas como suscet&iacute;veis, con
forme crit&eacute;rios estabelecidos pela Organiza&ccedil;&atilde;o Pan&#45;Amer
icana de Sa&uacute;de<SUP>22</SUP>. Os valores de RR<SUB>50</SUB> foram menores 
que dois, utilizando a popula&ccedil;&atilde;o de refer&ecirc;ncia de <I>T. sord
ida</I> (TsREF) com DL<SUB>50 </SUB>= 0,58ng/inseto.</font></p>     ^cY#aop01-11
.htm##
00602000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035600087002001300443#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#98#94#article#169#<p><font
 size="2" face="Verdana">Contudo, com utiliza&ccedil;&atilde;o da linhagem susce
t&iacute;vel de Pessoa<SUP>17</SUP>, cujo valor foi de DL<SUB>50 </SUB>= 0,065ng
 i.a./ninfa as amostras seriam classificadas como resistentes, inclusive com rec
omenda&ccedil;&otilde;es de troca de inseticidas para algumas popula&ccedil;&oti
lde;es. </font></p>     ^cY#aop01-11.htm##
00666000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042000087002001300507#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#99#95#article#169#<p><font
 size="2" face="Verdana">A utiliza&ccedil;&atilde;o de duas ou mais popula&ccedi
l;&otilde;es de refer&ecirc;ncia dificulta a interpreta&ccedil;&atilde;o dos lim
iares de RR. Para evitar poss&iacute;veis erros na an&aacute;lise dos dados, sug
ere&#45;se a padroniza&ccedil;&atilde;o de popula&ccedil;&atilde;o de refer&ecir
c;ncia para o monitoramento de resist&ecirc;ncia de triatom&iacute;neos.</font><
/p>     ^cY#aop01-11.htm##
00705000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704045800088002001300546#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#100#96#article#169#<p><fon
t size="2" face="Verdana">Neste trabalho, a popula&ccedil;&atilde;o utilizada co
mo linhagem de refer&ecirc;ncia (TsREF), foi obtida no in&iacute;cio da d&eacute
;cada de 80. Assim, muito embora, ela tenha se originado de ambiente nunca expos
to ao tratamento de inseticidas, a popula&ccedil;&atilde;o fundadora dessa popul
a&ccedil;&atilde;o pode ter chegado ao laborat&oacute;rio com presen&ccedil;a de
 indiv&iacute;duos resistentes.</font></p>     ^cY#aop01-11.htm##
00849000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704060200088002001300690#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#101#97#article#169#<p><fon
t size="2" face="Verdana">Para este trabalho, utilizou&#45;se popula&ccedil;&ati
lde;o de refer&ecirc;ncia procedente do munic&iacute;pio de Cordeiros, no Estado
 da Bahia. No passado, essa &aacute;rea pode ter sido submetida &agrave; forte p
ress&atilde;o de diferentes classes de inseticidas, principalmente para o contro
le de <I>T. infestans</I>, assim como de outros insetos transmissores de doen&cc
edil;a ao homem. Nesse contexto, ressalta&#45;se que a nossa linhagem de refer&e
circ;ncia, talvez tenha sido isolada j&aacute; com alguns ind&iacute;cios de res
ist&ecirc;ncia.</font></p>     ^cY#aop01-11.htm##
00956000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704070900088002001300797#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#102#98#article#169#<p><fon
t size="2" face="Verdana">Em resumo, as estimativas das raz&otilde;es de resist&
ecirc;ncia atribu&iacute;das para as onze popula&ccedil;&otilde;es de campo de <
I>T. sordida</I> apontaram elevadas taxas de mortalidade. Os resultados foram si
milares aqueles verificados para popula&ccedil;&otilde;es de <I>T. infestans</I>
 procedentes dos munic&iacute;pios de Doutor Maur&iacute;cio Cardoso (RR<SUB>50 
</SUB>= 0,72), Guarani das Miss&otilde;es    (RR<SUB>50 </SUB>= 0,97), Mato Quei
mado (RR<SUB>50 </SUB>= 1,47) e Tr&ecirc;s de Maio (RR<SUB>50 </SUB>= 1,86), Est
ado do Rio Grande do Sul, Brasil, as quais foram caracterizadas como sendo susce
t&iacute;veis a deltametrina<SUP>23</SUP>.</font></p>     ^cY#aop01-11.htm##
00575000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704032800088002001300416#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#103#99#article#169#<p><fon
t size="2" face="Verdana">No Brasil, o sucesso das campanhas de controle contra 
o principal vetor da DC, <I>T. infestans</I>, culminaram na certifica&ccedil;&at
ilde;o internacional de elimina&ccedil;&atilde;o da transmiss&atilde;o da doen&c
cedil;a de Chagas pelo <I>T. infestans</I>, em junho de 2006.</font></p>     ^cY
#aop01-11.htm##
00600000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704035200089002001300441#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#104#100#article#169#<p><fo
nt size="2" face="Verdana">A aplica&ccedil;&atilde;o de inseticidas visando &agr
ave; elimina&ccedil;&atilde;o de popula&ccedil;&otilde;es intradomiciliares e pe
ridomiciliares de <I>T. infestans</I>, aparentemente, tem ocasionado grande impa
cto no controle de popula&ccedil;&otilde;es sinantr&oacute;picas de <I>T. sordid
a</I>.</font></p>     ^cY#aop01-11.htm##
00800000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704055200089002001300641#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#105#101#article#169#<p><fo
nt size="2" face="Verdana">Recentemente, os estudos de biologia molecular com <I
>T. sordida</I> de &aacute;reas do cerrado (munic&iacute;pios de Espinosa e Mamo
nas), da Caatinga (munic&iacute;pio de Janu&aacute;ria) e da Floresta do Paran&a
acute; (munic&iacute;pio de Corinto) mostraram baixos n&iacute;veis de varia&cce
dil;&atilde;o gen&eacute;tica em popula&ccedil;&otilde;es peridom&eacute;sticas,
 o que poderia favorecer o modo de a&ccedil;&atilde;o dos inseticidas utilizados
 nas campanhas de controle da DC<SUP>24</SUP>.</font></p>     ^cY#aop01-11.htm##
00874000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704062600089002001300715#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#106#102#article#169#<p><fo
nt size="2" face="Verdana">As cinco popula&ccedil;&otilde;es de triatom&iacute;n
eos dos munic&iacute;pios de Firmin&oacute;polis/GO (TsF), Posse/GO (TsPs), Poxo
r&eacute;u/MT (TsPx), Douradina/MS (TsD) e Aparecida do Taboado/MS (TsA) apresen
taram maior probabilidade de evolu&ccedil;&atilde;o de resist&ecirc;ncia quando 
comparadas com a popula&ccedil;&atilde;o de refer&ecirc;ncia (TsREF). Dessa mane
ira, as altera&ccedil;&otilde;es temporais de suscetibilidade dever&atilde;o ser
 rigorosas e, continuamente, acompanhadas para orientar adequadamente o planejam
ento das estrat&eacute;gias de controle.</font></p>     ^cY#aop01-11.htm##
01173000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704092500089002001301014#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#107#103#article#169#<p><fo
nt size="2" face="Verdana">Conclui&#45;se que o monitoramento de resist&ecirc;nc
ia de popula&ccedil;&otilde;es nativas de <I>T. sordida</I> foi capaz de detecta
r pequenas altera&ccedil;&otilde;es de resposta na taxa de suscetibilidade a del
tametrina demonstrando baixos n&iacute;veis de resist&ecirc;ncia (RR<SUB>50 </SU
B>&lt; 2), nos onze munic&iacute;pios de 3 estados avaliados. Recomenda&#45;se a
 defini&ccedil;&atilde;o de uma &uacute;nica popula&ccedil;&atilde;o de refer&ec
irc;ncia de suscetibilidade para <I>T. sordida</I> e outras esp&eacute;cies a se
rem estudadas, assim como a ades&atilde;o de outros laborat&oacute;rios com infr
aestrutura e capacidade t&eacute;cnico&#45;cient&iacute;fica adequada para execu
tar os bioensaios biol&oacute;gicos e bioqu&iacute;micos, fornecendo subs&iacute
;dios para um melhor entendimento dos mecanismos de resist&ecirc;ncia e sua evol
u&ccedil;&atilde;o.</font></p>     ^cY#aop01-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#108#104#article#169#<p>&nb
sp;</p>     ^cY#aop01-11.htm##
00322000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007400089002001300163#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#109#105#article#169#<p><fo
nt size="3" face="Verdana"><b>AGRADECIMENTOS</b></font></p>     ^cY#aop01-11.htm
##
01158000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704091000089002001300999#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#110#106#article#169#<p><fo
nt size="2" face="Verdana">&Agrave; Drª. Claudia Vassena, do Centro de Investiga
ciones en Plagas e Insecticidas, Buenos Aires, Argentina, pela disponibiliza&cce
dil;&atilde;o das metodologias empregadas nos ensaios biol&oacute;gicos. &Agrave
; Grasiela D'&Aacute;vila Pessoa, do Centro de Pesquisas Ren&eacute; Rachou/FIOC
RUZ pelas sugest&otilde;es das doses aplicadas nos bioensaios. Aos colegas Carmo
 Pereira, Mardones da Costa Flores Sobrinho, K&aacute;tia Maria Leal Braga, Kari
na Cavalcante e Joyce Pereira, do Laborat&oacute;rio de Entomologia M&eacute;dic
a da CGLAB/SVS/MS, pelo aux&iacute;lio na cria&ccedil;&atilde;o e manuten&ccedil
;&atilde;o do inset&aacute;rio de triatom&iacute;neos. Aos funcion&aacute;rios A
&eacute;cio de Paula e Shirley R. Ramos, da Secretaria Estadual de Sa&uacute;de 
do Mato Grosso, pela viabiliza&ccedil;&atilde;o das capturas de triatom&iacute;n
eos.</font></p>     ^cY#aop01-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#111#107#article#169#<p>&nb
sp;</p>     ^cY#aop01-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704008100089002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#112#108#article#169#<p><fo
nt size="3" face="Verdana"><b>CONFLITO DE INTERESSE</b></font></p>     ^cY#aop01
-11.htm##
00404000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704015600089002001300245#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#113#109#article#169#<p><fo
nt size="2" face="Verdana">Os autores declaram n&atilde;o haver nenhum tipo de c
onflito de interesse no desenvolvimento do estudo.</font></p>     ^cY#aop01-11.h
tm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#114#110#article#169#<p>&nb
sp;</p>     ^cY#aop01-11.htm##
00325000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007700089002001300166#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#115#111#article#169#<p><fo
nt size="3" face="Verdana"><b>REFER&Ecirc;NCIAS</b></font></p>     ^cY#aop01-11.
htm##
00575000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704031300091002001300404#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#116#112#articl
e#169#1#<p><font size="2" face="Verdana">1. Toledo MJO, Kuhl JB, Silva SV, Gaspe
ri MV, Ara&uacute;jo SM. Estudo    sobre triatom&iacute;neos e reservat&oacute;r
ios silvetres de <I>Trypanosoma cruzi</I> no Estado do Paran&aacute;, Sul do Bra
sil. Resultados preliminares. Rev Soc Bras Med Trop 1997; 30:197&#45;203.    ^cY
#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#117#113#article#169#</font
></p>     ^cY#aop01-11.htm##
00525000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704026300091002001300354#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#118#114#articl
e#169#2#<p><font size="2" face="Verdana">2. Pires HHR, Borges EC, Andrade RE, Lo
rosa ES, Diotaiuti L. Peridomiciliary infestation with <I>Triatoma sordida</I> S
tal, 1859 in the county of Serra do Ramalho, Bahia, Brasil. Mem Inst Oswaldo Cru
z 1999; 94:147&#45;149.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#119#115#article#169#</font
></p>     ^cY#aop01-11.htm##
00535000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704027300091002001300364#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#120#116#articl
e#169#3#<p><font size="2" face="Verdana">3. Oliveira AWS, Silva IG. Distribui&cc
edil;&atilde;o geogr&aacute;fica e indicadores entomol&oacute;gicos de triatom&i
acute;neos sinantr&oacute;picos capturados no Estado de Goi&aacute;s. Rev Soc Br
as Med Trop 2007; 40:204&#45;208.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#121#117#article#169#</font
></p>     ^cY#aop01-11.htm##
00523000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704026100091002001300352#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#122#118#articl
e#169#4#<p><font size="2" face="Verdana">4. Diotaiuti L, Azeredo BVM, Busek SCU,
 Fernandes AJ. Controle do <I>Triatoma sordida</I> no peridomic&iacute;lio rural
 do munic&iacute;pio de Porteirinha, Minas Gerais, Brasil. Rev Panam Salud Publi
ca 1998; 3:21&#45;25.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#123#119#article#169#</font
></p>     ^cY#aop01-11.htm##
00590000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704032800091002001300419#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#124#120#articl
e#169#5#<p><font size="2" face="Verdana">5. Forattini OP, Rocha e Silva EO, Ferr
eira OA, Rabello EX, Pattoli D. Aspectos ecol&oacute;gicos da Tripanossom&iacute
;ase Americana: III &#45; Dispers&atilde;o local de triatom&iacute;neos, com esp
ecial refer&ecirc;ncia a <I>Triatoma sordida</I>. Rev Saude Publica 1971; 5:193&
#45;205.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#125#121#article#169#</font
></p>     ^cY#aop01-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704025600091002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#126#122#articl
e#169#6#<p><font size="2" face="Verdana">6. Diotaiuti L, Loiola CF, Dias JCP. Th
e ecology of <I>Triatoma sordida</I> in natural environments in two different re
gions of the state of Minas Gerais, Brasil.    Rev Inst Med Trop Sao Paulo 1993;
 35:237&#45;245.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#127#123#article#169#</font
></p>     ^cY#aop01-11.htm##
00487000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704022500091002001300316#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#128#124#articl
e#169#7#<p><font size="2" face="Verdana">7. Dias JP, Bastos C, Ara&uacute;jo E, 
Mascarenhas AV, Netto EM, Grassi F, et al. Acute Chagas disease associated with 
oral transmission. Rev Soc Bras Med Trop    2008; 41:296&#45;300.    ^cY#aop01-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#129#125#article#169#</font
></p>     ^cY#aop01-11.htm##
00550000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704028800091002001300379#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#130#126#articl
e#169#8#<p><font size="2" face="Verdana">8. Dias JCP. Controle da Doen&ccedil;a 
de Chagas. <I>In</I>: Dias JCP, Coura JR, organizadores. Cl&iacute;nica e terap&
ecirc;utica da Doen&ccedil;a de Chagas. Uma abordagem para o cl&iacute;nico gera
l. Rio de Janeiro: Fiocruz; 1997. p.453&#45;467.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#131#127#article#169#</font
></p>     ^cY#aop01-11.htm##
00416000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704015400091002001300245#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#132#128#articl
e#169#9#<p><font size="2" face="Verdana">9. Silveira AC. Enfoque de riesgo em ac
tividades de control de triatominos.    Rev Pat Trop 2004; 33:193&#45;206.    ^c
Y#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#133#129#article#169#</font
></p>     ^cY#aop01-11.htm##
00514000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025100092002001300343#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#134#130#articl
e#169#10#<p><font size="2" face="Verdana">10. Dias JCP, Macedo VO. Doen&ccedil;a
 de Chagas. <I>In</I>: Coura JR, editor. Din&acirc;mica das doen&ccedil;as infec
ciosas e parasit&aacute;rias. Rio de Janeiro: Guanabara Koogan;    2005. v.1. p.
557&#45;593.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#135#131#article#169#</font
></p>     ^cY#aop01-11.htm##
00480000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021700092002001300309#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#136#132#articl
e#169#11#<p><font size="2" face="Verdana">11. Vassena CV, Picollo MI, Zerba EN. 
Insecticide resistance in Brazilian <I>Triatoma infestans</I> and Venezuelan <I>
Rhodnius prolixus</I>. Med Vet Entomol 2000; 14:51&#45;55.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#137#133#article#169#</font
></p>     ^cY#aop01-11.htm##
00678000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704041500092002001300507#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#138#134#articl
e#169#12#<p><font size="2" face="Verdana">12. Vanessa CV, Picollo MI. Monitoreo 
de resistencia a insecticidas en poblaciones de campo de <I>Triatoma infestans</
I> y <I>Rhodnius prolixus</I>, insectos vectores de la efermedad de Chagas. 2003
. &#91;acesso 12 maio de 2007&#93;. Dispon&iacute;vel em: <a href="http://www.se
rtox.com.ar/retel/default.htm/" target="_blank">http://www.sertox.com.ar/retel/d
efault.htm/</a>.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#139#135#article#169#</font
></p>     ^cY#aop01-11.htm##
00568000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030500092002001300397#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#140#136#articl
e#169#13#<p><font size="2" face="Verdana">13. Gonz&aacute;lez&#45;Audino P, Vass
ena C, Barrios S, Zerba E, Picollo MI. Role of enhance detoxication in a deltame
thrin&#45;resistant population of <I>Triatoma infestans</I> (Hemiptera, Reduviid
ae) from Argentina. Mem Inst Oswaldo Cruz    2004; 99:335&#45;339.    ^cY#aop01-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#141#137#article#169#</font
></p>     ^cY#aop01-11.htm##
00582000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031900092002001300411#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#142#138#articl
e#169#14#<p><font size="2" face="Verdana">14. Picollo MI, Vassena C, Orihuela PS
, Barrios S, Zaidemberg M, Zerba E. High resistence to pyrethroid insecticides a
ssociated with ineffective field treatments in <I>Triatoma infestans</I> (Hemipe
tra: Reduviidae) from Northern Argentina.    J Med Entomol 2005; 42:637&#45;642.
    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#143#139#article#169#</font
></p>     ^cY#aop01-11.htm##
00552000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028900092002001300381#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#144#140#articl
e#169#15#<p><font size="2" face="Verdana">15. Orihuela PLS, Vassena CV, Zerba EM
, Picollo MI. Relative contribution of monooxygenase and esterase to pyrethroid 
resistance in <I>Triatoma infestans</I> (Hemiptera: Reduviidae) from Argentina a
nd Bolivia. J Med Entomol    2008; 45:298&#45;306.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#145#141#article#169#</font
></p>     ^cY#aop01-11.htm##
00561000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029800092002001300390#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#146#142#articl
e#169#16#<p><font size="2" face="Verdana">16. Toloza AC, Germano M, Cueto GM, Va
ssena C, Zerba E, Picollo MI. Differencial patterns of insecticide resistance in
 eggs and first instar of <I>Triatoma infestans</I> (Hemiptera: Reduviidae) from
 Argentina and Bolivia. J Med Entomol 2008; 45:421&#45;426.    ^cY#aop01-11.htm#
#
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#147#143#article#169#</font
></p>     ^cY#aop01-11.htm##
00649000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704038600092002001300478#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#148#144#articl
e#169#17#<p><font size="2" face="Verdana">17. Pessoa GCA. Monitoramento da susce
tibilidade ao piretr&oacute;ide deltametrina em popula&ccedil;&otilde;es de <I>T
riatoma sordida</I> St&aring;l, 1859 (Hemiptera: Reduviidae). &#91;Disserta&cced
il;&atilde;o de Mestrado&#93;. &#91;Belo Horizonte&#93;: Centro de Pesquisas Ren
&eacute; Rachou da Funda&ccedil;&atilde;o Oswaldo Cruz; 2008. 95 p.    ^cY#aop01
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#149#145#article#169#</font
></p>     ^cY#aop01-11.htm##
00482000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021900092002001300311#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#150#146#articl
e#169#18#<p><font size="2" face="Verdana">18. Lent H, Wygodzinsky P. Revision on
 the Triatominae (Hemiptera, Reduviidae) and their significance as vectors of Ch
agas'disease. Bull Am Mus Nat Hist    1979; 163:123&#45;520.    ^cY#aop01-11.htm
##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#151#147#article#169#</font
></p>     ^cY#aop01-11.htm##
00448000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018500092002001300277#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#152#148#articl
e#169#19#<p><font size="2" face="Verdana">19. World Health Organization. Protoco
lo de evaluaci&oacute;n de efecto insecticida sobre triatominos. Acta Toxicol Ar
gentina 1994; 2:29&#45;32.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#153#149#article#169#</font
></p>     ^cY#aop01-11.htm##
00437000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017400092002001300266#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#154#150#articl
e#169#20#<p><font size="2" face="Verdana">20. Lichfield J, Wilcoxon F. A simplif
ied method of evaluation dose&#45;effect experiments. J Pharmacol Exp Ther 1949;
 96:99&#45;113.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#155#151#article#169#</font
></p>     ^cY#aop01-11.htm##
00430000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016700092002001300259#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#156#152#articl
e#169#21#<p><font size="2" face="Verdana">21. LeOra Software. Polo&#45;PC: a use
r's guide to probit or logic analysis. Version 2.0. Berkeley, CA:  LeOra Softwar
e; 2002.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#157#153#article#169#</font
></p>     ^cY#aop01-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025500092002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#158#154#articl
e#169#22#<p><font size="2" face="Verdana">22. Organiza&ccedil;&atilde;o Pan Amer
icana de Sa&uacute;de. II Reunion tecnica latinoamericana de monitoreo de resist
encia a insecticidas em triatominos vectores de Chagas. Panam&aacute;, 11 a 13 d
e abril de 2005.    ^cY#aop01-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#159#155#article#169# </fon
t></p>     ^cY#aop01-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024800092002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#160#156#articl
e#169#23#<p><font size="2" face="Verdana">23. Sonoda IV, Pessoa GCA, Cortez MR, 
Dias JCP, Romanha AJ, Diotaiuti L. Susceptibility of <I>Triatoma infestans</I> t
o deltamethrin in Rio Grande do Sul, Brazil. Mem Inst Oswaldo Cruz 2009; 104:668
&#45;670.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#161#157#article#169#</font
></p>     ^cY#aop01-11.htm##
00558000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029500092002001300387#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#162#158#articl
e#169#24#<p><font size="2" face="Verdana">24. Monteiro FA, Jurberg J, Lasoki C. 
Very low levels of genetic variation in natural peridomestic populations of the 
Chagas disease vector <I>Triatoma sordida</I> (Hemiptera: Reduviidae) in Southea
stern Brazil. Am J Trop Med Hyg    2009; 81:223&#45;227.    ^cY#aop01-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#163#159#article#169#</font
></p>     ^cY#aop01-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#164#160#article#169#<p>&nb
sp;</p>     ^cY#aop01-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#165#161#article#169#<p>&nb
sp;</p>     ^cY#aop01-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018900089002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#166#162#article#169#<p><fo
nt size="2" face="Verdana"><b><a name="nt"></a><a href="#tx"><img src="/img/revi
stas/rsbmt/2011nahead/seta.jpg" border="0"></a> Endere&ccedil;o para correspond&
ecirc;ncia:</b>    ^cY#aop01-11.htm##
00287000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003900089002001300128#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#167#163#article#169#<br>  
 Dr. Marcos Takashi Obara    ^cY#aop01-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009500089002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#168#164#article#169#<br>  
 Lab. Entomologia M&eacute;dica/CGLAB/SVS/MS. SCS, Quadra 04, Bloco A, Lote 67/9
7    ^cY#aop01-11.htm##
00296000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004800089002001300137#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#169#165#article#169#<br>  
 70304&#45;000 Bras&iacute;lia, DF    ^cY#aop01-11.htm##
00287000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003900089002001300128#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#170#166#article#169#<br>  
 Tel: 55 61 3213&#45;8272    ^cY#aop01-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704011100089002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#171#167#article#169#<br>  
 e&#45;mail: <a href="mailto:marcos.obara@saude.gov.br">marcos.obara@saude.gov.b
r</a></font></p>     ^cY#aop01-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#172#168#article#169#<p><fo
nt size="2" face="Verdana">Recebido para publica&ccedil;&atilde;o em 29/07/2010 
   ^cY#aop01-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#p#173#169#article#169#<br>  
 Aceito em 21/10/2010</font></p>     ^cY#aop01-11.htm##
00724000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100015001060100
01600121010001800137010001700155012013700172030002200309065000900331064000500340
031000300345014000800348865000900356002001300365035001000378801002200388#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#174#1#article#24#1
#^rND^sToledo^nMJO#^rND^sKuhl^nJB#^rND^sSilva^nSV#^rND^sGasperi^nMV#^rND^sAraújo
^nSM#Estudo sobre triatomíneos e reservatórios silvetres de Trypanosoma cruzi no
 Estado do Paraná, Sul do Brasil. Resultados preliminares^lpt#Rev Soc Bras Med T
rop#19970000#1997#30#197-203#20110000#aop01-11.htm#0037-8682#Rev Soc Bras Med Tr
op##
00705000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100017001050100
01800122010001700140010001900157012011400176030002200290065000900312064000500321
031000300326014000800329865000900337002001300346035001000359801002200369#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#175#2#article#24#2
#^rND^sPires^nHHR#^rND^sBorges^nEC#^rND^sAndrade^nRE#^rND^sLorosa^nES#^rND^sDiot
aiuti^nL#Peridomiciliary infestation with Triatoma sordida Stal, 1859 in the cou
nty of Serra do Ramalho, Bahia, Brasil^len#Mem Inst Oswaldo Cruz#19990000#1999#9
4#147-149#20110000#aop01-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00619000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100016001080120
11600124030002200240065000900262064000500271031000300276014000800279865000900287
002001300296035001000309801002200319#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop01-11.htm#S#c#176#3#article#24#3#^rND^sOliveira^nAWS#^rND^sSilva^nIG
#Distribuição geográfica e indicadores entomológicos de triatomíneos sinantrópic
os capturados no Estado de Goiás^lpt#Rev Soc Bras Med Trop#20070000#2007#40#204-
208#20110000#aop01-11.htm#0037-8682#Rev Soc Bras Med Trop##
00673000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100019001070100
01700126010002000143012010600163030002400269065000900293064000500302031000200307
014000600309865000900315002001300324035001000337801002400347#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#177#4#article#24#4#^rND^sDiota
iuti^nL#^rND^sAzeredo^nBVM#^rND^sBusek^nSCU#^rND^sFernandes^nAJ#Controle do Tria
toma sordida no peridomicílio rural do município de Porteirinha, Minas Gerais, B
rasil^lpt#Rev Panam Salud Publica#19980000#1998#3#21-25#20110000#aop01-11.htm#10
20-4989#Rev Panam Salud Publica##
00729000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100024001080100
01900132010001800151010001800169012013600187030001800323065000900341064000500350
031000200355014000800357865000900365002001300374035001000387801001800397#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#178#5#article#24#5
#^rND^sForattini^nOP#^rND^sRocha e Silva^nEO#^rND^sFerreira^nOA#^rND^sRabello^nE
X#^rND^sPattoli^nD.#Aspectos ecológicos da Tripanossomíase Americana: III - Disp
ersão local de triatomíneos, com especial referência a Triatoma sordida^lpt#Rev 
Saude Publica#19710000#1971#5#193-205#20110000#aop01-11.htm#0034-8910#Rev Saude 
Publica##
00665000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100017001070100
01600124012012200140030002800262065000900290064000500299031000300304014000800307
865000900315002001300324035001000337801002800347#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop01-11.htm#S#c#179#6#article#24#6#^rND^sDiotaiuti^nL#^rND
^sLoiola^nCF#^rND^sDias^nJCP#The ecology of Triatoma sordida in natural environm
ents in two different regions of the state of Minas Gerais, Brasil^len#Rev Inst 
Med Trop Sao Paulo#19930000#1993#35#237-245#20110000#aop01-11.htm#0036-4665#Rev 
Inst Med Trop Sao Paulo##
00694000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100016001030100
01600119010002200135010001600157010001600173810000700189012005900196030002200255
06500090027706400050028603100030029101400080029486500090030200200130031103500100
0324801002200334#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.ht
m#S#c#180#7#article#24#7#^rND^sDias^nJP#^rND^sBastos^nC#^rND^sAraújo^nE#^rND^sMa
scarenhas^nAV#^rND^sNetto^nEM#^rND^sGrassi^nF#et al.#Acute Chagas disease associ
ated with oral transmission^len#Rev Soc Bras Med Trop#20080000#2008#41#296-300#2
0110000#aop01-11.htm#0037-8682#Rev Soc Bras Med Trop##
00598000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120033001040160
01700137016001700154018008200171066001500253062000800268065000900276064000500285
014000800290865000900298002001300307#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop01-11.htm#S#c#181#8#article#24#8#^rND^sDias^nJCP#Controle da Doença 
de Chagas^lpt#^rORG^sDias^nJCP#^rORG^sCoura^nJR#Clínica e terapêutica da Doença 
de Chagas: Uma abordagem para o clínico geral^lpt#Rio de Janeiro#Fiocruz#1997000
0#1997#453-467#20110000#aop01-11.htm##
00519000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880120063001070300
01300170065000900183064000500192031000300197014000800200865000900208002001300217
035001000230801001300240#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
01-11.htm#S#c#182#9#article#24#9#^rND^sSilveira^nAC#Enfoque de riesgo em activid
ades de control de triatominos^lpt#Rev Pat Trop#20040000#2004#33#193-206#2011000
0#aop01-11.htm#0301-0406#Rev Pat Trop##
00580000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060120
02100123016001600144018005200160066001500212062001700227065000900244064000500253
031000200258014000800260865000900268002001300277#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop01-11.htm#S#c#183#10#article#24#10#^rND^sDias^nJCP#^rND^
sMacedo^nVO#Doença de Chagas^lpt#^rED^sCoura^nJR#Dinâmica das doenças infecciosa
s e parasitárias^lpt#Rio de Janeiro#Guanabara Koogan#20050000#2005#1#557-593#201
10000#aop01-11.htm##
00611000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
01600126012009200142030001600234065000900250064000500259031000300264014000600267
865000900273002001300282035001000295801001600305#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop01-11.htm#S#c#184#11#article#24#11#^rND^sVassena^nCV#^rN
D^sPicollo^nMI#^rND^sZerba^nEN#Insecticide resistance in Brazilian Triatoma infe
stans and Venezuelan Rhodnius prolixus^len#Med Vet Entomol#20000000#2000#14#51-5
5#20110000#aop01-11.htm#0269-283X#Med Vet Entomol##
00640000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900160018001080180
15500126065000900281064000500290110000900295109001600304037004400320865000900364
002001300373#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#
c#185#12#article#24#12#^rND^sVanessa^nCV#^rND^sPicollo^nMI#Monitoreo de resisten
cia a insecticidas en poblaciones de campo de Triatoma infestans y Rhodnius prol
ixus, insectos vectores de la efermedad de Chagas^lpt#20030000#2003#20070512#12 
maio de 2007#http://www.sertox.com.ar/retel/default.htm/#20110000#aop01-11.htm##
00730000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100025000900100017001150100
01700132010001500149010001800164012013300182030002200315065000900337064000500346
031000300351014000800354865000900362002001300371035001000384801002200394#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#186#13#article#24#
13#^rND^sGonzález-Audino^nP#^rND^sVassena^nC#^rND^sBarrios^nS#^rND^sZerba^nE#^rN
D^sPicollo^nMI#Role of enhance detoxication in a deltamethrin-resistant populati
on of Triatoma infestans (Hemiptera, Reduviidae) from Argentina^len#Mem Inst Osw
aldo Cruz#20040000#2004#99#335-339#20110000#aop01-11.htm#0074-0276#Mem Inst Oswa
ldo Cruz##
00769000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01900125010001700144010002000161010001500181012016200196030001400358065000900372
06400050038103100030038601400080038986500090039700200130040603500100041980100140
0429#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#187#14
#article#24#14#^rND^sPicollo^nMI#^rND^sVassena^nC#^rND^sOrihuela^nPS#^rND^sBarri
os^nS#^rND^sZaidemberg^nM#^rND^sZerba^nE#High resistence to pyrethroid insectici
des associated with ineffective field treatments in Triatoma infestans (Hemipetr
a: Reduviidae) from Northern Argentina^len#J Med Entomol#20050000#2005#42#637-64
2#20110000#aop01-11.htm#0022-2585#J Med Entomol##
00703000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100018001100100
01600128010001800144012015400162030001400316065000900330064000500339031000300344
014000800347865000900355002001300364035001000377801001400387#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#188#15#article#24#15#^rND^sOri
huela^nPLS#^rND^sVassena^nCV#^rND^sZerba^nEM#^rND^sPicollo^nMI#Relative contribu
tion of monooxygenase and esterase to pyrethroid resistance in Triatoma infestan
s (Hemiptera: Reduviidae) from Argentina and Bolivia^len#J Med Entomol#20080000#
2008#45#298-306#20110000#aop01-11.htm#0022-2585#J Med Entomol##
00751000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100017001070100
01600124010001700140010001500157010001800172012015000190030001400340065000900354
06400050036303100030036801400080037186500090037900200130038803500100040180100140
0411#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#189#16
#article#24#16#^rND^sToloza^nAC#^rND^sGermano^nM#^rND^sCueto^nGM#^rND^sVassena^n
C#^rND^sZerba^nE#^rND^sPicollo^nMI#Differencial patterns of insecticide resistan
ce in eggs and first instar of Triatoma infestans (Hemiptera: Reduviidae) from A
rgentina and Bolivia^len#J Med Entomol#20080000#2008#45#421-426#20110000#aop01-1
1.htm#0022-2585#J Med Entomol##
00560000000000217000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900180133001080510
00900241046001500250050005500265865000900320002001300329#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#190#17#article#24#17#^rND^sPessoa^
nGCA#Monitoramento da suscetibilidade ao piretróide deltametrina em populações d
e Triatoma sordida Stål, 1859 (Hemiptera: Reduviidae)^lpt#Mestrado#Belo Horizont
e#Fundação Oswaldo Cruz^dCentro de Pesquisas René Rachou#20110000#aop01-11.htm##
00611000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100021001040120
10800125030002100233065000900254064000500263031000400268014000800272865000900280
002001300289035001000302801002100312#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop01-11.htm#S#c#191#18#article#24#18#^rND^sLent^nH#^rND^sWygodzinsky^n
P#Revision on the Triatominae (Hemiptera, Reduviidae) and their significance as 
vectors of Chagas'disease^len#Bull Am Mus Nat Hist#19790000#1979#163#123-520#201
10000#aop01-11.htm#0003-0090#Bull Am Mus Nat Hist##
00507000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870110026000900120068001160300
02300184710000200207065000900209064000500218031000200223014000600225865000900231
002001300240#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#
c#192#19#article#24#19#World Health Organization#Protocolo de evaluación de efec
to insecticida sobre triatominos^les#Acta Toxicol Argentina#2#19940000#1994#2#29
-32#20110000#aop01-11.htm##
00565000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090120
06200127030002100189065000900210064000500219031000300224014000700227865000900234
002001300243035001000256801002100266#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop01-11.htm#S#c#193#20#article#24#20#^rND^sLichfield^nJ#^rND^sWilcoxon
^nF#A simplified method of evaluation dose-effect experiments^len#J Pharmacol Ex
p Ther#19490000#1949#96#99-113#20110000#aop01-11.htm#0022-3565#J Pharmacol Exp T
her##
00468000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170015000900180069001050660
01300174062001500187065000900202064000500211865000900216002001300225#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#194#21#article#24#21#L
eOra Software#Polo-PC: a user's guide to probit or logic analysis. Version 2.0^l
en#Berkeley^eCA#LeOra Software#20020000#2002#20110000#aop01-11.htm##
00522000000000217000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170035000900180116001250670
00700241065000900248064002500257865000900282002001300291#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#195#22#article#24#22#Organização P
an Americana de Saúde#II Reunion tecnica latinoamericana de monitoreo de resiste
ncia a insecticidas em triatominos vectores de Chagas^lpt#Panamá#20050413#11 a 1
3 de abril de 2005#20110000#aop01-11.htm##
00709000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01700125010001600142010001800158010001900176012008600195030002200281065000900303
06400050031203100040031701400080032186500090032900200130033803500100035180100220
0361#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop01-11.htm#S#c#196#23
#article#24#23#^rND^sSonoda^nIV#^rND^sPessoa^nGCA#^rND^sCortez^nMR#^rND^sDias^nJ
CP#^rND^sRomanha^nAJ#^rND^sDiotaiuti^nL#Susceptibility of Triatoma infestans to 
deltamethrin in Rio Grande do Sul, Brazil^len#Mem Inst Oswaldo Cruz#20090000#200
9#104#668-670#20110000#aop01-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00695000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100017001090100
01600126012017000142030001800312065000900330064000500339031000300344014000800347
865000900355002001300364035001000377801001800387#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop01-11.htm#S#c#197#24#article#24#24#^rND^sMonteiro^nFA#^r
ND^sJurberg^nJ#^rND^sLasoki^nC#Very low levels of genetic variation in natural p
eridomestic populations of the Chagas disease vector Triatoma sordida (Hemiptera
: Reduviidae) in Southeastern Brazil^len#Am J Trop Med Hyg#20090000#2009#81#223-
227#20110000#aop01-11.htm#0002-9637#Am J Trop Med Hyg##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#o#1#
1#article#1#20110311#101242#aop02-11.htm#185##
04897000000000721000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701200650
01860120080002510100026003310100041003570100032003980100037004300100036004670100
03200503070007800535070003800613070007600651083154700727085000802274085001802282
08500210230008500370232108500350235808500350239308315250242808500080395308500190
39610850017039800850035039970850034040320850029040660580007040950600011041021170
00604113072000304119112000904122111001104131114000904142113001104151002001304162
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#h#2#1#articl
e#1#tr#pt#br1.1#1#4.0#MAP#TAB#01#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000
#^f0^l0#0037-8682#20110318#Os morcegos e a raiva na região oeste do Estado de Sã
o Paulo^lpt#The bats and rabies in the Western region of the State of São Paulo,
 Brazil^len#^rND^1A01^nAvelino^sAlbas#^rND^1A01^nEdson Aroldo Novaes de^sSouza#^
rND^1A01^nMiléia Ricci^sPicolo#^rND^1A02^nSilvana Regina^sFavoretto#^rND^1A03^nA
driana Ruckert da^sGama#^rND^1A03^nMiriam Martos^sSodré#Agência Paulista de Tecn
ologia dos Agronegócios^iA01^cPresidente Prudente^sSP#Instituto Pasteur^iA02^cSã
o Paulo^sSP#Prefeitura de São Paulo^iA03^1Centro de Controle de Zoonoses^cSão Pa
ulo^sSP#^lpt^aINTRODUÇÃO: O laboratório do Pólo da Alta Sorocabana de Presidente
 Prudente, SP, em parceria com outras instituições de pesquisa, realizou estudos
 pertinentes aos morcegos da região oeste do Estado de São Paulo, Brasil. Para t
al, foram pesquisadas algumas situações, tais como: a) isolamento do vírus rábic
o, no período 2006 a 2008; b) as respectivas variantes antigênicas; c) abrigos d
iurnos do morcego hematófago Desmodus rotundus. MÉTODOS: As amostras para exame 
foram provenientes de morcegos não hematófagos encaminhadas ao laboratório sendo
 submetidas aos testes de imunofluorescência direta e prova biológica. As amostr
as positivas foram caracterizadas antigenicamente por meio do teste de anticorpo
s monoclonais. Quanto aos morcegos, foram identificados e classificados, e també
m foi realizado mapeamento de abrigos dos mesmos. RESULTADOS: O laboratório rece
beu 1.113 morcegos não hematófagos para diagnóstico laboratorial, sendo 11 (1%) 
deles positivos, e dentre as amostras positivas, 5 (45,5%) delas tiveram variant
e antigênica 3 associada ao morcego D. rotundus e 4 (36,5%) foram compatíveis co
m amostras de morcegos insetívoros. Foram pesquisados 16 abrigos de morcegos hem
atófagos e observou-se a presença de outras 3 espécies de morcegos não hematófag
os convivendo com eles. CONCLUSÕES: Os experimentos mostraram que o vírus rábico
 continua circulando na região com pelo menos 3 variantes antigênicas, e que, a 
coabitação de morcegos hematófagos com não hematófagos pode ter alguma relação c
om a disseminação do vírus rábico.#^dnd^i1#^tm^lpt^kRaiva^i1#^tm^lpt^kMorcegos^i
1#^tm^lpt^kDiagnóstico laboratorial^i1#^tm^lpt^kAnticorpos monoclonais^i1#^tm^lp
t^kTipificação antigênica^i1#^len^aINTRODUCTION: The Polo da Alta Sorocabana Lab
oratory in Presidente Prudente, SP, in partnership with other research instituti
ons, conducted studies related to bats from the western region of the State of S
ao Paulo, Brazil. Thus, certain situations were investigated, including: a) isol
ation of the rabies virus from 2006 to 2008; b) identification of respective ant
igenic variants; and c) characterization of daytime shelters of Desmodus rotundu
s vampire bats. METHODS: Samples for examination originated from nonhematophagou
s bats forwarded to the laboratory and subjected to direct fluorescent antibody 
test and mouse inoculation test. Positive samples were characterized by the mono
clonal antibody test. Regarding the bats, they were identified and classified an
d mapping of their shelters was also performed. RESULTS: The laboratory received
 1,113 nonhematophagous bats for rabies diagnosis, 11 (1%) of which were positiv
es, and among the positive samples, 5 (45.5%) presented antigenic variant 3 (fro
m the bat Desmodus rotundus) and 4 (36.5%) were compatible with samples derived 
from Brazilian insectivorous bats. Sixteen vampire bat shelters were investigate
d and observation confirmed the presence of another 3 species of nonhematophagou
s bats coexisting with them. CONCLUSIONS: The experiments showed that at least 3
 antigenic variants of rabies virus are circulating in the region and that the c
ohabitation of vampire bats with nonhematophagous bats could be related to the d
issemination of the rabies virus.#^dnd^i2#^tm^len^kRabies^i2#^tm^len^kBats^i2#^t
m^len^kLaboratorial diagnosis^i2#^tm^len^kMonoclonal antibodies^i2#^tm^len^kAnti
genic typing^i2#FAPESP#05/59818-6#other#27#20100628#28/06/2010#20101108#08/11/20
10#aop02-11.htm##
05060000000000721000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701200720
01860120087002580100026003450100041003710100032004120100037004440100036004810100
03200517070007800549070003800627070007600665083158900741085000802330085001802338
08500210235608500370237708500350241408500350244908315740248408500080405808500190
40660850017040850850035041020850034041370850029041710580007042000600069042071170
00604276072000304282112000904285111001104294114000904305113001104314002001304325
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#f#3#1#articl
e#1#tr#pt#br1.1#1#4.0#MAP#TAB#01#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000
#^f0^l0#0037-8682#20110318#<b>Os morcegos e a raiva na região oeste do Estado de
 São Paulo</b>^lpt#<b>The bats and rabies in the Western region of the State of 
São Paulo, Brazil</b>^len#^rND^1A01^nAvelino^sAlbas#^rND^1A01^nEdson Aroldo Nova
es de^sSouza#^rND^1A01^nMiléia Ricci^sPicolo#^rND^1A02^nSilvana Regina^sFavorett
o#^rND^1A03^nAdriana Ruckert da^sGama#^rND^1A03^nMiriam Martos^sSodré#Agência Pa
ulista de Tecnologia dos Agronegócios^iA01^cPresidente Prudente^sSP#Instituto Pa
steur^iA02^cSão Paulo^sSP#Prefeitura de São Paulo^iA03^1Centro de Controle de Zo
onoses^cSão Paulo^sSP#^lpt^a<b>INTRODUÇÃO:</b> O laboratório do Pólo da Alta Sor
ocabana de Presidente Prudente, SP, em parceria com outras instituições de pesqu
isa, realizou estudos pertinentes aos morcegos da região oeste do Estado de São 
Paulo, Brasil. Para tal, foram pesquisadas algumas situações, tais como: a) isol
amento do vírus rábico, no período 2006 a 2008; b) as respectivas variantes anti
gênicas; c) abrigos diurnos do morcego hematófago <i>Desmodus rotundus</i>. <b>M
ÉTODOS:</b> As amostras para exame foram provenientes de morcegos não hematófago
s encaminhadas ao laboratório sendo submetidas aos testes de imunofluorescência 
direta e prova biológica. As amostras positivas foram caracterizadas antigenicam
ente por meio do teste de anticorpos monoclonais. Quanto aos morcegos, foram ide
ntificados e classificados, e também foi realizado mapeamento de abrigos dos mes
mos. <b>RESULTADOS:</b> O laboratório recebeu 1.113 morcegos não hematófagos par
a diagnóstico laboratorial, sendo 11 (1%) deles positivos, e dentre as amostras 
positivas, 5 (45,5%) delas tiveram variante antigênica 3 associada ao morcego <i
>D. rotundus</i> e 4 (36,5%) foram compatíveis com amostras de morcegos insetívo
ros. Foram pesquisados 16 abrigos de morcegos hematófagos e observou-se a presen
ça de outras 3 espécies de morcegos não hematófagos convivendo com eles. <b>CONC
LUSÕES:</b> Os experimentos mostraram que o vírus rábico continua circulando na 
região com pelo menos 3 variantes antigênicas, e que, a coabitação de morcegos h
ematófagos com não hematófagos pode ter alguma relação com a disseminação do vír
us rábico.#^dnd^i1#^tm^lpt^kRaiva^i1#^tm^lpt^kMorcegos^i1#^tm^lpt^kDiagnóstico l
aboratorial^i1#^tm^lpt^kAnticorpos monoclonais^i1#^tm^lpt^kTipificação antigênic
a^i1#^len^a<b>INTRODUCTION:</b> The <i>Polo da Alta Sorocabana</i> Laboratory in
 Presidente Prudente, SP, in partnership with other research institutions, condu
cted studies related to bats from the western region of the State of Sao Paulo, 
Brazil. Thus, certain situations were investigated, including: a) isolation of t
he rabies virus from 2006 to 2008; b) identification of respective antigenic var
iants; and c) characterization of daytime shelters of <i>Desmodus rotundus</i> v
ampire bats. <b>METHODS:</b> Samples for examination originated from nonhematoph
agous bats forwarded to the laboratory and subjected to direct fluorescent antib
ody test and mouse inoculation test. Positive samples were characterized by the 
monoclonal antibody test. Regarding the bats, they were identified and classifie
d and mapping of their shelters was also performed. <b>RESULTS:</b> The laborato
ry received 1,113 nonhematophagous bats for rabies diagnosis, 11 (1%) of which w
ere positives, and among the positive samples, 5 (45.5%) presented antigenic var
iant 3 (from the bat <i>Desmodus rotundus</i>) and 4 (36.5%) were compatible wit
h samples derived from Brazilian insectivorous bats. Sixteen vampire bat shelter
s were investigated and observation confirmed the presence of another 3 species 
of nonhematophagous bats coexisting with them. <b>CONCLUSIONS:</b> The experimen
ts showed that at least 3 antigenic variants of rabies virus are circulating in 
the region and that the cohabitation of vampire bats with nonhematophagous bats 
could be related to the dissemination of the rabies virus.#^dnd^i2#^tm^len^kRabi
es^i2#^tm^len^kBats^i2#^tm^len^kLaboratorial diagnosis^i2#^tm^len^kMonoclonal an
tibodies^i2#^tm^len^kAntigenic typing^i2#FAPESP#<span style='font-size:10.0pt;fo
nt-family:Verdana'>05/59818-6</span>#other#27#20100628#28/06/2010#20101108#08/11
/2010#aop02-11.htm##
05070000000000745000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120065001920120080002570100026003370100041003630100032004040100037004360100
03600473010003200509070008000541070004000621070007800661083157400739085000802313
08500180232108500210233908500370236008500350239708500350243208315460246708500080
40130850019040210850017040400850035040570850034040920850029041260580007041550600
01104162117000604173072000304179112000904182111001104191114000904202113001104211
002001304222008008904235#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
02-11.htm#S#l#4#1#article#1#^a2011#tr#pt#br1.1#1#4.0#map#tab#01#nd#nd#Rev. Soc. 
Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8682#20110318#Os morcegos e a raiva n
a região oeste do Estado de São Paulo^lpt#The bats and rabies in the Western reg
ion of the State of São Paulo, Brazil^len#^rND^1A01^nAvelino^sAlbas#^rND^1A01^nE
dson Aroldo Novaes de^sSouza#^rND^1A01^nMiléia Ricci^sPicolo#^rND^1A02^nSilvana 
Regina^sFavoretto#^rND^1A03^nAdriana Ruckert da^sGama#^rND^1A03^nMiriam Martos^s
Sodré#^iA01^1Agência Paulista de Tecnologia dos Agronegócios^cPresidente Prudent
e^sSP#^iA02^1Instituto Pasteur^cSão Paulo^sSP#^iA03^1Prefeitura de São Paulo^2Ce
ntro de Controle de Zoonoses^cSão Paulo^sSP#^lpt^aINTRODUÇÃO: O laboratório do P
ólo da Alta Sorocabana de Presidente Prudente, SP, em parceria com outras instit
uições de pesquisa, realizou estudos pertinentes aos morcegos da região oeste do
 Estado de São Paulo, Brasil. Para tal, foram pesquisadas algumas situações, tai
s como: a) isolamento do vírus rábico, no período 2006 a 2008; b) as respectivas
 variantes antigênicas; c) abrigos diurnos do morcego hematófago Desmodus rotund
us. MÉTODOS: As amostras para exame foram provenientes de morcegos não hematófag
os encaminhadas ao laboratório sendo submetidas aos testes de imunofluorescência
 direta e prova biológica. As amostras positivas foram caracterizadas antigenica
mente por meio do teste de anticorpos monoclonais. Quanto aos morcegos, foram id
entificados e classificados, e também foi realizado mapeamento de abrigos dos me
smos. RESULTADOS: O laboratório recebeu 1.113 morcegos não hematófagos para diag
nóstico laboratorial, sendo 11 (1 por cento) deles positivos, e dentre as amostr
as positivas, 5 (45,5 por cento) delas tiveram variante antigênica 3 associada a
o morcego D. rotundus e 4 (36,5 por cento) foram compatíveis com amostras de mor
cegos insetívoros. Foram pesquisados 16 abrigos de morcegos hematófagos e observ
ou-se a presença de outras 3 espécies de morcegos não hematófagos convivendo com
 eles. CONCLUSÕES: Os experimentos mostraram que o vírus rábico continua circula
ndo na região com pelo menos 3 variantes antigênicas, e que, a coabitação de mor
cegos hematófagos com não hematófagos pode ter alguma relação com a disseminação
 do vírus rábico.#^dnd^i1#^tm^lpt^kRaiva^i1#^tm^lpt^kMorcegos^i1#^tm^lpt^kDiagnó
stico laboratorial^i1#^tm^lpt^kAnticorpos monoclonais^i1#^tm^lpt^kTipificação an
tigênica^i1#^len^aINTRODUCTION: The Polo da Alta Sorocabana Laboratory in Presid
ente Prudente, SP, in partnership with other research institutions, conducted st
udies related to bats from the western region of the State of Sao Paulo, Brazil.
 Thus, certain situations were investigated, including: a) isolation of the rabi
es virus from 2006 to 2008; b) identification of respective antigenic variants; 
and c) characterization of daytime shelters of Desmodus rotundus vampire bats. M
ETHODS: Samples for examination originated from nonhematophagous bats forwarded 
to the laboratory and subjected to direct fluorescent antibody test and mouse in
oculation test. Positive samples were characterized by the monoclonal antibody t
est. Regarding the bats, they were identified and classified and mapping of thei
r shelters was also performed. RESULTS: The laboratory received 1,113 nonhematop
hagous bats for rabies diagnosis, 11 (1 percent) of which were positives, and am
ong the positive samples, 5 (45.5 percent) presented antigenic variant 3 (from t
he bat Desmodus rotundus) and 4 (36.5 percent) were compatible with samples deri
ved from Brazilian insectivorous bats. Sixteen vampire bat shelters were investi
gated and observation confirmed the presence of another 3 species of nonhematoph
agous bats coexisting with them. CONCLUSIONS: The experiments showed that at lea
st 3 antigenic variants of rabies virus are circulating in the region and that t
he cohabitation of vampire bats with nonhematophagous bats could be related to t
he dissemination of the rabies virus.#^dnd^i2#^tm^len^kRabies^i2#^tm^len^kBats^i
2#^tm^len^kLaboratorial diagnosis^i2#^tm^len^kMonoclonal antibodies^i2#^tm^len^k
Antigenic typing^i2#FAPESP#05/59818-6#other#27#20100628#28/06/2010#20101108#08/1
1/2010#aop02-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext
&pid=S0037-86822011005000001##
00395000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704015100085002001300236#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#5#1#article#154#<p><font s
ize="4" face="Verdana"><B><a name="tx"></a>Os morcegos e a raiva na regi&atilde;
o oeste do Estado de S&atilde;o Paulo</b></font></p>     ^cY#aop02-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#6#2#article#154#<p>&nbsp;<
/p>     ^cY#aop02-11.htm##
00386000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704014200085002001300227#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#7#3#article#154#<p><font s
ize="3" face="Verdana"><b>The bats and rabies in the Western region of the State
 of S&atilde;o Paulo, Brazil</b></font></p>     ^cY#aop02-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#8#4#article#154#<p>&nbsp;<
/p>     ^cY#aop02-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#9#5#article#154#<p>&nbsp;<
/p>     ^cY#aop02-11.htm##
00533000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704028800086002001300374#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#10#6#article#154#<p><font 
size="2" face="Verdana"><b>Avelino Albas<SUP>I</SUP>; Edson Aroldo Novaes de Sou
za<SUP>I</SUP>; Mil&eacute;ia Ricci Picolo<SUP>I</SUP>; Silvana Regina Favoretto
<SUP>II</SUP>;  Adriana Ruckert da Gama<SUP>III</SUP>; Miriam Martos Sodr&eacute
;<SUP>III</SUP></b></font></p>     ^cY#aop02-11.htm##
00415000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704017000086002001300256#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#11#7#article#154#<p><font 
size="2" face="Verdana"><sup>I</sup>Ag&ecirc;ncia Paulista de Tecnologia dos Agr
oneg&oacute;cios, P&oacute;lo da Alta Sorocabana, Presidente Prudente, SP    ^cY
#aop02-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704006900086002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#12#8#article#154#<br>     
<sup>II</sup>Instituto Pasteur, S&atilde;o Paulo, SP    ^cY#aop02-11.htm##
00373000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704012800086002001300214#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#13#9#article#154#<br>     
<sup>III</sup>Centro de Controle de Zoonoses, Prefeitura de S&atilde;o Paulo,  S
&atilde;o Paulo, SP</font></p>     ^cY#aop02-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011300087002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#14#10#article#154#<p><font
 size="2" face="Verdana"><a href="#nt">Endere&ccedil;o para correspond&ecirc;nci
a</a></font></p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#15#11#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#16#12#article#154#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop02-11.htm##
00312000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006600087002001300153#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#17#13#article#154#<p><font
 size="2" face="Verdana"><B>RESUMO</B></font></p>     ^cY#aop02-11.htm##
00838000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059200087002001300679#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#18#14#article#154#<p><font
 size="2" face="Verdana"><B>INTRODU&Ccedil;&Atilde;O:</B> O laborat&oacute;rio d
o P&oacute;lo da Alta Sorocabana de Presidente Prudente, SP, em parceria com out
ras institui&ccedil;&otilde;es de pesquisa, realizou estudos pertinentes aos mor
cegos da regi&atilde;o oeste do Estado de S&atilde;o Paulo, Brasil. Para tal, fo
ram pesquisadas algumas situa&ccedil;&otilde;es, tais como: a) isolamento do v&i
acute;rus r&aacute;bico, no per&iacute;odo 2006 a 2008; b) as respectivas varian
tes antig&ecirc;nicas; c) abrigos diurnos do morcego hemat&oacute;fago <I>Desmod
us rotundus</I>.    ^cY#aop02-11.htm##
00716000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047000087002001300557#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#19#15#article#154#<br>  <B
>M&Eacute;TODOS:</B> As amostras para exame foram provenientes de morcegos n&ati
lde;o hemat&oacute;fagos encaminhadas ao laborat&oacute;rio sendo submetidas aos
 testes de imunofluoresc&ecirc;ncia direta e prova biol&oacute;gica. As amostras
 positivas foram caracterizadas antigenicamente por meio do teste de anticorpos 
monoclonais. Quanto aos morcegos, foram identificados e classificados, e tamb&ea
cute;m foi realizado mapeamento de abrigos dos mesmos.    ^cY#aop02-11.htm##
00814000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056800087002001300655#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#20#16#article#154#<br>  <B
>RESULTADOS:</B> O laborat&oacute;rio recebeu 1.113 morcegos n&atilde;o hemat&oa
cute;fagos para diagn&oacute;stico laboratorial, sendo 11 (1%) deles positivos, 
e dentre as amostras positivas, 5 (45,5%) delas tiveram variante antig&ecirc;nic
a 3 associada ao morcego <I>D. rotundus</I> e 4 (36,5%) foram compat&iacute;veis
 com amostras de morcegos inset&iacute;voros. Foram pesquisados 16 abrigos de mo
rcegos hemat&oacute;fagos e observou&#45;se a presen&ccedil;a de outras 3 esp&ea
cute;cies de morcegos n&atilde;o hemat&oacute;fagos convivendo com eles.    ^cY#
aop02-11.htm##
00640000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039400087002001300481#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#21#17#article#154#<br>  <B
>CONCLUS&Otilde;ES:</B> Os experimentos mostraram que o v&iacute;rus r&aacute;bi
co continua circulando na regi&atilde;o com pelo menos 3 variantes antig&ecirc;n
icas, e que, a coabita&ccedil;&atilde;o de morcegos hemat&oacute;fagos com n&ati
lde;o hemat&oacute;fagos pode ter alguma rela&ccedil;&atilde;o com a dissemina&c
cedil;&atilde;o do v&iacute;rus r&aacute;bico.</font></p>     ^cY#aop02-11.htm##
00465000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021900087002001300306#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#22#18#article#154#<p><font
 size="2" face="Verdana"><B>Palavras&#45;chaves:</B> Raiva. Morcegos. Diagn&oacu
te;stico laboratorial. Anticorpos monoclonais.Tipifica&ccedil;&atilde;o antig&ec
irc;nica.</font></p> <hr size="1" noshade>     ^cY#aop02-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006800087002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#23#19#article#154#<p><font
 size="2" face="Verdana"><B>ABSTRACT</B></font></p>     ^cY#aop02-11.htm##
00768000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052200087002001300609#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#24#20#article#154#<p><font
 size="2" face="Verdana"><B>INTRODUCTION:</B> The <I>Polo da Alta Sorocabana</I>
 Laboratory in Presidente Prudente, SP, in partnership with other research insti
tutions, conducted studies related to bats from the western region of the State 
of Sao Paulo, Brazil. Thus, certain situations were investigated, including: a) 
isolation of the rabies virus from 2006 to 2008; b) identification of respective
 antigenic variants; and c) characterization of daytime shelters of <I>Desmodus 
rotundus</I> vampire bats.    ^cY#aop02-11.htm##
00618000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037200087002001300459#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#25#21#article#154#<br>  <B
>METHODS:</B> Samples for examination originated from nonhematophagous bats forw
arded to the laboratory and subjected to direct fluorescent antibody test and mo
use inoculation test. Positive samples were characterized by the monoclonal anti
body test. Regarding the bats, they were identified and classified and mapping o
f their shelters was also performed.    ^cY#aop02-11.htm##
00734000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048800087002001300575#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#26#22#article#154#<br>  <B
>RESULTS:</B> The laboratory received 1,113 nonhematophagous bats for rabies dia
gnosis, 11 (1%) of which were positives, and among the positive samples, 5 (45.5
%) presented antigenic variant 3 (from the bat <I>Desmodus rotundus</I>) and 4 (
36.5%) were compatible with samples derived from Brazilian insectivorous bats. S
ixteen vampire bat shelters were investigated and observation confirmed the pres
ence of another 3 species of nonhematophagous bats coexisting with them.    ^cY#
aop02-11.htm##
00523000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027700087002001300364#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#27#23#article#154#<br>  <B
>CONCLUSIONS:</B> The experiments showed that at least 3 antigenic variants of r
abies virus are circulating in the region and that the cohabitation of vampire b
ats with nonhematophagous bats could be related to the dissemination of the rabi
es virus.</font></p>     ^cY#aop02-11.htm##
00416000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017000087002001300257#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#28#24#article#154#<p><font
 size="2" face="Verdana"><B>Keywords:</B> Rabies. Bats. Laboratorial diagnosis. 
Monoclonal antibodies. Antigenic typing.</font></p> <hr size="1" noshade>     ^c
Y#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#29#25#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#30#26#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00330000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008400087002001300171#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#31#27#article#154#<p><font
 size="3" face="Verdana"><b>INTRODU&Ccedil;&Atilde;O</b></font></p>     ^cY#aop0
2-11.htm##
00824000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057800087002001300665#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#32#28#article#154#<p><font
 size="2" face="Verdana">Desde 1995, o laborat&oacute;rio do P&oacute;lo da Alta
 Sorocabana foi credenciado pelo Minist&eacute;rio da Sa&uacute;de com a finalid
ade de realizar o diagn&oacute;stico laboratorial da raiva para, aproximadamente
, 53 munic&iacute;pios que comp&otilde;em a 10ª regi&atilde;o administrativa do 
Estado de S&atilde;o Paulo. Presidente Prudente &eacute; a sede administrativa d
essa regi&atilde;o e, geograficamente, localiza&#45;se a sudoeste de S&atilde;o 
Paulo, latitude 22<SUP>0</SUP>07'04" e longitude 51<SUP>0</SUP>22'57".</font></p
>     ^cY#aop02-11.htm##
00670000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042400087002001300511#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#33#29#article#154#<p><font
 size="2" face="Verdana">A notifica&ccedil;&atilde;o dos casos de raiva em morce
gos aumentou significativamente nos &uacute;ltimos anos, e particularmente preoc
upantes, s&atilde;o os registros de casos em morcegos n&atilde;o hemat&oacute;fa
gos, pois sua adapta&ccedil;&atilde;o ao ambiente urbano pode ocasionar infec&cc
edil;&otilde;es de animais de estima&ccedil;&atilde;o e pessoas<SUP>1</SUP>.</fo
nt></p>     ^cY#aop02-11.htm##
00778000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053200087002001300619#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#34#30#article#154#<p><font
 size="2" face="Verdana">Na d&eacute;cada de 1996 a 2005, houve diminui&ccedil;&
atilde;o no n&uacute;mero de casos de raiva canina em 72%, nas Am&eacute;ricas, 
sem contar os pa&iacute;ses da Am&eacute;rica do Norte. Por&eacute;m, houve aume
nto de casos em rela&ccedil;&atilde;o &agrave; raiva silvestre de aproximadament
e 445%, com varia&ccedil;&atilde;o de 46 casos, em 1996, para 251, em 2005, send
o que a maioria foi formada por morcegos hemat&oacute;fagos e n&atilde;o hemat&o
acute;fagos<SUP>2</SUP>.</font></p>     ^cY#aop02-11.htm##
00613000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036700087002001300454#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#35#31#article#154#<p><font
 size="2" face="Verdana">Albas cols<SUP>3</SUP> realizaram estudo da presen&cced
il;a do v&iacute;rus r&aacute;bico, na regi&atilde;o de Presidente Prudente, SP,
 no per&iacute;odo de 1996 a 2003, e detectaram a presen&ccedil;a de 74 amostras
 positivas, sendo que destas, 58 (78,4%) foram referentes a morcegos n&atilde;o 
hemat&oacute;fagos.</font></p>     ^cY#aop02-11.htm##
00427000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018100087002001300268#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#36#32#article#154#<p><font
 size="2" face="Verdana">V&aacute;rios pesquisadores t&ecirc;m realizado experim
entos se utilizando do teste de anticorpos monoclonais<SUP>4&#45;7</SUP>.</font>
</p>     ^cY#aop02-11.htm##
00636000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039000087002001300477#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#37#33#article#154#<p><font
 size="2" face="Verdana">O v&iacute;rus da raiva parece ter, nos morcegos hemat&
oacute;fagos, o melhor e mais eficiente ve&iacute;culo de propaga&ccedil;&atilde
;o, uma vez que, para se alimentar, atacam, diariamente, outros animais, que s&a
tilde;o suas presas e/ou seus pr&oacute;prios companheiros, nas intera&ccedil;&o
tilde;es sociais agressivas<SUP>8,9</SUP>.</font></p>     ^cY#aop02-11.htm##
00568000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032200087002001300409#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#38#34#article#154#<p><font
 size="2" face="Verdana">V&aacute;rios autores estudaram o comportamento desses 
morcegos, bem como, sua participa&ccedil;&atilde;o na transmiss&atilde;o da raiv
a; para tal, realizaram experimentos observando v&aacute;rios tipos de abrigos d
iurnos do <I>Desmodus </I>rotundus<SUP>9&#45;12</SUP>.</font></p>     ^cY#aop02-
11.htm##
00485000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704023900087002001300326#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#39#35#article#154#<p><font
 size="2" face="Verdana">O objetivo deste trabalho &eacute; estudar os morcegos,
 na regi&atilde;o oeste do Estado de S&atilde;o Paulo, relacionados com a dissem
ina&ccedil;&atilde;o do v&iacute;rus r&aacute;bico.</font></p>     ^cY#aop02-11.
htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#40#36#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00320000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007400087002001300161#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#41#37#article#154#<p><font
 size="3" face="Verdana"><b>M&Eacute;TODOS</b></font></p>     ^cY#aop02-11.htm##
00380000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013400087002001300221#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#42#38#article#154#<p><font
 size="2" face="Verdana"><B>Amostras para exame e testes para diagn&oacute;stico
 laboratorial da raiva</B></font></p>     ^cY#aop02-11.htm##
01063000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081700087002001300904#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#43#39#article#154#<p><font
 size="2" face="Verdana">As amostras para exame foram provenientes de morcegos n
&atilde;o hemat&oacute;fagos encaminhados ao Laborat&oacute;rio da Ag&ecirc;ncia
 Paulista de Tecnologia dos Agroneg&oacute;cios (APTA), P&oacute;lo da Alta Soro
cabana de Presidente Prudente, SP. Foram utilizados fragmentos do sistema nervos
o central para o preparo de l&acirc;minas e in&oacute;culos. Para o diagn&oacute
;stico laboratorial da raiva, empregou&#45;se o teste de imunofluoresc&ecirc;nci
a direta, conforme descrito por Dean &amp; Abelseth<SUP>13</SUP> e a prova biol&
oacute;gica (inocula&ccedil;&atilde;o em camundongos), de acordo com o m&eacute;
todo preconizado por Koprowski<SUP>14</SUP>. Ambas as t&eacute;cnicas s&atilde;o
 recomendadas pela Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de.</font></p>
     ^cY#aop02-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#44#40#article#154#<p><font
 size="2" face="Verdana"><B>Caracteriza&ccedil;&atilde;o antig&ecirc;nica</B></f
ont></p>     ^cY#aop02-11.htm##
00771000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052500087002001300612#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#45#41#article#154#<p><font
 size="2" face="Verdana">Para tipifica&ccedil;&atilde;o antig&ecirc;nica de vari
antes do v&iacute;rus r&aacute;bico, isoladas nas Am&eacute;rica, foi utilizado 
um painel com oito anticorpos monoclonais antinucleoprote&iacute;na fornecidos p
elo <I>Centers for Disease Control and Prevention</I> (CDC), Atlanta, GA, USA. C
ada amostra foi testada frente a esse painel pelo menos duas vezes, em lotes e d
ias diferentes, para verificar a reprodutibilidade da caracteriza&ccedil;&atilde
;o<SUP>5,6</SUP>.</font></p>     ^cY#aop02-11.htm##
00395000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014900087002001300236#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#46#42#article#154#<p><font
 size="2" face="Verdana"><B>Identifica&ccedil;&atilde;o e classifica&ccedil;&ati
lde;o das esp&eacute;cies de morcegos</B></font></p>     ^cY#aop02-11.htm##
00723000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047700087002001300564#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#47#43#article#154#<p><font
 size="2" face="Verdana">Utilizou&#45;se algumas chaves dicot&ocirc;micas, onde 
as caracter&iacute;sticas externas e morfom&eacute;tricas, de cada grupo, s&atil
de;o analisadas, tais como: tamanho de antebra&ccedil;o, cabe&ccedil;a&#45;corpo
, orelha, membrana interfemural, arcada dent&aacute;ria, cor de pelo, presen&cce
dil;a ou n&atilde;o de ap&ecirc;ndice nasal e de outras estruturas que possam di
stinguir cada esp&eacute;cie<SUP>15&#45;17</SUP>.</font></p>     ^cY#aop02-11.ht
m##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#48#44#article#154#<p><font
 size="2" face="Verdana"><B>M&eacute;todos de captura de morcegos</B></font></p>
     ^cY#aop02-11.htm##
01079000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704083300087002001300920#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#49#45#article#154#<p><font
 size="2" face="Verdana">Com base na orienta&ccedil;&atilde;o do Minist&eacute;r
io da Sa&uacute;de, conforme Manual de Manejo e Controle da Funda&ccedil;&atilde
;o Nacional de Sa&uacute;de<SUP>8</SUP>, que dependendo do habitat das col&ocirc
;nias, se aplicou o melhor m&eacute;todo de captura: manual, com pu&ccedil;&aacu
te; ou coador ou ainda com redes. Essas redes, mais usadas nas capturas, s&atild
e;o do tipo <I>rede de pesca</I>, com malhas pequenas, em torno de 2cm, e que fo
ram preparadas e expostas junto aos abrigos. As esp&eacute;cies capturadas, ap&o
acute;s diagn&oacute;stico laboratorial da raiva, foram congeladas em freezer a 
&#45;20ºC e, em seguida, encaminhadas ao Centro de Controle de Zoonoses (CCZ), d
a Prefeitura Municipal de S&atilde;o Paulo, para serem identificadas e classific
adas.</font></p>     ^cY#aop02-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009500087002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#50#46#article#154#<p><font
 size="2" face="Verdana"><B>Mapeamento de abrigos dos morcegos</B> </font></p>  
   ^cY#aop02-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019100087002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#51#47#article#154#<p><font
 size="2" face="Verdana">Para tal, fez&#45;se uso de um aparelho GPS da marca Ga
rmin, modelo <I>Etrex Legend</I> que determinou as coordenadas geogr&aacute;fica
s. </font></p>     ^cY#aop02-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010100087002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#52#48#article#154#<p><font
 size="2" face="Verdana"><B>Considera&ccedil;&otilde;es &eacute;ticas</B></font>
</p>     ^cY#aop02-11.htm##
00457000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021100087002001300298#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#53#49#article#154#<p><font
 size="2" face="Verdana">Quanto &agrave; &eacute;tica, este experimento seguiu a
 Lei nº 11.794 de 8 de outubro de 2008 que trata do procedimento para uso cient&
iacute;fico de animais.</font></p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#54#50#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#55#51#article#154#<p><font
 size="3" face="Verdana"><b>RESULTADOS</b></font></p>     ^cY#aop02-11.htm##
00948000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070200087002001300789#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#56#52#article#154#<p><font
 size="2" face="Verdana">No per&iacute;odo de 2006 a 2008, o laborat&oacute;rio 
recebeu 1.113 amostras de morcegos n&atilde;o hemat&oacute;fagos para diagn&oacu
te;stico laboratorial da raiva. A an&aacute;lise demonstrou que 11 (1%) delas fo
ram positivas e, dentre as positivas,  4 (36,4%) pertenceram &agrave; fam&iacute
;lia Phyllostomidae e 7 (63,6%) &agrave; fam&iacute;lia Vespertilionidae. Quanto
 &agrave; fauna de morcegos recebidos, a maioria pertenceu ao g&ecirc;nero Molos
sus, num total de 901 (80,9%) exemplares e, desses, 403 (44,3%) foram identifica
dos como <I>Molossus molossus</I> e 498 (55,7%) como <I>Molossus rufus </I><B>(<
a href="#tab01">Tabela 1</a>)</B>.</font></p>     ^cY#aop02-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#57#53#article#154#<p><a na
me="tab01"></a></p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#58#54#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#59#55#article#154#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a02tab01.jpg"></p>     ^cY#ao
p02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#60#56#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00968000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072200087002001300809#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#61#57#article#154#<p><font
 size="2" face="Verdana">Quando se fez uso da t&eacute;cnica de anticorpos monoc
lonais, nas 11 amostras positivas, 5 (45,5%) delas apresentaram variante 3 compa
t&iacute;vel com amostras isoladas de morcegos <I>D. rotundus,</I> prevalecendo 
a esp&eacute;cie <I>Artibeus lituratus</I>; 4 (36,5%) amostras foram associadas 
com &agrave;s de morcegos inset&iacute;voros, predominando a esp&eacute;cie <I>M
yotis nigricans</I>. Das 2 amostras restantes, 1 (9%) delas foi a variante 6 com
pat&iacute;vel com amostras do g&ecirc;nero Lasiurus e a outra (9%) foi incompat
&iacute;vel com o perfil do painel de anticorpos monoclonais pr&eacute;estabelec
ido no painel. <B>(<a href="#tab02">Tabela 2</a>).</B></font></p>     ^cY#aop02-
11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#62#58#article#154#<p><a na
me="tab02"></a></p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#63#59#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#64#60#article#154#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a02tab02.jpg"></p>     ^cY#ao
p02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#65#61#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00711000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046500087002001300552#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#66#62#article#154#<p><font
 size="2" face="Verdana">Quanto aos 16 abrigos diurnos de morcegos, 8 (50%) dele
s se caracterizaram, principalmente, sob a forma de casas abandonadas e em segui
da foram os t&uacute;neis em n&uacute;mero de 4 (25%). Encontrou&#45;se  2 (12,5
%) abrigos em forma de bueiro; 1 (6,2%) como ponte e 1 (6,2%) foi caracterizado 
como barrac&atilde;o subterr&acirc;neo <B>(<a href="#fig01">Figura 1</a> </B>e <
B><a href="#tab03">Tabela 3</a>)</B>.</font></p>     ^cY#aop02-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#67#63#article#154#<p><a na
me="fig01"></a></p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#68#64#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#69#65#article#154#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a02fig01.jpg"></p>     ^cY#ao
p02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#70#66#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#71#67#article#154#<p><a na
me="tab03"></a></p>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#72#68#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#73#69#article#154#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a02tab03.jpg"></p>     ^cY#ao
p02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#74#70#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00963000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071700087002001300804#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#75#71#article#154#<p><font
 size="2" face="Verdana">Em rela&ccedil;&atilde;o &agrave;s esp&eacute;cies enco
ntradas nos abrigos, foram capturados 126 exemplares, sendo que em apenas 2 dele
s (abrigo 1 e abrigo 7) n&atilde;o foi capturado morcego hemat&oacute;fago da es
p&eacute;cie <I>Desmodus rotundus</I>. A esp&eacute;cie <I>Carollia perspicillat
a</I> foi a mais coletada, em n&uacute;mero de 75 (59,5%), seguida da hemat&oacu
te;faga <I>Desmodus rotundus</I> com 41 (32,5%) exemplares, da <I>Glossophaga so
ricina </I>com 8 (6,4%) e, por &uacute;ltimo, a esp&eacute;cie <I>Platyrrhinus l
ineatus</I> com 2 (1,6%) exemplares, conforme mostra a <B><a href="/img/revistas
/rsbmt/2011nahead/a02tab04.jpg">Tabela 4</a></B>.</font></p>     ^cY#aop02-11.ht
m##
00424000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017800087002001300265#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#76#72#article#154#<p><font
 size="2" face="Verdana">Todas as esp&eacute;cies coletadas foram submetidas ao 
diagn&oacute;stico laboratorial da raiva e 100% delas foram negativas.</font></p
>     ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#77#73#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00322000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007600087002001300163#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#78#74#article#154#<p><font
 size="3" face="Verdana"><b>DISCUSS&Atilde;O</b></font></p>     ^cY#aop02-11.htm
##
01368000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704112200087002001301209#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#79#75#article#154#<p><font
 size="2" face="Verdana">Nos &uacute;ltimos anos, os casos de raiva em morcegos 
tem aumentado em S&atilde;o Paulo e outros estados do Brasil<SUP>3,18&#45;20</SU
P>. Segundo Sodr&eacute; cols<SUP>20</SUP>, a nova lista de morcegos positivos p
ara raiva consiste de 41 esp&eacute;cies pertencentes a 25 g&ecirc;neros e tr&ec
irc;s fam&iacute;lias: Phyllostomidae (43,9%), Vespertilionidae (29,3%) e Moloss
idae (26,8%). O experimento realizado na regi&atilde;o de Presidente Prudente, S
P diverge um pouco desses achados, apresentando maioria na esp&eacute;cie Vesper
tilionidae (63,6%) e em segundo a fam&iacute;lia Phyllostomidae (36,4%) e nenhum
 caso na fam&iacute;lia Molossidae, apesar do grande n&uacute;mero de amostras a
nalisadas. Este experimento se aproximou mais dos resultados encontrados por Que
iroz cols<SUP>21</SUP> que, na regi&atilde;o noroeste do Estado de S&atilde;o Pa
ulo, encontraram 70% de morcegos inset&iacute;voros contaminados com o v&iacute;
rus e 30% em frug&iacute;voros; e tamb&eacute;m, como em Presidente Prudente, ne
nhum caso foi registrado em morcego hemat&oacute;fago.</font></p>     ^cY#aop02-
11.htm##
00983000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704073700087002001300824#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#80#76#article#154#<p><font
 size="2" face="Verdana">Favoretto cols<SUP>6</SUP> realizaram tipifica&ccedil;&
atilde;o antig&ecirc;nica de amostras brasileiras do v&iacute;rus r&aacute;bico 
isolado de animais e humanos, no per&iacute;odo de 1989 a 2000, e detectaram mai
or variabilidade entre as amostras isoladas de morcegos inset&iacute;voros e a v
ariante mais comum isolada, entre as esp&eacute;cies, foi a variante 3 (<I>D. ro
tundus</I>), observa&ccedil;&atilde;o esta, que corrobora parcialmente com os re
sultados encontrados na regi&atilde;o oeste do Estado de S&atilde;o Paulo, uma v
ez que essa regi&atilde;o, tem detectado acentuado aumento no n&uacute;mero de v
ariantes que se associam com amostras de morcegos inset&iacute;voros.</font></p>
     ^cY#aop02-11.htm##
01098000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704085200087002001300939#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#81#77#article#154#<p><font
 size="2" face="Verdana">A variante 3 tem sido identificada em v&aacute;rias esp
&eacute;cies animais, principalmente c&atilde;es, gatos e bovinos<SUP>22&#45; 24
</SUP>. Smith<SUP>7</SUP> recomenda especial aten&ccedil;&atilde;o ao morcego <I
>D. rotundus</I> que mant&eacute;m o v&iacute;rus em esp&eacute;cies animais ter
restres. No caso da morte de uma pessoa, na regi&atilde;o de Presidente Prudente
, em 2001, ap&oacute;s exaustiva investiga&ccedil;&atilde;o epidemiol&oacute;gic
a, concluiu&#45;se que a v&iacute;tima adquiriu a doen&ccedil;a pela agress&atil
de;o de um gato, que deve ter adquirido o v&iacute;rus de um morcego n&atilde;o 
hemat&oacute;fago portador da variante 3, associada ao <I>D. rotundus</I>, uma v
ez que a tipifica&ccedil;&atilde;o do v&iacute;rus que vitimou a mulher foi dest
a variante<SUP>25</SUP>.</font></p>     ^cY#aop02-11.htm##
00879000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063300087002001300720#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#82#78#article#154#<p><font
 size="2" face="Verdana">Diferentemente de estudo anterior realizado, tamb&eacut
e;m, na regi&atilde;o de Presidente Prudente<SUP>4</SUP>, onde se identificou ap
enas a variante 3  (<I>D. rotundus</I>) e a variante 4 (<I>Tadarida brasiliensis
</I>), esta pesquisa mostra o aparecimento de v&aacute;rias amostras identificad
as com morcegos inset&iacute;voros do Brasil, principalmente, morcegos dos g&eci
rc;neros Eptesicus e Myotis. Todas as amostras referentes ao g&ecirc;nero <I>Art
ibeus</I> foram portadoras da variante 3, resultado esse que corrobora o encontr
ado por Delpietro cols<SUP>26</SUP>, em 1977.</font></p>     ^cY#aop02-11.htm##
00864000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061800087002001300705#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#83#79#article#154#<p><font
 size="2" face="Verdana">Quanto aos abrigos diurnos de morcegos hemat&oacute;fag
os estudados, todos eles (100%), caracterizaram&#45;se como artificiais e 50% co
mo casas abandonadas, e nenhum abrigo natural. Da Rocha<SUP>9</SUP>, estudando e
sses mesmos tipos de abrigos nas regi&otilde;es centro&#45;sul e centro&#45;lest
e do Estado de S&atilde;o Paulo, encontrou 54,5% de abrigos artificiais, envolve
ndo casas e bueiros e 45,5% foram abrigos naturais, como cavernas e grutas (este
s tipos de abrigos s&atilde;o praticamente inexistentes na regi&atilde;o oeste d
o Estado de S&atilde;o Paulo).</font></p>     ^cY#aop02-11.htm##
00706000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046000087002001300547#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#84#80#article#154#<p><font
 size="2" face="Verdana">Segundo Cortes cols<SUP>10</SUP>, os abrigos artificiai
s geralmente fornecem boas condi&ccedil;&otilde;es microclim&aacute;ticas (tempe
ratura est&aacute;vel, alta umidade e baixa luminosidade), costumam ser amplos, 
de f&aacute;cil acesso para os morcegos e est&atilde;o situados pr&oacute;ximos 
dos alimentos (o que reduz gastos energ&eacute;ticos com deslocamento e exposi&c
cedil;&atilde;o aos predadores).</font></p>     ^cY#aop02-11.htm##
00592000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704034600087002001300433#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#85#81#article#154#<p><font
 size="2" face="Verdana">Todas as esp&eacute;cies de morcegos coletadas e submet
idas ao diagn&oacute;stico laboratorial da raiva foram 100% negativas. Resultado
s estes, que corroboram com a pesquisa de Rupprecht<SUP>27</SUP>, segundo a qual
, os morcegos capturados em v&ocirc;os, sugerem menos que 1% de positividade. </
font></p>     ^cY#aop02-11.htm##
01446000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704120000087002001301287#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#86#82#article#154#<p><font
 size="2" face="Verdana">Os resultados encontrados refor&ccedil;am a necessidade
 dos &oacute;rg&atilde;os respons&aacute;veis pelo controle da raiva, na regi&at
ilde;o, concentrarem esfor&ccedil;os no sentido de encaminhar maior n&uacute;mer
o poss&iacute;vel de amostras para an&aacute;lise laboratorial, uma vez que o v&
iacute;rus r&aacute;bico se faz presente na regi&atilde;o, principalmente, em mo
rcegos n&atilde;o hemat&oacute;fagos que t&ecirc;m contatos diretos com animais 
dom&eacute;sticos e pessoas, submetendo os mesmos ao risco de cont&aacute;gio. O
 estudo pertinente &agrave;s variantes antig&ecirc;nicas do v&iacute;rus r&aacut
e;bico demonstrou mudan&ccedil;as neste perfil com o aparecimento de v&aacute;ri
as amostras identificadas com morcegos inset&iacute;voros do Brasil, sendo que e
m estudos anteriores havia predom&iacute;nio da variante 3. Com rela&ccedil;&ati
lde;o aos abrigos estudados, conclui&#45;se que pode haver alguma rela&ccedil;&a
tilde;o na dissemina&ccedil;&atilde;o do v&iacute;rus r&aacute;bico entre morceg
os hemat&oacute;fagos e n&atilde;o hemat&oacute;fagos, tendo em vista a coabita&
ccedil;&atilde;o existente entre as esp&eacute;cies.</font></p>     ^cY#aop02-11
.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#87#83#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00327000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008100087002001300168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#88#84#article#154#<p><font
 size="3" face="Verdana"><b>CONFLITO DE INTERESSE</b></font></p>     ^cY#aop02-1
1.htm##
00402000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704015600087002001300243#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#89#85#article#154#<p><font
 size="2" face="Verdana">Os autores declaram n&atilde;o haver nenhum tipo de con
flito de interesse no desenvolvimento do estudo.</font></p>     ^cY#aop02-11.htm
##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#90#86#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00324000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007800087002001300165#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#91#87#article#154#<p><font
 size="3" face="Verdana"><b>SUPORTE FINANCEIRO</b></font></p>     ^cY#aop02-11.h
tm##
00334000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008800087002001300175#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#92#88#article#154#<p><font
 size="2" face="Verdana">FAPESP, processo nº 05/59818&#45;6.</font></p>     ^cY#
aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#93#89#article#154#<p>&nbsp
;</p>     ^cY#aop02-11.htm##
00323000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007700087002001300164#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#94#90#article#154#<p><font
 size="3" face="Verdana"><b>REFER&Ecirc;NCIAS</b></font></p>     ^cY#aop02-11.ht
m##
00406000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704014600089002001300235#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#95#91#article#
154#1#<p><font size="2" face="Verdana">1. Batista HBCR, Franco AC, Roehe PM. Rai
va: uma breve revis&atilde;o. Acta Sci Vet 2007; 35:125&#45;144.    ^cY#aop02-11
.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#96#92#article#154#</font><
/p>     ^cY#aop02-11.htm##
00731000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704047100089002001300560#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#97#93#article#
154#2#<p><font size="2" face="Verdana">2. Organiza&ccedil;&atilde;o Panamericana
 da Sa&uacute;de. Centro Panamericano de Febre Aftosa.Organiza&ccedil;&atilde;o 
Mundial de Sa&uacute;de. Sistema de Informa&ccedil;&atilde;o Regional de Vigil&a
circ;ncia Epidemiol&oacute;gica da Raiva nas Am&eacute;ricas. &#91;acesso: 01 ju
n 2010&#93;. Dispon&iacute;vel em: <a href="http://siepi.panaftosa.org.br/anuais
.aspx" target="_blank">http://siepi.panaftosa.org.br/anuais.aspx</a>.    ^cY#aop
02-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#98#94#article#154#</font><
/p>     ^cY#aop02-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022400089002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#99#95#article#
154#3#<p><font size="2" face="Verdana">3. Albas A, Zocolaro PT, Rosa TZ, Cunha S
EM. Diagn&oacute;stico laboratorial da raiva na regi&atilde;o oeste do Estado de
 S&atilde;o Paulo. Rev Soc Bras Med Trop 2005; 38:493&#45;495.    ^cY#aop02-11.h
tm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#100#96#article#154#</font>
</p>     ^cY#aop02-11.htm##
00615000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704035400090002001300444#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#101#97#article
#154#4#<p><font size="2" face="Verdana">4. Albas A, Edson ANS, Louren&ccedil;o R
A, Favoretto SR, Sodr&eacute; MM. Perfil antig&ecirc;nico do v&iacute;rus da rai
va isolado de diferentes esp&eacute;cies de morcegos n&atilde;o hemat&oacute;fag
os da Regi&atilde;o de Presidente Prudente, Estado de S&atilde;o Paulo. Rev Soc 
Bras Med Trop 2009; 42:15&#45;17.    ^cY#aop02-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#102#98#article#154#</font>
</p>     ^cY#aop02-11.htm##
00467000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704020600090002001300296#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#103#99#article
#154#5#<p><font size="2" face="Verdana">5. Diaz AM, Papo S, Rodriguez A, Smith J
S. Antigenic analysis of rabies&#45;virus isolates from Latin America and the Ca
ribbean. Zent fur Vet B 1994; 41:153&#45;160.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#104#100#article#154#</font
></p>     ^cY#aop02-11.htm##
00539000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704027700091002001300368#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#105#101#articl
e#154#6#<p><font size="2" face="Verdana">6. Favoretto SR, Carrieri ML, Cunha EMS
, Aguiar EAC, Silva LHQ, Sodr&eacute; MM, et al. Antigenic typing of Brazilian r
abies samples isolated from animals and humans, 1989&#45;2000. Rev Inst Med Trop
 S&atilde;o Paulo 2002; 44:91&#45;95.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#106#102#article#154#</font
></p>     ^cY#aop02-11.htm##
00438000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704017600091002001300267#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#107#103#articl
e#154#7#<p><font size="2" face="Verdana">7. Smith JS. Monoclonal antibody studie
s of rabies in insectivorous bats of the United States. Rev Inf Dis 1988; 10 (su
pl):637&#45;643.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#108#104#article#154#</font
></p>     ^cY#aop02-11.htm##
00534000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704027200091002001300363#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#109#105#articl
e#154#8#<p><font size="2" face="Verdana">8. Bredt A, Ara&uacute;jo FAA, Caetano&
#45;Jr J, Rodrigues MGR, Yoshikawa M, Silva MMS. Morcegos em &aacute;reas urbana
s e rurais: Manual de manejo e controle. Bras&iacute;lia: Funda&ccedil;&atilde;o
 Nacional de Sa&uacute;de; 1998.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#110#106#article#154#</font
></p>     ^cY#aop02-11.htm##
00655000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704039300091002001300484#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#111#107#articl
e#154#9#<p><font size="2" face="Verdana">9. Rocha FA. Abrigos diurnos, agrupamen
tos e les&otilde;es corporais no morcego hemat&oacute;fago <I>Desmodus rotundus<
/I> (Chiroptera, Phyllostomidae) do Estado de S&atilde;o Paulo. &#91;Disserta&cc
edil;&atilde;o de Mestrado&#93;. &#91;Botucatu, SP&#93;: Faculdade de Medicina V
eterin&aacute;ria e Zootecnia. Universidade Estadual Paulista; 2005. 70p.    ^cY
#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#112#108#article#154#</font
></p>     ^cY#aop02-11.htm##
00501000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023800092002001300330#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#113#109#articl
e#154#10#<p><font size="2" face="Verdana">10. Cortes VA, Souza LC, Uieda W, Figu
eiredo AC. Abrigos diurnos e infec&ccedil;&atilde;o r&aacute;bica em morcegos de
 Botucatu, S&atilde;o Paulo, Brasil. Vet e Zoot Sao Paulo  1994; 6:179&#45;186. 
   ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#114#110#article#154#</font
></p>     ^cY#aop02-11.htm##
00571000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030800092002001300400#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#115#111#articl
e#154#11#<p><font size="2" face="Verdana">11. Taddei VA, Gon&ccedil;alves CA, Pe
dro WA, Tadei WJ, Kotait I, Arieta C. Distribui&ccedil;&atilde;o do morcego hema
t&oacute;fago <I>Desmodus rotundus</I> no Estado de S&atilde;o Paulo e a raiva d
os animais dom&eacute;sticos. Campinas: Impresso Especial CATI; 1991.    ^cY#aop
02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#116#112#article#154#</font
></p>     ^cY#aop02-11.htm##
00459000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019600092002001300288#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#117#113#articl
e#154#12#<p><font size="2" face="Verdana">12. Uieda W, Hayashi NM, Gomes LH, Sil
va MMS. Esp&eacute;cies de quir&oacute;pteros diagnosticadas com raiva no Brasil
. Bol Inst Pasteur 1996; 1:17&#45;36.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#118#114#article#154#</font
></p>     ^cY#aop02-11.htm##
00509000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024600092002001300338#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#119#115#articl
e#154#13#<p><font size="2" face="Verdana">13. Dean DJ, Abelseth MK, Atanasiu P. 
The fluorescent antibody. <I>In:</I> Meslin FX, Kaplan NM, Koprowski H, editors.
 Laboratory techniques in rabies.Geneva: World Health Organization; 1966. p. 80&
#45;87.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#120#116#article#154#</font
></p>     ^cY#aop02-11.htm##
00533000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027000092002001300362#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#121#117#articl
e#154#14#<p><font size="2" face="Verdana">14. Koprowski H. Routine laboratory pr
ocedures: The mouse inoculation test.  <I>In:</I> Meslin FX, Kaplan NM, Koprowsk
i H, editors. Laboratory techniques in rabies. 40th ed. Genebra: World Health Or
ganization; 1966. p. 88&#45;96.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#122#118#article#154#</font
></p>     ^cY#aop02-11.htm##
00478000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021500092002001300307#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#123#119#articl
e#154#15#<p><font size="2" face="Verdana">15. Gregorin R, Taddei VA. Chave Artif
icial para a Identifica&ccedil;&atilde;o de Moloss&iacute;deos Brasileiros (Mamm
alia, Chiroptera). Mastoz&#45;Neotrop 2002; 9:13&#45;32.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#124#120#article#154#</font
></p>     ^cY#aop02-11.htm##
00398000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704013500092002001300227#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#125#121#articl
e#154#16#<p><font size="2" face="Verdana">16. Nowak RM. Walker's Bats of the wor
ld. Baltimore: The Johns Hopkins University Press; 2003.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#126#122#article#154#</font
></p>     ^cY#aop02-11.htm##
00394000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704013100092002001300223#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#127#123#articl
e#154#17#<p><font size="2" face="Verdana">17. Taddei VA. Sistem&aacute;tica de Q
uir&oacute;pteros. Bol Inst Pasteur1996; 1:3&#45;15.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#128#124#article#154#</font
></p>     ^cY#aop02-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#129#125#articl
e#154#18#<p><font size="2" face="Verdana">18. Cunha EMS, Silva LHQ, Lara MCCSH, 
Nassar AFC, Albas A, Sodr&eacute; MM,    et al. Bat rabies in the north&#45;nort
hwester regions of the State of S&atilde;o Paulo,  Brazil: 1997&#45;2002. Rev Sa
ude Publica 2006; 40:1082&#45;1086.    ^cY#aop02-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#130#126#article#154# </fon
t></p>     ^cY#aop02-11.htm##
00520000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025700092002001300349#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#131#127#articl
e#154#19#<p><font size="2" face="Verdana">19. Scheffer KC, Carrieri ML, Albas A,
 Santos HCP, Kotait I, Ito FH. V&iacute;rus da raiva em quir&oacute;pteros natur
almente infectados no Estado de S&atilde;o Paulo, Brasil.  Rev Saude Publica 200
7; 41:389&#45;395.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#132#128#article#154#</font
></p>     ^cY#aop02-11.htm##
00452000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018900092002001300281#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#133#129#articl
e#154#20#<p><font size="2" face="Verdana">20. Sodr&eacute; MM, Gama AR, Almeida 
MF. Updated list of bat species positive for rabies in Brazil. Rev Inst Med Trop
 Sao Paulo 2010; 52:75&#45;81.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#134#130#article#154#</font
></p>     ^cY#aop02-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026900092002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#135#131#articl
e#154#21#<p><font size="2" face="Verdana">21. Queiroz LH, Carvalho C, Buso DS, F
errari CIL, Pedro WA. Perfil epidemiol&oacute;gico da raiva na regi&atilde;o Nor
oeste do Estado de S&atilde;o Paulo no per&iacute;odo de 1993 a 2007. Rev Soc Br
as Med Trop 2009; 42:9&#45;14.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#136#132#article#154#</font
></p>     ^cY#aop02-11.htm##
00520000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025700092002001300349#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#137#133#articl
e#154#22#<p><font size="2" face="Verdana">22. Ito M, Arai YT, Itou T, Sakai T. G
enetic characterization and geographic distribution of rabies viruses isolates i
n Brazil: Identification of two reservoirs, dogs and vampire bats. Virology 2001
; 284:214&#45;222.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#138#134#article#154#</font
></p>     ^cY#aop02-11.htm##
00489000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022600092002001300318#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#139#135#articl
e#154#23#<p><font size="2" face="Verdana">23. Roehe PM, Cunha AC, Rodrigues RR, 
Gon&ccedil;alves AR, Ribeiro CLG. Diagn&oacute;stico laboratorial da raiva no Ri
o Grande do Sul, Brasil. Bol Ofic Sanit Pan  1985; 102:464&#45;475.    ^cY#aop02
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#140#136#article#154#</font
></p>     ^cY#aop02-11.htm##
00517000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025400092002001300346#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#141#137#articl
e#154#24#<p><font size="2" face="Verdana">24. Sacramento DRV, Tordo N, Kotait I.
 Estudo molecular do v&iacute;rus da raiva isolado no Estado de S&atilde;o Paulo
. S&atilde;o Paulo: Anais da 7ª Reuni&atilde;o Anual do Instituto Biol&oacute;gi
co; 1994. p.15.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#142#138#article#154#</font
></p>     ^cY#aop02-11.htm##
00435000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017200092002001300264#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#143#139#articl
e#154#25#<p><font size="2" face="Verdana">25. Kotait I. Past In: Raiva humana ca
usada pela variante 3 <I>Desmodus rotundus</I>. Instituto Pasteur S&atilde;o Pau
lo 2003; 7:3.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#144#140#article#154#</font
></p>     ^cY#aop02-11.htm##
00507000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024400092002001300336#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#145#141#articl
e#154#26#<p><font size="2" face="Verdana">26. Delpietro HA, Gury&#45;Dhomen F, L
arghi OP, Mena&#45;Segura C, Abramo L. Monoclonal antibody characterization of r
abies virus strains isolated in the River Plate Basin. Zent Vet 1977; 44:477&#45
;483.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#146#142#article#154#</font
></p>     ^cY#aop02-11.htm##
00585000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032200092002001300414#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#147#143#articl
e#154#27#<p><font size="2" face="Verdana">27. Rupprecht CE. Evolution of public 
health recommendations for human rabies prophylaxis after bat exposure in the Un
ited States. <I>In</I>: Basgoz N, editor. Rethinking rabies risks sharpening cli
nical skills for a reemergence threat. Boston: Harvard Medical School; 2000. p. 
46.    ^cY#aop02-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#148#144#article#154#</font
></p>     ^cY#aop02-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#149#145#article#154#<p>&nb
sp;</p>     ^cY#aop02-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#150#146#article#154#<p>&nb
sp;</p>     ^cY#aop02-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018900089002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#151#147#article#154#<p><fo
nt size="2" face="Verdana"><b><a name="nt"></a><a href="#tx"><img src="/img/revi
stas/rsbmt/2011nahead/seta.jpg" border="0"></a> Endere&ccedil;o para correspond&
ecirc;ncia:</b>    ^cY#aop02-11.htm##
00278000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003000089002001300119#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#152#148#article#154#<br> D
r. Avelino Albas    ^cY#aop02-11.htm##
00287000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003900089002001300128#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#153#149#article#154#<br> R
. Fern&atilde;o Sales 555    ^cY#aop02-11.htm##
00299000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005100089002001300140#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#154#150#article#154#<br> 1
9570&#45;000 Regente Feij&oacute;, SP    ^cY#aop02-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004200089002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#155#151#article#154#<br> T
elefax: 55 18 3222&#45;8688.    ^cY#aop02-11.htm##
00349000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010100089002001300190#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#156#152#article#154#<br> e
&#45;mail: <a href="mailto:avealbas@yahoo.com.br">avealbas@yahoo.com.br</a></fon
t></p>     ^cY#aop02-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#157#153#article#154#<p><fo
nt size="2" face="Verdana">Recebido para publica&ccedil;&atilde;o em 28/06/2010 
   ^cY#aop02-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#p#158#154#article#154#<br>  
 Aceito em 08/11/2010</font></p>     ^cY#aop02-11.htm##
00510000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100017001080100
01600125012002900141030001300170710000200183065000900185064000500194031000300199
014000800202865000900210002001300219#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop02-11.htm#S#c#159#1#article#27#1#^rND^sBatista^nHBCR#^rND^sFranco^nA
C#^rND^sRoehe^nPM#Raiva: uma breve revisão^lpt#Acta Sci Vet#2#20070000#2007#35#1
25-144#20110000#aop02-11.htm##
00578000000000217000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170071000880180116001591100
00900275109001200284037004200296865000900338002001300347#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#160#2#article#27#2#Organização Pan
americana da Saúde^dCentro Panamericano de Febre Aftosa#Organização Mundial de S
aúde. Sistema de Informação Regional de Vigilância Epidemiológica da Raiva nas A
méricas^lpt#20100601#01 jun 2010#http://siepi.panaftosa.org.br/anuais.aspx#20110
000#aop02-11.htm##
00634000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100019001030100
01500122010001700137012007700154030002200231065000900253064000500262031000300267
014000800270865000900278002001300287035001000300801002200310#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#161#3#article#27#3#^rND^sAlbas
^nA#^rND^sZocolaro^nPT#^rND^sRosa^nTZ#^rND^sCunha^nSEM#Diagnóstico laboratorial 
da raiva na região oeste do Estado de São Paulo^lpt#Rev Soc Bras Med Trop#200500
00#2005#38#493-495#20110000#aop02-11.htm#0037-8682#Rev Soc Bras Med Trop##
00741000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100017001030100
01900120010002000139010001600159012015300175030002200328065000900350064000500359
031000300364014000600367865000900373002001300382035001000395801002200405#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#162#4#article#27#4
#^rND^sAlbas^nA#^rND^sEdson^nANS#^rND^sLourenço^nRA#^rND^sFavoretto^nSR#^rND^sSo
dré^nMM#Perfil antigênico do vírus da raiva isolado de diferentes espécies de mo
rcegos não hematófagos da Região de Presidente Prudente, Estado de São Paulo^lpt
#Rev Soc Bras Med Trop#20090000#2009#42#15-17#20110000#aop02-11.htm#0037-8682#Re
v Soc Bras Med Trop##
00591000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100014001030100
01900117010001600136012008500152030001500237710000200252065000900254064000500263
031000300268014000800271865000900279002001300288#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop02-11.htm#S#c#163#5#article#27#5#^rND^sDiaz^nAM#^rND^sPa
po^nS#^rND^sRodriguez^nA#^rND^sSmith^nJS#Antigenic analysis of rabies-virus isol
ates from Latin America and the Caribbean^len#Zent fur Vet B#2#19940000#1994#41#
153-160#20110000#aop02-11.htm##
00743000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100019001080100
01700127010001800144010001700162010001600179810000600195012009300201030002800294
06500090032206400050033103100030033601400060033986500090034500200130035403500100
0367801002800377#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.ht
m#S#c#164#6#article#27#6#^rND^sFavoretto^nSR#^rND^sCarrieri^nML#^rND^sCunha^nEMS
#^rND^sAguiar^nEAC#^rND^sSilva^nLHQ#^rND^sSodré^nMM#et al#Antigenic typing of Br
azilian rabies samples isolated from animals and humans, 1989-2000^len#Rev Inst 
Med Trop São Paulo#20020000#2002#44#91-95#20110000#aop02-11.htm#0036-4665#Rev In
st Med Trop São Paulo##
00523000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120085001040300
01200189710000200201065000900203064000500212031000300217032000700220014000800227
865000900235002001300244#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
02-11.htm#S#c#165#7#article#27#7#^rND^sSmith^nJS#Monoclonal antibody studies of 
rabies in insectivorous bats of the United States^len#Rev Inf Dis#2#19880000#198
8#10#^ssupl#637-643#20110000#aop02-11.htm##
00628000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160015000880160018001030160
02000121016002100141016001900162016001700181018006800198066000900266062002700275
065000900302064000500311865000900316002001300325#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop02-11.htm#S#c#166#8#article#27#8#^rND^sBredt^nA#^rND^sAr
aújo^nFAA#^rND^sCaetano-Jr^nJ#^rND^sRodrigues^nMGR#^rND^sYoshikawa^nM#^rND^sSilv
a^nMMS#Morcegos em áreas urbanas e rurais: Manual de manejo e controle^lpt#Brasí
lia#Fundação Nacional de Saúde#19980000#1998#20110000#aop02-11.htm##
00623000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160016000880180145001040510
00900249046000900258050007800267045000900345044000500354865000900359002001300368
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#167#9#arti
cle#27#9#^rND^sRocha^nFA#Abrigos diurnos, agrupamentos e lesões corporais no mor
cego hematófago Desmodus rotundus (Chiroptera, Phyllostomidae) do Estado de São 
Paulo^lpt#Mestrado#Botucatu#Universidade Estadual Paulista^dFaculdade de Medicin
a Veterinária e Zootecnia#20050000#2005#20110000#aop02-11.htm##
00599000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01500123010002100138012008100159030002100240710000200261065000900263064000500272
031000200277014000800279865000900287002001300296#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop02-11.htm#S#c#168#10#article#27#10#^rND^sCortes^nVA#^rND
^sSouza^nLC#^rND^sUieda^nW#^rND^sFigueiredo^nAC#Abrigos diurnos e infecção rábic
a em morcegos de Botucatu, São Paulo, Brasil^lpt#Vet e Zoot Sao Paulo#2#19940000
#1994#6#179-186#20110000#aop02-11.htm##
00662000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160017000900160020001070160
01600127016001600143016001600159016001600175018011300191066000900304062002300313
065000900336064000500345865000900350002001300359#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop02-11.htm#S#c#169#11#article#27#11#^rND^sTaddei^nVA#^rND
^sGonçalves^nCA#^rND^sPedro^nWA#^rND^sTadei^nWJ#^rND^sKotait^nI#^rND^sArieta^nC#
Distribuição do morcego hematófago Desmodus rotundus no Estado de São Paulo e a 
raiva dos animais domésticos^lpt#Campinas#Impresso Especial CATI#19910000#1991#2
0110000#aop02-11.htm##
00572000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100018001050100
01600123010001700139012006300156030001700219710000200236065000900238064000500247
031000200252014000600254865000900260002001300269#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop02-11.htm#S#c#170#12#article#27#12#^rND^sUieda^nW#^rND^s
Hayashi^nNM#^rND^sGomes^nLH#^rND^sSilva^nMMS#Espécies de quirópteros diagnostica
das com raiva no Brasil^lpt#Bol Inst Pasteur#2#19960000#1996#1#17-36#20110000#ao
p02-11.htm##
00649000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100019001050100
01800124012002900142016001700171016001700188016001900205018003600224066000700260
062002600267065000900293064000500302014000600307865000900313002001300322#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#171#13#article#27#
13#^rND^sDean^nDJ#^rND^sAbelseth^nMK#^rND^sAtanasiu^nP#The fluorescent antibody^
len#^rED^sMeslin^nFX#^rED^sKaplan^nNM#^rED^sKoprowski^nH#Laboratory techniques i
n rabies^len#Geneva#World Health Organization#19660000#1966#80-87#20110000#aop02
-11.htm##
00641000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900120062001090160
01700171016001700188016001900205018003600224063000300260066000800263062002600271
065000900297064000500306014000600311865000900317002001300326#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#172#14#article#27#14#^rND^sKop
rowski^nH#Routine laboratory procedures: The mouse inoculation test^len#^rED^sMe
slin^nFX#^rED^sKaplan^nNM#^rED^sKoprowski^nH#Laboratory techniques in rabies^len
#40#Genebra#World Health Organization#19660000#1966#88-96#20110000#aop02-11.htm#
#
00544000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080120
09200125030001500217710000200232065000900234064000500243031000200248014000600250
865000900256002001300265#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
02-11.htm#S#c#173#15#article#27#15#^rND^sGregorin^nR#^rND^sTaddei^nVA#Chave Arti
ficial para a Identificação de Molossídeos Brasileiros (Mammalia, Chiroptera)^lp
t#Mastoz-Neotrop#2#20020000#2002#9#13-32#20110000#aop02-11.htm##
00448000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160016000900180031001060660
01000137062003500147065000900182064000500191865000900196002001300205#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#174#16#article#27#16#^
rND^sNowak^nRM#Walker's Bats of the world^len#Baltimore#The Johns Hopkins Univer
sity Press#20030000#2003#20110000#aop02-11.htm##
00454000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900120031001070300
01700138710000200155065000900157064000500166031000200171014000500173865000900178
002001300187#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#
c#175#17#article#27#17#^rND^sTaddei^nVA#Sistemática de Quirópteros^lpt#Bol Inst 
Pasteur#2#19960000#1996#1#3-15#20110000#aop02-11.htm##
00724000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100017001070100
01800124010001800142010001500160010001600175810000700191012009300198030001800291
06500090030906400050031803100030032301400100032686500090033600200130034503500100
0358801001800368#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.ht
m#S#c#176#18#article#27#18#^rND^sCunha^nEMS#^rND^sSilva^nLHQ#^rND^sLara^nMCCSH#^
rND^sNassar^nAFC#^rND^sAlbas^nA#^rND^sSodré^nMM#et al.#Bat rabies in the north-n
orthwester regions of the State of São Paulo, Brazil: 1997-2002^len#Rev Saude Pu
blica#20060000#2006#40#1082-1086#20110000#aop02-11.htm#0034-8910#Rev Saude Publi
ca##
00699000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
01500128010001800143010001600161010001400177012008900191030001800280065000900298
06400050030703100030031201400080031586500090032300200130033203500100034580100180
0355#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#177#19
#article#27#19#^rND^sScheffer^nKC#^rND^sCarrieri^nML#^rND^sAlbas^nA#^rND^sSantos
^nHCP#^rND^sKotait^nI#^rND^sIto^nFH#Vírus da raiva em quirópteros naturalmente i
nfectados no Estado de São Paulo, Brasil^lpt#Rev Saude Publica#20070000#2007#41#
389-395#20110000#aop02-11.htm#0034-8910#Rev Saude Publica##
00602000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060100
01800121012006200139030002800201065000900229064000500238031000300243014000600246
865000900252002001300261035001000274801002800284#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop02-11.htm#S#c#178#20#article#27#20#^rND^sSodré^nMM#^rND^
sGama^nAR#^rND^sAlmeida^nMF#Updated list of bat species positive for rabies in B
razil^len#Rev Inst Med Trop Sao Paulo#20100000#2010#52#75-81#20110000#aop02-11.h
tm#0036-4665#Rev Inst Med Trop Sao Paulo##
00691000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
01500126010001900141010001600160012010300176030002200279065000900301064000500310
031000300315014000500318865000900323002001300332035001000345801002200355#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#179#21#article#27#
21#^rND^sQueiroz^nLH#^rND^sCarvalho^nC#^rND^sBuso^nDS#^rND^sFerrari^nCIL#^rND^sP
edro^nWA#Perfil epidemiológico da raiva na região Noroeste do Estado de São Paul
o no período de 1993 a 2007^lpt#Rev Soc Bras Med Trop#20090000#2009#42#9-14#2011
0000#aop02-11.htm#0037-8682#Rev Soc Bras Med Trop##
00676000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100013000900100015001030100
01400118010001500132012015100147030000900298065000900307064000500316031000400321
014000800325865000900333002001300342035001000355801000900365#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#180#22#article#27#22#^rND^sIto
^nM#^rND^sArai^nYT#^rND^sItou^nT#^rND^sSakai^nT#Genetic characterization and geo
graphic distribution of rabies viruses isolates in Brazil: Identification of two
 reservoirs, dogs and vampire bats^len#Virology#20010000#2001#284#214-222#201100
00#aop02-11.htm#0042-6822#Virology##
00619000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
02000122010002000142010001900162012006700181030001900248710000200267065000900269
064000500278031000400283014000800287865000900295002001300304#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#181#23#article#27#23#^rND^sRoe
he^nPM#^rND^sCunha^nAC#^rND^sRodrigues^nRR#^rND^sGonçalves^nAR#^rND^sRibeiro^nCL
G#Diagnóstico laboratorial da raiva no Rio Grande do Sul, Brasil^lpt#Bol Ofic Sa
nit Pan#2#19850000#1985#102#464-475#20110000#aop02-11.htm##
00580000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160022000900160015001120160
01600127018007000143066001000213053004600223055001200269054000800281014000300289
865000900292002001300301#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
02-11.htm#S#c#182#24#article#27#24#^rND^sSacramento^nDRV#^rND^sTordo^nN#^rND^sKo
tait^nI#Estudo molecular do vírus da raiva isolado no Estado de São Paulo^lpt#Sã
o Paulo#Reunião Anual do Instituto Biológico^n7^i1^i1#19940000^i1#1994^i1#15#201
10000#aop02-11.htm##
00497000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900120009001070180
05900116062002800175065000900203064000500212031000200217014000200219865000900221
002001300230#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#
c#183#25#article#27#25#^rND^sKotait^nI.#Past^len#Raiva humana causada pela varia
nte 3 Desmodus rotundus^lpt#Instituto Pasteur São Paulo#20030000#2003#7#3#201100
00#aop02-11.htm##
00644000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100021001100100
01700131010002100148010001600169012009900185030000900284710000200293065000900295
064000500304031000300309014000800312865000900320002001300329#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop02-11.htm#S#c#184#26#article#27#26#^rND^sDel
pietro^nHA#^rND^sGury-Dhomen^nF#^rND^sLarghi^nOP#^rND^sMena-Segura^nC#^rND^sAbra
mo^nL#Monoclonal antibody characterization of rabies virus strains isolated in t
he River Plate Basin^len#Zent Vet#2#19770000#1977#44#477-483#20110000#aop02-11.h
tm##
00657000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900120116001100160
01600226018008000242066000700322062002300329065000900352064000500361014000300366
865000900369002001300378#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
02-11.htm#S#c#185#27#article#27#27#^rND^sRupprecht^nCE#Evolution of public healt
h recommendations for human rabies prophylaxis after bat exposure in the United 
States^len#^rED^sBasgoz^nN#Rethinking rabies risks sharpening clinical skills fo
r a reemergence threat^len#Boston#Harvard Medical School#20000000#2000#46#201100
00#aop02-11.htm##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#o#1#
1#article#1#20110311#101245#aop03-11.htm#239##
05223000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301200670018201200620
02490100041003110100040003520100049003920100045004410100037004860700085005230700
08500608070008400693083172800777085000802505085002802513085002702541085001802568
08500620258608316790264808500080432708500300433508500290436508500180439408500620
44120580005044740580008044791170006044870720003044931120009044961110011045051140
00904516113001104525002001304536#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop03-11.htm#S#h#2#1#article#1#tr#en#br1.1#1#4.0#TAB#02#nd#nd#Rev. Soc. Bra
s. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110318#Health-related quality of
 life in patients with Chagas disease^len#Qualidade de vida relacionada à saúde 
na doença de Chagas^lpt#^rND^1A01 A02^nBruna Guimarães^sOliveira#^rND^1A02 A03^n
Mery Natali Silva^sAbreu#^rND^1A01 A02^nClaudia Drummond Guimarães^sAbreu#^rND^1
A01 A02^nManoel Otavio da Costa^sRocha#^rND^1A01 A02^nAntonio Luiz^sRibeiro#Univ
ersidade Federal de Minas Gerais^iA01^1Hospital das Clínicas^cBelo Horizonte^sMG
#Universidade Federal de Minas Gerais^iA02^1Faculdade de Medicina^cBelo Horizont
e^sMG#Universidade Federal de Minas Gerais^iA03^1Escola de Enfermagem^cBelo Hori
zonte^sMG#^len^aINTRODUCTION: Chagas disease (ChD) is a chronic illness related 
to significant morbidity and mortality that can affect the quality of life (QoL)
 of infected patients. However, there are few studies regarding QoL in ChD. The 
objectives of this study are to construct a health-related QoL (HRQoL) profile o
f ChD patients and compare this with a non-ChD (NChD) group to identify factors 
associated with the worst HRQoL scores in ChD patients. METHODS: HRQoL was inves
tigated in 125 patients with ChD and 21 NChD individuals using the Medical Outco
mes Study 36-item Short-Form (SF-36) and the Minnesota Living with Heart Failure
 Questionnaire (MLWHFQ). Patients were submitted to a standard protocol that inc
luded clinical examination, ECG, Holter monitoring, Doppler echocardiogram and a
utonomic function tests. RESULTS: HRQoL scores were significantly worse among th
e ChD group compared to the NChD group in the SF-36 domains of physical function
ing and role-emotional and in the MLWHFQ scale. For the ChD group, univariate an
alysis showed that HRQoL score quartiles were associated with level of education
, sex, marital status, use of medication, functional classification and cardiova
scular and gastrointestinal symptoms. In the multivariate analysis, female sex, 
fewer years of education, single status, worst functional classification, presen
ce of cardiovascular and gastrointestinal symptoms, associated illnesses, Dopple
r echocardiographic abnormalities and ventricular arrhythmia detected during Hol
ter monitoring were predictors of lower HRQoL scores. CONCLUSIONS: ChD patients 
showed worse HRQoL scores compared to NChD. For the ChD group, sociodemographic 
and clinical variables were associated with worst scores.#^dnd^i1#^tm^len^kQuali
ty of life^i1#^tm^len^kChagas disease^i1#^tm^len^kSF-36^i1#^tm^len^kMinnesota Li
ving with Heart Failure Questionnaire^i1#^lpt^aINTRODUÇÃO: A doença de Chagas (D
Ch) é associada à morbidade e mortalidade significativas e que pode afetar a qua
lidade de vida (QV) dos pacientes infectados. Entretanto, encontramos poucos est
udos sobre a QV na DCh. Os objetivos deste estudo são definir o perfil de qualid
ade de vida relacionada à saúde (QVRS) em pacientes com DCh, compará-lo com indi
víduos sem a doença de Chagas (NDCh) e encontrar os fatores associados com os pi
ores escores de QV para aqueles com DCh. MÉTODOS: A QVRS foi investigada em 125 
pacientes com DCh e 21 NDCh aplicando-se os questionários Medical Outcomes Study
 36-item short-Form (SF36) e Minnesota Living With Heart Failure Questionanaire 
(MLWHFQ). Os pacientes foram submetidos a exame clínico, ECG, monitorização por 
Holter, Doppler ecocardiograma e testes de função autonômicas. RESULTADOS: Os es
cores de QVRS nos domínios capacidade física e aspecto emocional do SF36 e na es
cala de MLWHFQ foram significativamente piores entre os pacientes com DCh. A aná
lise univariada mostrou associação dos escores QVRS e nível de formação, gênero,
 situação conjugal, uso de medicamentos, classe funcional e sintomas cardiovascu
lares e gastrointestinais. Na análise multivariada, sexo feminino, poucos anos d
e estudos, situação conjugal de solteiro, pior classificação funcional, presença
 de sintomas cardiovasculares e gastrointestinais, doenças associadas, alteração
 ao Doppler ecocardiograma e arritmia ventricular ao Holter foram preditores de 
pior QVRS. CONCLUSÕES: Pacientes com DCh apresentaram piores escores de QVRS qua
ndo comparados com NDCh. Para o grupo com DCh, variáveis sociodemográficas e clí
nicas se associaram aos piores escores.#^dnd^i2#^tm^lpt^kQualidade de vida^i2#^t
m^lpt^kDoença de Chagas^i2#^tm^lpt^kSF-36^i2#^tm^lpt^kMinnesota Living with Hear
t Failure Questionnaire^i2#CNPq#FAPEMIG#other#44#20100704#04/07/2010#20101018#18
/10/2010#aop03-11.htm##
05329000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301200740018201200690
02560100041003250100040003660100049004060100045004550100037005000700085005370700
08500622070008400707083177100791085000802562085002802570085002702598085001802625
08500620264308317210270508500080442608500300443408500290446408500180449308500690
45110580005045800580008045851170006045930720003045991120009046021110011046111140
00904622113001104631002001304642#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop03-11.htm#S#f#3#1#article#1#tr#en#br1.1#1#4.0#TAB#02#nd#nd#Rev. Soc. Bra
s. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110318#<b>Health-related quality
 of life in patients with Chagas disease</b>^len#<b>Qualidade de vida relacionad
a à saúde na doença de Chagas</b>^lpt#^rND^1A01 A02^nBruna Guimarães^sOliveira#^
rND^1A02 A03^nMery Natali Silva^sAbreu#^rND^1A01 A02^nClaudia Drummond Guimarães
^sAbreu#^rND^1A01 A02^nManoel Otavio da Costa^sRocha#^rND^1A01 A02^nAntonio Luiz
^sRibeiro#Universidade Federal de Minas Gerais^iA01^1Hospital das Clínicas^cBelo
 Horizonte^sMG#Universidade Federal de Minas Gerais^iA02^1Faculdade de Medicina^
cBelo Horizonte^sMG#Universidade Federal de Minas Gerais^iA03^1Escola de Enferma
gem^cBelo Horizonte^sMG#^len^a<b>INTRODUCTION:</b> Chagas disease (ChD) is a chr
onic illness related to significant morbidity and mortality that can affect the 
quality of life (QoL) of infected patients. However, there are few studies regar
ding QoL in ChD. The objectives of this study are to construct a health-related 
QoL (HRQoL) profile of ChD patients and compare this with a non-ChD (NChD) group
 to identify factors associated with the worst HRQoL scores in ChD patients. <b>
METHODS:</b> HRQoL was investigated in 125 patients with ChD and 21 NChD individ
uals using the Medical Outcomes Study 36-item Short-Form (SF-36) and the Minneso
ta Living with Heart Failure Questionnaire (MLWHFQ). Patients were submitted to 
a standard protocol that included clinical examination, ECG, Holter monitoring, 
Doppler echocardiogram and autonomic function tests. <b>RESULTS:</b> HRQoL score
s were significantly worse among the&nbsp;ChD&nbsp;group compared to the&nbsp;NC
hD group in the SF-36 domains of physical functioning and role-emotional and in 
the MLWHFQ scale. For the ChD group, univariate analysis showed that HRQoL score
 quartiles were associated with level of education, sex, marital status, use of 
medication, functional classification and cardiovascular and gastrointestinal sy
mptoms. In the multivariate analysis, female sex, fewer years of education, sing
le status, worst functional classification, presence of cardiovascular and gastr
ointestinal symptoms, associated illnesses, Doppler echocardiographic abnormalit
ies and ventricular arrhythmia detected during Holter monitoring were predictors
 of lower HRQoL scores. <b>CONCLUSIONS:</b> ChD patients showed worse HRQoL scor
es compared to NChD. For the ChD group, sociodemographic and clinical variables 
were associated with worst scores.#^dnd^i1#^tm^len^kQuality of life^i1#^tm^len^k
Chagas disease^i1#^tm^len^kSF-36^i1#^tm^len^kMinnesota Living with Heart Failure
 Questionnaire^i1#^lpt^a<b>INTRODUÇÃO:</b> A doença de Chagas (DCh) é associada 
à morbidade e mortalidade significativas e que pode afetar a qualidade de vida (
QV) dos pacientes infectados. Entretanto, encontramos poucos estudos sobre a QV 
na DCh. Os objetivos deste estudo são definir o perfil de qualidade de vida rela
cionada à saúde (QVRS) em pacientes com DCh, compará-lo com indivíduos sem a doe
nça de Chagas (NDCh) e encontrar os fatores associados com os piores escores de 
QV para aqueles com DCh. <b>MÉTODOS:</b> A QVRS foi investigada em 125 pacientes
 com DCh e 21 NDCh aplicando-se os questionários <i>Medical Outcomes Study 36-it
em short-Form</i> (SF36) e <i>Minnesota Living With Heart Failure Questionanaire
</i> (MLWHFQ). Os pacientes foram submetidos a exame clínico, ECG, monitorização
 por Holter, Doppler ecocardiograma e testes de função autonômicas. <b>RESULTADO
S:</b> Os escores de QVRS nos domínios capacidade física e aspecto emocional do 
SF36 e na escala de MLWHFQ foram significativamente piores entre os pacientes co
m DCh. A análise univariada mostrou associação dos escores QVRS e nível de forma
ção, gênero, situação conjugal, uso de medicamentos, classe funcional e sintomas
 cardiovasculares e gastrointestinais. Na análise multivariada, sexo feminino, p
oucos anos de estudos, situação conjugal de solteiro, pior classificação funcion
al, presença de sintomas cardiovasculares e gastrointestinais, doenças associada
s, alteração ao Doppler ecocardiograma e arritmia ventricular ao Holter foram pr
editores de pior QVRS. <b>CONCLUSÕES: </b>Pacientes com DCh apresentaram piores 
escores de QVRS quando comparados com NDCh. Para o grupo com DCh, variáveis soci
odemográficas e clínicas se associaram aos piores escores.#^dnd^i2#^tm^lpt^kQual
idade de vida^i2#^tm^lpt^kDoença de Chagas^i2#^tm^lpt^kSF-36^i2#^tm^lpt^k<i>Minn
esota Living with Heart Failure Questionnaire</i>^i2#CNPq#FAPEMIG#other#44#20100
704#04/07/2010#20101018#18/10/2010#aop03-11.htm##
05348000000000697000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108121000300112049000300115158000300118
03000260012103200060014706500090015301400070016203500100016922300090017901200670
01880120062002550100041003170100040003580100049003980100045004470100037004920700
08700529070008700616070008600703083172800789085000802517085002802525085002702553
08500180258008500620259808316790266008500080433908500300434708500290437708500180
44060850062044240580005044860580008044911170006044990720003045051120009045081110
01104517114000904528113001104537002001304548008008904561#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop03-11.htm#S#l#4#1#article#1#^a2011#tr#en#br1.1#1
#4.0#tab#02#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8682#2011
0318#Health-related quality of life in patients with Chagas disease^len#Qualidad
e de vida relacionada à saúde na doença de Chagas^lpt#^rND^1A01 A02^nBruna Guima
rães^sOliveira#^rND^1A02 A03^nMery Natali Silva^sAbreu#^rND^1A01 A02^nClaudia Dr
ummond Guimarães^sAbreu#^rND^1A01 A02^nManoel Otavio da Costa^sRocha#^rND^1A01 A
02^nAntonio Luiz^sRibeiro#^iA01^1Universidade Federal de Minas Gerais^2Hospital 
das Clínicas^cBelo Horizonte^sMG#^iA02^1Universidade Federal de Minas Gerais^2Fa
culdade de Medicina^cBelo Horizonte^sMG#^iA03^1Universidade Federal de Minas Ger
ais^2Escola de Enfermagem^cBelo Horizonte^sMG#^len^aINTRODUCTION: Chagas disease
 (ChD) is a chronic illness related to significant morbidity and mortality that 
can affect the quality of life (QoL) of infected patients. However, there are fe
w studies regarding QoL in ChD. The objectives of this study are to construct a 
health-related QoL (HRQoL) profile of ChD patients and compare this with a non-C
hD (NChD) group to identify factors associated with the worst HRQoL scores in Ch
D patients. METHODS: HRQoL was investigated in 125 patients with ChD and 21 NChD
 individuals using the Medical Outcomes Study 36-item Short-Form (SF-36) and the
 Minnesota Living with Heart Failure Questionnaire (MLWHFQ). Patients were submi
tted to a standard protocol that included clinical examination, ECG, Holter moni
toring, Doppler echocardiogram and autonomic function tests. RESULTS: HRQoL scor
es were significantly worse among the ChD group compared to the NChD group in th
e SF-36 domains of physical functioning and role-emotional and in the MLWHFQ sca
le. For the ChD group, univariate analysis showed that HRQoL score quartiles wer
e associated with level of education, sex, marital status, use of medication, fu
nctional classification and cardiovascular and gastrointestinal symptoms. In the
 multivariate analysis, female sex, fewer years of education, single status, wor
st functional classification, presence of cardiovascular and gastrointestinal sy
mptoms, associated illnesses, Doppler echocardiographic abnormalities and ventri
cular arrhythmia detected during Holter monitoring were predictors of lower HRQo
L scores. CONCLUSIONS: ChD patients showed worse HRQoL scores compared to NChD. 
For the ChD group, sociodemographic and clinical variables were associated with 
worst scores.#^dnd^i1#^tm^len^kQuality of life^i1#^tm^len^kChagas disease^i1#^tm
^len^kSF-36^i1#^tm^len^kMinnesota Living with Heart Failure Questionnaire^i1#^lp
t^aINTRODUÇÃO: A doença de Chagas (DCh) é associada à morbidade e mortalidade si
gnificativas e que pode afetar a qualidade de vida (QV) dos pacientes infectados
. Entretanto, encontramos poucos estudos sobre a QV na DCh. Os objetivos deste e
studo são definir o perfil de qualidade de vida relacionada à saúde (QVRS) em pa
cientes com DCh, compará-lo com indivíduos sem a doença de Chagas (NDCh) e encon
trar os fatores associados com os piores escores de QV para aqueles com DCh. MÉT
ODOS: A QVRS foi investigada em 125 pacientes com DCh e 21 NDCh aplicando-se os 
questionários Medical Outcomes Study 36-item short-Form (SF36) e Minnesota Livin
g With Heart Failure Questionanaire (MLWHFQ). Os pacientes foram submetidos a ex
ame clínico, ECG, monitorização por Holter, Doppler ecocardiograma e testes de f
unção autonômicas. RESULTADOS: Os escores de QVRS nos domínios capacidade física
 e aspecto emocional do SF36 e na escala de MLWHFQ foram significativamente pior
es entre os pacientes com DCh. A análise univariada mostrou associação dos escor
es QVRS e nível de formação, gênero, situação conjugal, uso de medicamentos, cla
sse funcional e sintomas cardiovasculares e gastrointestinais. Na análise multiv
ariada, sexo feminino, poucos anos de estudos, situação conjugal de solteiro, pi
or classificação funcional, presença de sintomas cardiovasculares e gastrointest
inais, doenças associadas, alteração ao Doppler ecocardiograma e arritmia ventri
cular ao Holter foram preditores de pior QVRS. CONCLUSÕES: Pacientes com DCh apr
esentaram piores escores de QVRS quando comparados com NDCh. Para o grupo com DC
h, variáveis sociodemográficas e clínicas se associaram aos piores escores.#^dnd
^i2#^tm^lpt^kQualidade de vida^i2#^tm^lpt^kDoença de Chagas^i2#^tm^lpt^kSF-36^i2
#^tm^lpt^kMinnesota Living with Heart Failure Questionnaire^i2#CNPq#FAPEMIG#othe
r#44#20100704#04/07/2010#20101018#18/10/2010#aop03-11.htm#Internet^ihttp://www.s
cielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011005000002##
00387000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704014300085002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#5#1#article#191#<p><font s
ize="4" face="Verdana"><B><a name="tx"></a>Health&#45;related quality of life in
 patients with Chagas disease</b></font></p>     ^cY#aop03-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#6#2#article#191#<p>&nbsp;<
/p>     ^cY#aop03-11.htm##
00382000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704013800085002001300223#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#7#3#article#191#<p><font s
ize="3" face="Verdana"><b>Qualidade de vida relacionada &agrave; sa&uacute;de na
 doen&ccedil;a de Chagas</b></font></p>     ^cY#aop03-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#8#4#article#191#<p>&nbsp;<
/p>     ^cY#aop03-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#9#5#article#191#<p>&nbsp;<
/p>     ^cY#aop03-11.htm##
00532000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704028700086002001300373#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#10#6#article#191#<p><font 
size="2" face="Verdana"><b>Bruna Guimar&atilde;es Oliveira<SUP>I,II</SUP>; Mery 
Natali Silva Abreu<SUP>II,III</SUP>; Claudia Drummond Guimar&atilde;es Abreu<SUP
>I,II</SUP>;  Manoel Otavio da Costa Rocha<SUP>I,II</SUP>; Antonio Luiz Ribeiro<
SUP>I,II</SUP></b></font></p>     ^cY#aop03-11.htm##
00384000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013900086002001300225#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#11#7#article#191#<p><font 
size="2" face="Verdana"><sup>I</sup>Hospital das Cl&iacute;nicas, Universidade F
ederal de Minas Gerais, Belo Horizonte, MG    ^cY#aop03-11.htm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704010900086002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#12#8#article#191#<br>     
<sup>II</sup>Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo H
orizonte, MG    ^cY#aop03-11.htm##
00366000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704012100086002001300207#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#13#9#article#191#<br>     
<sup>III</sup>Escola de Enfermagem, Universidade Federal de Minas Gerais, Belo H
orizonte, MG</font></p>     ^cY#aop03-11.htm##
00327000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008100087002001300168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#14#10#article#191#<p><font
 size="2" face="Verdana"><a href="#nt">Address to</a></font></p>     ^cY#aop03-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#15#11#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#16#12#article#191#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop03-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006800087002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#17#13#article#191#<p><font
 size="2" face="Verdana"><B>ABSTRACT</B></font></p>     ^cY#aop03-11.htm##
00741000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049500087002001300582#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#18#14#article#191#<p><font
 size="2" face="Verdana"><B>INTRODUCTION:</B> Chagas disease (ChD) is a chronic 
illness related to significant morbidity and mortality that can affect the quali
ty of life (QoL) of infected patients. However, there are few studies regarding 
QoL in ChD. The objectives of this study are to construct a health&#45;related Q
oL (HRQoL) profile of ChD patients and compare this with a non&#45;ChD (NChD) gr
oup to identify factors associated with the worst HRQoL scores in ChD patients. 
   ^cY#aop03-11.htm##
00647000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040100087002001300488#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#19#15#article#191#<br>  <B
>METHODS:</B> HRQoL was investigated in 125 patients with ChD and 21 NChD indivi
duals using the Medical Outcomes Study 36&#45;item Short&#45;Form (SF&#45;36) an
d the Minnesota Living with Heart Failure Questionnaire (MLWHFQ). Patients were 
submitted to a standard protocol that included clinical examination, ECG, Holter
 monitoring, Doppler echocardiogram and autonomic function tests.    ^cY#aop03-1
1.htm##
01038000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704079200087002001300879#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#20#16#article#191#<br>  <B
>RESULTS:</B> HRQoL scores were significantly worse among the&nbsp;ChD&nbsp;grou
p compared to the&nbsp;NChD group in the SF&#45;36 domains of physical functioni
ng and role&#45;emotional and in the MLWHFQ scale. For the ChD group, univariate
 analysis showed that HRQoL score quartiles were associated with level of educat
ion, sex, marital status, use of medication, functional classification and cardi
ovascular and gastrointestinal symptoms. In the multivariate analysis, female se
x, fewer years of education, single status, worst functional classification, pre
sence of cardiovascular and gastrointestinal symptoms, associated illnesses, Dop
pler echocardiographic abnormalities and ventricular arrhythmia detected during 
Holter monitoring were predictors of lower HRQoL scores.    ^cY#aop03-11.htm##
00443000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019700087002001300284#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#21#17#article#191#<br>  <B
>CONCLUSIONS:</B> ChD patients showed worse HRQoL scores compared to NChD. For t
he ChD group, sociodemographic and clinical variables were associated with worst
 scores. </font></p>     ^cY#aop03-11.htm##
00432000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018600087002001300273#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#22#18#article#191#<p><font
 size="2" face="Verdana"><B>Keywords: </B>Quality of life. Chagas disease. SF&#4
5;36. Minnesota Living with Heart Failure Questionnaire.</font></p> <hr size="1"
 noshade>     ^cY#aop03-11.htm##
00312000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006600087002001300153#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#23#19#article#191#<p><font
 size="2" face="Verdana"><B>RESUMO</B></font></p>     ^cY#aop03-11.htm##
00849000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060300087002001300690#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#24#20#article#191#<p><font
 size="2" face="Verdana"><B>INTRODU&Ccedil;&Atilde;O:</B> A doen&ccedil;a de Cha
gas (DCh) &eacute;  associada &agrave; morbidade e mortalidade significativas e 
que pode afetar a qualidade de vida (QV) dos pacientes infectados. Entretanto, e
ncontramos poucos estudos sobre a QV na DCh. Os objetivos deste estudo s&atilde;
o definir o perfil de qualidade de vida relacionada &agrave; sa&uacute;de (QVRS)
 em pacientes com DCh, compar&aacute;&#45;lo com indiv&iacute;duos sem a doen&cc
edil;a de Chagas (NDCh) e encontrar os fatores associados com os piores escores 
de QV para aqueles com DCh.    ^cY#aop03-11.htm##
00689000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044300087002001300530#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#25#21#article#191#<br>  <B
>M&Eacute;TODOS:</B> A QVRS foi investigada em 125 pacientes com DCh e 21 NDCh a
plicando&#45;se os question&aacute;rios <I>Medical Outcomes Study 36&#45;item sh
ort&#45;Form</I> (SF36) e <I>Minnesota Living With Heart Failure Questionanaire<
/I> (MLWHFQ). Os pacientes foram submetidos a exame cl&iacute;nico, ECG, monitor
iza&ccedil;&atilde;o por Holter, Doppler ecocardiograma e testes de fun&ccedil;&
atilde;o auton&ocirc;micas.    ^cY#aop03-11.htm##
01073000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704082700087002001300914#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#26#22#article#191#<br>  <B
>RESULTADOS:</B> Os escores de QVRS nos dom&iacute;nios capacidade f&iacute;sica
 e aspecto emocional do SF36 e na escala de MLWHFQ foram significativamente pior
es entre os pacientes com DCh. A an&aacute;lise univariada mostrou associa&ccedi
l;&atilde;o dos escores QVRS e n&iacute;vel de forma&ccedil;&atilde;o, g&ecirc;n
ero, situa&ccedil;&atilde;o conjugal, uso de medicamentos, classe funcional e si
ntomas cardiovasculares e gastrointestinais. Na an&aacute;lise multivariada, sex
o feminino, poucos anos de estudos, situa&ccedil;&atilde;o conjugal de solteiro,
 pior classifica&ccedil;&atilde;o funcional, presen&ccedil;a de sintomas cardiov
asculares e gastrointestinais, doen&ccedil;as associadas, altera&ccedil;&atilde;
o ao Doppler ecocardiograma e arritmia ventricular ao Holter foram preditores de
 pior QVRS.    ^cY#aop03-11.htm##
00496000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025000087002001300337#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#27#23#article#191#<br>  <B
>CONCLUS&Otilde;ES: </B>Pacientes com DCh apresentaram piores escores de QVRS qu
ando comparados com NDCh. Para o grupo com DCh, vari&aacute;veis sociodemogr&aac
ute;ficas  e cl&iacute;nicas se associaram aos piores escores.</font></p>     ^c
Y#aop03-11.htm##
00461000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021500087002001300302#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#28#24#article#191#<p><font
 size="2" face="Verdana"><B>Palavras&#45;chaves:</B> Qualidade de vida. Doen&cce
dil;a de Chagas. SF&#45;36. <I>Minnesota Living with Heart Failure Questionnaire
.</I></font></p> <hr size="1" noshade>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#29#25#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#30#26#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00318000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007200087002001300159#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#31#27#article#191#<p><font
 size="3" face="Verdana"><b>INTRODUCTION</b></font></p>     ^cY#aop03-11.htm##
00959000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071300087002001300800#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#32#28#article#191#<p><font
 size="2" face="Verdana">Evaluation of quality of life (QoL) has been increasing
ly used to monitor and manage care strategies, clinical investigations, allocati
on of resources and to monitor the integration of new technologies<SUP>1&#45;3</
SUP>. Focusing on clinical outcomes that have an impact on the patient's life is
 one of the principles of evidence&#45;based medicine. Hence, QoL is not only a 
concern for patients, their families and doctors, but also for the health policy
 makers and the healthcare industry. Knowledge concerning the impact of diseases
 on the QoL of patients can improve planning and allocation of resources for res
earch, training and health care<SUP>4</SUP>. </font></p>     ^cY#aop03-11.htm##
00683000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043700087002001300524#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#33#29#article#191#<p><font
 size="2" face="Verdana">The definition and scope of the term <I>quality of life
</I> requires a thorough discussion. In this article, health&#45;related QoL (HR
QoL) is taken to be a measure that quantifies the patient's perception of the fu
nctional effects of the illness and treatment on different aspects of life, cons
idering the subjectivity of the physical, emotional and social dimensions<SUP>5,
6</SUP>. </font></p>     ^cY#aop03-11.htm##
00900000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704065400087002001300741#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#34#30#article#191#<p><font
 size="2" face="Verdana">Generic and specific measurement instruments can be use
d to evaluate HRQoL. The generic instruments, such as health profiles and utilit
y measurements, are applicable to a large variety of populations and pathologies
, allowing for comparison of different groups. They are most appropriate to epid
emiological studies and to planning and evaluation in the healthcare system. The
 utility measurements are most widely used for cost analysis. In contrast, speci
fic instruments are directed at evaluating individual and specific aspects of HR
QoL following illness, injury or medical intervention<SUP>7</SUP>.</font></p>   
  ^cY#aop03-11.htm##
00893000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064700087002001300734#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#35#31#article#191#<p><font
 size="2" face="Verdana">The generic Short&#45;Form Health Survey (SF&#45;36) wa
s developed in the early 1990s<SUP>8</SUP> and has been translated into Portugue
se and validated<SUP>9</SUP>. The SF&#45;36 has proven to be very useful with ge
neral populations and specific subgroups for comparing the impact of diverse dis
eases and treatments. It is currently the most commonly used generic instrument 
in Brazilian and international studies. The MLWHFQ is a specific instrument for 
evaluating patients with heart failure developed by Rector et al<SUP>10</SUP> an
d translated into Portuguese and validated<SUP>11,12</SUP>.</font></p>     ^cY#a
op03-11.htm##
00552000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030600087002001300393#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#36#32#article#191#<p><font
 size="2" face="Verdana">Despite the recognized importance of using HRQoL instru
ments when evaluating the effects of diseases and their treatments, particularly
 chronic diseases<SUP>4</SUP>, very few studies exist in research databases invo
lving HRQoL profiles of the ChD group.</font></p>     ^cY#aop03-11.htm##
00943000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704069700087002001300784#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#37#33#article#191#<p><font
 size="2" face="Verdana">Defined as the presence of infection from <I>Trypanosom
a cruzi</I>, ChD is part of a group of diseases that affect vulnerable populatio
ns and is associated with underdevelopment and poverty. According to the report 
of the WHO Scientific Work Group, ChD still represented a health threat in Latin
 America in 2006. Considering the information from 21 countries where the diseas
e is endemic, it is estimated that 7.7 million people are infected, presenting v
arying degrees of complications of medico&#45;social significance<SUP>13</SUP>. 
ChD is one of the principal causes of death from infectious disease, with 10,000
 deaths in 2008<SUP>14</SUP>.</font></p>     ^cY#aop03-11.htm##
01199000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704095300087002001301040#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#38#34#article#191#<p><font
 size="2" face="Verdana">In recent decades in Brazil, it is estimated that about
 6,000 patients have died each year due to ChD&#45;related causes, despite the e
ffectiveness of public policy measures. This means that it is still a significan
t public health problem, with about 3.5 million chronic patients remaining, of w
hich about 20% to 30% present cardiac impairment<SUP>15</SUP>. It is a chronic d
isease that mainly affects individuals of productive age and can be incapacitati
ng and debilitating. It is one of the main causes of early retirement and has ha
d a large social, economic and cultural impact<SUP>16</SUP>. The great variation
 in the clinical development of ChD, the lack of understanding of the mechanisms
 responsible for its progression and the wide spectrum of clinical, emotional an
d social manifestations<SUP>17,18</SUP> add to the importance of investigating t
he impact of ChD on the QoL of the patients. </font></p>     ^cY#aop03-11.htm##
00529000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028300087002001300370#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#39#35#article#191#<p><font
 size="2" face="Verdana">The objectives of this study were evaluate the HRQoL pr
ofile of ChD patients and compare it with a control group without Chagas disease
 (NChD) to identify the factors associated with the worst scores and, consequent
ly, poorer QoL.</font></p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#40#36#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006700087002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#41#37#article#191#<p><font
 size="3" face="Verdana"><b>METHODS</b></font></p>     ^cY#aop03-11.htm##
01504000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704125800087002001301345#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#42#38#article#191#<p><font
 size="2" face="Verdana">This transversal study was conducted between 2004 and 2
006 at the Clinical Hospital of the Federal University of Minas Gerais and the I
nfectious and Orestes Diniz Parasitic Disease Training and Reference Center (CTR
&#45;DIP). The patients studied were participants in a longitudinal prospective 
study begun in 1998 entitled: <I>Autonomic dysfunction in ChD: mechanisms and pr
ognostic implications</I>, which primarily involves patients without systemic il
lnesses who are or have been treated at the above&#45;mentioned health facility.
 During the follow&#45;up evaluation, 165 patients, of which 139 were ChD and 26
 NChD, were invited and agreed to participate. No additional exclusion criteria 
were used. The group was composed of those who provided free, informed consent. 
Nineteen patients were excluded because of incomplete exams. The group evaluated
 consisted of 146 patients, 125&nbsp;with ChD&nbsp;and 21 healthy controls (NChD
 group). A definite serological status for ChD was defined by the presence of tw
o or more different positive reactions to <I>Tripanossoma cruzi</I> (indirect im
munofluorescence, ELISA, indirect haemagglutination or complement fixation) in p
atients at risk of infection. </font></p>     ^cY#aop03-11.htm##
01326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704108000087002001301167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#43#39#article#191#<p><font
 size="2" face="Verdana">Patients were subjected to an initial standardized cons
ultation that was conducted by experienced cardiologists and trained personnel. 
The following information was gathered: I) demographic characteristics: sex, age
, skin color, marital status and educational level; II) clinical features: systo
lic and diastolic arterial pressure, heart rate, weight, height and calculated b
ody mass index, associated illnesses, use of continuous medication, the presence
 of cardiovascular and gastrointestinal ChD&#45;related symptoms;  III) function
al classification: using the Goldman scale, from Class I (no limitation to physi
cal activities and absence of symptoms) to Class IV (incapacity in physical acti
vities with symptoms even at rest)<SUP>19</SUP>; IV) level of physical activity:
 subjects were classified into two groups according to the International Physica
l Activity Questionnaire (IPAQ) as insufficiently active (sedentary + irregularl
y active) and sufficiently active (regularly active + active, very active)<SUP>2
0,21</SUP>; </font></p>     ^cY#aop03-11.htm##
01824000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704157800087002001301665#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#44#40#article#191#<p><font
 size="2" face="Verdana">Complementary tests included: ECG, 24&#45;hour Holter m
onitoring, Doppler echocardiogram and autonomic function evaluation, including s
hort tests (Valsalva maneuver and respiratory sinus arrhythmia) and 24&#45;hour 
heart rate variability analysis. The methodology used for these tests has been p
reviously described by our research group<SUP>22,23</SUP>. The examinations were
 conducted and analyzed by experienced cardiologists who were blind to the serol
ogical profile of the patients and used the following classification parameters:
    I) electrocardiogram: abnormal in accordance with the ChD&#45;specific Bueno
s Aires criterion<SUP>24,25</SUP>; II) ventricular arrhythmia detected during Ho
lter monitoring: presence of nonsustained ventricular tachycardia or more than t
en ventricular extrasystoles per hour<SUP>25</SUP>; III) abnormal Doppler echoca
rdiogram considering the presence of one of the following abnormalities: left ve
ntricular ejection fraction (LVEF) &lt; 0.50, right ventricle (RV) &gt; 56mm, le
ft atrium (LA)  &gt; 40mm, presence of apical aneurysm or alteration in contract
ility; IV) abnormal autonomic function tests, considering the presence of one of
 the following abnormalities: heart rate variability with a standard deviation f
or normal cardiac intervals (SDNN) &lt; 75ms on the 24h recordings, Valsalva rat
io &lt; 1.5 or respiratory sinus arrhythmia with a ratio of the greatest expirat
ory interval over the smallest inspiratory interval (mean of six respiratory cyc
les) &lt; 1.1<SUP>22,23</SUP>.</font></p>     ^cY#aop03-11.htm##
00491000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704024500087002001300332#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#45#41#article#191#<p><font
 size="2" face="Verdana">To evaluate HRQoL, interviews were conducted by trained
 professionals using the SF&#45;36 generic multidimensional questionnaire<SUP>8<
/SUP> and the specific questionnaire MLWHFQ<SUP>10</SUP>.</font></p>     ^cY#aop
03-11.htm##
00851000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060500087002001300692#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#46#42#article#191#<p><font
 size="2" face="Verdana">The SF&#45;36 is divided into eight domains: physical f
unctioning, role&#45;physical, bodily pain, general health, vitality, social fun
ctioning, role&#45;emotional and mental health, as well as into two summary comp
onents: physical component summary (physical functioning, role&#45;physical, bod
ily pain, general health, vitality) and mental component summary (mental health,
 role&#45;emotional, social functioning, vitality, and general health). The resu
lt is expressed as a score varying from 0 (the most impaired) to 100 (no impairm
ent)<SUP>9</SUP>.</font></p>     ^cY#aop03-11.htm##
00674000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042800087002001300515#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#47#43#article#191#<p><font
 size="2" face="Verdana">The MLWHFQ consists of 21 questions covering physical, 
socioeconomic and psychological dimensions of life relative to the limitations f
requently associated with the profile of cardiac insufficiency. The final score 
is the sum of the responses and varies from 0 (no impairment) to 105 (total impa
irment). The higher the score, the worse the quality of life<SUP>12,26,27</SUP>.
</font></p>     ^cY#aop03-11.htm##
00326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008000087002001300167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#48#44#article#191#<p><font
 size="2" face="Verdana"><B>Statistical analysis</B></font></p>     ^cY#aop03-11
.htm##
00729000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048300087002001300570#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#49#45#article#191#<p><font
 size="2" face="Verdana">For the categorical variables, either the Chi square or
 Fisher exact tests were used to compare the demographic, clinical and complemen
tary examination aspects of the NChD and ChD groups. For continuous variables, i
ncluding the QoL scores, the Mann&#45;Whitney test was used. In all analyses, a 
level of 5% was considered to be significant. Nonparametric tests were chosen be
cause of the asymmetric nature of the variables tested.</font></p>     ^cY#aop03
-11.htm##
01061000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081500087002001300902#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#50#46#article#191#<p><font
 size="2" face="Verdana">To evaluate the factors associated with QoL in the&nbsp
;ChD&nbsp;group, five different outcome variables were used: physical and mental
 component summary and domains which showed significant differences in QoL betwe
en the ChD and NChD groups, the physical functioning and role&#45;emotional from
 the SF&#45;36 scale, and the MLWHFQ. For all of the variables, except the SF&#4
5;36 role&#45;emotional scale, the Qol scores were coded with an ordinal variabl
e with four categories, which used the quartiles as cutoff points. The role&#45;
emotional scale was not recoded because it always produces a variable with four 
categories: scores 0, 33, 67, and 100. The explanatory variables were the clinic
al, sociodemographic and complementary examination characteristics.</font></p>  
   ^cY#aop03-11.htm##
00734000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048800087002001300575#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#51#47#article#191#<p><font
 size="2" face="Verdana">The ordinal logistic regression model was used for the 
univariate and multivariate analysis and the proportional odds model was chosen.
 In the model for the role&#45;emotional domain, due to the discrete distributio
n of data (scores of 0, 33, 66, and 100), the stereotype ordinal logistic regres
sion model was also performed, but the results were similar to those of the prop
ortional odds model, which was the one chosen<SUP>28</SUP>. </font></p>     ^cY#
aop03-11.htm##
00981000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704073500087002001300822#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#52#48#article#191#<p><font
 size="2" face="Verdana">The logistic regression procedure began with the select
ion of variables that had a p&#45;value of <u>&lt;</u> 0.20 in the univariate an
alysis and later was adjusted by eliminating individual variables. The criterion
 for the variables to remain in the final model was a p value <u>&lt;</u> 0.05 (
Wald test). The <I>odds ratio</I> (OR) and confidence interval (CI) was estimate
d for each covariable. This model provides a single OR estimate for all of the c
ategories compared, due to the proportional odds assumption, which was tested fo
r all of the variables individually and for the final model. A deviance test was
 used to evaluate the model's goodness&#45;of&#45;fit<SUP>29</SUP>.</font></p>  
   ^cY#aop03-11.htm##
00328000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008200087002001300169#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#53#49#article#191#<p><font
 size="2" face="Verdana"><B>Ethical considerations</B></font></p>     ^cY#aop03-
11.htm##
00739000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049300087002001300580#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#54#50#article#191#<p><font
 size="2" face="Verdana">This study involved reciprocal agreement between the re
searcher and the research line coordinator and was assessed and approved by the 
COEP UFMG (Research Ethics Committee of the Federal University of Minas Gerais).
 All of the study participants signed the informed consent forms and received wr
itten examination results, as well as the recommendations and appropriate referr
als, while being treated as usual in the specialized health unit.</font></p>    
 ^cY#aop03-11.htm##
00560000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031400087002001300401#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#55#51#article#191#<p><font
 size="2" face="Verdana">The WHO's recommendations and the Helsinki Declaration 
of 1975 were taken into consideration, along with Resolution 196/96 of the Minis
try of Health on Research involving Human Beings, to ensure that the rights and 
well&#45;being of the subjects were respected.</font></p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#56#52#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006700087002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#57#53#article#191#<p><font
 size="3" face="Verdana"><b>RESULTS</b></font></p>     ^cY#aop03-11.htm##
00379000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013300087002001300220#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#58#54#article#191#<p><font
 size="2" face="Verdana"><B>Demographic, clinical, and com&#45;plementary examin
ation characteristics</B></font></p>     ^cY#aop03-11.htm##
00843000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059700087002001300684#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#59#55#article#191#<p><font
 size="2" face="Verdana">The sociodemographic and clinical features and compleme
ntary test results of the ChD and NChD subjects are presented in <B><a href="#ta
b01">Table 1</a></B>. Significant differences were observed in the level of educ
ation, percentage of obese participants, frequency of use of medication, reports
 of cardiovascular symptoms, median cardiac frequency, systolic and diastolic ar
terial pressure, abnormal ECG, abnormal Doppler echocardiogram, ventricular arrh
ythmia detected during Holter monitoring and abnormality in the autonomic functi
on tests.</font></p>     ^cY#aop03-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#60#56#article#191#<p><a na
me="tab01"></a></p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#61#57#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#62#58#article#191#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a03tab01.jpg"></p>     ^cY#ao
p03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#63#59#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00321000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007500087002001300162#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#64#60#article#191#<p><font
 size="2" face="Verdana"><B>Quality of life</B></font></p>     ^cY#aop03-11.htm#
#
01209000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704096300087002001301050#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#65#61#article#191#<p><font
 size="2" face="Verdana"><B><a href="#tab02">Table 2</a></B> shows that the QoL 
scores were significantly worse amongst the&nbsp;ChD&nbsp;group compared to the&
nbsp;NChD&nbsp;group in the SF&#45;36 domains of physical functioning and role&#
45;emotional. Poor QoL was also observed in the&nbsp;ChD&nbsp;group with the MLW
HFQ scale. The SF&#45;36 item evaluating the patient's perception of the develop
ment of their state of health over the past year did not show statistically sign
ificant differences between the groups, 9.6% of the&nbsp;ChD&nbsp;group consider
ed that their state of health was worse or much worse compared to 0% of the&nbsp
;NChD&nbsp;group. About 30% of the&nbsp;NChD&nbsp;considered that their health w
as better or much better, in contrast to 21.6% in the&nbsp;ChD&nbsp;group. In th
e two groups, the most common response was no change, as reported by 68.8% of th
e&nbsp;ChD&nbsp;and 61.9% of the&nbsp;NChD&nbsp;group. </font></p>     ^cY#aop03
-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#66#62#article#191#<p><a na
me="tab02"></a></p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#67#63#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#68#64#article#191#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a03tab02.jpg"></p>     ^cY#ao
p03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#69#65#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
02413000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704216700087002001302254#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#70#66#article#191#<p><font
 size="2" face="Verdana">Multivariate analyses using the ordinal logistic regres
sion model are presented in <B><a href="/img/revistas/rsbmt/2011nahead/a03tab03.
jpg">Table 3</a></B>. The models were well fitted, considering the Deviance test
 and the supposition of proportional <I>odds</I>; i.e., the single OR for all of
 the QoL categories compared were valid for all of the constructed models. The <
I>abnormal echo</I> variable    (p = 0.063) was kept in the model for the SF&#45
;36 physical summary score because of its clinical importance. The covariables a
ssociated with a poor QoL according to the final logistic regression model were:
 I) Medical Outcomes Study 36&#45;item Short&#45;Form (SF&#45;36): a) physical c
omponent summary: poorer functional classification    (OR = 8.02, 95% CI = 2.63&
#150;24.41), presence of cardiovascular symptoms (OR = 4.12, 95%CI = 1.78&#150;9
.55), and Doppler echocardiogram examination abnormalities (OR = 2.05, 95%   CI 
= 0.96&#150;4.36); b) mental component summary: presence of cardiovascular sympt
oms (OR = 2.69, 95%CI = 1.26&#150;5.78), female sex (OR = 2.49, 95%CI = 4.31&#15
0;20.66) poorer physical functioning    (OR = 2.49, 95%CI = 1.12&#45;5.52); c) p
hysical functioning: less than two years of education (OR = 16.82, 95%CI = 4.10&
#150;68.97), female sex (OR = 3.36, 95%CI = 1.51&#150;8.72), presence of cardiov
ascular symptoms (OR = 4.6, 95%CI = 1.93&#150;11.30), presence of gastrointestin
al symptoms (OR = 3.7, 95%CI = 1.19&#150;6.37), associated illness (OR = 2.75, 9
5%CI = 1.19&#150;6.37), and ventricular arrhythmia detected during Holter monito
ring (OR = 2.47, 95%   CI = 1.12&#150;5.45); d) role&#45;emotional: presence of 
cardiovascular symptoms (OR = 8.6, 95%CI = 3.60&#150;20.59) and female sex (OR =
 7.04, 95%   CI = 3.4&#150;16.32). II) Minnesota Living with Heart Failure Quest
ionnaire (MLWHFQ): marital status (single) (OR = 2.30, 95% CI = 1.02&#45;5.15), 
fewer years of education (OR = 4.39,&#45;95%CI = 1.37&#45;14.13), poorer functio
nal classification (OR = 3.30, 95%CI = 1.54&#150;7.05), presence of cardiovascul
ar symptoms (OR = 9.11,&nbsp;95%CI =&nbsp;3.93&#150;21.12).</font></p>     ^cY#a
op03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#71#67#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#72#68#article#191#<p><font
 size="3" face="Verdana"><b>DISCUSSION</b></font></p>     ^cY#aop03-11.htm##
00511000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026500087002001300352#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#73#69#article#191#<p><font
 size="2" face="Verdana"><B>Differences in the clinical, demographic and complem
entary examination characteristics of the&nbsp;Chagas disease&nbsp;and&nbsp;non&
#45;Chagas disease&nbsp;groups and their association with quality of life</B></f
ont></p>     ^cY#aop03-11.htm##
01223000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704097700087002001301064#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#74#70#article#191#<p><font
 size="2" face="Verdana">Considering the demographic and clinical differences fo
und between the ChD and NChD groups and the results of complementary tests, a lo
wer level of education, lower percentage of obesity and lower median functional 
class was verified in the&nbsp;ChD&nbsp;group. The same group showed greater rat
es of continuous use of medication, presence of cardiovascular symptoms, abnorma
lities in ECG and Doppler echocardiogram tests and autonomic function tests, gre
ater ventricular arrhythmia detected during Holter monitoring, as well as greate
r median systolic and diastolic pressure. According to the relevant literature, 
the differences observed are related, either directly or indirectly, to the ChD 
profile and the potential development of cardiac disease. An exception was the s
maller percentage of obesity in the group, since no specific data exists in the 
literature regarding this condition in Ch<SUP>16,18,30&#45;34</SUP>. </font></p>
     ^cY#aop03-11.htm##
00809000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056300087002001300650#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#75#71#article#191#<p><font
 size="2" face="Verdana">The known vulnerability associated with underdevelopmen
t and poverty, observed in the majority of the population affected by ChD<SUP>35
</SUP>, was expressed in this study by the lower level of education verified in 
the&nbsp;ChD&nbsp;group. In the literature, this condition is highlighted as pre
dictive of mortality from cardiovascular diseases<SUP>26,36</SUP>, and in this s
tudy, it was predictive of poorer HRQoL in the&nbsp;ChD&nbsp;group for the SF&#4
5;36 physical functioning domain and the MLWHFQ scale. </font></p>     ^cY#aop03
-11.htm##
00769000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052300087002001300610#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#76#72#article#191#<p><font
 size="2" face="Verdana">Features identified in the&nbsp;ChD&nbsp;group, includi
ng a lower level of education, greater frequency of continuous medication use an
d greater presence of cardiovascular symptoms, were associated with poorer HRQoL
 scores. Such findings suggest that, in addition to the relevance of further stu
dy, a multidisciplinary health team is important in the development of a care mo
del, as highlighted in the literature for patients suffering from chronic diseas
es<SUP>4</SUP>.</font></p>     ^cY#aop03-11.htm##
00363000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011700087002001300204#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#77#73#article#191#<p><font
 size="2" face="Verdana"><B>Health&#45;related quality of life of&nbsp;Chagas di
sease</B></font></p>     ^cY#aop03-11.htm##
00951000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070500087002001300792#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#78#74#article#191#<p><font
 size="2" face="Verdana">Reports in the literature indicate poorer HRQoL scores 
for individuals with chronic diseases, mainly in the case of diseases that are m
ore symptomatic and cause greater incapacity<SUP>3</SUP>. Studies concerning QoL
 in ChD are scarce and most articles addressed this QoL issue in a generic sense
, without using validated instruments. Some papers deal with specific conditions
, such as those of pacemaker users, heart failure, or pre&#45; and posttreatment
 evaluations, and do not describe the profile of QoL in ChD patients. Furthermor
e, some authors suggest that the putative relation between ChD and depression de
serves to be elucidated<SUP>37</SUP>.</font></p>     ^cY#aop03-11.htm##
01374000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704112800087002001301215#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#79#75#article#191#<p><font
 size="2" face="Verdana">Four studies evaluated ChD patients using a validated Q
oL instrument (WHOQoL&#45;bref), although with different methodologies. Hueb, us
ing self&#45;evaluations, reported that ChD&nbsp;subjects were significantly dis
satisfied with their QoL, general health and daily activity performance in gener
al<SUP>38</SUP>. Ozaki demonstrated that worse QoL scores correlated with a grea
ter intensity of depression symptoms<SUP>39</SUP>. Dias verified the lowest scor
e in the environment domain in ChD. The worst perception of  QoL in the physical
 domain was related to a greater number of associated diseases and cardiac and g
astric forms of&nbsp;ChD. The psychological and social relation domains were rel
ated to cardiac and gastric forms of ChD, while the environment domain correlate
d with women<SUP>40</SUP>. Gontijo et al<SUP>41 </SUP>analyzed the QoL in&nbsp;C
hD&nbsp;and verified that the cardiac form of the disease is associated with gre
ater psychological suffering compared to the absence of cardiopathy and that fai
th helped to deal with the day&#45;to&#45;day difficulties. </font></p>     ^cY#
aop03-11.htm##
00869000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062300087002001300710#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#80#76#article#191#<p><font
 size="2" face="Verdana">In this study, the&nbsp;ChD&nbsp;group presented signif
icantly worse scores for the SF&#45;36 physical functioning and role&#45;emotion
al domains and for the MLWHFQ. Studying pacemaker patients, Oliveira also report
ed that the SF&#45;36 physical functioning scores were lower in the&nbsp;ChD&nbs
p;group compared to a&nbsp;NChD&nbsp;group<SUP>42</SUP>. Hidden fear of the impo
ssibility of stopping the disease and its possible malign development<SUP>43</SU
P> are perhaps expressed by the worse role&#45;emotional score verified for the&
nbsp;ChD&nbsp;group in this study. </font></p>     ^cY#aop03-11.htm##
00695000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044900087002001300536#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#81#77#article#191#<p><font
 size="2" face="Verdana">Significant differences were observed in the HRQoL scor
es between the&nbsp;ChD&nbsp;and&nbsp;NChD&nbsp;groups only in the SF&#45;36 dom
ains of physical functionality and role&#45;emotional and in the MLWHFQ. However
, <B><a href="#tab02">Table 2</a></B> shows that the medians of the scores in th
e&nbsp;ChD&nbsp;group were lower in all of the valid aspects, as also reported b
y Hueb<SUP>38</SUP>. </font></p>     ^cY#aop03-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#82#78#article#191#<p><font
 size="2" face="Verdana"><B>Factors associated with the worst scores</B></font><
/p>     ^cY#aop03-11.htm##
01123000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704087700087002001300964#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#83#79#article#191#<p><font
 size="2" face="Verdana">In the present study, it is noteworthy that being femal
e appears to be a risk for over nine&#45;fold poorer QoL for the mental componen
ts summary, seven&#45;fold for the role&#45;emotional domain and over three&#45;
fold for the physical functioning domain, in agreement with data in the literatu
re for other clinical conditions. It is interesting that the ChD literature indi
cates being male as a risk factor for more severe myocardial damage<SUP>44</SUP>
. In addition, an abnormal ECG, which is recognized as a factor associated with 
an increased risk of events amongst ChD patients, did not correlate with poorer 
QoL. Such findings demonstrate the complementary nature of the HRQoL evaluation 
and that it adds valuable information to routine clinical methods by considering
 other aspects related to patient well&#45;being.</font></p>     ^cY#aop03-11.ht
m##
00692000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044600087002001300533#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#84#80#article#191#<p><font
 size="2" face="Verdana">It is also noteworthy that the presence of factors subj
ect to intervention, such as associated illness and gastrointestinal and cardiov
ascular symptoms, negatively influenced the QoL of ChD. The presence of cardiova
scular symptoms, for example, impacted on five of the HRQoL aspects evaluated an
d the MLWHFQ score, indicating the great effect of this factor on the well&#45;b
eing of patients. </font></p>     ^cY#aop03-11.htm##
00800000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055400087002001300641#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#85#81#article#191#<p><font
 size="2" face="Verdana">An abnormal Doppler echocardiogram, the presence of ven
tricular arrhythmia and poorer functional classification, indicated by Rassi et 
al<SUP>32</SUP> as risk factors for sudden cardiac death due to cardiovascular c
auses, also appeared in this study as risk factors for poorer HRQoL in the&nbsp;
ChD&nbsp;group. It is noteworthy that poorer functional classification increased
 the odds of poorer QoL eight&#45;fold in the physical components summary and 17
&#45;fold in the physical functioning domain. </font></p>     ^cY#aop03-11.htm##
00317000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007100087002001300158#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#86#82#article#191#<p><font
 size="2" face="Verdana"><B>Limitations</B></font></p>     ^cY#aop03-11.htm##
00953000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070700087002001300794#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#87#83#article#191#<p><font
 size="2" face="Verdana">Some limitations of this study should be considered. Th
e main limitation is the small available sample of NChD subjects. This study was
 conducted in patients followed in a longitudinal prospective study and it was n
ot possible to recruit new patients, since all of them had been selected almost 
ten years before. It was not possible to retrieve some potentially significant i
nformation, because of the duration of residence in the rural area and of exposu
re to reinfection. The absence of SF&#45;36 reference scores for the Brazilian p
opulation is also an important issue, since it prevents further comparison betwe
en ChD patients and other populations. </font></p>     ^cY#aop03-11.htm##
00317000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007100087002001300158#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#88#84#article#191#<p><font
 size="2" face="Verdana"><B>Conclusions</B></font></p>     ^cY#aop03-11.htm##
00883000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063700087002001300724#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#89#85#article#191#<p><font
 size="2" face="Verdana">Chagas disease is related to the poorest QoL scores in 
the physical functioning and role&#45;emotional domains of the SF&#45;36 generic
 questionnaire and the MLWHFQ specific questionnaire. The factors which stand ou
t among those related to the worst scores in the&nbsp;ChD&nbsp;are being female,
 cardiovascular symptoms and poor functional classification. Although further st
udies are required in order to define SF&#45;36 reference values for the Brazili
an population, the data strongly suggest that the evaluation of HRQoL should be 
incorporated into clinical studies involving ChD.</font></p>     ^cY#aop03-11.ht
m##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#90#86#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008000087002001300167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#91#87#article#191#<p><font
 size="3" face="Verdana"><b>CONFLICT OF INTEREST</b></font></p>     ^cY#aop03-11
.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#92#88#article#191#<p><font
 size="2" face="Verdana">The authors declare that there is no conflict of intere
st.</font></p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#93#89#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00323000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007700087002001300164#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#94#90#article#191#<p><font
 size="3" face="Verdana"><b>FINANCIAL SUPPORT</b></font></p>     ^cY#aop03-11.ht
m##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#95#91#article#191#<p><font
 size="2" face="Verdana">CNPq and FAPEMIG.</font></p>     ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#96#92#article#191#<p>&nbsp
;</p>     ^cY#aop03-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#97#93#article#191#<p><font
 size="3" face="Verdana"><b>REFERENCES</b></font></p>     ^cY#aop03-11.htm##
00410000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704015000089002001300239#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#98#94#article#
191#1#<p><font size="2" face="Verdana">1. Badia X, Carne X. Evaluation of qualit
y of life in clinical trials. Med Clin (Barc) 1998; 110:550&#45;556.    ^cY#aop0
3-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#99#95#article#191#</font><
/p>     ^cY#aop03-11.htm##
00434000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704017300090002001300263#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#100#96#article
#191#2#<p><font size="2" face="Verdana">2. Alonso J. The measurement of health r
elated&#45;quality of life in clinical research and practice. Gac Sanit 2000;14:
163&#45;167.    ^cY#aop03-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#101#97#article#191#</font>
</p>     ^cY#aop03-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704031700090002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#102#98#article
#191#3#<p><font size="2" face="Verdana">3. Alonso J, Ferrer M, Gandek B, Ware Jr
 JE, Aaronson NK, Mosconi P, et al. Health&#45;related quality of life associate
d with chronic conditions in eight countries: results from the International Qua
lity of Life Assessment (IQOLA) Project. Qual Life Res 2004; 13:283&#45;298.    
^cY#aop03-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#103#99#article#191#</font>
</p>     ^cY#aop03-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704023800091002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#104#100#articl
e#191#4#<p><font size="2" face="Verdana">4. Sprangers MA, de Regt EB, Andries F,
 van Agt HM, Bijl RV, de Boer JB, et al. Which chronic conditions are associated
 with better or poorer quality of life? J Clin Epidemiol 2000; 53:895&#45;907.  
  ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#105#101#article#191#</font
></p>     ^cY#aop03-11.htm##
00486000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704022400091002001300315#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#106#102#articl
e#191#5#<p><font size="2" face="Verdana">5. Fitzpatrick R, Fletcher A, Gore S, J
ones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I: Appl
ications and issues in assessment. Bmj  1992; 305:1074&#45;1077.    ^cY#aop03-11
.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#107#103#article#191#</font
></p>     ^cY#aop03-11.htm##
00432000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704017000091002001300261#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#108#104#articl
e#191#6#<p><font size="2" face="Verdana">6. Seidl EM, Zannon CM. Quality of life
 and health: conceptual and methodological issues. Cad Saude Publica 2004; 20:58
0&#45;588.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#109#105#article#191#</font
></p>     ^cY#aop03-11.htm##
00436000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704017400091002001300265#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#110#106#articl
e#191#7#<p><font size="2" face="Verdana">7. Minayo MCS, Hartz ZMA, Buss PM. Qual
idade de vida em sa&uacute;de: um debate necess&aacute;rio. Cien Saude Colet 200
0; 5:7&#45;18.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#111#107#article#191#</font
></p>     ^cY#aop03-11.htm##
00469000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704020700091002001300298#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#112#108#articl
e#191#8#<p><font size="2" face="Verdana">8. Ware Jr JE, Sherbourne CD. The MOS 3
6&#45;item short&#45;form health survey (SF&#45;36). I. Conceptual framework and
 item selection. Med Care 1992; 30:473&#45;483.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#113#109#article#191#</font
></p>     ^cY#aop03-11.htm##
00601000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704033900091002001300430#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#114#110#articl
e#191#9#<p><font size="2" face="Verdana">9. Ciconelli RM, Ferraz MB, Santos W, M
einao I, Quaresma MR. Tradu&ccedil;&atilde;o para a l&iacute;ngua portuguesa e v
alida&ccedil;&atilde;o do question&aacute;rio gen&eacute;rico de avalia&ccedil;&
atilde;o de qualidade de vida SF&#45;36 (Brasil SF&#45;36). Rev Bras Reumatol 19
99; 39:143&#45;150.    ^cY#aop03-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#115#111#article#191# </fon
t></p>     ^cY#aop03-11.htm##
00549000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028600092002001300378#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#116#112#articl
e#191#10#<p><font size="2" face="Verdana">10. Rector TS, Kubo SH, Cohn JN. Patie
nts self&#45;assessment of their congestive heart failure, part 2: content, reli
ability and validation of a new measure, the Minnesota Living With Heart Failure
 Questionnaire. Heart Fail 1987; 3:198&#45;219.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#117#113#article#191#</font
></p>     ^cY#aop03-11.htm##
00565000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030200092002001300394#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#118#114#articl
e#191#11#<p><font size="2" face="Verdana">11. Carrara DE. Avalia&ccedil;&atilde;
o prospectiva da qualidade de vida em pacientes com miocardiopatia dilatada subm
etidos &agrave; ventriculectomia parcial esquerda. &#91;Mestrado&#93;. &#91;S&at
ilde;o Paulo&#93;: Universidade de S&atilde;o Paulo; 2001. 85p.    ^cY#aop03-11.
htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#119#115#article#191#</font
></p>     ^cY#aop03-11.htm##
00533000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027000092002001300362#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#120#116#articl
e#191#12#<p><font size="2" face="Verdana">12. Carvalho VO, Guimar&atilde;es GV, 
Carrara D, Bacal F, Bocchi A. Valida&ccedil;&atilde;o da vers&atilde;o em portug
u&ecirc;s do Minnesota Living With Heart Failure Questionnaire. Arq Bras Cardiol
 2009; 93:39&#45;44</font></p>     ^cY#aop03-11.htm##
00767000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704050400092002001300596#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#121#117#articl
e#191#13#<p><font size="2" face="Verdana">13. World Health Organization. Program
a Especial de Investigaciones y Ensenanzas sobre Enfermedades Tropicales. Report
 del grupo de trabajo cientifico sobre la enfermedad de Chagas &#91;Internet&#93
;. Buenos Aires. Argentina: World Health Organization; 2007. &#91;Cited 2009 jun
e&#93;. Available from: <a href="http://who.int/tdr/publications/publications/pd
f/swg_chagas.pdf/" target="_blank">http://who.int/tdr/publications/publications/
pdf/swg_chagas.pdf/</a> .    ^cY#aop03-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#122#118#article#191# </fon
t></p>     ^cY#aop03-11.htm##
00796000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704053300092002001300625#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#123#119#articl
e#191#14#<p><font size="2" face="Verdana">14. Organizacion Panamericana de la Sa
lud. World Health Organization. Neglected Tropical Diseases. Intensified Disease
 Management Estimaci&oacute;n cuantitativa de la enfermedad de Chagas en las Am&
eacute;ricas. Vigilancia Santaria Y Atenci&oacute;n de las Enfermidades Transmis
ibles. &#91;cited 2009 feb&#93; Available from: <a href="http://who.int/tdrold/p
ublications/publications/pdf/swg_chagas.pdf/" target="_blank">http://who.int/tdr
old/publications/publications/pdf/swg_chagas.pdf/</a>.    ^cY#aop03-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#124#120#article#191# </fon
t></p>     ^cY#aop03-11.htm##
00641000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704037800092002001300470#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#125#121#articl
e#191#15#<p><font size="2" face="Verdana">15. World Health Organization. New glo
bal effort to eliminate Chagas disease &#91;Internet&#93;. Genebra: World Health
 Organization; 2007. &#91;cited 2010 June&#93;. Available from <a href="http://w
ww.who.int/mediacentre/factsheets/fs340/en/index.html/" target="_blank">http://w
ww.who.int/mediacentre/factsheets/fs340/en/index.html/</a>.    ^cY#aop03-11.htm#
#
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#126#122#article#191# </fon
t></p>     ^cY#aop03-11.htm##
00457000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019400092002001300286#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#127#123#articl
e#191#16#<p><font size="2" face="Verdana">16. Ribeiro AL, Rocha MO. Indeterminat
e form of Chagas disease: considerations about diagnosis and prognosis. Rev Soc 
Bras Med Trop 1998; 31:301&#45;314.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#128#124#article#191#</font
></p>     ^cY#aop03-11.htm##
00456000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019300092002001300285#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#129#125#articl
e#191#17#<p><font size="2" face="Verdana">17. Hueb MFD, Loureiro SR. Revis&atild
e;o: aspectos cognitivos e psicossociais associados a doen&ccedil;a de Chagas.  
Psicol Estud 2005; 10:137&#45;142.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#130#126#article#191#</font
></p>     ^cY#aop03-11.htm##
00445000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018200092002001300274#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#131#127#articl
e#191#18#<p><font size="2" face="Verdana">18. Rocha MO, Teixeira MM, Ribeiro AL.
 An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Th
er 2007; 5:727&#45;743.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#132#128#article#191#</font
></p>     ^cY#aop03-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026900092002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#133#129#articl
e#191#19#<p><font size="2" face="Verdana">19. Goldman L, Hashimoto B, Cook EF, L
oscalzo A. Comparative reproducibility and validity of systems for assessing car
diovascular functional class: advantages of a new specific activity scale. Circu
lation 1981; 64:1227&#45;1334.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#134#130#article#191#</font
></p>     ^cY#aop03-11.htm##
00549000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028600092002001300378#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#135#131#articl
e#191#20#<p><font size="2" face="Verdana">20. Matsudo S, Araujo T, Marsudo V, An
drade D, Andrade E, Oliveira LC, et al. Question&aacute;rio internacional de ati
vidade f&iacute;sica (IPAC): estudo de validade e reprodutibilidade no Brasil. R
ev Bras Ativ F&iacute;s Saude 2001; 6:5&#45;18.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#136#132#article#191#</font
></p>     ^cY#aop03-11.htm##
00503000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024000092002001300332#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#137#133#articl
e#191#21#<p><font size="2" face="Verdana">21. Hallal PC, Matsudo SM, Matsudo VKR
, Araujo TL, Andrade DR, Bertoldi AD. Physical activity in adults from two Brazi
lian areas: similarities and differences. Cad Saude Publica 2005; 21:573&#45;580
.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#138#134#article#191#</font
></p>     ^cY#aop03-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024900092002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#139#135#articl
e#191#22#<p><font size="2" face="Verdana">22. Ribeiro AL, Moraes RS, Ribeiro JP,
 Ferlin EL, Torres RM, Oliveira E, et al. Parasympathetic dysautonomia precedes 
left ventricular systolic dysfunction in Chagas disease. Am Heart J 2001; 141:26
0&#45;265.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#140#136#article#191#</font
></p>     ^cY#aop03-11.htm##
00472000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020900092002001300301#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#141#137#articl
e#191#23#<p><font size="2" face="Verdana">23. Oliveira E, Ribeiro AL, Assis Silv
a F, Torres RM, Rocha MO. The Valsalva maneuver in Chagas disease patients witho
ut cardiopathy. Int J Cardiol  2002; 82:49&#45;54.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#142#138#article#191#</font
></p>     ^cY#aop03-11.htm##
00569000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030600092002001300398#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#143#139#articl
e#191#24#<p><font size="2" face="Verdana">24. Lazzari JO, Pereira M, Antunes CM,
 Guimaraes A, Moncayo A,    Chavez Dominguez R, et al. Diagnostic electrocardiog
raphy in epidemiological studies of Chagas' disease: multicenter evaluation of a
 standardized method.  Rev Panam Salud Publica 1998; 4:317&#45;330.    ^cY#aop03
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#144#140#article#191#</font
></p>     ^cY#aop03-11.htm##
00460000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019700092002001300289#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#145#141#articl
e#191#25#<p><font size="2" face="Verdana">25. Goncalves JG, Prata A. A compariso
n of three electrocardiogram coding systems for chronic Chagas' disease. Rev Pan
am Salud Publica 2003; 14:201&#45;208.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#146#142#article#191#</font
></p>     ^cY#aop03-11.htm##
00588000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032500092002001300417#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#147#143#articl
e#191#26#<p><font size="2" face="Verdana">26. Liu K, Cedres LB, Stamler J, Dyer 
A, Stamler R, Nanas S, et al. Relationship of education to major risk factors an
d death from coronary heart disease, cardiovascular deseases and all causes. Fin
dings of three&nbsp;Chicago epidemiologic studies. Circulation 1982; 66:1308&#45
;1314.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#148#144#article#191#</font
></p>     ^cY#aop03-11.htm##
00525000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026200092002001300354#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#149#145#articl
e#191#27#<p><font size="2" face="Verdana">27. Scattolin FA, Diogo MJ, Colombo RC
. Correlation between instruments for measuring health&#45;related quality of li
fe and functional independence in elderly with heart failure. Cad Saude Publica 
2007; 23:2705&#45;2715.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#150#146#article#191#</font
></p>     ^cY#aop03-11.htm##
00474000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021100092002001300303#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#151#147#articl
e#191#28#<p><font size="2" face="Verdana">28. Abreu MNS, Siqueira AL, Cardoso CS
, Caiaffa WT. Ordinal logistic regression models: application in quality of life
 studies. Cad Saude Publica 2008; 24: 5581&#45;5591.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#152#148#article#191#</font
></p>     ^cY#aop03-11.htm##
00439000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017600092002001300268#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#153#149#articl
e#191#29#<p><font size="2" face="Verdana">29. Abreu MNS, Siqueira AL, Caiaffa WT
. Ordinal logistic regression in epidemiological studies. Rev Saude Publica 2009
, 43:183&#45;194.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#154#150#article#191#</font
></p>     ^cY#aop03-11.htm##
00409000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704014600092002001300238#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#155#151#articl
e#191#30#<p><font size="2" face="Verdana">30. Prata A. Clinical and epidemiologi
cal aspects of Chagas disease. Lancet Infect Dis 2001;1:92&#45;100.    ^cY#aop03
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#156#152#article#191#</font
></p>     ^cY#aop03-11.htm##
00551000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028800092002001300380#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#157#153#articl
e#191#31#<p><font size="2" face="Verdana">31. Silva AS. Estudo caso controle de 
fatores associados &agrave; cardiopatia chag&aacute;sica em pacientes com mais d
e 50 anos. &#91;Mestrado&#93;. &#91;Belo Horizonte&#93;: Faculdade de Medicina. 
Universidade Federal de Minas Gerais; 2006. 110p.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#158#154#article#191#</font
></p>     ^cY#aop03-11.htm##
00472000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020900092002001300301#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#159#155#articl
e#191#32#<p><font size="2" face="Verdana">32. Rassi Jr A, Rassi A, Rassi SG. Pre
dictors of mortality in chronic Chagas disease: a systematic review of observati
onal studies. Circulation 2007; 115:1101&#45;1108.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#160#156#article#191#</font
></p>     ^cY#aop03-11.htm##
00505000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024200092002001300334#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#161#157#articl
e#191#33#<p><font size="2" face="Verdana">33. Ribeiro AL, Cavalvanti PS, Lombard
i F, Nunes MC, Barros MV, Rocha MO. Prognostic value of signal&#45;averaged elec
trocardiogram in Chagas disease.  J Cardiovasc Electrophysiol 2008; 19:502&#45;5
09.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#162#158#article#191#</font
></p>     ^cY#aop03-11.htm##
00477000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021400092002001300306#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#163#159#articl
e#191#34#<p><font size="2" face="Verdana">34. Ianni B. Diagnostico e prognostico
 da forma indeterminada da doen&ccedil;a de Chagas: o que h&aacute; de novo? Rev
 Soc Cardiol Estado S&atilde;o Paulo 2009; 19:6&#45;15.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#164#160#article#191#</font
></p>     ^cY#aop03-11.htm##
00639000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704037600092002001300468#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#165#161#articl
e#191#35#<p><font size="2" face="Verdana">35. Funda&ccedil;&atilde;o Oswaldo Cru
z. Doen&ccedil;a de Chagas &#91;Internet&#93;. Se&ccedil;&atilde;o import&acirc;
ncia social.  &#91;cited 2008 June&#93;. Available from:  <a href="http://www.fi
ocruz.br?chagas/cgi/cgilua.exe/sus/start.htm?sid=1" target="_blank">http://www.f
iocruz.br?chagas/cgi/cgilua.exe/sus/start.htm?sid=1</a> .    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#166#162#article#191#</font
></p>     ^cY#aop03-11.htm##
00476000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021300092002001300305#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#167#163#articl
e#191#36#<p><font size="2" face="Verdana">36. Lopes CC, Yamada A, Araujo F, Barr
eto AP, Mansur A. Socioeconomic factors in the prognosis of heart failure in a B
razilian cohort. Int J Cardiol 2005; 113: 181&#45;187.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#168#164#article#191#</font
></p>     ^cY#aop03-11.htm##
00489000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022600092002001300318#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#169#165#articl
e#191#37#<p><font size="2" face="Verdana">37. Mosovich SA, Mady C, Lopes N, Iann
i B, Dias JC, Correia D, et al. Chagas    disease as a mechanistic model for tes
ting a novel hypothesis. Rev Soc Bras  Med Trop 2008; 41:70&#45;72.    ^cY#aop03
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#170#166#article#191#</font
></p>     ^cY#aop03-11.htm##
00586000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032300092002001300415#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#171#167#articl
e#191#38#<p><font size="2" face="Verdana">38. Hueb MFD. Doen&ccedil;a de Chagas:
 indicadores cognitivos, de transtorno org&acirc;nico cerebral, de uso de alcool
 e qualidade de vida. &#91;Doutorado&#93;.  &#91;Ribeir&atilde;o Preto&#93;: Fac
uldade de Medicina de Ribeir&atilde;o Preto. Universidade de S&atilde;o Paulo; 2
006.    ^cY#aop03-11.htm##
00273000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002500089002001300114#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#172#168#article#191#156p.<
/font></p>     ^cY#aop03-11.htm##
00608000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034500092002001300437#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#173#169#articl
e#191#39#<p><font size="2" face="Verdana">39. Ozaki Y. Qualidade de vida e sinto
mas depressivos em portadores da doen&ccedil;a de Chagas em atendimento no ambul
at&oacute;rio do grupo de estudos em doen&ccedil;as de Chagas. &#91;Mestrado&#93
;. &#91;Campinas&#93;: Faculdade de Ci&ecirc;ncias Medicas. Universidade Estadua
l de Campinas; 2008. 112p.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#174#170#article#191#</font
></p>     ^cY#aop03-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025500092002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#175#171#articl
e#191#40#<p><font size="2" face="Verdana">40. Dias ELF. Qualidade de vida de adu
ltos e idosos portadores da Doen&ccedil;a de Chagas. &#91;Mestrado&#93;. &#91;Ca
mpinas&#93;: Faculdade de Ci&ecirc;ncias Medicas. Universidade Estadual de Campi
nas; 2009. 136p.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#176#172#article#191#</font
></p>     ^cY#aop03-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023700092002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#177#173#articl
e#191#41#<p><font size="2" face="Verdana">41. Gontijo ED, Guimar&atilde;es TN, M
agnani C, Paix&atilde;o GM, Dupin S, Paix&atilde;o LM. Qualidade de vida dos por
tadores de doen&ccedil;a de Chagas. Rev Med Minas Gerais 2009; 19:281&#45;285.  
  ^cY#aop03-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#178#174#article#191# </fon
t></p>     ^cY#aop03-11.htm##
00570000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030700092002001300399#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#179#175#articl
e#191#42#<p><font size="2" face="Verdana">42. Oliveira BG. Medida da qualidade d
e vida em portadores de marcapasso: tradu&ccedil;&atilde;o e valida&ccedil;&atil
de;o de instrumento especifico. &#91;Mestrado&#93;. &#91;Belo Horizonte&#93;: Es
cola de Enfermagem, Universidade Federal de Minas Gerais; 2003.116p.    ^cY#aop0
3-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#180#176#article#191#</font
></p>     ^cY#aop03-11.htm##
00491000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022800092002001300320#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#181#177#articl
e#191#43#<p><font size="2" face="Verdana">43. Jorg M, Storino R, Sapino RV. Part
icipacion encefalopatica en la enfermedad de Chagas cronica. Reflexiones derivad
as de experiencia personal. Rev Soc Bras Med Trop 1994; 27:31&#45;37.    ^cY#aop
03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#182#178#article#191#</font
></p>     ^cY#aop03-11.htm##
00459000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019600092002001300288#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#183#179#articl
e#191#44#<p><font size="2" face="Verdana">44. Barretto AC, Arteaga E, Mady C, Ia
nni BM, Bellotti G, Pileggi F. Male sex. Prognostic factor in Chagas' disease. A
rq Bras Cardiol 1993; 60:225&#45;227.    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#184#180#article#191#</font
></p>     ^cY#aop03-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#185#181#article#191#<p>&nb
sp;</p>     ^cY#aop03-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#186#182#article#191#<p>&nb
sp;</p>     ^cY#aop03-11.htm##
00405000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704015700089002001300246#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#187#183#article#191#<p><fo
nt size="2" face="Verdana"><b><a name="nt"></a><a href="#tx"><img src="/img/revi
stas/rsbmt/2011nahead/seta.jpg" border="0"></a> Address to:</b>    ^cY#aop03-11.
htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#188#184#article#191#<br> D
ra. Bruna Guimar&atilde;es Oliveira    ^cY#aop03-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#189#185#article#191#<br> H
C/UFMG    ^cY#aop03-11.htm##
00300000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005200089002001300141#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#190#186#article#191#<br> R
ua Ana de Carvalho da Silveira 269/802    ^cY#aop03-11.htm##
00301000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005300089002001300142#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#191#187#article#191#<br> 3
1140&#45;440 Belo Horizonte, MG, Brasil    ^cY#aop03-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004400089002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#192#188#article#191#<br> P
hone/Fax.: 55 31 3423&#45;8485    ^cY#aop03-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009500089002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#193#189#article#191#<br> e
&#45;mail: <a href="mailto:brunago@hc.ufmg.br">brunago@hc.ufmg.br</a></font></p>
     ^cY#aop03-11.htm##
00311000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006300089002001300152#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#194#190#article#191#<p><fo
nt size="2" face="Verdana">Received in 04/07/2010    ^cY#aop03-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#p#195#191#article#191#<br>  
 Accepted in 18/10/2010</font></p>     ^cY#aop03-11.htm##
00539000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100015001030120
05300118030001600171065000900187064000500196031000400201014000800205865000900213
002001300222035001000235801001600245#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#196#1#article#44#1#^rND^sBadia^nX#^rND^sCarne^nX#Evalu
ation of quality of life in clinical trials^len#Med Clin (Barc)#19980000#1998#11
0#550-556#20110000#aop03-11.htm#0025-7753#Med Clin (Barc)##
00536000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880120088001050300
01000193065000900203064000500212031000300217014000800220865000900228002001300237
035001000250801001000260#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
03-11.htm#S#c#197#2#article#44#2#^rND^sAlonso^nJ.#The measurement of health rela
ted-quality of life in clinical research and practice^len#Gac Sanit#20000000#200
0#14#163-167#20110000#aop03-11.htm#0213-9111#Gac Sanit##
00784000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100016001040100
01600120010001800136010001900154010001700173810000700190012016400197030001400361
06500090037506400050038403100030038901400080039286500090040000200130040903500100
0422801001400432#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.ht
m#S#c#198#3#article#44#3#^rND^sAlonso^nJ#^rND^sFerrer^nM#^rND^sGandek^nB#^rND^sW
are Jr^nJE#^rND^sAaronson^nNK#^rND^sMosconi^nP#et al.#Health-related quality of 
life associated with chronic conditions in eight countries: results from the Int
ernational Quality of Life Assessment (IQOLA) Project^len#Qual Life Res#20040000
#2004#13#283-298#20110000#aop03-11.htm#0962-9343#Qual Life Res##
00713000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100018001080100
01700126010001800143010001500161010001800176810000700194012008300201030001700284
06500090030106400050031003100030031501400080031886500090032600200130033503500100
0348801001700358#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.ht
m#S#c#199#4#article#44#4#^rND^sSprangers^nMA#^rND^sde Regt^nEB#^rND^sAndries^nF#
^rND^svan Agt^nHM#^rND^sBijl^nRV#^rND^sde Boer^nJB#et al.#Which chronic conditio
ns are associated with better or poorer quality of life?^len#J Clin Epidemiol#20
000000#2000#53#895-907#20110000#aop03-11.htm#0895-4356#J Clin Epidemiol##
00672000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100018001090100
01400127010001500141010002300156010001300179012008600192030000400278065000900282
06400050029103100040029601400100030086500090031000200130031903500100033280100040
0342#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#200#5#
article#44#5#^rND^sFitzpatrick^nR#^rND^sFletcher^nA#^rND^sGore^nS#^rND^sJones^nD
#^rND^sSpiegelhalter^nD#^rND^sCox^nD#Quality of life measures in health care. I:
 Applications and issues in assessment^len#Bmj#19920000#1992#305#1074-1077#20110
000#aop03-11.htm#0959-8138#BMJ##
00561000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100017001040120
06900121030001800190065000900208064000500217031000300222014000800225865000900233
002001300242035001000255801001800265#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#201#6#article#44#6#^rND^sSeidl^nEM#^rND^sZannon^nCM#Qu
ality of life and health: conceptual and methodological issues^len#Cad Saude Pub
lica#20040000#2004#20#580-588#20110000#aop03-11.htm#0102-311X#Cad Saude Publica#
#
00531000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100017001060100
01500123012005300138030001700191710000200208065000900210064000500219031000200224
014000500226865000900231002001300240#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#202#7#article#44#7#^rND^sMinayo^nMCS#^rND^sHartz^nZMA#
^rND^sBuss^nPM#Qualidade de vida em saúde: um debate necessário^lpt#Cien Saude C
olet#2#20000000#2000#5#7-18#20110000#aop03-11.htm##
00577000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100021001060120
09700127030000900224065000900233064000500242031000300247014000800250865000900258
002001300267035001000280801000900290#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#203#8#article#44#8#^rND^sWare Jr^nJE#^rND^sSherbourne^
nCD#The MOS 36-item short-form health survey (SF-36). I: Conceptual framework an
d item selection^len#Med Care#19920000#1992#30#473-483#20110000#aop03-11.htm#002
5-7079#Med Care##
00675000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100017001080100
01600125010001600141010001900157012013000176030001800306710000200324065000900326
064000500335031000300340014000800343865000900351002001300360#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#204#9#article#44#9#^rND^sCicon
elli^nRM#^rND^sFerraz^nMB#^rND^sSantos^nW#^rND^sMeinao^nI#^rND^sQuaresma^nMR#Tra
dução para a língua portuguesa e validação do questionário genérico de avaliação
 de qualidade de vida SF-36 (Brasil SF-36)^lpt#Rev Bras Reumatol#2#19990000#1999
#39#143-150#20110000#aop03-11.htm##
00654000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100015001070100
01500122012018000137030001100317710000200328065000900330064000500339031000200344
014000800346865000900354002001300363#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#205#10#article#44#10#^rND^sRector^nTS#^rND^sKubo^nSH#^
rND^sCohn^nJN#Patients self-assessment of their congestive heart failure, part 2
: content, reliability and validation of a new measure, the Minnesota Living Wit
h Heart Failure Questionnaire^len#Heart Fail#2#19870000#1987#3#198-219#20110000#
aop03-11.htm##
00581000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900180135001080510
00900243046001000252050002600262045000900288044000500297020000300302865000900305
002001300314#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#206#11#article#44#11#^rND^sCarrara^nDE#Avaliação prospectiva da qualidade de v
ida em pacientes com miocardiopatia dilatada submetidos à ventriculectomia parci
al esquerda^lpt#Mestrado#São Paulo#Universidade de São Paulo#20010000#2001#85#20
110000#aop03-11.htm##
00670000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100020001090100
01700129010001500146010001600161012009000177030001700267065000900284064000500293
031000300298014000600301865000900307002001300316035001000329801001700339#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#207#12#article#44#
12#^rND^sCarvalho^nVO#^rND^sGuimarães^nGV#^rND^sCarrara^nD#^rND^sBacal^nF#^rND^s
Bocchi^nA#Validação da versão em português do Minnesota Living With Heart Failur
e Questionnaire^lpt#Arq Bras Cardiol#20090000#2009#93#39-44#20110000#aop03-11.ht
m#0066-782X#Arq Bras Cardiol##
00717000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170026000900180154001160660
01300270067001000283062002600293065000900319064000500328110000900333109001000342
037006500352865000900417002001300426#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#208#13#article#44#13#World Health Organization#Program
a Especial de Investigaciones y Ensenanzas sobre Enfermedades Tropicales: Report
 del grupo de trabajo cientifico sobre la enfermedad de Chagas^les#Buenos Aires#
Argentina#World Health Organization#20070000#2007#20090600#2009 june#http://who.
int/tdr/publications/publications/pdf/swg_chagas.pdf/#20110000#aop03-11.htm##
00678000000000217000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170065000900180197001551100
00900352109000900361037006800370865000900438002001300447#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#209#14#article#44#14#World Health 
Organization^dOrganizacion Panamericana de la Salud#Neglected Tropical Diseases:
 Intensified Disease Management Estimación cuantitativa de la enfermedad de Chag
as en las Américas. Vigilancia Santaria Y Atención de las Enfermidades Transmisi
bles^len#20090200#2009 feb#http://who.int/tdrold/publications/publications/pdf/s
wg_chagas.pdf/#20110000#aop03-11.htm##
00584000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170026000900180050001160660
00800166062002600174065000900200064000500209110000900214109001000223037006300233
865000900296002001300305#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
03-11.htm#S#c#210#15#article#44#15#World Health Organization#New global effort t
o eliminate Chagas disease^len#Genebra#World Health Organization#20070000#2007#2
0100600#2010 June#http://www.who.int/mediacentre/factsheets/fs340/en/index.html/
#20110000#aop03-11.htm##
00590000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100016001080120
08700124030002200211065000900233064000500242031000300247014000800250865000900258
002001300267035001000280801002200290#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#211#16#article#44#16#^rND^sRibeiro^nAL#^rND^sRocha^nMO
#Indeterminate form of Chagas disease: considerations about diagnosis and progno
sis^len#Rev Soc Bras Med Trop#19980000#1998#31#301-314#20110000#aop03-11.htm#003
7-8682#Rev Soc Bras Med Trop##
00532000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060120
07900125030001300204710000200217065000900219064000500228031000300233014000800236
865000900244002001300253#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
03-11.htm#S#c#212#17#article#44#17#^rND^sHueb^nMFD#^rND^sLoureiro^nSR#Revisão: a
spectos cognitivos e psicossociais associados a doença de Chagas^lpt#Psicol Estu
d#2#20050000#2005#10#137-142#20110000#aop03-11.htm##
00554000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01800125012005700143030002800200710000200228065000900230064000500239031000200244
014000800246865000900254002001300263#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#213#18#article#44#18#^rND^sRocha^nMO#^rND^sTeixeira^nM
M#^rND^sRibeiro^nAL#An update on the management of Chagas cardiomyopathy^len#Exp
ert Rev Anti Infect Ther#2#20070000#2007#5#727-743#20110000#aop03-11.htm##
00691000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070100
01500126010001800141012014700159030001200306065000900318064000500327031000300332
014001000335865000900345002001300354035001000367801001200377#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#214#19#article#44#19#^rND^sGol
dman^nL#^rND^sHashimoto^nB#^rND^sCook^nEF#^rND^sLoscalzo^nA#Comparative reproduc
ibility and validity of systems for assessing cardiovascular functional class: a
dvantages of a new specific activity scale^len#Circulation#19810000#1981#64#1227
-1334#20110000#aop03-11.htm#0009-7322#Circulation##
00703000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01700123010001700140010001700157010001900174810000700193012010800200030002400308
71000020033206500090033406400050034303100020034801400050035086500090035500200130
0364#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#215#20
#article#44#20#^rND^sMatsudo^nS#^rND^sAraujo^nT#^rND^sMarsudo^nV#^rND^sAndrade^n
D#^rND^sAndrade^nE#^rND^sOliveira^nLC#et al.#Questionário internacional de ativi
dade física (IPAC): estudo de validade e reprodutibilidade no Brasil^lpt#Rev Bra
s Ativ Fís Saude#2#20010000#2001#6#5-18#20110000#aop03-11.htm##
00704000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01900125010001700144010001800161010001900179012008700198030001800285065000900303
06400050031203100030031701400080032086500090032800200130033703500100035080100180
0360#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#216#21
#article#44#21#^rND^sHallal^nPC#^rND^sMatsudo^nSM#^rND^sMatsudo^nVKR#^rND^sArauj
o^nTL#^rND^sAndrade^nDR#^rND^sBertoldi^nAD#Physical activity in adults from two 
Brazilian areas: similarities and differences^len#Cad Saude Publica#20050000#200
5#21#573-580#20110000#aop03-11.htm#0102-311X#Cad Saude Publica##
00718000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01800125010001700143010001700160010001800177810000700195012009800202030001100300
06500090031106400050032003100040032501400080032986500090033700200130034603500100
0359801001100369#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.ht
m#S#c#217#22#article#44#22#^rND^sRibeiro^nAL#^rND^sMoraes^nRS#^rND^sRibeiro^nJP#
^rND^sFerlin^nEL#^rND^sTorres^nRM#^rND^sOliveira^nE#et al.#Parasympathetic dysau
tonomia precedes left ventricular systolic dysfunction in Chagas disease^len#Am 
Heart J#20010000#2001#141#260-265#20110000#aop03-11.htm#0002-8703#Am Heart J##
00650000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
02100126010001700147010001600164012007300180030001400253065000900267064000500276
031000300281014000600284865000900290002001300299035001000312801001400322#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#218#23#article#44#
23#^rND^sOliveira^nE#^rND^sRibeiro^nAL#^rND^sAssis Silva^nF#^rND^sTorres^nRM#^rN
D^sRocha^nMO#The Valsalva maneuver in Chagas disease patients without cardiopath
y^len#Int J Cardiol#20020000#2002#82#49-54#20110000#aop03-11.htm#0167-5273#Int J
 Cardiol##
00784000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01800125010001900143010001700162010002600179810000700205012013000212030002400342
06500090036606400050037503100020038001400080038286500090039000200130039903500100
0412801002400422#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.ht
m#S#c#219#24#article#44#24#^rND^sLazzari^nJO#^rND^sPereira^nM#^rND^sAntunes^nCM#
^rND^sGuimaraes^nA#^rND^sMoncayo^nA#^rND^sChavez Dominguez^nR#et al.#Diagnostic 
electrocardiography in epidemiological studies of Chagas' disease: multicenter e
valuation of a standardized method^len#Rev Panam Salud Publica#19980000#1998#4#3
17-330#20110000#aop03-11.htm#1020-4989#Rev Panam Salud Publica##
00596000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100016001100120
08700126030002400213065000900237064000500246031000300251014000800254865000900262
002001300271035001000284801002400294#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop03-11.htm#S#c#220#25#article#44#25#^rND^sGoncalves^nJG#^rND^sPrata^n
A.#A comparison of three electrocardiogram coding systems for chronic Chagas' di
sease^len#Rev Panam Salud Publica#20030000#2003#14#201-208#20110000#aop03-11.htm
#1020-4989#Rev Panam Salud Publica##
00790000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100013000900100017001030100
01700120010001400137010001700151010001500168810000700183012017900190030001200369
06500090038106400050039003100030039501400100039886500090040800200130041703500100
0430801001200440#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.ht
m#S#c#221#26#article#44#26#^rND^sLiu^nK#^rND^sCedres^nLB#^rND^sStamler^nJ#^rND^s
Dyer^nA#^rND^sStamler^nR#^rND^sNanas^nS#et al.#Relationship of education to majo
r risk factors and death from coronary heart disease, cardiovascular deseases an
d all causes: Findings of three Chicago epidemiologic studies^len#Circulation#19
820000#1982#66#1308-1314#20110000#aop03-11.htm#0009-7322#Circulation##
00668000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100016001100100
01800126012013900144030001800283065000900301064000500310031000300315014001000318
865000900328002001300337035001000350801001800360#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop03-11.htm#S#c#222#27#article#44#27#^rND^sScattolin^nFA#^
rND^sDiogo^nMJ#^rND^sColombo^nRC#Correlation between instruments for measuring h
ealth-related quality of life and functional independence in elderly with heart 
failure^len#Cad Saude Publica#20070000#2007#23#2705-2715#20110000#aop03-11.htm#0
102-311X#Cad Saude Publica##
00638000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070100
01800126010001800144012007900162030001800241065000900259064000500268031000300273
014001000276865000900286002001300295035001000308801001800318#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#223#28#article#44#28#^rND^sAbr
eu^nMNS#^rND^sSiqueira^nAL#^rND^sCardoso^nCS#^rND^sCaiaffa^nWT#Ordinal logistic 
regression models: application in quality of life studies^len#Cad Saude Publica#
20080000#2008#24#5581-5591#20110000#aop03-11.htm#0102-311X#Cad Saude Publica##
00586000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070100
01800126012005900144030001800203065000900221064000500230031000300235014000800238
865000900246002001300255035001000268801001800278#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop03-11.htm#S#c#224#29#article#44#29#^rND^sAbreu^nMNS#^rND
^sSiqueira^nAL#^rND^sCaiaffa^nWT#Ordinal logistic regression in epidemiological 
studies^len#Rev Saude Publica#20090000#2009#43#183-194#20110000#aop03-11.htm#003
4-8910#Rev Saude Publica##
00484000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900120059001060300
01800165710000200183065000900185064000500194031000200199014000700201865000900208
002001300217#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#225#30#article#44#30#^rND^sPrata^nA.#Clinical and epidemiological aspects of C
hagas disease^len#Lancet Infect Dis#2#20010000#2001#1#92-100#20110000#aop03-11.h
tm##
00589000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160017000900180104001070510
00900211046001500220050006000235045000900295044000500304020000400309865000900313
002001300322#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#226#31#article#44#31#^rND^sSilva^nAS.#Estudo caso controle de fatores associad
os à cardiopatia chagásica em pacientes com mais de 50 anos^lpt#Mestrado#Belo Ho
rizonte#Universidade Federal de Minas Gerais^dFaculdade de Medicina#20060000#200
6#110#20110000#aop03-11.htm##
00613000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100015001080100
01600123012010000139030001200239065000900251064000500260031000400265014001000269
865000900279002001300288035001000301801001200311#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop03-11.htm#S#c#227#32#article#44#32#^rND^sRassi Jr^nA#^rN
D^sRassi^nA#^rND^sRassi^nSG#Predictors of mortality in chronic Chagas disease: a
 systematic review of observational studies^len#Circulation#20070000#2007#115#11
01-1108#20110000#aop03-11.htm#0009-7322#Circulation##
00711000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100021001080100
01800129010001600147010001700163010001600180012007600196030002800272065000900300
06400050030903100030031401400080031786500090032500200130033403500100034780100280
0357#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#228#33
#article#44#33#^rND^sRibeiro^nAL#^rND^sCavalvanti^nPS#^rND^sLombardi^nF#^rND^sNu
nes^nMC#^rND^sBarros^nMV#^rND^sRocha^nMO#Prognostic value of signal-averaged ele
ctrocardiogram in Chagas disease^len#J Cardiovasc Electrophysiol#20080000#2008#1
9#502-509#20110000#aop03-11.htm#1045-3873#J Cardiovasc Electrophysiol##
00530000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900120092001050300
03300197710000200230065000900232064000500241031000300246014000500249865000900254
002001300263#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#229#34#article#44#34#^rND^sIanni^nB#Diagnostico e prognostico da forma indeter
minada da doença de Chagas: o que há de novo?^lpt#Rev Soc Cardiol Estado São Pau
lo#2#20090000#2009#19#6-15#20110000#aop03-11.htm##
00482000000000217000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170022000900180047001121100
00900159109001000168037006400178865000900242002001300251#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#230#35#article#44#35#Fundação Oswa
ldo Cruz#Doença de Chagas: Seção importância social^lpt#20080600#2008 June#http:
//www.fiocruz.br?chagas/cgi/cgilua.exe/sus/start.htm?sid=1#20110000#aop03-11.htm
##
00654000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01600122010001800138010001600156012008200172030001400254065000900268064000500277
031000400282014000800286865000900294002001300303035001000316801001400326#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#231#36#article#44#
36#^rND^sLopes^nCC#^rND^sYamada^nA#^rND^sAraujo^nF#^rND^sBarreto^nAP#^rND^sMansu
r^nA#Socioeconomic factors in the prognosis of heart failure in a Brazilian coho
rt^len#Int J Cardiol#20050000#2005#113#181-187#20110000#aop03-11.htm#0167-5273#I
nt J Cardiol##
00702000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100014001090100
01500123010001500138010001500153010001700168810000700185012007300192030002200265
06500090028706400050029603100030030101400060030486500090031000200130031903500100
0332801002200342#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.ht
m#S#c#232#37#article#44#37#^rND^sMosovich^nSA#^rND^sMady^nC#^rND^sLopes^nN#^rND^
sIanni^nB#^rND^sDias^nJC#^rND^sCorreia^nD#et al.#Chagas disease as a mechanistic
 model for testing a novel hypothesis^len#Rev Soc Bras Med Trop#20080000#2008#41
#70-72#20110000#aop03-11.htm#0037-8682#Rev Soc Bras Med Trop##
00592000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160016000900180116001060510
01000222046001500232050006700247045000900314044000500323865000900328002001300337
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#233#38#art
icle#44#38#^rND^sHueb^nMFD#Doença de Chagas: indicadores cognitivos, de transtor
no orgânico cerebral, de uso de alcool e qualidade de vida^lpt#Doutorado#Ribeirã
o Preto#Universidade de São Paulo^dFaculdade de Medicina de Ribeirão Preto#20060
000#2006#20110000#aop03-11.htm##
00632000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160015000900180150001050510
00900255046000900264050006500273045000900338044000500347020000400352865000900356
002001300365#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#234#39#article#44#39#^rND^sOzaki^nY#Qualidade de vida e sintomas depressivos e
m portadores da doença de Chagas em atendimento no ambulatório do grupo de estud
os em doenças de Chagas^lpt#Mestrado#Campinas#Universidade Estadual de Campinas^
dFaculdade de Ciências Medicas#20080000#2008#112#20110000#aop03-11.htm##
00556000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160016000900180073001060510
00900179046000900188050006500197045000900262044000500271020000400276865000900280
002001300289#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#235#40#article#44#40#^rND^sDias^nELF#Qualidade de vida de adultos e idosos por
tadores da Doença de Chagas^lpt#Mestrado#Campinas#Universidade Estadual de Campi
nas^dFaculdade de Ciências Medicas#20090000#2009#136#20110000#aop03-11.htm##
00635000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100020001080100
01700128010001700145010001500162010001700177012005700194030002100251710000200272
065000900274064000500283031000300288014000800291865000900299002001300308#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#236#41#article#44#
41#^rND^sGontijo^nED#^rND^sGuimarães^nTN#^rND^sMagnani^nC#^rND^sPaixão^nGM#^rND^
sDupin^nS#^rND^sPaixão^nLM#Qualidade de vida dos portadores de doença de Chagas^
lpt#Rev Med Minas Gerais#2#20090000#2009#19#281-285#20110000#aop03-11.htm##
00594000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160019000900180108001090510
00900217046001500226050005900241045000900300044000500309020000400314865000900318
002001300327#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#
c#237#42#article#44#42#^rND^sOliveira^nBG#Medida da qualidade de vida em portado
res de marcapasso: tradução e validação de instrumento especifico^lpt#Mestrado#B
elo Horizonte#Universidade Federal de Minas Gerais^dEscola de Enfermagem#2003000
0#2003#116#20110000#aop03-11.htm##
00642000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100017001040100
01700121012011500138030002200253065000900275064000500284031000300289014000600292
865000900298002001300307035001000320801002200330#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop03-11.htm#S#c#238#43#article#44#43#^rND^sJorg^nM#^rND^sS
torino^nR#^rND^sSapino^nRV#Participacion encefalopatica en la enfermedad de Chag
as cronica: Reflexiones derivadas de experiencia personal^les#Rev Soc Bras Med T
rop#19940000#1994#27#31-37#20110000#aop03-11.htm#0037-8682#Rev Soc Bras Med Trop
##
00659000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100017001090100
01400126010001600140010001800156010001700174012005100191030001700242065000900259
06400050026803100030027301400080027686500090028400200130029303500100030680100170
0316#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop03-11.htm#S#c#239#44
#article#44#44#^rND^sBarretto^nAC#^rND^sArteaga^nE#^rND^sMady^nC#^rND^sIanni^nBM
#^rND^sBellotti^nG#^rND^sPileggi^nF#Male sex. Prognostic factor in Chagas' disea
se^len#Arq Bras Cardiol#19930000#1993#60#225-227#20110000#aop03-11.htm#0066-782X
#Arq Bras Cardiol##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#o#1#
1#article#1#20110311#101248#aop04-11.htm#194##
06155000000000805000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201430
01860120119003290100043004480100033004910100038005240100034005620100029005960100
04200625010003600667010005200703010003700755010003400792070012200826070016500948
07001090111307001310122207001530135308317550150608500080326108500250326908500280
32940850025033220850020033470850023033670850033033900831693034230850008051160850
02505124085002805149085002505177085002005202085002305222085003405245058000805279
11700060528707200030529311200090529611100110530511400090531611300110532500200130
5336#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#h#2#1#ar
ticle#1#tr#en#br1.1#1#4.0#MAP#TAB#05#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#2011
0000#^f0^l0#0037-8682#20110318#Malacological survey of Biomphalaria snails in mu
nicipalities along the Estrada Real in the southeast of the State of Minas Gerai
s, Brazil^len#Pesquisa malacológica de Biomphalaria em municípios da Estrada Rea
l, situados no sudeste do Estado de Minas Gerais^lpt#^rND^1A01^nSandra Helena Ce
rrato^sTibiriçá#^rND^1A02^nAdalberto^sMitterofhe#^rND^1A02^nMilton Ferreira de^s
Castro#^rND^1A02^nAdilson da Costa^sLima#^rND^1A02^nMurilo^sGonçalves#^rND^1A02^
nIzabella de Oliveira^sPinheiro#^rND^1A03^nCorina da Costa^sFreitas#^rND^1A04^nR
icardo José Paula de Souza e^sGuimarães#^rND^1A04^nOmar dos Santos^sCarvalho#^rN
D^1A05^nElaine Soares^sCoimbra#Universidade Federal de Juiz de Fora^iA01^1Instit
uto de Ciências Biológicas^2Departamento de Morfologia^cJuiz de Fora^sMG#Secreta
ria Estadual de Saúde de Minas Gerais Juiz de Fora^iA02^1Gerência Regional de Sa
úde de Juiz de Fora^2Coordenadoria de Epidemiologia e Vigilância em Saúde^sMG#In
stituto Nacional de Pesquisas Espaciais^iA03^1Divisão de Processamento de Imagen
s^cSão José dos Campos^sSP#Fundação Oswaldo Cruz^iA04^1Centro de Pesquisas René 
Rachou^2Laboratório de Helmintologia e Malacologia Médica^cBelo Horizonte^sMG#Un
iversidade Federal de Juiz de Fora^iA05^1Instituto de Ciências Biológicas^2Micro
biologia e Imunologia^3Departamento de Parasitologia^cJuiz de Fora^sMG#^len^aINT
RODUCTION: The increasing practice of ecotourism and rural tourism in the State 
of Minas Gerais, Brazil, highlights the importance of studies concerning the occ
urrence of potential intermediate hosts of Schistosoma mansoni. This study aimed
 to identify species of Biomphalaria snails in municipalities along the Estrada 
Real, an important Brazilian tourism project. METHODS: The specimens were collec
ted in different water collections of 36 municipalities along the Estrada Real i
n the southeast of the State of Minas Gerais. Biomphalaria species were characte
rized using both morphological and molecular approaches. The research was conduc
ted between August 2005 and September 2009 and all the sites visited were georef
erenced using GPS. RESULTS: Six Biomphalaria species were found in 30 of the 36 
municipalities studied: glabrata, tenagophila, straminea, peregrina, occidentali
s and schrammi. The first three species of Biomphalaria, recognized as intermedi
ate hosts of S. mansoni, were present in 33.3%, 47.2% and 8.3% of the municipali
ties studied, respectively. The mollusks were found in different types of water 
collections and no infection by S. mansoni was detected. The highest occurrence 
of Biomphalaria concentration was verified in the area covered by the Caminho No
vo route (Diamantina/MG to Rio de Janeiro/RJ). CONCLUSIONS: Considering the occu
rrence of schistosomiasis in the State of Minas Gerais and the socioeconomic rep
ercussions involved in the Estrada Real Project, this work focuses on the vulner
ability of water collections due to the presence of Biomphalaria mollusks and em
phasizes the need for epidemiological surveillance and sanitary and educational 
measures integrated with the local community and tourism sectors.#^dnd^i1#^tm^le
n^kBiomphalaria^i1#^tm^len^kSchistosomiasis^i1#^tm^len^kEstrada Real^i1#^tm^len^
kTourism^i1#^tm^len^kEcotourism^i1#^tm^len^kSpatial distribution^i1#^lpt^aINTROD
UÇÃO: O aumento das práticas de ecoturismo e turismo rural, em Minas Gerais, Bra
sil, evidencia a importância de se realizarem estudos sobre a ocorrência de hosp
edeiros intermediários do Schistosoma mansoni, no estado. O presente trabalho ob
jetivou a busca e identificação das espécies de caramujos Biomphalaria encontrad
os em municípios mineiros pertencentes à Estrada Real, um importante projeto de 
turismo brasileiro. MÉTODOS: Os moluscos foram coletados em 36 municípios da Est
rada Real, no sudeste de Minas Gerais. A pesquisa foi realizada de agosto de 200
5 a setembro de 2009 e todos os locais visitados foram georreferenciados com o u
so de GPS. RESULTADOS: Dos 36 municípios estudados, 30 apresentaram a ocorrência
 de pelo menos uma entre as seis espécies de Biomphalaria: glabrata, tenagophila
, straminea, peregrina, occidentalis e schrammi. As três primeiras espécies cita
das, reconhecidas como hospedeiras intermediárias do S. mansoni, estavam present
es em 33,3%, 47,2% e 8,3% dos municípios estudados, respectivamente. Os moluscos
 foram encontrados em diferentes tipos de coleções hídricas e em nenhum deles fo
i detectada infecção pelo S. mansoni. Houve maior ocorrência de Biomphalaria na 
área referente ao Caminho Novo (Diamantina/MG ao Rio de Janeiro/RJ). CONCLUSÕES:
 Considerando-se a ocorrência da esquistossomose, no Estado de Minas Gerais, e a
s repercussões socioeconômicas que envolvem o projeto Estrada Real, este trabalh
o aponta para a vulnerabilidade das coleções hídricas devido à presença de molus
cos Biomphalaria e enfatiza a necessidade de vigilância epidemiológica e medidas
 educativas e sanitárias integradas com a comunidade local e setores de turismo.
#^dnd^i2#^tm^lpt^kBiomphalaria^i2#^tm^lpt^kEsquistossomose^i2#^tm^lpt^kEstrada R
eal^i2#^tm^lpt^kTurismo^i2#^tm^lpt^kEcoturismo^i2#^tm^lpt^kDistribuição espacial
^i2#FAPEMIG#other#35#20100910#10/09/2010#20101104#04/11/2010#aop04-11.htm##
06484000000000805000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201640
01860120140003500100043004900100033005330100038005660100034006040100029006380100
04200667010003600709010005200745010003700797010003400834070012200868070016500990
07001090115507001310126407001530139508319160154808500080346408500320347208500280
35040850025035320850020035570850023035770850033036000831805036330850008054380850
03205446085002805478085002505506085002005531085002305551085003405574058000805608
11700060561607200030562211200090562511100110563411400090564511300110565400200130
5665#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#f#3#1#ar
ticle#1#tr#en#br1.1#1#4.0#MAP#TAB#05#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#2011
0000#^f0^l0#0037-8682#20110318#<b>Malacological survey of <i>Biomphalaria</i> sn
ails in municipalities along the <i>Estrada Real</i> in the southeast of the Sta
te of Minas Gerais, Brazil</b>^len#<b>Pesquisa malacológica de <i>Biomphalaria</
i> em municípios da <i>Estrada Real</i>, situados no sudeste do Estado de Minas 
Gerais</b>^lpt#^rND^1A01^nSandra Helena Cerrato^sTibiriçá#^rND^1A02^nAdalberto^s
Mitterofhe#^rND^1A02^nMilton Ferreira de^sCastro#^rND^1A02^nAdilson da Costa^sLi
ma#^rND^1A02^nMurilo^sGonçalves#^rND^1A02^nIzabella de Oliveira^sPinheiro#^rND^1
A03^nCorina da Costa^sFreitas#^rND^1A04^nRicardo José Paula de Souza e^sGuimarãe
s#^rND^1A04^nOmar dos Santos^sCarvalho#^rND^1A05^nElaine Soares^sCoimbra#Univers
idade Federal de Juiz de Fora^iA01^1Instituto de Ciências Biológicas^2Departamen
to de Morfologia^cJuiz de Fora^sMG#Secretaria Estadual de Saúde de Minas Gerais 
Juiz de Fora^iA02^1Gerência Regional de Saúde de Juiz de Fora^2Coordenadoria de 
Epidemiologia e Vigilância em Saúde^sMG#Instituto Nacional de Pesquisas Espaciai
s^iA03^1Divisão de Processamento de Imagens^cSão José dos Campos^sSP#Fundação Os
waldo Cruz^iA04^1Centro de Pesquisas René Rachou^2Laboratório de Helmintologia e
 Malacologia Médica^cBelo Horizonte^sMG#Universidade Federal de Juiz de Fora^iA0
5^1Instituto de Ciências Biológicas^2Microbiologia e Imunologia^3Departamento de
 Parasitologia^cJuiz de Fora^sMG#^len^a<b>INTRODUCTION:</b> The increasing pract
ice of ecotourism and rural tourism in the State of <i>Minas Gerais</i>, Brazil,
 highlights the importance of studies concerning the occurrence of potential int
ermediate hosts of <i>Schistosoma mansoni</i>. This study aimed to identify spec
ies of <i>Biomphalaria</i> snails in municipalities along the <i>Estrada Real</i
>, an important Brazilian tourism project. <b>METHODS:</b> The specimens were co
llected in different water collections of 36 municipalities along the <i>Estrada
 Real</i> in the southeast of the State of <i>Minas Gerais</i>. <i>Biomphalaria<
/i> species were characterized using both morphological and molecular approaches
. The research was conducted between August 2005 and September 2009 and all the 
sites visited were georeferenced using GPS. <b>RESULTS:</b> Six <i>Biomphalaria 
</i>species were found in 30 of the 36 municipalities studied: <i>glabrata, tena
gophila, straminea, peregrina, occidentalis</i> and <i>schrammi</i>. The first t
hree species of <i>Biomphalaria</i>, recognized as intermediate hosts of <i>S. m
ansoni</i>, were present in 33.3%, 47.2% and 8.3% of the municipalities studied,
 respectively. The mollusks were found in different types of water collections a
nd no infection by <i>S. mansoni</i> was detected. The highest occurrence of <i>
Biomphalaria</i> concentration was verified in the area covered by the <i>Caminh
o Novo</i> route (<i>Diamantina</i>/MG to <i>Rio de Janeiro</i>/RJ). <b>CONCLUSI
ONS:</b> Considering the occurrence of schistosomiasis in the State of Minas Ger
ais and the socioeconomic repercussions involved in the <i>Estrada Real</i> Proj
ect, this work focuses on the vulnerability of water collections due to the pres
ence of <i>Biomphalaria</i> mollusks and emphasizes the need for epidemiological
 surveillance and sanitary and educational measures integrated with the local co
mmunity and tourism sectors.#^dnd^i1#^tm^len^k<i>Biomphalaria</i>^i1#^tm^len^kSc
histosomiasis^i1#^tm^len^kEstrada Real^i1#^tm^len^kTourism^i1#^tm^len^kEcotouris
m^i1#^tm^len^kSpatial distribution^i1#^lpt^a<b>INTRODUÇÃO:</b> O aumento das prá
ticas de ecoturismo e turismo rural, em Minas Gerais, Brasil, evidencia a import
ância de se realizarem estudos sobre a ocorrência de hospedeiros intermediários 
do <i>Schistosoma mansoni</i>, no estado. O presente trabalho objetivou a busca 
e identificação das espécies de caramujos <i>Biomphalaria </i>encontrados em mun
icípios mineiros pertencentes à <i>Estrada Real</i>, um importante projeto de tu
rismo brasileiro. <b>MÉTODOS:</b> Os moluscos foram coletados em 36 municípios d
a <i>Estrada Real</i>, no sudeste de Minas Gerais. A pesquisa foi realizada de a
gosto de 2005 a setembro de 2009 e todos os locais visitados foram georreferenci
ados com o uso de GPS. <b>RESULTADOS:</b> Dos 36 municípios estudados, 30 aprese
ntaram a ocorrência de pelo menos uma entre as seis espécies de <i>Biomphalaria:
 glabrata, tenagophila, straminea, peregrina, occidentalis</i> e <i>schrammi</i>
. As três primeiras espécies citadas, reconhecidas como hospedeiras intermediári
as do <i>S. mansoni</i>, estavam presentes em 33,3%, 47,2% e 8,3% dos municípios
 estudados, respectivamente. Os moluscos foram encontrados em diferentes tipos d
e coleções hídricas e em nenhum deles foi detectada infecção pelo <i>S. mansoni<
/i>. Houve maior ocorrência de <i>Biomphalaria</i> na área referente ao <i>Camin
ho Novo</i> (Diamantina/MG ao Rio de Janeiro/RJ). <b>CONCLUSÕES:</b> Considerand
o-se a ocorrência da esquistossomose, no Estado de Minas Gerais, e as repercussõ
es socioeconômicas que envolvem o projeto <i>Estrada Real</i>, este trabalho apo
nta para a vulnerabilidade das coleções hídricas devido à presença de moluscos <
i>Biomphalaria</i> e enfatiza a necessidade de vigilância epidemiológica e medid
as educativas e sanitárias integradas com a comunidade local e setores de turism
o.#^dnd^i2#^tm^lpt^k<i>Biomphalaria</i>^i2#^tm^lpt^kEsquistossomose^i2#^tm^lpt^k
Estrada Real^i2#^tm^lpt^kTurismo^i2#^tm^lpt^kEcoturismo^i2#^tm^lpt^kDistribuição
 espacial^i2#FAPEMIG#other#35#20100910#10/09/2010#20101104#04/11/2010#aop04-11.h
tm##
06332000000000829000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120143001920120119003350100043004540100033004970100038005300100034005680100
02900602010004200631010003600673010005200709010003700761010003400798070012400832
07001670095607001110112307001330123407001550136708317760152208500080329808500250
33060850028033310850025033590850020033840850023034040850033034270831720034600850
00805180085002505188085002805213085002505241085002005266085002305286085003405309
05800080534311700060535107200030535711200090536011100110536911400090538011300110
5389002001305400008008905413#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup
\aop04-11.htm#S#l#4#1#article#1#^a2011#tr#en#br1.1#1#4.0#map#tab#05#nd#nd#Rev. S
oc. Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8682#20110318#Malacological surve
y of Biomphalaria snails in municipalities along the Estrada Real in the southea
st of the State of Minas Gerais, Brazil^len#Pesquisa malacológica de Biomphalari
a em municípios da Estrada Real, situados no sudeste do Estado de Minas Gerais^l
pt#^rND^1A01^nSandra Helena Cerrato^sTibiriçá#^rND^1A02^nAdalberto^sMitterofhe#^
rND^1A02^nMilton Ferreira de^sCastro#^rND^1A02^nAdilson da Costa^sLima#^rND^1A02
^nMurilo^sGonçalves#^rND^1A02^nIzabella de Oliveira^sPinheiro#^rND^1A03^nCorina 
da Costa^sFreitas#^rND^1A04^nRicardo José Paula de Souza e^sGuimarães#^rND^1A04^
nOmar dos Santos^sCarvalho#^rND^1A05^nElaine Soares^sCoimbra#^iA01^1Universidade
 Federal de Juiz de Fora^2Instituto de Ciências Biológicas^3Departamento de Morf
ologia^cJuiz de Fora^sMG#^iA02^1Secretaria Estadual de Saúde de Minas Gerais Jui
z de Fora^2Gerência Regional de Saúde de Juiz de Fora^3Coordenadoria de Epidemio
logia e Vigilância em Saúde^sMG#^iA03^1Instituto Nacional de Pesquisas Espaciais
^2Divisão de Processamento de Imagens^cSão José dos Campos^sSP#^iA04^1Fundação O
swaldo Cruz^2Centro de Pesquisas René Rachou^3Laboratório de Helmintologia e Mal
acologia Médica^cBelo Horizonte^sMG#^iA05^1Universidade Federal de Juiz de Fora^
2Instituto de Ciências Biológicas^3Microbiologia e Imunologia. Departamento de P
arasitologia^cJuiz de Fora^sMG#^len^aINTRODUCTION: The increasing practice of ec
otourism and rural tourism in the State of Minas Gerais, Brazil, highlights the 
importance of studies concerning the occurrence of potential intermediate hosts 
of Schistosoma mansoni. This study aimed to identify species of Biomphalaria sna
ils in municipalities along the Estrada Real, an important Brazilian tourism pro
ject. METHODS: The specimens were collected in different water collections of 36
 municipalities along the Estrada Real in the southeast of the State of Minas Ge
rais. Biomphalaria species were characterized using both morphological and molec
ular approaches. The research was conducted between August 2005 and September 20
09 and all the sites visited were georeferenced using GPS. RESULTS: Six Biomphal
aria species were found in 30 of the 36 municipalities studied: glabrata, tenago
phila, straminea, peregrina, occidentalis and schrammi. The first three species 
of Biomphalaria, recognized as intermediate hosts of S. mansoni, were present in
 33.3 percent, 47.2 percent and 8.3 percent of the municipalities studied, respe
ctively. The mollusks were found in different types of water collections and no 
infection by S. mansoni was detected. The highest occurrence of Biomphalaria con
centration was verified in the area covered by the Caminho Novo route (Diamantin
a/MG to Rio de Janeiro/RJ). CONCLUSIONS: Considering the occurrence of schistoso
miasis in the State of Minas Gerais and the socioeconomic repercussions involved
 in the Estrada Real Project, this work focuses on the vulnerability of water co
llections due to the presence of Biomphalaria mollusks and emphasizes the need f
or epidemiological surveillance and sanitary and educational measures integrated
 with the local community and tourism sectors.#^dnd^i1#^tm^len^kBiomphalaria^i1#
^tm^len^kSchistosomiasis^i1#^tm^len^kEstrada Real^i1#^tm^len^kTourism^i1#^tm^len
^kEcotourism^i1#^tm^len^kSpatial distribution^i1#^lpt^aINTRODUÇÃO: O aumento das
 práticas de ecoturismo e turismo rural, em Minas Gerais, Brasil, evidencia a im
portância de se realizarem estudos sobre a ocorrência de hospedeiros intermediár
ios do Schistosoma mansoni, no estado. O presente trabalho objetivou a busca e i
dentificação das espécies de caramujos Biomphalaria encontrados em municípios mi
neiros pertencentes à Estrada Real, um importante projeto de turismo brasileiro.
 MÉTODOS: Os moluscos foram coletados em 36 municípios da Estrada Real, no sudes
te de Minas Gerais. A pesquisa foi realizada de agosto de 2005 a setembro de 200
9 e todos os locais visitados foram georreferenciados com o uso de GPS. RESULTAD
OS: Dos 36 municípios estudados, 30 apresentaram a ocorrência de pelo menos uma 
entre as seis espécies de Biomphalaria: glabrata, tenagophila, straminea, peregr
ina, occidentalis e schrammi. As três primeiras espécies citadas, reconhecidas c
omo hospedeiras intermediárias do S. mansoni, estavam presentes em 33,3 por cent
o, 47,2 por cento e 8,3 por cento dos municípios estudados, respectivamente. Os 
moluscos foram encontrados em diferentes tipos de coleções hídricas e em nenhum 
deles foi detectada infecção pelo S. mansoni. Houve maior ocorrência de Biomphal
aria na área referente ao Caminho Novo (Diamantina/MG ao Rio de Janeiro/RJ). CON
CLUSÕES: Considerando-se a ocorrência da esquistossomose, no Estado de Minas Ger
ais, e as repercussões socioeconômicas que envolvem o projeto Estrada Real, este
 trabalho aponta para a vulnerabilidade das coleções hídricas devido à presença 
de moluscos Biomphalaria e enfatiza a necessidade de vigilância epidemiológica e
 medidas educativas e sanitárias integradas com a comunidade local e setores de 
turismo.#^dnd^i2#^tm^lpt^kBiomphalaria^i2#^tm^lpt^kEsquistossomose^i2#^tm^lpt^kE
strada Real^i2#^tm^lpt^kTurismo^i2#^tm^lpt^kEcoturismo^i2#^tm^lpt^kDistribuição 
espacial^i2#FAPEMIG#other#35#20100910#10/09/2010#20101104#04/11/2010#aop04-11.ht
m#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-8682201
1005000005##
00473000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704022900085002001300314#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#5#1#article#155#<p><font s
ize="4" face="Verdana"><B><a name="tx"></a>Malacological survey of <I>Biomphalar
ia</I> snails in municipalities along the <I>Estrada Real</I> in the southeast o
f the State of Minas Gerais, Brazil</B></font></p>     ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#6#2#article#155#<p>&nbsp;<
/p>     ^cY#aop04-11.htm##
00446000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704020200085002001300287#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#7#3#article#155#<p><font s
ize="3" face="Verdana"><b>Pesquisa malacol&oacute;gica de <I>Biomphalaria</I> em
 munic&iacute;pios da <I>Estrada Real</I>, situados no sudeste do Estado de Mina
s Gerais</b></font></p>     ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#8#4#article#155#<p>&nbsp;<
/p>     ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#9#5#article#155#<p>&nbsp;<
/p>     ^cY#aop04-11.htm##
00735000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704049000086002001300576#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#10#6#article#155#<p><font 
size="2" face="Verdana"><b>Sandra Helena Cerrato Tibiri&ccedil;&aacute;<SUP>I</S
UP>; Adalberto Mitterofhe<SUP>II</SUP>; Milton Ferreira de Castro<SUP>II</SUP>; 
Adilson da Costa Lima<SUP>II</SUP>; Murilo Gon&ccedil;alves<SUP>II</SUP>; Izabel
la de Oliveira Pinheiro<SUP>II</SUP>; Corina da Costa Freitas<SUP>III</SUP>; Ric
ardo Jos&eacute; Paula de Souza e Guimar&atilde;es<SUP>IV</SUP>; Omar dos Santos
 Carvalho<SUP>IV</SUP>; Elaine Soares Coimbra<SUP>V</SUP></b></font></p>     ^cY
#aop04-11.htm##
00427000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704018200086002001300268#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#11#7#article#155#<p><font 
size="2" face="Verdana"><sup>I</sup>Departamento de Morfologia, Instituto de Ci&
ecirc;ncias Biol&oacute;gicas, Universidade Federal de Juiz de Fora, Juiz de For
a, MG    ^cY#aop04-11.htm##
00467000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704022200086002001300308#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#12#8#article#155#<br>     
<sup>II</sup>Coordenadoria de Epidemiologia e Vigil&acirc;ncia em Sa&uacute;de, 
Ger&ecirc;ncia Regional de Sa&uacute;de de Juiz de Fora, Secretaria Estadual de 
Sa&uacute;de de Minas Gerais Juiz de Fora, MG    ^cY#aop04-11.htm##
00400000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704015500086002001300241#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#13#9#article#155#<br>     
<sup>III</sup>Divis&atilde;o de Processamento de Imagens, Instituto Nacional de 
Pesquisas Espaciais, S&atilde;o Jos&eacute; dos Campos, SP    ^cY#aop04-11.htm##
00436000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019000087002001300277#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#14#10#article#155#<br>    
 <sup>IV</sup>Laborat&oacute;rio de Helmintologia e Malacologia M&eacute;dica, C
entro de Pesquisas Ren&eacute; Rachou, Funda&ccedil;&atilde;o Oswaldo Cruz, Belo
 Horizonte, MG    ^cY#aop04-11.htm##
00447000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020100087002001300288#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#15#11#article#155#<br>    
 <sup>V</sup>Departamento de Parasitologia, Microbiologia e Imunologia, Institut
o de Ci&ecirc;ncias Biol&oacute;gicas, Universidade Federal de Juiz de Fora, Jui
z de Fora, MG</font></p>     ^cY#aop04-11.htm##
00327000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008100087002001300168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#16#12#article#155#<p><font
 size="2" face="Verdana"><a href="#nt">Address to</a></font></p>     ^cY#aop04-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#17#13#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#18#14#article#155#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop04-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006800087002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#19#15#article#155#<p><font
 size="2" face="Verdana"><B>ABSTRACT</B></font></p>     ^cY#aop04-11.htm##
00690000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044400087002001300531#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#20#16#article#155#<p><font
 size="2" face="Verdana"><B>INTRODUCTION:</B> The increasing practice of ecotour
ism and rural tourism in the State of <I>Minas Gerais</I>, Brazil, highlights th
e importance of studies concerning the occurrence of potential intermediate host
s of <I>Schistosoma mansoni</I>. This study aimed to identify species of <I>Biom
phalaria</I> snails in municipalities along the <I>Estrada Real</I>, an importan
t Brazilian tourism project.    ^cY#aop04-11.htm##
00660000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041400087002001300501#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#21#17#article#155#<br>  <B
>METHODS:</B> The specimens were collected in different water collections of 36 
municipalities along the <I>Estrada Real</I> in the southeast of the State of <I
>Minas Gerais</I>. <I>Biomphalaria</I> species were characterized using both mor
phological and molecular approaches. The research was conducted between August 2
005 and September 2009 and all the sites visited were georeferenced using GPS.  
  ^cY#aop04-11.htm##
00925000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704067900087002001300766#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#22#18#article#155#<br>  <B
>RESULTS:</B> Six <I>Biomphalaria </I>species were found in 30 of the 36 municip
alities studied: <I>glabrata, tenagophila, straminea, peregrina, occidentalis</I
> and <I>schrammi</I>. The first three species of <I>Biomphalaria</I>, recognize
d as intermediate hosts of <I>S. mansoni</I>, were present in 33.3%, 47.2% and 8
.3% of the municipalities studied, respectively. The mollusks were found in diff
erent types of water collections and no infection by <I>S. mansoni</I> was detec
ted.  The highest occurrence of <I>Biomphalaria</I> concentration was verified i
n the area covered by the <I>Caminho Novo</I> route (<I>Diamantina</I>/MG to <I>
Rio de Janeiro</I>/RJ).    ^cY#aop04-11.htm##
00711000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046500087002001300552#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#23#19#article#155#<br>  <B
>CONCLUSIONS:</B> Considering the occurrence of schistosomiasis in the State of 
Minas Gerais and the socioeconomic repercussions involved in the <I>Estrada Real
</I> Project, this work focuses on the vulnerability of water collections due to
 the presence of <I>Biomphalaria</I> mollusks and emphasizes the need for epidem
iological surveillance and sanitary and educational measures integrated with the
 local community and tourism sectors.</font></p>     ^cY#aop04-11.htm##
00433000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018700087002001300274#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#24#20#article#155#<p><font
 size="2" face="Verdana"><B>Keywords: </B><I>Biomphalaria.</I> Schistosomiasis. 
Estrada Real.  Tourism. Ecotourism. Spatial distribution.</font></p> <hr size="1
" noshade>     ^cY#aop04-11.htm##
00312000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006600087002001300153#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#25#21#article#155#<p><font
 size="2" face="Verdana"><B>RESUMO</B></font></p>     ^cY#aop04-11.htm##
00815000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056900087002001300656#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#26#22#article#155#<p><font
 size="2" face="Verdana"><B>INTRODU&Ccedil;&Atilde;O:</B> O aumento das pr&aacut
e;ticas de ecoturismo e turismo rural, em Minas Gerais, Brasil, evidencia a impo
rt&acirc;ncia de se realizarem estudos sobre a ocorr&ecirc;ncia de hospedeiros i
ntermedi&aacute;rios do <I>Schistosoma mansoni</I>, no estado. O presente trabal
ho objetivou a busca e identifica&ccedil;&atilde;o das esp&eacute;cies de caramu
jos <I>Biomphalaria </I>encontrados em munic&iacute;pios mineiros pertencentes &
agrave; <I>Estrada Real</I>, um importante projeto de turismo brasileiro.    ^cY
#aop04-11.htm##
00518000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027200087002001300359#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#27#23#article#155#<br>  <B
>M&Eacute;TODOS:</B> Os moluscos foram coletados em 36 munic&iacute;pios da <I>E
strada Real</I>, no sudeste de Minas Gerais. A pesquisa foi realizada de agosto 
de 2005 a setembro de 2009 e todos os locais visitados foram georreferenciados c
om o uso de GPS.    ^cY#aop04-11.htm##
01021000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704077500087002001300862#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#28#24#article#155#<br>  <B
>RESULTADOS:</B> Dos 36 munic&iacute;pios estudados, 30 apresentaram a ocorr&eci
rc;ncia de pelo menos uma entre as seis esp&eacute;cies de <I>Biomphalaria: glab
rata, tenagophila, straminea, peregrina, occidentalis</I> e <I>schrammi</I>. As 
tr&ecirc;s primeiras esp&eacute;cies citadas, reconhecidas como hospedeiras inte
rmedi&aacute;rias do <I>S. mansoni</I>, estavam presentes em 33,3%, 47,2% e 8,3%
 dos munic&iacute;pios estudados, respectivamente. Os moluscos foram encontrados
 em diferentes tipos de cole&ccedil;&otilde;es h&iacute;dricas e em nenhum deles
 foi detectada infec&ccedil;&atilde;o pelo <I>S. mansoni</I>. Houve maior ocorr&
ecirc;ncia de <I>Biomphalaria</I> na &aacute;rea referente ao <I>Caminho Novo</I
> (Diamantina/MG ao Rio de Janeiro/RJ).    ^cY#aop04-11.htm##
00789000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054300087002001300630#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#29#25#article#155#<br>  <B
>CONCLUS&Otilde;ES:</B> Considerando&#45;se a ocorr&ecirc;ncia da esquistossomos
e, no Estado de Minas Gerais, e as repercuss&otilde;es socioecon&ocirc;micas que
 envolvem o projeto <I>Estrada Real</I>, este trabalho aponta para a vulnerabili
dade das cole&ccedil;&otilde;es h&iacute;dricas devido &agrave; presen&ccedil;a 
de moluscos <I>Biomphalaria</I> e enfatiza a necessidade de vigil&acirc;ncia epi
demiol&oacute;gica e medidas educativas e sanit&aacute;rias integradas com a com
unidade local e setores de turismo.</font></p>     ^cY#aop04-11.htm##
00459000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021300087002001300300#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#30#26#article#155#<p><font
 size="2" face="Verdana"><B>Palavras&#45;chaves:</B> <I>Biomphalaria.</I> Esquis
tossomose. Estrada Real.  Turismo. Ecoturismo. Distribui&ccedil;&atilde;o espaci
al.</font></p> <hr size="1" noshade>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#31#27#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#32#28#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00318000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007200087002001300159#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#33#29#article#155#<p><font
 size="3" face="Verdana"><b>INTRODUCTION</b></font></p>     ^cY#aop04-11.htm##
01186000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704094000087002001301027#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#34#30#article#155#<p><font
 size="2" face="Verdana">Mollusks of the genus <I>Biomphalaria</I> infected with
 <I>Schistosoma mansoni</I> maintain the cycle of schistosomiasis in several Bra
zilian municipalities, despite recent improvements in the socioeconomic status o
f the population and education programs focusing on health, which were expected 
to reduce transmission of the disease. The relation between disease occurrence i
n human populations and the geographical presence of susceptible intermediate ho
sts is a well documented fact<SUP>1</SUP>. Poor rural communities continue to be
 major areas of schistosomiasis transmission<SUP>1</SUP>. With the phenomena of 
urbanization (migration to the outskirts of large cities), all aspects of the di
sease are reappearing, such as: neuroschistosomiasis, pulmonary hypertension, he
patosplenic schistosomiasis, acute episodes, glomerulonephritis and pyogenic liv
er abscesses<SUP>1&#45;13</SUP>.</font></p>     ^cY#aop04-11.htm##
00617000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037100087002001300458#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#35#31#article#155#<p><font
 size="2" face="Verdana">The State of <I>Minas Gerais</I> presents one of the hi
ghest prevalence rates for schistosomiasis in Brazil<SUP>14,15</SUP>. The presen
ce of schistosomiasis in this state causes a number of concerns, not only for th
e healthcare sector, but also for economic sectors, such as tourism, which invol
ve significant capital.</font></p>     ^cY#aop04-11.htm##
01349000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704110300087002001301190#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#36#32#article#155#<p><font
 size="2" face="Verdana">In the historical context of the economic development o
f State of <I>Minas Gerais</I>, the term <I>Estrada Real</I> refers to the route
s taken by settlers from the time of the discovery of gold in <I>Minas Gerais</I
> to the period of its exhaustion<SUP>16,17</SUP>. The <I>Estrada Real</I> was c
reated by the Portuguese Crown in the 17<SUP>th</SUP> century with the intention
 of controlling the flow of wealth, in the form of gold and diamonds and goods, 
which passed between the State of <I>Minas Gerais</I> and the coastal city of <I
>Rio de Janeiro</I>, the capital of the colony at the that time<SUP>17</SUP>. Th
e association of tourist attractions, including colonial buildings, churches, mu
seums, nature reserves, adventure sports, mineral springs and culinary attractio
ns, led to the creation of the <I>Estrada Real</I> Project. The <I>Estrada Real<
/I> Project consists of 193 municipalities, 162 of which are in the State of <I>
Minas Gerais</I>, nine in the State of <I>Rio de Janeiro</I> and 22 in the State
 of S&atilde;o Paulo<SUP>17</SUP>. </font></p>     ^cY#aop04-11.htm##
00828000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058200087002001300669#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#37#33#article#155#<p><font
 size="2" face="Verdana">The State of Minas Gerais includes the majority of the 
municipalities of the <I>Estrada Real</I> Project with great potential for expan
ding ecotourism and rural tourism, because of the attraction represented by hist
orical&#45;cultural monuments, the diversity of the topography, fauna and flora 
and water bodies. Thus, mapping the geographical areas vulnerable to the transmi
ssion of schistosomiasis becomes a task not only of health surveillance, but als
o of encouraging productive sectors that drive the economy in this state. </font
></p>     ^cY#aop04-11.htm##
00674000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042800087002001300515#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#38#34#article#155#<p><font
 size="2" face="Verdana">In order to contribute to the generation of georeferenc
ed epidemiological data and the control of schistosomiasis in the municipalities
 of the <I>Estrada Real</I> Project in southeastern Minas Gerais, this work repo
rts a malacological survey designed to verify the occurrence of mollusks of the 
genus <I>Biomphalaria</I> and the possibility of infection by <I>S. mansoni.</I>
</font></p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#39#35#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006700087002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#40#36#article#155#<p><font
 size="3" face="Verdana"><b>METHODS</b></font></p>     ^cY#aop04-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#41#37#article#155#<p><font
 size="2" face="Verdana"><B>Study area</B></font></p>     ^cY#aop04-11.htm##
01073000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704082700087002001300914#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#42#38#article#155#<p><font
 size="2" face="Verdana">The study municipalities are located in the southeast o
f the State of <I>Minas Gerais</I>, Brazil, and belong to the Regional Healthcar
e Administration of<I> Juiz de Fora</I> (<I>Ger&ecirc;ncia Regional de Sa&uacute
;de</I>, GRS/JF). The state is administratively divided into 13 macroregions. Am
ong these, the southeastern macroregion consists of eight microregions, of which
 the <I>Juiz de Fora/Lima Duarte/Bom Jardim de Minas</I> microregion is under th
e responsibility of the GRS/JF. This microregion is composed of 37 municipalitie
s. Of these, 36 were included in the study. The core urban area of the city of <
I>Juiz de Fora</I> was not included, because the results of a local malacologica
l survey conducted prior to this study had already been published<SUP>18</SUP>.<
/font></p>     ^cY#aop04-11.htm##
00326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008000087002001300167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#43#39#article#155#<p><font
 size="2" face="Verdana"><B>Malacological survey</B></font></p>     ^cY#aop04-11
.htm##
01327000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704108100087002001301168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#44#40#article#155#<p><font
 size="2" face="Verdana">Mollusks of the <I>Biomphalaria</I> genus were collecte
d from August 2005 to September 2009, by technicians of the GRS/JF. Catches were
 made in several areas of the municipalities in order to cover the largest possi
ble area, with the aid of gloves, tongs and dip nets. In all 36 municipalities, 
the type and quantity of water collection sites surveyed were selected by the fo
llowing criteria: reported local cases of human schistosomiasis, existence of wa
ter bodies (lotic and lentic) whose characteristics favored the occurrence of th
e <I>Biomphalaria</I> genus and the possibility of contact with human population
s. Thus, based in these criteria, at least three water collections in each munic
ipality were surveyed. The points were georeferenced using a Global Positioning 
System (GPS), Garmin Model II&#45;12, and imported into a Geographic Information
 System (GIS) to permit visualization of their spatial distribution. Sites in wh
ich the presence of <I>Biomphalaria</I> was verified were photographed with a di
gital camera.</font></p>     ^cY#aop04-11.htm##
00384000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013800087002001300225#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#45#41#article#155#<p><font
 size="2" face="Verdana"><B>Mollusk identification and examination of <I>Schisto
soma mansoni</I> infection</B></font></p>     ^cY#aop04-11.htm##
01129000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704088300087002001300970#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#46#42#article#155#<p><font
 size="2" face="Verdana">The captured snails were counted, transported in plasti
c containers and maintained in the laboratory until identification. Following co
llection, the snails were transported to the laboratory where they were measured
 and examined under artificial light. Some specimens from each sample were ident
ified at the Parasitology Laboratory in the Federal University of <I>Juiz de For
a</I> and the Entomology Laboratory of the GRS/JF, <I>Secretaria de Estado de Sa
&uacute;de de Minas Gerais</I> (SES/MG), according to the protocol established b
y Paraense<SUP>19,20</SUP>. Some specimens were sent to the Laboratory of Helmin
thology and Malacology at the <I>Ren&eacute; Rachou</I> Medical Research Center,
 Oswaldo Cruz Foundation (CPqRR/FIOCRUZ), for confirmation of species by the tec
hnique of polymerase chain reaction (PCR)<SUP>21</SUP>.</font></p>     ^cY#aop04
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#47#43#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006700087002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#48#44#article#155#<p><font
 size="3" face="Verdana"><b>RESULTS</b></font></p>     ^cY#aop04-11.htm##
01164000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704091800087002001301005#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#49#45#article#155#<p><font
 size="2" face="Verdana">Research on <I>Biomphalaria </I>was conducted in 36 mun
icipalities,  19 of which form part of the <I>Estrada Real</I> Project, while th
e remainder are located within the coverage area (<B><a href="#tab01">Table 1</a
></B>). As presented in <B><a href="#tab01">Table 1</a></B>, 30 municipalities w
ere positive for snails of the genus <I>Biomphalaria</I>, while in six, the pres
ence of these mollusks not observed. Six <I>Biomphalaria</I> species were identi
fied<I>: glabrata, tenagophila, straminea, peregrina, occidentalis</I> and <I>sc
hrammi</I>.<I> B. tenagophila</I> was the most prevalent species and was found i
n 17 municipalities, followed by <I>B. peregrina</I>, in 16 municipalities and b
y <I>B. glabrata</I>, in 12. A total of 3,772 specimens of mollusks were collect
ed, all negative for cercariae of <I>S. mansoni </I><B>(<a href="#tab01">Table 1
</a>).</B></font></p>     ^cY#aop04-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#50#46#article#155#<p><a na
me="tab01"></a></p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#51#47#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#52#48#article#155#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a04tab01.jpg"></p>     ^cY#ao
p04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#53#49#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
01602000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704135600087002001301443#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#54#50#article#155#<p><font
 size="2" face="Verdana"><B><a href="#tab02">Table 2</a></B> shows the water col
lections visited in the municipalities studied and the number of positive sites 
for <I>Biomphalaria</I> snails. The sites were classified according to the follo
wing definitions intentionally left in their categories as defined in Portuguese
 to preserve the distinctions between site types: stream, water flowing in a cha
nnel; dam, a barrier constructed to contain the flow of water; tank, a large art
ificial container used to hold water; irrigation ditch, a channel for water irri
gation; bog, wet spongy ground containing clay; waterfall, a cascade of water; w
ater tank, a container for supplying water under pressure; water trough, a conta
iner providing water for animals; canal, an artificial waterway; spring, water r
ising from the earth; well, a hole or shaft sunk into the earth to obtain water;
 and reservoir, a natural or artificial pond or lake used for storage and regula
tion of water. Among the various water collections, streams were the most positi
ve sites for <I>Biomphalaria</I> species, with  35 locations, followed by dams. 
The greatest variety of species was found in the dams. Among the 12 water collec
tions surveyed, 10 showed the presence of <I>B. glabrata</I> and/or <I>B. tenago
phila </I><B>(<a href="#tab02">Table 2</a>)</B>.</font></p>     ^cY#aop04-11.htm
##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#55#51#article#155#<p><a na
me="tab02"></a></p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#56#52#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#57#53#article#155#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a04tab02.jpg"></p>     ^cY#ao
p04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#58#54#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
01591000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704134500087002001301432#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#59#55#article#155#<p><font
 size="2" face="Verdana"><B><a href="/img/revistas/rsbmt/2011nahead/a04fig01.jpg
">Figure 1</a></B> shows the coverage area of the <I>Estrada Real</I> Project in
 Brazil and highlights the positive and negative areas for <I>Biomphalaria</I> s
nails. A higher concentration of <I>Biomphalaria</I> occurs in the eastern regio
n of the map, in the area covered by the <I>Caminho Novo</I> (<I>Diamantina/MG t
o Rio de Janeiro/RJ</I>), than in the western region of the map, which is closer
 to the <I>Caminho Velho</I> (<I>Diamantina/MG</I> to <I>Paraty/RJ</I>). In the 
eastern region, between the rivers <I>Pinho</I> and <I>Paraibuna</I>, belonging 
to the <I>Para&iacute;ba do Sul</I> river basin, all the species of mollusks rep
orted in this work were found. The western region, between the rivers <I>Grande<
/I> and <I>Aiuruoca</I>, belonging to the <I>Rio Grande</I> water basin, is the 
area with just one positive collection dot for <I>B. peregrina. </I>In the south
ern region, between the rivers <I>Grande</I> and <I>Preto</I>, belonging to the 
<I>Rio Grande</I> and to the <I>Rio Para&iacute;ba do Sul</I> water basins, resp
ectively, there are various collection dots for <I>B. peregrina</I>, but only on
e positive dot for <I>B. tenagophila</I> <B>(<a href="/img/revistas/rsbmt/2011na
head/a04fig01.jpg">Figure 1</a>).</B></font></p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#60#56#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#61#57#article#155#<p><font
 size="3" face="Verdana"><b>DISCUSSION</b></font></p>     ^cY#aop04-11.htm##
00885000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063900087002001300726#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#62#58#article#155#<p><font
 size="2" face="Verdana">Increased ecotourism and rural tourism in the State of 
<I>Minas Gerais</I> has highlighted the importance of studies regarding the occu
rrence of potential intermediate hosts of <I>S. mansoni</I>. This study revealed
 the presence of <I>Biomphalaria </I>snails in 30 municipalities, in the southea
st region of the state, belonging to the <I>Estrada Real</I> Project or to its c
overage area. This is a pioneering work, undertaken to investigate <I>Biomphalar
ia</I> snails in municipalities of the <I>Estrada Real</I> route with the use of
 geographic coordinates (GPS) for mollusk location.</font></p>     ^cY#aop04-11.
htm##
01416000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704117000087002001301257#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#63#59#article#155#<p><font
 size="2" face="Verdana">In Brazil, there are 11 species and one subspecies of m
ollusks of the genus <I>Biomphalaria</I>, but only <I>B. glabrata</I>, <I>B. ten
agophila</I> and <I>B. straminea</I> are recognized as intermediate hosts of <I>
S. mansoni</I>.    <I>B. peregrina</I> proved to be experimentally susceptible t
o <I>S. mansoni</I>, while <I>B. occidentalis</I> and <I>B. schrammi</I> proved 
to be refractory to infection<SUP>22&#45;26</SUP>. <I>B. tenagophila</I> was pre
sent in 47.2% of the municipalities surveyed,  <I>B. glabrata</I> in 33.3% and <
I>B. straminea</I> in 8.3%. Despite the undeniable importance of <I>B. glabrata<
/I> in Brazil, it is interesting to observe that <I>B. tenagophila</I> is the ma
in species transmitting schistosomiasis in the State of <I>S&atilde;o Paulo</I>.
 These data reveal the importance of surveillance and the need for a control pro
gram for schistosomiasis in such areas, since <I>B. glabrata</I> showed signific
ant occurrence and is of great importance due to its extensive geographic distri
bution, high infection indices and effectiveness in the transmission of schistos
omiasis<SUP>27</SUP>. </font></p>     ^cY#aop04-11.htm##
00648000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040200087002001300489#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#64#60#article#155#<p><font
 size="2" face="Verdana">Among the 36 municipalities studied, the absence of <I>
Biomphalaria</I> snails was verified in only six. However, it is important to hi
ghlight that the present study was conducted over four years, which means that s
easonal cycles, such as temperature and rainfall, for example, may have affected
 the abundance of mollusk populations<SUP>28,29</SUP>.</font></p>     ^cY#aop04-
11.htm##
00605000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035900087002001300446#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#65#61#article#155#<p><font
 size="2" face="Verdana">This study revealed several water collections colonized
 by mollusks of the <I>Biomphalaria </I>genus,  including streams, dams and wate
rfalls, which could serve for sporting practices or for the construction of pool
s, providing further sources of infection by schistosomiasis among tourists<SUP>
4,30</SUP>.</font></p>     ^cY#aop04-11.htm##
00862000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061600087002001300703#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#66#62#article#155#<p><font
 size="2" face="Verdana">The <I>Estrada Real</I> Project is based on the explora
tion of the touristic potential of the region, with the implementation of region
al ecotourism and the preservation of the natural patrimony<SUP>17</SUP>. These 
goals also culminate, unintentionally, in maintaining the habitat of the interme
diate hosts of <I>S. mansoni</I>, which may promote outbreaks and the spread of 
schistosomiasis in the region, since in the majority of these sites sanitation c
onditions are poor, representing contamination risks for water collections in ca
ses of infected individuals.</font></p>     ^cY#aop04-11.htm##
01823000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704157700087002001301664#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#67#63#article#155#<p><font
 size="2" face="Verdana">Little information exists regarding the prevalence of s
chistosomiasis in the municipalities studied, because the region is generally co
nsidered to be of low endemicity<SUP>18</SUP>. The presence of <I>Biomphalaria</
I> species was previously reported in the municipalities of Piau, Rio Novo and J
uiz de Fora<SUP>15,18,31</SUP>, although considering their geographical location
, only <I>Juiz de Fora</I> has been surveyed<SUP>18</SUP>. Models to estimate th
e prevalence of schistosomiasis have been perfomed in the State of <I>Minas Gera
is</I><SUP>14,32&#45;34 </SUP>and in some <I>Estrada Real</I> municipalities<SUP
>16</SUP>, but in both studies, due to lack of georeferenced information for <I>
Biomphalaria</I>, only data concerning the prevalence of human schistosomiasis a
nd <I>Biomphalaria</I> species in relation to the municipality were used. In thi
s study, all the sites where the occurrence of <I>Biomphalaria</I> was verified 
were mapped using GPS. Knowing the exact location of the breeding/water collecti
ons of the intermediate host participant in the chain of transmission of schisto
somiasis permits greater flexibility in structuring measures for disease control
. Moreover, these data may favor the use of geostatistical techniques, generatin
g predictive values for the occurrence of <I>Biomphalaria</I> at sites in the re
gion with no information regarding the intermediate hosts<SUP>34,35</SUP>, which
 could contribute to the drafting of a map of <I>Biomphalaria </I>snails in the 
State of <I>Minas Gerais</I>.</font></p>     ^cY#aop04-11.htm##
00734000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048800087002001300575#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#68#64#article#155#<p><font
 size="2" face="Verdana">Considering the occurrence of schistosomiasis in the St
ate of <I>Minas Gerais</I> and the socioeconomic repercussions that involve the 
<I>Estrada Real</I> Project, this work focuses on the vulnerability of the local
 water collections due to the presence of <I>Biomphalaria</I> mollusks and empha
sizes the need for epidemiological surveillance and sanitary and education measu
res integrated with the local community and tourism sectors.</font></p>     ^cY#
aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#69#65#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00321000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007500087002001300162#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#70#66#article#155#<p><font
 size="3" face="Verdana"><b>ACKNOWLEDGMENTS</b></font></p>     ^cY#aop04-11.htm#
#
00524000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027800087002001300365#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#71#67#article#155#<p><font
 size="2" face="Verdana">The authors are grateful to the entire team of the Regi
onal Healthcare Administration in <I>Juiz de Fora</I>, <I>Minas Gerais</I>, (GRS
/JF) and to Sandra C Drummond (State of <I>Minas Gerais</I> Health Administrativ
e Office).</font></p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#72#68#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008000087002001300167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#73#69#article#155#<p><font
 size="3" face="Verdana"><b>CONFLICT OF INTEREST</b></font></p>     ^cY#aop04-11
.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#74#70#article#155#<p><font
 size="2" face="Verdana">The authors declare that there is no conflict of intere
st.</font></p>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#75#71#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00323000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007700087002001300164#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#76#72#article#155#<p><font
 size="3" face="Verdana"><b>FINANCIAL SUPPORT</b></font></p>     ^cY#aop04-11.ht
m##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#77#73#article#155#<p><font
 size="2" face="Verdana">This work was partially supported by FAPEMIG.</font></p
>     ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#78#74#article#155#<p>&nbsp
;</p>     ^cY#aop04-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#79#75#article#155#<p><font
 size="3" face="Verdana"><b>REFERENCES</b></font></p>     ^cY#aop04-11.htm##
00548000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704028800089002001300377#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#80#76#article#
155#1#<p><font size="2" face="Verdana">1. Enk MJ, Amorim A, Schall VT. Acute sch
istosomiasis outbreak in the metropolitan area of Belo Horizonte, Minas Gerais: 
alert about the risk of unnoticed transmission increased by growing rural touris
m. Mem Inst Oswaldo Cruz 2003; 98:745&#45;750.    ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#81#77#article#155#</font><
/p>     ^cY#aop04-11.htm##
00509000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024900089002001300338#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#82#78#article#
155#2#<p><font size="2" face="Verdana">2. Barbosa CS, Domingues ALC, Abath F, Mo
ntenegro SML, Guida U, Carneiro J,  et al. An outbreak of acute schistosomiasis 
at Porto de Galinhas beach, Pernambuco, Brazil. Cad Saude Publica 2001; 17:725&#
45;728.    ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#83#79#article#155#</font><
/p>     ^cY#aop04-11.htm##
00477000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021700089002001300306#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#84#80#article#
155#3#<p><font size="2" face="Verdana">3. Barbosa CS, Pieri OS, Silva CB, Barbos
a FS. Ecoepidemiology of urban schistossomiasis in Itamarac&aacute; Island, Pern
ambuco, Brazil. Rev Saude Publica 2000; 34:337&#45;341.    ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#85#81#article#155#</font><
/p>     ^cY#aop04-11.htm##
00508000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024800089002001300337#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#86#82#article#
155#4#<p><font size="2" face="Verdana">4. De Jesus AR, Silva A, Santana LB, Maga
lh&atilde;es A, Jesus AA, Almeida RP, et al. Clinical and immunologic evaluation
 of 31 patients with acute schistosomiasis mansoni. J Infect Dis 2002; 185:98&#4
5;105.    ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#87#83#article#155#</font><
/p>     ^cY#aop04-11.htm##
00508000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024800089002001300337#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#88#84#article#
155#5#<p><font size="2" face="Verdana">5. Gon&ccedil;alves JF, Santana W, Barbos
a CS, Coutinho A. Esquistossomose aguda, de car&aacute;ter epis&oacute;dico, na 
Ilha de Itamarac&aacute;, Estado de Pernambuco. Cad Saude Publica 1991; 7:424&#4
5;425.    ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#89#85#article#155#</font><
/p>     ^cY#aop04-11.htm##
00491000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704023100089002001300320#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#90#86#article#
155#6#<p><font size="2" face="Verdana">6. Massara CL, Amaral GL, Caldeira RL, Dr
ummond SC, Enk MJ, Carvalho OS. Esquistossomose em &aacute;rea de ecoturismo do 
estado de Minas Gerais, Brasil. Cad Saude Publica 2008; 24:13&#45;22.    ^cY#aop
04-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#91#87#article#155# </font>
</p>     ^cY#aop04-11.htm##
00483000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022300089002001300312#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#92#88#article#
155#7#<p><font size="2" face="Verdana">7. Drummond SC, Pereira SR, Silva LC, Ant
unes CM, Lambertucci JR. Schistosomiasis control program in the State of Minas G
erais in Brazil. Mem Inst Oswaldo Cruz 2010; 105:519&#45;523.    ^cY#aop04-11.ht
m##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#93#89#article#155# </font>
</p>     ^cY#aop04-11.htm##
00423000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016300089002001300252#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#94#90#article#
155#8#<p><font size="2" face="Verdana">8. Lambertucci JR. Acute schistosomiasis 
mansoni: revisited and reconsidered. Mem Inst Oswaldo Cruz 2010; 105:422&#45;435
.    ^cY#aop04-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#95#91#article#155# </font>
</p>     ^cY#aop04-11.htm##
00420000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016000089002001300249#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#96#92#article#
155#9#<p><font size="2" face="Verdana">9. Lambertucci JR, Voieta I, Silveira IS.
 Cerebral schistosomiasis mansoni. Rev Soc Bras Med Trop 2008; 41:693&#45;694.  
  ^cY#aop04-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#97#93#article#155#</font><
/p>     ^cY#aop04-11.htm##
00444000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704018300090002001300273#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#98#94#article#
155#10#<p><font size="2" face="Verdana">10. Lambertucci JR, Otoni A, Reis MA. Ne
phrotic syndrome in hepatosplenic schistosomiasis mansoni. Rev Soc Bras Med Trop
 2007; 40:492&#45;493.    ^cY#aop04-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#99#95#article#155# </font>
</p>     ^cY#aop04-11.htm##
00517000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704025500091002001300346#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#100#96#article
#155#11#<p><font size="2" face="Verdana">11. Drummond SC, Silva LC, Amaral RS, S
ousa&#45;Pereira SR, Antunes CM, Lambertucci JR. Morbidity of schistosomiasis ma
nsoni in the State of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2006; 101(supp
l 1):37&#45;44.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002100088002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#101#97#article#155# </font
></p>     ^cY#aop04-11.htm##
00543000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704028100091002001300372#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#102#98#article
#155#12#<p><font size="2" face="Verdana">12. Teixeira R, Ferreira MD, Coelho PM,
 Filho GB, Azevedo J&uacute;nior GM, Lambertucci JR. Pyogenic liver abscesses an
d acute schistosomiasis mansoni: report on 3 cases and experimental study. Trans
 R Soc Trop Med Hyg 1996; 90:280&#45;283.    ^cY#aop04-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#103#99#article#155#</font>
</p>     ^cY#aop04-11.htm##
00437000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017400092002001300266#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#104#100#articl
e#155#13#<p><font size="2" face="Verdana">13. Lambertucci JR, Rocha RS, Carvalho
 OS, Katz N. Schistosomiasis mansoni in Minas Gerais. Rev Soc Bras Med Trop 1987
; 20:47&#45;52.    ^cY#aop04-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#105#101#article#155# </fon
t></p>     ^cY#aop04-11.htm##
00535000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027200092002001300364#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#106#102#articl
e#155#14#<p><font size="2" face="Verdana">14. Guimar&atilde;es RJPS, Freitas CC,
 Dutra LV, Moura ACM, Amaral RS, Drummond SC, et al. Schistosomiasis risk estima
tion in Minas Gerais State, Brazil, using environmental data and GIS techniques.
 Acta Trop 2008; 108:234&#45;341.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#107#103#article#155#</font
></p>     ^cY#aop04-11.htm##
00530000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026700092002001300359#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#108#104#articl
e#155#15#<p><font size="2" face="Verdana">15. Souza CP, Caldeira RL, Drummond SC
, Melo AL, Guimar&atilde;es CT, Soares DM,  et al. Geographical distribution of 
<I>Biomphalaria</I> snails in the state of Minas Gerais, Brazil. Mem Inst Oswald
o Cruz 2001; 96:293&#45;302.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#109#105#article#155#</font
></p>     ^cY#aop04-11.htm##
00550000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028700092002001300379#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#110#106#articl
e#155#16#<p><font size="2" face="Verdana">16. Carvalho OS, Scholte RGC, Guimar&a
tilde;es RJPS, Freitas CC, Drummond SC, Amaral RS, et al. The "Estrada Real" Pro
ject and endemic diseases: the case of schistosomiasis, geoprocessing and touris
m. Mem Inst Oswaldo Cruz  2010; 105:532&#45;536.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#111#107#article#155#</font
></p>     ^cY#aop04-11.htm##
00676000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704041300092002001300505#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#112#108#articl
e#155#17#<p><font size="2" face="Verdana">17. Federa&ccedil;&atilde;o das Ind&ua
cute;stria de Minas Gerais. Instituto Estrada Real &#45; Conhe&ccedil;a um pouco
 o "Instituto Estrada Real", sua atua&ccedil;&atilde;o e seus objetivos &#91;Int
ernet&#93;. &#91;uptaded 2010 April 11; cited 2010 April 12&#93;. Available from
: <a href="http://www.estradareal.org.br/" target="_blank">http://www.estradarea
l.org.br/</a>.    ^cY#aop04-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#113#109#article#155# </fon
t></p>     ^cY#aop04-11.htm##
00591000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032800092002001300420#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#114#110#articl
e#155#18#<p><font size="2" face="Verdana">18. Tibiric&aacute; SHC, Bessa EC, Mit
therofhe A, Castro MF, Carvalho ODOS, Caldeira R, et al. <I>Biomphalaria </I>spp
. (Preston,1910) snails in the municipality of Juiz de Fora, Zona da Mata Mineir
a mesoregion, State of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2006; 101:179
&#45;184.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#115#111#article#155#</font
></p>     ^cY#aop04-11.htm##
00426000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016300092002001300255#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#116#112#articl
e#155#19#<p><font size="2" face="Verdana">19. Paraense WL. Estudo atual da siste
m&aacute;tica dos planorb&iacute;deos brasileiros. Arq Mus Nac 1975; 55:105&#45;
128.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#117#113#article#155#</font
></p>     ^cY#aop04-11.htm##
00459000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019600092002001300288#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#118#114#articl
e#155#20#<p><font size="2" face="Verdana">20. Paraense WL. <I>Biomphalaria occid
entalis</I> sp. from South America (Mollusca: Basommatophora: Pulmonata). Mem In
st Oswaldo Cruz 1981; 76:199&#45;211.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#119#115#article#155#</font
></p>     ^cY#aop04-11.htm##
00488000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022500092002001300317#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#120#116#articl
e#155#21#<p><font size="2" face="Verdana">21. Vidigal THDA, Caldeira RL, Simpson
 AJ, Carvalho OS. Further studies on the molecular systematic of <I>Biomphalaria
 </I>snails from Brazil. Mem Inst Oswaldo Cruz 2000; 95:57&#45;66.    ^cY#aop04-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#121#117#article#155#</font
></p>     ^cY#aop04-11.htm##
00611000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034800092002001300440#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#122#118#articl
e#155#22#<p><font size="2" face="Verdana">22. Coimbra Jr CEA, Engel LA. Suscetib
ilidade de <I>Biomphalaria occidentalis </I>do Acre e Mato Grosso &agrave; infe&
ccedil;&atilde;o pelo <I>Schistosoma mansoni </I>e sua implica&ccedil;&atilde;o 
na epidemiologia da esquistossomose na Amaz&ocirc;nia Ocidental, Brasil. Acta Am
azonica 1982; 12:795&#45;799.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#123#119#article#155#</font
></p>     ^cY#aop04-11.htm##
00504000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024100092002001300333#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#124#120#articl
e#155#23#<p><font size="2" face="Verdana">23. Corr&ecirc;a LR, Paraense WL. Susc
eptibility of <I>Biomphalaria amazonica </I>to infection with two strains of <I>
Schistosoma mansoni</I>. Rev Inst Med Trop S&atilde;o Paulo  1971; 13:387&#45;39
0.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#125#121#article#155#</font
></p>     ^cY#aop04-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024900092002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#126#122#articl
e#155#24#<p><font size="2" face="Verdana">24. Paraense WL, Corr&ecirc;a LR. Susc
eptibility of <I>Biomphalaria peregrina </I>from Brazil and Ecuador to two strai
ns of <I>Schistosoma mansoni. </I>Rev Inst Med Trop S&atilde;o Paulo 1973; 15:12
7&#45;130.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#127#123#article#155#</font
></p>     ^cY#aop04-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022100092002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#128#124#articl
e#155#25#<p><font size="2" face="Verdana">25. Paraense WL, Correa LR. Insuscepti
bility of <I>Biomphalaria occidentalis </I>to infection with a strain of <I>Schi
stosoma mansoni</I>. Mem Inst Oswaldo Cruz 1982; 77:55&#45;58.    ^cY#aop04-11.h
tm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#129#125#article#155#</font
></p>     ^cY#aop04-11.htm##
00557000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029400092002001300386#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#130#126#articl
e#155#26#<p><font size="2" face="Verdana">26. Souza CP, Passos LKJ. Resistance o
f <I>Biomphalaria occidentalis</I> from Varzea das Flores Dam, Minas Gerais, to 
<I>Schistosoma mansoni</I> infection detected by  low stringency Polymerase Chai
n Reaction. Mem Inst Oswaldo Cruz 2001; 96:381&#45;383.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#131#127#article#155#</font
></p>     ^cY#aop04-11.htm##
00523000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026000092002001300352#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#132#128#articl
e#155#27#<p><font size="2" face="Verdana">27. Caldeira RL, Jannotti&#45;Passos L
K, Carvalho OS. Molecular epidemiology of Brazilian <I>Biomphalaria</I>: a revie
w of the identification of species and the detection of infected snails. Acta Tr
op 2009; 111:1&#45;6.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#133#129#article#155#</font
></p>     ^cY#aop04-11.htm##
00432000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016900092002001300261#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#134#130#articl
e#155#28#<p><font size="2" face="Verdana">28. Freita JM. Ecologia de vetores de 
doen&ccedil;as. O habitat da <I>Biomphalaria glabrata</I>. Cien Cult 1976; 28:21
2&#45;217.    ^cY#aop04-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#135#131#article#155# </fon
t></p>     ^cY#aop04-11.htm##
00504000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024100092002001300333#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#136#132#articl
e#155#29#<p><font size="2" face="Verdana">29. Grisolia MLM, Freitas JR. Caracter
&iacute;sticas f&iacute;sicas e qu&iacute;micas do habitat da <I>Biomphalaria te
nagophila </I>(Mollusca, Planorbidae). Mem Inst Oswaldo Cruz 1985; 80:237&#45;24
4.    ^cY#aop04-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#137#133#article#155# </fon
t></p>     ^cY#aop04-11.htm##
00490000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022700092002001300319#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#138#134#articl
e#155#30#<p><font size="2" face="Verdana">30. Enk MJ, Caldeira RL, Carvalho OS, 
Schall VT. Rural tourism as risk factor for the transmission of schistosomiasis 
in Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2004; 99:105&#45;108.    ^cY#aop0
4-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#139#135#article#155#</font
></p>     ^cY#aop04-11.htm##
00423000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016000092002001300252#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#140#136#articl
e#155#31#<p><font size="2" face="Verdana">31. Freitas CA. Situa&ccedil;&atilde;o
 atual da esquistossomose no Brasil. Rev Bras Malariol D Trop 1972; 24:31&#45;55
.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#141#137#article#155#</font
></p>     ^cY#aop04-11.htm##
00444000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018100092002001300273#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#142#138#articl
e#155#32#<p><font size="2" face="Verdana">32. Paraense WL, Deslandes N. Observat
ions on <I>Australorbis janeirensis </I>(Clessin, 1884). Rev Bras Biol 1956; 16:
81&#45;102</font></p>     ^cY#aop04-11.htm##
00594000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033100092002001300423#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#143#139#articl
e#155#33#<p><font size="2" face="Verdana">33. Guimar&atilde;es RJPS, Freitas CC,
 Dutra LV, Moura ACM, Amaral RS, Drummond SC,  et al. Analyses and estimative of
 schistosomiasis prevalence for Minas Gerais State, Brazil, using multiple regre
ssion with social and environmental spatial data. Mem Inst Oswaldo Cruz 2006; 10
1:91&#45;96.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#144#140#article#155#</font
></p>     ^cY#aop04-11.htm##
00555000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029200092002001300384#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#145#141#articl
e#155#34#<p><font size="2" face="Verdana">34. Guimar&atilde;es RJPS, Freitas CC,
 Dutra LV, Scholte RGC, Martins FT, Fonseca FR,  et al. A geoprocessing approach
 for schistosomiasis studying and controlling in the State of Minas Gerais &#45;
 Brazil. Mem Inst Oswaldo Cruz 2010; 105:524&#45;531.    ^cY#aop04-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#146#142#article#155#</font
></p>     ^cY#aop04-11.htm##
00575000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031200092002001300404#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#147#143#articl
e#155#35#<p><font size="2" face="Verdana">35. Guimar&atilde;es RJPS, Freitas CC,
 Dutra LV, Felgueiras CA, Moura ACM, Amaral RS, et al. Spatial distribution of <
I>Biomphalaria </I>mollusks at S&atilde;o Francisco River Basin, Minas Gerais, B
razil, using geostatistical procedures. Acta Trop 2009; 109: 181&#45;186.    ^cY
#aop04-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#148#144#article#155# </fon
t></p>     ^cY#aop04-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#149#145#article#155#<p>&nb
sp;</p>     ^cY#aop04-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#150#146#article#155#<p>&nb
sp;</p>     ^cY#aop04-11.htm##
00405000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704015700089002001300246#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#151#147#article#155#<p><fo
nt size="2" face="Verdana"><b><a name="nt"></a><a href="#tx"><img src="/img/revi
stas/rsbmt/2011nahead/seta.jpg" border="0"></a> Address to:</b>    ^cY#aop04-11.
htm##
00288000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004000089002001300129#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#152#148#article#155#<br>  
Dra. Elaine Soares Coimbra    ^cY#aop04-11.htm##
00302000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005400089002001300143#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#153#149#article#155#<br> D
eptº Parasitol Microbiol Imunol/ICB/UFJF    ^cY#aop04-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005700089002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#154#150#article#155#<br> C
ampus Universit&aacute;rio, Bairro Martelos    ^cY#aop04-11.htm##
00299000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005100089002001300140#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#155#151#article#155#<br> 3
6036&#45;900 Juiz de Fora, MG, Brasil    ^cY#aop04-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006500089002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#156#152#article#155#<br> P
hone: 55 32 2102&#45;3219; Fax: 55 32 2102&#45;3214    ^cY#aop04-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704011100089002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#157#153#article#155#<br> e
&#45;mail: <a href="mailto:elaine.coimbra@ufjf.edu.br">elaine.coimbra@ufjf.edu.b
r</a></font></p>     ^cY#aop04-11.htm##
00311000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006300089002001300152#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#158#154#article#155#<p><fo
nt size="2" face="Verdana">Received in 10/09/2010    ^cY#aop04-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#p#159#155#article#155#<br>  
 Accepted in 04/11/2010</font></p>     ^cY#aop04-11.htm##
00701000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100014000880100016001020100
01700118012017500135030002200310065000900332064000500341031000300346014000800349
865000900357002001300366035001000379801002200389#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop04-11.htm#S#c#160#1#article#35#1#^rND^sEnk^nMJ#^rND^sAmo
rim^nA#^rND^sSchall^nVT#Acute schistosomiasis outbreak in the metropolitan area 
of Belo Horizonte, Minas Gerais: alert about the risk of unnoticed transmission 
increased by growing rural tourism^len#Mem Inst Oswaldo Cruz#20030000#2003#98#74
5-750#20110000#aop04-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00723000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100021001060100
01500127010002200142010001500164010001800179810000700197012008800204030001800292
06500090031006400050031903100030032401400080032786500090033500200130034403500100
0357801001800367#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#161#2#article#35#2#^rND^sBarbosa^nCS#^rND^sDomingues^nALC#^rND^sAbath^nF#^
rND^sMontenegro^nSML#^rND^sGuida^nU#^rND^sCarneiro^nJ#et al.#An outbreak of acut
e schistosomiasis at Porto de Galinhas beach, Pernambuco, Brazil^len#Cad Saude P
ublica#20010000#2001#17#725-728#20110000#aop04-11.htm#0102-311X#Cad Saude Public
a##
00637000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100016001060100
01600122010001800138012008600156030001800242065000900260064000500269031000300274
014000800277865000900285002001300294035001000307801001800317#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#162#3#article#35#3#^rND^sBarbo
sa^nCS#^rND^sPieri^nOS#^rND^sSilva^nCB#^rND^sBarbosa^nFS#Ecoepidemiology of urba
n schistossomiasis in Itamaracá Island, Pernambuco, Brazil^len#Rev Saude Publica
#20000000#2000#34#337-341#20110000#aop04-11.htm#0034-8910#Rev Saude Publica##
00711000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100015001070100
01800122010001900140010001600159010001800175810000700193012009000200030001300290
06500090030306400050031203100040031701400070032186500090032800200130033703500100
0350801001300360#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#163#4#article#35#4#^rND^sDe Jesus^nAR#^rND^sSilva^nA#^rND^sSantana^nLB#^rN
D^sMagalhães^nA#^rND^sJesus^nAA#^rND^sAlmeida^nRP#et al.#Clinical and immunologi
c evaluation of 31 patients with acute schistosomiasis mansoni^len#J Infect Dis#
20020000#2002#185#98-105#20110000#aop04-11.htm#0022-1899#J Infect Dis##
00647000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100017001080100
01800125010001800143012009200161030001800253065000900271064000500280031000200285
014000800287865000900295002001300304035001000317801001800327#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#164#5#article#35#5#^rND^sGonça
lves^nJF#^rND^sSantana^nW#^rND^sBarbosa^nCS#^rND^sCoutinho^nA#Esquistossomose ag
uda, de caráter episódico, na Ilha de Itamaracá, Estado de Pernambuco^lpt#Cad Sa
ude Publica#19910000#1991#7#424-425#20110000#aop04-11.htm#0102-311X#Cad Saude Pu
blica##
00687000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100017001060100
01900123010001900142010001400161010001900175012007600194030001800270065000900288
06400050029703100030030201400060030586500090031100200130032003500100033380100180
0343#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#165#6#
article#35#6#^rND^sMassara^nCL#^rND^sAmaral^nGL#^rND^sCaldeira^nRL#^rND^sDrummon
d^nSC#^rND^sEnk^nMJ#^rND^sCarvalho^nOS#Esquistossomose em área de ecoturismo do 
estado de Minas Gerais, Brasil^lpt#Cad Saude Publica#20080000#2008#24#13-22#2011
0000#aop04-11.htm#0102-311X#Cad Saude Publica##
00672000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100018001070100
01600125010001800141010002200159012007500181030002200256065000900278064000500287
031000400292014000800296865000900304002001300313035001000326801002200336#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#166#7#article#35#7
#^rND^sDrummond^nSC#^rND^sPereira^nSR#^rND^sSilva^nLC#^rND^sAntunes^nCM#^rND^sLa
mbertucci^nJR#Schistosomiasis control program in the State of Minas Gerais in Br
azil^len#Mem Inst Oswaldo Cruz#20100000#2010#105#519-523#20110000#aop04-11.htm#0
074-0276#Mem Inst Oswaldo Cruz##
00540000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100022000880120062001100300
02200172065000900194064000500203031000400208014000800212865000900220002001300229
035001000242801002200252#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
04-11.htm#S#c#167#8#article#35#8#^rND^sLambertucci^nJR#Acute schistosomiasis man
soni: revisited and reconsidered^len#Mem Inst Oswaldo Cruz#20100000#2010#105#422
-435#20110000#aop04-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00573000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100022000880100016001100100
01900126012003700145030002200182065000900204064000500213031000300218014000800221
865000900229002001300238035001000251801002200261#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop04-11.htm#S#c#168#9#article#35#9#^rND^sLambertucci^nJR#^
rND^sVoieta^nI#^rND^sSilveira^nIS#Cerebral schistosomiasis mansoni^len#Rev Soc B
ras Med Trop#20080000#2008#41#693-694#20110000#aop04-11.htm#0037-8682#Rev Soc Br
as Med Trop##
00597000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100015001120100
01500127012006400142030002200206065000900228064000500237031000300242014000800245
865000900253002001300262035001000275801002200285#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop04-11.htm#S#c#169#10#article#35#10#^rND^sLambertucci^nJR
#^rND^sOtoni^nA#^rND^sReis^nMA#Nephrotic syndrome in hepatosplenic schistosomias
is mansoni^len#Rev Soc Bras Med Trop#20070000#2007#40#492-493#20110000#aop04-11.
htm#0037-8682#Rev Soc Bras Med Trop##
00732000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
01700125010002400142010001800166010002200184012007800206030002200284065000900306
06400050031503100040032003200100032401400060033486500090034000200130034903500100
0362801002200372#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#170#11#article#35#11#^rND^sDrummond^nSC#^rND^sSilva^nLC#^rND^sAmaral^nRS#^
rND^sSousa-Pereira^nSR#^rND^sAntunes^nCM#^rND^sLambertucci^nJR#Morbidity of schi
stosomiasis mansoni in the State of Minas Gerais, Brazil^len#Mem Inst Oswaldo Cr
uz#20060000#2006#101#^ssuppl 1#37-44#20110000#aop04-11.htm#0074-0276#Mem Inst Os
waldo Cruz##
00745000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100019001080100
01700127010001600144010002500160010002200185012010500207030002500312065000900337
06400050034603100030035101400080035486500090036200200130037103500100038480100250
0394#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#171#12
#article#35#12#^rND^sTeixeira^nR#^rND^sFerreira^nMD#^rND^sCoelho^nPM#^rND^sFilho
^nGB#^rND^sAzevedo Júnior^nGM#^rND^sLambertucci^nJR#Pyogenic liver abscesses and
 acute schistosomiasis mansoni: report on 3 cases and experimental study^len#Tra
ns R Soc Trop Med Hyg#19960000#1996#90#280-283#20110000#aop04-11.htm#0035-9203#T
rans R Soc Trop Med Hyg##
00606000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100016001120100
01900128010001400147012004400161030002200205065000900227064000500236031000300241
014000600244865000900250002001300259035001000272801002200282#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#172#13#article#35#13#^rND^sLam
bertucci^nJR#^rND^sRocha^nRS#^rND^sCarvalho^nOS#^rND^sKatz^nN#Schistosomiasis ma
nsoni in Minas Gerais^len#Rev Soc Bras Med Trop#19870000#1987#20#47-52#20110000#
aop04-11.htm#0037-8682#Rev Soc Bras Med Trop##
00733000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01600130010001700146010001700163010001900180810000700199012011100206030001000317
06500090032706400050033603100040034101400080034586500090035300200130036203500100
0375801001000385#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#173#14#article#35#14#^rND^sGuimarães^nRJPS#^rND^sFreitas^nCC#^rND^sDutra^n
LV#^rND^sMoura^nACM#^rND^sAmaral^nRS#^rND^sDrummond^nSC#et al.#Schistosomiasis r
isk estimation in Minas Gerais State, Brazil, using environmental data and GIS t
echniques^len#Acta Trop#20080000#2008#108#234-341#20110000#aop04-11.htm#0001-706
X#Acta Trop##
00732000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01900125010001500144010002000159010001700179810000700196012009000203030002200293
06500090031506400050032403100030032901400080033286500090034000200130034903500100
0362801002200372#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#174#15#article#35#15#^rND^sSouza^nCP#^rND^sCaldeira^nRL#^rND^sDrummond^nSC
#^rND^sMelo^nAL#^rND^sGuimarães^nCT#^rND^sSoares^nDM#et al.#Geographical distrib
ution of Biomphalaria snails in the state of Minas Gerais, Brazil^len#Mem Inst O
swaldo Cruz#20010000#2001#96#293-302#20110000#aop04-11.htm#0074-0276#Mem Inst Os
waldo Cruz##
00759000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
02200128010001800150010001900168010001700187810000700204012010800211030002200319
06500090034106400050035003100040035501400080035986500090036700200130037603500100
0389801002200399#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#175#16#article#35#16#^rND^sCarvalho^nOS#^rND^sScholte^nRGC#^rND^sGuimarães
^nRJPS#^rND^sFreitas^nCC#^rND^sDrummond^nSC#^rND^sAmaral^nRS#et al.#The "Estrada
 Real" Project and endemic diseases: the case of schistosomiasis, geoprocessing 
and tourism^len#Mem Inst Oswaldo Cruz#20010000#2010#105#532-536#20110000#aop04-1
1.htm#0074-0276#Mem Inst Oswaldo Cruz##
00573000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170064000900180078001540650
00900232064001400241110000900255109001400264037003100278865000900309002001300318
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#176#17#art
icle#35#17#Federação das Indústria de Minas Gerais^dInstituto Estrada Real#Conhe
ça um pouco o "Instituto Estrada Real", sua atuação e seus objetivos^lpt#2010041
1#2010 April 11#20100412#2010 April 12#http://www.estradareal.org.br/#20110000#a
op04-11.htm##
00794000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100016001100100
02100126010001700147010002100164010001800185810000700203012014400210030002200354
06500090037606400050038503100040039001400080039486500090040200200130041103500100
0424801002200434#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#177#18#article#35#18#^rND^sTibiricá^nSHC#^rND^sBessa^nEC#^rND^sMittherofhe
^nA#^rND^sCastro^nMF#^rND^sCarvalho^nODOS#^rND^sCaldeira^nR#et al.#Biomphalaria 
spp. (Preston,1910) snails in the municipality of Juiz de Fora, Zona da Mata Min
eira mesoregion, State of Minas Gerais, Brazil^len#Mem Inst Oswaldo Cruz#2006000
0#2006#101#179-184#20110000#aop04-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00485000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900120061001090300
01200170710000200182065000900184064000500193031000300198014000800201865000900209
002001300218#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#
c#178#19#article#35#19#^rND^sParaense^nWL#Estudo atual da sistemática dos planor
bídeos brasileiros^lpt#Arq Mus Nac#2#19750000#1975#55#105-128#20110000#aop04-11.
htm##
00567000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900120091001090300
02200200065000900222064000500231031000300236014000800239865000900247002001300256
035001000269801002200279#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
04-11.htm#S#c#179#20#article#35#20#^rND^sParaense^nWL#Biomphalaria occidentalis 
sp. from South America (Mollusca: Basommatophora: Pulmonata)^len#Mem Inst Oswald
o Cruz#19810000#1981#76#199-211#20110000#aop04-11.htm#0074-0276#Mem Inst Oswaldo
 Cruz##
00650000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100019001100100
01800129010001900147012008300166030002200249065000900271064000500280031000300285
014000600288865000900294002001300303035001000316801002200326#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#180#21#article#35#21#^rND^sVid
igal^nTHDA#^rND^sCaldeira^nRL#^rND^sSimpson^nAJ#^rND^sCarvalho^nOS#Further studi
es on the molecular systematic of Biomphalaria snails from Brazil^len#Mem Inst O
swaldo Cruz#20000000#2000#95#57-66#20110000#aop04-11.htm#0074-0276#Mem Inst Oswa
ldo Cruz##
00682000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100016001120120
18900128030001500317065000900332064000500341031000300346014000800349865000900357
002001300366035001000379801001500389#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#181#22#article#35#22#^rND^sCoimbra Jr^nCEA#^rND^sEngel
^nLA#Suscetibilidade de Biomphalaria occidentalis do Acre e Mato Grosso à infeçã
o pelo Schistosoma mansoni e sua implicação na epidemiologia da esquistossomose 
na Amazônia Ocidental, Brasil^lpt#Acta Amazonica#19820000#1982#12#795-799#201100
00#aop04-11.htm#0100-1329#Acta amazonica##
00615000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070120
09800126030002800224065000900252064000500261031000300266014000800269865000900277
002001300286035001000299801002800309#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#182#23#article#35#23#^rND^sCorrêa^nLR#^rND^sParaense^n
WL#Susceptibility of Biomphalaria amazonica to infection with two strains of Sch
istosoma mansoni^len#Rev Inst Med Trop São Paulo#19710000#1971#13#387-390#201100
00#aop04-11.htm#0036-4665#Rev Inst Med Trop São Paulo##
00624000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100017001090120
10700126030002800233065000900261064000500270031000300275014000800278865000900286
002001300295035001000308801002800318#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#183#24#article#35#24#^rND^sParaense^nWL#^rND^sCorrêa^n
LR#Susceptibility of Biomphalaria peregrina from Brazil and Ecuador to two strai
ns of Schistosoma mansoni^len#Rev Inst Med Trop São Paulo#19730000#1973#15#127-1
30#20110000#aop04-11.htm#0036-4665#Rev Inst Med Trop São Paulo##
00603000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100017001090120
10000126030002200226065000900248064000500257031000300262014000600265865000900271
002001300280035001000293801002200303#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#184#25#article#35#25#^rND^sParaense^nWL#^rND^sCorrea^n
LR#Insusceptibility of Biomphalaria occidentalis to infection with a strain of S
chistosoma mansoni^len#Mem Inst Oswaldo Cruz#19820000#1982#77#55-58#20110000#aop
04-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00675000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060120
17200124030002200296065000900318064000500327031000300332014000800335865000900343
002001300352035001000365801002200375#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#185#26#article#35#26#^rND^sSouza^nCP#^rND^sPassos^nLKJ
#Resistance of Biomphalaria occidentalis from Varzea das Flores Dam, Minas Gerai
s, to Schistosoma mansoni infection detected by low stringency Polymerase Chain 
Reaction^len#Mem Inst Oswaldo Cruz#20010000#2001#96#381-383#20110000#aop04-11.ht
m#0074-0276#Mem Inst Oswaldo Cruz##
00651000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100026001090100
01900135012013300154030001000287065000900297064000500306031000400311014000400315
865000900319002001300328035001000341801001000351#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop04-11.htm#S#c#186#27#article#35#27#^rND^sCaldeira^nRL#^r
ND^sJannotti-Passos^nLK#^rND^sCarvalho^nOS#Molecular epidemiology of Brazilian B
iomphalaria: a review of the identification of species and the detection of infe
cted snails^len#Acta Trop#20090000#2009#111#1-6#20110000#aop04-11.htm#0001-706X#
Acta Trop##
00491000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900120071001070300
01000178710000200188065000900190064000500199031000300204014000800207865000900215
002001300224#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#
c#187#28#article#35#28#^rND^sFreita^nJM#Ecologia de vetores de doenças: O habita
t da Biomphalaria glabrata^lpt#Cien Cult#2#19760000#1976#28#212-217#20110000#aop
04-11.htm##
00609000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100018001100120
10200128030002200230065000900252064000500261031000300266014000800269865000900277
002001300286035001000299801002200309#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#188#29#article#35#29#^rND^sGrisolia^nMLM#^rND^sFreitas
^nJR#Características físicas e químicas do habitat da Biomphalaria tenagophila (
Mollusca, Planorbidae)^lpt#Mem Inst Oswaldo Cruz#19850000#1985#80#237-244#201100
00#aop04-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00659000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100019001040100
01900123010001700142012009700159030002200256065000900278064000500287031000300292
014000800295865000900303002001300312035001000325801002200335#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop04-11.htm#S#c#189#30#article#35#30#^rND^sEnk
^nMJ#^rND^sCaldeira^nRL#^rND^sCarvalho^nOS#^rND^sSchall^nVT#Rural tourism as ris
k factor for the transmission of schistosomiasis in Minas Gerais, Brazil^len#Mem
 Inst Oswaldo Cruz#20040000#2004#99#105-108#20110000#aop04-11.htm#0074-0276#Mem 
Inst Oswaldo Cruz##
00527000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900120048001080300
02500156065000900181064000500190031000300195014000600198865000900204002001300213
035001000226801002500236#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
04-11.htm#S#c#190#31#article#35#31#^rND^sFreitas^nCA#Situação atual da esquistos
somose no Brasil^lpt#Rev Bras Malariol D Trop#19720000#1972#24#31-55#20110000#ao
p04-11.htm#0034-7256#Rev Bras Malariol D trop##
00551000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090120
06100128030001400189065000900203064000500212031000300217014000700220865000900227
002001300236035001000249801001400259#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop04-11.htm#S#c#191#32#article#35#32#^rND^sParaense^nWL#^rND^sDeslande
s^nN#Observations on Australorbis janeirensis (Clessin, 1884)^len#Rev Bras Biol#
19560000#1956#16#81-102#20110000#aop04-11.htm#0034-7108#Rev Bras Biol##
00803000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01600130010001700146010001700163010001900180810000700199012015900206030002200365
06500090038706400050039603100040040101400060040586500090041100200130042003500100
0433801002200443#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#192#33#article#35#33#^rND^sGuimarães^nRJPS#^rND^sFreitas^nCC#^rND^sDutra^n
LV#^rND^sMoura^nACM#^rND^sAmaral^nRS#^rND^sDrummond^nSC#et al.#Analyses and esti
mative of schistosomiasis prevalence for Minas Gerais State, Brazil, using multi
ple regression with social and environmental spatial data^len#Mem Inst Oswaldo C
ruz#20060000#2006#101#91-96#20110000#aop04-11.htm#0074-0276#Mem Inst Oswaldo Cru
z##
00760000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01600130010001900146010001800165010001800183810000700201012011200208030002200320
06500090034206400050035103100040035601400080036086500090036800200130037703500100
0390801002200400#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#193#34#article#35#34#^rND^sGuimarães^nRJPS#^rND^sFreitas^nCC#^rND^sDutra^n
LV#^rND^sScholte^nRGC#^rND^sMartins^nFT#^rND^sFonseca^nFR#et al.#A geoprocessing
 approach for schistosomiasis studying and controlling in the State of Minas Ger
ais - Brazil^len#Mem Inst Oswaldo Cruz#20100000#2010#105#524-531#20110000#aop04-
11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00758000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01600130010002100146010001700167010001700184810000700201012013400208030001000342
06500090035206400050036103100040036601400080037086500090037800200130038703500100
0400801001000410#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop04-11.ht
m#S#c#194#35#article#35#35#^rND^sGuimarães^nRJPS#^rND^sFreitas^nCC#^rND^sDutra^n
LV#^rND^sFelgueiras^nCA#^rND^sMoura^nACM#^rND^sAmaral^nRS#et al.#Spatial distrib
ution of Biomphalaria mollusks at São Francisco River Basin, Minas Gerais, Brazi
l, using geostatistical procedures^len#Acta Trop#20090000#2009#109#181-186#20110
000#aop04-11.htm#0001-706X#Acta Trop##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#o#1#
1#article#1#20110311#101250#aop05-11.htm#156##
04444000000000757000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201670
01860120157003530100039005100100031005490100035005800100048006150100044006630100
04200707010003700749010003700786010003400823070011300857070007000970070007101040
08311130111108500080222408500470223208500260227908500220230508500220232708500330
23490831003023820850008033850850046033930850026034390850022034650850026034870850
03303513058002203546058005603568117000603624072000303630112000903633111001103642
114000903653113001103662002001303673#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop05-11.htm#S#h#2#1#article#1#tr#en#br1.1#1#4.0#GRA#TAB#03#nd#nd#Rev. 
Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110318#Phlebotomine sand
flies (Diptera: Psychodidae) in Governador Valadares, a transmission area for Am
erican tegumentary leishmaniasis in State of Minas Gerais, Brazil^len#Flebotomín
eos (Diptera: Psychodidae) em Governador Valadares, área de transmissão de leish
maniose tegumentar americana no Estado de Minas Gerais, Brasil^lpt#^rND^1A01 A02
^nRicardo Andrade^sBarata#^rND^1A02^nGustavo Fontes^sPaz#^rND^1A02^nMarcela Card
oso^sBastos#^rND^1A02^nRoberta Christiane Oliveira^sAndrade#^rND^1A02^nDaniela C
ampos Mendes de^sBarros#^rND^1A02^nFabiana Oliveira Lara e^sSilva#^rND^1A02^nÉri
ka Monteiro^sMichalsky#^rND^1A03^nAimara da Costa^sPinheiro#^rND^1A02^nEdelberto
 Santos^sDias#Universidade Federal do Vale do Jequitinhonha e Mucuri^iA01^1Depar
tamento de Ciências Biológicas^cDiamantina^sMG#Fundação Oswaldo Cruz^iA02^1Insti
tuto René Rachou^cBelo Horizonte^sMG#Secretaria Municipal de Saúde^iA03^1Centro 
de Controle de Zoonoses^sMG#^len^aINTRODUCTION: A study on the phlebotomine sand
fly fauna was carried out in an endemic area for American tegumentary leishmania
sis in the municipality of Governador Valadares, in the State of Minas Gerais, B
razil. METHODS: Captures were undertaken using HP light traps in four districts,
 on three nights per month, for one year (from January to December 2008). Correl
ations between climatic factors (temperature, relative air humidity and rainfall
) and the numbers of sandflies collected was observed. RESULTS: 5,413 phlebotomi
ne specimens were caught and were identified as belonging to 12 species. Of thes
e specimens, 2,851 (52%) were females and 2,562 (48%) were males. CONCLUSIONS: L
utzomyia intermedia predominated (29.9% of the species caught), thus suggesting 
that they were responsible for transmission of American tegumentary leishmaniasi
s, together with L. whitmani, which was also found in the area (4.3%). The prese
nce of L. longipalpis (11.9%), the main vector for visceral leishmaniasis in Bra
zil, is an important finding, which makes rigorous entomological surveillance of
 the area necessary.#^dnd^i1#^tm^len^kAmerican tegumentary leishmaniasis^i1#^tm^
len^kPhlebotominae^i1#^tm^len^kLutzomyia^i1#^tm^len^kSandflies^i1#^tm^len^kGover
nador Valadares^i1#^lpt^aINTRODUÇÃO: Um estudo da fauna de flebotomíneos foi rea
lizado em uma área endêmica para leishmaniose tegumentar americana no município 
de Governador Valadares, no Estado de Minas Gerais, Brasil. MÉTODOS: Capturas fo
ram feitas com armadilhas luminosas HP em quatro bairros, três noites por mês, d
urante o período de janeiro a dezembro de 2008. A correlação entre fatores climá
ticos (temperatura, umidade relativa do ar e pluviosidade) e o número de fleboto
míneos coletados foi avaliada. RESULTADOS: Foram capturados 5.413 espécimes de f
lebotomíneos, distribuídos em 12 espécies, sendo 2.851 (52%) fêmeas e 2.562 (48%
) machos. CONCLUSÕES: Lutzomyia intermedia foi predominante com 29,9% das espéci
es capturadas, sugerindo ser a responsável pela transmissão de LTA, juntamente c
om L. whitmani, que também foi encontrada na região (4,3%). A presença de L. lon
gipalpis (11,9%), principal vetor de LV no Brasil, é um dado relevante tornando-
se necessário uma rigorosa vigilância entomológica na região.#^dnd^i2#^tm^lpt^kL
eishmaniose tegumentar americana^i2#^tm^lpt^kPhlebotominae^i2#^tm^lpt^kLutzomyia
^i2#^tm^lpt^kFlebotomíneos^i2#^tm^lpt^kGovernador Valadares^i2#Fundação Oswaldo 
Cruz#Fundação de Amparo à Pesquisa do Estado de Minas Gerais#other#18#20100914#1
4/09/2010#20101014#14/10/2010#aop05-11.htm##
04570000000000757000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201740
01860120164003600100039005240100031005630100035005940100048006290100044006770100
04200721010003700763010003700800010003400837070011300871070007000984070007101054
08311620112508500080228708500470229508500260234208500290236808500220239708500330
24190831052024520850008035040850046035120850026035580850029035840850026036130850
03303639058002203672058005603694117000603750072000303756112000903759111001103768
114000903779113001103788002001303799#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop05-11.htm#S#f#3#1#article#1#tr#en#br1.1#1#4.0#GRA#TAB#03#nd#nd#Rev. 
Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110318#<b>Phlebotomine s
andflies (Diptera: Psychodidae) in Governador Valadares, a transmission area for
 American tegumentary leishmaniasis in State of Minas Gerais, Brazil</b>^len#<b>
Flebotomíneos (Diptera: Psychodidae) em Governador Valadares, área de transmissã
o de leishmaniose tegumentar americana no Estado de Minas Gerais, Brasil</b>^lpt
#^rND^1A01 A02^nRicardo Andrade^sBarata#^rND^1A02^nGustavo Fontes^sPaz#^rND^1A02
^nMarcela Cardoso^sBastos#^rND^1A02^nRoberta Christiane Oliveira^sAndrade#^rND^1
A02^nDaniela Campos Mendes de^sBarros#^rND^1A02^nFabiana Oliveira Lara e^sSilva#
^rND^1A02^nÉrika Monteiro^sMichalsky#^rND^1A03^nAimara da Costa^sPinheiro#^rND^1
A02^nEdelberto Santos^sDias#Universidade Federal do Vale do Jequitinhonha e Mucu
ri^iA01^1Departamento de Ciências Biológicas^cDiamantina^sMG#Fundação Oswaldo Cr
uz^iA02^1Instituto René Rachou^cBelo Horizonte^sMG#Secretaria Municipal de Saúde
^iA03^1Centro de Controle de Zoonoses^sMG#^len^a<b>INTRODUCTION:</b> A study on 
the phlebotomine sandfly fauna was carried out in an endemic area for American t
egumentary leishmaniasis in the municipality of Governador Valadares, in the Sta
te of Minas Gerais, Brazil. <b>METHODS:</b> Captures were undertaken using HP li
ght traps in four districts, on three nights per month, for one year (from Janua
ry to December 2008). Correlations between climatic factors (temperature, relati
ve air humidity and rainfall) and the numbers of sandflies collected was observe
d. <b>RESULTS:</b> 5,413 phlebotomine specimens were caught and were identified 
as belonging to 12 species. Of these specimens, 2,851 (52%) were females and 2,5
62 (48%) were males. <b>CONCLUSIONS:</b> <i>Lutzomyia intermedia</i> predominate
d (29.9% of the species caught), thus suggesting that they were responsible for 
transmission of American tegumentary leishmaniasis, together with <i>L. whitmani
</i>, which was also found in the area (4.3%). The presence of <i>L. longipalpis
</i> (11.9%), the main vector for visceral leishmaniasis in Brazil, is an import
ant finding, which makes rigorous entomological surveillance of the area necessa
ry.#^dnd^i1#^tm^len^kAmerican tegumentary leishmaniasis^i1#^tm^len^kPhlebotomina
e^i1#^tm^len^k<i>Lutzomyia</i>^i1#^tm^len^kSandflies^i1#^tm^len^kGovernador Vala
dares^i1#^lpt^a<b>INTRODUÇÃO:</b> Um estudo da fauna de flebotomíneos foi realiz
ado em uma área endêmica para leishmaniose tegumentar americana no município de 
Governador Valadares, no Estado de Minas Gerais, Brasil. <b>MÉTODOS:</b> Captura
s foram feitas com armadilhas luminosas HP em quatro bairros, três noites por mê
s, durante o período de janeiro a dezembro de 2008. A correlação entre fatores c
limáticos (temperatura, umidade relativa do ar e pluviosidade) e o número de fle
botomíneos coletados foi avaliada. <b>RESULTADOS:</b> Foram capturados 5.413 esp
écimes de flebotomíneos, distribuídos em 12 espécies, sendo 2.851 (52%) fêmeas e
 2.562 (48%) machos. <b>CONCLUSÕES:</b> <i>Lutzomyia intermedia</i> foi predomin
ante com 29,9% das espécies capturadas, sugerindo ser a responsável pela transmi
ssão de LTA, juntamente com <i>L. whitmani</i>, que também foi encontrada na reg
ião (4,3%). A presença de <i>L. longipalpis</i> (11,9%), principal vetor de LV n
o Brasil, é um dado relevante tornando-se necessário uma rigorosa vigilância ent
omológica na região.#^dnd^i2#^tm^lpt^kLeishmaniose tegumentar americana^i2#^tm^l
pt^kPhlebotominae^i2#^tm^lpt^k<i>Lutzomyia</i>^i2#^tm^lpt^kFlebotomíneos^i2#^tm^
lpt^kGovernador Valadares^i2#Fundação Oswaldo Cruz#Fundação de Amparo à Pesquisa
 do Estado de Minas Gerais#other#18#20100914#14/09/2010#20101014#14/10/2010#aop0
5-11.htm##
04649000000000781000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120167001920120157003590100039005160100031005550100035005860100048006210100
04400669010004200713010003700755010003700792010003400829070011500863070007200978
07000730105008311480112308500080227108500470227908500260232608500220235208500220
23740850033023960831048024290850008034770850046034850850026035310850022035570850
02603579085003303605058002203638058005603660117000603716072000303722112000903725
111001103734114000903745113001103754002001303765008008903778#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#l#4#1#article#1#^a2011#tr#en#br1
.1#1#4.0#gra#tab#03#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8
682#20110318#Phlebotomine sandflies (Diptera: Psychodidae) in Governador Valadar
es, a transmission area for American tegumentary leishmaniasis in State of Minas
 Gerais, Brazil^len#Flebotomíneos (Diptera: Psychodidae) em Governador Valadares
, área de transmissão de leishmaniose tegumentar americana no Estado de Minas Ge
rais, Brasil^lpt#^rND^1A01 A02^nRicardo Andrade^sBarata#^rND^1A02^nGustavo Fonte
s^sPaz#^rND^1A02^nMarcela Cardoso^sBastos#^rND^1A02^nRoberta Christiane Oliveira
^sAndrade#^rND^1A02^nDaniela Campos Mendes de^sBarros#^rND^1A02^nFabiana Oliveir
a Lara e^sSilva#^rND^1A02^nÉrika Monteiro^sMichalsky#^rND^1A03^nAimara da Costa^
sPinheiro#^rND^1A02^nEdelberto Santos^sDias#^iA01^1Universidade Federal do Vale 
do Jequitinhonha e Mucuri^2Departamento de Ciências Biológicas^cDiamantina^sMG#^
iA02^1Fundação Oswaldo Cruz^2Instituto René Rachou^cBelo Horizonte^sMG#^iA03^1Se
cretaria Municipal de Saúde^2Centro de Controle de Zoonoses^sMG#^len^aINTRODUCTI
ON: A study on the phlebotomine sandfly fauna was carried out in an endemic area
 for American tegumentary leishmaniasis in the municipality of Governador Valada
res, in the State of Minas Gerais, Brazil. METHODS: Captures were undertaken usi
ng HP light traps in four districts, on three nights per month, for one year (fr
om January to December 2008). Correlations between climatic factors (temperature
, relative air humidity and rainfall) and the numbers of sandflies collected was
 observed. RESULTS: 5,413 phlebotomine specimens were caught and were identified
 as belonging to 12 species. Of these specimens, 2,851 (52 percent) were females
 and 2,562 (48 percent) were males. CONCLUSIONS: Lutzomyia intermedia predominat
ed (29.9 percent of the species caught), thus suggesting that they were responsi
ble for transmission of American tegumentary leishmaniasis, together with L. whi
tmani, which was also found in the area (4.3 percent). The presence of L. longip
alpis (11.9 percent), the main vector for visceral leishmaniasis in Brazil, is a
n important finding, which makes rigorous entomological surveillance of the area
 necessary.#^dnd^i1#^tm^len^kAmerican tegumentary leishmaniasis^i1#^tm^len^kPhle
botominae^i1#^tm^len^kLutzomyia^i1#^tm^len^kSandflies^i1#^tm^len^kGovernador Val
adares^i1#^lpt^aINTRODUÇÃO: Um estudo da fauna de flebotomíneos foi realizado em
 uma área endêmica para leishmaniose tegumentar americana no município de Govern
ador Valadares, no Estado de Minas Gerais, Brasil. MÉTODOS: Capturas foram feita
s com armadilhas luminosas HP em quatro bairros, três noites por mês, durante o 
período de janeiro a dezembro de 2008. A correlação entre fatores climáticos (te
mperatura, umidade relativa do ar e pluviosidade) e o número de flebotomíneos co
letados foi avaliada. RESULTADOS: Foram capturados 5.413 espécimes de flebotomín
eos, distribuídos em 12 espécies, sendo 2.851 (52 por cento) fêmeas e 2.562 (48 
por cento) machos. CONCLUSÕES: Lutzomyia intermedia foi predominante com 29,9 po
r cento das espécies capturadas, sugerindo ser a responsável pela transmissão de
 LTA, juntamente com L. whitmani, que também foi encontrada na região (4,3 por c
ento). A presença de L. longipalpis (11,9 por cento), principal vetor de LV no B
rasil, é um dado relevante tornando-se necessário uma rigorosa vigilância entomo
lógica na região.#^dnd^i2#^tm^lpt^kLeishmaniose tegumentar americana^i2#^tm^lpt^
kPhlebotominae^i2#^tm^lpt^kLutzomyia^i2#^tm^lpt^kFlebotomíneos^i2#^tm^lpt^kGover
nador Valadares^i2#Fundação Oswaldo Cruz#Fundação de Amparo à Pesquisa do Estado
 de Minas Gerais#other#18#20100914#14/09/2010#20101014#14/10/2010#aop05-11.htm#I
nternet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-8682201100
5000003##
00483000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704023900085002001300324#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#5#1#article#134#<p><font s
ize="4" face="Verdana"><B><a name="tx"></a>Phlebotomine sandflies (Diptera: Psyc
hodidae) in Governador Valadares, a transmission area for American tegumentary l
eishmaniasis in State of Minas Gerais, Brazil</b></font></p>     ^cY#aop05-11.ht
m##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#6#2#article#134#<p>&nbsp;<
/p>     ^cY#aop05-11.htm##
00477000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704023300085002001300318#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#7#3#article#134#<p><font s
ize="3" face="Verdana"><b>Flebotom&iacute;neos (Diptera: Psychodidae) em Governa
dor Valadares, &aacute;rea de transmiss&atilde;o de leishmaniose tegumentar amer
icana no Estado de Minas Gerais, Brasil</b></font></p>     ^cY#aop05-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#8#4#article#134#<p>&nbsp;<
/p>     ^cY#aop05-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#9#5#article#134#<p>&nbsp;<
/p>     ^cY#aop05-11.htm##
00674000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704042900086002001300515#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#10#6#article#134#<p><font 
size="2" face="Verdana"><b>Ricardo Andrade Barata<SUP>I,II</SUP>; Gustavo Fontes
 Paz<SUP>II</SUP>; Marcela Cardoso Bastos<SUP>II</SUP>; Roberta Christiane Olive
ira Andrade<SUP>II</SUP>; Daniela Campos Mendes de Barros<SUP>II</SUP>; Fabiana 
Oliveira Lara e Silva<SUP>II</SUP>; &Eacute;rika Monteiro Michalsky<SUP>II</SUP>
; Aimara da Costa Pinheiro<SUP>III</SUP>; Edelberto Santos Dias<SUP>II</SUP></b>
</font></p>     ^cY#aop05-11.htm##
00418000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704017300086002001300259#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#11#7#article#134#<p><font 
size="2" face="Verdana"><sup>I</sup>Departamento de Ci&ecirc;ncias Biol&oacute;g
icas, Universidade Federal do Vale do Jequitinhonha e Mucuri, Diamantina, MG    
^cY#aop05-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011500086002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#12#8#article#134#<br>     
<sup>II</sup>Instituto Ren&eacute; Rachou, Funda&ccedil;&atilde;o Oswaldo Cruz, 
Belo Horizonte, MG    ^cY#aop05-11.htm##
00382000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013700086002001300223#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#13#9#article#134#<br>     
<sup>III</sup>Centro de Controle de Zoonoses, Secretaria Municipal de Sa&uacute;
de, Governador Valadares, MG</font></p>     ^cY#aop05-11.htm##
00327000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008100087002001300168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#14#10#article#134#<p><font
 size="2" face="Verdana"><a href="#nt">Address to</a></font></p>     ^cY#aop05-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#15#11#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#16#12#article#134#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop05-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006800087002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#17#13#article#134#<p><font
 size="2" face="Verdana"><B>ABSTRACT</B></font></p>     ^cY#aop05-11.htm##
00506000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026000087002001300347#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#18#14#article#134#<p><font
 size="2" face="Verdana"><B>INTRODUCTION:</B> A study on the phlebotomine sandfl
y fauna was carried out in an endemic area for American tegumentary leishmaniasi
s in the municipality of Governador Valadares, in the State of Minas Gerais, Bra
zil.    ^cY#aop05-11.htm##
00554000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030800087002001300395#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#19#15#article#134#<br>  <B
>METHODS:</B> Captures were undertaken using HP light traps in four districts, o
n three nights per month, for one year (from January to December 2008). Correlat
ions between climatic factors (temperature, relative air humidity and rainfall) 
and the numbers of sandflies collected was observed.    ^cY#aop05-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019100087002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#20#16#article#134#<br>  <B
>RESULTS:</B> 5,413 phlebotomine specimens were caught and were identified as be
longing to 12 species. Of these specimens, 2,851 (52%) were females and 2,562 (4
8%) were males.    ^cY#aop05-11.htm##
00735000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048900087002001300576#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#21#17#article#134#<br>  <B
>CONCLUSIONS:</B> <I>Lutzomyia intermedia</I> predominated (29.9% of the species
 caught), thus suggesting that they were responsible for transmission of America
n tegumentary leishmaniasis, together with <I>L. whitmani</I>, which was also fo
und in the area (4.3%). The presence of <I>L. longipalpis</I> (11.9%), the main 
vector for visceral leishmaniasis in Brazil, is an important finding, which make
s rigorous entomological surveillance of the area necessary. </font></p>     ^cY
#aop05-11.htm##
00439000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019300087002001300280#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#22#18#article#134#<p><font
 size="2" face="Verdana"><B>Keywords:</B> American tegumentary leishmaniasis. Ph
lebotominae. <I>Lutzomyia</I>. Sandflies. Governador Valadares.</font></p> <hr s
ize="1" noshade>     ^cY#aop05-11.htm##
00312000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006600087002001300153#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#23#19#article#134#<p><font
 size="2" face="Verdana"><B>RESUMO</B></font></p>     ^cY#aop05-11.htm##
00529000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028300087002001300370#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#24#20#article#134#<p><font
 size="2" face="Verdana"><B>INTRODU&Ccedil;&Atilde;O:</B> Um estudo da fauna de 
flebotom&iacute;neos foi realizado em uma &aacute;rea end&ecirc;mica para leishm
aniose tegumentar americana no munic&iacute;pio de Governador Valadares, no Esta
do de Minas Gerais, Brasil.    ^cY#aop05-11.htm##
00618000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037200087002001300459#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#25#21#article#134#<br>  <B
>M&Eacute;TODOS:</B> Capturas foram feitas com armadilhas luminosas HP em quatro
 bairros, tr&ecirc;s noites por m&ecirc;s, durante o per&iacute;odo de janeiro a
 dezembro de 2008. A correla&ccedil;&atilde;o entre fatores clim&aacute;ticos (t
emperatura, umidade relativa do ar e pluviosidade) e o n&uacute;mero de flebotom
&iacute;neos coletados foi avaliada.    ^cY#aop05-11.htm##
00439000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019300087002001300280#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#26#22#article#134#<br>  <B
>RESULTADOS:</B> Foram capturados 5.413 esp&eacute;cimes de flebotom&iacute;neos
, distribu&iacute;dos em 12 esp&eacute;cies, sendo 2.851 (52%) f&ecirc;meas e 2.
562 (48%) machos.    ^cY#aop05-11.htm##
00759000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051300087002001300600#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#27#23#article#134#<br>  <B
>CONCLUS&Otilde;ES:</B> <I>Lutzomyia intermedia</I> foi predominante com 29,9% d
as esp&eacute;cies capturadas, sugerindo ser a respons&aacute;vel pela transmiss
&atilde;o de LTA, juntamente com <I>L. whitmani</I>, que tamb&eacute;m foi encon
trada na regi&atilde;o (4,3%). A presen&ccedil;a de <I>L. longipalpis</I> (11,9%
), principal vetor de LV no Brasil, &eacute; um dado relevante tornando&#45;se n
ecess&aacute;rio uma rigorosa vigil&acirc;ncia entomol&oacute;gica na regi&atild
e;o. </font></p>     ^cY#aop05-11.htm##
00460000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021400087002001300301#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#28#24#article#134#<p><font
 size="2" face="Verdana"><B>Palavras&#45;chaves: </B>Leishmaniose tegumentar ame
ricana. Phlebotominae. <I>Lutzomyia</I>. Flebotom&iacute;neos. Governador Valada
res.</font></p> <hr size="1" noshade>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#29#25#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#30#26#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00318000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007200087002001300159#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#31#27#article#134#<p><font
 size="3" face="Verdana"><b>INTRODUCTION</b></font></p>     ^cY#aop05-11.htm##
00984000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704073800087002001300825#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#32#28#article#134#<p><font
 size="2" face="Verdana">In Brazil, American tegumentary leishmaniasis (ATL) is 
an important public health problem because of increasing numbers of human cases.
 The infection can cause mutilating lesions and lead to loss of the capacity to 
work and even death<SUP>1</SUP>. Over recent years, the significant increase in 
deforestation has favored adaptation of vectors to anthropic environments and co
nsequently increased human exposure to the parasite<SUP>2</SUP>. The circulation
 of <I>Leishmania</I> in domestic environments has favored the emergence of a di
stinct profile for transmission of the disease that differs from the classical p
attern<SUP>3</SUP> and is associated with a wider range of activities.</font></p
>     ^cY#aop05-11.htm##
00811000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056500087002001300652#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#33#29#article#134#<p><font
 size="2" face="Verdana">Nowadays, in the State of Minas Gerais (MG), ATL is pre
sent in practically all municipalities, in areas where highways and hydroelectri
c power stations have been built and where clusters of people have settled<SUP>4
</SUP>. In addition to its continuing presence in old endemic foci in the Atlant
ic forest and in the Rio Doce and Mucuri valleys<SUP>5</SUP>, numerous cases hav
e also been reported in urban areas of large and medium&#45;sized cities, such a
s Belo Horizonte, Montes Claros and Governador Valadares.</font></p>     ^cY#aop
05-11.htm##
00779000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053300087002001300620#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#34#30#article#134#<p><font
 size="2" face="Verdana">Governador Valadares, in MG, is considered to be an end
emic area. It had 221 new cases of ATL between 2004 and 2007, and approximately 
75% of the cases were in the urban area. In an epidemiological study in the 1970
s, in the municipality of Caratinga, near to Governador Valadares, Mayrink et al
<SUP>5</SUP> recorded the presence of <I>Lutzomyia whitmani</I> and <I>L. interm
edia</I>, which are known to transmit <I>Leishmania braziliensis</I> in southeas
tern Brazil<SUP>6</SUP>. </font></p>     ^cY#aop05-11.htm##
00877000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063100087002001300718#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#35#31#article#134#<p><font
 size="2" face="Verdana">The aim of the present study was to identify the phlebo
tomine fauna and some aspects of the population's behavior, such as the frequenc
y of presence in peridomestic and domestic environments, seasonal variation of t
he species implicated as vectors for leishmaniasis and the influence of climatic
 factors on the species density. Through this, better understanding of the trans
mission cycle of ATL in the municipality was sought, along with correlations bet
ween the data obtained and the risk of <I>Leishmania</I> transmission, as suppor
t for applying control actions in the area.</font></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#36#32#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006700087002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#37#33#article#134#<p><font
 size="3" face="Verdana"><b>METHODS</b></font></p>     ^cY#aop05-11.htm##
00317000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007100087002001300158#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#38#34#article#134#<p><font
 size="2" face="Verdana"><B>Study area</B> </font></p>     ^cY#aop05-11.htm##
00806000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056000087002001300647#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#39#35#article#134#<p><font
 size="2" face="Verdana">The municipality of Governador Valadares (18º 51' 12" S
 and 41º 56' 42" W) is part of the administrative area of Rio Doce valley. The t
otal area of the municipality is 2,349 km<SUP>2</SUP>, and it is physically char
acterized by predominance of hills, with altitude levels ranging from 191 to 1,0
08 m above sea level. The climate is classified, according to Koppen, as the AW 
type (tropical sub&#45;warm and sub&#45;dry), with a mean annual temperature of 
25.6 ºC and mean annual rainfall of around 1,350 mm.</font></p>     ^cY#aop05-11
.htm##
00319000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007300087002001300160#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#40#36#article#134#<p><font
 size="2" face="Verdana"><B>Capture sites</B></font></p>     ^cY#aop05-11.htm##
00888000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064200087002001300729#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#41#37#article#134#<p><font
 size="2" face="Verdana">Systematic captures were carried out using HP light tra
ps<SUP>7</SUP> between January and December 2008. Sixteen traps were distributed
 in four districts of the municipality (Elvamar, Vila Isa, Vila Parque Ibituruna
 and Village da Serra): two inside homes (domestic areas) and two in areas surro
unding homes (peridomestic areas). These districts are characterized as transiti
onal environments between the urban area and an area of environmental preservati
on. These traps were exposed from 4:00 pm to 8:00 am, for three consecutive nigh
ts every month, always in the last week of each month.</font></p>     ^cY#aop05-
11.htm##
00333000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008700087002001300174#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#42#38#article#134#<p><font
 size="2" face="Verdana"><B>Phlebotomine identification</B></font></p>     ^cY#a
op05-11.htm##
00664000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041800087002001300505#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#43#39#article#134#<p><font
 size="2" face="Verdana">The taxonomic keys of Young and Duncan<SUP>8</SUP> and 
Forattini<SUP>9</SUP> were used for identification of the sandfly species. Speci
mens with missing or damaged characteristics that impaired identification at the
 species level were considered to be <I>Lutzomyia</I> spp. Females belonging to 
the genus <I>Brumptomyia</I> were not identified to the species level.</font></p
>     ^cY#aop05-11.htm##
00319000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007300087002001300160#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#44#40#article#134#<p><font
 size="2" face="Verdana"><B>Climatic data</B></font></p>     ^cY#aop05-11.htm##
00553000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030700087002001300394#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#45#41#article#134#<p><font
 size="2" face="Verdana">Climatic data for the study period were obtained throug
h the website <a href="http://www.inmet.gov.br/sim/sonabra/convencionais.php" ta
rget="_blank">http://www.inmet.gov.br/sim/sonabra/convencionais.php</a>. Average
 monthly values were used in our study.</font></p>     ^cY#aop05-11.htm##
00326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008000087002001300167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#46#42#article#134#<p><font
 size="2" face="Verdana"><B>Statistical analysis</B></font></p>     ^cY#aop05-11
.htm##
00505000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025900087002001300346#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#47#43#article#134#<p><font
 size="2" face="Verdana">The correlations between climatic variables (temperatur
e, air humidity and rainfall) and population density of phlebotomines were evalu
ated by means of Spearman's coefficient (p&#45;value <u>&lt;</u> 0.05).</font></
p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#48#44#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00313000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704006700087002001300154#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#49#45#article#134#<p><font
 size="3" face="Verdana"><b>RESULTS</b></font></p>     ^cY#aop05-11.htm##
01335000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704108900087002001301176#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#50#46#article#134#<p><font
 size="2" face="Verdana">The phlebotomine fauna of Governador Valadares was comp
osed of 12 species: <I>Brumptomyia avellari </I>(Costa Lima, 1932), <I>B. nitzul
escui</I> (Costa Lima, 1932), <I>Lutzomyia cortellezzii</I> (Br&egrave;thes, 192
3), <I>L. intermedia</I> (Lutz &amp; Neiva, 1912), <I>L. ischyracantha</I> (Mart
ins, Falc&atilde;o &amp; Silva, 1962), <I>L</I>. <I>lenti</I> (Mangabeira, 1938)
, <I>L. longipalpis</I> (Lutz &amp; Neiva, 1912), <I>L. minasensis</I> (Mangabei
ra, 1942), <I>L. quinquefer</I> (Dyar, 1929), <I>L. sordellii </I>(Shannon &amp;
 Del Ponte, 1927), <I>L. termitophila</I> (Martins, Falc&atilde;o &amp; Silva, 1
964) and <I>L. whitmani</I> (Antunes &amp; Coutinho, 1939). A total of 5,413 spe
cimens was caught, of which 2,851 were females (52%) and 2,562 were males (48%).
 The peridomestic and domestic areas accounted for 64% and 36% of the specimens 
caught, respectively. <I>Lutzomyia intermedia</I> was the predominant species, c
omprising 29.9% of the total number of phlebotomines collected <B>(<a href="#tab
01">Table 1</a>)</B>.</font></p>     ^cY#aop05-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#51#47#article#134#<p><a na
me="tab01"></a></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#52#48#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#53#49#article#134#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a05tab01.jpg"></p>     ^cY#ao
p05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#54#50#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00880000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063400087002001300721#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#55#51#article#134#<p><font
 size="2" face="Verdana">The monthly averages for climatic variables, considerin
g rainfall, temperature and relative air humidity, can be seen in <B><a href="#t
ab02">Table 2</a></B>. The correlation between the number of phlebotomines captu
red and the climatic conditions is represented in <B><a href="#fig01">Figure 1</
a></B>. All the variables evaluated showed a positive Spearman correlation coeff
icient in relation to phlebotomine density, but only the rainfall and humidity s
howed significant values (p = 0.008 and p = 0.007, respectively), while the temp
erature variable showed a p&#45;value = 0.064.</font></p>     ^cY#aop05-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#56#52#article#134#<p><a na
me="tab02"></a></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#57#53#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#58#54#article#134#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a05tab02.jpg"></p>     ^cY#ao
p05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#59#55#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#60#56#article#134#<p><a na
me="fig01"></a></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#61#57#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#62#58#article#134#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a05fig01.jpg"></p>     ^cY#ao
p05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#63#59#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00925000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704067900087002001300766#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#64#60#article#134#<p><font
 size="2" face="Verdana"><B><a href="#fig02">Figure 2</a></B> shows the monthly 
distribution of vector species in the municipality of Governador Valadares. <B>T
able 3</B> displays the monthly distribution of phlebotomines captured in each n
eighborhood, in Governador Valadares, from January to December, 2008. It was obs
erved that in all neighborhoods located in the transitional area between the syl
vatic and urban environments, the number of insects captured was considerable, w
ith greatest success in Village da Serra and Vila Isa, probably due to the prese
nce of domestic animals (dogs, chickens, cows, horses and pigs) next to the samp
ling sites.</font></p>     ^cY#aop05-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#65#61#article#134#<p><a na
me="fig02"></a></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#66#62#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#67#63#article#134#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a05fig02.jpg"></p>     ^cY#ao
p05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#68#64#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003600087002001300123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#69#65#article#134#<p><a na
me="tab03"></a></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#70#66#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00332000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008600087002001300173#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#71#67#article#134#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/a05tab03.jpg"></p>     ^cY#ao
p05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#72#68#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#73#69#article#134#<p><font
 size="3" face="Verdana"><b>DISCUSSION</b></font></p>     ^cY#aop05-11.htm##
00651000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040500087002001300492#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#74#70#article#134#<p><font
 size="2" face="Verdana">The results showed that the phlebotomine fauna in the m
unicipality of Governador Valadares is diversified, with some species of epidemi
ological interest. The presence of <I>L. intermedia</I> and <I>L. whitmani</I> s
uggests that these species participate as vectors for ATL in this area, as well 
as in other Brazilian endemic areas<SUP>10&#45;12</SUP>. </font></p>     ^cY#aop
05-11.htm##
00855000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060900087002001300696#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#75#71#article#134#<p><font
 size="2" face="Verdana">In Governador Valadares, the larger proportion of <I>L.
 intermedia</I> in relation to <I>L. whitmani</I> indicates that the first of th
ese is a better adapted and more domesticated species, as shown by Souza et al<S
UP>11</SUP>. Females of <I>L. intermedia</I> were frequently found in and around
 homes, while <I>L. whitmani</I> was predominantly captured in peridomestic area
s characterized by the presence of domestic animals and banana plantations. The 
presence of both species in these environments increases the risk of <I>Leishman
ia</I> transmission. </font></p>     ^cY#aop05-11.htm##
00831000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058500087002001300672#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#76#72#article#134#<p><font
 size="2" face="Verdana">Forattini<SUP>13</SUP> studied the seasonal variation o
f phlebotomines and found that in the hottest and most humid months (December to
 February), the number of species caught was greater, while in the coldest and d
riest months (June and August), the population density of these insects became c
onsiderably reduced. This was also observed by Dias et al<SUP>14</SUP> and Barat
a et al<SUP>15</SUP>. Our results support this pattern of population distributio
n, with high densities during periods of high rainfall and high temperatures.</f
ont></p>     ^cY#aop05-11.htm##
00792000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054600087002001300633#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#77#73#article#134#<p><font
 size="2" face="Verdana">In the present study, the climatic variables of rainfal
l and relative humidity were statistically significant (p <u>&lt;</u> 0.05). Thi
s observation agrees with several other studies that showed that temperature doe
s not present a positive correlation with phlebotomine density<SUP>14&#45;16</SU
P>. In fact, this finding is not a rule, and therefore the climatic characterist
ics of each region, which are essential for the knowledge of the disease epidemi
ology, need to be taken into account. </font></p>     ^cY#aop05-11.htm##
01056000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081000087002001300897#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#78#74#article#134#<p><font
 size="2" face="Verdana">If only the vector species are considered <B>(<a href="
#fig02">Figure 2</a>)</B>, it can be seen that after an intense period of rains 
(January), the populations of <I>L. intermedia</I>, <I>L. whitmani</I> and <I>L.
 longipalpis</I> increased during the subsequent month (February), with a tenden
cy to decrease during the coldest and driest months. In an endemic area for tegu
mentary and visceral leishmaniasis, Souza et al<SUP>17</SUP> observed that <I>L.
 longipalpis</I> and <I>L. whitmani</I> tended to undergo noticeable increases i
n populations after rainfall periods (March and April). This may be explained by
 the favorable environmental conditions of the microhabitats. Michalsky et al<SU
P>18</SUP> showed similar results reinforcing this hypothesis.</font></p>     ^c
Y#aop05-11.htm##
00742000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049600087002001300583#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#79#75#article#134#<p><font
 size="2" face="Verdana">Another finding that deserves special attention is the 
high density of <I>L. longipalpis</I> in the districts studied. The presence of 
the vector for <I>Leishmania infantum</I> makes it necessary to undertake intens
ive entomological surveillance for visceral leishmaniasis prevention in this are
a. Moreover, the high phlebotomine percentage inside homes increases the synanth
ropy index and the possibility of <I>Leishmania</I> sp transmission.</font></p> 
    ^cY#aop05-11.htm##
00774000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052800087002001300615#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#80#76#article#134#<p><font
 size="2" face="Verdana">In Brazil, the use of residual insecticides against phl
ebotomines is feasible in situations of peridomestic and domestic transmission. 
In the particular case of Governador Valadares, the use of insecticide in the di
stricts studied is possible because they are a transitional area between sylvati
c and urban environments. It is therefore recommended that insecticides should b
e used in the months of March, April and May, with the aim of reducing the numbe
rs of phlebotomines.</font></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#81#77#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00321000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007500087002001300162#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#82#78#article#134#<p><font
 size="3" face="Verdana"><b>ACKNOWLEDGMENTS</b></font></p>     ^cY#aop05-11.htm#
#
00397000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704015100087002001300238#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#83#79#article#134#<p><font
 size="2" face="Verdana">We thank the residents Val&eacute;ria de Oliveira Ambr&
oacute;sio and Edson C&acirc;ndido Pereira.</font></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#84#80#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00326000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008000087002001300167#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#85#81#article#134#<p><font
 size="3" face="Verdana"><b>CONFLICT OF INTEREST</b></font></p>     ^cY#aop05-11
.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#86#82#article#134#<p><font
 size="2" face="Verdana">The authors declare that there is no conflict of intere
st.</font></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#87#83#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00323000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007700087002001300164#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#88#84#article#134#<p><font
 size="3" face="Verdana"><b>FINANCIAL SUPPORT</b></font></p>     ^cY#aop05-11.ht
m##
00464000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021800087002001300305#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#89#85#article#134#<p><font
 size="2" face="Verdana">This research was funded by Funda&ccedil;&atilde;o Oswa
ldo Cruz (FIOCRUZ) and Funda&ccedil;&atilde;o de Amparo &agrave; Pesquisa do Est
ado de Minas Gerais (FAPEMIG).</font></p>     ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#90#86#article#134#<p>&nbsp
;</p>     ^cY#aop05-11.htm##
00316000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704007000087002001300157#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#91#87#article#134#<p><font
 size="3" face="Verdana"><b>REFERENCES</b></font></p>     ^cY#aop05-11.htm##
00493000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704023300089002001300322#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#92#88#article#
134#1#<p><font size="2" face="Verdana">1. Oliveira MC, Amorim RFB, Freitas RA, C
osta ALL. &Oacute;bito em caso de leishmaniose cutaneomucosa ap&oacute;s o uso d
e antimonial pentavalente. Rev Soc Bras Med Trop 2005; 38: 258&#45;260.    ^cY#a
op05-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#93#89#article#134#</font><
/p>     ^cY#aop05-11.htm##
00420000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016000089002001300249#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#94#90#article#
134#2#<p><font size="2" face="Verdana">2. Gomes AC. Perfil epidemiol&oacute;gico
 da leishmaniose tegumentar no Brasil.  Rev Bras Dermatol 1992; 67: 55&#45;60.  
  ^cY#aop05-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#95#91#article#134# </font>
</p>     ^cY#aop05-11.htm##
00587000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704032700089002001300416#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#96#92#article#
134#3#<p><font size="2" face="Verdana">3. Campbell&#45;Lendrum D, Dujardin JP, M
artinez E, Feliciangeli MD, Perez JE,  Silans LN, et al. Domestic and peridomest
ic transmission of American cutaneous leishmaniasis: changing epidemiological pa
tterns present new control opportunities. Mem Inst Oswaldo Cruz 2001; 96:159&#45
;162.    ^cY#aop05-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#97#93#article#134# </font>
</p>     ^cY#aop05-11.htm##
00423000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016300089002001300252#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#98#94#article#
134#4#<p><font size="2" face="Verdana">4. Furtado T, Vieira JBF. Geografia da le
ishmaniose tegumentar americana no Brasil. An Bras Dermatol 1982; 57:135&#45;140
.    ^cY#aop05-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#99#95#article#134#</font><
/p>     ^cY#aop05-11.htm##
00523000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704026200090002001300352#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#100#96#article
#134#5#<p><font size="2" face="Verdana">5. Mayrink W, Williams P, Coelho MV, Dia
s M, Martins AV, Magalh&atilde;es PA, et al. Epidemiology of dermal leishmaniasi
s in the Rio Doce Valley, State of Minas Gerais, Brazil. Ann Trop Med Parasitolo
gy 1979; 73:1&#45;14.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002100088002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#101#97#article#134# </font
></p>     ^cY#aop05-11.htm##
00526000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704026500090002001300355#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#102#98#article
#134#6#<p><font size="2" face="Verdana">6. Peterson AT, Shaw JJ. <I>Lutzomyia</I
> vectors for cutaneous leishmaniasis in Southern Brazil: ecological niche model
s, predicted geographic distributions, and climate change effects. Int J Parasit
ol 2003; 33:919&#45;931.    ^cY#aop05-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#103#99#article#134#</font>
</p>     ^cY#aop05-11.htm##
00522000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704026000091002001300351#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#104#100#articl
e#134#7#<p><font size="2" face="Verdana">7. Pugedo H, Barata RA, Fran&ccedil;a&#
45;Silva JC, Silva JC, Dias ES. HP: um modelo aprimorado de armadilha luminosa d
e suc&ccedil;&atilde;o para a captura de pequenos insetos. Rev Soc Bras Med Trop
 2005; 38:70&#45;72.    ^cY#aop05-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#105#101#article#134# </fon
t></p>     ^cY#aop05-11.htm##
00527000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704026500091002001300356#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#106#102#articl
e#134#8#<p><font size="2" face="Verdana">8. Young DG, Duncan MA. Guide to the id
entification and geographic distribution of <I>Lutzomyia </I>sand flies in Mexic
o, the West Indies, Central and South America (Diptera: Psychodidae). Mem Am Ent
 Inst 1994; 54:1&#45;881.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#107#103#article#134#</font
></p>     ^cY#aop05-11.htm##
00404000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704014200091002001300233#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#108#104#articl
e#134#9#<p><font size="2" face="Verdana">9. Forattini OP. Entomologia M&eacute;d
ica. S&atilde;o Paulo: Ed. Edgard Bl&uuml;cher. Ed. USP; 1973.    ^cY#aop05-11.h
tm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#109#105#article#134#</font
></p>     ^cY#aop05-11.htm##
00632000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036900092002001300461#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#110#106#articl
e#134#10#<p><font size="2" face="Verdana">10. Mayo RC, Casanova C, Mascarini LM,
 Pignatti MG, Rangel O, Galati EAB, et al. Flebotom&iacute;neos (Diptera, Psycho
didae) de &aacute;rea de transmiss&atilde;o de leishmaniose tegumentar americana
, no munic&iacute;pio de Itupeva, regi&atilde;o sudeste do Estado de S&atilde;o 
Paulo. Rev Soc Bras Med Trop 1998; 31:339&#45;345.    ^cY#aop05-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#111#107#article#134# </fon
t></p>     ^cY#aop05-11.htm##
00629000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036600092002001300458#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#112#108#articl
e#134#11#<p><font size="2" face="Verdana">11. Souza NA, Andrade&#45;Coelho CA, V
ilela ML, Peixoto AA, Rangel EF. Seasonality of <I>Lutzomyia intermedia</I> and 
<I>Lutzomyia whitmani</I> (Diptera: Psychodidae: Phlebotominae), occurring sympa
trically in area of cutaneous leishmaniasis in the State of Rio de Janeiro, Braz
il. Mem Inst Oswaldo Cruz 2002; 97:759&#45;765.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#113#109#article#134#</font
></p>     ^cY#aop05-11.htm##
00630000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036700092002001300459#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#114#110#articl
e#134#12#<p><font size="2" face="Verdana">12. Saraiva L, Lopes JS, Oliveira GBM,
 Batista FA, Falc&atilde;o AL, Andrade&#45;Filho JD. Estudo dos flebotom&iacute;
neos (Diptera: Psychodidae) em &aacute;rea de leishmaniose tegumentar americana 
nos munic&iacute;pios de Alto Capara&oacute; e Capara&oacute;, Estado de Minas G
erais. Rev Soc Bras Med Trop 2006; 39:56&#45;63.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#115#111#article#134#</font
></p>     ^cY#aop05-11.htm##
00493000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023000092002001300322#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#116#112#articl
e#134#13#<p><font size="2" face="Verdana">13. Forattini OP. Novas observa&ccedil
;&otilde;es sobre a biologia de fleb&oacute;tomos em condi&ccedil;&otilde;es nat
urais (Diptera: Psychodidae). Arch Hyg Saude Publ 1960; 25:209&#45;215.    ^cY#a
op05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#117#113#article#134#</font
></p>     ^cY#aop05-11.htm##
00552000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028900092002001300381#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#118#114#articl
e#134#14#<p><font size="2" face="Verdana">14. Dias ES, Fran&ccedil;a&#45;Silva J
C, Silva JC, Michalsky EM, Paula KM, Macedo CG, et al. Flebotom&iacute;neos (Dip
tera: Psychodidae) em foco de leishmaniose tegumentar no Estado de Minas Gerais,
 Brasil. Rev Soc Bras Med Trop 2007; 40:49&#45;52.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#119#115#article#134#</font
></p>     ^cY#aop05-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031500092002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#120#116#articl
e#134#15#<p><font size="2" face="Verdana">15. Barata RA, Fran&ccedil;a&#45;Silva
 JC, Fortes&#45;Dias CL, Costa RT, Silva JC, Vieira EP, et al. Phlebotomines san
d flies in Porteirinha, an endemic area of American visceral leishmaniasis in th
e State of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2004; 99:481&#45;487.    
^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#121#117#article#134#</font
></p>     ^cY#aop05-11.htm##
00552000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028900092002001300381#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#122#118#articl
e#134#16#<p><font size="2" face="Verdana">16. Missawa NA, Dias ES. Phlebotomine 
sand flies (Diptera: Psychodidae) in the municipality of V&aacute;rzea Grande: a
n area of transmission of visceral leishmaniasis in the State of Mato Grosso, Br
azil. Mem Inst Oswaldo Cruz 2007; 102:913&#45;918.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#123#119#article#134#</font
></p>     ^cY#aop05-11.htm##
00527000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026400092002001300356#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#124#120#articl
e#134#17#<p><font size="2" face="Verdana">17. Souza CM, Pessanha JE, Barata RA, 
Monteiro EM, Costa DC, Dias ES. Study on phlebotomine sand fly (Diptera: Psychod
idae) fauna in Belo Horizonte, state of Minas Gerais, Brazil. Mem Inst Oswaldo C
ruz 2004; 99:795&#45;803.    ^cY#aop05-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#125#121#article#134#</font
></p>     ^cY#aop05-11.htm##
00569000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030600092002001300398#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#126#122#articl
e#134#18#<p><font size="2" face="Verdana">18. Michalsky EM, Fran&ccedil;a&#45;Si
lva JC, Barata RA, Lara e Silva FO, Loureiro AM,  Fortes&#45;Dias CL, et al. Phl
ebotominae distribution in Jana&uacute;ba, an area of transmission for visceral 
leishmaniasis in Brazil. Mem Inst Oswaldo Cruz 2009; 104:56&#45;61.    ^cY#aop05
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#127#123#article#134#</font
></p>     ^cY#aop05-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#128#124#article#134#<p>&nb
sp;</p>     ^cY#aop05-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#129#125#article#134#<p>&nb
sp;</p>     ^cY#aop05-11.htm##
00405000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704015700089002001300246#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#130#126#article#134#<p><fo
nt size="2" face="Verdana"><b><a name="nt"></a><a href="#tx"><img src="/img/revi
stas/rsbmt/2011nahead/seta.jpg" border="0"></a> Address to:</b>    ^cY#aop05-11.
htm##
00288000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004000089002001300129#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#131#127#article#134#<br>  
Dr. Ricardo Andrade Barata    ^cY#aop05-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005700089002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#132#128#article#134#<br> D
eptº Ci&ecirc;ncias Biol&oacute;gicas/UFVJM    ^cY#aop05-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#133#129#article#134#<br> C
ampus JK, BR 367,  Alto da Jacuba    ^cY#aop05-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#134#130#article#134#<br> 3
9100&#45;000 Diamantina, MG, Brasil    ^cY#aop05-11.htm##
00285000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003700089002001300126#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#135#131#article#134#<br> T
el: 55 38 3532&#45;1236    ^cY#aop05-11.htm##
00349000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010100089002001300190#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#136#132#article#134#<br> e
&#45;mail: <a href="mailto:ricbarata@hotmail.com">ricbarata@hotmail.com</a></fon
t></p>     ^cY#aop05-11.htm##
00311000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006300089002001300152#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#137#133#article#134#<p><fo
nt size="2" face="Verdana">Received in 14/09/2010    ^cY#aop05-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#p#138#134#article#134#<br>  
 Accepted in 14/10/2010</font></p>     ^cY#aop05-11.htm##
00649000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100018001070100
01800125010001700143012008600160030002200246065000900268064000500277031000300282
014000800285865000900293002001300302035001000315801002200325#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#139#1#article#18#1#^rND^sOlive
ira^nMC#^rND^sAmorim^nRFB#^rND^sFreitas^nRA#^rND^sCosta^nALL#Óbito em caso de le
ishmaniose cutaneomucosa após o uso de antimonial pentavalente^lpt#Rev Soc Bras 
Med Trop#20050000#2005#38#258-260#20110000#aop05-11.htm#0037-8682#Rev Soc Bras M
ed Trop##
00486000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120063001040300
01800167710000200185065000900187064000500196031000300201014000600204865000900210
002001300219#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#
c#140#2#article#18#2#^rND^sGomes^nAC#Perfil epidemiológico da leishmaniose tegum
entar no Brasil^lpt#Rev Bras Dermatol#2#19920000#1992#67#55-60#20110000#aop05-11
.htm##
00801000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100026000880100019001140100
01800133010002300151010001600174010001700190810000700207012014800214030002200362
06500090038406400050039303100030039801400080040186500090040900200130041803500100
0431801002200441#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.ht
m#S#c#141#3#article#18#3#^rND^sCampbell-Lendrum^nD#^rND^sDujardin^nJP#^rND^sMart
inez^nE#^rND^sFeliciangeli^nMD#^rND^sPerez^nJE#^rND^sSilans^nLN#et al.#Domestic 
and peridomestic transmission of American cutaneous leishmaniasis: changing epid
emiological patterns present new control opportunities^len#Mem Inst Oswaldo Cruz
#20010000#2001#96#159-162#20110000#aop05-11.htm#0074-0276#Mem Inst Oswaldo Cruz#
#
00553000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100018001050120
06100123030001700184065000900201064000500210031000300215014000800218865000900226
002001300235035001000248801001700258#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop05-11.htm#S#c#142#4#article#18#4#^rND^sFurtado^nT#^rND^sVieira^nJBF#
Geografia da leishmaniose tegumentar americana no Brasil^lpt#An Bras Dermatol#19
820000#1982#57#135-140#20110000#aop05-11.htm#0365-0596#An Bras Dermatol##
00692000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100018001050100
01700123010001400140010001800154010002000172810000700192012009500199030002600294
71000020032006500090032206400050033103100030033601400050033986500090034400200130
0353#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#143#5#
article#18#5#^rND^sMayrink^nW#^rND^sWilliams^nP#^rND^sCoelho^nMV#^rND^sDias^nM#^
rND^sMartins^nAV#^rND^sMagalhães^nPA#et al.#Epidemiology of dermal leishmaniasis
 in the Rio Doce Valley, State of Minas Gerais, Brazil^len#Ann Trop Med Parasito
logy#2#19790000#1979#73#1-14#20110000#aop05-11.htm##
00647000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100015001070120
15800122030001600280065000900296064000500305031000300310014000800313865000900321
002001300330035001000343801001600353#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop05-11.htm#S#c#144#6#article#18#6#^rND^sPeterson^nAT#^rND^sShaw^nJJ#L
utzomyia vectors for cutaneous leishmaniasis in Southern Brazil: ecological nich
e models, predicted geographic distributions, and climate change effects^len#Int
 J Parasitol#20030000#2003#33#919-931#20110000#aop05-11.htm#0020-7519#Int J Para
sitol##
00684000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100017001040100
02300121010001600144010001500160012009600175030002200271065000900293064000500302
031000300307014000600310865000900316002001300325035001000338801002200348#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#145#7#article#18#7
#^rND^sPugedo^nH#^rND^sBarata^nRA#^rND^sFrança-Silva^nJC#^rND^sSilva^nJC#^rND^sD
ias^nES#HP: um modelo aprimorado de armadilha luminosa de sucção para a captura 
de pequenos insetos^lpt#Rev Soc Bras Med Trop#20050000#2005#38#70-72#20110000#ao
p05-11.htm#0037-8682#Rev Soc Bras Med Trop##
00611000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100017001040120
16100121030001600282710000200298065000900300064000500309031000300314014000600317
865000900323002001300332#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
05-11.htm#S#c#146#8#article#18#8#^rND^sYoung^nDG#^rND^sDuncan^nMA#Guide to the i
dentification and geographic distribution of Lutzomyia sand flies in Mexico, the
 West Indies, Central and South America (Diptera: Psychodidae)^len#Mem Am Ent In
st#2#19940000#1994#54#1-881#20110000#aop05-11.htm##
00447000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160020000880180023001080660
01000131062002000141062000800161065000900169064000500178865000900183002001300192
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#147#9#arti
cle#18#9#^rND^sForattini^nOP#Entomologia Médica^lpt#São Paulo#Ed. Edgard Blücher
.#Ed. USP#19730000#1973#20110000#aop05-11.htm##
00807000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100018001050100
02000123010001900143010001600162010001800178810000700196012016500203030002200368
06500090039006400050039903100030040401400080040786500090041500200130042403500100
0437801002200447#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.ht
m#S#c#148#10#article#18#10#^rND^sMayo^nRC#^rND^sCasanova^nC#^rND^sMascarini^nLM#
^rND^sPignatti^nMG#^rND^sRangel^nO#^rND^sGalati^nEAB#et al.#Flebotomíneos (Dipte
ra, Psychodidae) de área de transmissão de leishmaniose tegumentar americana, no
 município de Itupeva, região sudeste do Estado de São Paulo^lpt#Rev Soc Bras Me
d Trop#19980000#1998#31#339-345#20110000#aop05-11.htm#0037-8682#Rev Soc Bras Med
 Trop##
00798000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100025001060100
01700131010001800148010001700166012020000183030002200383065000900405064000500414
031000300419014000800422865000900430002001300439035001000452801002200462#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#149#11#article#18#
11#^rND^sSouza^nNA#^rND^sAndrade-Coelho^nCA#^rND^sVilela^nML#^rND^sPeixoto^nAA#^
rND^sRangel^nEF#Seasonality of Lutzomyia intermedia and Lutzomyia whitmani (Dipt
era: Psychodidae: Phlebotominae), occurring sympatrically in area of cutaneous l
eishmaniasis in the State of Rio de Janeiro, Brazil^len#Mem Inst Oswaldo Cruz#20
020000#2002#97#759-765#20110000#aop05-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00789000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
02000123010001800143010001700161010002400178012016200202030002200364065000900386
06400050039503100030040001400060040386500090040900200130041803500100043180100220
0441#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#150#12
#article#18#12#^rND^sSaraiva^nL#^rND^sLopes^nJS#^rND^sOliveira^nGBM#^rND^sBatist
a^nFA#^rND^sFalcão^nAL#^rND^sAndrade-Filho^nJD#Estudo dos flebotomíneos (Diptera
: Psychodidae) em área de leishmaniose tegumentar americana nos municípios de Al
to Caparaó e Caparaó, Estado de Minas Gerais^lpt#Rev Soc Bras Med Trop#20060000#
2006#39#56-63#20110000#aop05-11.htm#0037-8682#Rev Soc Bras Med Trop##
00531000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900120098001100300
02000208710000200228065000900230064000500239031000300244014000800247865000900255
002001300264#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#
c#151#13#article#18#13#^rND^sForattini^nOP#Novas observações sobre a biologia de
 flebótomos em condições naturais (Diptera: Psychodidae)^lpt#Arch Hyg Saude Publ
#2#19600000#1960#25#209-215#20110000#aop05-11.htm##
00751000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100023001050100
01600128010002000144010001600164010001700180810000700197012011000204030002200314
06500090033606400050034503100030035001400060035386500090035900200130036803500100
0381801002200391#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.ht
m#S#c#152#14#article#18#14#^rND^sDias^nES#^rND^sFrança-Silva^nJC#^rND^sSilva^nJC
#^rND^sMichalsky^nEM#^rND^sPaula^nKM#^rND^sMacedo^nCG#et al.#Flebotomíneos (Dipt
era: Psychodidae) em foco de leishmaniose tegumentar no Estado de Minas Gerais, 
Brasil^lpt#Rev Soc Bras Med Trop#20080000#2007#40#49-52#20110000#aop05-11.htm#00
37-8682#Rev Soc Bras Med Trop##
00780000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100023001070100
02200130010001600152010001600168010001700184810000700201012013300208030002200341
06500090036306400050037203100030037701400080038086500090038800200130039703500100
0410801002200420#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.ht
m#S#c#153#15#article#18#15#^rND^sBarata^nRA#^rND^sFrança-Silva^nJC#^rND^sFortes-
Dias^nCL#^rND^sCosta^nRT#^rND^sSilva^nJC#^rND^sVieira^nEP#et al.#Phlebotomines s
and flies in Porteirinha, an endemic area of American visceral leishmaniasis in 
the State of Minas Gerais, Brazil^len#Mem Inst Oswaldo Cruz#20040000#2004#99#481
-487#20110000#aop05-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00678000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100015001080120
17500123030002200298065000900320064000500329031000400334014000800338865000900346
002001300355035001000368801002200378#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop05-11.htm#S#c#154#16#article#18#16#^rND^sMissawa^nNA#^rND^sDias^nES#
Phlebotomine sand flies (Diptera: Psychodidae) in the municipality of Várzea Gra
nde: an area of transmission of visceral leishmaniasis in the State of Mato Gros
so, Brazil^len#Mem Inst Oswaldo Cruz#20070000#2007#102#913-918#20110000#aop05-11
.htm#0074-0276#Mem Inst Oswaldo Cruz##
00732000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01700125010001900142010001600161010001500177012011300192030002200305065000900327
06400050033603100030034101400080034486500090035200200130036103500100037480100220
0384#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.htm#S#c#155#17
#article#18#17#^rND^sSouza^nCM#^rND^sPessanha^nJE#^rND^sBarata^nRA#^rND^sMonteir
o^nEM#^rND^sCosta^nDC#^rND^sDias^nES#Study on phlebotomine sand fly (Diptera: Ps
ychodidae) fauna in Belo Horizonte, state of Minas Gerais, Brazil^len#Mem Inst O
swaldo Cruz#20040000#2004#99#795-803#20110000#aop05-11.htm#0074-0276#Mem Inst Os
waldo Cruz##
00763000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100023001100100
01700133010002300150010001900173010002200192810000700214012010400221030002200325
06500090034706400050035603100040036101400060036586500090037100200130038003500100
0393801002200403#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop05-11.ht
m#S#c#156#18#article#18#18#^rND^sMichalsky^nEM#^rND^sFrança-Silva^nJC#^rND^sBara
ta^nRA#^rND^sLara e Silva^nFO#^rND^sLoureiro^nAM#^rND^sFortes-Dias^nCL#et al.#Ph
lebotominae distribution in Janaúba, an area of transmission for visceral leishm
aniasis in Brazil^len#Mem Inst Oswaldo Cruz#20090000#2009#104#56-61#20110000#aop
05-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#o#1#
1#article#1#20110328#093849#aop06-11.htm#151##
04566000000000553000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701200990
01860120099002850100036003840100032004200700088004520831716005400850008022560850
01802264085002102282085002802303085004102331083150902372085000803881085001903889
085002203908085002803930085003203958117000603990072000303996002001303999#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#h#2#1#article#1#oa#p
t#br1.1#1#4.0#MAP#TAB#08#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#
0037-8682#20110401#Infecção por Yersinia pestis, no Estado da Bahia: controle ef
etivo ou silêncio epidemiológico?^lpt#Yersinia pestis infection in the State of 
Bahia: effective control or epidemiological silence?^len#^rND^1A01^nRamon da Cos
ta^sSaavedra#^rND^1A01^nJuarez Pereira^sDias#Diretoria de Vigilância Epidemiológ
ica^iA01^1Secretaria de Saúde da Bahia^cSalvador^sBA#^lpt^aINTRODUÇÃO: A peste, 
doença infectocontagiosa milenar, continua sendo considerada da maior importânci
a do ponto de vista epidemiológico devido ao alto potencial epidêmico, estando i
nclusive sujeita ao Regulamento Sanitário Internacional. Apesar da ausência de c
asos humanos da doença no Brasil, seu agente etiológico, a bactéria Yersinia pes
tis, permanece firmemente arraigado em seus focos naturais. A ocorrência de soro
logia positiva em carnívoros domésticos de regiões pestígenas da Bahia, nos últi
mos anos, objetivou a realização deste estudo, que se propõe a verificar a exist
ência de circulação do agente no estado, tendo em vista que fatores condicionant
es para a doença são mantidos, oferecendo riscos à população. MÉTODOS: Trata-se 
de um estudo para verificação da presença de infecção por Y. pestis através do i
nquérito de soroprevalência em humanos, cães e roedores; e pesquisa da bactéria 
em roedores e pulgas. Utilizou-se de questionário estruturado para avaliação da 
associação existente entre fatores ambientais, sócioeconômicos e biológicos e a 
soroprevalência da infecção em humanos. RESULTADOS: Os 630 soros examinados (88 
de humanos, 480 de cães, 62 de roedores) apresentaram-se não reagentes para pest
e e as análises bacteriológicas realizadas em 14 roedores e dois lotes de pulgas
 não identificaram a bactéria. CONCLUSÕES: Os resultados não configuram erradica
ção da doença no estado, pois sua natureza cíclica indica que pode passar longos
 períodos silente e depois ressurgir acometendo um grande número de pessoas. Por
tanto, a manutenção da vigilância ativa e permanente se faz necessária para a de
tecção precoce da doença e desenvolvimento oportuno das medidas de controle pert
inentes.#^dnd^i1#^tm^lpt^kPeste^i1#^tm^lpt^kInfecção^i1#^tm^lpt^kYersinia pestis
^i1#^tm^lpt^kInquérito de soroprevalência^i1#^len^aINTRODUCTION: From an epidemi
ological point of view, the plague is still being considered of great importance
, because of its high epidemic potential. Despite the absence of cases of human 
plague in Brazil, its etiologic agent, the bacteria Yersinia pestis, is still de
ep rooted in its natural environment. The occurrence of positive serology for pl
ague in domestic carnivores in plague areas in Bahia in the past few years impli
es the need for a more rigorous evaluation in order to verify whether the bacill
us of the plague is still active in these areas. METHODS: In this study, the pre
sence of infection caused by Y. pestis was analyzed by seroprevalence tests on h
umans, dogs and rodents and by the detection of the bacteria in rodents and flea
s. A structured questionnaire was used to analyze the association between enviro
nmental, socioeconomic and biological factors and seroprevalence in humans. RESU
LTS: Of the 630 serum samples examined (88 from humans, 480 from dogs and 62 fro
m rodents), all were nonreactive for plague and bacteriological analyses perform
ed on 14 rodents and 2 flea lots showed no signs of the bacteria. CONCLUSIONS: T
hese results cannot confirm the eradication of the disease in the entire State, 
since the cyclic nature of the plague indicates that it can go silent for long p
eriods and then resurge, affecting large numbers of people. Thus, maintenance of
 active, permanent surveillance is required for early detection and the developm
ent of adequate control measures.#^dnd^i2#^tm^len^kPlague^i2#^tm^len^kInfection^
i2#^tm^len^kYersinia pestis^i2#^tm^len^kSeroprevalence test^i2#other#19#aop06-11
.htm##
04713000000000553000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201200
01860120127003060100036004330100032004690700088005010831758005890850008023470850
01802355085002102373085003502394085004102429083155102470085000804021085001904029
085002204048085003504070085003204105117000604137072000304143002001304146#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#f#3#1#article#1#oa#p
t#br1.1#1#4.0#MAP#TAB#08#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#
0037-8682#20110401#<b>Infecção por <i>Yersinia pestis</i>, no Estado da Bahia</b
>: <b>controle efetivo ou silêncio epidemiológico?</b>^lpt#<b><i>Yersinia pestis
</i></b><b> infection in the State of Bahia</b>: <b>effective control or epidemi
ological silence?</b>^len#^rND^1A01^nRamon da Costa^sSaavedra#^rND^1A01^nJuarez 
Pereira^sDias#Diretoria de Vigilância Epidemiológica^iA01^1Secretaria de Saúde d
a Bahia^cSalvador^sBA#^lpt^a<b>INTRODUÇÃO: </b>A peste, doença infectocontagiosa
 milenar, continua sendo considerada da maior importância do ponto de vista epid
emiológico devido ao alto potencial epidêmico, estando inclusive sujeita ao Regu
lamento Sanitário Internacional. Apesar da ausência de casos humanos da doença n
o Brasil, seu agente etiológico, a bactéria <i>Yersinia pestis</i>, permanece fi
rmemente arraigado em seus focos naturais. A ocorrência de sorologia positiva em
 carnívoros domésticos de regiões pestígenas da Bahia, nos últimos anos, objetiv
ou a realização deste estudo, que se propõe a verificar a existência de circulaç
ão do agente no estado, tendo em vista que fatores condicionantes para a doença 
são mantidos, oferecendo riscos à população. <b>MÉTODOS: </b>Trata-se de um estu
do para verificação da presença de infecção por <i>Y. pestis </i>através do inqu
érito de soroprevalência em humanos, cães e roedores; e pesquisa da bactéria em 
roedores e pulgas. Utilizou-se de questionário estruturado para avaliação da ass
ociação existente entre fatores ambientais, sócioeconômicos e biológicos e a sor
oprevalência da infecção em humanos. <b>RESULTADOS: </b>Os 630 soros examinados 
(88 de humanos, 480 de cães, 62 de roedores) apresentaram-se não reagentes para 
peste e as análises bacteriológicas realizadas em 14 roedores e dois lotes de pu
lgas não identificaram a bactéria. <b>CONCLUSÕES: </b>Os resultados não configur
am erradicação da doença no estado, pois sua natureza cíclica indica que pode pa
ssar longos períodos silente e depois ressurgir acometendo um grande número de p
essoas. Portanto, a manutenção da vigilância ativa e permanente se faz necessári
a para a detecção precoce da doença e desenvolvimento oportuno das medidas de co
ntrole pertinentes.#^dnd^i1#^tm^lpt^kPeste^i1#^tm^lpt^kInfecção^i1#^tm^lpt^k<i>Y
ersinia pestis</i>^i1#^tm^lpt^kInquérito de soroprevalência^i1#^len^a<b>INTRODUC
TION: </b>From an epidemiological point of view, the plague is still being consi
dered of great importance, because of its high epidemic potential. Despite the a
bsence of cases of human plague in Brazil, its etiologic agent, the bacteria <i>
Yersinia pestis</i>, is still deep rooted in its natural environment. The occurr
ence of positive serology for plague in domestic carnivores in plague areas in B
ahia in the past few years implies the need for a more rigorous evaluation in or
der to verify whether the bacillus of the plague is still active in these areas.
 <b>METHODS: </b>In this study, the presence of infection caused by <i>Y. pestis
 </i>was analyzed by seroprevalence tests on humans, dogs and rodents and by the
 detection of the bacteria in rodents and fleas. A structured questionnaire was 
used to analyze the association between environmental, socioeconomic and biologi
cal factors and seroprevalence in humans. <b>RESULTS: </b>Of the 630 serum sampl
es examined (88 from humans, 480 from dogs and 62 from rodents), all were nonrea
ctive for plague and bacteriological analyses performed on 14 rodents and 2 flea
 lots showed no signs of the bacteria. <b>CONCLUSIONS: </b>These results cannot 
confirm the eradication of the disease in the entire State, since the cyclic nat
ure of the plague indicates that it can go silent for long periods and then resu
rge, affecting large numbers of people. Thus, maintenance of active, permanent s
urveillance is required for early detection and the development of adequate cont
rol measures.#^dnd^i2#^tm^len^kPlague^i2#^tm^len^kInfection^i2#^tm^len^k<i>Yersi
nia pestis</i>^i2#^tm^len^kSeroprevalence test^i2#other#19#aop06-11.htm##
04687000000000577000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120099001920120099002910100036003900100032004260700090004580831716005480850
00802264085001802272085002102290085002802311085004102339083150902380085000803889
08500190389708500220391608500280393808500320396611700060399807200030400400200130
4007008008904020#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.ht
m#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#map#tab#08#nd#nd#Rev. Soc. Bras. Me
d. Trop#ahead#20110000#^f0^l0#0037-8682#20110401#Infecção por Yersinia pestis, n
o Estado da Bahia: controle efetivo ou silêncio epidemiológico?^lpt#Yersinia pes
tis infection in the State of Bahia: effective control or epidemiological silenc
e?^len#^rND^1A01^nRamon da Costa^sSaavedra#^rND^1A01^nJuarez Pereira^sDias#^iA01
^1Diretoria de Vigilância Epidemiológica^2Secretaria de Saúde da Bahia^cSalvador
^sBA#^lpt^aINTRODUÇÃO: A peste, doença infectocontagiosa milenar, continua sendo
 considerada da maior importância do ponto de vista epidemiológico devido ao alt
o potencial epidêmico, estando inclusive sujeita ao Regulamento Sanitário Intern
acional. Apesar da ausência de casos humanos da doença no Brasil, seu agente eti
ológico, a bactéria Yersinia pestis, permanece firmemente arraigado em seus foco
s naturais. A ocorrência de sorologia positiva em carnívoros domésticos de regiõ
es pestígenas da Bahia, nos últimos anos, objetivou a realização deste estudo, q
ue se propõe a verificar a existência de circulação do agente no estado, tendo e
m vista que fatores condicionantes para a doença são mantidos, oferecendo riscos
 à população. MÉTODOS: Trata-se de um estudo para verificação da presença de inf
ecção por Y. pestis através do inquérito de soroprevalência em humanos, cães e r
oedores; e pesquisa da bactéria em roedores e pulgas. Utilizou-se de questionári
o estruturado para avaliação da associação existente entre fatores ambientais, s
ócioeconômicos e biológicos e a soroprevalência da infecção em humanos. RESULTAD
OS: Os 630 soros examinados (88 de humanos, 480 de cães, 62 de roedores) apresen
taram-se não reagentes para peste e as análises bacteriológicas realizadas em 14
 roedores e dois lotes de pulgas não identificaram a bactéria. CONCLUSÕES: Os re
sultados não configuram erradicação da doença no estado, pois sua natureza cícli
ca indica que pode passar longos períodos silente e depois ressurgir acometendo 
um grande número de pessoas. Portanto, a manutenção da vigilância ativa e perman
ente se faz necessária para a detecção precoce da doença e desenvolvimento oport
uno das medidas de controle pertinentes.#^dnd^i1#^tm^lpt^kPeste^i1#^tm^lpt^kInfe
cção^i1#^tm^lpt^kYersinia pestis^i1#^tm^lpt^kInquérito de soroprevalência^i1#^le
n^aINTRODUCTION: From an epidemiological point of view, the plague is still bein
g considered of great importance, because of its high epidemic potential. Despit
e the absence of cases of human plague in Brazil, its etiologic agent, the bacte
ria Yersinia pestis, is still deep rooted in its natural environment. The occurr
ence of positive serology for plague in domestic carnivores in plague areas in B
ahia in the past few years implies the need for a more rigorous evaluation in or
der to verify whether the bacillus of the plague is still active in these areas.
 METHODS: In this study, the presence of infection caused by Y. pestis was analy
zed by seroprevalence tests on humans, dogs and rodents and by the detection of 
the bacteria in rodents and fleas. A structured questionnaire was used to analyz
e the association between environmental, socioeconomic and biological factors an
d seroprevalence in humans. RESULTS: Of the 630 serum samples examined (88 from 
humans, 480 from dogs and 62 from rodents), all were nonreactive for plague and 
bacteriological analyses performed on 14 rodents and 2 flea lots showed no signs
 of the bacteria. CONCLUSIONS: These results cannot confirm the eradication of t
he disease in the entire State, since the cyclic nature of the plague indicates 
that it can go silent for long periods and then resurge, affecting large numbers
 of people. Thus, maintenance of active, permanent surveillance is required for 
early detection and the development of adequate control measures.#^dnd^i2#^tm^le
n^kPlague^i2#^tm^len^kInfection^i2#^tm^len^kYersinia pestis^i2#^tm^len^kSeroprev
alence test^i2#other#19#aop06-11.htm#Internet^ihttp://www.scielo.br/scielo.php?s
cript=sci_arttext&pid=S0037-86822011005000008##
00483000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704023900085002001300324#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#5#1#article#128#<p><font s
ize="4" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota_1"></a><b>Inf
ec&ccedil;&atilde;o por <i>Yersinia pestis</i>, no Estado da Bahia: controle efe
tivo ou sil&ecirc;ncio epidemiol&oacute;gico?</b></font></p>     ^cY#aop06-11.ht
m##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#6#2#article#128#<p>&nbsp;<
/p>     ^cY#aop06-11.htm##
00435000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704019100085002001300276#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#7#3#article#128#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b><i>Yersinia pestis</i> i
nfection in the State of Bahia: effective control or epidemiological silence?</b
></font></p>     ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#8#4#article#128#<p>&nbsp;<
/p>     ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#9#5#article#128#<p>&nbsp;<
/p>     ^cY#aop06-11.htm##
00379000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013400086002001300220#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#10#6#article#128#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Ramon da Costa Saavedra
; Juarez Pereira Dias</b></font></p>     ^cY#aop06-11.htm##
00430000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704018500086002001300271#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#11#7#article#128#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif">Diretoria de Vigil&acirc;n
cia Epidemiol&oacute;gica, Secretaria de Sa&uacute;de da Bahia, Salvador, BA</fo
nt></p>     ^cY#aop06-11.htm##
00391000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704014600086002001300232#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#12#8#article#128#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#nota1">Endere&cc
edil;o para correspond&ecirc;ncia</a></font></p>     ^cY#aop06-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704002200086002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#13#9#article#128#<p>&nbsp;
</p>     ^cY#aop06-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#14#10#article#128#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop06-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#15#11#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop06-11.htm##
01244000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704099800087002001301085#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#16#12#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b>A peste, doen&ccedil;a infectocontagiosa milenar, continua sendo conside
rada da maior import&acirc;ncia do ponto de vista epidemiol&oacute;gico devido a
o alto potencial epid&ecirc;mico, estando inclusive sujeita ao Regulamento Sanit
&aacute;rio Internacional. Apesar da aus&ecirc;ncia de casos humanos da doen&cce
dil;a no Brasil, seu agente etiol&oacute;gico, a bact&eacute;ria <i>Yersinia pes
tis</i>, permanece firmemente arraigado em seus focos naturais. A ocorr&ecirc;nc
ia de sorologia positiva em carn&iacute;voros dom&eacute;sticos de regi&otilde;e
s pest&iacute;genas da Bahia, nos &uacute;ltimos anos, objetivou a realiza&ccedi
l;&atilde;o deste estudo, que se prop&otilde;e a verificar a exist&ecirc;ncia de
 circula&ccedil;&atilde;o do agente no estado, tendo em vista que fatores condic
ionantes para a doen&ccedil;a s&atilde;o mantidos, oferecendo riscos &agrave; po
pula&ccedil;&atilde;o.    ^cY#aop06-11.htm##
00803000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055700087002001300644#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#17#13#article#128#<br>   <
b>M&Eacute;TODOS: </b>Trata-se de um estudo para verifica&ccedil;&atilde;o da pr
esen&ccedil;a de infec&ccedil;&atilde;o por <i>Y. pestis </i>atrav&eacute;s do i
nqu&eacute;rito de soropreval&ecirc;ncia em humanos, c&atilde;es e roedores; e p
esquisa da bact&eacute;ria em roedores e pulgas. Utilizou-se de question&aacute;
rio estruturado para avalia&ccedil;&atilde;o da associa&ccedil;&atilde;o existen
te entre fatores ambientais, s&oacute;cioecon&ocirc;micos e biol&oacute;gicos e 
a soropreval&ecirc;ncia da infec&ccedil;&atilde;o em humanos.    ^cY#aop06-11.ht
m##
00540000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704029400087002001300381#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#18#14#article#128#<br>   <
b>RESULTADOS: </b>Os 630 soros examinados (88 de humanos, 480 de c&atilde;es, 62
 de roedores) apresentaram-se n&atilde;o reagentes para peste e as an&aacute;lis
es bacteriol&oacute;gicas realizadas em 14 roedores e dois lotes de pulgas n&ati
lde;o identificaram a bact&eacute;ria.    ^cY#aop06-11.htm##
00761000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051500087002001300602#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#19#15#article#128#<br>   <
b>CONCLUS&Otilde;ES: </b>Os resultados n&atilde;o configuram erradica&ccedil;&at
ilde;o da doen&ccedil;a no estado, pois sua natureza c&iacute;clica indica que p
ode passar longos per&iacute;odos silente e depois ressurgir acometendo um grand
e n&uacute;mero de pessoas. Portanto, a manuten&ccedil;&atilde;o da vigil&acirc;
ncia ativa e permanente se faz necess&aacute;ria para a detec&ccedil;&atilde;o p
recoce da doen&ccedil;a e desenvolvimento oportuno das medidas de controle perti
nentes.</font></p>     ^cY#aop06-11.htm##
00472000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022600087002001300313#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#20#16#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves:</b> P
este. Infec&ccedil;&atilde;o. <i>Yersinia pestis</i>. Inqu&eacute;rito de soropr
eval&ecirc;ncia.</font></p> <hr size="1" noshade>     ^cY#aop06-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#21#17#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop06-11.htm##
00888000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064200087002001300729#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#22#18#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION: </b>From
 an epidemiological point of view, the plague is still being considered of great
 importance, because of its high epidemic potential. Despite the absence of case
s of human plague in Brazil, its etiologic agent, the bacteria <i>Yersinia pesti
s</i>, is still deep rooted in its natural environment. The occurrence of positi
ve serology for plague in domestic carnivores in plague areas in Bahia in the pa
st few years implies the need for a more rigorous evaluation in order to verify 
whether the bacillus of the plague is still active in these areas.    ^cY#aop06-
11.htm##
00621000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037500087002001300462#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#23#19#article#128#<br>   <
b>METHODS: </b>In this study, the presence of infection caused by <i>Y. pestis <
/i>was analyzed by seroprevalence tests on humans, dogs and rodents and by the d
etection of the bacteria in rodents and fleas. A structured questionnaire was us
ed to analyze the association between environmental, socioeconomic and biologica
l factors and seroprevalence in humans.    ^cY#aop06-11.htm##
00497000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025100087002001300338#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#24#20#article#128#<br>   <
b>RESULTS: </b>Of the 630 serum samples examined (88 from humans, 480 from dogs 
and 62 from rodents), all were nonreactive for plague and bacteriological analys
es performed on 14 rodents and 2 flea lots showed no signs of the bacteria.    ^
cY#aop06-11.htm##
00647000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040100087002001300488#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#25#21#article#128#<br>   <
b>CONCLUSIONS: </b>These results cannot confirm the eradication of the disease i
n the entire State, since the cyclic nature of the plague indicates that it can 
go silent for long periods and then resurge, affecting large numbers of people. 
Thus, maintenance of active, permanent surveillance is required for early detect
ion and the development of adequate control measures.</font></p>     ^cY#aop06-1
1.htm##
00431000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018500087002001300272#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#26#22#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Plague. 
Infection. <i>Yersinia pestis</i>. Seroprevalence test.</font></p> <hr size="1" 
noshade>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#27#23#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#28#24#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011400087002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#29#25#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O</b></font></p>     ^cY#aop06-11.htm##
00763000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051700087002001300604#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#30#26#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A peste &eacute; essencia
lmente uma zoonose de roedores, causada pela bact&eacute;ria <i>Yersinia pestis<
/i>, que pode infectar o homem quando este invade o seu ecossistema<sup>1</sup>.
 Trata-se de um grave problema de sa&uacute;de p&uacute;blica em algumas &aacute
;reas do mundo e atualmente tem merecido aten&ccedil;&atilde;o pelo fato desse a
gente etiol&oacute;gico ser considerado potencial arma bacteriol&oacute;gica<sup
>2</sup>.</font></p>     ^cY#aop06-11.htm##
00909000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704066300087002001300750#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#31#27#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A transmiss&atilde;o da p
este ocorre principalmente atrav&eacute;s da picada de pulgas infectadas, sendo 
a <i>Xenopsylla cheopis </i>considerada vetor cl&aacute;ssico da doen&ccedil;a, 
apesar de haver in&uacute;meras outras esp&eacute;cies com potencial vetorial. O
s roedores s&atilde;o os principais reservat&oacute;rios da doen&ccedil;a e esti
ma-se que cerca de 200 esp&eacute;cies estejam envolvidas no seu ciclo epidemiol
&oacute;gico<sup>1</sup>. No Brasil, predominam os g&ecirc;neros <i>Necromys</i>
 (<i>Bolomys), Calomys, Oligoryzomys, Rattus, Galea </i>e<i> Trychomys</i>.</fon
t></p>     ^cY#aop06-11.htm##
00730000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048400087002001300571#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#32#28#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As manifesta&ccedil;&otil
de;es cl&iacute;nicas da doen&ccedil;a podem ocorrer sob as formas bub&ocirc;nic
a, septic&ecirc;mica e pneum&ocirc;nica. A bub&ocirc;nica &eacute; a mais freque
nte, a septic&ecirc;mica mais rara e a pneum&ocirc;nica, a forma mais grave da d
oen&ccedil;a, tanto pelo quadro cl&iacute;nico agressivo, quanto pela alta conta
giosidade, podendo causar grandes epidemias<sup>3</sup>.</font></p>     ^cY#aop0
6-11.htm##
00809000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056300087002001300650#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#33#29#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Atualmente, a peste &eacu
te; uma doen&ccedil;a end&ecirc;mica em diversos pa&iacute;ses do mundo, concent
rados 98% dos casos nas zonas rurais da &Aacute;frica, principalmente, na Rep&ua
cute;blica Democr&aacute;tica do Congo e Madagascar, e o restante distribu&iacut
e;do na Am&eacute;rica do Norte, no meio-oeste dos Estados Unidos; Am&eacute;ric
a do Sul, no Peru, Equador e Bol&iacute;via; &Aacute;sia, na China, Vietnam e &I
acute;ndia; al&eacute;m do sudeste europeu<sup>4</sup>.</font></p>     ^cY#aop06
-11.htm##
01184000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704093800087002001301025#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#34#30#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">No Brasil, a peste chegou
 pelo porto de Santos em 1899 atingindo, em seguida, v&aacute;rias cidades do li
toral<sup>5</sup>. Dados registrados desde 1935 revelam que o per&iacute;odo de 
maior intensidade na ocorr&ecirc;ncia da doen&ccedil;a antecede a d&eacute;cada 
de 70, entrando em decl&iacute;nio logo ap&oacute;s, verificando epidemias isola
das nos anos 1970, na Bahia, e 1980, nos Estados do Cear&aacute; e Para&iacute;b
a<sup>6,7</sup>. A d&eacute;cada seguinte &eacute; caracterizada pelo registro d
e casos espor&aacute;dicos, concentrados na Bahia, sendo os &uacute;ltimos regis
trados, neste estado, no munic&iacute;pio de Feira de Santana, em 2000. Ap&oacut
e;s um per&iacute;odo silente de quatro anos, o Cear&aacute; registrou o &uacute
;ltimo caso do pa&iacute;s no munic&iacute;pio <sup>M&Eacute;TODOS </sup>de Pedr
a Branca, em 2005<sup>3</sup>.</font></p>     ^cY#aop06-11.htm##
00924000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704067800087002001300765#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#35#31#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Atualmente, existem duas 
&aacute;reas principais com focos naturais da peste no Brasil: parte da regi&ati
lde;o nordeste e a Serra dos &Oacute;rg&atilde;os no Rio de Janeiro. No nordeste
, h&aacute; focos na regi&atilde;o semi&aacute;rida, em v&aacute;rios Estados, c
omo: Piau&iacute;, Cear&aacute;, Rio Grande do Norte, Para&iacute;ba, Pernambuco
, Alagoas e Bahia, alcan&ccedil;ando inclusive parte do nordeste de Minas Gerais
, no Vale do Jequitinhonha. J&aacute; na Serra dos &Oacute;rg&atilde;os, o foco 
envolve os munic&iacute;pios de Teres&oacute;polis, Nova Friburgo e Sumidouro<su
p>5</sup>.</font></p>     ^cY#aop06-11.htm##
00893000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064700087002001300734#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#36#32#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A atividade pestosa no pa
&iacute;s &eacute; monitorada, continuamente, pelos Programas de Controle da Pes
te (PCP) dos estados/munic&iacute;pios, atrav&eacute;s de inqu&eacute;ritos soro
l&oacute;gicos em animais sentinelas. Carn&iacute;voros dom&eacute;sticos t&ecir
c;m a capacidade de produzir anticorpos contra o bacilo da peste, que permanecem
 ativos por pelo menos 300 dias. Desta forma, inqu&eacute;ritos sorol&oacute;gic
os, em c&atilde;es e gatos, t&ecirc;m sido considerados valiosos instrumentos na
 detec&ccedil;&atilde;o da atividade pestosa<sup>8,9</sup>.</font></p>     ^cY#a
op06-11.htm##
01315000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704106900087002001301156#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#37#33#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">N&atilde;o obstante o n&u
acute;mero de casos humanos de peste ser relativamente baixo e estar restrito a 
&aacute;reas espec&iacute;ficas do territ&oacute;rio brasileiro, a doen&ccedil;a
 &eacute; considerada da maior import&acirc;ncia do ponto de vista epidemiol&oac
ute;gico, devido ao seu alto potencial epid&ecirc;mico, estando inclusive sujeit
a ao Regulamento Sanit&aacute;rio Internacional (RSI)<sup>10</sup>. Por outro la
do, em se tratando de uma doen&ccedil;a com cadeia epidemiol&oacute;gica complex
a, onde seu agente etiol&oacute;gico permanece firmemente arraigado em seus foco
s naturais, em roedores e hospedeiros selvagens, torna dif&iacute;cil a sua erra
dica&ccedil;&atilde;o e determina a manuten&ccedil;&atilde;o de uma vigil&acirc;
ncia constante e ativa<sup>11</sup>. Diante desse contexto, o presente estudo pr
op&otilde;e-se a verificar a exist&ecirc;ncia de circula&ccedil;&atilde;o da <i>
Y. pestis</i> em &aacute;reas consideradas pest&iacute;genas, no Estado da Bahia
.</font></p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#38#34#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#39#35#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODOS</b></fo
nt></p>     ^cY#aop06-11.htm##
00788000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054200087002001300629#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#40#36#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Trata-se de um estudo par
a verifica&ccedil;&atilde;o da presen&ccedil;a da <i>Y. pestis</i>, atrav&eacute
;s de inqu&eacute;rito de soropreval&ecirc;ncia da infec&ccedil;&atilde;o em hum
anos, c&atilde;es e roedores; pesquisa da bact&eacute;ria em roedores e pulgas; 
e an&aacute;lise da associa&ccedil;&atilde;o existente entre fatores ambientais,
 s&oacute;cioecon&ocirc;micos e biol&oacute;gicos, e a soropreval&ecirc;ncia da 
infec&ccedil;&atilde;o em humanos.</font></p>     ^cY#aop06-11.htm##
00990000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704074400087002001300831#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#41#37#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A popula&ccedil;&atilde;o
 do estudo foi composta por indiv&iacute;duos residentes, c&atilde;es domiciliad
os, roedores capturados no domic&iacute;lio e peridomic&iacute;lio e pulgas cole
tadas, nas resid&ecirc;ncias onde ocorreram registros de carn&iacute;voros dom&e
acute;sticos com sorologia positiva para peste no per&iacute;odo de 2006 a 2008.
 O estudo foi desenvolvido em 10 munic&iacute;pios pertencentes a oito Diretoria
s Regionais de Sa&uacute;de (DIRES), envolvendo 15 localidades, no per&iacute;od
o de julho a outubro de 2009. A <b><a href="#fig1">Figura 1</a></b> mostra a dis
tribui&ccedil;&atilde;o dos munic&iacute;pios do estudo, por DIRES da Bahia.</fo
nt></p>     ^cY#aop06-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#42#38#article#128#<p><a na
me="fig1"></a></p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#43#39#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#44#40#article#128#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop06-11_fig01.jpg"></p>     
^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#45#41#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
01200000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704095400087002001301041#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#46#42#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Para a realiza&ccedil;&at
ilde;o do inqu&eacute;rito epidemiol&oacute;gico, em humanos, utilizou-se como i
nstrumento para coleta de dados um question&aacute;rio estruturado, onde constav
am dados biol&oacute;gicos: sexo (masculino e feminino), idade (10 a 49 anos e 5
0 ou mais anos) e ra&ccedil;a/cor (branca e preta/parda); socioecon&ocirc;micos:
 escolaridade (analfabeto e alfabetizado compreendendo 1º e 2º grau), ocupa&cced
il;&atilde;o (agropecu&aacute;ria e outros), e renda familiar (menor que 1 sal&a
acute;rio m&iacute;nimo e igual ou maior a 1 sal&aacute;rio m&iacute;nimo); e am
bientais: piso do domic&iacute;lio (presente, com cimento ou cer&acirc;mica, e a
usente, com ch&atilde;o batido); cobertura do domic&iacute;lio (aberta, com telh
a, e fechada, com laje) e relato da presen&ccedil;a de roedores no domic&iacute;
lio e peridomic&iacute;lio (sim e n&atilde;o).</font></p>     ^cY#aop06-11.htm##
01140000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089400087002001300981#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#47#43#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A verifica&ccedil;&atilde
;o da infec&ccedil;&atilde;o por <i>Y. pestis</i> foi realizada atrav&eacute;s d
e an&aacute;lises sorol&oacute;gicas com quantifica&ccedil;&atilde;o de anticorp
os contra a prote&iacute;na capsular F1, espec&iacute;fica da <i>Y. pestis</i>, 
atrav&eacute;s do teste de hemaglutina&ccedil;&atilde;o (HA) com hem&aacute;cias
 de carneiro controlada pela rea&ccedil;&atilde;o de inibi&ccedil;&atilde;o da h
emaglutina&ccedil;&atilde;o (HI)<sup>3</sup>. Essa t&eacute;cnica est&aacute; en
tre as principais abordagens recomendadas pela Organiza&ccedil;&atilde;o Mundial
 de Sa&uacute;de (OMS), para o diagn&oacute;stico laboratorial da peste e permit
e identificar a presen&ccedil;a da infec&ccedil;&atilde;o em &aacute;reas onde n
&atilde;o h&aacute; evid&ecirc;ncia da doen&ccedil;a<sup>11</sup>.</font></p>   
  ^cY#aop06-11.htm##
00782000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053600087002001300623#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#48#44#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A hemaglutina&ccedil;&ati
lde;o (HA) compreende as seguintes etapas: inativa&ccedil;&atilde;o dos soros em
 banho-maria a 56ºC, dilui&ccedil;&atilde;o do soro em salina com soro normal de
 coelho, em placas de microtitula&ccedil;&atilde;o, triagem inicial diluindo tod
os os soros de 1:4 &agrave; 1:32 e, simultaneamente, prova de inibi&ccedil;&atil
de;o da hemaglutina&ccedil;&atilde;o (HI) para verificar especificidade da rea&c
cedil;&atilde;o<sup>3</sup>.</font></p>     ^cY#aop06-11.htm##
00835000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058900087002001300676#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#49#45#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A pesquisa da Y. <i>pesti
s </i>nos roedores foi realizada atrav&eacute;s de esfrega&ccedil;o em l&acirc;m
ina para exame em microsc&oacute;pio com lente de imers&atilde;o. Para pesquisa 
nas pulgas, lotes de pulgas foram triturados com bast&atilde;o de vidro em graal
 est&eacute;reis, depois suspenso em salina e semeado em placas de gelose, insti
lando-se uma gota de bacteri&oacute;fago antipestoso em uma das placas, incubado
 a 28ºC por 48 a 72h para observar se houve lise provocada pelo fago<sup>3</sup>
.</font></p>     ^cY#aop06-11.htm##
00758000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051200087002001300599#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#50#46#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As an&aacute;lises estat&
iacute;sticas foram realizadas no <i>software Epiinfo Windows </i>vers&atilde;o 
3.4.3. Raz&atilde;o de preval&ecirc;ncia foi a medida de associa&ccedil;&atilde;
o utilizada, considerando-se um intervalo de confian&ccedil;a de 95% como valor 
para signific&acirc;ncia estat&iacute;stica. Os dados foram apresentados sob for
ma de tabelas e gr&aacute;ficos, utilizando-se o <i>Microsoft Office Excel</i> 2
003.</font></p>     ^cY#aop06-11.htm##
00377000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013100087002001300218#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#51#47#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Considera&ccedil;&otil
de;es &eacute;ticas</b></font></p>     ^cY#aop06-11.htm##
00662000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041600087002001300503#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#52#48#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">O presente trabalho foi s
ubmetido, conforme definido na Resolu&ccedil;&atilde;o 196/96 do Conselho Nacion
al de Sa&uacute;de, e aprovado pelo Comit&ecirc; de &Eacute;tica em Pesquisa da 
Escola Estadual de Sa&uacute;de P&uacute;blica da Secretaria de Sa&uacute;de do 
Estado da Bahia, sob registro n.º 388/2009 e CAAE 0047.0.053.000-09.</font></p> 
    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#53#49#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#54#50#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font><
/p>     ^cY#aop06-11.htm##
00529000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028300087002001300370#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#55#51#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A popula&ccedil;&atilde;o
 estudada envolveu 88 humanos, 480 c&atilde;es, 62 roedores sinantr&oacute;picos
 e 52 pulgas (<b><a href="/img/revistas/rsbmt/2011nahead/aop06-11_tab01.jpg">Tab
ela 1</a></b>).</font></p>     ^cY#aop06-11.htm##
00954000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070800087002001300795#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#56#52#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Entre os humanos, observo
u-se um predom&iacute;nio do sexo feminino (52,3%), da faixa et&aacute;ria de 10
 a 49 anos (73,9%), e da ra&ccedil;a/cor preta ou parda (61,4%). Setenta e meio 
por cento das amostras foram compostas por alfabetizados, 62,5% por trabalhadore
s em atividades agropecu&aacute;rias, e 63,6% possu&iacute;am renda familiar inf
erior a 1 sal&aacute;rio m&iacute;nimo. A maioria dos domic&iacute;lios apresent
ou piso (95,4%) e cobertura aberta (95,4%); e 67% dos entrevistados n&atilde;o r
elataram a presen&ccedil;a de roedores no domic&iacute;lio e peridomic&iacute;li
o (<b><a href="#tab2">Tabela 2</a></b>).</font></p>     ^cY#aop06-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#57#53#article#128#<p><a na
me="tab2"></a></p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#58#54#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#59#55#article#128#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop06-11_tab02.jpg"></p>     
^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#60#56#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00854000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060800087002001300695#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#61#57#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os roedores capturados su
bdividiram-se em 75,8% comensais e 24,2% silvestres. Dentre os comensais, 97,1% 
foram da esp&eacute;cie <i>Rattus rattus </i>e 2,9% <i>Mus musculus</i>, enquant
o dentre os silvestres 63,6% foram <i>Galea spixii</i>, 18,2% <i>Necromys </i>(<
i>Bolomys</i>) <i>Lasiurus</i>, 9,1% <i>Wiedomys pirrhorinos </i>e 9,1% <i>Didel
pis paraguaniensis</i>. Todas as pulgas examinadas foram capturadas em roedores 
comensais e pertenciam a esp&eacute;cie <i>Xenopsyla cheopis</i>, sendo 33 f&eci
rc;meas e 19 machos.</font></p>     ^cY#aop06-11.htm##
00652000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040600087002001300493#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#62#58#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Foram analisados 630 soro
s, sendo que nenhum deles apresentou-se reagente para <i>Y. pestis</i>. Os exame
s bacteriol&oacute;gicos para isolamento da bact&eacute;ria foram realizados em 
14 roedores, sendo 10 comensais e 4 silvestres, e dois lotes de pulgas, n&atilde
;o sendo identificada a presen&ccedil;a do bacilo pestoso.</font></p>     ^cY#ao
p06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#63#59#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010600087002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#64#60#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></
font></p>     ^cY#aop06-11.htm##
01155000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090900087002001300996#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#65#61#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os resultados da presente
 investiga&ccedil;&atilde;o demonstram que, nas &aacute;reas estudadas, n&atilde
;o h&aacute; evid&ecirc;ncias de marcadores sorol&oacute;gicos sugestivos da pre
sen&ccedil;a de infec&ccedil;&atilde;o por <i>Y. pestis</i> em humanos, carn&iac
ute;voros dom&eacute;sticos, roedores do domicilio e peridomic&iacute;lio, nem a
 presen&ccedil;a desta bact&eacute;ria em roedores resistentes e pulgas. Este ac
hado n&atilde;o surpreende vez que na Bahia h&aacute; registros de sil&ecirc;nci
o epidemiol&oacute;gico da sorologia positiva para peste em animais dom&eacute;s
ticos, evidenciados pelo Sistema de Informa&ccedil;&atilde;o do Programa de Cont
role da Peste (SISPESTE). Vale considerar que durante esse per&iacute;odo as ati
vidades do PCP foram executadas rotineiramente, sem que houvesse descontinuidade
.</font></p>     ^cY#aop06-11.htm##
00776000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053000087002001300617#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#66#62#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Possivelmente, a natureza
 c&iacute;clica da doen&ccedil;a, que tende a reaparecer depois de longos interv
alos de inatividade, seja um fator que explique este quadro, resultando na falsa
 impress&atilde;o de rradica&ccedil;&atilde;o do bacilo da peste at&eacute; que 
uma nova manifesta&ccedil;&atilde;o ocorra de forma s&uacute;bita e repentina, g
eralmente como resultado de contato entre roedores silvestres e animais peridomi
ciliares<sup>12</sup>.</font></p>     ^cY#aop06-11.htm##
01059000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081300087002001300900#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#67#63#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Ressalta-se que todos os 
continentes apresentam relatos de reaparecimento de peste ap&oacute;s longo hiat
o. Na Am&eacute;rica do Sul, Equador, em 1998, e Peru, em 1999, registraram surt
os com &oacute;bitos da doen&ccedil;a depois de anos sem ocorr&ecirc;ncias<sup>1
3</sup>. No Brasil, per&iacute;odos de sil&ecirc;ncio s&atilde;o comumente citad
os na literatura, associando-os a ciclos peri&oacute;dicos. Um levantamento de d
ados sobre a tend&ecirc;ncia da peste no Cear&aacute;, entre 1935 e 2004, caract
erizou a ocorr&ecirc;ncia de casos humanos pela altern&acirc;ncia de momentos co
m elevadas incid&ecirc;ncias e per&iacute;odos de sil&ecirc;ncio, sendo o &uacut
e;ltimo caso registrado em 2005 e o anterior em 1997<sup>6</sup>.</font></p>    
 ^cY#aop06-11.htm##
01209000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704096300087002001301050#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#68#64#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Sabe-se ainda que o bacil
o tem a capacidade de sofrer rearranjos gen&ocirc;micos, o que lhe confere uma e
xtraordin&aacute;ria adaptabilidade. Consequ&ecirc;ncia disso &eacute; sua aptid
&atilde;o em manter-se permanente em focos com grande diversidade de condi&ccedi
l;&otilde;es ecol&oacute;gicas. A <i>Y. pestis</i> demonstrou ser capaz de adqui
rir plasm&iacute;deos de resist&ecirc;ncia a antibi&oacute;ticos sob condi&ccedi
l;&otilde;es naturais, podendo transmiti-lo para outras cepas, disseminando esse
 padr&atilde;o de resist&ecirc;ncia<sup>14</sup>. Uma cepa do bacilo com resist&
ecirc;ncia aos antimicrobianos mais utilizados no tratamento da doen&ccedil;a fo
i isolada em Madagascar, em 1995. Obviamente, o surgimento e a propaga&ccedil;&a
tilde;o de bacilos multirresistentes da <i>Y. pestis</i> representaria um grande
 amea&ccedil;a para a sa&uacute;de humana<sup>15</sup>.</font></p>     ^cY#aop06
-11.htm##
01321000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704107500087002001301162#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#69#65#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Altera&ccedil;&otilde;es 
clim&aacute;ticas tamb&eacute;m t&ecirc;m exercido importante influ&ecirc;ncia n
a recente contextualiza&ccedil;&atilde;o da peste no mundo, podendo aumentar pot
encialmente o risco de surtos da doen&ccedil;a. Muitas vezes, os efeitos causado
s por fen&ocirc;menos meteorol&oacute;gicos e modifica&ccedil;&otilde;es ecol&oa
cute;gicas n&atilde;o s&atilde;o correlacionados com a peste, oportunamente, por
que os registros da doen&ccedil;a ocorrem anos mais tarde, ap&oacute;s as altera
&ccedil;&otilde;es clim&aacute;ticas<sup>16</sup>. Foi o que aconteceu, por exem
plo, no norte do Peru, quando o fen&ocirc;meno El Ni&ntilde;o intensificou a pre
cipita&ccedil;&atilde;o pluviom&eacute;trica em toda a regi&atilde;o, no ver&ati
lde;o de 1998. Esse fen&ocirc;meno foi correlacionado, tardiamente, ao surto de 
peste ocorrido em fevereiro de 1999, numa comunidade ind&iacute;gena da regi&ati
lde;o, ap&oacute;s sil&ecirc;ncio epidemiol&oacute;gico de quatro anos<sup>17,18
</sup>.</font></p>     ^cY#aop06-11.htm##
00949000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070300087002001300790#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#70#66#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Portanto, a peste &eacute
; um problema de sa&uacute;de p&uacute;blica que chama a aten&ccedil;&atilde;o p
ela situa&ccedil;&atilde;o, extremamente paradoxal, que ocupa no mundo contempor
&acirc;neo, uma doen&ccedil;a milenar coexistindo, em algumas localidades do pla
neta, com outras surgidas nos &uacute;ltimos s&eacute;culos, como AIDS, hantavir
ose e ebola. Ao mesmo tempo em que &eacute; pouco conhecida pela maioria da popu
la&ccedil;&atilde;o, sendo praticamente ignorada, &eacute; uma amea&ccedil;a rea
l &agrave; sa&uacute;de coletiva e que n&atilde;o deve ser subestimada, sobretud
o em &aacute;reas subdesenvolvidas.</font></p>     ^cY#aop06-11.htm##
01228000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704098200087002001301069#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#71#67#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Apesar da limita&ccedil;&
atilde;o do desenho deste estudo, que s&oacute; possibilita medir efeito para um
a exposi&ccedil;&atilde;o ocorrida no passado, pode-se afirmar que os resultados
 obtidos nesta pesquisa, aliados &agrave; informa&ccedil;&atilde;o sobre os 10 a
nos sem confirma&ccedil;&atilde;o de caso humano, e dois anos sem a indica&ccedi
l;&atilde;o da presen&ccedil;a da infec&ccedil;&atilde;o em animais, n&atilde;o 
inspiram a certeza de que a doen&ccedil;a est&aacute; sob absoluto controle, no 
Estado da Bahia. Ao contr&aacute;rio, a hist&oacute;ria demonstra ser mais prov&
aacute;vel que a peste esteja atravessando um per&iacute;odo de sil&ecirc;ncio, 
sem que se possa determinar at&eacute; quando. N&atilde;o h&aacute; como erradic
ar a doen&ccedil;a, visto que est&aacute; amplamente difundida entre os reservat
&oacute;rios silvestres que, por sua vez, n&atilde;o podem ser eliminados.</font
></p>     ^cY#aop06-11.htm##
00793000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054700087002001300634#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#72#68#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A qualquer momento, por r
az&otilde;es e mecanismos ainda desconhecidos, a peste pode reaparecer e atingir
 o homem na sua forma epid&ecirc;mica. Por isso, deve ser permanentemente tratad
a como um problema atual e merecedor de aten&ccedil;&atilde;o cont&iacute;nua, c
om manuten&ccedil;&atilde;o de uma vigil&acirc;ncia ativa e permanente para dete
c&ccedil;&atilde;o precoce da doen&ccedil;a, permitindo o desencadeamento imedia
to das medidas de controle pertinentes.</font></p>     ^cY#aop06-11.htm##
01389000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704114300087002001301230#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#73#69#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Em conclus&atilde;o, a re
du&ccedil;&atilde;o ou descontinuidade da vigil&acirc;ncia, bem como a pobreza e
 a insalubridade, podem vir a serem fatores de influ&ecirc;ncia no ressurgimento
 de casos humanos, uma vez que permitem a intensifica&ccedil;&atilde;o do contat
o com roedores infectados e pulgas. Altera&ccedil;&otilde;es de ambiente, como m
udan&ccedil;as clim&aacute;ticas, desmatamento e urbaniza&ccedil;&atilde;o, indu
zem mudan&ccedil;as em popula&ccedil;&otilde;es de pulgas e roedores, al&eacute;
m de alterarem os habitats dos roedores. O surgimento de novos vetores, reservat
&oacute;rios e rearranjos gen&ocirc;micos da <i>Y. pestis </i>tamb&eacute;m pode
m desencadear o aparecimento de novos e inesperados surtos. Contudo, existe gran
de possibilidade da combina&ccedil;&atilde;o entre mais de um desses fatores ori
ginarem o ressurgimento da infec&ccedil;&atilde;o. Sendo assim, torna-se fundame
ntal concentrar as a&ccedil;&otilde;es de monitoramento, vigil&acirc;ncia e cont
role dentro de uma l&oacute;gica biol&oacute;gica e ambiental<sup>19</sup>.</fon
t></p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#74#70#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#75#71#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>AGRADECIMENTOS</b></fo
nt></p>     ^cY#aop06-11.htm##
00891000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064500087002001300732#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#76#72#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Ao Servi&ccedil;o de Refe
r&ecirc;ncia em Peste (SRP), no Centro de Pesquisa Aggeu Magalh&atilde;es (CPqAM
) da Funda&ccedil;&atilde;o Oswaldo Cruz (FIOCRUZ), em Recife/PE, onde foram exe
cutadas as an&aacute;lises sorol&oacute;gicas. Ao Laborat&oacute;rio de Refer&ec
irc;ncia Estadual para Peste no munic&iacute;pio de Feira de Santana/BA, onde se
 realizou a pesquisa da <i>Y. pestis </i>em pulgas e roedores. &Agrave; equipe d
o Programa de Controle da Peste da Secretaria de Sa&uacute;de do Estado da Bahia
 pelo imprescind&iacute;vel apoio nos trabalhos de campo.</font></p>     ^cY#aop
06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#77#73#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#78#74#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLITO DE INTERESSE<
/b></font></p>     ^cY#aop06-11.htm##
00432000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018600087002001300273#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#79#75#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os autores declaram n&ati
lde;o haver nenhum tipo de conflito de interesse no desenvolvimento do estudo.</
font></p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#80#76#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010800087002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#81#77#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>SUPORTE FINANCEIRO</b>
</font></p>     ^cY#aop06-11.htm##
00375000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704012900087002001300216#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#82#78#article#128#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Secretaria de Sa&uacute;d
e do Estado da Bahia.</font></p>     ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#83#79#article#128#<p>&nbsp
;</p>     ^cY#aop06-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#84#80#article#128#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b><
/font></p>     ^cY#aop06-11.htm##
00471000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021100089002001300300#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#85#81#article#
128#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Gage KL,
 Kosoy MY. The natural history of Plague: Perspectives from more than a century 
of research. Ann Rev Entomology 2004; 50:505-528.    ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#86#82#article#128#</font><
/p>     ^cY#aop06-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022400089002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#87#83#article#
128#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Higgins 
R. Emerging or re-emerging bacterial zoonotic diseases: bartonellosis, leptospir
osis, Lyme borreliosis, plague. Rev Sci Tech 2004; 23:569-581.    ^cY#aop06-11.h
tm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#88#84#article#128#</font><
/p>     ^cY#aop06-11.htm##
00650000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704039000089002001300479#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#89#85#article#
128#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Minist&e
acute;rio da Sa&uacute;de. Secretaria de Vigil&acirc;ncia em Sa&uacute;de. Manua
l de Vigil&acirc;ncia Epidemiol&oacute;gica e Controle da Peste. S&eacute;rie A.
 Normas e Manuais T&eacute;cnicos. Bras&iacute;lia: Departamento de Vigil&acirc;
ncia Epidemiol&oacute;gica. Minist&eacute;rio da Sa&uacute;de; 2008.    ^cY#aop0
6-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#90#86#article#128#</font><
/p>     ^cY#aop06-11.htm##
00472000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021200089002001300301#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#91#87#article#
128#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Stenseth
 NC, Atshabar BB, Begon M, Belmain SR, Bertherat C, Gage KL, et al. Plague: past
, present, and future. PLoS Medicine 2008; 5:9-13.    ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#92#88#article#128#</font><
/p>     ^cY#aop06-11.htm##
00504000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024400089002001300333#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#93#89#article#
128#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Baltazar
d M. Viagem de estudo ao Brasil para a organiza&ccedil;&atilde;o de um projeto d
e pesquisas sobre a peste. Rev Bras Malariol Doen&ccedil;as Trop 1968; 20:335-36
6.    ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#94#90#article#128#</font><
/p>     ^cY#aop06-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704025800089002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#95#91#article#
128#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Arag&ati
lde;o AI, Pontes RJS, Seoane ACM, Nascimento OJ, Tavares C, Almeida AMP. Tend&ec
irc;ncia secular da peste no Estado do Cear&aacute;, Brasil. Cad Saude Publica 2
007; 23:715-724.    ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#96#92#article#128#</font><
/p>     ^cY#aop06-11.htm##
00554000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029400089002001300383#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#97#93#article#
128#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Almeida 
AMP, Brasil DP, Leal NC, Melo MEB, R&ecirc;go RVB, Almeida CR. Estudos bacteriol
&oacute;gicos e sorol&oacute;gicos de um surto de peste no Estado da Para&iacute
;ba, Brasil. Mem Inst Oswaldo Cruz 1989; 84:249-256.    ^cY#aop06-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#98#94#article#128#</font><
/p>     ^cY#aop06-11.htm##
00560000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030000089002001300389#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#99#95#article#
128#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Almeida 
AMP, Brasil DP, Melo MEB, Leal NC, Almeida CR. Import&acirc;ncia dos carn&iacute
;voros dom&eacute;sticos (c&atilde;es e gatos) na epidemiologia da peste nos foc
os do Nordeste do Brasil. Cad Saude Publica 1988; 1:49-55.    ^cY#aop06-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#100#96#article#128#</font>
</p>     ^cY#aop06-11.htm##
00476000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704021500090002001300305#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#101#97#article
#128#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Rust Jr
 JH, Cavanaugh DC, O'Shita R, Marshall Jr JD. The role of domestic animals in th
e epidemiology of plague. J Inf Dis 1971; 124:527-531.    ^cY#aop06-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#102#98#article#128#</font>
</p>     ^cY#aop06-11.htm##
00517000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704025500091002001300346#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#103#99#article
#128#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Almei
da AMP, Souza GT, Santos S, Silva SC, Petrib&uacute; MMV, Haver PO, et al. Contr
ibui&ccedil;&atilde;o para o diagn&oacute;stico de peste. Rev Soc Bras Med Trop 
2007; 40:53-55.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#104#100#article#128#</font
></p>     ^cY#aop06-11.htm##
00498000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023500092002001300327#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#105#101#articl
e#128#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Worl
d Health Organization. International meeting on prevention and controlling plagu
e: the old calamity still has a future. Wkly Epidemiol Rec 2006; 81:278-284.    
^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#106#102#article#128#</font
></p>     ^cY#aop06-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#107#103#articl
e#128#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Dupl
antier JC, Duchemin JB, Chanteau S, Carniel E. From the recent lessons of the Ma
lagasy foci towards a global understanding of the factors involved in plague ree
mergence. Vet Res 2005; 36:437-453.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#108#104#article#128#</font
></p>     ^cY#aop06-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020500092002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#109#105#articl
e#128#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Worl
d Health Organization. Human plague: review of regional morbidity and mortality,
 2004-2009. Wkly Epidemiol Rec 2010; 85:40-45.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#110#106#article#128#</font
></p>     ^cY#aop06-11.htm##
00478000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021500092002001300307#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#111#107#articl
e#128#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Eise
n RJ, Gage KL. Adaptive strategies of <i>Yersinia pestis </i>to persist during i
nterepizootic and epizootic periods. Vet Res 2009; 40:1.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#112#108#article#128#</font
></p>     ^cY#aop06-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026900092002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#113#109#articl
e#128#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Gali
mand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, et al. Mult
idrug resistance in <i>Yersinia pestis </i>mediated by a transferable plasmid. N
 Engl J Med 1997; 337:677-680.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#114#110#article#128#</font
></p>     ^cY#aop06-11.htm##
00506000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024300092002001300335#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#115#111#articl
e#128#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Sten
seth NC, Samia NI, Viljugrein H, Kausrud KL, Begon M, Davis S, et al. Plague dyn
amics are driven by climate variation. Proc Natl Acad Sci USA 2006; 103:13110-13
115.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#116#112#article#128#</font
></p>     ^cY#aop06-11.htm##
00531000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026800092002001300360#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#117#113#articl
e#128#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. D&aa
cute;valos VA, Torres MA, Mauricci CO, Laguna-Torres VA, Chinarro MP. Surto de P
este bub&ocirc;nica na localidade de Jacocha, Huancabamba, Per&uacute;. Rev Soc 
Bras Med Trop 2001; 34:87-90.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#118#114#article#128#</font
></p>     ^cY#aop06-11.htm##
00437000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017400092002001300266#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#119#115#articl
e#128#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Ruiz
 A. Plague in the Americas. Pan American Health Organization. Emerg Infect Dis 2
001; 7:539-540.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#120#116#article#128#</font
></p>     ^cY#aop06-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#121#117#articl
e#128#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Dupl
antier JC, Duchemin JB, Chanteau S, Carniel E. From the recent lessons of the Ma
lagasy foci towards a global understanding of the factors involved in plague ree
mergence. Vet Res 2005; 36:437-453.    ^cY#aop06-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#122#118#article#128#</font
></p>     ^cY#aop06-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#123#119#article#128#<p>&nb
sp;</p>     ^cY#aop06-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#124#120#article#128#<p>&nb
sp;</p>     ^cY#aop06-11.htm##
00474000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704022600089002001300315#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#125#121#article#128#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota1"></a><a 
href="#nota_1"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a
> <b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#aop06-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004200089002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#126#122#article#128#<br>  
 Dr. Ramon da Costa Saavedra    ^cY#aop06-11.htm##
00301000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005300089002001300142#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#127#123#article#128#<br>  
 Rua Met&oacute;dio Coelho 55, Cidadela    ^cY#aop06-11.htm##
00285000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003700089002001300126#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#128#124#article#128#<br>  
 40279-120 Salvador, BA    ^cY#aop06-11.htm##
00300000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005200089002001300141#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#129#125#article#128#<br>  
 Tel: 55 71 3116-0018; 55 71 3116-0037    ^cY#aop06-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010500089002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#130#126#article#128#<br>  
 e-mail: <a href="mailto:saavedra@saude.ba.gov.br">saavedra@saude.ba.gov.br</a><
/font></p>     ^cY#aop06-11.htm##
00371000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704012300089002001300212#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#131#127#article#128#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Recebido para publica&c
cedil;&atilde;o em 20/08/2010    ^cY#aop06-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#p#132#128#article#128#<br>  
 Aceito em 17/11/2010</font></p>     ^cY#aop06-11.htm##
00538000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100016001030120
08500119030001900204710000200223065000900225064000500234031000300239014000800242
865000900250002001300259#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
06-11.htm#S#c#133#1#article#19#1#^rND^sGage^nKL#^rND^sKosoy^nMY#The natural hist
ory of Plague: Perspectives from more than a century of research^len#Ann Rev Ent
omology#2#20040000#2004#50#505-528#20110000#aop06-11.htm##
00566000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880120112001050300
01300217065000900230064000500239031000300244014000800247865000900255002001300264
035001000277801001300287#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
06-11.htm#S#c#134#2#article#19#2#^rND^sHiggins^nR#Emerging or re-emerging bacter
ial zoonotic diseases: bartonellosis, leptospirosis, Lyme borreliosis, plague^le
n#Rev Sci Tech#20040000#2004#23#569-581#20110000#aop06-11.htm#0253-1933#Rev Sci 
Tech##
00588000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170055000880180096001430660
00900239062004200248062002000290065000900310064000500319865000900324002001300333
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#135#3#arti
cle#19#3#Ministério da Saúde^dSecretaria de Vigilância em Saúde#Manual de Vigilâ
ncia Epidemiológica e Controle da Peste. Série A: Normas e Manuais Técnicos^lpt#
Brasília#Departamento de Vigilância Epidemiológica#Ministério da Saúde#20080000#
2008#20110000#aop06-11.htm##
00622000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100019001070100
01500126010001800141010001900159010001500178810000600193012003800199030001400237
71000020025106500090025306400050026203100020026701400050026986500090027400200130
0283#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#136#4#
article#19#4#^rND^sStenseth^nNC#^rND^sAtshabar^nBB#^rND^sBegon^nM#^rND^sBelmain^
nSR#^rND^sBertherat^nC#^rND^sGage^nKL#et al#Plague: past, present, and future^le
n#PLoS Medicine#2#20080000#2008#5#9-13#20110000#aop06-11.htm##
00532000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880120091001070300
03100198710000200229065000900231064000500240031000300245014000800248865000900256
002001300265#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#
c#137#5#article#19#5#^rND^sBaltazard^nM#Viagem de estudo ao Brasil para a organi
zação de um projeto de pesquisas sobre a peste^lpt#Rev Bras Malariol Doenças Tro
p#2#19680000#1968#20#335-366#20110000#aop06-11.htm##
00675000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100018001050100
01800123010002100141010001700162010001900179012005800198030001800256065000900274
06400050028303100030028801400080029186500090029900200130030803500100032180100180
0331#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#138#6#
article#19#6#^rND^sAragão^nAI#^rND^sPontes^nRJS#^rND^sSeoane^nACM#^rND^sNascimen
to^nOJ#^rND^sTavares^nC#^rND^sAlmeida^nAMP#Tendência secular da peste no Estado 
do Ceará, Brasil^lpt#Cad Saude Publica#20070000#2007#23#715-724#20110000#aop06-1
1.htm#0102-311X#Cad Saude Publica##
00707000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100017001070100
01500124010001600139010001600155010001800171012009100189030002200280065000900302
06400050031103100030031601400080031986500090032700200130033603500100034980100220
0359#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#139#7#
article#19#7#^rND^sAlmeida^nAMP#^rND^sBrasil^nDP#^rND^sLeal^nNC#^rND^sMelo^nMEB#
^rND^sRêgo^nRVB#^rND^sAlmeida^nCR#Estudos bacteriológicos e sorológicos de um su
rto de peste no Estado da Paraíba, Brasi^lpt#Mem Inst Oswaldo Cruz#19890000#1989
#84#249-256#20110000#aop06-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00692000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100017001070100
01600124010001500140010001800155012011500173030001800288065000900306064000500315
031000200320014000600322865000900328002001300337035001000350801001800360#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#140#8#article#19#.
#^rND^sAlmeida^nAMP#^rND^sBrasil^nDP#^rND^sMelo^nMEB#^rND^sLeal^nNC#^rND^sAlmeid
a^nCR#Importância dos carnívoros domésticos (cães e gatos) na epidemiologia da p
este nos focos do Nordeste do Brasil^lpt#Cad Saude Publica#19880000#1988#1#49-55
#20110000#aop06-11.htm#0102-311X#Cad Saude Publica##
00578000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100020001060100
01700126010002200143012006300165030001000228710000200238065000900240064000500249
031000400254014000800258865000900266002001300275#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop06-11.htm#S#c#141#9#article#19#9#^rND^sRust Jr^nJH#^rND^
sCavanaugh^nDC#^rND^sO'Shita^nR#^rND^sMarshall Jr^nJD#The role of domestic anima
ls in the epidemiology of plague^len#J Inf Dis#2#19710000#1971#124#527-531#20110
000#aop06-11.htm##
00680000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
01600125010001600141010001900157010001600176810000600192012004500198030002200243
06500090026506400050027403100030027901400060028286500090028800200130029703500100
0310801002200320#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.ht
m#S#c#142#10#article#19#10#^rND^sAlmeida^nAMP#^rND^sSouza^nGT#^rND^sSantos^nS#^r
ND^sSilva^nSC#^rND^sPetribú^nMMV#^rND^sHaver^nPO#et al#Contribuição para o diagn
óstico de peste^lpt#Rev Soc Bras Med Trop#20070000#2007#40#53-55#20110000#aop06-
11.htm#0037-8682#Rev Soc Bras Med Trop##
00577000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870110026000900120100001160300
01900216065000900235064000500244031000300249014000800252865000900260002001300269
035001000282801001900292#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
06-11.htm#S#c#143#11#article#19#11#World Health Organization#International meeti
ng on prevention and controlling plague: the old calamity still has a future^len
#Wkly Epidemiol Rec#20060000#2006#81#278-284#20110000#aop06-11.htm#0049-8114#Wkl
y Epidemiol Rec##
00666000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100019001110100
01800130010001700148012012600165030000800291065000900299064000500308031000300313
014000800316865000900324002001300333035001000346801000800356#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#144#12#article#19#12#^rND^sDup
lantier^nJC#^rND^sDuchemin^nJB#^rND^sChanteau^nS#^rND^sCarniel^nE#From the recen
t lessons of the Malagasy foci towards a global understanding of the factors inv
olved in plague reemergence^len#Vet Res#20050000#2005#36#437-453#20110000#aop06-
11.htm#0928-4249#Vet Res##
00547000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870110026000900120072001160300
01900188065000900207064000500216031000300221014000600224865000900230002001300239
035001000252801001900262#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
06-11.htm#S#c#145#13#article#19#13#World Health Organization#Human plague: revie
w of regional morbidity and mortality, 2004-2009^len#Wkly Epidemiol Rec#20100000
#2010#85#40-45#20110000#aop06-11.htm#0049-8114#Wkly Epidemiol Rec##
00564000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060120
09800121030000800219065000900227064000500236031000300241014000200244865000900246
002001300255035001000268801000800278#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop06-11.htm#S#c#146#14#article#19#14#^rND^sEisen^nRJ#^rND^sGage^nKL#Ad
aptive strategies of Yersinia pestis to persist during interepizootic and epizoo
tic periods^len#Vet Res#20090000#2009#40#1#20110000#aop06-11.htm#0928-4249#Vet R
es##
00706000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
01700126010002100143010001800164010001700182810000600199012007900205030001300284
06500090029706400050030603100040031101400080031586500090032300200130033203500100
0345801001300355#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.ht
m#S#c#147#15#article#19#15#^rND^sGalimand^nM#^rND^sGuiyoule^nA#^rND^sGerbaud^nG#
^rND^sRasoamanana^nB#^rND^sChanteau^nS#^rND^sCarniel^nE#et al#Multidrug resistan
ce in Yersinia pestis mediated by a transferable plasmid^len#N Engl J Med#199700
00#1997#337#677-680#20110000#aop06-11.htm#0028-4793#N Engl J Med##
00697000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
02000125010001800145010001500163010001500178810000600193012005200199030002300251
06500090027406400050028303100040028801400120029286500090030400200130031303500100
0326801002300336#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.ht
m#S#c#148#16#article#19#16#^rND^sStenseth^nNC#^rND^sSamia^nNI#^rND^sViljugrein^n
H#^rND^sKausrud^nKL#^rND^sBegon^nM#^rND^sDavis^nS#et al#Plague dynamics are driv
en by climate variation^len#Proc Natl Acad Sci USA#20060000#2006#103#13110-13115
#20110000#aop06-11.htm#0027-8424#Proc Natl Acad Sci USA##
00672000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01900125010002400144010001900168012007200187030002200259065000900281064000500290
031000300295014000600298865000900304002001300313035001000326801002200336#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#149#17#article#19#
17#^rND^sDávalos^nVA#^rND^sTorres^nMA#^rND^sMauricci^nCO#^rND^sLaguna-Torres^nVA
#^rND^sChinarro^nMP#Surto de Peste bubônica na localidade de Jacocha, Huancabamb
a, Perú^lpt#Rev Soc Bras Med Trop#20010000#2001#34#87-90#20110000#aop06-11.htm#0
037-8682#Rev Soc Bras Med Trop##
00521000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900120061001040300
01700165065000900182064000500191031000200196014000800198865000900206002001300215
035001000228801001700238#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
06-11.htm#S#c#150#18#article#19#18#^rND^sRuiz^nA#Plague in the Americas: Pan Ame
rican Health Organization^lpt#Emerg Infect Dis#20010000#2001#7#539-540#20110000#
aop06-11.htm#1080-6040#Emerg Infect Dis##
00666000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100019001110100
01800130010001700148012012600165030000800291065000900299064000500308031000300313
014000800316865000900324002001300333035001000346801000800356#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop06-11.htm#S#c#151#19#article#19#19#^rND^sDup
lantier^nJC#^rND^sDuchemin^nJB#^rND^sChanteau^nS#^rND^sCarniel^nE#From the recen
t lessons of the Malagasy foci towards a global understanding of the factors inv
olved in plague reemergence^len#Vet Res#20050000#2005#36#437-453#20110000#aop06-
11.htm#0928-4249#Vet Res##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#o#1#
1#article#1#20110325#103629#aop07-11.htm#121##
04637000000000709000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101121000300106049000300109158000300112030002700115
03200060014206500090014801400070015703500100016422300090017401200930018301200990
02760100040003750100046004150100032004610100043004930100028005360100032005640700
13000596070012000726083131800846085000802164085002802172085002902200085001802229
08500260224708500240227308500220229708313740231908500080369308500280370108500310
37290850018037600850028037780850024038060850023038300580012038531170006038650720
00303871112000903874111001103883114000903894113001103903002001303914#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#h#2#1#article#1#oa#en#br
1.1#1#4.0#ILUS#07#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-86
82#20110401#Evaluation of pathogenic fungi occurrence in traumatogenic structure
s of freshwater fish^len#Avaliação da ocorrência de fungos patogênicos em estrut
uras traumatogênicas de peixes fluviais^lpt#^rND^1A01^nFabio Caetano Oliveira^sL
eme#^rND^1A01^nMarcos Mendes de Barros^sNegreiros#^rND^1A01^nFernando Akira^sKog
a#^rND^1A02^nSandra de Moraes Gimenes^sBosco#^rND^1A02^nEduardo^sBagagli#^rND^1A
01^nVidal^sHaddad Junior#Universidade Estadual Paulista^iA01^1Faculdade de Medic
ina de Botucatu^2Departamento de Dermatologia e Radioterapia^cBotucatu^sSP#Unive
rsidade Estadual Paulista^iA02^1Instituto de Biociências^2Departamento de Microb
iologia e Imunologia^cBotucatu^sSP#^len^aINTRODUCTION: Fungal infections in huma
n skin, such as sporotrichosis, can occur after fish induced trauma. This work a
imed to identify fungi in freshwater fish that are pathogenic to humans. METHODS
: Extraction of dental arches from Serrassalmus maculatus (piranha) and Hoplias 
malabaricus (wolf fish), stings from Pimelodus maculatus (mandis catfish), dorsa
l fin rays from Plagioscion spp. (corvina) and Tilapia spp., for culture in Myco
sel agar. Some cultures were submitted to DNA extraction for molecular identific
ation by sequencing ITS-5.8S rDNA. RESULTS: Cultures identified most yeast as Ca
ndida spp., while sequencing also permitted the identification of Phoma spp. and
 Yarrowia lipolytica. CONCLUSIONS: While the search for S. schenckii was negativ
e, the presence of fungus of the genera Phoma and Candida revealed the pathogeni
c potential of this infection route. The genus Phoma is involved in certain form
s of phaeohyphomycosis, a subcutaneous mycosis caused by dematiaceous fungi, wit
h reports of infections in human organs and systems. Traumatizing structures of 
some freshwater fish present pathogenic fungi and this may be an important infec
tion route that must be considered in some regions of Brazil, since there are a 
large number of a fisherman in constant contact with traumatogenic fish.#^dnd^i1
#^tm^len^kFreshwater fish^i1#^tm^len^kPathogenic fungi^i1#^tm^len^kPhoma^i1#^tm^
len^kHuman mycosis^i1#^tm^len^kCandida spp^i1#^tm^len^kFishermen^i1#^lpt^aINTROD
UÇÃO: Infecções fúngicas na pele humana (como a esporotricose) podem se manifest
ar após traumatismos por peixes. O objetivo deste trabalho é procurar fungos pat
ogênicos para o homem em peixes fluviais. MÉTODOS: Extração de arcadas dentárias
 Serrassalmus maculatus (piranha) e Hoplias malabaricus (traíra), ferrões de Pim
elodus maculatus (mandis), raios da nadadeira dorsal de Plagioscion spp. (corvin
a) e Tilapia spp. para a realização do cultivo em agar Mycosel. Algumas culturas
 foram submetidas à extração de DNA para a identificação molecular pelo seqüenci
amento da região ITS-5.8S do rDNA. RESULTADOS: As culturas mostraram que a maior
ia das leveduras era Candida spp. e o sequenciamento também permitiu a identific
ação de Phoma spp. e Yarrowia lipolytica. CONCLUSÕES: Embora a pesquisa para S. 
schenckii tenha sido negativa, a presença de fungos do gênero Phoma e Candida re
vela o potencial patogênico desta via de infecção. O gênero Phoma está envolvido
 em alguns casos de feohifomicoses, micoses subcutâneas causadas por fungos dema
tiáceos com relatos de infecções em órgãos e sistemas humanos. As estruturas tra
umatizantes de alguns peixes fluviais apresentam fungos patogênicos e esta pode 
ser uma importante via de infecção que deve ser considerada em algumas regiões d
o Brasil, uma vez que há um grande número de pescadores e peixes traumatogênicos
.#^dnd^i2#^tm^lpt^kPeixes fluviais^i2#^tm^lpt^kFungos patogênicos^i2#^tm^lpt^kPh
oma^i2#^tm^lpt^kMicoses humanas^i2#^tm^lpt^kCandida spp^i2#^tm^lpt^kPescadores^i
2#CNPq^dPIBIC#other#14#20100914#14/09/2010#20101124#24/11/2010#aop07-11.htm##
04903000000000709000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101121000300106049000300109158000300112030002700115
03200060014206500090014801400070015703500100016422300090017401201000018301201060
02830100040003890100046004290100032004750100043005070100028005500100032005780700
13000610070012000740083143000860085000802290085002802298085002902326085002502355
08500260238008500310240608500220243708314860245908500080394508500280395308500310
39810850025040120850028040370850031040650850023040960580012041191170006041310720
00304137112000904140111001104149114000904160113001104169002001304180#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#f#3#1#article#1#oa#en#br
1.1#1#4.0#ILUS#07#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-86
82#20110401#<b>Evaluation of pathogenic fungi occurrence in traumatogenic struct
ures of freshwater fish</b>^len#<b>Avaliação da ocorrência de fungos patogênicos
 em estruturas traumatogênicas de peixes fluviais</b>^lpt#^rND^1A01^nFabio Caeta
no Oliveira^sLeme#^rND^1A01^nMarcos Mendes de Barros^sNegreiros#^rND^1A01^nFerna
ndo Akira^sKoga#^rND^1A02^nSandra de Moraes Gimenes^sBosco#^rND^1A02^nEduardo^sB
agagli#^rND^1A01^nVidal^sHaddad Junior#Universidade Estadual Paulista^iA01^1Facu
ldade de Medicina de Botucatu^2Departamento de Dermatologia e Radioterapia^cBotu
catu^sSP#Universidade Estadual Paulista^iA02^1Instituto de Biociências^2Departam
ento de Microbiologia e Imunologia^cBotucatu^sSP#^len^a<b>INTRODUCTION:</b> Fung
al infections in human skin, such as sporotrichosis, can occur after fish induce
d trauma. This work aimed to identify fungi in freshwater fish that are pathogen
ic to humans. <b>METHODS:</b> Extraction of dental arches from <i>Serrassalmus m
aculatus </i>(piranha) and <i>Hoplias malabaricus </i>(wolf fish), stings from <
i>Pimelodus maculatus </i>(mandis catfish), dorsal fin rays from <i>Plagioscion 
</i>spp. (corvina) and <i>Tilapia </i>spp., for culture in Mycosel agar. Some cu
ltures were submitted to DNA extraction for molecular identification by sequenci
ng ITS-5.8S rDNA. <b>RESULTS:</b> Cultures identified most yeast as <i>Candida <
/i>spp., while sequencing also permitted the identification of <i>Phoma </i>spp.
 and <i>Yarrowia lipolytica</i>. <b>CONCLUSIONS: </b>While the search for <i>S. 
schenckii </i>was negative, the presence of fungus of the genera <i>Phoma </i>an
d <i>Candida </i>revealed the pathogenic potential of this infection route. The 
genus <i>Phoma </i>is involved in certain forms of phaeohyphomycosis, a subcutan
eous mycosis caused by dematiaceous fungi, with reports of infections in human o
rgans and systems. Traumatizing structures of some freshwater fish present patho
genic fungi and this may be an important infection route that must be considered
 in some regions of Brazil, since there are a large number of a fisherman in con
stant contact with traumatogenic fish.#^dnd^i1#^tm^len^kFreshwater fish^i1#^tm^l
en^kPathogenic fungi^i1#^tm^len^k<i>Phoma</i>^i1#^tm^len^kHuman mycosis^i1#^tm^l
en^k<i>Candida </i>spp^i1#^tm^len^kFishermen^i1#^lpt^a<b>INTRODUÇÃO: </b>Infecçõ
es fúngicas na pele humana (como a esporotricose) podem se manifestar após traum
atismos por peixes. O objetivo deste trabalho é procurar fungos patogênicos para
 o homem em peixes fluviais. <b>MÉTODOS: </b>Extração de arcadas dentárias <i>Se
rrassalmus maculatus </i>(piranha) e <i>Hoplias malabaricus </i>(traíra), ferrõe
s de <i>Pimelodus maculatus </i>(mandis), raios da nadadeira dorsal de <i>Plagio
scion </i>spp. (corvina) e <i>Tilapia </i>spp. para a realização do cultivo em a
gar Mycosel. Algumas culturas foram submetidas à extração de DNA para a identifi
cação molecular pelo seqüenciamento da região ITS-5.8S do rDNA. <b>RESULTADOS: <
/b>As culturas mostraram que a maioria das leveduras era <i>Candida </i>spp. e o
 sequenciamento também permitiu a identificação de <i>Phoma </i>spp. e <i>Yarrow
ia lipolytica</i>. <b>CONCLUSÕES: </b>Embora a pesquisa para <i>S. schenckii </i
>tenha sido negativa, a presença de fungos do gênero <i>Phoma</i> e <i>Candida <
/i>revela o potencial patogênico desta via de infecção. O gênero <i>Phoma </i>es
tá envolvido em alguns casos de feohifomicoses, micoses subcutâneas causadas por
 fungos dematiáceos com relatos de infecções em órgãos e sistemas humanos. As es
truturas traumatizantes de alguns peixes fluviais apresentam fungos patogênicos 
e esta pode ser uma importante via de infecção que deve ser considerada em algum
as regiões do Brasil, uma vez que há um grande número de pescadores e peixes tra
umatogênicos.#^dnd^i2#^tm^lpt^kPeixes fluviais^i2#^tm^lpt^kFungos patogênicos^i2
#^tm^lpt^k<i>Phoma</i>^i2#^tm^lpt^kMicoses humanas^i2#^tm^lpt^k<i>Candida</i> sp
p^i2#^tm^lpt^kPescadores^i2#CNPq^dPIBIC#other#14#20100914#14/09/2010#20101124#24
/11/2010#aop07-11.htm##
04760000000000733000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000500108121000300113049000300116158000300119
03000260012203200060014806500090015401400070016303500100017022300090018001200930
01890120099002820100040003810100046004210100032004670100043004990100028005420100
03200570070013200602070012200734083131800856085000802174085002802182085002902210
08500180223908500260225708500240228308500220230708313740232908500080370308500280
37110850031037390850018037700850028037880850024038160850023038400580012038631170
00603875072000303881112000903884111001103893114000903904113001103913002001303924
008008903937#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#
l#4#1#article#1#^a2011#oa#en#br1.1#1#4.0#ilus#07#nd#nd#Rev. Soc. Bras. Med. Trop
#ahead#20110000#^f0^l0#0037-8682#20110401#Evaluation of pathogenic fungi occurre
nce in traumatogenic structures of freshwater fish^len#Avaliação da ocorrência d
e fungos patogênicos em estruturas traumatogênicas de peixes fluviais^lpt#^rND^1
A01^nFabio Caetano Oliveira^sLeme#^rND^1A01^nMarcos Mendes de Barros^sNegreiros#
^rND^1A01^nFernando Akira^sKoga#^rND^1A02^nSandra de Moraes Gimenes^sBosco#^rND^
1A02^nEduardo^sBagagli#^rND^1A01^nVidal^sHaddad Junior#^iA01^1Universidade Estad
ual Paulista^2Faculdade de Medicina de Botucatu^3Departamento de Dermatologia e 
Radioterapia^cBotucatu^sSP#^iA02^1Universidade Estadual Paulista^2Instituto de B
iociências^3Departamento de Microbiologia e Imunologia^cBotucatu^sSP#^len^aINTRO
DUCTION: Fungal infections in human skin, such as sporotrichosis, can occur afte
r fish induced trauma. This work aimed to identify fungi in freshwater fish that
 are pathogenic to humans. METHODS: Extraction of dental arches from Serrassalmu
s maculatus (piranha) and Hoplias malabaricus (wolf fish), stings from Pimelodus
 maculatus (mandis catfish), dorsal fin rays from Plagioscion spp. (corvina) and
 Tilapia spp., for culture in Mycosel agar. Some cultures were submitted to DNA 
extraction for molecular identification by sequencing ITS-5.8S rDNA. RESULTS: Cu
ltures identified most yeast as Candida spp., while sequencing also permitted th
e identification of Phoma spp. and Yarrowia lipolytica. CONCLUSIONS: While the s
earch for S. schenckii was negative, the presence of fungus of the genera Phoma 
and Candida revealed the pathogenic potential of this infection route. The genus
 Phoma is involved in certain forms of phaeohyphomycosis, a subcutaneous mycosis
 caused by dematiaceous fungi, with reports of infections in human organs and sy
stems. Traumatizing structures of some freshwater fish present pathogenic fungi 
and this may be an important infection route that must be considered in some reg
ions of Brazil, since there are a large number of a fisherman in constant contac
t with traumatogenic fish.#^dnd^i1#^tm^len^kFreshwater fish^i1#^tm^len^kPathogen
ic fungi^i1#^tm^len^kPhoma^i1#^tm^len^kHuman mycosis^i1#^tm^len^kCandida spp^i1#
^tm^len^kFishermen^i1#^lpt^aINTRODUÇÃO: Infecções fúngicas na pele humana (como 
a esporotricose) podem se manifestar após traumatismos por peixes. O objetivo de
ste trabalho é procurar fungos patogênicos para o homem em peixes fluviais. MÉTO
DOS: Extração de arcadas dentárias Serrassalmus maculatus (piranha) e Hoplias ma
labaricus (traíra), ferrões de Pimelodus maculatus (mandis), raios da nadadeira 
dorsal de Plagioscion spp. (corvina) e Tilapia spp. para a realização do cultivo
 em agar Mycosel. Algumas culturas foram submetidas à extração de DNA para a ide
ntificação molecular pelo seqüenciamento da região ITS-5.8S do rDNA. RESULTADOS:
 As culturas mostraram que a maioria das leveduras era Candida spp. e o sequenci
amento também permitiu a identificação de Phoma spp. e Yarrowia lipolytica. CONC
LUSÕES: Embora a pesquisa para S. schenckii tenha sido negativa, a presença de f
ungos do gênero Phoma e Candida revela o potencial patogênico desta via de infec
ção. O gênero Phoma está envolvido em alguns casos de feohifomicoses, micoses su
bcutâneas causadas por fungos dematiáceos com relatos de infecções em órgãos e s
istemas humanos. As estruturas traumatizantes de alguns peixes fluviais apresent
am fungos patogênicos e esta pode ser uma importante via de infecção que deve se
r considerada em algumas regiões do Brasil, uma vez que há um grande número de p
escadores e peixes traumatogênicos.#^dnd^i2#^tm^lpt^kPeixes fluviais^i2#^tm^lpt^
kFungos patogênicos^i2#^tm^lpt^kPhoma^i2#^tm^lpt^kMicoses humanas^i2#^tm^lpt^kCa
ndida spp^i2#^tm^lpt^kPescadores^i2#CNPq^dPIBIC#other#14#20100914#14/09/2010#201
01124#24/11/2010#aop07-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=s
ci_arttext&pid=S0037-86822011005000007##
00443000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704019900085002001300284#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#5#1#article#103#<p><font s
ize="4" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota_1"></a><b>Eva
luation of pathogenic fungi occurrence in traumatogenic structures of freshwater
 fish</b></font></p>     ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#6#2#article#103#<p>&nbsp;<
/p>     ^cY#aop07-11.htm##
00460000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704021600085002001300301#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#7#3#article#103#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Avalia&ccedil;&atilde;o 
da ocorr&ecirc;ncia de fungos patog&ecirc;nicos em estruturas traumatog&ecirc;ni
cas de peixes fluviais</b></font></p>     ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#8#4#article#103#<p>&nbsp;<
/p>     ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#9#5#article#103#<p>&nbsp;<
/p>     ^cY#aop07-11.htm##
00562000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704031700086002001300403#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#10#6#article#103#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Fabio Caetano Oliveira 
Leme<sup>I</sup>; Marcos Mendes de Barros Negreiros<sup>I</sup>; Fernando Akira 
Koga<sup>I</sup>; Sandra de Moraes Gimenes Bosco<sup>II</sup>; Eduardo Bagagli<s
up>II</sup>; Vidal Haddad Junior<sup>I</sup></b></font></p>     ^cY#aop07-11.htm
##
00452000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704020700086002001300293#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#11#7#article#103#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Departamento d
e Dermatologia e Radioterapia, Faculdade de Medicina de Botucatu, Universidade E
stadual Paulista, Botucatu, SP    ^cY#aop07-11.htm##
00405000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704016000086002001300246#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#12#8#article#103#<br>   <s
up>II</sup>Departamento de Microbiologia e Imunologia, Instituto de Bioci&ecirc;
ncias, Universidade Estadual Paulista, Botucatu, SP</font></p>     ^cY#aop07-11.
htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011400086002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#13#9#article#103#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#nota1">Address t
o</a></font></p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#14#10#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#15#11#article#103#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop07-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#16#12#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop07-11.htm##
00515000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026900087002001300356#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#17#13#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b> Fung
al infections in human skin, such as sporotrichosis, can occur after fish induce
d trauma. This work aimed to identify fungi in freshwater fish that are pathogen
ic to humans.    ^cY#aop07-11.htm##
00664000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041800087002001300505#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#18#14#article#103#<br>   <
b>METHODS:</b> Extraction of dental arches from <i>Serrassalmus maculatus </i>(p
iranha) and <i>Hoplias malabaricus </i>(wolf fish), stings from <i>Pimelodus mac
ulatus </i>(mandis catfish), dorsal fin rays from <i>Plagioscion </i>spp. (corvi
na) and <i>Tilapia </i>spp., for culture in Mycosel agar. Some cultures were sub
mitted to DNA extraction for molecular identification by sequencing ITS-5.8S rDN
A.    ^cY#aop07-11.htm##
00435000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018900087002001300276#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#19#15#article#103#<br>   <
b>RESULTS:</b> Cultures identified most yeast as <i>Candida </i>spp., while sequ
encing also permitted the identification of <i>Phoma </i>spp. and <i>Yarrowia li
polytica</i>.    ^cY#aop07-11.htm##
00918000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704067200087002001300759#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#20#16#article#103#<br>   <
b>CONCLUSIONS: </b>While the search for <i>S. schenckii </i>was negative, the pr
esence of fungus of the genera <i>Phoma </i>and <i>Candida </i>revealed the path
ogenic potential of this infection route. The genus <i>Phoma </i>is involved in 
certain forms of phaeohyphomycosis, a subcutaneous mycosis caused by dematiaceou
s fungi, with reports of infections in human organs and systems. Traumatizing st
ructures of some freshwater fish present pathogenic fungi and this may be an imp
ortant infection route that must be considered in some regions of Brazil, since 
there are a large number of a fisherman in constant contact with traumatogenic f
ish.</font></p>     ^cY#aop07-11.htm##
00462000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021600087002001300303#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#21#17#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Freshwat
er fish. Pathogenic fungi. <i>Phoma</i>. Human mycosis. <i>Candida </i>spp. Fish
ermen.</font></p> <hr size="1" noshade>     ^cY#aop07-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#22#18#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop07-11.htm##
00586000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704034000087002001300427#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#23#19#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b>Infec&ccedil;&otilde;es f&uacute;ngicas na pele humana (como a esporotri
cose) podem se manifestar ap&oacute;s traumatismos por peixes. O objetivo deste 
trabalho &eacute; procurar fungos patog&ecirc;nicos para o homem em peixes fluvi
ais.    ^cY#aop07-11.htm##
00798000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055200087002001300639#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#24#20#article#103#<br>   <
b>M&Eacute;TODOS: </b>Extra&ccedil;&atilde;o de arcadas dent&aacute;rias <i>Serr
assalmus maculatus </i>(piranha) e <i>Hoplias malabaricus </i>(tra&iacute;ra), f
err&otilde;es de <i>Pimelodus maculatus </i>(mandis), raios da nadadeira dorsal 
de <i>Plagioscion </i>spp. (corvina) e <i>Tilapia </i>spp. para a realiza&ccedil
;&atilde;o do cultivo em agar Mycosel. Algumas culturas foram submetidas &agrave
; extra&ccedil;&atilde;o de DNA para a identifica&ccedil;&atilde;o molecular pel
o seq&uuml;enciamento da regi&atilde;o ITS-5.8S do rDNA.    ^cY#aop07-11.htm##
00476000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704023000087002001300317#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#25#21#article#103#<br>   <
b>RESULTADOS: </b>As culturas mostraram que a maioria das leveduras era <i>Candi
da </i>spp. e o sequenciamento tamb&eacute;m permitiu a identifica&ccedil;&atild
e;o de <i>Phoma </i>spp. e <i>Yarrowia lipolytica</i>.    ^cY#aop07-11.htm##
01048000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704080200087002001300889#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#26#22#article#103#<br>   <
b>CONCLUS&Otilde;ES: </b>Embora a pesquisa para <i>S. schenckii </i>tenha sido n
egativa, a presen&ccedil;a de fungos do g&ecirc;nero <i>Phoma</i> e <i>Candida <
/i>revela o potencial patog&ecirc;nico desta via de infec&ccedil;&atilde;o. O g&
ecirc;nero <i>Phoma </i>est&aacute; envolvido em alguns casos de feohifomicoses,
 micoses subcut&acirc;neas causadas por fungos demati&aacute;ceos com relatos de
 infec&ccedil;&otilde;es em &oacute;rg&atilde;os e sistemas humanos. As estrutur
as traumatizantes de alguns peixes fluviais apresentam fungos patog&ecirc;nicos 
e esta pode ser uma importante via de infec&ccedil;&atilde;o que deve ser consid
erada em algumas regi&otilde;es do Brasil, uma vez que h&aacute; um grande n&uac
ute;mero de pescadores e peixes traumatog&ecirc;nicos.</font></p>     ^cY#aop07-
11.htm##
00480000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704023400087002001300321#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#27#23#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves:</b> P
eixes fluviais. Fungos patog&ecirc;nicos. <i>Phoma. </i>Micoses humanas. <i>Cand
ida</i> spp. Pescadores.</font></p> <hr size="1" noshade>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#28#24#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#29#25#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#30#26#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop07-11.htm##
02327000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704208100087002001302168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#31#27#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Fungi are ubiquitous and 
are found in soil, water, vegetables, animals and in humans. Fungal species unde
rgo changes in incidence and according to location, season and air moisture cont
ent, as well as other variables<sup>1</sup>. The growth of fungi can be divided 
into two phases, vegetative and reproductive. Most of these microorganisms are m
ade up of microscopic filaments with well-defined cell walls called hyphae. Fung
i were classified as plants until 1969 and then inserted into a separate kingdom
 called Fungi. In fact, they are phylogenetically more closely related to animal
s than plants and some of them are responsible for infections in several tissues
. <i>Sporothrix schenckii </i>is an example of a fungus causing infections in hu
mans; it causes subcutaneous mycosis with acute or chronic evolution. Fungi are 
installed by previous injuries, such as scratches by sharp plant or animal struc
tures<sup>2,3</sup>. There are well documented infections transmitted by dog bit
es<sup>4</sup>, rats<sup>5 </sup>and other animals. Sporotrichosis has also been
 documented from handling fish, originally reported by Mayorga &amp; Caceres in 
1978<sup>6 </sup>and more recently in Brazil<sup>7,8</sup>. The incidence of acc
idents in river fishermen appears to be high, as observed in retrospective and p
rospective studies<sup>9</sup>. Poor working conditions and a lack of preventive
 measures are precipitating factors and the main fish species causing accidents 
are of commercial value and present traumatic structures or are venomous, such a
s mandis catfish, tilapia, tra&iacute;ras, piranhas and others. A large number o
f injuries and envenomings result in secondary fungal and bacterial infections t
hat require further study to develop improved treatment and preventive measures 
against these accidents in fishing communities<sup>10</sup>. The objectives of t
his communication were to research the possible presence of pathogenic fungi in 
common fish present in the nets of fluvial fishermen.</font></p>     ^cY#aop07-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#32#28#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#33#29#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>
     ^cY#aop07-11.htm##
01347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704110100087002001301188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#34#30#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Considering the cases of 
sporotrichosis reported by one of the authors<sup>7,8</sup>, this work aimed to 
verify the existence of <i>S. schenkii </i>and other potentially pathogenic fung
i in traumatogenic structures (stings, rays of fins and sharp teeth) of fish cit
ed as the most hazardous by local fishermen and documented as such in previous p
ublications<sup>9</sup>. The methods were applied in the same river where the ca
ses of sporotrichosis were previously identified, in the Piracicaba River, near 
the Tiet&ecirc; River, in the central region of the State of S&atilde;o Paulo, B
razil. In three samples collected on three mornings of daily routine work of the
 colony of fishermen, two specimens each of corvina or freshwater silver croaker
 (<i>Plagioscion squamosissimus</i>), piranha (<i>Serrasalmus maculatus</i>), do
g-fish (<i>Acestrothychus lacustris</i>), mandijuba or mandiamarelo catfish (<i>
Pimelodus maculatus</i>), tilapia (<i>Tilapia </i>spp.) and wolf fish (<i>Hoplia
s malabaricus</i>) were obtained.</font></p>     ^cY#aop07-11.htm##
00909000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704066300087002001300750#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#35#31#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A sterile scalpel blade w
as used to remove traumatic structures from each fish, which were then directly 
inoculated into culture medium: upper and lower dental arches from <i>Acestrothy
chus lacustris, Hoplias malabaricus </i>and <i>Serrassalmus maculatus</i>; dorsa
l fin rays from <i>Plagioscion squamosissimus </i>and <i>Tilapia </i>spp. and st
ingers from <i>Pimelodus maculatus </i><b>(<a href="#fig1">Figure 1</a>)</b>. Th
ese steps were conducted where the fish were captured, at the fishermen's colony
 on the Piracicaba River, close to the junction with the Tiet&ecirc; River.</fon
t></p>     ^cY#aop07-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#36#32#article#103#<p><a na
me="fig1"></a></p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#37#33#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#38#34#article#103#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop07-11_fig01.jpg"></p>     
^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#39#35#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00747000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050100087002001300588#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#40#36#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The cultures were duplica
ted and incubated at 25ºC and 35ºC. Cultures at 25ºC, close to ambient temperatu
re, were used to investigate fungal flora and assess possible changes in fungi m
orphology. Cultures at 35ºC were intended to investigate the possible presence o
f fungal pathogens, because this is closer to human body temperature and pathoge
nic fungi, such as <i>S. schenckii</i>, show increased tolerance to heat.</font>
</p>     ^cY#aop07-11.htm##
00929000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068300087002001300770#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#41#37#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The yeasts were isolated 
in the samples and maintained in Sabouraud Dextrose Agar (SDA) with subcultures 
every 15 days. During the final period, the yeasts were cultivated on CHROMagar-
<i>Candida </i>(CHROMagar-<i>Candida</i>, Difco&trade;), a differential culture 
medium for identifying <i>Candida albicans, Candida tropicalis, </i>and <i>Candi
da spp.</i>, by respectively developing green, blue, and pink colonies<sup>10</s
up>. The CHROMagar-<i>Candida </i>plates were divided and, following colony cult
ivation, were incubated up to 25ºC for a maximum of five days to observe stainin
g<sup>10</sup>.</font></p>     ^cY#aop07-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#42#38#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Ethical considerations
</b></font></p>     ^cY#aop07-11.htm##
00412000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704016600087002001300253#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#43#39#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The study was approved by
 Botucatu Medical School Animal Research Ethics Committee.</font></p>     ^cY#ao
p07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#44#40#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#45#41#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>
     ^cY#aop07-11.htm##
00625000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037900087002001300466#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#46#42#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><a href="#fig2">Figure
 2</a> </b>is a macroscopic view of the isolated colonies. Evaluation by CHORMag
ar<sup>TM</sup> enabled most of the yeasts to be classified. One isolate obtaine
d from <i>Tilapia </i>was classified as <i>C. tropicalis </i>(blue color; <b><a 
href="#fig2">Figure 2</a></b>).</font></p>     ^cY#aop07-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#47#43#article#103#<p><a na
me="fig2"></a></p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#48#44#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#49#45#article#103#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop07-11_fig02.jpg"></p>     
^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#50#46#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00850000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060400087002001300691#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#51#47#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">DNA extraction permitted 
high concentrations to be obtained, making it necessary to dilute samples for us
e in PCR reactions. The PCR reactions were all successful, demonstrating amplico
ns of approximately 400-650bp, as shown in <b><a href="#fig3">Figure 3</a></b>. 
These amplicons were purified and subjected to gene sequencing analysis to obtai
n the nucleotide sequence to compare with NCBI genomic databases (National Cente
r for Biotechnology Information) using BLAST (Basic Local Alignment Search Tool 
for nucleotide).</font></p>     ^cY#aop07-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#52#48#article#103#<p><a na
me="fig3"></a></p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#53#49#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#54#50#article#103#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop07-11_fig03.jpg"></p>     
^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#55#51#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00745000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049900087002001300586#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#56#52#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Nucleotide sequence analy
ses presented consistency with fungi of the genus <i>Phoma </i>spp. and <i>Yarro
wia lipolytica</i>, the latter is used in genetic engineering experiments and is
 currently reported as nonpathogenic, while the former is a pathogenic fungus as
sociated with diseases in various organs and human systems, primarily the skin. 
<i>Phoma</i> belongs to the group of phaeohyphomycosis<sup>11-14</sup>.</font></
p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#57#53#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#58#54#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font><
/p>     ^cY#aop07-11.htm##
01239000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704099300087002001301080#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#59#55#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Due the fact that this re
search was original, certain difficulties were experienced when identifying the 
fungi, even with positive cultures from various yeasts and the inclusion of CHOR
Magar-<i>Candida </i>to analyze the colonies, the molecular methods were very im
portant steps in helping to identify the microorganisms. While the association b
etween sporotrichosis and trauma caused by fish has strong supporting evidence<s
up>7-9</sup>, the search for <i>S. schenkii </i>was unsuccessfully. However, the
 identification of fungi of the <i>Phoma </i>genus reveals the pathogenic potent
ial of this infection route: this microorganism is still poorly known in medical
 circles, even though several reports exists of human illness associated with th
is fungus<sup>11-14</sup>, especially when iatrogenic states or immunosuppressio
n is also present, or pathological states, such as AIDS and heterologous transpl
ants.</font></p>     ^cY#aop07-11.htm##
00781000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053500087002001300622#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#60#56#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In conclusion, the trauma
tic structures of certain river fish contain <i>Candida </i>yeasts and DNA extra
ction, PCR reactions and ribosomal region DNA sequencing revealed the presence o
f fungus of the <i>Phoma genus </i>and the species <i>Yarrowia lipolytica. </i>F
urther studies are required to improve current understand of these and other fun
gi, especially when considering the large number of fishermen and potentially tr
aumatogenic fish in Brazil.</font></p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#61#57#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#62#58#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop07-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#63#59#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors declare that 
there is no conflict of interest.</font></p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#64#60#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#65#61#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>FINANCIAL SUPPORT</b><
/font></p>     ^cY#aop07-11.htm##
00494000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704024800087002001300335#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#66#62#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">F&aacute;bio Caetano Oliv
eira Leme and Marcos M. de B. Negreiros were awarded scientific initiation grant
s, PIBIC/CNPq (Scientific initiation scholarship recipient).</font></p>     ^cY#
aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#67#63#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#68#64#article#103#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop07-11.htm##
00427000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016700089002001300256#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#69#65#article#
103#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Lacaz CS
. Tratado de Micologia M&eacute;dica. 9ª ed. S&atilde;o Paulo: Editora Sarvier; 
2002.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#70#66#article#103#</font><
/p>     ^cY#aop07-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020800089002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#71#67#article#
103#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Powell K
E, Taylor A. Cutaneous sporotrichosis in forestry workers. Epidemic due to conta
minated sphagnum moss. JAMA 1978; 240:232-235.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#72#68#article#103#</font><
/p>     ^cY#aop07-11.htm##
00456000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704019600089002001300285#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#73#69#article#
103#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Kenyon E
M, Rusel LH, McMurray DN. Isolation of <i>Sporothrix schenckii </i>from potting 
soil. Mycopathologia 1984; 87:128.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#74#70#article#103#</font><
/p>     ^cY#aop07-11.htm##
00416000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704015600089002001300245#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#75#71#article#
103#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Rippon J
W. Medical Mycology. 3<sup>th</sup> ed. Philadelphia: W.B. Saunders; 1988.    ^c
Y#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#76#72#article#103#</font><
/p>     ^cY#aop07-11.htm##
00464000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020400089002001300293#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#77#73#article#
103#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Millingt
on FR, Leite EV. Esporotricose humana provavelmente transmitida por mordedura de
 rato. Rev Bras Clin Ter 1941; 10:389-394.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#78#74#article#103#</font><
/p>     ^cY#aop07-11.htm##
00450000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704019000089002001300279#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#79#75#article#
103#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Mayorga 
R, Caceres A. &Eacute;tude d'une zone d'endemie sporotrichosique au Guatemala. S
abouraudia 1978; 76:185-198.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#80#76#article#103#</font><
/p>     ^cY#aop07-11.htm##
00503000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024300089002001300332#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#81#77#article#
103#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Haddad J
r V, Miot HA, Bartoli LD, Cardoso AC, Camargo RMP. Localized lymphatic sporotric
hosis after fish-induced injury (<i>Tilapia </i>sp.). Med Mycol 2002; 40:425-427
.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#82#78#article#103#</font><
/p>     ^cY#aop07-11.htm##
00604000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704034400089002001300433#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#83#79#article#
103#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Haddad J
r V. Infec&ccedil;&otilde;es cut&acirc;neas e acidentes por animais traumatizant
es e venenosos ocorridos em aqu&aacute;rios comerciais e dom&eacute;sticos no Br
asil: descri&ccedil;&atilde;o de 18 casos e revis&atilde;o do tema. An Bras Derm
atol 2004; 79:157-167.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#84#80#article#103#</font><
/p>     ^cY#aop07-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022400089002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#85#81#article#
103#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Haddad J
r V. Animais aqu&aacute;ticos potencialmente perigosos do Brasil: Guia M&eacute;
dico e Biol&oacute;gico. S&atilde;o Paulo: Editora Roca; 2008.    ^cY#aop07-11.h
tm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#86#82#article#103#</font><
/p>     ^cY#aop07-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704027600090002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#87#83#article#
103#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Beight
on D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, et al. Use o
f CHROMagar <i>Candida </i>medium for isolation of yeasts from dental samples. J
 Clin Microbiol 1995; 33:3025-3027.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#88#84#article#103#</font><
/p>     ^cY#aop07-11.htm##
00448000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704018700090002001300277#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#89#85#article#
103#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Gordon
 MA, Salkin IF, Stone WB. <i>Phoma</i> (<i>Peyronellaea</i>) as zoopathogen. Sab
ouraudia 1975; 13:329-333.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#90#86#article#103#</font><
/p>     ^cY#aop07-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704025700090002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#91#87#article#
103#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Baker 
JG, Salkin IF, Forgacs P, Haines JH, Kemma ME. First report of subcutaneous phae
ohyphomycosis of the foot caused by <i>Phoma minutella</i>. J Clin Microbiol 198
7; 25:2395-2397.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#92#88#article#103#</font><
/p>     ^cY#aop07-11.htm##
00478000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704021700090002001300307#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#93#89#article#
103#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Hirsch
 AH, Schiff TA. Subcutaneous phaeohyphomycosis caused by an unusual pathogen: <i
>Phoma </i>species. J Am Acad Dermatol 1996; 34:679-680.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#94#90#article#103#</font><
/p>     ^cY#aop07-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704025100090002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#95#91#article#
103#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Everet
t JE, Busick NP, Sielaff T, Wahoff DC, Dunn DL. A Deeply Invasive <i>Phoma </i>S
pecies Infection in a Renal Transplant Recipient. Transplantation Proc 2003; 35:
1387-1389.    ^cY#aop07-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#96#92#article#103#</font><
/p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#97#93#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#98#94#article#103#<p>&nbsp
;</p>     ^cY#aop07-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019400087002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#99#95#article#103#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota1"></a><a hr
ef="#nota_1"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a> 
<b>Address to:</b>    ^cY#aop07-11.htm##
00286000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704003900088002001300127#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#100#96#article#103#<br>   
Dr. Vidal Haddad Junior.    ^cY#aop07-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704005800088002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#101#97#article#103#<br>   
Deptº Dermatologia e Radioterapia/FMB/UNESP    ^cY#aop07-11.htm##
00278000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704003100088002001300119#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#102#98#article#103#<br>   
Caixa Postal 557    ^cY#aop07-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704004500088002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#103#99#article#103#<br>   
18618-970 Botucatu, SP, Brasil    ^cY#aop07-11.htm##
00289000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004100089002001300130#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#104#100#article#103#<br>  
 Phone/Fax: 55 14 3882-4922    ^cY#aop07-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009900089002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#105#101#article#103#<br>  
 e-mail: <a href="mailto:haddadjr@fmb.unesp.br">haddadjr@fmb.unesp.br</a></font>
</p>     ^cY#aop07-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#106#102#article#103#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 14/09/2010 
   ^cY#aop07-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#p#107#103#article#103#<br>  
 Accepted in 24/11/2010</font></p>     ^cY#aop07-11.htm##
00442000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160016000880180032001040630
00200136066001000138062001600148065000900164064000500173865000900178002001300187
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#c#108#1#arti
cle#14#1#^rND^sLacaz^nCS#Tratado de Micologia Médica^lpt#9#São Paulo#Editora Sar
vier#20020000#2002#20110000#aop07-11.htm##
00560000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100016001050120
09300121030000500214065000900219064000500228031000400233014000800237865000900245
002001300254035001000267801000500277#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop07-11.htm#S#c#109#2#article#14#2#^rND^sPowell^nKE#^rND^sTaylor^nA#Cu
taneous sporotrichosis in forestry workers. Epidemic due to contaminated sphagnu
m moss^len#JAMA#19780000#1978#240#232-235#20110000#aop07-11.htm#0098-7484#JAMA##
00569000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100016001050100
01900121012005600140030001500196065000900211064000500220031000300225014000400228
865000900232002001300241035001000254801001500264#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop07-11.htm#S#c#110#3#article#14#3#^rND^sKenyon^nEM#^rND^s
Rusel^nLH#^rND^sMcMurray^nDN#Isolation of Sporothrix schenckii from potting soil
^len#Mycopathologia#19840000#1984#87#128#20110000#aop07-11.htm#0301-486X#Mycopat
hologia##
00433000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160017000880180021001050630
00200126066001300128062001400141065000900155064000500164865000900169002001300178
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#c#111#4#arti
cle#14#4#^rND^sRippon^nJW#Medical Mycology^len#3#Philadelphia#W.B. Saunders#1988
0000#1988#20110000#aop07-11.htm##
00569000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100016001090120
07300125030001800198065000900216064000500225031000300230014000800233865000900241
002001300250035001000263801001800273#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop07-11.htm#S#c#112#5#article#14#5#^rND^sMillington^nFR#^rND^sLeite^nE
V#Esporotricose humana provavelmente transmitida por mordedura de rato^lpt#Rev B
ras Clin Ter#19410000#1941#10#389-394#20110000#aop07-11.htm#0100-3232#REV Bras C
lin Ter##
00542000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100017001050120
06100122030001200183065000900195064000500204031000300209014000800212865000900220
002001300229035001000242801001200252#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop07-11.htm#S#c#113#6#article#14#6#^rND^sMayorga^nR#^rND^sCaceres^nA#É
tude d'une zone d'endemie sporotrichosique au Guatemala^lfr#Sabouraudia#19780000
#1978#76#185-198#20110000#aop07-11.htm#0036-2174#Sabouraudia##
00647000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100015001070100
01800122010001800140010001900158012007900177030001000256065000900266064000500275
031000300280014000800283865000900291002001300300035001000313801001000323#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#c#114#7#article#14#7
#^rND^sHaddad Jr^nV#^rND^sMiot^nHA#^rND^sBartoli^nLD#^rND^sCardoso^nAC#^rND^sCam
argo^nRMP#Localized lymphatic sporotrichosis after fish-induced injury (Tilapia 
sp.)^len#Med Mycol#20020000#2002#40#425-427#20110000#aop07-11.htm#1369-3786#Med 
Mycol##
00635000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880120171001070300
01700278065000900295064000500304031000300309014000800312865000900320002001300329
035001000342801001700352#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
07-11.htm#S#c#115#8#article#14#8#^rND^sHaddad Jr^nV#Infecções cutâneas e acident
es por animais traumatizantes e venenosos ocorridos em aquários comerciais e dom
ésticos no Brasil: descrição de 18 casos e revisão do tema^lpt#An Bras Dermatol#
20040000#2004#79#157-167#20110000#aop07-11.htm#0365-0596#An Bras Dermatol##
00478000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160019000880180082001070660
01000189062001300199065000900212064000500221865000900226002001300235#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#c#116#9#article#14#9#^rN
D^sHaddad Jr^nV#Animais aquáticos potencialmente perigosos do Brasil: Guia Médic
o e Biológico^lpt#São Paulo#Editora Roca#20080000#2008#20110000#aop07-11.htm##
00717000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01600125010002100141010002000162010001800182810000600200012008000206030001700286
06500090030306400050031203100030031701400100032086500090033000200130033903500100
0352801001700362#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.ht
m#S#c#117#10#article#14#10#^rND^sBeighton^nD#^rND^sLudford^nR#^rND^sClark^nDT#^r
ND^sBrailsford^nSR#^rND^sPankhurst^nCL#^rND^sTinsley^nGF#et al#Use of CHROMagar 
Candida medium for isolation of yeasts from dental samples^len#J Clin Microbiol#
19950000#1995#33#3025-3027#20110000#aop07-11.htm#0095-1137#J Clin Microbiol##
00551000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100017001070100
01600124012004000140030001200180065000900192064000500201031000300206014000800209
865000900217002001300226035001000239801001200249#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop07-11.htm#S#c#118#11#article#14#11#^rND^sGordon^nMA#^rND
^sSalkin^nIF#^rND^sStone^nWB#Phoma (Peyronellaea) as zoopathogen^len#Sabouraudia
#19750000#1975#13#329-333#20110000#aop07-11.htm#0036-2174#Sabouraudia##
00669000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01700123010001700140010001600157012008900173030001700262065000900279064000500288
031000300293014001000296865000900306002001300315035001000328801001700338#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#c#119#12#article#14#
12#^rND^sBaker^nJG#^rND^sSalkin^nIF#^rND^sForgacs^nP#^rND^sHaines^nJH#^rND^sKemm
a^nME#First report of subcutaneous phaeohyphomycosis of the foot caused by Phoma
 minutella^len#J Clin Microbiol#19870000#1987#25#2395-2397#20110000#aop07-11.htm
#0095-1137#J Clin Microbiol##
00577000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100017001070120
08000124030001900204065000900223064000500232031000300237014000800240865000900248
002001300257035001000270801001900280#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop07-11.htm#S#c#120#13#article#14#13#^rND^sHirsch^nAH#^rND^sSchiff^nTA
#Subcutaneous phaeohyphomycosis caused by an unusual pathogen: Phoma species^len
#J Am Acad Dermatol#19960000#1996#34#679-680#20110000#aop07-11.htm#0190-9622#J A
m Acad Dermatol##
00626000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01700125010001700142010001500159012007800174030002100252710000200273065000900275
064000500284031000300289014001000292865000900302002001300311#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop07-11.htm#S#c#121#14#article#14#14#^rND^sEve
rett^nJE#^rND^sBusick^nNP#^rND^sSielaff^nT#^rND^sWahoff^nDC#^rND^sDunn^nDL#A Dee
ply Invasive Phoma Species Infection in a Renal Transplant Recipient^len#Transpl
antation Proc#2#20030000#2003#35#1387-1389#20110000#aop07-11.htm##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#o#1#
1#article#1#20110328#093952#aop09-11.htm#159##
05388000000000721000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101121000300106049000300109158000300112030002700115
03200060014206500090014801400070015703500100016422300090017401202050018301202090
03880100044005970100043006410100028006840100025007120100034007370100037007710700
16400808070008200972070007101054070008101125083161901206085000802825085002602833
08500330285908500300289208500210292208500270294308314790297008500080444908500260
44570850033044830850030045160850020045460850027045660580005045930580006045981170
00604604072000304610112000904613111001104622114000904633113001104642002001304653
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#h#2#1#articl
e#1#oa#pt#br1.1#1#4.0#ILUS#10#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f
0^l0#0037-8682#20110401#Alterações ultraestruturais em larvas de Aedes aegypti s
ubmetidas ao diterpeno labdano, isolado de Copaifera reticulata (Leguminosae), e
 à uma fração rica em taninos de Magonia pubescens (Sapindaceae)^lpt#Ultrastruct
ural alterations in larvae of Aedes aegypti subject to labdane diterpene isolate
d from Copaifera reticulata (Leguminosae) and a fraction enriched with tannins o
f Magonia pubescens (Sapindaceae)^len#^rND^1A01^nCleyde Ferreira Barreto^sValott
o#^rND^1A01^nHeloisa Helena Garcia da^sSilva#^rND^1A02^nGláucia^sCavasin#^rND^1A
03^nRegina^sGeris#^rND^1A04^nEdson^sRodrigues Filho#^rND^1A01^nIonizete Garcia d
a^sSilva#Universidade Federal de Goiás^iA01^1Instituto de Patologia Tropical e S
aúde Pública^2Departamento Microbiologia, Imunologia, Parasitologia e Patologia^
cGoiânia^sGO#Universidade Federal de Goiás^iA02^1Instituto de Ciências Biológica
s^cGoiânia^sGO#Universidade Federal da Bahia^iA03^1Instituto de Química^cSalvado
r^sBA#Universidade Federal de São Carlos^iA04^1Departamento de Química^cSão Carl
os^sSP#^lpt^aINTRODUÇÃO: Dengue é um importante problema de saúde pública, em vá
rios países, e tem como principal vetor o Aedes aegypti, mosquito mais adaptado 
às áreas urbanizadas. Apresenta-se, pela primeira vez, as alterações ultraestrut
urais em larvas de 3º estádio, desse mosquito, causadas pelos larvicidas naturai
s, um diterpeno labdano, extraído de Copaifera reticulata, e uma fração rica em 
taninos catéquicos, extraída de Magonia pubescens, evidenciando o mecanismo de a
ção dessas substâncias. MÉTODOS: Os experimentos foram realizados com larvas de 
3º estádio em solução de 0,9ppm, do diterpeno (3-&#946;-acetoxylabdan-8(17)-13-d
ien-15-óico) e de 3,7ppm, da fração majoritária de tanino catéquico de massa mol
ecular 864Da. Obtiveram-se as substâncias através de fracionamentos cromatográfi
cos sucessivos, identificadas por ressonância magnética nuclear de hidrogênio e 
espectrometria de massas. As larvas que atingiram estado letárgico foram coletad
as e dissecadas e seus tubos digestórios fixados, desidratados, emblocados e pol
imerizados. Cortes ultrafinos foram feitos e contrastados com acetato de uranila
 3% e citrato de chumbo, posteriormente, levados ao microscópio eletrônico. RESU
LTADOS: As principais alterações ultraestruturais provocadas pelos diterpeno e t
anino sobre larvas de Aedes aegypti foram vacuolização citoplasmática, desorgani
zação e degeneração celular, mudança estrutural dos microvilos e deslocamento da
s células da lâmina basal. CONCLUSÕES: O diterpeno e a fração rica em taninos ca
téquicos provocaram a morte das larvas de Aedes aegypti através da destruição ce
lular no intestino médio.#^dnd^i1#^tm^lpt^kAedes aegypti^i1#^tm^lpt^kCopaifera r
eticulata^i1#^tm^lpt^kMagonia pubescens^i1#^tm^lpt^kControle^i1#^tm^lpt^kUltraes
trutura^i1#^len^aINTRODUCTION: Dengue is an important public health problem in m
any countries and its main vector Aedes aegypti, is the mosquito most adapted to
 urban areas. For the first time, the mechanism of action of labdane diterpenoid
 extracted from Copaifera reticulata and the fraction enriched of catechin tanni
ns extracted from Magonia pubescens is demonstrated through ultrastructural alte
rations of Aedes aegypti larvae. METHODS: Experiments were performed using a 0.9
ppm solution of diterpenoid and 3.7ppm of the fraction as the main catechin tann
in of molecular mass 846Da. The compounds were obtained by thin layer chromatogr
aphy and identified by nuclear magnetic resonance of hydrogen and mass spectrome
try. Larvae that achieved lethargic state were collected and dissected. Next, th
ey were contrasted with 1% uranyl acetate, dehydrated, embedded and polymerized.
 Ultrathin sections were made, mixed with 3% uranyl acetate and lead citrate and
 placed in an electron microscope. RESULTS: The main ultrastructural alterations
 caused by the diterpenoid and by tanins in larvae of Aedes aegypti were: cytopl
asmic vacuolation, alteration of microvilli, cellular aging, cell disruption and
 degeneration, formation of secretion vesicles and structural changes in microvi
lli, irregular nuclei and displacement of cells in the basal lamina. CONCLUSIONS
: The fraction containing tannins and the diterpenoid caused the death of Aedes 
aegypti larvae by cell destruction in the midgut.#^dnd^i2#^tm^len^kAedes aegypti
^i2#^tm^len^kCopaifera reticulata^i2#^tm^len^kMagonia pubescens^i2#^tm^len^kCont
rol^i2#^tm^len^kUltrastructure^i2#CNPq#FAPEG#other#26#20100602#02/06/2010#201011
04#04/11/2010#aop09-11.htm##
05626000000000721000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101121000300106049000300109158000300112030002700115
03200060014206500090014801400070015703500100016422300090017401202400018301202370
04230100044006600100043007040100028007470100025007750100034008000100037008340700
16400871070008201035070007101117070008101188083168201269085000802951085003302959
08500400299208500370303208500210306908500270309008315490311708500080466608500330
46740850040047070850037047470850020047840850027048040580005048310580006048361170
00604842072000304848112000904851111001104860114000904871113001104880002001304891
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#f#3#1#articl
e#1#oa#pt#br1.1#1#4.0#ILUS#10#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f
0^l0#0037-8682#20110401#<b>Alterações ultraestruturais em larvas de <i>Aedes aeg
ypti </i>submetidas ao diterpeno labdano, isolado de <i>Copaifera reticulata </i
>(Leguminosae), e à uma fração rica em taninos de <i>Magonia pubescens</i> (<i>S
</i>apindaceae)</b>^lpt#<b>Ultrastructural alterations in larvae of <i>Aedes aeg
ypti</i> subject to labdane diterpene isolated from <i>Copaifera reticulata</i> 
(Leguminosae) and a fraction enriched with tannins of <i>Magonia pubescens</i> (
Sapindaceae)</b>^len#^rND^1A01^nCleyde Ferreira Barreto^sValotto#^rND^1A01^nHelo
isa Helena Garcia da^sSilva#^rND^1A02^nGláucia^sCavasin#^rND^1A03^nRegina^sGeris
#^rND^1A04^nEdson^sRodrigues Filho#^rND^1A01^nIonizete Garcia da^sSilva#Universi
dade Federal de Goiás^iA01^1Instituto de Patologia Tropical e Saúde Pública^2Dep
artamento Microbiologia, Imunologia, Parasitologia e Patologia^cGoiânia^sGO#Univ
ersidade Federal de Goiás^iA02^1Instituto de Ciências Biológicas^cGoiânia^sGO#Un
iversidade Federal da Bahia^iA03^1Instituto de Química^cSalvador^sBA#Universidad
e Federal de São Carlos^iA04^1Departamento de Química^cSão Carlos^sSP#^lpt^a<b>I
NTRODUÇÃO: </b>Dengue é um importante problema de saúde pública, em vários paíse
s, e tem como principal vetor o <i>Aedes aegypti</i>, mosquito mais adaptado às 
áreas urbanizadas. Apresenta-se, pela primeira vez, as alterações ultraestrutura
is em larvas de 3º estádio, desse mosquito, causadas pelos larvicidas naturais, 
um diterpeno labdano, extraído de <i>Copaifera reticulata</i>, e uma fração rica
 em taninos catéquicos, extraída de <i>Magonia pubescens, </i>evidenciando o mec
anismo de ação dessas substâncias. <b>MÉTODOS: </b>Os experimentos foram realiza
dos com larvas de 3º estádio em solução de 0,9ppm, do diterpeno (3-&#946;-acetox
ylabdan-8(17)-13-dien-15-óico) e de 3,7ppm, da fração majoritária de tanino caté
quico de massa molecular 864Da. Obtiveram-se as substâncias através de fracionam
entos cromatográficos sucessivos, identificadas por ressonância magnética nuclea
r de hidrogênio e espectrometria de massas. As larvas que atingiram estado letár
gico foram coletadas e dissecadas e seus tubos digestórios fixados, desidratados
, emblocados e polimerizados. Cortes ultrafinos foram feitos e contrastados com 
acetato de uranila 3% e citrato de chumbo, posteriormente, levados ao microscópi
o eletrônico. <b>RESULTADOS: </b>As principais alterações ultraestruturais provo
cadas pelos diterpeno e tanino sobre larvas de <i>Aedes aegypti </i>foram vacuol
ização citoplasmática, desorganização e degeneração celular, mudança estrutural 
dos microvilos e deslocamento das células da lâmina basal. <b>CONCLUSÕES: </b>O 
diterpeno e a fração rica em taninos catéquicos provocaram a morte das larvas de
 <i>Aedes aegypti</i> através da destruição celular no intestino médio.#^dnd^i1#
^tm^lpt^k<i>Aedes aegypti</i>^i1#^tm^lpt^k<i>Copaifera reticulata</i>^i1#^tm^lpt
^k<i>Magonia pubescens</i>^i1#^tm^lpt^kControle^i1#^tm^lpt^kUltraestrutura^i1#^l
en^a<b>INTRODUCTION:</b> Dengue is an important public health problem in many co
untries and its main vector <i>Aedes aegypti</i>, is the mosquito most adapted t
o urban areas. For the first time, the mechanism of action of labdane diterpenoi
d extracted from <i>Copaifera reticulata </i>and the fraction enriched of catech
in tannins extracted from <i>Magonia pubescens </i>is demonstrated through ultra
structural alterations of <i>Aedes aegypti </i>larvae. <b>METHODS: </b>Experimen
ts were performed using a 0.9ppm solution of diterpenoid and 3.7ppm of the fract
ion as the main catechin tannin of molecular mass 846Da. The compounds were obta
ined by thin layer chromatography and identified by nuclear magnetic resonance o
f hydrogen and mass spectrometry. Larvae that achieved lethargic state were coll
ected and dissected. Next, they were contrasted with 1% uranyl acetate, dehydrat
ed, embedded and polymerized. Ultrathin sections were made, mixed with 3% uranyl
 acetate and lead citrate and placed in an electron microscope. <b>RESULTS: </b>
The main ultrastructural alterations caused by the diterpenoid and by tanins in 
larvae of <i>Aedes aegypti </i>were: cytoplasmic vacuolation, alteration of micr
ovilli, cellular aging, cell disruption and degeneration, formation of secretion
 vesicles and structural changes in microvilli, irregular nuclei and displacemen
t of cells in the basal lamina. <b>CONCLUSIONS: </b>The fraction containing tann
ins and the diterpenoid caused the death of <i>Aedes aegypti</i> larvae by cell 
destruction in the midgut.#^dnd^i2#^tm^len^k<i>Aedes aegypti</i>^i2#^tm^len^k<i>
Copaifera reticulata</i>^i2#^tm^len^k<i>Magonia pubescens</i>^i2#^tm^len^kContro
l^i2#^tm^len^kUltrastructure^i2#CNPq#FAPEG#other#26#20100602#02/06/2010#20101104
#04/11/2010#aop09-11.htm##
05538000000000745000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000500108121000300113049000300116158000300119
03000260012203200060014806500090015401400070016303500100017022300090018001202050
01890120209003940100044006030100043006470100028006900100025007180100034007430100
03700777070016600814070008400980070007301064070008301137083162801220085000802848
08500260285608500330288208500300291508500210294508500270296608314930299308500080
44860850026044940850033045200850030045530850020045830850027046030580005046300580
00604635117000604641072000304647112000904650111001104659114000904670113001104679
002001304690008008904703#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
09-11.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#10#nd#nd#Rev. Soc. Bra
s. Med. Trop#ahead#20110000#^f0^l0#0037-8682#20110401#Alterações ultraestruturai
s em larvas de Aedes aegypti submetidas ao diterpeno labdano, isolado de Copaife
ra reticulata (Leguminosae), e à uma fração rica em taninos de Magonia pubescens
 (Sapindaceae)^lpt#Ultrastructural alterations in larvae of Aedes aegypti subjec
t to labdane diterpene isolated from Copaifera reticulata (Leguminosae) and a fr
action enriched with tannins of Magonia pubescens (Sapindaceae)^len#^rND^1A01^nC
leyde Ferreira Barreto^sValotto#^rND^1A01^nHeloisa Helena Garcia da^sSilva#^rND^
1A02^nGláucia^sCavasin#^rND^1A03^nRegina^sGeris#^rND^1A04^nEdson^sRodrigues Filh
o#^rND^1A01^nIonizete Garcia da^sSilva#^iA01^1Universidade Federal de Goiás^2Ins
tituto de Patologia Tropical e Saúde Pública^3Departamento Microbiologia, Imunol
ogia, Parasitologia e Patologia^cGoiânia^sGO#^iA02^1Universidade Federal de Goiá
s^2Instituto de Ciências Biológicas^cGoiânia^sGO#^iA03^1Universidade Federal da 
Bahia^2Instituto de Química^cSalvador^sBA#^iA04^1Universidade Federal de São Car
los^2Departamento de Química^cSão Carlos^sSP#^lpt^aINTRODUÇÃO: Dengue é um impor
tante problema de saúde pública, em vários países, e tem como principal vetor o 
Aedes aegypti, mosquito mais adaptado às áreas urbanizadas. Apresenta-se, pela p
rimeira vez, as alterações ultraestruturais em larvas de 3º estádio, desse mosqu
ito, causadas pelos larvicidas naturais, um diterpeno labdano, extraído de Copai
fera reticulata, e uma fração rica em taninos catéquicos, extraída de Magonia pu
bescens, evidenciando o mecanismo de ação dessas substâncias. MÉTODOS: Os experi
mentos foram realizados com larvas de 3º estádio em solução de 0,9ppm, do diterp
eno (3-&#946;-acetoxylabdan-8(17)-13-dien-15-óico) e de 3,7ppm, da fração majori
tária de tanino catéquico de massa molecular 864Da. Obtiveram-se as substâncias 
através de fracionamentos cromatográficos sucessivos, identificadas por ressonân
cia magnética nuclear de hidrogênio e espectrometria de massas. As larvas que at
ingiram estado letárgico foram coletadas e dissecadas e seus tubos digestórios f
ixados, desidratados, emblocados e polimerizados. Cortes ultrafinos foram feitos
 e contrastados com acetato de uranila 3 por cento e citrato de chumbo, posterio
rmente, levados ao microscópio eletrônico. RESULTADOS: As principais alterações 
ultraestruturais provocadas pelos diterpeno e tanino sobre larvas de Aedes aegyp
ti foram vacuolização citoplasmática, desorganização e degeneração celular, muda
nça estrutural dos microvilos e deslocamento das células da lâmina basal. CONCLU
SÕES: O diterpeno e a fração rica em taninos catéquicos provocaram a morte das l
arvas de Aedes aegypti através da destruição celular no intestino médio.#^dnd^i1
#^tm^lpt^kAedes aegypti^i1#^tm^lpt^kCopaifera reticulata^i1#^tm^lpt^kMagonia pub
escens^i1#^tm^lpt^kControle^i1#^tm^lpt^kUltraestrutura^i1#^len^aINTRODUCTION: De
ngue is an important public health problem in many countries and its main vector
 Aedes aegypti, is the mosquito most adapted to urban areas. For the first time,
 the mechanism of action of labdane diterpenoid extracted from Copaifera reticul
ata and the fraction enriched of catechin tannins extracted from Magonia pubesce
ns is demonstrated through ultrastructural alterations of Aedes aegypti larvae. 
METHODS: Experiments were performed using a 0.9ppm solution of diterpenoid and 3
.7ppm of the fraction as the main catechin tannin of molecular mass 846Da. The c
ompounds were obtained by thin layer chromatography and identified by nuclear ma
gnetic resonance of hydrogen and mass spectrometry. Larvae that achieved letharg
ic state were collected and dissected. Next, they were contrasted with 1 percent
 uranyl acetate, dehydrated, embedded and polymerized. Ultrathin sections were m
ade, mixed with 3 percent uranyl acetate and lead citrate and placed in an elect
ron microscope. RESULTS: The main ultrastructural alterations caused by the dite
rpenoid and by tanins in larvae of Aedes aegypti were: cytoplasmic vacuolation, 
alteration of microvilli, cellular aging, cell disruption and degeneration, form
ation of secretion vesicles and structural changes in microvilli, irregular nucl
ei and displacement of cells in the basal lamina. CONCLUSIONS: The fraction cont
aining tannins and the diterpenoid caused the death of Aedes aegypti larvae by c
ell destruction in the midgut.#^dnd^i2#^tm^len^kAedes aegypti^i2#^tm^len^kCopaif
era reticulata^i2#^tm^len^kMagonia pubescens^i2#^tm^len^kControl^i2#^tm^len^kUlt
rastructure^i2#CNPq#FAPEG#other#26#20100602#02/06/2010#20101104#04/11/2010#aop09
-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-8
6822011005000010##
00618000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704037400085002001300459#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#5#1#article#129#<p><font s
ize="4" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota_1"></a><b>Alt
era&ccedil;&otilde;es ultraestruturais em larvas de <i>Aedes aegypti </i>submeti
das ao diterpeno labdano, isolado de <i>Copaifera reticulata </i>(Leguminosae), 
e &agrave; uma fra&ccedil;&atilde;o rica em taninos de <i>Magonia pubescens</i> 
(<i>S</i>apindaceae)</b></font></p>     ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#6#2#article#129#<p>&nbsp;<
/p>     ^cY#aop09-11.htm##
00559000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704031500085002001300400#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#7#3#article#129#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Ultrastructural alterati
ons in larvae of <i>Aedes aegypti</i> subject to labdane diterpene isolated from
 <i>Copaifera reticulata</i> (Leguminosae) and a fraction enriched with tannins 
of <i>Magonia pubescens</i> (Sapindaceae)</b></font></p>     ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#8#4#article#129#<p>&nbsp;<
/p>     ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#9#5#article#129#<p>&nbsp;<
/p>     ^cY#aop09-11.htm##
00561000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704031600086002001300402#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#10#6#article#129#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Cleyde Ferreira Barreto
 Valotto<sup>I</sup>; Heloisa Helena Garcia da Silva<sup>I</sup>; Gl&aacute;ucia
 Cavasin<sup>II</sup>; Regina Geris<sup>III</sup>; Edson Rodrigues Filho<sup>IV<
/sup>; Ionizete Garcia da Silva<sup>I</sup></b></font></p>     ^cY#aop09-11.htm#
#
00513000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704026800086002001300354#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#11#7#article#129#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Departamento M
icrobiologia, Imunologia, Parasitologia e Patologia, Instituto de Patologia Trop
ical e Sa&uacute;de P&uacute;blica, Universidade Federal de Goi&aacute;s, Goi&ac
irc;nia, GO    ^cY#aop09-11.htm##
00375000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013000086002001300216#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#12#8#article#129#<br>   <s
up>II</sup>Instituto de Ci&ecirc;ncias Biol&oacute;gicas, Universidade Federal d
e Goi&aacute;s, Goi&acirc;nia, GO    ^cY#aop09-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704010100086002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#13#9#article#129#<br>   <s
up>III</sup>Instituto de Qu&iacute;mica, Universidade Federal da Bahia, Salvador
, BA    ^cY#aop09-11.htm##
00382000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013600087002001300223#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#14#10#article#129#<br>   <
sup>IV</sup>Departamento de Qu&iacute;mica, Universidade Federal de S&atilde;o C
arlos, S&atilde;o Carlos, SP</font></p>     ^cY#aop09-11.htm##
00392000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014600087002001300233#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#15#11#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#nota1">Endere&c
cedil;o para correspond&ecirc;ncia</a></font></p>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#16#12#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#17#13#article#129#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop09-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#18#14#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop09-11.htm##
00974000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072800087002001300815#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#19#15#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b>Dengue &eacute; um importante problema de sa&uacute;de p&uacute;blica, e
m v&aacute;rios pa&iacute;ses, e tem como principal vetor o <i>Aedes aegypti</i>
, mosquito mais adaptado &agrave;s &aacute;reas urbanizadas. Apresenta-se, pela 
primeira vez, as altera&ccedil;&otilde;es ultraestruturais em larvas de 3º est&a
acute;dio, desse mosquito, causadas pelos larvicidas naturais, um diterpeno labd
ano, extra&iacute;do de <i>Copaifera reticulata</i>, e uma fra&ccedil;&atilde;o 
rica em taninos cat&eacute;quicos, extra&iacute;da de <i>Magonia pubescens, </i>
evidenciando o mecanismo de a&ccedil;&atilde;o dessas subst&acirc;ncias.    ^cY#
aop09-11.htm##
01155000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090900087002001300996#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#20#16#article#129#<br>   <
b>M&Eacute;TODOS: </b>Os experimentos foram realizados com larvas de 3º est&aacu
te;dio em solu&ccedil;&atilde;o de 0,9ppm, do diterpeno (3-</font>&#946;<font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">-acetoxylabdan-8(17)-13-dien
-15-&oacute;ico) e de 3,7ppm, da fra&ccedil;&atilde;o majorit&aacute;ria de tani
no cat&eacute;quico de massa molecular 864Da. Obtiveram-se as subst&acirc;ncias 
atrav&eacute;s de fracionamentos cromatogr&aacute;ficos sucessivos, identificada
s por resson&acirc;ncia magn&eacute;tica nuclear de hidrog&ecirc;nio e espectrom
etria de massas. As larvas que atingiram estado let&aacute;rgico foram coletadas
 e dissecadas e seus tubos digest&oacute;rios fixados, desidratados, emblocados 
e polimerizados. Cortes ultrafinos foram feitos e contrastados com acetato de ur
anila 3% e citrato de chumbo, posteriormente, levados ao microsc&oacute;pio elet
r&ocirc;nico.    ^cY#aop09-11.htm##
00628000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038200087002001300469#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#21#17#article#129#<br>   <
b>RESULTADOS: </b>As principais altera&ccedil;&otilde;es ultraestruturais provoc
adas pelos diterpeno e tanino sobre larvas de <i>Aedes aegypti </i>foram vacuoli
za&ccedil;&atilde;o citoplasm&aacute;tica, desorganiza&ccedil;&atilde;o e degene
ra&ccedil;&atilde;o celular, mudan&ccedil;a estrutural dos microvilos e deslocam
ento das c&eacute;lulas da l&acirc;mina basal.    ^cY#aop09-11.htm##
00501000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025500087002001300342#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#22#18#article#129#<br>   <
b>CONCLUS&Otilde;ES: </b>O diterpeno e a fra&ccedil;&atilde;o rica em taninos ca
t&eacute;quicos provocaram a morte das larvas de <i>Aedes aegypti</i> atrav&eacu
te;s da destrui&ccedil;&atilde;o celular no intestino m&eacute;dio.</font></p>  
   ^cY#aop09-11.htm##
00470000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022400087002001300311#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#23#19#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves: </b><
i>Aedes aegypti. Copaifera reticulata</i>. <i>Magonia pubescens.</i> Controle. U
ltraestrutura.</font></p> <hr size="1" noshade>     ^cY#aop09-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#24#20#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop09-11.htm##
00767000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052100087002001300608#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#25#21#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b> Deng
ue is an important public health problem in many countries and its main vector <
i>Aedes aegypti</i>, is the mosquito most adapted to urban areas. For the first 
time, the mechanism of action of labdane diterpenoid extracted from <i>Copaifera
 reticulata </i>and the fraction enriched of catechin tannins extracted from <i>
Magonia pubescens </i>is demonstrated through ultrastructural alterations of <i>
Aedes aegypti </i>larvae.    ^cY#aop09-11.htm##
00829000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058300087002001300670#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#26#22#article#129#<br>   <
b>METHODS: </b>Experiments were performed using a 0.9ppm solution of diterpenoid
 and 3.7ppm of the fraction as the main catechin tannin of molecular mass 846Da.
 The compounds were obtained by thin layer chromatography and identified by nucl
ear magnetic resonance of hydrogen and mass spectrometry. Larvae that achieved l
ethargic state were collected and dissected. Next, they were contrasted with 1% 
uranyl acetate, dehydrated, embedded and polymerized. Ultrathin sections were ma
de, mixed with 3% uranyl acetate and lead citrate and placed in an electron micr
oscope.    ^cY#aop09-11.htm##
00628000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038200087002001300469#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#27#23#article#129#<br>   <
b>RESULTS: </b>The main ultrastructural alterations caused by the diterpenoid an
d by tanins in larvae of <i>Aedes aegypti </i>were: cytoplasmic vacuolation, alt
eration of microvilli, cellular aging, cell disruption and degeneration, formati
on of secretion vesicles and structural changes in microvilli, irregular nuclei 
and displacement of cells in the basal lamina.    ^cY#aop09-11.htm##
00427000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018100087002001300268#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#28#24#article#129#<br>   <
b>CONCLUSIONS: </b>The fraction containing tannins and the diterpenoid caused th
e death of <i>Aedes aegypti</i> larvae by cell destruction in the midgut.</font>
</p>     ^cY#aop09-11.htm##
00455000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020900087002001300296#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#29#25#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b><i>Aedes
 aegypti. Copaifera reticulata. Magonia pubescens.</i> Control. Ultrastructure.<
/font></p> <hr size="1" noshade>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#30#26#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#31#27#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011400087002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#32#28#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O</b></font></p>     ^cY#aop09-11.htm##
00684000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043800087002001300525#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#33#29#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A dengue est&aacute; entr
e as mais importantes arboviroses do mundo e o <i>Aedes aegypti </i>&eacute; o v
etor reconhecido dos quatro sorotipos do v&iacute;rus (Den1, 2, 3, 4). Suas mani
festa&ccedil;&otilde;es cl&iacute;nicas variam de uma s&iacute;ndrome viral ines
pec&iacute;fica at&eacute; um quadro grave e fatal por hemorragia ou choque<sup>
1-3</sup>.</font></p>     ^cY#aop09-11.htm##
01005000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704075900087002001300846#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#34#30#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A transmiss&atilde;o e a 
preval&ecirc;ncia de dengue est&atilde;o associadas &agrave;s condi&ccedil;&otil
de;es ecol&oacute;gicas e s&oacute;cioambientais que propiciam a cria&ccedil;&at
ilde;o do vetor e o contato com o homem. Como n&atilde;o h&aacute; vacina dispon
&iacute;vel at&eacute; o momento, a principal estrat&eacute;gia de controle tem 
sido o combate ao <i>Aedes aegypti</i><sup>4-6</sup>. Dentre as ferramentas util
izadas, a mais pr&aacute;tica e r&aacute;pida tem sido a aplica&ccedil;&atilde;o
 de inseticidas sint&eacute;ticos. A press&atilde;o constante desses produtos te
m levado ao aparecimento de resist&ecirc;ncia do mosquito a esses compostos<sup>
7-10</sup>.</font></p>     ^cY#aop09-11.htm##
00544000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704029800087002001300385#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#35#31#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Em busca de novas alterna
tivas para o controle do <i>Aedes aegypti</i>, v&aacute;rias pesquisas v&ecirc;m
 sendo desenvolvidas no intuito de encontrar um inseticida eficaz com menor impa
cto ambiental<sup>11-19</sup>.</font></p>     ^cY#aop09-11.htm##
00697000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045100087002001300538#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#36#32#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Neste contexto, subst&aci
rc;ncias larvicidas de <i>Copaifera reticulata </i>e <i>Magonia pubescens </i>fo
ram isoladas, purificadas, testadas e as altera&ccedil;&otilde;es ultraestrutura
is do intestino de larvas de <i>Aedes aegypti </i>s&atilde;o apresentadas em ele
tromicrografia de transmiss&atilde;o, com a finalidade de esclarecer o mecanismo
 de a&ccedil;&atilde;o.</font></p>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#37#33#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#38#34#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODOS</b></fo
nt></p>     ^cY#aop09-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#39#35#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Bioensaios</b></font><
/p>     ^cY#aop09-11.htm##
01288000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704104200087002001301129#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#40#36#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Larvas de <i>Aedes aegypt
i </i>foram obtidas de uma col&ocirc;nia permanente, alimentadas com ra&ccedil;&
atilde;o para gatos, finamente triturada, e mantida a 28±1ºC, umidade relativa d
e 80±5% e fotoper&iacute;odo de 12h<sup>20</sup>. Os experimentos foram separado
s em tr&ecirc;s grupos: o primeiro grupo contendo o diterpen&oacute;ide (&aacute
;cido 3-</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif"
>-acetoxi-labdan-8(17)-13-dien-15-&oacute;ico) isolado do &oacute;leo-resina de 
<i>Copaifera reticulata</i><sup>18 </sup>na concentra&ccedil;&atilde;o de 0,9ppm
, o segundo contendo uma fra&ccedil;&atilde;o enriquecida em taninos condensados
, cuja unidade monom&eacute;rica principal &eacute; uma catequina (flavan-3-ol) 
encontrada no c&oacute;rtex do caule de <i>Magonia pubescens</i><sup>16</sup>, a
 3,7ppm e, por &uacute;ltimo, o controle, contendo somente &aacute;gua destilada
. Todos os experimentos foram realizados em duplicata.</font></p>     ^cY#aop09-
11.htm##
00750000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050400087002001300591#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#41#37#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Foram colocadas 20 larvas
 em cada frasco, imediatamente ap&oacute;s a ecdise para o 3º est&aacute;dio, co
ntendo 30mL das solu&ccedil;&otilde;es dos compostos a serem testados. Estes exp
erimentos foram deixados por 22h, per&iacute;odo determinado em experi&ecirc;nci
a piloto para evidenciar as altera&ccedil;&otilde;es, e somente as larvas em est
&aacute;gio de letargia foram coletadas para os estudos morfol&oacute;gicos.</fo
nt></p>     ^cY#aop09-11.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#42#38#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Sec&ccedil;&otilde;es<
/b></font></p>     ^cY#aop09-11.htm##
00679000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043300087002001300520#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#43#39#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As larvas coletadas foram
 dissecadas sob estereomicrosc&oacute;pio (MZS-250), em uma gota do fixador apro
priado e seus tubos digest&oacute;rios foram retirados e fixados para microscopi
a eletr&ocirc;nica de transmiss&atilde;o, em 2% glutaralde&iacute;do, 2% parafor
malde&iacute;do, 3% sacarose em tamp&atilde;o cacodilato de s&oacute;dio 0,1M pH
 7,2.</font></p>     ^cY#aop09-11.htm##
01522000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704127600087002001301363#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#44#40#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Ap&oacute;s esta fixa&cce
dil;&atilde;o, o material foi lavado no tamp&atilde;o cacodilato de s&oacute;dio
 (2 lavagens de 30min) e p&oacute;s-fixado em tetr&oacute;xido de &oacute;smio 1
% em cacodilato de s&oacute;dio 0,1M, por 2h, a 4ºC. Depois submetido a duas lav
agens por 30min com o tamp&atilde;o cacodilato de s&oacute;dio 0,1M. Em seguida,
 foi colocado em &aacute;lcool 10% como preparativo para a contrasta&ccedil;&ati
lde;o em bloco. Esta foi feita com acetato de uranila a 1%, em &aacute;lcool 10%
, &agrave; temperatura ambiente <i>overnight</i>. O material foi lavado com &aac
ute;gua destilada e submetido ao processo de desidrata&ccedil;&atilde;o em conce
ntra&ccedil;&otilde;es crescentes de &aacute;lcool a 70, 80, 90, 95, 100% (3x), 
&aacute;lcool + &oacute;xido de propileno (volume/volume) e &oacute;xido de prop
ileno por 15min cada. Ap&oacute;s a desidrata&ccedil;&atilde;o os tubos digest&o
acute;rios foram deixados em &oacute;xido de propileno+<i>spurr </i>(volume/volu
me), e <i>spurr </i>puro, por 1h. Este &uacute;ltimo procedimento foi repetido p
or tr&ecirc;s vezes, e em seguida deixado em <i>spurr </i>por mais 24h, emblocad
o e polimerizado por 24h a 70ºC<sup>21-23</sup>.</font></p>     ^cY#aop09-11.htm
##
00940000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704069400087002001300781#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#45#41#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os blocos foram seccionad
os em ultramicr&oacute;tomo <i>Leica Ultracult </i>UCT, transferidos para l&acir
c;minas e corados com azul de toluidina para rastreamento das altera&ccedil;&oti
lde;es em microscopia de luz. Em seguida cortes ultrafinos foram colocados em te
linhas de cobre recobertas com col&oacute;dio/carbono, contrastadas com acetato 
de uranila a 3%, por 30min e solu&ccedil;&atilde;o de citrato de chumbo, por 10m
in &agrave; temperatura ambiente. Ap&oacute;s a secagem, os cortes foram levados
 ao microsc&oacute;pio eletr&ocirc;nico de transmiss&atilde;o para serem examina
dos e eletromicrografados.</font></p>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#46#42#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#47#43#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font><
/p>     ^cY#aop09-11.htm##
01293000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704104700087002001301134#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#48#44#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">No grupo controle, o inte
stino m&eacute;dio ou mes&ecirc;ntero de larvas de 3º est&aacute;dio de <i>Aedes
 aegypti </i>apresentou tr&ecirc;s partes distintas: anterior, mediana e posteri
or. As c&eacute;lulas da regi&atilde;o anterior <b>(<a href="/img/revistas/rsbmt
/2011nahead/html/aop09-11_fig01.html">Figura 1A</a>) </b>apresentaram-se c&uacut
e;bicas com n&uacute;cleo esf&eacute;rico evidenciando &aacute;reas de eurocroma
tina e heterocromatina e nucl&eacute;olo distinto. No citoplasma destas c&eacute
;lulas, foi poss&iacute;vel observar uma grande quantidade de mitoc&ocirc;ndrias
 de formatos irregulares <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-
11_fig01.html">Figura 1A</a> e <a href="/img/revistas/rsbmt/2011nahead/html/aop0
9-11_fig01.html">B</a>)</b>. A regi&atilde;o apical destas c&eacute;lulas demons
trou a presen&ccedil;a de curtas microvilosidades <b>(<a href="/img/revistas/rsb
mt/2011nahead/html/aop09-11_fig01.html">Figura 1C</a>)</b>.</font></p>     ^cY#a
op09-11.htm##
01238000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704099200087002001301079#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#49#45#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A regi&atilde;o mediana t
amb&eacute;m se apresentou formada por um epit&eacute;lio cil&iacute;ndrico <b>(
<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig01.html#fig1def">Figura
 1D</a>) </b>com a presen&ccedil;a de in&uacute;meras pregas na l&acirc;mina bas
al destas c&eacute;lulas, indicando a realiza&ccedil;&atilde;o de trocas i&ocirc
;nicas nesta regi&atilde;o <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop0
9-11_fig01.html#fig1def">Figura 1E</a>)</b>. A regi&atilde;o apical destas c&eac
ute;lulas mostrou microvilosidades mais altas que as da regi&atilde;o anterior <
b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig01.html#fig1def">Fig
ura 1F</a>)</b>. O n&uacute;cleo apresentou-se grande e com cromatina descondens
ada, mostrando caracter&iacute;sticas de intensa atividade celular <b>(<a href="
/img/revistas/rsbmt/2011nahead/html/aop09-11_fig01.html#fig1def">Figura 1E</a>)<
/b>.</font></p>     ^cY#aop09-11.htm##
00896000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704065000087002001300737#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#50#46#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A regi&atilde;o posterior
 apresentou-se formada por c&eacute;lulas colunares <b>(<a href="/img/revistas/r
sbmt/2011nahead/html/aop09-11_fig01.html#fig1ghi">Figura 1G</a>)</b>, com in&uac
ute;meros vac&uacute;olos digestivos e figuras miel&iacute;nicas no seu interior
 na por&ccedil;&atilde;o basal <b>(<a href="/img/revistas/rsbmt/2011nahead/html/
aop09-11_fig01.html#fig1ghi">Figura 1H</a>)</b>. As microvilosidades apicais nes
ta regi&atilde;o mostraram-se longas e finas <b>(<a href="/img/revistas/rsbmt/20
11nahead/html/aop09-11_fig01.html#fig1ghi">Figura 1I</a>)</b>.</font></p>     ^c
Y#aop09-11.htm##
01098000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704085200087002001300939#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#51#47#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Mudan&ccedil;as morfol&oa
cute;gicas nas c&eacute;lulas do mes&ecirc;ntero das larvas foram notadas com 22
h de exposi&ccedil;&atilde;o ao diterpeno. Na regi&atilde;o anterior, as c&eacut
e;lulas apresentaram-se mais baixas que as do grupo controle <b>(<a href="/img/r
evistas/rsbmt/2011nahead/html/aop09-11_fig02.html">Figura 2A</a>)</b>, com regi&
atilde;o basal e apical demostrando certo grau de conserva&ccedil;&atilde;o <b>(
<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html">Figuras 2B</a>
 </b>e <b><a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html">2C</
a>)</b>. A <b><a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html">
Figura 2B</a> </b>mostra em detalhe o aspecto de integridade das mitoc&ocirc;ndr
ias desta regi&atilde;o.</font></p>     ^cY#aop09-11.htm##
01137000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089100087002001300978#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#52#48#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As c&eacute;lulas da regi
&atilde;o mediana <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig0
2.html#fig2def">Figura 2D</a>) </b>apresentaram alto grau de destrui&ccedil;&ati
lde;o, com evidente desorganiza&ccedil;&atilde;o celular e not&aacute;vel forma&
ccedil;&atilde;o de vac&uacute;olos digestivos <b>(<a href="/img/revistas/rsbmt/
2011nahead/html/aop09-11_fig02.html#fig2def">Figura 2E</a>)</b>. Al&eacute;m dis
so, a presen&ccedil;a de in&uacute;meros vac&uacute;olos secretores, de variados
 tamanhos, localizados na regi&atilde;o apical celular pode ser observada <b>(<a
 href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html#fig2def">Figura 2
F</a>)</b>. As microvilosidades da por&ccedil;&atilde;o apical apresentam-se pou
co desenvolvidas, irregulares e praticamente destru&iacute;das.</font></p>     ^
cY#aop09-11.htm##
01073000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704082700087002001300914#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#53#49#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Na regi&atilde;o posterio
r <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html#fig2ghi">
Figura 2G</a>), </b>a membrana citoplasm&aacute;tica basal mostrou grandes dobra
s <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html#fig2ghi">
Figura 2H</a>) </b>e o citoplasma altamente vacuolizado. Tamb&eacute;m houve a f
orma&ccedil;&atilde;o de ves&iacute;culas secretoras por todo o citoplasma, com 
aspecto de expelir para a luz intestinal. No interior dessas ves&iacute;culas, o
correu a forma&ccedil;&atilde;o de grandes e v&aacute;rios vac&uacute;olos diges
tivos <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig02.html#fig2g
hi">Figura 2I</a>)</b>, com restos celulares observados no interior dos mesmos.<
/font></p>     ^cY#aop09-11.htm##
01826000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704158000087002001301667#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#54#50#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Larvas submetidas &agrave
; fra&ccedil;&atilde;o contendo taninos cat&eacute;quicos, cujo constituinte maj
orit&aacute;rio &eacute; uma proantocianidina na forma trim&eacute;rica, apresen
taram diversas altera&ccedil;&otilde;es ultraestruturais, ap&oacute;s 22h, evide
nciando grande destrui&ccedil;&atilde;o celular. A regi&atilde;o anterior aprese
ntou-se com grande quantidade de vac&uacute;olos digestivos, n&uacute;cleo com c
romatina descondensada <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11
_fig03.html">Figura 3A</a>)</b>. A c&eacute;lula em geral apresentou-se sem form
a definida e com apar&ecirc;ncia de degenera&ccedil;&atilde;o. Na regi&atilde;o 
basal celular notou-se a presen&ccedil;a de grande quantidade de mitoc&ocirc;ndr
ias em diversas formas, eletrodensidade e tamanhos <b>(<a href="/img/revistas/rs
bmt/2011nahead/html/aop09-11_fig03.html">Figura 3A</a>)</b>, al&eacute;m de preg
as na l&acirc;mina basal com espa&ccedil;os evidentes entre as dobras desta memb
rana <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig03.html">Figur
a 3B</a>)</b>. A regi&atilde;o apical celular apresentou maior concentra&ccedil;
&atilde;o de vac&uacute;olos digestivos, de v&aacute;rios tamanhos e formas <b>(
<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig03.html">Figura 3C</a>)
</b>. As microvilosidades desta regi&atilde;o apresentaram-se menores e parcialm
ente destru&iacute;das <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11
_fig03.html">Figura 3C</a>)</b>.</font></p>     ^cY#aop09-11.htm##
01151000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090500087002001300992#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#55#51#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A regi&atilde;o mediana d
iferiu-se do controle, pela destrui&ccedil;&atilde;o celular <b>(<a href="/img/r
evistas/rsbmt/2011nahead/html/aop09-11_fig03.html#fig3def">Figura 3D</a>)</b>, c
itoplasma com uma grande quantidade de vac&uacute;olos digestivos, de v&aacute;r
ios tamanhos e formas, n&uacute;cleo com cromatina condensada e nucl&eacute;olo 
evidente <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig03.html#fi
g3def">Figura 3E</a>)</b>. Foi poss&iacute;vel observar a forma&ccedil;&atilde;o
 de ves&iacute;culas secretoras na por&ccedil;&atilde;o apical, onde o conte&uac
ute;do citoplasm&aacute;tico se projeta para o meio externo <b>(<a href="/img/re
vistas/rsbmt/2011nahead/html/aop09-11_fig03.html#fig3def">Figura 3F</a>)</b>. As
 microvilosidades n&atilde;o apresentaram altera&ccedil;&otilde;es evidentes.</f
ont></p>     ^cY#aop09-11.htm##
01148000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090200087002001300989#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#56#52#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Na regi&atilde;o posterio
r, o epit&eacute;lio apresentou-se estratificado, c&eacute;lulas com citoplasma 
heterog&ecirc;neo, n&uacute;cleos irregulares e com presen&ccedil;a de vac&uacut
e;olos <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig03.html#fig3
ghi">Figura 3G</a>)</b>. Na regi&atilde;o basal, houve um deslocamento celular d
a l&acirc;mina basal, formando um isolamento entre a c&eacute;lula epitelial e o
 restante do conte&uacute;do da larva. Notou-se a l&acirc;mina basal celular des
tru&iacute;da <b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig03.ht
ml#fig3ghi">Figura 3H</a>)</b>. A regi&atilde;o apical apresentou-se com microvi
losidades mais curtas e citoplasma altamente vacuolizado <b>(<a href="/img/revis
tas/rsbmt/2011nahead/html/aop09-11_fig03.html#fig3ghi">Figura 3I</a>)</b>.</font
></p>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#57#53#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010600087002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#58#54#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></
font></p>     ^cY#aop09-11.htm##
01455000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704120900087002001301296#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#59#55#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Estudos ultraestruturais 
das c&eacute;lulas do mes&ecirc;ntero de insetos em est&aacute;gios larvais s&at
ilde;o bastante escassos. As observa&ccedil;&otilde;es sobre a ultraestrutura no
rmal das c&eacute;lulas do mes&ecirc;ntero das larvas de 3º est&aacute;dio de <i
>Aedes aegypti </i>realizadas neste trabalho coincidiram com as observa&ccedil;&
otilde;es descritas na literatura<sup>12</sup>, que tamb&eacute;m descrevem a pr
esen&ccedil;a de mitoc&ocirc;ndrias grandes e irregulares e microvilosidades na 
por&ccedil;&atilde;o apical nas c&eacute;lulas do mes&ecirc;ntero associadas &ag
rave; fun&ccedil;&atilde;o de absor&ccedil;&atilde;o. Neste trabalho, as microvi
losidades foram observadas nas tr&ecirc;s regi&otilde;es do mes&ecirc;ntero, sen
do maiores e mais espessas na regi&atilde;o posterior <b>(<a href="/img/revistas
/rsbmt/2011nahead/html/aop09-11_fig01.html">Figuras 1C</a>, <a href="/img/revist
as/rsbmt/2011nahead/html/aop09-11_fig01.html#fig1def">1F</a> </b>e <b><a href="/
img/revistas/rsbmt/2011nahead/html/aop09-11_fig01.html#fig1ghi">1I</a>) </b>dest
acando assim a maior capacidade absortiva das c&eacute;lulas.</font></p>     ^cY
#aop09-11.htm##
00776000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053000087002001300617#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#60#56#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Estudos descritivos sobre
 os tipos de c&eacute;lulas encontrados nos insetos relataram uma associa&ccedil
;&atilde;o de grandes dobras da membrana plasm&aacute;tica basal com mitoc&ocirc
;ndrias, fato tamb&eacute;m observado neste trabalho que indica a realiza&ccedil
;&atilde;o de transporte de &aacute;gua e &iacute;ons por esta membrana<sup>24 <
/sup><b>(<a href="/img/revistas/rsbmt/2011nahead/html/aop09-11_fig01.html#fig1de
f">Figura 1E</a>)</b>.</font></p>     ^cY#aop09-11.htm##
00759000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051300087002001300600#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#61#57#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os efeitos do diterpeno s
obre as c&eacute;lulas do mes&ecirc;ntero das larvas de <i>Aedes aegypti </i>inc
lu&iacute;ram intensas modifica&ccedil;&otilde;es citoplasm&aacute;ticas como va
cuoliza&ccedil;&atilde;o, presen&ccedil;a de grandes vac&uacute;olos de variadas
 formas, desorganiza&ccedil;&atilde;o celular, forma&ccedil;&atilde;o de ves&iac
ute;culas de secre&ccedil;&atilde;o e mudan&ccedil;a estrutural das microvilosid
ades.</font></p>     ^cY#aop09-11.htm##
00985000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704073900087002001300826#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#62#58#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os principais efeitos do 
diterpeno e da fra&ccedil;&atilde;o rica em taninos foram &agrave; degenera&cced
il;&atilde;o celular, vacuoliza&ccedil;&atilde;o citoplasm&aacute;tica, altera&c
cedil;&atilde;o das microvilosidades, n&uacute;cleos irregulares e deslocamento 
das c&eacute;lulas da l&acirc;mina basal. Isto seria consequ&ecirc;ncia da intox
ica&ccedil;&atilde;o celular causada tanto pelo diterpeno quanto pelos taninos, 
levando &agrave; forma&ccedil;&atilde;o de ves&iacute;culas e &agrave; lise celu
lar. Efeitos similares foram obtidos com as plantas <i>Alnus glutinosa, Magonia 
pubescens, Populus nigra </i>e <i>Quercus robur</i><sup>11,25,26</sup>.</font></
p>     ^cY#aop09-11.htm##
01377000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704113100087002001301218#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#63#59#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A forma&ccedil;&atilde;o 
de ves&iacute;culas secretoras na por&ccedil;&atilde;o apical das c&eacute;lulas
 analisadas indica que o conte&uacute;do citoplasm&aacute;tico celular est&aacut
e; sendo expelido para a luz intestinal como forma de defesa &agrave; a&ccedil;&
atilde;o do diterpeno e do tanino. A presen&ccedil;a dessas ves&iacute;culas, as
sociada &agrave; intensa vacuoliza&ccedil;&atilde;o citoplasm&aacute;tica, demon
stra a acelera&ccedil;&atilde;o do processo de lise celular provocado pelo efeit
o t&oacute;xico das subst&acirc;ncias analisadas. Estudos ultraestruturais sobre
 larvas de <i>Aedes aegypti </i>tratadas com <i>Bacilllus thuringiensis </i>rela
taram a presen&ccedil;a dessas mesmas altera&ccedil;&otilde;es al&eacute;m de de
formidades no n&uacute;cleo destas c&eacute;lulas com mudan&ccedil;a na forma e 
forma&ccedil;&atilde;o de mais poros no envelope nuclear<sup>26</sup>. Nas larva
s tratadas com taninos, as c&eacute;lulas apresentaram n&uacute;cleos irregulare
s, sem o aumento no n&uacute;mero de poros no envelope nuclear.</font></p>     ^
cY#aop09-11.htm##
01143000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089700087002001300984#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#64#60#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">O mes&ecirc;ntero &eacute
; o principal &oacute;rg&atilde;o respons&aacute;vel pela absor&ccedil;&atilde;o
 de nutrientes pelos insetos em geral<sup>26</sup>. V&aacute;rios trabalhos sobr
e o efeito larvicida de diversas subst&acirc;ncias, em Diptera, relatam que as p
rincipais altera&ccedil;&otilde;es morfohistol&oacute;gicas ocorrem no mes&ecirc
;ntero, desta forma, fica claro o importante papel desta por&ccedil;&atilde;o do
 tubo digest&oacute;rio no processo de absor&ccedil;&atilde;o<sup>1,11,12,25</su
p>. As altera&ccedil;&otilde;es provocadas por estas subst&acirc;ncias, independ
ente se s&atilde;o de origem qu&iacute;mica ou biol&oacute;gica, s&atilde;o semp
re semelhantes. Isto comprova que estas altera&ccedil;&otilde;es s&atilde;o resp
ostas das c&eacute;lulas diante da intoxica&ccedil;&atilde;o sofrida.</font></p>
     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#65#61#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#66#62#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLITO DE INTERESSE<
/b></font></p>     ^cY#aop09-11.htm##
00432000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018600087002001300273#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#67#63#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os autores declaram n&ati
lde;o haver nenhum tipo de conflito de interesse no desenvolvimento do estudo.</
font></p>     ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#68#64#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010800087002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#69#65#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>SUPORTE FINANCEIRO</b>
</font></p>     ^cY#aop09-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#70#66#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">CNPq e FAPEG.</font></p> 
    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#71#67#article#129#<p>&nbsp
;</p>     ^cY#aop09-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#72#68#article#129#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b><
/font></p>     ^cY#aop09-11.htm##
00427000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016700089002001300256#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#73#69#article#
129#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Derouich
 M, Boutayeb A, Twizell EH. A model of dengue fever. Bio Med Eng Online 2003; 19
:2-4.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#74#70#article#129#</font><
/p>     ^cY#aop09-11.htm##
00488000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022800089002001300317#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#75#71#article#
129#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Minist&e
acute;rio da Sa&uacute;de. Guia de vigil&acirc;ncia epidemiol&oacute;gica. Bras&
iacute;lia: Funda&ccedil;&atilde;o Nacional de Sa&uacute;de; 2009.    ^cY#aop09-
11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#76#72#article#129#</font><
/p>     ^cY#aop09-11.htm##
00470000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021000089002001300299#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#77#73#article#
129#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. World He
alth Organization. Dengue/dengue hemorrhagic fever prevention and control. New D
elhi: Regional Office for South-East Asia; 2000.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#78#74#article#129#</font><
/p>     ^cY#aop09-11.htm##
00472000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021200089002001300301#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#79#75#article#
129#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Donal&ia
cute;sio MR, Glasser CM. Vigil&acirc;ncia entomol&oacute;gica e controle de veto
res do dengue. Rev Bras Epidemiol 2002; 5:259-272.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#80#76#article#129#</font><
/p>     ^cY#aop09-11.htm##
00668000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704040800089002001300497#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#81#77#article#
129#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Minist&e
acute;rio da Sa&uacute;de. Secretaria de Vigil&acirc;ncia em Sa&uacute;de. Infor
me epidemiol&oacute;gico da dengue, 1 a 52 semanas de 2009. &#91;Acesso 20 mar&c
cedil;o 2010&#93;. Dispon&iacute;vel em <a href="http://portal.saude.gov.br/port
al/arquivos/pdf/" target="_blank">http://portal.saude.gov.br/portal/arquivos/pdf
/</a>.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#82#78#article#129#</font><
/p>     ^cY#aop09-11.htm##
00459000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704019900089002001300288#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#83#79#article#
129#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Serufo J
C, Nobre V, Rayes A, Marcial TM, Lambertuccil JR. Dengue: uma nova abordagem. Re
v Soc Bras Med Trop 2000; 33:465-476.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#84#80#article#129#</font><
/p>     ^cY#aop09-11.htm##
00557000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029700089002001300386#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#85#81#article#
129#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Braga IA
, Lima JBP, Silva SS, Valle D. <i>Aedes aegypti </i>resistance to temephos durin
g 2001 in several municipalities in the states of Rio de Janeiro, Sergipe, and A
lagoas, Brazil. Mem Inst Oswaldo Cruz 2004; 99:199-203.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#86#82#article#129#</font><
/p>     ^cY#aop09-11.htm##
00549000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030300087002001300390#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#87#83#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Carvalho MSL, Caldas E
D, Degallier N, Vilarinhos PTR, Souza LCKR, Yoshizawa MAC, et al. Suscetibilidad
e de larvas de <i>Aedes aegypti </i>ao inseticida temephos no Distrito Federal. 
Rev Saude Publica 2004; 38:623-629.</font></p>     ^cY#aop09-11.htm##
00580000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704032000089002001300409#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#88#84#article#
129#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Cunha MP
, Lima JBP, Brogdon WG, Moya GE, Valle D. Monitoring of resistance to the pyreth
roid cypermethrin in Brazilian <i>Aedes aegypti </i>(Diptera: Culicidae) populat
ions collected between 2001 and 2003. Mem Inst Oswaldo Cruz 2005; 100:441-444.  
  ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#89#85#article#129#</font><
/p>     ^cY#aop09-11.htm##
00521000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027500087002001300362#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#90#86#article#129#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Luna JED, Martins MF,
 Anjos AF, Kuwabara EF, Navarro-Silva MA. Susceptibilidade de <i>Aedes aegypti <
/i>aos inseticidas temephos e cipermetrina, Brasil. Rev Saude Publica 2004; 38:8
42-843.</font></p>     ^cY#aop09-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704025100090002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#91#87#article#
129#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Arruda
 W, Oliveira GMC, Silva IG. Toxicidade do extrato etan&oacute;lico de <i>Magonia
 pubescens </i>sobre larvas de <i>Aedes aegypti</i>. Rev Soc Bras Med Trop 2003;
 36:17-25.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#92#88#article#129#</font><
/p>     ^cY#aop09-11.htm##
00580000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704031900090002001300409#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#93#89#article#
129#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Arruda
 W, Oliveira GMC, Silva IG. Estudo ultra-estrutural do efeito da toxicidade do e
xtrato da <i>Magonia pubescens </i>(St. Hil.) no mes&ecirc;ntero de larvas de <i
>Aedes aegypti </i>(L.) (Diptera, Culicidae). Rev Patol Trop 2008; 37:255-267.  
  ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#94#90#article#129#</font><
/p>     ^cY#aop09-11.htm##
00517000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704025600090002001300346#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#95#91#article#
129#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Cavalc
anti ESB, Morais SM, Lima MAA, Santana EWP. Larvicidal Activity of Essential Oil
s from Brazilian Plants against <i>Aedes aegypti </i>L. Mem Inst Oswaldo Cruz 20
04; 99:541-544.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#96#92#article#129#</font><
/p>     ^cY#aop09-11.htm##
00546000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704028500090002001300375#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#97#93#article#
129#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Lima M
GA, Maia ICC, Sousa BD, Morais SM, Freitas SM. Effect of stalk and leaf extracts
 from Euphorbiaceae species on <i>Aedes aegypti </i>(Diptera, Culicidae) larvae.
 Rev Inst Med Trop S Paulo 2006; 48:211-214.    ^cY#aop09-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#98#94#article#129#</font><
/p>     ^cY#aop09-11.htm##
00561000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704030000090002001300390#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#99#95#article#
129#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Pohlit
 AM, Quignard ELJ, Nunomura SM, Tadei WP, Hidalgo AF, Pinto ACS, et al. Screenin
g of plants found in the State of Amazonas, Brazil for larvicidal activity again
st <i>Aedes aegypti</i> larvae. Acta Amaz 2004; 34: 97-105.    ^cY#aop09-11.htm#
#
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#100#96#article#129#</font>
</p>     ^cY#aop09-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704031600091002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#101#97#article
#129#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Silva
 HHG, Silva IG, Santos RMG, Rodrigues Filho E, Elias CN. Atividade larvicida de 
taninos isolados de <i>Magonia pubescens </i>St. Hil. (Sapindaceae) sobre <i>Aed
es aegypti</i> (Diptera, Culicidae). Rev Soc Bras Med Trop 2004; 37:396-399.    
^cY#aop09-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#102#98#article#129#</font>
</p>     ^cY#aop09-11.htm##
00533000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704027100091002001300362#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#103#99#article
#129#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Silva
 IG, Zanon VOM, Silva HHG. Larvicidal Activity of <i>Copaifera reticulata </i>Du
cke Oil-Resin against <i>Culex quinquefasciatus </i>Say (Diptera: Culicidae). Ne
otrop Entomol 2003; 32:729-732.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#104#100#article#129#</font
></p>     ^cY#aop09-11.htm##
00628000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036500092002001300457#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#105#101#articl
e#129#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Silv
a HHG, Geris R, Rodrigues Filho E, Rocha C, Silva IG. Larvicidal activity of oil
-resin fractions from the Brazilian medicinal plant <i>Copaifera reticulata </i>
Ducke (Leguminosae-Caesalpinoideae) against <i>Aedes aegypti </i>(Diptera, Culic
idae). Rev Soc Bras Med Trop 2007; 40:264-267.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#106#102#article#129#</font
></p>     ^cY#aop09-11.htm##
00547000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028400092002001300376#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#107#103#articl
e#129#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Geri
s R, Rodrigues Filho E, Silva HHG, Silva IG. Larvicidal effects of fungal merote
rpenoids in the control of <i>Aedes aegypti </i>L., the main vector dengue and y
ellow fever. Chem Biodivers 2008; 5: 341-345.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#108#104#article#129#</font
></p>     ^cY#aop09-11.htm##
00556000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029300092002001300385#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#109#105#articl
e#129#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Silv
a HHG, Silva IG, Lira KS. Metodologia de cria&ccedil;&atilde;o, manuten&ccedil;&
atilde;o de adultos e estocagem de ovos de <i>Aedes aegypti </i>(Linnaeus, 1762)
 em laborat&oacute;rio. Rev Patol Trop 1998; 27:53-63.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#110#106#article#129#</font
></p>     ^cY#aop09-11.htm##
00543000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028000092002001300372#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#111#107#articl
e#129#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Benc
himol M, Attias M, Silva NLC, Carvalho TMU. M&eacute;todos de estudo da c&eacute
;lula. Rio de Janeiro: Funda&ccedil;&atilde;o Estadual Norte Fluminense. Univers
idade Estadual do Norte Fluminense; 1996.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#112#108#article#129#</font
></p>     ^cY#aop09-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020500092002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#113#109#articl
e#129#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Bozz
ola JJ, Russel LD. Electron Microscopy: principles and techiniques for biologist
. Boston: Jones and Bartlett Publishers; 1992.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#114#110#article#129#</font
></p>     ^cY#aop09-11.htm##
00499000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023600092002001300328#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#115#111#articl
e#129#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Souz
a W. Manual sobre t&eacute;cnicas b&aacute;sicas em microscopia eletr&ocirc;nica
. Rio de Janeiro: Sociedade Brasileira de Microscopia Eletr&ocirc;nica; 1989.   
 ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#116#112#article#129#</font
></p>     ^cY#aop09-11.htm##
00456000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019300092002001300285#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#117#113#articl
e#129#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Cava
lcante VM, Cruz-Landim C. Types of cells present in the midgut of the insects: a
 review. Naturalia 1999; 24:19-40.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#118#114#article#129#</font
></p>     ^cY#aop09-11.htm##
00505000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024200092002001300334#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#119#115#articl
e#129#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Davi
d JP, Delphine R, Pautou MP, Meyran JC. Differential toxicity of leaf litter to 
dipteran larvae of mosquito developmental sites. J Invertebr Pathol 2000; 75: 9-
18.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#120#116#article#129#</font
></p>     ^cY#aop09-11.htm##
00506000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024300092002001300335#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#121#117#articl
e#129#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Delp
hine R, Pautou MP, Meyran JP. Histopathological effects of tannic acid on the mi
dgut epithelium of some aquatic Diptera larvae. J Invertebr Pathol 1999; 73:173-
181.    ^cY#aop09-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#122#118#article#129#</font
></p>     ^cY#aop09-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#123#119#article#129#<p>&nb
sp;</p>     ^cY#aop09-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#124#120#article#129#<p>&nb
sp;</p>     ^cY#aop09-11.htm##
00474000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704022600089002001300315#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#125#121#article#129#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota1"></a><a 
href="#nota_1"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a
> <b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#aop09-11.htm##
00291000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004300089002001300132#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#126#122#article#129#<br>  
 Dr. Ionizete Garcia da Silva    ^cY#aop09-11.htm##
00322000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007400089002001300163#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#127#123#article#129#<br>  
 Deptº Microbiologia, Imunol, Parasitol e Patologia/PTSP/UFG    ^cY#aop09-11.htm
##
00307000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005900089002001300148#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#128#124#article#129#<br>  
 Caixa Postal 131, Setor Universit&aacute;rio    ^cY#aop09-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004200089002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#129#125#article#129#<br>  
 74605-050 Goi&acirc;nia, GO    ^cY#aop09-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005700089002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#130#126#article#129#<br>  
 Tel: 55 62 3209-6128; Fax: 55 62 3261-2077    ^cY#aop09-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009900089002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#131#127#article#129#<br>  
 e-mail: <a href="mailto:ionizete@iptsp.ufg.br">ionizete@iptsp.ufg.br</a></font>
</p>     ^cY#aop09-11.htm##
00371000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704012300089002001300212#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#132#128#article#129#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Recebido para publica&c
cedil;&atilde;o em 02/06/2010    ^cY#aop09-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#p#133#129#article#129#<br>  
 Aceito em 04/11/2010</font></p>     ^cY#aop09-11.htm##
00512000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100018001060100
01800124012002800142030001900170710000200189065000900191064000500200031000300205
014000400208865000900212002001300221#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop09-11.htm#S#c#134#1#article#26#1#^rND^sDerouich^nM#^rND^sBoutayeb^nA
#^rND^sTwizell^nEH#A model of dengue fever^len#Bio Med Eng Online#2#20030000#200
3#19#2-4#20110000#aop09-11.htm##
00448000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170020000880180038001080660
00900146062002700155065000900182064000500191865000900196002001300205#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#135#2#article#26#2#Min
istério da Saúde#Guia de vigilância epidemiológica^lpt#Brasília#Fundação Naciona
l de Saúde#20090000#2009#20110000#aop09-11.htm##
00486000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170026000880180060001140660
01000174062003600184065000900220064000500229865000900234002001300243#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#136#3#article#26#3#Wor
ld Health Organization#Dengue: dengue hemorrhagic fever prevention and control^l
en#New Delhi#Regional Office for South-East Asia#20000000#2000#20110000#aop09-11
.htm##
00505000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100018001080120
06000126033001900186065000900205064000500214031000200219014000800221865000900229
002001300238#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#
c#137#4#article#26#4#^rND^sDonalísio^nMR#^rND^sGlasser^nCM#Vigilância entomológi
ca e controle de vetores do dengue^lpt#Rev Bras Epidemiol#20020000#2002#5#259-27
2#20110000#aop09-11.htm##
00515000000000217000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170020000880180096001081100
00900204109001400213037004800227865000900275002001300284#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#138#5#article#26#5#Ministério da S
aúde#Secretaria de Vigilância em Saúde: Informe epidemiológico da dengue, 1 a 52
 semanas de 2009^lpt#20100320#20 março 2010#http://portal.saude.gov.br/portal/ar
quivos/pdf/#20110000#aop09-11.htm##
00622000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100015001050100
01500120010001800135010002300153012003100176030002200207065000900229064000500238
031000300243014000800246865000900254002001300263035001000276801002200286#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#139#6#article#26#6
#^rND^sSerufo^nJC#^rND^sNobre^nV#^rND^sRayes^nA#^rND^sMarcial^nTM#^rND^sLambertu
ccil^nJR#Dengue: uma nova abordagem^lpt#Rev Soc Bras Med Trop#20000000#2000#33#4
65-476#20110000#aop09-11.htm#0037-8682#Rev Soc Bras Med Trop##
00695000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100016001040100
01600120010001500136012014100151030002200292065000900314064000500323031000300328
014000800331865000900339002001300348035001000361801002200371#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#140#7#article#26#7#^rND^sBraga
^nIA#^rND^sLima^nJBP#^rND^sSilva^nSS#^rND^sValle^nD#Aedes aegypti resistance to 
temephos during 2001 in several municipalities in the states of Rio de Janeiro, 
Sergipe, and Alagoas, Brazil^len#Mem Inst Oswaldo Cruz#20040000#2004#99#199-203#
20110000#aop09-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00732000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100017001080100
01900125010002200144010001800166010002100184810000600205012009000211030001800301
06500090031906400050032803100030033301400080033686500090034400200130035303500100
0366801001800376#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.ht
m#S#c#141#8#article#26#8#^rND^sCarvalho^nMSL#^rND^sCaldas^nED#^rND^sDegallier^nN
#^rND^sVilarinhos^nPTR#^rND^sSouza^nLCKR#^rND^sYoshizawa^nMAC#et al#Suscetibilid
ade de larvas de Aedes aegypti ao inseticida temephos no Distrito Federal^lpt#Re
v Saude Publica#20040000#2004#38#623-629#20110000#aop09-11.htm#0034-8910#Rev Sau
de Publica##
00736000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100016001040100
01800120010001500138010001500153012015200168030002200320065000900342064000500351
031000400356014000800360865000900368002001300377035001000390801002200400#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#142#9#article#26#9
#^rND^sCunha^nMP#^rND^sLima^nJBP#^rND^sBrogdon^nWG#^rND^sMoya^nGE#^rND^sValle^nD
#Monitoring of resistance to the pyrethroid cypermethrin in Brazilian Aedes aegy
pti (Diptera: Culicidae) populations collected between 2001 and 2003^len#Mem Ins
t Oswaldo Cruz#20050000#2005#100#441-444#20110000#aop09-11.htm#0074-0276#Mem Ins
t Oswaldo Cruz##
00676000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01600124010001900140010002400159012008600183030001800269065000900287064000500296
031000300301014000800304865000900312002001300321035001000334801001800344#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#143#10#article#26#
10#^rND^sLuna^nJED#^rND^sMartins^nMF#^rND^sAnjos^nAF#^rND^sKuwabara^nEF#^rND^sNa
varro-Silva^nMA#Susceptibilidade de Aedes aegypti aos inseticidas temephos e cip
ermetrina, Brasil^lpt#Rev Saude Publica#20040000#2004#38#842-843#20110000#aop09-
11.htm#0034-8910#Rev Saude Publica##
00618000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100020001060100
01600126012008700142030002200229065000900251064000500260031000300265014000600268
865000900274002001300283035001000296801002200306#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop09-11.htm#S#c#144#11#article#26#11#^rND^sArruda^nW#^rND^
sOliveira^nGMC#^rND^sSilva^nIG#Toxicidade do extrato etanólico de Magonia pubesc
ens sobre larvas de Aedes aegypti^lpt#Rev Soc Bras Med Trop#20030000#2003#36#17-
25#20110000#aop09-11.htm#0037-8682#Rev Soc Bras Med Trop##
00680000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100020001060100
01600126012016100142030001500303065000900318064000500327031000300332014000800335
865000900343002001300352035001000365801001500375#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop09-11.htm#S#c#145#12#article#26#12#^rND^sArruda^nW#^rND^
sOliveira^nGMC#^rND^sSilva^nIG#Estudo ultra-estrutural do efeito da toxicidade d
o extrato da Magonia pubescens (St. Hil.) no mesêntero de larvas de Aedes aegypt
i (L.) (Diptera, Culicidae)^lpt#Rev Patol Trop#20080000#2008#37#255-267#20110000
#aop09-11.htm#0301-0406#Rev Patol Trop##
00655000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100017001120100
01600129010001900145012008800164030002200252065000900274064000500283031000300288
014000800291865000900299002001300308035001000321801002200331#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#146#13#article#26#13#^rND^sCav
alcanti^nESB#^rND^sMorais^nSM#^rND^sLima^nMAA#^rND^sSantana^nEWP#Larvicidal Acti
vity of Essential Oils from Brazilian Plants against Aedes aegypti L^lpt#Mem Ins
t Oswaldo Cruz#20040000#2004#99#541-544#20110000#aop09-11.htm#0074-0276#Mem Inst
 Oswaldo Cruz##
00706000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01600122010001700138010001800155012011000173030002600283065000900309064000500318
031000300323014000800326865000900334002001300343035001000356801002600366#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#147#14#article#26#
14#^rND^sLima^nMGA#^rND^sMaia^nICC#^rND^sSousa^nBD#^rND^sMorais^nSM#^rND^sFreita
s^nSM#Effect of stalk and leaf extracts from Euphorbiaceae species on Aedes aegy
pti (Diptera, Culicidae) larvae^lpt#Rev Inst Med Trop S Paulo#20060000#2006#48#2
11-214#20110000#aop09-11.htm#0036-4665#Rev Inst Med Trop S Paulo##
00597000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100020001070120
11600127030001000243065000900253064000500262031000300267014000700270865000900277
002001300286035001000299801001000309#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop09-11.htm#S#c#148#15#article#26#15#^rND^sPohlit^nAM#^rND^sQuignard^n
ELJ#Screening of plants found in the State of Amazonas, Brazil for larvicidal ac
tivity against Aedes aegypti larvae^lpt#Acta Amaz#20040000#2004#34#97-105#201100
00#aop09-11.htm#0044-5967#Acta amaz##
00726000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01800123010002500141010001600166012012900182030002200311065000900333064000500342
031000300347014000800350865000900358002001300367035001000380801002200390#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#149#16#article#26#
16#^rND^sSilva^nHHG#^rND^sSilva^nIG#^rND^sSantos^nRMG#^rND^sRodrigues Filho^nE#^
rND^sElias^nCN#Atividade larvicida de taninos isolados de Magonia pubescens St. 
Hil. (Sapindaceae) sobre Aedes aegypti (Diptera, Culicidae)^lpt#Rev Soc Bras Med
 Trop#20040000#2004#37#396-399#20110000#aop09-11.htm#0037-8682#Rev Soc Bras Med 
Trop##
00603000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01700123012012000140030001600260710000200276065000900278064000500287031000300292
014000800295865000900303002001300312#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop09-11.htm#S#c#150#17#article#26#17#^rND^sSilva^nIG#^rND^sZanon^nVOM#
^rND^sSilva^nHHG#Larvicidal Activity of Copaifera reticulata Ducke Oil-Resin aga
inst Culex quinquefasciatus Say (Diptera: Culicidae)^len#Neotrop Entomol#2#20030
000#2003#32#729-732#20110000#aop09-11.htm##
00775000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100015001070100
02500122010001500147010001600162012018200178030002200360065000900382064000500391
031000300396014000800399865000900407002001300416035001000429801002200439#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#151#18#article#26#
18#^rND^sSilva^nHHG#^rND^sGeris^nR#^rND^sRodrigues Filho^nE#^rND^sRocha^nC#^rND^
sSilva^nIG#Larvicidal activity of oil-resin fractions from the Brazilian medicin
al plant Copaifera reticulata Ducke (Leguminosae-Caesalpinoideae) against Aedes 
aegypti (Diptera, Culicidae)^len#Rev Soc Bras Med Trop#20070000#2007#40#264-267#
20110000#aop09-11.htm#0037-8682#Rev Soc Bras Med Trop##
00640000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100025001050100
01700130010001600147012012400163030001500287710000200302065000900304064000500313
031000200318014000800320865000900328002001300337#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop09-11.htm#S#c#152#19#article#26#19#^rND^sGeris^nR#^rND^s
Rodrigues Filho^nE#^rND^sSilva^nHHG#^rND^sSilva^nIG#Larvicidal effects of fungal
 meroterpenoids in the control of Aedes aegypti L., the main vector dengue and y
ellow fever^len#Chem Biodivers#2#20080000#2008#5#341-345#20110000#aop09-11.htm##
00632000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01500123012011900138030001500257065000900272064000500281031000300286014000600289
865000900295002001300304035001000317801001500327#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop09-11.htm#S#c#153#20#article#26#20#^rND^sSilva^nHHG#^rND
^sSilva^nIG#^rND^sLira^nKS#Metodologia de criação, manutenção de adultos e estoc
agem de ovos de Aedes aegypti (Linnaeus, 1762) em laboratório^lpt#Rev Patol Trop
#19980000#1998#27#53-63#20110000#aop09-11.htm#0301-0406#Rev Patol Trop##
00600000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160019000900160016001090160
01700125016002000142018003200162066001500194062003500209062004200244065000900286
064000500295865000900300002001300309#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop09-11.htm#S#c#154#21#article#26#21#^rND^sBenchimol^nM#^rND^sAttias^n
M#^rND^sSilva^nNLC#^rND^sCarvalho^nTMU#Métodos de estudo da célula^lpt#Rio de Ja
neiro#Fundação Estadual Norte Fluminense#Universidade Estadual do Norte Fluminen
se#19960000#1996#20110000#aop09-11.htm##
00506000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900160017001080180
06600125066000700191062003000198065000900228064000500237865000900242002001300251
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#155#22#art
icle#26#22#^rND^sBozzola^nJJ#^rND^sRussel^nLD#Electron Microscopy: principles an
d techiniques for biologist^len#Boston#Jones and Bartlett Publishers#19920000#19
92#20110000#aop09-11.htm##
00493000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160015000900180060001050660
01500165062004700180065000900227064000500236865000900241002001300250#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#156#23#article#26#23#^
rND^sSouza^nW#Manual sobre técnicas básicas em microscopia eletrônica^lpt#Rio de
 Janeiro#Sociedade Brasileira de Microscopia Eletrônica#19890000#1989#20110000#a
op09-11.htm##
00541000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100021001110120
05600132030001000188065000900198064000500207031000300212014000600215865000900221
002001300230035001000243801001000253#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop09-11.htm#S#c#157#24#article#26#24#^rND^sCavalcante^nVM#^rND^sCruz-L
andim^nC#Types of cells present in the midgut of the insects^len#Naturalia#19990
000#1999#24#19-40#20110000#aop09-11.htm#0101-1444#NATURALIA##
00644000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01700124010001700141012009200158030001900250065000900269064000500278032000300283
014000500286865000900291002001300300035001000313801001900323#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop09-11.htm#S#c#158#25#article#26#25#^rND^sDav
id^nJP#^rND^sDelphine^nR#^rND^sPautou^nMP#^rND^sMeyran^nJC#Differential toxicity
 of leaf litter to dipteran larvae of mosquito developmental sites^len#J Inverte
br Pathol#20000000#2000#75#9-18#20110000#aop09-11.htm#0022-2011#J Invertebr Path
ol##
00628000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01700125012010100142030001900243065000900262064000500271031000300276014000800279
865000900287002001300296035001000309801001900319#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop09-11.htm#S#c#159#26#article#26#26#^rND^sDelphine^nR#^rN
D^sPautou^nMP#^rND^sMeyran^nJP#Histopathological effects of tannic acid on the m
idgut epithelium of some aquatic Diptera larvae^len#J Invertebr Pathol#19990000#
1999#73#173-181#20110000#aop09-11.htm#0022-2011#J Invertebr Pathol##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#o#1#
1#article#1#20110325#103638#aop10-11.htm#200##
05558000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201270
01860120144003130100030004570100054004870100035005410100037005760100042006130700
09700655070009200752083181900844085000802663085004502671085002402716085004502740
08500330278508317400281808500080455808500520456608500240461808500500464208500330
46920580056047250580041047811170006048220720003048281120009048311110011048401140
00904851113001104860002001304871#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop10-11.htm#S#h#2#1#article#1#oa#en#br1.1#1#4.0#GRA#TAB#09#nd#nd#Rev. Soc.
 Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110401#Trends in antimicrobi
al resistance among clinical isolates of enterococci in a Brazilian tertiary hos
pital: a 4-year study^len#Evolução da resistência aos antimicrobianos entre isol
ados clínicos de enterococos em um hospital terciário brasileiro: um estudo de 4
 anos^lpt#^rND^1A01^nNatália^sConceição#^rND^1A02^nCristina da Cunha Hueb Barata
 de^sOliveira#^rND^1A01^nPaulo Roberto da^sSilva#^rND^1A01^nBárbara Godoi Melo^s
Ávila#^rND^1A01^nAdriana Gonçalves de^sOliveira#Universidade Federal do Triângul
o Mineiro^iA01^1Departamento de Ciências Biológicas^cUberaba^sMG#Universidade Fe
deral do Triângulo Mineiro^iA02^1Departamento de Clínica Médica^cUberaba^sMG#^le
n^aINTRODUCTION: In the past two decades members of the genus Enterococcus have 
emerged as important nosocomial pathogens worldwide. This study prospectively an
alyzed the distribution of species and trends in antimicrobial resistance among 
clinical isolates of enterococci in a Brazilian tertiary hospital from 2006-2009
. METHODS: Enterococcal species were identified by conventional biochemical test
s. The antimicrobial susceptibility profile was performed by disk diffusion in a
ccordance with the Clinical and Laboratory Standards Institute (CLSI). A screeni
ng test for vancomycin was also performed. Minimal inhibitory concentration (MIC
) for vancomycin was determined using the broth dilution method. Molecular assay
s were used to confirm speciation and genotype of vancomycin-resistant enterococ
ci (VRE). RESULTS: A total of 324 non-repetitive enterococcal isolates were reco
vered, of which 87% were E. faecalis and 10.8% E. faecium. The incidence of E. f
aecium per 1,000 admissions increased significantly (p < 0.001) from 0.3 in 2006
 to 2.3 in 2009. The VRE rate also increased over time from 2.5% to 15.5% (p < 0
.001). All VRE expressed high-level resistance to vancomycin (MIC &gt;256µg/ mL)
 and harbored vanA genes. The majority (89.5%) of VRE belonged to E. faecium spe
cies, which were characteristically resistant to ampicillin and quinolones. Over
all, ampicillin resistance rate increased significantly from 2.5% to 21.4% from 
2006-2009. Resistance rates for gentamicin, chloramphenicol, tetracycline, and e
rythromycin significantly decreased over time, although they remained high. Quin
olones resistance rates were high and did not change significantly over time. CO
NCLUSIONS: The data obtained show a significant increasing trend in the incidenc
e of E. faecium resistant to ampicillin and vancomycin.#^dnd^i1#^tm^len^kAntimic
robial resistance profile^i1#^tm^len^kEnterococci^i1#^tm^len^kVancomycin-resista
nt enterococci^i1#^tm^len^kEnterococcus faecium^i1#^lpt^aINTRODUÇÃO: Nas últimas
 duas décadas, os enterococos emergiram como importantes patógenos nosocomiais n
o mundo inteiro. Neste estudo, foi analisada a distribuição das espécies e a evo
lução da resistência aos antimicrobianos entre isolados clínicos de enterococos 
obtidos em um hospital terciário, no período de 2006 a 2009. MÉTODOS: As espécie
s foram identificadas por testes bioquímicos convencionais e o perfil de sensibi
lidade foi determinado pelo método de disco difusão. A sensibilidade à vancomici
na foi também determinada pela triagem em agar e pela concentração inibitória mí
nima (CIM). Testes moleculares foram utilizados para confirmar as espécies e det
erminar os genótipos dos enterococos resistentes à vancomicina (VRE). RESULTADOS
: Foram analisadas 324 amostras de enterococos, sendo 87% E. faecalis e 10,8% E.
 faecium. A incidência de E. faecium por 1.000 pacientes internados aumentou sig
nificativamente (p < 0,001) de 0,3 em 2006 para 2,3 em 2009. A taxa de VRE també
m aumentou significativamente de 2,5% para 15,5% (p < 0,001). Todos os VRE apres
entaram genótipo VanA e CIM &gt;256µg/mL para vancomicina. A maioria (89,5%) dos
 VRE pertencia à espécie E. faecium e foram resistentes à ampicilina e quinolona
s. Foi observado um aumento significativo na taxa de resistência à ampicilina, d
e 2,5% (2006) para 21,4% (2009). As taxas de resistência para gentamicina, clora
nfenicol, tetraciclina e eritromicina diminuíram significativamente no período d
o estudo. Para as quinolonas, as taxas de resistência foram elevadas não alterar
am significativamente, no período do estudo. CONCLUSÕES: Os resultados do presen
te estudo mostram um aumento significativo na incidência de E. faecium resistent
es à ampicilina e vancomicina.#^dnd^i2#^tm^lpt^kPerfil de resistência a antimicr
obianos^i2#^tm^lpt^kEnterococos^i2#^tm^lpt^kEnterococos resistentes à vancomicin
a^i2#^tm^lpt^kEnterococcus faecium^i2#Fundação de Amparo à Pesquisa do Estado de
 Minas Gerais#Fundação de Ensino e Pesquisa de Uberaba#other#34#20101022#22/10/2
010#20101117#17/11/2010#aop10-11.htm##
05752000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201410
01860120158003270100030004850100054005150100035005690100037006040100042006410700
09700683070009200780083190200872085000802774085004502782085002402827085004502851
08500400289608318090293608500080474508500520475308500240480508500500482908500400
48790580056049190580041049751170006050160720003050221120009050251110011050341140
00905045113001105054002001305065#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop10-11.htm#S#f#3#1#article#1#oa#en#br1.1#1#4.0#GRA#TAB#09#nd#nd#Rev. Soc.
 Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110401#<b>Trends in antimicr
obial resistance among clinical isolates of enterococci in a Brazilian tertiary 
hospital</b>: <b>a 4-year study</b>^len#<b>Evolução da resistência aos antimicro
bianos entre isolados clínicos de enterococos em um hospital terciário brasileir
o</b>: <b>um estudo de 4 anos</b>^lpt#^rND^1A01^nNatália^sConceição#^rND^1A02^nC
ristina da Cunha Hueb Barata de^sOliveira#^rND^1A01^nPaulo Roberto da^sSilva#^rN
D^1A01^nBárbara Godoi Melo^sÁvila#^rND^1A01^nAdriana Gonçalves de^sOliveira#Univ
ersidade Federal do Triângulo Mineiro^iA01^1Departamento de Ciências Biológicas^
cUberaba^sMG#Universidade Federal do Triângulo Mineiro^iA02^1Departamento de Clí
nica Médica^cUberaba^sMG#^len^a<b>INTRODUCTION: </b>In the past two decades memb
ers of the genus <i>Enterococcus </i>have emerged as important nosocomial pathog
ens worldwide. This study prospectively analyzed the distribution of species and
 trends in antimicrobial resistance among clinical isolates of enterococci in a 
Brazilian tertiary hospital from 2006-2009. <b>METHODS: </b>Enterococcal species
 were identified by conventional biochemical tests. The antimicrobial susceptibi
lity profile was performed by disk diffusion in accordance with the Clinical and
 Laboratory Standards Institute (CLSI). A screening test for vancomycin was also
 performed. Minimal inhibitory concentration (MIC) for vancomycin was determined
 using the broth dilution method. Molecular assays were used to confirm speciati
on and genotype of vancomycin-resistant enterococci (VRE). <b>RESULTS:</b> A tot
al of 324 non-repetitive enterococcal isolates were recovered, of which 87% were
 <i>E. faecalis </i>and 10.8% <i>E. faecium</i>. The incidence of <i>E. faecium 
</i>per 1,000 admissions increased significantly (p &lt; 0.001) from 0.3 in 2006
 to 2.3 in 2009. The VRE rate also increased over time from 2.5% to 15.5% (p &lt
; 0.001). All VRE expressed high-level resistance to vancomycin (MIC &gt;256µg/ 
mL) and harbored <i>vanA </i>genes. The majority (89.5%) of VRE belonged to <i>E
. faecium </i>species, which were characteristically resistant to ampicillin and
 quinolones. Overall, ampicillin resistance rate increased significantly from 2.
5% to 21.4% from 2006-2009. Resistance rates for gentamicin, chloramphenicol, te
tracycline, and erythromycin significantly decreased over time, although they re
mained high. Quinolones resistance rates were high and did not change significan
tly over time. <b>CONCLUSIONS:</b> The data obtained show a significant increasi
ng trend in the incidence of <i>E. faecium </i>resistant to ampicillin and vanco
mycin.#^dnd^i1#^tm^len^kAntimicrobial resistance profile^i1#^tm^len^kEnterococci
^i1#^tm^len^kVancomycin-resistant enterococci^i1#^tm^len^k<i>Enterococcus faeciu
m</i>^i1#^lpt^a<b>INTRODUÇÃO: </b>Nas últimas duas décadas, os enterococos emerg
iram como importantes patógenos nosocomiais no mundo inteiro. Neste estudo, foi 
analisada a distribuição das espécies e a evolução da resistência aos antimicrob
ianos entre isolados clínicos de enterococos obtidos em um hospital terciário, n
o período de 2006 a 2009. <b>MÉTODOS: </b>As espécies foram identificadas por te
stes bioquímicos convencionais e o perfil de sensibilidade foi determinado pelo 
método de disco difusão. A sensibilidade à vancomicina foi também determinada pe
la triagem em agar e pela concentração inibitória mínima (CIM). Testes molecular
es foram utilizados para confirmar as espécies e determinar os genótipos dos ent
erococos resistentes à vancomicina (VRE). <b>RESULTADOS: </b>Foram analisadas 32
4 amostras de enterococos, sendo 87% <i>E. faecalis </i>e 10,8% <i>E. faecium</i
>. A incidência de <i>E. faecium </i>por 1.000 pacientes internados aumentou sig
nificativamente (p &lt; 0,001) de 0,3 em 2006 para 2,3 em 2009. A taxa de VRE ta
mbém aumentou significativamente de 2,5% para 15,5% (p &lt; 0,001). Todos os VRE
 apresentaram genótipo VanA e CIM &gt;256µg/mL para vancomicina. A maioria (89,5
%) dos VRE pertencia à espécie <i>E. faecium </i>e foram resistentes à ampicilin
a e quinolonas. Foi observado um aumento significativo na taxa de resistência à 
ampicilina, de 2,5% (2006) para 21,4% (2009). As taxas de resistência para genta
micina, cloranfenicol, tetraciclina e eritromicina diminuíram significativamente
 no período do estudo. Para as quinolonas, as taxas de resistência foram elevada
s não alteraram significativamente, no período do estudo. <b>CONCLUSÕES: </b>Os 
resultados do presente estudo mostram um aumento significativo na incidência de 
<i>E. faecium</i> resistentes à ampicilina e vancomicina.#^dnd^i2#^tm^lpt^kPerfi
l de resistência a antimicrobianos^i2#^tm^lpt^kEnterococos^i2#^tm^lpt^kEnterococ
os resistentes à vancomicina^i2#^tm^lpt^k<i>Enterococcus faecium</i>^i2#Fundação
 de Amparo à Pesquisa do Estado de Minas Gerais#Fundação de Ensino e Pesquisa de
 Uberaba#other#34#20101022#22/10/2010#20101117#17/11/2010#aop10-11.htm##
05793000000000697000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120127001920120144003190100030004630100054004930100035005470100037005820100
04200619070009900661070009400760083186800854085000802722085004502730085002402775
08500450279908500330284408318030287708500080468008500520468808500240474008500500
47640850033048140580056048470580041049031170006049440720003049501120009049531110
01104962114000904973113001104982002001304993008008905006#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop10-11.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1
#4.0#gra#tab#09#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8682#
20110401#Trends in antimicrobial resistance among clinical isolates of enterococ
ci in a Brazilian tertiary hospital: a 4-year study^len#Evolução da resistência 
aos antimicrobianos entre isolados clínicos de enterococos em um hospital terciá
rio brasileiro: um estudo de 4 anos^lpt#^rND^1A01^nNatália^sConceição#^rND^1A02^
nCristina da Cunha Hueb Barata de^sOliveira#^rND^1A01^nPaulo Roberto da^sSilva#^
rND^1A01^nBárbara Godoi Melo^sÁvila#^rND^1A01^nAdriana Gonçalves de^sOliveira#^i
A01^1Universidade Federal do Triângulo Mineiro^2Departamento de Ciências Biológi
cas^cUberaba^sMG#^iA02^1Universidade Federal do Triângulo Mineiro^2Departamento 
de Clínica Médica^cUberaba^sMG#^len^aINTRODUCTION: In the past two decades membe
rs of the genus Enterococcus have emerged as important nosocomial pathogens worl
dwide. This study prospectively analyzed the distribution of species and trends 
in antimicrobial resistance among clinical isolates of enterococci in a Brazilia
n tertiary hospital from 2006-2009. METHODS: Enterococcal species were identifie
d by conventional biochemical tests. The antimicrobial susceptibility profile wa
s performed by disk diffusion in accordance with the Clinical and Laboratory Sta
ndards Institute (CLSI). A screening test for vancomycin was also performed. Min
imal inhibitory concentration (MIC) for vancomycin was determined using the brot
h dilution method. Molecular assays were used to confirm speciation and genotype
 of vancomycin-resistant enterococci (VRE). RESULTS: A total of 324 non-repetiti
ve enterococcal isolates were recovered, of which 87 percent were E. faecalis an
d 10.8 percent E. faecium. The incidence of E. faecium per 1,000 admissions incr
eased significantly (p < 0.001) from 0.3 in 2006 to 2.3 in 2009. The VRE rate al
so increased over time from 2.5 percent to 15.5 percent (p < 0.001). All VRE exp
ressed high-level resistance to vancomycin (MIC &gt;256µg/ mL) and harbored vanA
 genes. The majority (89.5 percent) of VRE belonged to E. faecium species, which
 were characteristically resistant to ampicillin and quinolones. Overall, ampici
llin resistance rate increased significantly from 2.5 percent to 21.4 percent fr
om 2006-2009. Resistance rates for gentamicin, chloramphenicol, tetracycline, an
d erythromycin significantly decreased over time, although they remained high. Q
uinolones resistance rates were high and did not change significantly over time.
 CONCLUSIONS: The data obtained show a significant increasing trend in the incid
ence of E. faecium resistant to ampicillin and vancomycin.#^dnd^i1#^tm^len^kAnti
microbial resistance profile^i1#^tm^len^kEnterococci^i1#^tm^len^kVancomycin-resi
stant enterococci^i1#^tm^len^kEnterococcus faecium^i1#^lpt^aINTRODUÇÃO: Nas últi
mas duas décadas, os enterococos emergiram como importantes patógenos nosocomiai
s no mundo inteiro. Neste estudo, foi analisada a distribuição das espécies e a 
evolução da resistência aos antimicrobianos entre isolados clínicos de enterococ
os obtidos em um hospital terciário, no período de 2006 a 2009. MÉTODOS: As espé
cies foram identificadas por testes bioquímicos convencionais e o perfil de sens
ibilidade foi determinado pelo método de disco difusão. A sensibilidade à vancom
icina foi também determinada pela triagem em agar e pela concentração inibitória
 mínima (CIM). Testes moleculares foram utilizados para confirmar as espécies e 
determinar os genótipos dos enterococos resistentes à vancomicina (VRE). RESULTA
DOS: Foram analisadas 324 amostras de enterococos, sendo 87 por cento E. faecali
s e 10,8 por cento E. faecium. A incidência de E. faecium por 1.000 pacientes in
ternados aumentou significativamente (p < 0,001) de 0,3 em 2006 para 2,3 em 2009
. A taxa de VRE também aumentou significativamente de 2,5 por cento para 15,5 po
r cento (p < 0,001). Todos os VRE apresentaram genótipo VanA e CIM &gt;256µg/mL 
para vancomicina. A maioria (89,5 por cento) dos VRE pertencia à espécie E. faec
ium e foram resistentes à ampicilina e quinolonas. Foi observado um aumento sign
ificativo na taxa de resistência à ampicilina, de 2,5 por cento (2006) para 21,4
 por cento (2009). As taxas de resistência para gentamicina, cloranfenicol, tetr
aciclina e eritromicina diminuíram significativamente no período do estudo. Para
 as quinolonas, as taxas de resistência foram elevadas não alteraram significati
vamente, no período do estudo. CONCLUSÕES: Os resultados do presente estudo most
ram um aumento significativo na incidência de E. faecium resistentes à ampicilin
a e vancomicina.#^dnd^i2#^tm^lpt^kPerfil de resistência a antimicrobianos^i2#^tm
^lpt^kEnterococos^i2#^tm^lpt^kEnterococos resistentes à vancomicina^i2#^tm^lpt^k
Enterococcus faecium^i2#Fundação de Amparo à Pesquisa do Estado de Minas Gerais#
Fundação de Ensino e Pesquisa de Uberaba#other#34#20101022#22/10/2010#20101117#1
7/11/2010#aop10-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_artt
ext&pid=S0037-86822011005000009##
00477000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704023300085002001300318#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#5#1#article#162#<p><font s
ize="4" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota_1"></a><b>Tre
nds in antimicrobial resistance among clinical isolates of enterococci in a Braz
ilian tertiary hospital: a 4-year study</b></font></p>     ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#6#2#article#162#<p>&nbsp;<
/p>     ^cY#aop10-11.htm##
00507000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704026300085002001300348#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#7#3#article#162#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Evolu&ccedil;&atilde;o d
a resist&ecirc;ncia aos antimicrobianos entre isolados cl&iacute;nicos de entero
cocos em um hospital terci&aacute;rio brasileiro: um estudo de 4 anos</b></font>
</p>     ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#8#4#article#162#<p>&nbsp;<
/p>     ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#9#5#article#162#<p>&nbsp;<
/p>     ^cY#aop10-11.htm##
00579000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704033400086002001300420#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#10#6#article#162#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Nat&aacute;lia Concei&c
cedil;&atilde;o<sup>I</sup>; Cristina da Cunha Hueb Barata de Oliveira<sup>II</s
up>; Paulo Roberto da Silva<sup>I</sup>; B&aacute;rbara Godoi Melo &Aacute;vila<
sup>I</sup>; Adriana Gon&ccedil;alves de Oliveira<sup>I</sup></b></font></p>    
 ^cY#aop10-11.htm##
00438000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704019300086002001300279#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#11#7#article#162#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Departamento d
e Ci&ecirc;ncias Biol&oacute;gicas, Universidade Federal do Tri&acirc;ngulo Mine
iro, Uberaba, MG    ^cY#aop10-11.htm##
00391000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704014600086002001300232#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#12#8#article#162#<br>   <s
up>II</sup>Departamento de Cl&iacute;nica M&eacute;dica, Universidade Federal do
 Tri&acirc;ngulo Mineiro, Uberaba, MG</font></p>     ^cY#aop10-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011400086002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#13#9#article#162#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#nota1">Address t
o</a></font></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#14#10#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#15#11#article#162#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop10-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#16#12#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop10-11.htm##
00649000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040300087002001300490#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#17#13#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION: </b>In t
he past two decades members of the genus <i>Enterococcus </i>have emerged as imp
ortant nosocomial pathogens worldwide. This study prospectively analyzed the dis
tribution of species and trends in antimicrobial resistance among clinical isola
tes of enterococci in a Brazilian tertiary hospital from 2006-2009.    ^cY#aop10
-11.htm##
00758000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051200087002001300599#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#18#14#article#162#<br>   <
b>METHODS: </b>Enterococcal species were identified by conventional biochemical 
tests. The antimicrobial susceptibility profile was performed by disk diffusion 
in accordance with the Clinical and Laboratory Standards Institute (CLSI). A scr
eening test for vancomycin was also performed. Minimal inhibitory concentration 
(MIC) for vancomycin was determined using the broth dilution method. Molecular a
ssays were used    to confirm speciation and genotype of vancomycin-resistant en
terococci (VRE).    ^cY#aop10-11.htm##
01187000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704094100087002001301028#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#19#15#article#162#<br>   <
b>RESULTS:</b> A total of 324 non-repetitive enterococcal isolates were recovere
d, of which 87% were <i>E. faecalis </i>and 10.8% <i>E. faecium</i>. The inciden
ce of <i>E. faecium </i>per 1,000 admissions increased significantly (p &lt; 0.0
01) from 0.3 in 2006 to 2.3 in 2009. The VRE rate also increased over time from 
2.5% to 15.5% (p &lt; 0.001). All VRE expressed high-level resistance to vancomy
cin (MIC &gt;256&#181;g/    mL) and harbored <i>vanA </i>genes. The majority (89
.5%) of VRE belonged to <i>E. faecium </i>species, which were characteristically
 resistant to ampicillin and quinolones. Overall, ampicillin resistance rate inc
reased significantly from 2.5% to 21.4% from 2006-2009. Resistance rates    for 
gentamicin, chloramphenicol, tetracycline, and erythromycin significantly decrea
sed over time, although they remained high. Quinolones resistance rates were hig
h and did not change significantly over time.    ^cY#aop10-11.htm##
00424000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017800087002001300265#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#20#16#article#162#<br>   <
b>CONCLUSIONS:</b> The data obtained show a significant increasing trend in the 
incidence of <i>E. faecium </i>resistant to ampicillin and vancomycin.</font></p
>     ^cY#aop10-11.htm##
00477000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704023100087002001300318#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#21#17#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Antimicr
obial resistance profile. Enterococci. Vancomycin-resistant enterococci. <i>Ente
rococcus faecium</i>.</font></p> <hr size="1" noshade>     ^cY#aop10-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#22#18#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop10-11.htm##
00744000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049800087002001300585#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#23#19#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b>Nas &uacute;ltimas duas d&eacute;cadas, os enterococos emergiram como im
portantes pat&oacute;genos nosocomiais no mundo inteiro. Neste estudo, foi anali
sada a distribui&ccedil;&atilde;o das esp&eacute;cies e a evolu&ccedil;&atilde;o
 da resist&ecirc;ncia aos antimicrobianos entre isolados cl&iacute;nicos de ente
rococos obtidos em um hospital terci&aacute;rio, no per&iacute;odo de 2006 a 200
9.    ^cY#aop10-11.htm##
00774000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052800087002001300615#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#24#20#article#162#<br>   <
b>M&Eacute;TODOS: </b>As esp&eacute;cies foram identificadas por testes bioqu&ia
cute;micos convencionais e o perfil de sensibilidade foi determinado pelo m&eacu
te;todo de disco difus&atilde;o. A sensibilidade &agrave; vancomicina foi tamb&e
acute;m determinada pela triagem em agar e pela concentra&ccedil;&atilde;o inibi
t&oacute;ria m&iacute;nima (CIM). Testes moleculares foram utilizados para confi
rmar as esp&eacute;cies e determinar os gen&oacute;tipos dos enterococos resiste
ntes &agrave; vancomicina (VRE).    ^cY#aop10-11.htm##
01255000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704100900087002001301096#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#25#21#article#162#<br>   <
b>RESULTADOS: </b>Foram analisadas 324 amostras de enterococos, sendo 87% <i>E. 
faecalis </i>e 10,8% <i>E. faecium</i>. A incid&ecirc;ncia de <i>E. faecium </i>
por 1.000 pacientes internados aumentou significativamente (p &lt; 0,001) de 0,3
 em 2006 para 2,3 em 2009. A taxa de VRE tamb&eacute;m aumentou significativamen
te de 2,5% para 15,5% (p &lt; 0,001). Todos os VRE apresentaram gen&oacute;tipo 
VanA e CIM &gt;256&#181;g/mL para vancomicina. A maioria (89,5%) dos VRE pertenc
ia &agrave; esp&eacute;cie <i>E. faecium </i>e foram resistentes &agrave; ampici
lina e quinolonas. Foi observado um aumento significativo na taxa de resist&ecir
c;ncia &agrave; ampicilina, de 2,5% (2006) para 21,4% (2009). As taxas de resist
&ecirc;ncia para gentamicina, cloranfenicol, tetraciclina e eritromicina diminu&
iacute;ram significativamente no per&iacute;odo do estudo. Para as quinolonas, a
s taxas de resist&ecirc;ncia foram elevadas n&atilde;o alteraram significativame
nte, no per&iacute;odo do estudo.    ^cY#aop10-11.htm##
00452000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020600087002001300293#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#26#22#article#162#<br>   <
b>CONCLUS&Otilde;ES: </b>Os resultados do presente estudo mostram um aumento sig
nificativo na incid&ecirc;ncia de <i>E. faecium</i> resistentes &agrave; ampicil
ina e vancomicina.</font></p>     ^cY#aop10-11.htm##
00509000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026300087002001300350#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#27#23#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves: </b>P
erfil de resist&ecirc;ncia a antimicrobianos. Enterococos. Enterococos resistent
es &agrave; vancomicina. <i>Enterococcus faecium.</i></font></p> <hr size="1" no
shade>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#28#24#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#29#25#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#30#26#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop10-11.htm##
00999000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704075300087002001300840#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#31#27#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Enterococci are widesprea
d in nature and are normal constituents of the human gastrointestinal tract, but
 nowadays they have been recognized as important pathogens, especially among hos
pitalized patients. Enterococci may cause a range of different disorders, such a
s urinary tract infections, intraabdominal abscesses, wound infections, endocard
itis and bacteraemia<sup>1</sup>. According to the SENTRY Antimicrobial Surveill
ance Program, enterococci are the fourth most common pathogen of bacteremia in N
orth America and the fifth in Europe<sup>2</sup>. In Brazil, they are the eighth
 agent of bacteremia overall and the third among the Gram-positive cocci<sup>3</
sup>.</font></p>     ^cY#aop10-11.htm##
00680000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043400087002001300521#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#32#28#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Intrinsic or acquired res
istance to various commonly used antimicrobial agents is a remarkable characteri
stic of enterococci<sup>4</sup>. Acquired resistance to glycopeptides (vancomyci
n and teicoplanin), penicillins and aminoglycosides (high-level resistance) are 
the most clinically important, because therapeutic options in these cases are li
mited.</font></p>     ^cY#aop10-11.htm##
00797000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055100087002001300638#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#33#29#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Six types of acquired van
comycin resistance have been reported in enterococci; however, the most prevalen
t are VanA and VanB, in which the genes encoding resistance are associated with 
mobile genetic elements that allow resistance to spread clonally and laterally<s
up>5</sup>. The VanC type confers an intrinsic nontransferable low-level resista
nce to vancomycin that has been observed primarily in <i>Enterococcus gallinarum
 </i>and <i>Enterococcus casseliflavus</i>.</font></p>     ^cY#aop10-11.htm##
00901000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704065500087002001300742#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#34#30#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Clinical vancomycin-resis
tant enterococci (VRE) isolates were first recognized in the 1980s in Europe and
 USA<sup>4</sup>. Approximately ten years later, the first VRE were isolated in 
Brazil, in the States of Paran&aacute; and S&atilde;o Paulo, located in the sout
hern and southeastern regions of the country, respectively<sup>6,7</sup>. Althou
gh these VRE isolates belong to <i>Enterococcus faecium </i>species, until recen
tly in Brazil, <i>Enterococcus faecalis </i>was the predominant VRE commonly rep
orted in hospitals in the State of S&atilde;o Paulo<sup>8-13</sup>.</font></p>  
   ^cY#aop10-11.htm##
00784000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053800087002001300625#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#35#31#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Despite the increasing nu
mber of reports regarding the evolution of antimicrobial resistance of enterococ
ci in different countries, published data on this subject are still sporadic in 
Brazil. In this study, our group analyzed the distribution of species and trends
 in antimicrobial resistance among enterococci recovered from clinical specimens
 in a Brazilian tertiary hospital over a four-year period. The genotypes of VRE 
isolates were also determined.</font></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#36#32#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#37#33#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>
     ^cY#aop10-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#38#34#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Study design</b></font
></p>     ^cY#aop10-11.htm##
00955000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070900087002001300796#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#39#35#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A prospective study was c
onducted from 2006 to 2009 in the hospital of the Triangulo Mineiro University H
ospital of the Federal University (<i>Universidade Federal do Tri&acirc;ngulo Mi
neiro</i>, UFTM). This hospital, located in the State of Minas Gerais in southea
stern Brazil, is a 294-bed tertiary-care teaching hospital with a 40-bed intensi
ve care unit (ICU) and a full range of medical specialties. Over the study perio
d, an average of 11,000 patients were admitted annually. All enterococci isolate
s recovered from hospitalized patients were included in the study, but only the 
first isolate from each patient was used.</font></p>     ^cY#aop10-11.htm##
00392000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014600087002001300233#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#40#36#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Phenotypic identificat
ion of <i>Enterococcus </i>species</b></font></p>     ^cY#aop10-11.htm##
00848000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060200087002001300689#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#41#37#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Isolates were identified 
at genus level by Gram staining, cellular morphology, absence of catalase produc
tion, hydrolysis of L-pyrrolidonyl-</font>&#946;<font size="2" face="Verdana, Ar
ial, Helvetica, sans-serif">-naphthylamide (PYR test), hydrolysis of esculin in 
presence of bile salts (bile-esculin test) and tolerance to 6.5% NaCl. Species i
dentification was determined based on tests of carbohydrate fermentation, argini
ne hydrolysis, mobility, yellow pigment production and growth in 0.04% tellurite
<sup>14</sup>.</font></p>     ^cY#aop10-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#42#38#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Susceptibility testing
</b></font></p>     ^cY#aop10-11.htm##
01544000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704129800087002001301385#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#43#39#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The antimicrobial suscept
ibility profile was performed using the disk diffusion method. The antimicrobial
s agents tested were: vancomycin (30&#181;g), teicoplanin (30&#181;g), ampicilli
n (10&#181;g), penicillin (10U), streptomycin (300&#181;g), gentamicin (120&#181
;g), norfloxacin (10&#181;g), ciprofloxacin (5&#181;g), chloramphenicol (30&#181
;g), tetracycline (30&#181;g), and erythromycin (15&#181;g). Beta-lactamase prod
uction was tested with chromogenic nitrocefin disk (Becton, Dickinson and Compan
y, Cefinase<sup>TM</sup>, USA), in accordance withthe manufacturer's instruction
s. A screening test for vancomycin was performed on BHI agar supplemented with 6
&#181;g/mL of this drug for all enterococcal isolates. For isolates resistant ac
cording to the screening test, the minimal inhibitory concentration (MIC) for va
ncomycin was determined using the broth dilution method. All susceptibility test
s were performed and interpreted according to guidelines established by the Clin
ical and Laboratory Standards Institute (CLSI)<sup>15</sup>. <i>Staphylococcus a
ureus </i>ATCC (American Type Culture Collection) 25923, <i>S. aureus </i>ATCC 2
9213, and <i>E. faecalis </i>ATCC 29212 were used for quality control.</font></p
>     ^cY#aop10-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#44#40#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Molecular testing</b><
/font></p>     ^cY#aop10-11.htm##
00946000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070000087002001300787#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#45#41#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Bacterial DNA was extract
ed from the enterococcal isolates that were phenotypically resistant to vancomyc
in using the QIAamp<sup>&reg;</sup> DNA Mini kit (<b>Qiagen, </b>Hilden, Germany
), in accordance with the manufacturer's guidelines. Detection of vancomycin res
istance genes was performed by a multiplex polymerase chain reaction (PCR) assay
, in accordance with procedures described<sup>16 </sup>by Woodford et al. Specie
s identification of VRE isolates was confirmed by PCR, as described previously<s
up>17</sup>. PCR products were analyzed by electrophoresis on 1.5% agarose gels 
and stained by ethidium bromide.</font></p>     ^cY#aop10-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#46#42#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Statistical analysis</
b></font></p>     ^cY#aop10-11.htm##
00652000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040600087002001300493#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#47#43#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">To evaluate the trend in 
antimicrobial resistance among enterococci over time, the </font>&#967;<font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>2</sup>-test for trend w
as performed using Epi Info (CDC, Atlanta, GA) statistical software (version 3.5
.1). The significance level was set at p <u>&lt;</u> 0.05.</font></p>     ^cY#ao
p10-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#48#44#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Ethical considerations
</b></font></p>     ^cY#aop10-11.htm##
00401000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704015500087002001300242#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#49#45#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The present study was app
roved by Research Ethics Committee of the UFTM.</font></p>     ^cY#aop10-11.htm#
#
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#50#46#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#51#47#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>
     ^cY#aop10-11.htm##
00925000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704067900087002001300766#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#52#48#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A total of 324 non-repeti
tive enterococcal isolates were consecutively recovered during the study period.
 These isolates were recovered from different clinical specimens, but they were 
more frequent in wounds (38.9%) and in urine (29.9%). <b><a href="/img/revistas/
rsbmt/2011nahead/aop10-11_tab01.jpg">Table 1</a> </b>shows the distribution of e
nterococcal species according to clinical specimens. The species identified were
 <i>E. faecalis </i>(87%), <i>E. faecium </i>(10.8%), <i>E. casseliflavus </i>(1
.2%), <i>E. gallinarum </i>(0.3%), <i>E. hirae </i>(0.3%) and <i>E. pseudoavium<
/i> (0.3%).</font></p>     ^cY#aop10-11.htm##
00698000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045200087002001300539#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#53#49#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b><a href="#fig1">Figure
 1</a> </b>shows the incidence of <i>E. faecalis, E. faecium </i>and other enter
ococcal species per 1,000 patient admissions from 2006 to 2009. A significant in
creasing trend in the incidence of <i>E. faecium </i>(p &lt; 0.001) from 0.3 in 
2006 to 2.3 in 2009 was observed, but not of <i>E. faecalis</i> or other enteroc
occal species over time.</font></p>     ^cY#aop10-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#54#50#article#162#<p><a na
me="fig1"></a></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#55#51#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#56#52#article#162#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop10-11_fig01.jpg"></p>     
^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#57#53#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00931000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068500087002001300772#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#58#54#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The rate of VRE also incr
eased significantly over time (p &lt; 0.001), from 2.5% in 2006 to 15.5% in 2009
 in our institution, although in 2007 there were no VRE and in 2008 the rate was
 only 1.4% <b>(<a href="#tab2">Table 2</a>)</b>. Among the 19 VRE isolates, 2 (1
0.5%) were identified phenotypically and by PCR as <i>E. faecalis </i>(VREfs) an
d 17 (89.5%) as <i>E. faecium </i>(VREfm). The first two VREfs were isolated in 
2006. Thereafter, no other VREfs were isolated during the study period. The firs
t VREfm appeared at the end of 2008, since then an increasing number of VREfm we
re noted in 2009.</font></p>     ^cY#aop10-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#59#55#article#162#<p><a na
me="tab2"></a></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#60#56#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#61#57#article#162#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop10-11_tab02.jpg"></p>     
^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#62#58#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00945000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704069900087002001300786#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#63#59#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">All VRE isolates uniforml
y harbored <i>vanA </i>genes, as demonstrated by PCR. They were resistant to tei
coplanin and expressed high-level resistance to vancomycin (MIC &gt;256&#181;g/m
L). The two VREfs showed the same antimicrobial susceptibility profile character
ized by resistance to norfloxacin, ciprofloxacin, chloramphenicol, tetracycline,
 and erythromycin, and susceptibility to ampicillin, penicillin, streptomycin, a
nd gentamicin. All VREfm were resistant to ampicillin, penicillin, norfloxacin, 
ciprofloxacin, and erythromycin and susceptible to streptomycin, gentamicin, chl
oramphenicol, and tetracycline.</font></p>     ^cY#aop10-11.htm##
00648000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040200087002001300489#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#64#60#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><i>Enterococcus gallinaru
m </i>(n = 1) and <i>E. casseliflavus </i>(n = 4) isolates were susceptible to v
ancomycin by the disk diffusion method, but grew on agar screening with 6&#181;g
/mL of vancomycin, while the MIC observed for this drug was 8&#181;g/mL. These f
ive isolates were not considered as VRE in this study.</font></p>     ^cY#aop10-
11.htm##
00930000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068400087002001300771#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#65#61#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As demonstrated in <b><a 
href="#tab2">Table 2</a></b>, ampicillin and penicillin resistance rates increas
ed from 2006 to 2009 from 2.5% to 21.4% and 23.8% to 35.9%, respectively, but on
ly the increasing rate of ampicillin was statistically significant (p &lt; 0.001
). Among the 282 <i>E. faecalis </i>and 35 <i>E. faecium </i>isolates, 4 (1.4%) 
and 25 (77.4%) of them, respectively, were resistant to ampicillin and to penici
llin. However, 63 (22.3%) <i>E. faecalis </i>isolates were resistant to penicill
in, but remained susceptible to ampicillin. Beta-lactamase producing isolates we
re not detected.</font></p>     ^cY#aop10-11.htm##
00709000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046300087002001300550#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#66#62#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Rates of resistance to ge
ntamicin (41.2% to 25.2%), chloramphenicol (55% to 29.1%), tetracycline (75% to 
57.3%), and erythromycin (95% to 80.6%) significantly decreased from 2006 to 200
9, as demonstrated in <b><a href="#tab2">Table 2</a></b>. Regarding streptomycin
, norfloxacin and ciprofloxacin, the resistance rates did not change significant
ly over the four-year study period.</font></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#67#63#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#68#64#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font><
/p>     ^cY#aop10-11.htm##
01149000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090300087002001300990#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#69#65#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Although there are at lea
st 30 species of the genus <i>Enterococcus</i>, both <i>E. faecalis </i>and <i>E
. faecium </i>are the most common species causing human infections<sup>1,14</sup
>. Similarly, in this study, <i>E. faecalis </i>was the most prevalent species f
ollowed by <i>E. faecium</i>, while the other species were rarely recovered from
 clinical specimens. Nevertheless, a significant increasing trend in the inciden
ce of <i>E. faecium </i>per 1,000 patient admissions from 0.3 in 2006 to 2.3 in 
2009 was verified, approximately an eight-fold increase. In a study conducted in
 a hospital in Greece, the authors reported a similar increased incidence of <i>
E. faecium </i>infections (0.7 in 2002 to 2.4 in 2007), although that hospital i
s larger than ours, with more than 60,000 admissions annually<sup>18</sup>.</fon
t></p>     ^cY#aop10-11.htm##
01217000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704097100087002001301058#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#70#66#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The vancomycin-resistant 
enterococci rate also increased in our institution, by almost the same proportio
n as the incidence of <i>E. faecium </i>incidence. Most (89.5%) of the VRE isola
tes were <i>E. faecium </i>exhibiting the <i>vanA </i>genotype. In a retrospecti
ve study conducted at a tertiary Brazilian hospital located in the State of S&at
ilde;o Paulo, Furtado <i>et al. </i>also showed an increase in the rate of VRE o
ver time from 9.5% in 2000 to 14.7% in 2001 and to 15.8% in 2002. However, the a
uthors did not identify the VRE species or genotypes<sup>19</sup>. According to 
more recent data from the SENTRY Program, the percentage of VRE in Brazil increa
sed from 6.9% in 2003 to 31.1% in 2008 and the majority (68.5%) of these isolate
s were <i>E. faecium</i><sup>20</sup>. These VRE rates are much higher than that
 observed in other Latin America countries and in our hospital.</font></p>     ^
cY#aop10-11.htm##
01374000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704112800087002001301215#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#71#67#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In the last two decades, 
the importance of <i>E. faecium </i>as a nosocomial pathogen has increased throu
ghout the world due to the greater ability of this species to acquire resistance
 to multiple drugs than <i>E. faecalis. </i>Molecular epidemiological studies ha
ve reported the spread of a hospital-adapted complex of <i>E. faecium </i>design
ated as clonal complex-17 (CC-17), which is associated with the majority of hosp
itals outbreaks and clinical infections on all continents<sup>21,22</sup>. This 
complex is characterized by ampicillin and quinolones resistance and by the pres
ence of a putative pathogenicity island. Currently, the increase in <i>E. faeciu
m </i>resistant to ampicillin usually precedes increasing rates of VREfm in vari
ous locations around the world, especially in certain European countries, where 
until recently, VRE rates were low<sup>4,23-26</sup>. In the USA, since the 1990
s, <i>E. faecium </i>isolates account for more than 95% of all VRE recovered and
 most of them are also resistant to ampicillin<sup>24</sup>.</font></p>     ^cY#
aop10-11.htm##
01032000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704078600087002001300873#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#72#68#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Likewise, our group obser
ved a significant increasing trend in resistance to ampicillin among clinical is
olates of enterococci due to increased incidence of <i>E. faecium </i>in our ins
titution, since resistance rates to this drug among <i>E. faecium </i>(71.4%) we
re much higher than among <i>E. faecalis </i>(1.4%) isolates. Of note, all VREfm
 isolated in this study were resistant to both ampicillin and quinolones, showin
g the same antimicrobial resistance profile observed for <i>E. faecium </i>of CC
-17. Nevertheless, molecular epidemiological studies conducted with Brazilian <i
>E. faecium </i>isolates from several hospitals showed that this complex is not 
common in our country<sup>27,28</sup>.</font></p>     ^cY#aop10-11.htm##
01123000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704087700087002001300964#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#73#69#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In contrast to trends in 
ampicillin resistance, a significant decrease in resistance rates to chloramphen
icol and tetracycline occurred from 2006 to 2009 and it is probably related to t
he increasing incidence of <i>E. faecium </i>in the present study. Decreasing ra
tes of chloramphenicol resistance among enterococci has previously been observed
 from 1997 to 1999 in the USA (19% to 12%) and Latin America (34% to 27%), accor
ding to the SENTRY Program<sup>29</sup>. In addition, all VREfm isolates during 
this study were uniformly susceptible to both drugs. A similar chloramphenicol r
esistance rate among VREfm of 0.5% was observed in North America<sup>21</sup>; h
owever, chloramphenicol use for the treatment of VRE infections is known to resu
lt in the development of resistance<sup>30</sup>.</font></p>     ^cY#aop10-11.ht
m##
00926000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068000087002001300767#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#74#70#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Regarding tetracycline, a
lthough the enterococci resistance rate decreased over time, it remained high in
 2009 (57%), but was slightly lower than that reported by the SENTRY Program for
 Latin America (67.2%)<sup>31 </sup>and by other Brazilian studies performed wit
h clinical enterococci strains isolated in 1996 and 1997 (62%)<sup>32 </sup>and 
in 2006 and 2007 (66.5%)<sup>8</sup>. Likewise, the resistance rates to erythrom
ycin were very high, despite the significant decrease observed (95% to 80.6%), c
onfirming that resistance to this drug is very common among enterococci<sup>1,8,
31,33</sup>.</font></p>     ^cY#aop10-11.htm##
00825000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057900087002001300666#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#75#71#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Overall, moderate rates o
f high-level resistance to aminoglycosides were observed over the four-year, sim
ilar to those observed recently in Brazil of 32.1% and 26.7% and in the USA of 3
0.6% and 25.2% for streptomycin and gentamicin, respectively<sup>3,34</sup>. Reg
arding quinolones, resistance rates did not change significantly during the stud
y period, whereas the overall resistance rates to ciprofloxacin were slightly hi
gher compared to Latin America (50%) and the USA (58%)<sup>29,31</sup>.</font></
p>     ^cY#aop10-11.htm##
00959000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071300087002001300800#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#76#72#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In conclusion, the presen
t data show an increasing incidence of <i>E. faecium </i>resistant to ampicillin
 and vancomycin, corroborating the worldwide trends. Considering that all the VR
Efm identified in our institution expressed resistance to ampicillin and quinolo
ne, it is quite probable that they belong to the hospital-adapted CC-17. However
, future molecular characterization is necessary to verify this, since there are
 no studies demonstrating the spread of <i>E. faecium </i>CC-17 in Brazil to dat
e. Therefore, more rigorous strategies should be developed in order to prevent f
urther spread of <i>E. faecium </i>in Brazil.</font></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#77#73#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#78#74#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop10-11.htm##
00507000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026100087002001300348#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#79#75#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors would like to
 thank the Clinical Pathology Laboratory staff at the Triangulo Mineiro Federal 
University (Minas Gerais, Brazil) for providing the enterococci isolates.</font>
</p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#80#76#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#81#77#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop10-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#82#78#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors declare that 
there is no conflict of interest.</font></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#83#79#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#84#80#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>FINANCIAL SUPPORT</b><
/font></p>     ^cY#aop10-11.htm##
00469000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022300087002001300310#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#85#81#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Funda&ccedil;&atilde;o de
 Amparo &agrave; Pesquisa do Estado de Minas Gerais and the Funda&ccedil;&atilde
;o de Ensino e Pesquisa de Uberaba.</font></p>     ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#86#82#article#162#<p>&nbsp
;</p>     ^cY#aop10-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#87#83#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop10-11.htm##
00425000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016500089002001300254#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#88#84#article#
162#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Murray B
E. The life and times of the <i>Enterococcus</i>. Clin Microbiol Rev 1990; 3:46-
65.    ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#89#85#article#162#</font><
/p>     ^cY#aop10-11.htm##
00571000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704031100089002001300400#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#90#86#article#
162#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Biedenba
ch DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern compar
isons among bloodstream infection isolates from the SENTRY Antimicrobial Surveil
lance Program (1997-2002). Diagn Microbiol Infect Dis 2004; 50:56-69.    ^cY#aop
10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#91#87#article#162#</font><
/p>     ^cY#aop10-11.htm##
00568000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030800089002001300397#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#92#88#article#
162#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Gales AC
, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC. Antimicrobial susceptib
ility of gram-positive bacteria isolated in Brazilian hospitals participating in
 the SENTRY Program (2005-2008). Braz J Infect Dis 2009; 13:90-98.    ^cY#aop10-
11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#93#89#article#162#</font><
/p>     ^cY#aop10-11.htm##
00422000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704016200089002001300251#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#94#90#article#
162#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Murray B
E. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342:710-721.
    ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#95#91#article#162#</font><
/p>     ^cY#aop10-11.htm##
00449000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704018900089002001300278#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#96#92#article#
162#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Courvali
n P. Genetics of glycopeptide resistance in gram-positive pathogens. Int J Med M
icrobiol 2005; 294:479-486.    ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#97#93#article#162#</font><
/p>     ^cY#aop10-11.htm##
00527000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026700089002001300356#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#98#94#article#
162#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Dalla-Co
sta LM, Souza DC, Martins LTF, Zanella RC, Brandileone MC, Bokermann S, et al. V
ancomycin-resistant <i>Enterococcus faecium</i>: first case in Brazil. Braz J In
fect Dis 1998; 2:160-163.    ^cY#aop10-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#99#95#article#162#</font><
/p>     ^cY#aop10-11.htm##
00611000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704035000090002001300440#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#100#96#article
#162#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Zanella
 RC, Valdetaro F, Lovgren M, Tyrrel GJ, Bokermann S, Almeida SC, et al. First co
nfirmed case of a vancomycin-resistant <i>Enterococcus faecium </i>with vanA phe
notype from Brazil: isolation from a meningitis case in S&atilde;o Paulo. Microb
 Drug Resist 1999; 5:159-162.    ^cY#aop10-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#101#97#article#162#</font>
</p>     ^cY#aop10-11.htm##
00556000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704029500090002001300385#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#102#98#article
#162#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Bender 
EA, Freitas ALP, Reiter KC, Lutz L, Barth AL. Identification, antimicrobial resi
stance and genotypic characterization of <i>Enterococcus </i>spp. isolated in Po
rto Alegre, Brazil. Braz J Microbiol 2009; 40:693-700.    ^cY#aop10-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#103#99#article#162#</font>
</p>     ^cY#aop10-11.htm##
00624000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704036200091002001300453#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#104#100#articl
e#162#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Caiaff
a Filho HH, Almeida GD, Oliveira GA, Sarahyba L, Mamizuka EM, Burattini MN. Mole
cular characterization of van genes found in vancomycin resistant <i>Enterococcu
s </i>spp. isolated from Hospital das Cl&iacute;nicas, FMUSP, S&atilde;o Paulo, 
Brazil. Braz J Infect Dis 2003; 7:173-174.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#105#101#article#162#</font
></p>     ^cY#aop10-11.htm##
00605000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034200092002001300434#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#106#102#articl
e#162#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Cere
da RF, Sader HS, Jones RN, Sejas L, Machado AM, Zanatta YP, Rego STMS, Medeiros 
EAS. <i>Enterococcus faecalis </i>resistant to vancomycin and teicoplanin (VanA 
phenotype) isolated from a bone marrow transplanted patient in Brazil. Braz J In
fect Dis 2001; 5:40-46.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#107#103#article#162#</font
></p>     ^cY#aop10-11.htm##
00515000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025200092002001300344#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#108#104#articl
e#162#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Cord
eiro JC, Silbert S, Reis AO, Sader HS. Inter-hospital dissemination of glycopept
ides resistant <i>Enterococcus faecalis </i>in Brazil. Clin Microbiol Infect 200
4; 3:260-262.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#109#105#article#162#</font
></p>     ^cY#aop10-11.htm##
00569000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030600092002001300398#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#110#106#articl
e#162#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Riba
s RM, Darini ALC, Moreira TA, Freitas C, Gontijo Filho PP. Vancomycinresistant v
anA phenotype <i>Enterococcus faecalis</i>: first case in Minas Gerais state and
 epidemiological considerations. Braz J Infec Dis 2007; 11:439-440.    ^cY#aop10
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#111#107#article#162#</font
></p>     ^cY#aop10-11.htm##
00593000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033000092002001300422#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#112#108#articl
e#162#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Zane
lla RC, Brandileone MCC, Bokermann S, Almeida SCG, Valdetaro F, Vit&oacute;rio F
, et al. Phenotypic and genotypic characterization of vanA <i>Enterococcus </i>i
solated during the first nosocomial outbreak in Brazil. Microb Drug Resist 2003;
 9:283-291.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#113#109#article#162#</font
></p>     ^cY#aop10-11.htm##
00571000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030800092002001300400#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#114#110#articl
e#162#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Teix
eira LM, Carvalho MGS, Facklam RR. <i>Enterococcus. In:</i> Murray BE, Baron EJ,
 Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology. 
Washington (DC): American Society for Microbiology; 2007. p. 430-442.    ^cY#aop
10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#115#111#article#162#</font
></p>     ^cY#aop10-11.htm##
00521000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025800092002001300350#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#116#112#articl
e#162#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Clin
ical and Laboratory Standards Institute. Performance standards for antimicrobial
 susceptibility testing. Ninth tenth Informational Supplement. Wayne: CLSI docum
ent M100-S19; 2009.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#117#113#article#162#</font
></p>     ^cY#aop10-11.htm##
00575000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031200092002001300404#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#118#114#articl
e#162#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Wood
ford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. Application of D
NA probes for rRNA and <i>vanA </i>genes to investigation of a nosocomial cluste
r of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31:653-658.    ^cY
#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#119#115#article#162#</font
></p>     ^cY#aop10-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#120#116#articl
e#162#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Dutk
a-malen S, Evers S, Courvalin P. Detection of glicopeptide resistance genotypes 
and identification to the species level of clinically relevant enterococci by PC
R. J Clin Microbiol 1995; 33:24-27.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#121#117#article#162#</font
></p>     ^cY#aop10-11.htm##
00602000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033900092002001300431#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#122#118#articl
e#162#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Prot
onotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A. Tren
ds in antimicrobial resistance of clinical isolates of <i>Enterococcus faecalis 
</i>and <i>Enterococcus faecium </i>in Greece between 2002 and 2007. J Hosp Infe
ct 2010; 75:225-227.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#123#119#article#162#</font
></p>     ^cY#aop10-11.htm##
00534000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027100092002001300363#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#124#120#articl
e#162#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Furt
ado GHC, Martins ST, Coutinho AN, Soares GMM, Wey SB, Medeiros EAS. Incidence of
 vancomycin-resistance <i>Enterococcus </i>at a university hospital in Brazil. R
ev Saude Publica 2005; 39:41-46.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#125#121#article#162#</font
></p>     ^cY#aop10-11.htm##
00488000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022500092002001300317#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#126#122#articl
e#162#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Sade
r HS, Moet GJ, Jones RN. Antimicrobial resistance among gram-positive bacteria i
solated in Latin American hospitals. J Chemother 2009; 21:611-620.    ^cY#aop10-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#127#123#article#162#</font
></p>     ^cY#aop10-11.htm##
00624000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036100092002001300453#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#128#124#articl
e#162#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Desh
pande LM, Fritsche TR, Moet GJ, Biendenbach DJ, Jones RN. Antimicrobial resistan
ce and molecular epidemiology of vancomycin-resistant enterococci from North Ame
rica and Europe: a report from the SENTRY Antimicrobial Surveillance Program. Di
agn Microbiol Infect Dis 2007; 58:163-170.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#129#125#article#162#</font
></p>     ^cY#aop10-11.htm##
00514000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025100092002001300343#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#130#126#articl
e#162#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Leav
is HL, Bonten MJM, Willems RJL. Identification of high-risk enterococcal clonal 
complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006
; 9:454-460.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#131#127#article#162#</font
></p>     ^cY#aop10-11.htm##
00604000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034100092002001300433#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#132#128#articl
e#162#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Oteo
 J, Cuevas O, Navarro C, Aracil B, Campos J. Trends in antimicrobial resistance 
in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): incre
asing ampicillin resistance in <i>Enterococcus faecium</i>. J Antimicrob Chemoth
er 2007; 59:1044-1045.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#133#129#article#162#</font
></p>     ^cY#aop10-11.htm##
00493000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023000092002001300322#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#134#130#articl
e#162#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Shep
ard BD, Gilmore MS. Antibiotic-resistant enterococci: the mechanisms and dynamic
s of drug introduction and resistance. Microbes Infect 2002; 4:215-224.    ^cY#a
op10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#135#131#article#162#</font
></p>     ^cY#aop10-11.htm##
00508000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024500092002001300337#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#136#132#articl
e#162#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Trei
tman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of <i>Enterococcus 
faecium </i>among hospital isolates (1993 to 2002). J Clin Microbiol 2005; 43:46
2-463.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#137#133#article#162#</font
></p>     ^cY#aop10-11.htm##
00514000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025100092002001300343#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#138#134#articl
e#162#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Wern
er G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al. Emergence a
nd spread of vancomycin resistance among enterococci in Europe. Euro Surveill 20
08; 13:1-11.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#139#135#article#162#</font
></p>     ^cY#aop10-11.htm##
00586000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032300092002001300415#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#140#136#articl
e#162#27#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. Cama
rgo ILBC, Gilmore MS, Darini ALC. Multilocus sequence typing and analysis of put
ative virulence factors in vancomycin-resistant and vancomycin-sensitive <i>Ente
rococcus faecium </i>isolates from Brazil. Clin Microbiol Infect 2006; 12:1123-1
130.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#141#137#article#162#</font
></p>     ^cY#aop10-11.htm##
00582000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031900092002001300411#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#142#138#articl
e#162#28#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28. Titz
e-de-Almeida R, Van Belkum A, Felipe MSS, Zanella RC, Top J, Willems RJL. Multil
ocus sequence typing of hospital associated <i>Enterococcus faecium</i> from Bra
zil reveals their unique evolutionary history. Microb Drug Res 2006; 12:121-125.
    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#143#139#article#162#</font
></p>     ^cY#aop10-11.htm##
00582000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031900092002001300411#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#144#140#articl
e#162#29#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29. Low 
DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibili
ty, and geographic resistance patterns of Enterococci: results from the SENTRY A
ntimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32:S133-145.
    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#145#141#article#162#</font
></p>     ^cY#aop10-11.htm##
00568000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030500092002001300397#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#146#142#articl
e#162#30#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30. Laut
enbach E, Gould CV, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, et al. Emergence
 of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) 
bloodstream isolates. Intern J Antimicrob Agents 2004; 23:200-203.    ^cY#aop10-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#147#143#article#162#</font
></p>     ^cY#aop10-11.htm##
00533000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027000092002001300362#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#148#144#articl
e#162#31#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">31. Sade
r HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveilla
nce program report: Latin American and Brazilian result for 1997 through 2001. B
raz J Infect Dis 2004; 8:25-79.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#149#145#article#162#</font
></p>     ^cY#aop10-11.htm##
00544000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028100092002001300373#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#150#146#articl
e#162#32#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">32. d'Az
evedo PA, Dias CAG, Lemos SK, Bittencourt JAF, Teixeira LM. Antimicrobial suscep
tibility among <i>Enterococcus </i>isolates from the city of Porto Alegre, RS, B
razil. Braz J Infect Dis 2004; 35:199-204.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#151#147#article#162#</font
></p>     ^cY#aop10-11.htm##
00595000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033200092002001300424#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#152#148#articl
e#162#33#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">33. Sade
r HS, Gales AC, Pfaller MA, Mendes RE, Zocolli C, Barth A, et al. Pathogen frequ
ency and resistance patterns in Brazilian hospitals: summary of results from thr
ee years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 200
1; 5:200-214.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#153#149#article#162#</font
></p>     ^cY#aop10-11.htm##
00551000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028800092002001300380#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#154#150#articl
e#162#34#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">34. Sade
r HS, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated 
from US medical centers: results of the daptomycin surveillance program (2007-20
08). Diagn Microbiol Infect Dis 2009; 65:158-162.    ^cY#aop10-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#155#151#article#162#</font
></p>     ^cY#aop10-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#156#152#article#162#<p>&nb
sp;</p>     ^cY#aop10-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#157#153#article#162#<p>&nb
sp;</p>     ^cY#aop10-11.htm##
00442000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704019400089002001300283#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#158#154#article#162#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota1"></a><a 
href="#nota_1"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a
> <b>Address to:</b>    ^cY#aop10-11.htm##
00304000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005600089002001300145#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#159#155#article#162#<br>  
 Dra. Adriana Gon&ccedil;alves de Oliveira    ^cY#aop10-11.htm##
00271000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002300089002001300112#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#160#156#article#162#<br>  
 DCB/UFTM    ^cY#aop10-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004400089002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#161#157#article#162#<br>  
 Pra&ccedil;a Manoel Terra 330    ^cY#aop10-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004400089002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#162#158#article#162#<br>  
 38015-050 Uberaba, MG, Brasil    ^cY#aop10-11.htm##
00307000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005900089002001300148#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#163#159#article#162#<br>  
 Phone: 55 34 3318-5480; Fax: 55 34 3318-5462    ^cY#aop10-11.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010900089002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#164#160#article#162#<br>  
 e-mail: <a href="mailto:agoliveira@dcb.uftm.edu.br">agoliveira@dcb.uftm.edu.br<
/a></font></p>     ^cY#aop10-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#165#161#article#162#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 22/10/2010 
   ^cY#aop10-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#p#166#162#article#162#<br>  
 Accepted in 17/11/2010</font></p>     ^cY#aop10-11.htm##
00506000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880120043001050300
01900148065000900167064000500176031000200181014000600183865000900189002001300198
035001000211801001900221#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
10-11.htm#S#c#167#1#article#34#1#^rND^sMurray^nBE#The life and times of the Ente
rococcus^len#Clin Microbiol Rev#19900000#1990#3#46-65#20110000#aop10-11.htm#0893
-8512#Clin Microbiol Rev##
00703000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100015001090100
01600124012016400140030002700304065000900331064000500340031000300345014000600348
865000900354002001300363035001000376801002700386#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop10-11.htm#S#c#168#2#article#34#2#^rND^sBiedenbach^nDJ#^r
ND^sMoet^nGJ#^rND^sJones^nRN#Occurrence and antimicrobial resistance pattern com
parisons among bloodstream infection isolates from the SENTRY Antimicrobial Surv
eillance Program (1997-2002)^len#Diagn Microbiol Infect Dis#20040000#2004#50#56-
69#20110000#aop10-11.htm#0732-8893#Diagn Microbiol Infect Dis##
00768000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100016001040100
01700120010001700137010001500154010002000169012013900189030001800328065000900346
06400050035503100030036001400060036386500090036900200130037803500100039180100410
0401#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#169#3#
article#34#3#^rND^sGales^nAC#^rND^sSader^nHS#^rND^sRibeiro^nJ#^rND^sZoccoli^nC#^
rND^sBarth^nA#^rND^sPignatari^nAC#Antimicrobial susceptibility of gram-positive 
bacteria isolated in Brazilian hospitals participating in the SENTRY Program (20
05-2008)^len#Braz J Infect Dis#20090000#2009#13#90-98#20110000#aop10-11.htm#1413
-8670#Brazilian Journal of Infectious Diseases##
00504000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880120049001050300
01300154065000900167064000500176031000400181014000800185865000900193002001300202
035001000215801001300225#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
10-11.htm#S#c#170#4#article#34#4#^rND^sMurray^nBE#Vancomycin-resistant enterococ
cal infections^len#N Engl J Med#20000000#2000#342#710-721#20110000#aop10-11.htm#
0028-4793#N Engl J Med##
00538000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880120067001070300
02000174065000900194064000500203031000400208014000800212865000900220002001300229
035001000242801002000252#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
10-11.htm#S#c#171#5#article#34#5#^rND^sCourvalin^nP#Genetics of glycopeptide res
istance in gram-positive pathogens^len#Int J Med Microbiol#20050000#2005#294#479
-486#20110000#aop10-11.htm#0934-8840#Int J Med Microbiol##
00731000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100022000880100016001100100
01900126010001800145010002200163010001900185810000600204012006800210030001800278
06500090029606400050030503100020031001400080031286500090032000200130032903500100
0342801004100352#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.ht
m#S#c#172#6#article#34#6#^rND^sDalla-Costa^nLM#^rND^sSouza^nDC#^rND^sMartins^nLT
F#^rND^sZanella^nRC#^rND^sBrandileone^nMC#^rND^sBokermann^nS#et al#Vancomycin-re
sistant Enterococcus faecium: first case in Brazil^len#Braz J Infect Dis#1998000
0#1998#2#160-163#20110000#aop10-11.htm#1413-8670#Brazilian Journal of Infectious
 Diseases##
00785000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100019001060100
01700125010001700142010001900159010001800178810000600196012015100202030001900353
06500090037206400050038103100020038601400080038886500090039600200130040503500100
0418801001900428#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.ht
m#S#c#173#7#article#34#7#^rND^sZanella^nRC#^rND^sValdetaro^nF#^rND^sLovgren^nM#^
rND^sTyrrel^nGJ#^rND^sBokermann^nS#^rND^sAlmeida^nSC#et al#First confirmed case 
of a vancomycin-resistant Enterococcus faecium with vanA phenotype from Brazil: 
isolation from a meningitis case in São Paulo^len#Microb Drug Resist#19990000#19
99#5#159-162#20110000#aop10-11.htm#1076-6294#Microb Drug Resist##
00669000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100019001050100
01700124010001400141010001600155012013000171030001700301710000200318065000900320
064000500329031000300334014000800337865000900345002001300354#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#174#8#article#34#8#^rND^sBende
r^nEA#^rND^sFreitas^nALP#^rND^sReiter^nKC#^rND^sLutz^nL#^rND^sBarth^nAL#Identifi
cation, antimicrobial resistance and genotypic characterization of Enterococcus 
spp. isolated in Porto Alegre, Brazil^len#Braz J Microbiol#2#20090000#2009#40#69
3-700#20110000#aop10-11.htm##
00801000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100024000880100018001120100
01900130010001800149010001900167010002000186012015400206030001800360065000900378
06400050038703100020039201400080039486500090040200200130041103500100042480100410
0434#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#175#9#
article#34#9#^rND^sCaiaffa Filho^nHH#^rND^sAlmeida^nGD#^rND^sOliveira^nGA#^rND^s
Sarahyba^nL#^rND^sMamizuka^nEM#^rND^sBurattini^nMN#Molecular characterization of
 van genes found in vancomycin resistant Enterococcus spp. isolated from Hospita
l das Clínicas, FMUSP, São Paulo, Brazil^len#Braz J Infect Dis#20030000#2003#7#1
73-174#20110000#aop10-11.htm#1413-8670#Brazilian Journal of Infectious Diseases#
#
00832000000000349000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01600123010001500139010001800154010001800172010001700190010002000207012014200227
03000180036906500090038706400050039603100020040101400060040386500090040900200130
0418035001000431801004100441#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup
\aop10-11.htm#S#c#176#10#article#34#10#^rND^sCereda^nRF#^rND^sSader^nHS#^rND^sJo
nes^nRN#^rND^sSejas^nL#^rND^sMachado^nAM#^rND^sZanatta^nYP#^rND^sRego^nSTMS#^rND
^sMedeiros^nEAS#Enterococcus faecalis resistant to vancomycin and teicoplanin (V
anA phenotype) isolated from a bone marrow transplanted patient in Brazil^len#Br
az J Infect Dis#20010000#2001#5#40-46#20110000#aop10-11.htm#1413-8670#Brazilian 
Journal of Infectious Diseases##
00609000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100017001090100
01500126010001600141012009200157030002200249710000200271065000900273064000500282
031000200287014000800289865000900297002001300306#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop10-11.htm#S#c#177#11#article#34#11#^rND^sCordeiro^nJC#^r
ND^sSilbert^nS#^rND^sReis^nAO#^rND^sSader^nHS#Inter-hospital dissemination of gl
ycopeptides resistant Enterococcus faecalis in Brazil^len#Clin Microbiol Infect#
2#20040000#2004#3#260-262#20110000#aop10-11.htm##
00681000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01800124010001700142010002400159012013000183030001700313710000200330065000900332
064000500341031000300346014000800349865000900357002001300366#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#178#12#article#34#12#^rND^sRib
as^nRM#^rND^sDarini^nALC#^rND^sMoreira^nTA#^rND^sFreitas^nC#^rND^sGontijo Filho^
nPP#Vancomycinresistant vanA phenotype Enterococcus faecalis: first case in Mina
s Gerais state and epidemiological considerations^len#Braz J Infec Dis#2#2007000
0#2007#11#439-440#20110000#aop10-11.htm##
00766000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100023001080100
01900131010001900150010001900169010001700188810000600205012012300211030001900334
06500090035306400050036203100020036701400080036986500090037700200130038603500100
0399801001900409#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.ht
m#S#c#179#13#article#34#13#^rND^sZanella^nRC#^rND^sBrandileone^nMCC#^rND^sBokerm
ann^nS#^rND^sAlmeida^nSCG#^rND^sValdetaro^nF#^rND^sVitório^nF#et al#Phenotypic a
nd genotypic characterization of vanA Enterococcus isolated during the first nos
ocomial outbreak in Brazil^len#Microb Drug Resist#20030000#2003#9#283-291#201100
00#aop10-11.htm#1076-6294#Microb Drug Resist##
00719000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100020001090100
01800129012001700147016001700164016001600181016002000197016001700217016001800234
01800360025206600150028806200340030306500090033706400050034601400080035186500090
0359002001300368#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.ht
m#S#c#180#14#article#34#14#^rND^sTeixeira^nLM#^rND^sCarvalho^nMGS#^rND^sFacklam^
nRR#Enterococcus^len#^rED^sMurray^nBE#^rED^sBaron^nEJ#^rED^sJorgensen^nJH#^rED^s
Landry^nML#^rED^sPfaller^nMA#Manual of Clinical Microbiology^len#Washington^eDC#
American Society for Microbiology#20070000#2007#430-442#20110000#aop10-11.htm##
00534000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170044000900180105001340660
00600239062002300245065000900268064000500277865000900282002001300291#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#181#15#article#34#15#C
linical and Laboratory Standards Institute#Performance standards for antimicrobi
al susceptibility testing: Ninth tenth Informational Supplement^len#Wayne#CLSI d
ocument M100-S19#20090000#2009#20110000#aop10-11.htm##
00742000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
01800126010001600144010001700160010001700177012013100194030001700325065000900342
06400050035103100030035601400080035986500090036700200130037603500100038980100170
0399#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#182#16
#article#34#16#^rND^sWoodford^nN#^rND^sMorrison^nD#^rND^sJohnson^nAP#^rND^sBrian
t^nV#^rND^sGeorge^nRC#^rND^sCookson^nB#Application of DNA probes for rRNA and va
nA genes to investigation of a nosocomial cluster of vancomycin-resistant entero
cocci^len#J Clin Microbiol#19930000#1993#31#653-658#20110000#aop10-11.htm#0095-1
137#J Clin Microbiol##
00657000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100015001110100
01900126012013300145030001700278065000900295064000500304031000300309014000600312
865000900318002001300327035001000340801001700350#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop10-11.htm#S#c#183#17#article#34#17#^rND^sDutka-malen^nS#
^rND^sEvers^nS#^rND^sCourvalin^nP#Detection of glicopeptide resistance genotypes
 and identification to the species level of clinically relevant enterococci by P
CR^len#J Clin Microbiol#19950000#1995#33#24-27#20110000#aop10-11.htm#0095-1137#J
 Clin Microbiol##
00759000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100023000900100021001130100
01900134010001800153010001800171010001700189012014200206030001400348065000900362
06400050037103100030037601400080037986500090038700200130039603500100040980100140
0419#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#184#18
#article#34#18#^rND^sProtonotariou^nE#^rND^sDimitroulia^nE#^rND^sPournaras^nS#^r
ND^sPitiriga^nV#^rND^sSofianou^nD#^rND^sTsakris^nA#Trends in antimicrobial resis
tance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in 
Greece between 2002 and 2007^len#J Hosp Infect#20100000#2010#75#225-227#20110000
#aop10-11.htm#0195-6701#J Hosp Infect##
00702000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090100
01900127010001800146010001400164010002000178012008700198030001800285065000900303
06400050031203100030031701400060032086500090032600200130033503500100034880100180
0358#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#185#19
#article#34#19#^rND^sFurtado^nGHC#^rND^sMartins^nST#^rND^sCoutinho^nAN#^rND^sSoa
res^nGMM#^rND^sWey^nSB#^rND^sMedeiros^nEAS#Incidence of vancomycin-resistance En
terococcus at a university hospital in Brazil^len#Rev Saude Publica#20050000#200
5#39#41-46#20110000#aop10-11.htm#0034-8910#Rev Saude Publica##
00603000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060100
01600121012009500137030001200232065000900244064000500253031000300258014000800261
865000900269002001300278035001000291801001200301#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop10-11.htm#S#c#186#20#article#34#20#^rND^sSader^nHS#^rND^
sMoet^nGJ#^rND^sJones^nRN#Antimicrobial resistance among gram-positive bacteria 
isolated in Latin American hospitals^len#J Chemother#20090000#2009#21#611-620#20
110000#aop10-11.htm#1120-009X#J Chemother##
00790000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100019001100100
01500129010002200144010001600166012018300182030002700365065000900392064000500401
031000300406014000800409865000900417002001300426035001000439801002700449#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#187#21#article#34#
21#^rND^sDeshpande^nLM#^rND^sFritsche^nTR#^rND^sMoet^nGJ#^rND^sBiendenbach^nDJ#^
rND^sJones^nRN#Antimicrobial resistance and molecular epidemiology of vancomycin
-resistant enterococci from North America and Europe: a report from the SENTRY A
ntimicrobial Surveillance Program^len#Diagn Microbiol Infect Dis#20070000#2007#5
8#163-170#20110000#aop10-11.htm#0732-8893#Diagn Microbiol Infect Dis##
00597000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01900125012010700144030002000251710000200271065000900273064000500282031000200287
014000800289865000900297002001300306#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop10-11.htm#S#c#188#22#article#34#22#^rND^sLeavis^nHL#^rND^sBonten^nMJ
M#^rND^sWillems^nRJL#Identification of high-risk enterococcal clonal complexes: 
global dispersion and antibiotic resistance^len#Curr Opin Microbiol#2#20060000#2
006#9#454-460#20110000#aop10-11.htm##
00759000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100016001040100
01700120010001600137010001600153012017100169030002300340065000900363064000500372
031000300377014001000380865000900390002001300399035001000412801002300422#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#189#23#article#34#
23#^rND^sOteo^nJ#^rND^sCuevas^nO#^rND^sNavarro^nC#^rND^sAracil^nB#^rND^sCampos^n
J#Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EA
RSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus
 faecium^len#J Antimicrob Chemother#20070000#2007#59#1044-1045#20110000#aop10-11
.htm#0305-7453#J Antimicrob Chemother##
00558000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080120
10200126030001600228710000200244065000900246064000500255031000200260014000800262
865000900270002001300279#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
10-11.htm#S#c#190#24#article#34#24#^rND^sShepard^nBD#^rND^sGilmore^nMS#Antibioti
c-resistant enterococci: the mechanisms and dynamics of drug introduction and re
sistance^len#Microbes Infect#2#20020000#2002#4#215-224#20110000#aop10-11.htm##
00639000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090100
01600127010001700143012008600160030001700246065000900263064000500272031000300277
014000800280865000900288002001300297035001000310801001700320#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#191#25#article#34#25#^rND^sTre
itman^nAN#^rND^sYarnold^nPR#^rND^sWarren^nJ#^rND^sNoskin^nGA#Emerging incidence 
of Enterococcus faecium among hospital isolates (1993 to 2002)^len#J Clin Microb
iol#20050000#2005#43#462-463#20110000#aop10-11.htm#0095-1137#J Clin Microbiol##
00641000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01900122010001400141010002000155010001700175810000600192012007800198030001400276
710000200290014000500292031000300297014000500300865000900305002001300314#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#192#26#article#34#
26#^rND^sWerner^nG#^rND^sCoque^nTM#^rND^sHammerum^nAM#^rND^sHope^nR#^rND^sHrynie
wicz^nW#^rND^sJohnson^nA#et al#Emergence and spread of vancomycin resistance amo
ng enterococci in Europe^len#Euro Surveill#2#2008#13#1-11#20110000#aop10-11.htm#
#
00662000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100018001100100
01800128012016500146030002200311710000200333065000900335064000500344031000300349
014001000352865000900362002001300371#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop10-11.htm#S#c#193#27#article#34#27#^rND^sCamargo^nILBC#^rND^sGilmore
^nMS#^rND^sDarini^nALC#Multilocus sequence typing and analysis of putative virul
ence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faeci
um isolates from Brazil^len#Clin Microbiol Infect#2#20060000#2006#12#1123-1130#2
0110000#aop10-11.htm##
00712000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100026000900100020001160100
01800136010001800154010001300172010001900185012012900204030001600333710000200349
065000900351064000500360031000300365014000800368865000900376002001300385#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#194#28#article#34#
28#^rND^sTitze-de-Almeida^nR#^rND^sVan Belkum^nA#^rND^sFelipe^nMSS#^rND^sZanella
^nRC#^rND^sTop^nJ#^rND^sWillems^nRJL#Multilocus sequence typing of hospital asso
ciated Enterococcus faecium from Brazil reveals their unique evolutionary histor
y^len#Microb Drug Res#2#20060000#2006#12#121-125#20110000#aop10-11.htm##
00719000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100016001040100
01500120010001600135012017600151030001600327065000900343064000500352031000300357
014000900360865000900369002001300378035001000391801001600401#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#195#29#article#34#29#^rND^sLow
^nDE#^rND^sKeller^nN#^rND^sBarth^nA#^rND^sJones^nRN#Clinical prevalence, antimic
robial susceptibility, and geographic resistance patterns of Enterococci: result
s from the SENTRY Antimicrobial Surveillance Program, 1997-1999^len#Clin Infect 
Dis#20010000#2001#32#S133-145#20110000#aop10-11.htm#1058-4838#Clin Infect Dis##
00716000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100016001100100
01700126010001500143010001900158010001700177810000600194012011400200030002700314
71000020034106500090034306400050035203100030035701400080036086500090036800200130
0377#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#196#30
#article#34#30#^rND^sLautenbach^nE#^rND^sGould^nCV#^rND^sLaRosa^nLA#^rND^sMarr^n
AM#^rND^sNachamkin^nI#^rND^sBilker^nWB#et al#Emergence of resistance to chloramp
henicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates^len#I
ntern J Antimicrob Agents#2#20040000#2004#23#200-203#20110000#aop10-11.htm##
00713000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01600122010001600138010002000154012011200174030001800286065000900304064000500313
031000200318014000600320865000900326002001300335035001000348801004100358#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#197#31#article#34#
31#^rND^sSader^nHS#^rND^sJones^nRN#^rND^sGales^nAC#^rND^sSilva^nJB#^rND^sPignata
ri^nAC#SENTRY antimicrobial surveillance program report: Latin American and Braz
ilian result for 1997 through 2001^len#Braz J Infect Dis#20040000#2004#8#25-79#2
0110000#aop10-11.htm#1413-8670#Brazilian Journal of Infectious Diseases##
00716000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
01600125010002300141010001900164012010300183030001800286065000900304064000500313
031000300318014000800321865000900329002001300338035001000351801004100361#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#198#32#article#34#
32#^rND^s'Azevedo^nPA#^rND^sDias^nCAG#^rND^sLemos^nSK#^rND^sBittencourt^nJAF#^rN
D^sTeixeira^nLM#Antimicrobial susceptibility among Enterococcus isolates from th
e city of Porto Alegre, RS, Brazil^len#Braz J Infect Dis#20040000#2004#35#199-20
4#20110000#aop10-11.htm#1413-8670#Brazilian Journal of Infectious Diseases##
00743000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01800122010001700140010001700157010001500174810000600189012015600195030001800351
71000020036906500090037106400050038003100020038501400080038786500090039500200130
0404#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop10-11.htm#S#c#199#33
#article#34#33#^rND^sSader^nHS#^rND^sGales^nAC#^rND^sPfaller^nMA#^rND^sMendes^nR
E#^rND^sZocolli^nC#^rND^sBarth^nA#et al#Pathogen frequency and resistance patter
ns in Brazilian hospitals: summary of results from three years of the SENTRY Ant
imicrobial Surveillance Program^len#Braz J Infect Dis#2#20010000#2001#5#200-214#
20110000#aop10-11.htm##
00663000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060120
15200122030002700274065000900301064000500310031000300315014000800318865000900326
002001300335035001000348801002700358#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop10-11.htm#S#c#200#34#article#34#34#^rND^sSader^nHS#^rND^sJones^nRN#A
ntimicrobial susceptibility of gram-positive bacteria isolated from US medical c
enters: results of the daptomycin surveillance program (2007-2008)^len#Diagn Mic
robiol Infect Dis#20090000#2009#65#158-162#20110000#aop10-11.htm#0732-8893#Diagn
 Microbiol Infect Dis##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#o#1#
1#article#1#20110325#103642#aop11-11.htm#202##
04743000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400070016103500100016822300090017801200990
01870120109002860100037003950100041004320100025004730700107004980700118006050831
55600723085000802279085002302287085004502310085002202355083153302377085000803910
08500230391808500610394108500220400205800430402411700060406707200030407311200090
4076111001104085114000904096113001104105002001304116#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop11-11.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#T
AB#13#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f1^l5#0037-8682#20110401#
Serosurvey of hantavirus infection in humans in the border region between Brazil
 and Argentina^len#Estudo sorológico de infecção por hantavírus em humanos na re
gião de fronteira, entre Brasil e Argentina^lpt#^rND^1A01^nWilliam Marciel de^sS
ouza#^rND^1A01^nLuiz Tadeu Moraes^sFigueiredo#^rND^1A02^nEverton^sBoff#Universid
ade de São Paulo^iA01^1Faculdade de Medicina^2Centro de Pesquisa em Virologia^cR
ibeirão Preto^sSP#Universidade do Oeste de Santa Catarina^iA02^1Departamento de 
Ciências Biológicas e da Saúde^cSão Miguel do Oeste^sSC#^len^aINTRODUCTION: Acco
rding to reports by the Ministry of Health, in the far western region of the Sta
te of Santa Catarina, there have been no reports of hantavirus pulmonary syndrom
e, a zoonotic disease transmitted by feces of infected rodents. A seroepidemiolo
gical study of residents of this region, was conducted, with the aim of determin
ing the presence of hantavirus infections. A total of 340 volunteers of both gen
us, from the towns of Belmonte and Paraíso, were studied. METHODS: The serum of 
these patients was collected and used to detect IgG antibodies against recombina
nt N protein of Araraquara hantavirus, by ELISA assay. The positive samples were
 then titrated and confirmed by immunofluorescence assay. RESULTS: This study de
monstrated the presence of IgG antibodies against hantavirus N protein in 3.5% o
f the population. The most frequent occupation was farm worker, 81% had direct a
nd indirect contact with rodents, 91.7% of positive cases were farm workers, ind
icating that the probable cause of infection occurred during barn cleaning. Thes
e antibodies are noteworthy, given that the levels of antibodies were verified i
n individuals whose contact with hantavirus may have occurred many years ago. CO
NCLUSIONS: This study shows the circulation of hantavirus in the region, a fact 
that until now, had not reported. All the serum reagents had contact with the pa
thogen, but did not develop pulmonary and cardiovascular syndrome. It is importa
nt to remain alert, because hantavirus is a serious and emerging disease of some
 relevance.#^dnd^i1#^tm^len^kHantavirus^i1#^tm^len^kSeroprevalence in Santa Cata
rina^i1#^tm^len^kMorbidity^i1#^lpt^aINTRODUÇÃO: De acordo com relatórios do Mini
stério da Saúde, na região do extremo oeste do Estado de Santa Catarina, não há 
relatos de síndrome pulmonar por hantavírus, doença zoonótica transmitida por ex
cretas de roedores contaminados. Com a finalidade de demosntrar a infecção por h
antavírus, um estudo soroepidemiológico de moradores da região foi realizado. As
sim, foi estudado um total de 340 voluntários de ambos os gêneros, dos município
s de Belmonte e Paraíso. MÉTODOS: O soro destes pacientes foi coletado e usado p
ara a detecção de anticorpos IgG contra a proteína N recombinante de hantavírus 
Araraquara, pelo teste de ELISA. As amostras positivas foram tituladas e confirm
adas por imunofluorescência indireta. RESULTADOS: Este estudo demonstrou a prese
nça de anticorpos IgG contra a proteína N hantavírus em 3,5% da população. A ocu
pação de lavrador foi a mais frequente, e 81% tiveram contato direto e indireto 
com os roedores, 91,7% dos casos positivos foram os agricultores, a causa prováv
el da infecção foi através da limpeza de celeiros. Estes anticorpos são notáveis
, dado que os níveis de anticorpos são encontrados nos indivíduos cujo contato c
om o hantavírus pode ter ocorrido há muitos anos. CONCLUSÕES: Este estudo mostra
 a circulação de hantavírus na região, um fato que até então não havia relatado,
 todos os reagentes soro tiveram contato com o patógeno, mas não desenvolveram a
 síndrome pulmonar e cardiovascular. É preciso estar alerta, porque é uma doença
 grave e emergente com grande importância.#^dnd^i2#^tm^lpt^kHantavírus^i2#^tm^lp
t^kSoroprevalência de hantavirose em Santa Catarina^i2#^tm^lpt^kMorbidade^i2#USP
^dCenter for Research in Virology, FMRP#other#36#20100330#30/03/2010#20101116#16
/11/2010#aop11-11.htm##
04827000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400070016103500100016822300090017801201060
01870120116002930100037004090100041004460100025004870700107005120700118006190831
59100737085000802328085002302336085004502359085002202404083156802426085000803994
08500230400208500610402508500220408605800430410811700060415107200030415711200090
4160111001104169114000904180113001104189002001304200#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop11-11.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#T
AB#13#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f1^l5#0037-8682#20110401#
<b>Serosurvey of hantavirus infection in humans in the border region between Bra
zil and Argentina</b>^len#<b>Estudo sorológico de infecção por hantavírus em hum
anos na região de fronteira, entre Brasil e Argentina</b>^lpt#^rND^1A01^nWilliam
 Marciel de^sSouza#^rND^1A01^nLuiz Tadeu Moraes^sFigueiredo#^rND^1A02^nEverton^s
Boff#Universidade de São Paulo^iA01^1Faculdade de Medicina^2Centro de Pesquisa e
m Virologia^cRibeirão Preto^sSP#Universidade do Oeste de Santa Catarina^iA02^1De
partamento de Ciências Biológicas e da Saúde^cSão Miguel do Oeste^sSC#^len^a<b>I
NTRODUCTION:</b> According to reports by the Ministry of Health, in the far west
ern region of the State of Santa Catarina, there have been no reports of hantavi
rus pulmonary syndrome, a zoonotic disease transmitted by feces of infected rode
nts. A seroepidemiological study of residents of this region, was conducted, wit
h the aim of determining the presence of hantavirus infections. A total of 340 v
olunteers of both genus, from the towns of Belmonte and Paraíso, were studied. <
b>METHODS: </b>The serum of these patients was collected and used to detect IgG 
antibodies against recombinant N protein of <i>Araraquara</i> hantavirus, by ELI
SA assay. The positive samples were then titrated and confirmed by immunofluores
cence assay. <b>RESULTS: </b>This study demonstrated the presence of IgG antibod
ies against hantavirus N protein in 3.5% of the population. The most frequent oc
cupation was farm worker, 81% had direct and indirect contact with rodents, 91.7
% of positive cases were farm workers, indicating that the probable cause of inf
ection occurred during barn cleaning. These antibodies are noteworthy, given tha
t the levels of antibodies were verified in individuals whose contact with hanta
virus may have occurred many years ago. <b>CONCLUSIONS: </b>This study shows the
 circulation of hantavirus in the region, a fact that until now, had not reporte
d. All the serum reagents had contact with the pathogen, but did not develop pul
monary and cardiovascular syndrome. It is important to remain alert, because han
tavirus is a serious and emerging disease of some relevance.#^dnd^i1#^tm^len^kHa
ntavirus^i1#^tm^len^kSeroprevalence in Santa Catarina^i1#^tm^len^kMorbidity^i1#^
lpt^a<b>INTRODUÇÃO: </b>De acordo com relatórios do Ministério da Saúde, na regi
ão do extremo oeste do Estado de Santa Catarina, não há relatos de síndrome pulm
onar por hantavírus, doença zoonótica transmitida por excretas de roedores conta
minados. Com a finalidade de demosntrar a infecção por hantavírus, um estudo sor
oepidemiológico de moradores da região foi realizado. Assim, foi estudado um tot
al de 340 voluntários de ambos os gêneros, dos municípios de Belmonte e Paraíso.
 <b>MÉTODOS: </b>O soro destes pacientes foi coletado e usado para a detecção de
 anticorpos IgG contra a proteína N recombinante de hantavírus <i>Araraquara</i>
, pelo teste de ELISA. As amostras positivas foram tituladas e confirmadas por i
munofluorescência indireta. <b>RESULTADOS: </b>Este estudo demonstrou a presença
 de anticorpos IgG contra a proteína N hantavírus em 3,5% da população. A ocupaç
ão de lavrador foi a mais frequente, e 81% tiveram contato direto e indireto com
 os roedores, 91,7% dos casos positivos foram os agricultores, a causa provável 
da infecção foi através da limpeza de celeiros. Estes anticorpos são notáveis, d
ado que os níveis de anticorpos são encontrados nos indivíduos cujo contato com 
o hantavírus pode ter ocorrido há muitos anos. <b>CONCLUSÕES: </b>Este estudo mo
stra a circulação de hantavírus na região, um fato que até então não havia relat
ado, todos os reagentes soro tiveram contato com o patógeno, mas não desenvolver
am a síndrome pulmonar e cardiovascular. É preciso estar alerta, porque é uma do
ença grave e emergente com grande importância.#^dnd^i2#^tm^lpt^kHantavírus^i2#^t
m^lpt^kSoroprevalência de hantavirose em Santa Catarina^i2#^tm^lpt^kMorbidade^i2
#USP^dCenter for Research in Virology, FMRP#other#36#20100330#30/03/2010#2010111
6#16/11/2010#aop11-11.htm##
04914000000000637000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000500108038000400113121000300117049000300120
15800030012303000260012603200060015206500090015801400070016703500100017422300090
01840120099001930120109002920100037004010100041004380100025004790700109005040700
12000613083157700733085000802310085002302318085004502341085002202386083156002408
08500080396808500230397608500610399908500220406005800430408211700060412507200030
4131112000904134111001104143114000904154113001104163002001304174008008904187#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#l#4#1#article#1#
^a2011#oa#pt#br1.1#1#4.0#ilus#tab#13#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110
000#^f1^l5#0037-8682#20110401#Serosurvey of hantavirus infection in humans in th
e border region between Brazil and Argentina^len#Estudo sorológico de infecção p
or hantavírus em humanos na região de fronteira, entre Brasil e Argentina^lpt#^r
ND^1A01^nWilliam Marciel de^sSouza#^rND^1A01^nLuiz Tadeu Moraes^sFigueiredo#^rND
^1A02^nEverton^sBoff#^iA01^1Universidade de São Paulo^2Faculdade de Medicina^3Ce
ntro de Pesquisa em Virologia^cRibeirão Preto^sSP#^iA02^1Universidade do Oeste d
e Santa Catarina^2Departamento de Ciências Biológicas e da Saúde^cSão Miguel do 
Oeste^sSC#^len^aINTRODUCTION: According to reports by the Ministry of Health, in
 the far western region of the State of Santa Catarina, there have been no repor
ts of hantavirus pulmonary syndrome, a zoonotic disease transmitted by feces of 
infected rodents. A seroepidemiological study of residents of this region, was c
onducted, with the aim of determining the presence of hantavirus infections. A t
otal of 340 volunteers of both genus, from the towns of Belmonte and Paraíso, we
re studied. METHODS: The serum of these patients was collected and used to detec
t IgG antibodies against recombinant N protein of Araraquara hantavirus, by ELIS
A assay. The positive samples were then titrated and confirmed by immunofluoresc
ence assay. RESULTS: This study demonstrated the presence of IgG antibodies agai
nst hantavirus N protein in 3.5 percent of the population. The most frequent occ
upation was farm worker, 81 percent had direct and indirect contact with rodents
, 91.7 percent of positive cases were farm workers, indicating that the probable
 cause of infection occurred during barn cleaning. These antibodies are notewort
hy, given that the levels of antibodies were verified in individuals whose conta
ct with hantavirus may have occurred many years ago. CONCLUSIONS: This study sho
ws the circulation of hantavirus in the region, a fact that until now, had not r
eported. All the serum reagents had contact with the pathogen, but did not devel
op pulmonary and cardiovascular syndrome. It is important to remain alert, becau
se hantavirus is a serious and emerging disease of some relevance.#^dnd^i1#^tm^l
en^kHantavirus^i1#^tm^len^kSeroprevalence in Santa Catarina^i1#^tm^len^kMorbidit
y^i1#^lpt^aINTRODUÇÃO: De acordo com relatórios do Ministério da Saúde, na regiã
o do extremo oeste do Estado de Santa Catarina, não há relatos de síndrome pulmo
nar por hantavírus, doença zoonótica transmitida por excretas de roedores contam
inados. Com a finalidade de demosntrar a infecção por hantavírus, um estudo soro
epidemiológico de moradores da região foi realizado. Assim, foi estudado um tota
l de 340 voluntários de ambos os gêneros, dos municípios de Belmonte e Paraíso. 
MÉTODOS: O soro destes pacientes foi coletado e usado para a detecção de anticor
pos IgG contra a proteína N recombinante de hantavírus Araraquara, pelo teste de
 ELISA. As amostras positivas foram tituladas e confirmadas por imunofluorescênc
ia indireta. RESULTADOS: Este estudo demonstrou a presença de anticorpos IgG con
tra a proteína N hantavírus em 3,5 por cento da população. A ocupação de lavrado
r foi a mais frequente, e 81 por cento tiveram contato direto e indireto com os 
roedores, 91,7 por cento dos casos positivos foram os agricultores, a causa prov
ável da infecção foi através da limpeza de celeiros. Estes anticorpos são notáve
is, dado que os níveis de anticorpos são encontrados nos indivíduos cujo contato
 com o hantavírus pode ter ocorrido há muitos anos. CONCLUSÕES: Este estudo most
ra a circulação de hantavírus na região, um fato que até então não havia relatad
o, todos os reagentes soro tiveram contato com o patógeno, mas não desenvolveram
 a síndrome pulmonar e cardiovascular. É preciso estar alerta, porque é uma doen
ça grave e emergente com grande importância.#^dnd^i2#^tm^lpt^kHantavírus^i2#^tm^
lpt^kSoroprevalência de hantavirose em Santa Catarina^i2#^tm^lpt^kMorbidade^i2#U
SP^dCenter for Research in Virology, FMRP#other#36#20100330#30/03/2010#20101116#
16/11/2010#aop11-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_art
text&pid=S0037-86822011005000013##
00447000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704020300085002001300288#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#5#1#article#162#<p><a name
="enda"></a><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b>Seros
urvey of hantavirus infection in humans in the border region between Brazil and 
Argentina</b></font></p>     ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#6#2#article#162#<p>&nbsp;<
/p>     ^cY#aop11-11.htm##
00473000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704022900085002001300314#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#7#3#article#162#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Estudo sorol&oacute;gico
 de infec&ccedil;&atilde;o por hantav&iacute;rus em humanos na regi&atilde;o de 
fronteira, entre Brasil e Argentina</b></font></p>     ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#8#4#article#162#<p>&nbsp;<
/p>     ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#9#5#article#162#<p>&nbsp;<
/p>     ^cY#aop11-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704019500086002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#10#6#article#162#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>William Marciel de Souz
a<sup>I</sup>; Luiz Tadeu Moraes Figueiredo<sup>I</sup>; Everton Boff<sup>II</su
p></b></font></p>     ^cY#aop11-11.htm##
00443000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704019800086002001300284#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#11#7#article#162#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Centro de Pesq
uisa em Virologia, Faculdade de Medicina, Universidade de S&atilde;o Paulo, Ribe
ir&atilde;o Preto, SP    ^cY#aop11-11.htm##
00424000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704017900086002001300265#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#12#8#article#162#<br>   <s
up>II</sup>Departamento de Ci&ecirc;ncias Biol&oacute;gicas e da Sa&uacute;de, U
niversidade do Oeste de Santa Catarina, S&atilde;o Miguel do Oeste, SC</font></p
>     ^cY#aop11-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011300086002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#13#9#article#162#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#endb">Address to
</a></font></p>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#14#10#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#15#11#article#162#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop11-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#16#12#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop11-11.htm##
00807000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056100087002001300648#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#17#13#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b> Acco
rding to reports by the Ministry of Health, in the far western region of the Sta
te of Santa Catarina, there have been no reports of hantavirus pulmonary syndrom
e, a zoonotic disease transmitted by feces of infected rodents. A seroepidemiolo
gical study of  residents of this region, was conducted, with the aim of determi
ning the presence of hantavirus infections. A total of 340 volunteers of both ge
nus, from the towns of Belmonte and Para&iacute;so, were studied.    ^cY#aop11-1
1.htm##
00514000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026800087002001300355#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#18#14#article#162#<br>   <
b>METHODS: </b>The serum of these patients was collected and used to detect IgG 
antibodies against recombinant N protein of <i>Araraquara</i> hantavirus, by ELI
SA assay. The positive samples were then titrated and confirmed by immunofluores
cence assay.    ^cY#aop11-11.htm##
00768000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052200087002001300609#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#19#15#article#162#<br>   <
b>RESULTS: </b>This study demonstrated the presence of IgG antibodies against ha
ntavirus N protein in 3.5% of the population. The most frequent occupation was f
arm worker, 81% had direct and indirect contact with rodents, 91.7% of positive 
cases were farm workers, indicating that the probable cause of infection occurre
d during barn cleaning. These antibodies are noteworthy, given that the levels o
f antibodies were verified in individuals whose contact with hantavirus may have
 occurred many years ago.     ^cY#aop11-11.htm##
00613000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036700087002001300454#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#20#16#article#162#<br>   <
b>CONCLUSIONS: </b>This study shows the circulation of hantavirus in the region,
 a fact that until now, had not reported. All the serum reagents had contact wit
h the pathogen, but did not develop pulmonary and cardiovascular syndrome. It is
 important to remain alert, because hantavirus is a serious and emerging disease
 of some relevance.</font></p>     ^cY#aop11-11.htm##
00424000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017800087002001300265#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#21#17#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Hantavir
us. Seroprevalence in Santa Catarina. Morbidity.</font></p> <hr size="1" noshade
>     ^cY#aop11-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#22#18#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop11-11.htm##
00939000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704069300087002001300780#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#23#19#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b>De acordo com relat&oacute;rios do Minist&eacute;rio da Sa&uacute;de, na
 regi&atilde;o do extremo oeste do Estado de Santa Catarina, n&atilde;o h&aacute
; relatos de s&iacute;ndrome pulmonar por hantav&iacute;rus, doen&ccedil;a zoon&
oacute;tica transmitida por excretas de roedores contaminados. Com a finalidade 
de demosntrar a infec&ccedil;&atilde;o por hantav&iacute;rus, um estudo soroepid
emiol&oacute;gico de  moradores da regi&atilde;o foi realizado. Assim, foi estud
ado um total de 340 volunt&aacute;rios de ambos os g&ecirc;neros, dos munic&iacu
te;pios de Belmonte e Para&iacute;so.    ^cY#aop11-11.htm##
00568000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032200087002001300409#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#24#20#article#162#<br>   <
b>M&Eacute;TODOS: </b>O soro destes pacientes foi coletado e usado para a detec&
ccedil;&atilde;o de anticorpos IgG contra a prote&iacute;na N recombinante de ha
ntav&iacute;rus <i>Araraquara</i>, pelo teste de ELISA. As amostras positivas fo
ram tituladas e confirmadas por imunofluoresc&ecirc;ncia indireta.    ^cY#aop11-
11.htm##
00886000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064000087002001300727#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#25#21#article#162#<br>   <
b>RESULTADOS: </b>Este estudo demonstrou a presen&ccedil;a de anticorpos IgG con
tra a prote&iacute;na N hantav&iacute;rus em 3,5% da popula&ccedil;&atilde;o. A 
ocupa&ccedil;&atilde;o de lavrador foi a mais frequente, e 81% tiveram contato d
ireto e indireto com os roedores, 91,7% dos casos positivos foram os agricultore
s, a causa prov&aacute;vel da infec&ccedil;&atilde;o foi atrav&eacute;s da limpe
za de celeiros. Estes anticorpos s&atilde;o not&aacute;veis, dado que os n&iacut
e;veis de anticorpos s&atilde;o encontrados nos indiv&iacute;duos cujo contato c
om o hantav&iacute;rus pode ter ocorrido h&aacute; muitos anos.     ^cY#aop11-11
.htm##
00696000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045000087002001300537#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#26#22#article#162#<br>   <
b>CONCLUS&Otilde;ES: </b>Este estudo mostra a circula&ccedil;&atilde;o de hantav
&iacute;rus na regi&atilde;o, um fato que at&eacute; ent&atilde;o n&atilde;o hav
ia relatado, todos os reagentes soro tiveram contato com o pat&oacute;geno, mas 
n&atilde;o desenvolveram a s&iacute;ndrome pulmonar e cardiovascular. &Eacute; p
reciso estar alerta, porque &eacute; uma doen&ccedil;a grave e emergente com gra
nde import&acirc;ncia.</font></p>     ^cY#aop11-11.htm##
00460000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021400087002001300301#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#27#23#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves: </b>H
antav&iacute;rus. Soropreval&ecirc;ncia de hantavirose em Santa Catarina. Morbid
ade.</font></p> <hr size="1" noshade>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#28#24#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#29#25#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#30#26#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop11-11.htm##
00647000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040100087002001300488#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#31#27#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Viruses of the genus <i>h
antavirus</i> can cause two serious illnesses when transmitted from rodents to h
umans: hemorrhagic fever with renal syndrome (HFSR) or hantavirus pulmonary synd
rome (HPS), characterized by respiratory failure, shock and high mortality, maki
ng it an important public health problem<sup>1</sup>.</font></p>     ^cY#aop11-1
1.htm##
00719000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047300087002001300560#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#32#28#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Hantavirus is an envelope
d virus with trisegmented negative sense RNA genome, defined as small, medium an
d large. Human infection is acquired by inhalation of aerosols containing excret
a of rodents infected with hantavirus; i.e., infected by a virus of the family <
i>Bunyaviridae</i><sup>2</sup>, which includes than 20 hantaviruses identified t
hroughout the American continent<sup>3</sup>.</font></p>     ^cY#aop11-11.htm##
00866000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062000087002001300707#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#33#29#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Interpersonal transmissio
n of hantavirus has been reported only in Argentina and Chile, but further inves
tigation indicated that this possibility is very unlikely<sup>4-6</sup>. The con
tact with hantavirus in and of itself does not cause HPS, since infection is dep
endent on the quantity of viral particles, such that lower concentrations of par
ticles could lead to subclinical infection. However, another possibility is infe
ction by a nonpathogenic strain that induces immune response activation with ant
ibody production<sup>3,7</sup>. </font></p>     ^cY#aop11-11.htm##
01176000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704093000087002001301017#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#34#30#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The pathogenesis of HPS i
n humans is hypothesized to be mediated by immune activation and excess inflamma
tory responses, especially macrophages and CD8 + T cells<sup>3</sup>. Excess cyt
okines IL-1-</font>&#945;<font size="2" face="Verdana, Arial, Helvetica, sans-se
rif">, IL-1-</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-se
rif">, IL-6 and TNF-</font>&#945;<font size="2" face="Verdana, Arial, Helvetica,
 sans-serif"> interferon-</font>&#947;<font size="2" face="Verdana, Arial, Helve
tica, sans-serif">, IL-2, IL-4 and TNF-</font>&#946;<font size="2" face="Verdana
, Arial, Helvetica, sans-serif"> produced by activated macrophages in hantavirus
es, specific T cells in recognition antigen infected pulmonary endothelial cells
, are thought to be critical due to the increased permeability in the pathogenes
is of HPS<sup>8</sup>.</font></p>     ^cY#aop11-11.htm##
00539000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704029300087002001300380#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#35#31#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Despite the severity of H
PS, cases of human infection with mild forms of hantavirus without respiratory f
ailure do occur; however the causes and factors involved in clinical behavior re
main unknown<sup>9</sup>.</font></p>     ^cY#aop11-11.htm##
00584000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704033800087002001300425#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#36#32#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Numerous diagnostic metho
ds for these viruses have been produced, among these, the production of recombin
ant proteins, which are used as antigen in ELISA to enable detection of specific
 antibodies against this virus, should be highlighted<sup>10,11</sup>.</font></p
>     ^cY#aop11-11.htm##
01007000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704076100087002001300848#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#37#33#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In South America, hantavi
ruses have been reported in Argentina, Chile, Uruguay, Paraguay, Bolivia and Ven
ezuela<sup>12</sup>. In Brazil, the first evidence that this virus was circulati
ng was observed in the study of three individuals living in a rural area of Juqu
itiba, S&atilde;o Paulo, in 1993<sup>13</sup>. Today, over 1,200 cases of hantav
irus pulmonary syndrome have occurred in Brazil since 1993, fatalities were repo
rted at a rate of 39%, according to geographic and ethnic differences<sup>14</su
p>. Five hantaviruses associated with HPS are currently known in Brazil: the Juq
uitiba, Araraquara, Laguna Negra-like, Castelo dos Sonhos and Anajatuba viruses<
sup>15</sup>.</font></p>     ^cY#aop11-11.htm##
01250000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704100400087002001301091#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#38#34#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The first confirmed case 
of hantavirus in Santa Catarina was in 1999 and up to 2009, 205 cases have been 
confirmed. The first death from hantavirus in the state was reported in 2001 and
 48 deaths have been reported up to the present, making this the state with the 
second highest death rate<sup>16</sup>. HPS is an emerging public health problem
 in Brazil due to the overlap of urban and agricultural areas, livestock and the
 disorderly growth of human population in areas where imbalance occurs, which in
creases human contact with several species of rodents that are reservoirs of han
tavirus<sup>15</sup>. This study was conducted to investigate the presence of an
tibodies against hantavirus in the far western region of the State of Santa Cata
rina and the southern border of Brazil and northern Argentina and correlate this
 presence through interviews to elucidate the medical history and morbidity of t
he participants.</font></p>     ^cY#aop11-11.htm##
00798000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055200087002001300639#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#39#35#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The study region has an e
conomic base that comes from agricultural activities and accordingly, the degrad
ing of native forest has occurred throughout the region, which is favorable to c
olonization by wild rodents. The study revealed the presence of<i> Necromyslasiu
rus</i> and <i>Oryzomys nigripes</i> in the region, which are known rodent reser
voirs of hantavirus, suggesting there is a chance of viral circulation and, ther
efore, risk of human infection<sup>17</sup>.</font></p>     ^cY#aop11-11.htm##
00664000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041800087002001300505#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#40#36#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Although Santa Catarina i
s the state with the second d highest number of HPS cases, no cases of the disea
se have been recorded in the far west of the state<sup>16</sup> or in municipali
ties in the study area that borders northeastern Argentina; however, previous st
udies have shown that the region has high numbers of HPS<sup>18</sup>.</font></p
>     ^cY#aop11-11.htm##
00780000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053400087002001300621#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#41#37#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Thus, it is unclear wheth
er the lack of notification of hantavirus disease in this region is due, in fact
, the absence of local disease or that infections occur and diagnosis is neglige
nt. So far, no accurate survey of the presence of hantavirus has been conducted 
in the far west of Santa Catarina. Diagnostic tests to detect hantaviruses are o
nly performed following clinical suspicion during hospital attendance, which is 
not common in the region. </font></p>     ^cY#aop11-11.htm##
00570000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032400087002001300411#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#42#38#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The serological survey ai
med to assess, for the first time, current results and scientific evidence of th
e absence or circulation of hantavirus in the far west of the state by helping t
o clarify the real situation of the virus in the region.</font></p>     ^cY#aop1
1-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#43#39#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#44#40#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>
     ^cY#aop11-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#45#41#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Study area</b></font><
/p>     ^cY#aop11-11.htm##
00867000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062100087002001300708#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#46#42#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The towns of Belmonte and
 Para&iacute;so have respective populations of 2,681 and 4,195 inhabitants, who 
are mostly descended from Italians, Germans and Poles. They have a mesothermal h
umid climate, with hot summers and an average temperature of 18.3ºC, with the ma
in economic activity based on agriculture, particularly the cultivation of monoc
ultures of corn, wheat, tobacco and, consequently, a large part of the native fo
rest has suffered degradation (<b><a href="/img/revistas/rsbmt/2011nahead/aop11-
11fig01m.jpg">Figure 1</a></b>). </font></p>     ^cY#aop11-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#47#43#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Human samples </b></fo
nt></p>     ^cY#aop11-11.htm##
00588000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704034200087002001300429#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#48#44#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Prior statistical analysi
s determined the calculation of a proportional stratified sample of the populati
on; thus, a total of 340 volunteers of both sexes, aged between 18 and 90 years-
old in December (summer) 2009, permitted the collection of blood samples. </font
></p>     ^cY#aop11-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010100087002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#49#45#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Immunoassay</b></font>
</p>     ^cY#aop11-11.htm##
01204000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704095800087002001301045#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#50#46#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The blood samples were su
bjected to centrifugation to extract the serum, which were subjected to enzyme l
inked immunosorbent assay (ELISA) using as antigen a recombinant N protein of <i
>Araraquara</i> hantavirus produced in <i>E. coli</i>. The samples were tested i
n duplicate, using a known sample positive for hantavirus <i>Araraquara</i> as t
he positive control and as the negative control, a protein extract of <i>E. coli
</i> not containing the plasmid encoding the recombinant protein, according to t
he protocol developed by Figueiredo 2009 (Evaluation of an ELISA using rNucleopr
otein of Araquarara). Following the test, the samples considered positive were t
hen titrated. To achieve this, the sera were subjected to serial dilution of 1:1
00 to 1:12,800. These dilutions were retested in ELISA to determine the concentr
ation of IgG anti-hantavirus in each of the serum.</font></p>     ^cY#aop11-11.h
tm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010800087002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#51#47#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Immunofluorescence</b>
</font></p>     ^cY#aop11-11.htm##
00951000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070500087002001300792#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#52#48#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As a confirmatory test, p
ositive sera in ELISA and titrated by the same method were submitted to indirect
 immunofluorescence assay (IFA) using cells infected with <i>Rio Mamor&eacute;</
i> hantavirus and prefixed in spot slides for IFA, as described by Leduc<sup>19<
/sup>. The sera were then added to each of the spots. To determine the presence 
or absence of IgG anti-hantavirus, the sera were tested in a second antibody ant
i-human IgG labeled with the fluorochrome FITC and then observed under a fluores
cent microscope. Positive and negative controls were performed using sera with o
r without anti-hantavirus antibodies.</font></p>     ^cY#aop11-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#53#49#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Ethical considerations
</b></font></p>     ^cY#aop11-11.htm##
00557000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031100087002001300398#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#54#50#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The study was reviewed an
d approved by the Research Ethics Committee, in accordance with Ministry of Heal
th protocol  nº. 073/2009. Free informed consent was obtained from all patients,
 and the information was kept confidential.</font></p>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#55#51#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#56#52#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>
     ^cY#aop11-11.htm##
00825000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057900087002001300666#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#57#53#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A total of 340 volunteers
 with no prior history of hantaviruses were studied, residents of the microregio
n of the far west of the State of Santa Catarina, from the towns of Belmonte and
 Para&iacute;so, on the Brazilian border with the Province of Misiones of the Re
public of Argentina. Of these, 52.7% were men and 47.3% were women. Regarding th
e occupation of the respondents, 96% were directly related to the agricultural s
ystem and the occupation of farm worker was the most frequent with 85%.</font></
p>     ^cY#aop11-11.htm##
00797000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055100087002001300638#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#58#54#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Among those interviewed, 
80% reported storing food in barns and sheds (grain and tobacco) and at these si
tes and in the surrounding areas, 81% reported visual or physical contact with r
odents. The procedure for cleaning these sites included sweeping and raking in 7
5.9%. In houses, 64.3% said there was no garbage collection, such that this accu
mulated and was then incinerated, a practice that could attract rodents, thus in
creasing possible contact with hantavirus. </font></p>     ^cY#aop11-11.htm##
00712000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046600087002001300553#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#59#55#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In enzyme immunoassays, 1
2 samples were seroreactive for the presence of IgG antibodies against N protein
 of hantaviruses, determining a prevalence of 3.5% of these antibodies in the po
pulation studied, while quantitative analysis, involving titration of positive s
era, showed evidence of variation of up to 1:200 1:6,400. Sera positive for hant
avirus by ELISA were confirmed by IFA.</font></p>     ^cY#aop11-11.htm##
00991000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704074500087002001300832#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#60#56#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Regarding medical history
 of morbidity presented by individuals who were positive for hantavirus, these p
atients reported the following symptoms: fever over 38ºC for several days (33.3%
), dyspnea (25%) and nasal bleeding (16.6%), though the symptoms evolved to cure
 in a few days without medical intervention or hospitalization (<b><a href="#tab
1">Table 1</a></b>). Although these symptoms are common in HPS, they are not ver
y specific and the events cited by respondents cannot be directly linked to any 
disease or infection, since few responded with certainty regarding the moment of
 contact and any subsequent production of IgG antibodies against hantavirus. </f
ont></p>     ^cY#aop11-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#61#57#article#162#<p><a na
me="tab1"></a></p>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#62#58#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#63#59#article#162#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop11-11tab01.jpg"></p>     ^
cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#64#60#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#65#61#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font><
/p>     ^cY#aop11-11.htm##
01420000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704117400087002001301261#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#66#62#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Evidence of the presence 
of hantavirus in Brazil have been observed since the 1970's, initially isolated 
in Brazil in the State of Par&aacute; in <i>Rattus norvegicus</i> in the 1980's<
sup>19</sup>. At this time showed, the presence of antibodies to <i>Hantaan</i> 
virus was also observed, the prototype of the genus hantavirus in rodent sera in
 the cities of  Bel&eacute;m, S&atilde;o Paulo and Recife<sup>19</sup>. Seroepid
emiology in patients of northern Brazil identified <i>Hantaan</i> IgG and IgM in
 8.4% to 1.9%. In S&atilde;o Paulo, in 1976, 1.2% of patients admitted presented
 <i>Hantaan</i> IgM<sup>19</sup>. In 1993, between November and December, three 
individuals living in rural area of Juquitiba, SP<sup>7</sup>, became ill and fr
om these cases, the importance of intensive epidemiological studies of hantaviru
ses in Brazil became apparent. Since then, HPS has been observed in all regions 
of the country; however, most known cases of HPS occurred in the south and south
east of Brazil, where studies conducted in different periods showed volunteer pr
evalence in these regions.</font></p>     ^cY#aop11-11.htm##
01450000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704120400087002001301291#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#67#63#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The seroprevalence in thi
s study falls within the expected profile of areas with confirmed cases of hanta
virus infection, as shown by previous studies<sup>7,19-22</sup>. However, this f
inding contradicts the epidemiological situation for hantaviruses, which accordi
ng to the Brazilian Ministry of Health, is considered harmless for hantavirus. I
n the region studied, the overall prevalence of anti-hantavirus antibodies among
 rural and peri-urban residents was 3.5%, with higher prevalence among women, wh
o represented 58.3% of the total number of positive cases. Another study showing
 seroprevalence of 0.7% in the City of Jardin&oacute;polis, State of S&atilde;o 
Paulo, verified that  contact occurred irrespective of genus, profession or hist
ory of contact with rodents, indicating that many people had been exposed to han
tavirus and had presented severe clinical symptoms<sup>7</sup>. However, all the
 positive samples in this work were rural workers. This finding is similar to a 
serum prevalence study conducted in Colombia, where all positive samples came fr
om men involved in agricultural activities<sup>23</sup>.</font></p>     ^cY#aop1
1-11.htm##
00999000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704075300087002001300840#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#68#64#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Other serological surveys
 in Latin America, show the presence of antibodies against hantavirus in previou
sly healthy populations, with no significant differences between sex or age. Pre
valence in Venezuela was 1.7%<sup>24</sup>; in northeastern Argentina, seropreva
lence was 6.5% and was statistically significant for rural activity compared to 
other studies<sup>25</sup>; while Chile showed a seroprevalence of 1.9% among fa
mily members of patients with HPS<sup>25-27</sup>. The highest prevalence occurr
ed in Paraguay, with a mean of 42.7%, and the risk of infection was higher among
 those who lived in rural environments, similar to the present study<sup>21,27</
sup>.</font></p>     ^cY#aop11-11.htm##
00950000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070400087002001300791#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#69#65#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Two hypotheses are propos
ed to explain these striking differences between the epidemiology of countries a
nd regions, as well as different areas of a particular country: I) the circulati
on of distinct hantavirus strains, some of which are less virulent; and II) the 
existence of two coincident variables, the nature of exposure and the genetic co
nstitution of the host. In the second case, increased strength of the local popu
lation could be associated with greater exposure to the virus in some regions, b
ut it is unclear how ethnicity might play a role or interact with environmental 
factors of exposure<sup>27-29</sup>.</font></p>     ^cY#aop11-11.htm##
01068000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704082200087002001300909#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#70#66#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The probable contact with
 hantavirus, reported by respondents, may simply involve the procedure of sweepi
ng or raking barns and sheds, causing the suspension of aerosols containing rode
nt excreta and the aspiration of viral particles in the air<sup>7,13</sup>; this
 is the likely form of infection, especially in women, who are primarily respons
ible for this task and who presented 58.3% of reactive sera in the present study
; in contrast, 41.7% of positive samples were from men, who are primarily respon
sible for planting and harvesting. The practice of storing food in barns suggest
s that the infection occurs around the home, since the abundance of food would a
ttract a large population of rodents to the peridomicile area<sup>3</sup>.</font
></p>     ^cY#aop11-11.htm##
00966000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072000087002001300807#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#71#67#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Among seroreactive indivi
duals, 91% were farm workers, who are considered by other studies to be the larg
est population at risk<sup>30</sup>. One serum sample that was reactive was coll
ected from a young student who assisted his parents with the agricultural activi
ties. Similar to that previously reported, all were involved in the practice of 
storing food in barns and sheds<sup>31</sup>. The infection probably occurred cl
ose to home or during manual work planting corn in a place abundant with rodents
; this is due to both the wider choice of food during planting and the provision
 of natural forest and Araucaria pines<sup>13</sup>.</font></p>     ^cY#aop11-11
.htm##
01152000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090600087002001300993#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#72#68#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The antibody titers are o
f some interest, particularly when taking into account that the antibody levels 
verified in these individuals could be due to contact with hantavirus that may h
ave occurred many years ago. Despite the severity of HPS, cases of human infecti
on with hantavirus that produce mild disease without respiratory failure do occu
r; however the causes and factors involved in clinical behavior remain unknown<s
up>9</sup>. These cases are proven by the presence of hantavirus antibodies in t
he general population, detected in serological surveys that include people with 
no history of HPS: in regions of Paraguay, 40%; Salta Province in Argentina, 17%
; and the City of Jardin&oacute;polis in S&atilde;o Paulo, 14.3%<sup>7</sup>. In
 other similar works, the highest titers were 1:400 and 1:3200<sup>7,21</sup>.</
font></p>     ^cY#aop11-11.htm##
00737000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049100087002001300578#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#73#69#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Among the studies conduct
ed on rodents in the vicinity of the region, reports of the transmission of hant
avirus in southern Brazil indicate that the Araraquara virus is associated with 
<i>N. lasiurus</i>, while the Juquitiba virus is associated with <i>O. nigripes<
/i><sup>17</sup>. The presence of these rodents in the region suggests that the 
viruses circulating in this area are Araraquara and Juquitiba. </font></p>     ^
cY#aop11-11.htm##
01104000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704085800087002001300945#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#74#70#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Each hantavirus is primar
ily associated with a specific rodent host in a particular geographic region, bu
t occasional transmissions can occur sporadically among rodents<sup>33-36</sup>.
 Conclusive evidence that the virus studied can establish productive infections 
in more than one species of rodent host has not been established. We suggest Ara
raquara and Juquitiba as possible viruses circulating in this study area, based 
on the geographical distribution of these viruses and the assumption that no oth
er strain is in circulation. However, the possibility of an unknown hantavirus o
r one not yet reported in Brazil<sup>31,32</sup>, or even a hantavirus previousl
y reported in Argentina, given the proximity of this region with the neighboring
 country, cannot be discarded.</font></p>     ^cY#aop11-11.htm##
00865000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061900087002001300706#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#75#71#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The present findings sugg
est that in the far west of the State of Santa Catarina, hantavirus is in circul
ation, even though it is considered harmless by the Ministry of Health. Consider
ing that Argentina is an endemic location for hantavirus, in particular the Prov
ince of Misiones, which borders the area under study, further studies should be 
conducted to assess which virus is circulating in the region and rodents involve
d in its transmission, since the border in this region is only a geopolitical is
sue and not a physical barrier.</font></p>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#76#72#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#77#73#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop11-11.htm##
00727000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048100087002001300568#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#78#74#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors would like to
 thank the towns of Para&iacute;so and Belmonte for their contribution to the fi
eldwork and technician Neusa Salete Fiorini and biomedic Evanio Junior Wronski f
or their assistance during the sample collection procedures and interviews. The 
authors are also grateful to the Center for Research in Virology, FMRP-USP, Ribe
ir&atilde;o Preto, for their support in the analysis.</font></p>     ^cY#aop11-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#79#75#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#80#76#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop11-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#81#77#article#162#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors declare that 
there is no conflict of interest.</font></p>     ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#82#78#article#162#<p>&nbsp
;</p>     ^cY#aop11-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#83#79#article#162#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop11-11.htm##
00440000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704018000089002001300269#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#84#80#article#
162#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1.	Jonsson 
CB, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res
 2008; 78:162-169.    ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#85#81#article#162#</font><
/p>     ^cY#aop11-11.htm##
00536000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704027600089002001300365#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#86#82#article#
162#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2.	Zeier M,
 Handermann M, Bahr U, Rensch B, Muller S, Kehm R, et al. New ecological aspects
 of hantavirus infection: a change of a paradigm and a challenge of prevention-a
 review. Vir Gen 2005; 30:157-180.    ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#87#83#article#162#</font><
/p>     ^cY#aop11-11.htm##
00463000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020300089002001300292#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#88#84#article#
162#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3.	Easterbr
ook JD, Klein SL. Immunological Mechanisms Mediating Hantavirus Persistence in R
odent Reservoirs. PLoS Pathog 2008; 4:11.    ^cY#aop11-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#89#85#article#162# </font>
</p>     ^cY#aop11-11.htm##
00526000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026600089002001300355#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#90#86#article#
162#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4.	Wells RM
, Sosa Stani S, Yad&oacute;n Z, Enria D, Padula P, Pini N, et al. An unusual han
tavirus outbreak in southern Argentina: person-to-person transmission? Emerg Inf
ect Dis 1997; 3:171-174.    ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#91#87#article#162#</font><
/p>     ^cY#aop11-11.htm##
00553000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029300089002001300382#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#92#88#article#
162#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5.	Padula P
J, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. Hantavirus pulmona
ry syndrome outbreak in Argentina: Molecular evidence for person-to-person trans
mission of Andes virus. Virology 1998; 241:323-330.    ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#93#89#article#162#</font><
/p>     ^cY#aop11-11.htm##
00489000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022900089002001300318#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#94#90#article#
162#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6.	Martinez
 VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-perso
n transmission of Andes virus. Emerg Infect Dis 2005; 11:1848-1853.    ^cY#aop11
-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#95#91#article#162# </font>
</p>     ^cY#aop11-11.htm##
00503000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024300089002001300332#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#96#92#article#
162#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7.	Campos G
M, Sousa RL, Badra SJ, Pane C, Gomes UA, Figueiredo LT. Serological survey of ha
ntavirus infection in Jardinopolis County, Brazil. J Med Virol  2003; 71:417-422
.    ^cY#aop11-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#97#93#article#162# </font>
</p>     ^cY#aop11-11.htm##
00550000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029000089002001300379#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#98#94#article#
162#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8.	Mori M, 
Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, et al. High levels of cyt
okine- producing cells in the lung tissues of patients with fatal hantavirus pul
monary syndrome. J Infect Dis 1999; 179:295-302.    ^cY#aop11-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#99#95#article#162#</font><
/p>     ^cY#aop11-11.htm##
00561000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704030000090002001300390#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#100#96#article
#162#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9.	Mertz G
J. <i>Bunyaviridae</i>: Bunyaviruses, phleboviruses, nairoviruses, and hantaviru
ses. <i>In</i>: Richmann DD, Whitley RJ, Hayden FG, editors. Clinical virology. 
2nd Ed. New York: Churchill-livinsgstone; 1997. p. 943-972.    ^cY#aop11-11.htm#
#
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#101#97#article#162#</font>
</p>     ^cY#aop11-11.htm##
00510000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704024800091002001300339#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#102#98#article
#162#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10.	Macha
do AM, Figueiredo GG, Sabino GSJ, Figueiredo LTM. Laboratory diagnosis of human 
hantavirus infection: novel insights and future potential. Future Virol 2009; 4:
383-389.    ^cY#aop11-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#103#99#article#162#</font>
</p>     ^cY#aop11-11.htm##
00567000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030400092002001300396#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#104#100#articl
e#162#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11.	Figu
eiredo LTM, Moreli ML, Borges AA, Figueiredo GG, Bisordi I, Suzuki A,  et al. Ev
aluation of an Enzyme-Linked Immunosorbent Assay Based on Araraquara Virus Recom
binant Nucleocapsid Protein. Am J Trop  Med Hyg 2009; 81:273-276.    ^cY#aop11-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#105#101#article#162#</font
></p>     ^cY#aop11-11.htm##
00590000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032700092002001300419#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#106#102#articl
e#162#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12.	Padu
la PJ, Colavecchia SB, Martinez VP, Gonzalez Della Valle MO, Edelstein A, Miguel
 SDL, et al. Genetic diversity, distribution, and serological features of hantav
irus infection in five countries in South America. J Clin Microbiol  2000; 38:30
29-3035.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#107#103#article#162#</font
></p>     ^cY#aop11-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#108#104#articl
e#162#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13.	Figu
eiredo LTM, Moreli ML, Souza LM, Borges AA, Figueiredo GG, Machado AM, et al. Ha
ntavirus pulmonary syndrome, Central Plateau, Southeastern, and Southern Brazil.
 Emerg Infect Dis 2009; 15:561-567.    ^cY#aop11-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#109#105#article#162# </fon
t></p>     ^cY#aop11-11.htm##
00548000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028500092002001300377#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#110#106#articl
e#162#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14.	Rabo
ni SM, Rubio G, De Borba L, Zeferino A, Skraba SG, Santos CND. Clinical survey o
f hantavirus in southern Brazil and the development of specific molecular diagno
sis tools. Am J Trop Med Hyg 2005; 72:800-804.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#111#107#article#162#</font
></p>     ^cY#aop11-11.htm##
00533000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027000092002001300362#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#112#108#articl
e#162#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15.	Figu
eiredo LTM, Moreli ML, Borges AA, Figueiredo GG, Souza RLM, Aquino VH. Expressio
n of a hantavirus N protein and its efficacy as antigen in immune assays. Braz J
 Med Biol Res 2008; 41:596-599.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#113#109#article#162#</font
></p>     ^cY#aop11-11.htm##
00673000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704041000092002001300502#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#114#110#articl
e#162#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16.	Mini
st&eacute;rio da Sa&uacute;de. Minist&eacute;rio da Sa&uacute;de Web Site &#91;I
nternet&#93;. &#91;Cited  2010 Feb 8&#93;. Available from: <a href="http://porta
l.saude.gov.br/portal/saude/Gestor/visualizar_texto.cfm?idtxt=27673/" target="_b
lank">http://portal.saude.gov.br/portal/saude/Gestor/visualizar_texto.cfm?idtxt=
27673/</a>.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#115#111#article#162#</font
></p>     ^cY#aop11-11.htm##
00493000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023000092002001300322#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#116#112#articl
e#162#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17.	Suzu
ki A, Bisordi I, Levis S, Garcia J, Pereira LE, Souza RP, et al. Identifying rod
ent hantavirus reservoirs. Brazil. Emerg Infect Dis 2004; 10:2127-2134.    ^cY#a
op11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#117#113#article#162#</font
></p>     ^cY#aop11-11.htm##
00522000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025900092002001300351#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#118#114#articl
e#162#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18.	Padu
la P, Martinez VP, Bellomo C, Maidana S, San Juan J, Tagliaferri P, et al Pathog
enic Hantaviruses, Northeastern Argentina and Eastern Paraguay. Emerg Infect Dis
 2007; 13:1211-1214.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#119#115#article#162#</font
></p>     ^cY#aop11-11.htm##
00577000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031400092002001300406#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#120#116#articl
e#162#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19.	Ledu
c JW, Smith GA, Pinheiro FP, Vasconcelos PFC, Rosa EST, Maiztegui JI. Isolation 
of a hantaan-.related virus from brazilian rats and serologic evidence of its wi
despread distribution in south america. Am J Trop Med Hyg1985;  34:810-815.    ^
cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#121#117#article#162#</font
></p>     ^cY#aop11-11.htm##
00510000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024700092002001300339#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#122#118#articl
e#162#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20.	Iver
sson LB. Doen&ccedil;a humana por hantavirus. <i>In:</i> Veronesi R, Focaccia R,
 editores. Tratado de infectologia. 1st Ed. S&atilde;o Paulo: Atheneu; 1996. p. 
219-228.    ^cY#aop11-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#123#119#article#162# </fon
t></p>     ^cY#aop11-11.htm##
00635000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704037200092002001300464#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#124#120#articl
e#162#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21.	Pere
ira GW, Teixeira AM, Souza MS, Pereira TSS, Braga AD, Santos Junior GS, et al. I
nqu&eacute;rito sorol&oacute;gico e de morbidade para hantav&iacute;rus na popul
a&ccedil;&atilde;o rural e periurbana da cidade de Turvo, SC. Jornada Unisul de 
Inicia&ccedil;&atilde;o Cient&iacute;fica  2009; 1-6.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#125#121#article#162#</font
></p>     ^cY#aop11-11.htm##
00538000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027500092002001300367#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#126#122#articl
e#162#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22.	Holm
es R, Boccanera R, Figueiredo LT, Man&ccedil;ano SR, Pane C. Seroprevalence of h
uman hantavirus infection in the Ribeirao Preto region of Sao Paulo State, Brazi
l. Emerg Infect Dis 2000; 6:560-561.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#127#123#article#162#</font
></p>     ^cY#aop11-11.htm##
00464000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020100092002001300293#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#128#124#articl
e#162#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23.	M&aa
cute;ttar S, Parra M. Serologic evidence of hantavirus infection in humans, Colo
mbia. Emerg Infect Dis 2004; 10:2263-2264.    ^cY#aop11-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#129#125#article#162# </fon
t></p>     ^cY#aop11-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#130#126#articl
e#162#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24.	Riva
s YJ, Moros Z, Moron D, Uzcategui MG, Duran Z, Pujol FH, et al. The seroprevalen
ces of anti-hantavirus IgG antibodies among selected Venezuelan populations. Ann
 Trop Med Parasitol 2003; 97:61-67.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#131#127#article#162#</font
></p>     ^cY#aop11-11.htm##
00515000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025200092002001300344#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#132#128#articl
e#162#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25.	Pini
 N, Levis S, Calder&oacute;n G, Ramirez J, Bravo D, Lozano E, et al.. Hantavirus
 infection in humans and rodents, northwestern Argentina. Emerg Infect Dis 2003;
 9:1070-1076.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#133#129#article#162#</font
></p>     ^cY#aop11-11.htm##
00671000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704040800092002001300500#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#134#130#articl
e#162#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26.	Cast
illo C, Villagra E, Sanhueza L, Ferres M, Mardones J, Mertz GJ. Prevalence of an
tibodies to hantavirus among family and health care worker contacts of persons w
ith hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmi
ssion of Andes virus to health care workers in Chile. Am J Trop Med Hyg 2004; 70
:302-304.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#135#131#article#162#</font
></p>     ^cY#aop11-11.htm##
00432000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016900092002001300261#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#136#132#articl
e#162#27#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27.	Pini
 N. Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis 2004; 1
7:427-431.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#137#133#article#162#</font
></p>     ^cY#aop11-11.htm##
00424000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016100092002001300253#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#138#134#articl
e#162#28#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28.	Ferr
es M, Vial P. Hantavirus infection in children. Curr Opin Pediatr  2004; 16:70-7
5.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#139#135#article#162#</font
></p>     ^cY#aop11-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023700092002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#140#136#articl
e#162#29#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29.	T&au
ml;ger Frey MT, Vial PC, Castillo CH, Godoy PM, Hjelle B, Ferr&eacute;s MG. Hant
avirus prevalence in the IX Region of Chile. Emerg Infect Dis 2003; 9:827-832.  
  ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#141#137#article#162#</font
></p>     ^cY#aop11-11.htm##
00467000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020400092002001300296#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#142#138#articl
e#162#30#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30.	Figu
eiredo LTM, Moreli ML, Campos GM, Sousa RL. Hantaviruses in S&atilde;o Paulo Sta
te, Brazil. Emerg Infect Dis 2003; 9:891-892.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#143#139#article#162#</font
></p>     ^cY#aop11-11.htm##
00538000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027500092002001300367#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#144#140#articl
e#162#31#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">31.	Mend
es WS, Arag&atilde;o NJL, Santos HJ, Raposo L, Vasconcelos PFC, Rosa EST,  et al
. Hantavirus pulmonary syndrome in Anajatuba, Maranh&atilde;o, Brazil. Rev Inst 
Med Trop Sao Paulo 2001; 43:237-240.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#145#141#article#162#</font
></p>     ^cY#aop11-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025500092002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#146#142#articl
e#162#32#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">32.	John
son AM, Souza LTM, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, et al. Geneti
c investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol 1
999; 59:527-535.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#147#143#article#162#</font
></p>     ^cY#aop11-11.htm##
00633000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704037000092002001300462#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#148#144#articl
e#162#33#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">33.	Rosa
 ES, Mills JN, Padula PJ, Elkhoury MR, Ksiazek TG, Mendes WS, et al. Newly recog
nized hantaviruses associated with hantavirus pulmonary syndrome in northern Bra
zil: partial genetic characterization of viruses and serologic implication of li
kely reservoirs. Vect Born Zoon Dis 2005; 5: 11-19.    ^cY#aop11-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#149#145#article#162# </fon
t></p>     ^cY#aop11-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022100092002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#150#146#articl
e#162#34#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">34.	Plyu
snin A, Morzunov SP. Virus evolution and genetic diversity of hantaviruses and t
heir rodent hosts. Curr Top Microbiol Immunol 2001; 256:47-75.    ^cY#aop11-11.h
tm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#151#147#article#162#</font
></p>     ^cY#aop11-11.htm##
00498000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023500092002001300327#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#152#148#articl
e#162#35#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">35.	Rams
den C, Melo FL, Figueiredo LM, Holmes EC, Zanotto PM, VGDN Consortium. High rate
s of molecular evolution in hantaviruses. Mol Biol  Evol 2008; 25:1488-1492.    
^cY#aop11-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#153#149#article#162# </fon
t></p>     ^cY#aop11-11.htm##
00526000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026300092002001300355#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#154#150#articl
e#162#36#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">36.	Chu 
YK, Milligan B, Owen RD, Goodin DG, Jonsson CB. Phylogenetic and geographical re
lationships of hantavirus strains in eastern and western Paraguay. Am J Trop Med
 Hyg 2006; 75:1127-1134.    ^cY#aop11-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#155#151#article#162#</font
></p>     ^cY#aop11-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#156#152#article#162#<p>&nb
sp;</p>     ^cY#aop11-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#157#153#article#162#<p>&nb
sp;</p>     ^cY#aop11-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704019200089002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#158#154#article#162#<p><a 
name="endb"></a><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a h
ref="#enda"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a><b
> Address to:</b>     ^cY#aop11-11.htm##
00291000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004300089002001300132#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#159#155#article#162#<br>  
 Dr. William Marciel de Souza    ^cY#aop11-11.htm##
00301000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005300089002001300142#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#160#156#article#162#<br>  
 Centro de Pesquisa em Virologia/FM/USP    ^cY#aop11-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003500089002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#161#157#article#162#<br>  
 Av Bandeirantes 3900    ^cY#aop11-11.htm##
00306000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005800089002001300147#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#162#158#article#162#<br>  
 14049-900 Ribeir&atilde;o Preto, SP, Brasil    ^cY#aop11-11.htm##
00286000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003800089002001300127#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#163#159#article#162#<br>  
 Phone: 55 16 3289-7646     ^cY#aop11-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009600089002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#164#160#article#162#<br>  
 email: <a href="mailto:wmarciel@hotmail.com">wmarciel@hotmail.com</a></font></p
>     ^cY#aop11-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#165#161#article#162#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 30/03/2010 
   ^cY#aop11-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#p#166#162#article#162#<br>  
 Accepted in 16/11/2010</font></p>     ^cY#aop11-11.htm##
00559000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100016001060100
01500122012004700137030001400184065000900198064000500207031000300212014000800215
865000900223002001300232035001000245801001400255#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop11-11.htm#S#c#167#1#article#36#1#^rND^sJonsson^nCB#^rND^
sHooper^nJ#^rND^sMertz^nG#Treatment of hantavirus pulmonary syndrome^len#Antivir
al Res#20080000#2008#78#162-169#20110000#aop11-11.htm#0166-3542#Antiviral Res##
00686000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100020001030100
01400123010001600137010001600153010001400169810000600183012011400189030000800303
71000020031106500090031306400050032203100030032701400080033086500090033800200130
0347#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#168#2#
article#36#2#^rND^sZeier^nM#^rND^sHandermann^nM#^rND^sBahr^nU#^rND^sRensch^nB#^r
ND^sMuller^nS#^rND^sKehm^nR#et al#New ecological aspects of hantavirus infection
: a change of a paradigm and a challenge of prevention-a review^len#Vir Gen#2#20
050000#2005#30#157-180#20110000#aop11-11.htm##
00530000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100022000880100016001100120
08300126030001200209710000200221065000900223064000500232031000200237020000300239
865000900242002001300251#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
11-11.htm#S#c#169#3#article#36#3#^rND^sEasterbrook^nJD#^rND^sKlein^nSL#Immunolog
ical Mechanisms Mediating Hantavirus Persistence in Rodent Reservoirs^len#PLoS P
athog#2#20080000#2008#4#11#20110000#aop11-11.htm##
00707000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100020001040100
01500124010001500139010001600154010001400170810000600184012008900190030001700279
06500090029606400050030503100020031001400080031286500090032000200130032903500100
0342801001700352#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#170#4#article#36#4#^rND^sWells^nRM#^rND^sSosa Stani^nS#^rND^sYadón^nZ#^rND
^sEnria^nD#^rND^sPadula^nP#^rND^sPini^nN#et al#An unusual hantavirus outbreak in
 southern Argentina: person-to-person transmission?^len#Emerg Infect Dis#1997000
0#1997#3#171-174#20110000#aop11-11.htm#1080-6040#Emerg Infect Dis##
00721000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100019001050100
01700124010001600141010001600157010002100173012012500194030000900319065000900328
06400050033703100040034201400080034686500090035400200130036303500100037680100090
0386#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#171#5#
article#36#5#^rND^sPadula^nPJ#^rND^sEdelstein^nA#^rND^sMiguel^nSD#^rND^sLopez^nN
M#^rND^sRossi^nCM#^rND^sRabinovich^nRD#Hantavirus pulmonary syndrome outbreak in
 Argentina: Molecular evidence for person-to-person transmission of Andes virus^
len#Virology#19980000#1998#241#323-330#20110000#aop11-11.htm#0042-6822#Virology#
#
00676000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100017001070100
01800124010001500142010001800157010001500175810000600190012004900196030001700245
06500090026206400050027103100030027601400100027986500090028900200130029803500100
0311801001700321#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#172#6#article#36#6#^rND^sMartinez^nVP#^rND^sBellomo^nC#^rND^sSan Juan^nJ#^
rND^sPinna^nD#^rND^sForlenza^nR#^rND^sElder^nM#et al#Person-to-person transmissi
on of Andes virus^len#Emerg Infect Dis#20050000#2005#11#1848-1853#20110000#aop11
-11.htm#1080-6040#Emerg Infect Dis##
00673000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100016001050100
01600121010001400137010001600151010002100167012007800188030001200266065000900278
06400050028703100030029201400080029586500090030300200130031203500100032580100120
0335#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#173#7#
article#36#7#^rND^sCampos^nGM#^rND^sSousa^nRL#^rND^sBadra^nSJ#^rND^sPane^nC#^rND
^sGomes^nUA#^rND^sFigueiredo^nLT#Serological survey of hantavirus infection in J
ardinopolis County, Brazil^len#J Med Virol#20030000#2003#71#417-422#20110000#aop
11-11.htm#0146-6615#J Med Virol##
00733000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100014000880100018001020100
01600120010001800136010001600154010001700170810000600187012011800193030001300311
06500090032406400050033303100040033801400080034286500090035000200130035903500100
0372801001300382#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#174#8#article#36#8#^rND^sMori^nM#^rND^sRothman^nAL#^rND^sKurane^nI#^rND^sM
ontoya^nJM#^rND^sNolte^nKB#^rND^sNorman^nJE#et al#High levels of cytokine: produ
cing cells in the lung tissues of patients with fatal hantavirus pulmonary syndr
ome^len#J Infect Dis#19990000#1999#179#295-302#20110000#aop11-11.htm#0022-1899#J
 Infect Dis##
00638000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120078001040160
01900182016001800201016001700219018002200236063000200258066000900260062002300269
065000900292064000500301014000800306865000900314002001300323#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#175#9#article#36#9#^rND^sMertz
^nGJ#Bunyaviridae: Bunyaviruses, phleboviruses, nairoviruses, and hantaviruses^l
en#^rED^sRichmann^nDD#^rED^sWhitley^nRJ#^rED^sHayden^nFG#Clinical virology^len#2
#New York#Churchill-livinsgstone#19970000#1997#943-972#20110000#aop11-11.htm##
00612000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100021001080100
01800129010002200147012009200169030001300261710000200274065000900276064000500285
031000200290014000800292865000900300002001300309#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop11-11.htm#S#c#176#10#article#36#10#^rND^sMachado^nAM#^rN
D^sFigueiredo^nGG#^rND^sSabino^nGSJ#^rND^sFigueiredo^nLTM#Laboratory diagnosis o
f human hantavirus infection: novel insights and future potential^len#Future Vir
ol#2#20090000#2009#4#383-389#20110000#aop11-11.htm##
00751000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100017001120100
01700129010002100146010001700167010001600184810000600200012011400206030001800320
06500090033806400050034703100030035201400080035586500090036300200130037203500100
0385801001800395#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#177#11#article#36#11#^rND^sFigueiredo^nLTM#^rND^sMoreli^nML#^rND^sBorges^n
AA#^rND^sFigueiredo^nGG#^rND^sBisordi^nI#^rND^sSuzuki^nA#et al#Evaluation of an 
Enzyme-Linked Immunosorbent Assay Based on Araraquara Virus Recombinant Nucleoca
psid Protein^len#Am J Trop Med Hyg#20090000#2009#81#273-276#20110000#aop11-11.ht
m#0002-9637#Am J Trop Med Hyg##
00774000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100022001070100
01900129010003100148010001900179010001800198810000600216012012100222030001700343
06500090036006400050036903100030037401400100037786500090038700200130039603500100
0409801001700419#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#178#12#article#36#12#^rND^sPadula^nPJ#^rND^sColavecchia^nSB#^rND^sMartinez
^nVP#^rND^sGonzalez Della Valle^nMO#^rND^sEdelstein^nA#^rND^sMiguel^nSDL#et al#G
enetic diversity, distribution, and serological features of hantavirus infection
 in five countries in South America^len#J Clin Microbiol#20000000#2000#38#3029-3
035#20110000#aop11-11.htm#0095-1137#J Clin Microbiol##
00722000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100017001120100
01600129010001700145010002100162010001800183810000600201012008600207030001700293
06500090031006400050031903100030032401400080032786500090033500200130034403500100
0357801001700367#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#179#13#article#36#13#^rND^sFigueiredo^nLTM#^rND^sMoreli^nML#^rND^sSouza^nL
M#^rND^sBorges^nAA#^rND^sFigueiredo^nGG#^rND^sMachado^nAM#et al#Hantavirus pulmo
nary syndrome, Central Plateau, Southeastern, and Southern Brazil^len#Emerg Infe
ct Dis#20090000#2009#15#561-567#20110000#aop11-11.htm#1080-6040#Emerg Infect Dis
##
00723000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100015001070100
01800122010001800140010001700158010001800175012011100193030001800304065000900322
06400050033103100030033601400080033986500090034700200130035603500100036980100180
0379#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#180#14
#article#36#14#^rND^sRaboni^nSM#^rND^sRubio^nG#^rND^sDe Borba^nL#^rND^sZeferino^
nA#^rND^sSkraba^nSG#^rND^sSantos^nCND#Clinical survey of hantavirus in southern 
Brazil and the development of specific molecular diagnosis tools^len#Am J Trop M
ed Hyg#20050000#2005#72#800-804#20110000#aop11-11.htm#0002-9637#Am J Trop Med Hy
g##
00710000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100017001120100
01700129010002100146010001700167010001700184012008600201030002000287065000900307
06400050031603100030032101400080032486500090033200200130034103500100035480100200
0364#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#181#15
#article#36#15#^rND^sFigueiredo^nLTM#^rND^sMoreli^nML#^rND^sBorges^nAA#^rND^sFig
ueiredo^nGG#^rND^sSouza^nRLM#^rND^sAquino^nVH#Expression of a hantavirus N prote
in and its efficacy as antigen in immune assays^len#Braz J Med Biol Res#20080000
#2008#41#596-599#20110000#aop11-11.htm#0100-879X#Braz J Med Biol Res##
00505000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170020000900180033001100610
00900143110000900152109001100161037008100172865000900253002001300262#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#182#16#article#36#16#M
inistério da Saúde#Ministério da Saúde Web Site^lpt#Internet#20100208#2010 Feb 8
#http://portal.saude.gov.br/portal/saude/Gestor/visualizar_texto.cfm?idtxt=27673
/#20110000#aop11-11.htm##
00678000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01500123010001600138010001800154010001600172810000600188012005300194030001700247
06500090026406400050027303100030027801400100028186500090029100200130030003500100
0313801001700323#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#183#17#article#36#17#^rND^sSuzuki^nA#^rND^sBisordi^nI#^rND^sLevis^nS#^rND^
sGarcia^nJ#^rND^sPereira^nLE#^rND^sSouza^nRP#et al#Identifying rodent hantavirus
 reservoirs: Brazil^len#Emerg Infect Dis#20040000#2004#10#2127-2134#20110000#aop
11-11.htm#1080-6040#Emerg Infect Dis##
00708000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01700125010001700142010001800159010002100177810000600198012007300204030001700277
06500090029406400050030303100030030801400100031186500090032100200130033003500100
0343801001700353#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#184#18#article#36#18#^rND^sPadula^nP#^rND^sMartinez^nVP#^rND^sBellomo^nC#^
rND^sMaidana^nS#^rND^sSan Juan^nJ#^rND^sTagliaferri^nP#et al#Pathogenic Hantavir
uses, Northeastern Argentina and Eastern Paraguay^len#Emerg Infect Dis#20070000#
2007#13#1211-1214#20110000#aop11-11.htm#1080-6040#Emerg Infect Dis##
00752000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01900122010002300141010001600164010002000180012013300200030001800333065000900351
06400050036003100030036501400080036886500090037600200130038503500100039880100180
0408#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#185#19
#article#36#19#^rND^sLeduc^nJW#^rND^sSmith^nGA#^rND^sPinheiro^nFP#^rND^sVasconce
los^nPFC#^rND^sRosa^nEST#^rND^sMaiztegui^nJI#Isolation of a hantaan: related vir
us from brazilian rats and serologic evidence of its widespread distribution in 
south america^len#Am J Trop Med Hyg#19850000#1985#34#810-815#20110000#aop11-11.h
tm#0002-9637#Am J Trop Med Hyg##
00560000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900120033001090160
01800142016001800160018002800178063000200206066001000208062000800218065000900226
064000500235014000800240865000900248002001300257#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop11-11.htm#S#c#186#20#article#36#20#^rND^sIversson^nLB#Do
ença humana por hantavirus^lpt#^rED^sVeronesi^nR#^rED^sFocaccia^nR#Tratado de in
fectologia^lpt#1#São Paulo#Atheneu#19960000#1996#219-228#20110000#aop11-11.htm##
00709000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900160019001080160
01600127016001900143016001600162016002400178810000600202018011100208053004200319
055001200361054000800373014000400381865000900385002001300394#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#187#21#article#36#21#^rND^sPer
eira^nGW#^rND^sTeixeira^nAM#^rND^sSouza^nMS#^rND^sPereira^nTSS#^rND^sBraga^nAD#^
rND^sSantos Junior^nGS#et al#Inquérito sorológico e de morbidade para hantavírus
 na população rural e periurbana da cidade de Turvo, SC^lpt#Jornada Unisul de In
iciação Científica^i1#20090000^i1#2009^i1#1-6#20110000#aop11-11.htm##
00687000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
02100125010001800146010001400164012010500178030001700283065000900300064000500309
031000200314014000800316865000900324002001300333035001000346801001700356#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#188#22#article#36#
22#^rND^sHolmes^nR#^rND^sBoccanera^nR#^rND^sFigueiredo^nLT#^rND^sMançano^nSR#^rN
D^sPane^nC#Seroprevalence of human hantavirus infection in the Ribeirao Preto re
gion of Sao Paulo State, Brazil^len#Emerg Infect Dis#20000000#2000#6#560-561#201
10000#aop11-11.htm#1080-6040#Emerg Infect Dis##
00559000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060120
06700121030001700188065000900205064000500214031000300219014001000222865000900232
002001300241035001000254801001700264#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop11-11.htm#S#c#189#23#article#36#23#^rND^sMáttar^nS#^rND^sParra^nM#Se
rologic evidence of hantavirus infection in humans, Colombia^len#Emerg Infect Di
s#20040000#2004#10#2263-2264#20110000#aop11-11.htm#1080-6040#Emerg Infect Dis##
00728000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060100
01500121010002000136010001500156010001600171810000600187012009600193030002300289
06500090031206400050032103100030032601400060032986500090033500200130034403500100
0357801002300367#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#190#24#article#36#24#^rND^sRivas^nYJ#^rND^sMoros^nZ#^rND^sMoron^nD#^rND^sU
zcategui^nMG#^rND^sDuran^nZ#^rND^sPujol^nFH#et al#The seroprevalences of anti-ha
ntavirus IgG antibodies among selected Venezuelan populations^len#Ann Trop Med P
arasitol#20030000#2003#97#61-67#20110000#aop11-11.htm#0003-4983#Ann Trop Med Par
asitol##
00692000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100015001040100
01800119010001700137010001500154010001600169810000600185012007100191030001700262
06500090027906400050028803100020029301400100029586500090030500200130031403500100
0327801001700337#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#191#25#article#36#25#^rND^sPini^nN#^rND^sLevis^nS#^rND^sCalderón^nG#^rND^s
Ramirez^nJ#^rND^sBravo^nD#^rND^sLozano^nE#et al#Hantavirus infection in humans a
nd rodents, northwestern Argentina^len#Emerg Infect Dis#20030000#2003#9#1070-107
6#20110000#aop11-11.htm#1080-6040#Emerg Infect Dis##
00846000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
01800126010001600144010001800160010001600178012023300194030001800427065000900445
06400050045403100030045901400080046286500090047000200130047903500100049280100180
0502#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#192#26
#article#36#26#^rND^sCastillo^nC#^rND^sVillagra^nE#^rND^sSanhueza^nL#^rND^sFerre
s^nM#^rND^sMardones^nJ#^rND^sMertz^nGJ#Prevalence of antibodies to hantavirus am
ong family and health care worker contacts of persons with hantavirus cardiopulm
onary syndrome: lack of evidence for nosocomial transmission of Andes virus to h
ealth care workers in Chile^len#Am J Trop Med Hyg#20040000#2004#70#302-304#20110
000#aop11-11.htm#0002-9637#Am J Trop Med Hyg##
00479000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900120051001040300
02100155710000200176065000900178064000500187031000300192014000800195865000900203
002001300212#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#
c#193#27#article#36#27#^rND^sPini^nN#Hantavirus pulmonary syndrome in Latin Amer
ica^len#Curr Opin Infect Dis#2#20040000#2004#17#427-431#20110000#aop11-11.htm##
00526000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100014001060120
03700120030001800157065000900175064000500184031000300189014000600192865000900198
002001300207035001000220801001800230#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop11-11.htm#S#c#194#28#article#36#28#^rND^sFerres^nM#^rND^sVial^nP#Han
tavirus infection in children^len#Curr Opin Pediatr#20040000#2004#16#70-75#20110
000#aop11-11.htm#1040-8703#Curr Opin Pediatr##
00662000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100015001110100
01900126010001600145010001600161010001700177012005200194030001700246065000900263
06400050027203100020027701400080027986500090028700200130029603500100030980100170
0319#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#195#29
#article#36#29#^rND^sTäger Frey^nMT#^rND^sVial^nPC#^rND^sCastillo^nCH#^rND^sGodo
y^nPM#^rND^sHjelle^nB#^rND^sFerrés^nMG#Hantavirus prevalence in the IX Region of
 Chile^len#Emerg Infect Dis#20030000#2003#9#827-832#20110000#aop11-11.htm#1080-6
040#Emerg Infect Dis##
00598000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100017001120100
01700129010001600146012004400162030001700206065000900223064000500232031000200237
014000800239865000900247002001300256035001000269801001700279#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#196#30#article#36#30#^rND^sFig
ueiredo^nLTM#^rND^sMoreli^nML#^rND^sCampos^nGM#^rND^sSousa^nRL#Hantaviruses in S
ão Paulo State, Brazil^len#Emerg Infect Dis#20030000#2003#9#891-892#20110000#aop
11-11.htm#1080-6040#Emerg Infect Dis##
00719000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01700125010001600142010002300158010001600181810000600197012006500203030002800268
06500090029606400050030503100030031001400080031386500090032100200130033003500100
0343801002800353#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#197#31#article#36#31#^rND^sMendes^nWS#^rND^sAragão^nNJL#^rND^sSantos^nHJ#^
rND^sRaposo^nL#^rND^sVasconcelos^nPFC#^rND^sRosa^nEST#et al#Hantavirus pulmonary
 syndrome in Anajatuba, Maranhão, Brazil^len#Rev Inst Med Trop Sao Paulo#2001000
0#2001#43#237-240#20110000#aop11-11.htm#0036-4665#Rev Inst Med Trop Sao Paulo##
00698000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
01900125010001800144010001800162010001700180810000600197012007600203030001200279
06500090029106400050030003100030030501400080030886500090031600200130032503500100
0338801001200348#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.ht
m#S#c#198#32#article#36#32#^rND^sJohnson^nAM#^rND^sSouza^nLTM#^rND^sFerreira^nIB
#^rND^sPereira^nLE#^rND^sKsiazek^nTG#^rND^sRollin^nPE#et al#Genetic investigatio
n of novel hantaviruses causing fatal HPS in Brazil^len#J Med Virol#19990000#199
9#59#527-535#20110000#aop11-11.htm#0146-6615#J Med Virol##
00780000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100016001050100
01700121010001900138010001800157010001700175810000600192012019100198030001900389
71000020040806500090041006400050041903100020042401400060042686500090043200200130
0441#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#199#33
#article#36#33#^rND^sRosa^nES#^rND^sMills^nJN#^rND^sPadula^nPJ#^rND^sElkhoury^nM
R#^rND^sKsiazek^nTG#^rND^sMendes^nWS#et al#Newly recognized hantaviruses associa
ted with hantavirus pulmonary syndrome in northern Brazil: partial genetic chara
cterization of viruses and serologic implication of likely reservoirs^len#Vect B
orn Zoon Dis#2#20050000#2005#5#11-19#20110000#aop11-11.htm##
00596000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100019001080120
08100127030002700208065000900235064000500244031000400249014000600253865000900259
002001300268035001000281801002700291#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop11-11.htm#S#c#200#34#article#36#34#^rND^sPlyusnin^nA#^rND^sMorzunov^
nSP#Virus evolution and genetic diversity of hantaviruses and their rodent hosts
^len#Curr Top Microbiol Immunol#20010000#2001#256#47-75#20110000#aop11-11.htm#00
70-217X#Curr Top Microbiol Immunol##
00661000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100015001070100
02100122010001700143010001800160011001600178012005400194030001400248065000900262
06400050027103100030027601400100027986500090028900200130029803500100031180100140
0321#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#201#35
#article#36#35#^rND^sRamsden^nC#^rND^sMelo^nFL#^rND^sFigueiredo^nLM#^rND^sHolmes
^nEC#^rND^sZanotto^nPM#VGDN Consortium#High rates of molecular evolution in hant
aviruses^len#Mol Biol Evol#20080000#2008#25#1488-1492#20110000#aop11-11.htm#0737
-4038#Mol Biol Evol##
00683000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900100018001040100
01500122010001700137010001800154012010200172030001800274065000900292064000500301
031000300306014001000309865000900319002001300328035001000341801001800351#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop11-11.htm#S#c#202#36#article#36#
36#^rND^sChu^nYK#^rND^sMilligan^nB#^rND^sOwen^nRD#^rND^sGoodin^nDG#^rND^sJonsson
^nCB#Phylogenetic and geographical relationships of hantavirus strains in easter
n and western Paraguay^len#Am J Trop Med Hyg#20060000#2006#75#1127-1134#20110000
#aop11-11.htm#0002-9637#Am J Trop Med Hyg##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#o#1#
1#article#1#20110325#103646#aop12-11.htm#214##
04898000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400080015603500100016422300090017401201410018301201450
03240100041004690100044005100100038005540100047005920700118006390700091007570831
64100848085000802489085002002497085002502517085002802542083151002570085000804080
08500210408808500260410908500270413505800600416211700060422207200030422811200090
4231111001104240114000904251113001104260002001304271#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop12-11.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#TAB#12
#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f6^l11#0037-8682#20110401#Soro
vares de Leptospira spp. predominantes em exames sorológicos de caninos e humano
s no município de Uberlândia, Estado de Minas Gerais^lpt#Predominant Leptospira 
spp. serovars in serological diagnosis of canines and humans in the City of Uber
lândia, State of Minas Gerais, Brazil^len#^rND^1A01^nJacqueline Ribeiro de^sCast
ro#^rND^1A02^nSandra Renata Sampaio^sSalaberry#^rND^1A02^nMariana Assunção de^sS
ouza#^rND^1A02^nAnna Monteiro Correia^sLima-Ribeiro#Universidade Federal de Uber
lândia^iA01^1Faculdade de Medicina Veterinária^2Programa de Pós-Graduação^cUberl
ândia^sMG#Universidade Federal de Uberlândia^iA02^1Faculdade de Medicina Veterin
ária^cUberlândia^sMG#^lpt^aINTRODUÇÃO: O objetivo desta pesquisa foi verificar a
 ocorrência dos principais sorovares de Leptospira spp. em cães domésticos e hum
anos, notificados no ano de 2008, bem como os principais fatores de riscos em um
a abordagem geográfica relacionados à doença no município de Uberlândia, Estado 
de Minas Gerais, Brasil. MÉTODOS: Foram examinadas 268 amostras de soro sanguíne
o de cães de diferentes bairros pertencentes aos distritos sanitários norte, sul
, leste, oeste e central deste município, colhidas durante a campanha de vacinaç
ão antirrábica animal, em agosto de 2008. Foi realizada uma abordagem geográfica
 do município e avaliada a localização de áreas periféricas, aterro sanitário, c
oleta de lixo, notificação de roedores, casos de leptospirose humana e áreas de 
alagamento decorrente de enchentes, durante o ano de 2008. A leptospirose foi di
agnosticada pela técnica de soroaglutinação microscópica (SAM), padrão-ouro para
 diagnóstico da leptospirose animal e humana. RESULTADOS: Os cães reagiram princ
ipalmente aos sorovares Autumnalis (34,2%) e Tarassovi (23,7%), sendo este, tamb
ém detectado em humanos em 2008. A ocorrência destes sorovares pode estar relaci
onada com uma fonte de infecção comum as duas espécies, ou a hipótese de que o c
ão possa ser a fonte de infecção para o ser humano. O distrito sanitário leste a
presentou um maior número de cães reagentes. CONCLUSÕES: A leptospirose ocorreu 
nos cães e humanos no município de Uberlândia no ano de 2008. Esta doença muitas
 vezes negligenciada deve ser prevenida por representar risco à saúde pública e 
se parecer com outras doenças também endêmicas como a dengue.#^dnd^i1#^tm^lpt^kZ
oonose^i1#^tm^lpt^kLeptospirose^i1#^tm^lpt^kSoroprevalência^i1#^len^aINTRODUCTIO
N:This study aimed to verify the occurrence of the principal Leptospira spp. ser
ovars in domestic dogs and humans, notified in 2008, and the main risk factors i
n a geographic approach to the disease in the City of Uberlândia, State of Minas
 Gerais, Brazil. METHODS: Canine blood serum samples (n=268) from different dist
ricts, belonging to the Northern, Southern, Eastern, Western and Central Sanitar
y Districts of Uberlandia, were collected during an animal vaccination campaign 
against rabies, in August 2008. A geographic approach to the city was conducted,
 including evaluation of locations in peripheral areas, waste landfills, garbage
 collection, rodent notification, human leptospirosis cases and overflow flood a
reas, during 2008. Leptospirosis was diagnosed using the microscopic agglutinati
on test (MAT), the gold standard for animal and human leptospirosis diagnosis. R
ESULTS: Dogs mainly reacted to Autumnalis (34.2%) and Tarassovi (23.7%) serovars
, while in humans, predominance of Tarassovi serovars occurred in the cases regi
stered. The occurrence of these serovars could be related to an infection source
 common to both species, or dogs could be the infection source for humans. The E
astern Sanitary District showed a greater number of reactive dogs. CONCLUSIONS: 
Leptospirosis occurred in dogs and humans of the City of Uberlandia in 2008. Thi
s often neglected disease must be prevented because represents a public health r
isk and resembles other endemic illness like dengue.#^dnd^i2#^tm^len^kZoonosis^i
2#^tm^len^kLeptospirosis^i2#^tm^len^kSeroprevalence^i2#Coordenação de Aperfeiçoa
mento de Pessoal de Nível Superior#other#28#20100830#30/08/2010#20101116#16/11/2
010#aop12-11.htm##
04996000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400080015603500100016422300090017401201550018301201590
03380100041004970100044005380100038005820100047006200700118006670700091007850831
67600876085000802552085002002560085002502580085002802605083154502633085000804178
08500210418608500260420708500270423305800600426011700060432007200030432611200090
4329111001104338114000904349113001104358002001304369#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop12-11.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#TAB#12
#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f6^l11#0037-8682#20110401#<b>S
orovares de <i>Leptospira</i> spp. predominantes em exames sorológicos de canino
s e humanos no município de Uberlândia, Estado de Minas Gerais</b>^lpt#<b>Predom
inant <i>Leptospira</i> spp. serovars in serological diagnosis of canines and hu
mans in the City of Uberlândia, State of Minas Gerais, Brazil</b>^len#^rND^1A01^
nJacqueline Ribeiro de^sCastro#^rND^1A02^nSandra Renata Sampaio^sSalaberry#^rND^
1A02^nMariana Assunção de^sSouza#^rND^1A02^nAnna Monteiro Correia^sLima-Ribeiro#
Universidade Federal de Uberlândia^iA01^1Faculdade de Medicina Veterinária^2Prog
rama de Pós-Graduação^cUberlândia^sMG#Universidade Federal de Uberlândia^iA02^1F
aculdade de Medicina Veterinária^cUberlândia^sMG#^lpt^a<b>INTRODUÇÃO: </b>O obje
tivo desta pesquisa foi verificar a ocorrência dos principais sorovares de <i>Le
ptospira</i> spp. em cães domésticos e humanos, notificados no ano de 2008, bem 
como os principais fatores de riscos em uma abordagem geográfica relacionados à 
doença no município de Uberlândia, Estado de Minas Gerais, Brasil. <b>MÉTODOS: <
/b>Foram examinadas 268 amostras de soro sanguíneo de cães de diferentes bairros
 pertencentes aos distritos sanitários norte, sul, leste, oeste e central deste 
município, colhidas durante a campanha de vacinação antirrábica animal, em agost
o de 2008. Foi realizada uma abordagem geográfica do município e avaliada a loca
lização de áreas periféricas, aterro sanitário, coleta de lixo, notificação de r
oedores, casos de leptospirose humana e áreas de alagamento decorrente de enchen
tes, durante o ano de 2008. A leptospirose foi diagnosticada pela técnica de sor
oaglutinação microscópica (SAM), padrão-ouro para diagnóstico da leptospirose an
imal e humana. <b>RESULTADOS: </b>Os cães reagiram principalmente aos sorovares 
Autumnalis (34,2%) e Tarassovi (23,7%), sendo este, também detectado em humanos 
em 2008. A ocorrência destes sorovares pode estar relacionada com uma fonte de i
nfecção comum as duas espécies, ou a hipótese de que o cão possa ser a fonte de 
infecção para o ser humano. O distrito sanitário leste apresentou um maior númer
o de cães reagentes. <b>CONCLUSÕES: </b>A leptospirose ocorreu nos cães e humano
s no município de Uberlândia no ano de 2008. Esta doença muitas vezes negligenci
ada deve ser prevenida por representar risco à saúde pública e se parecer com ou
tras doenças também endêmicas como a dengue.#^dnd^i1#^tm^lpt^kZoonose^i1#^tm^lpt
^kLeptospirose^i1#^tm^lpt^kSoroprevalência^i1#^len^a<b>INTRODUCTION:</b>This stu
dy aimed to verify the occurrence of the principal <i>Leptospira</i> spp. serova
rs in domestic dogs and humans, notified in 2008, and the main risk factors in a
 geographic approach to the disease in the City of Uberlândia, State of Minas Ge
rais, Brazil. <b>METHODS: </b>Canine blood serum samples (n=268) from different 
districts, belonging to the Northern, Southern, Eastern, Western and Central San
itary Districts of Uberlandia, were collected during an animal vaccination campa
ign against rabies, in August 2008. A geographic approach to the city was conduc
ted, including evaluation of locations in peripheral areas, waste landfills, gar
bage collection, rodent notification, human leptospirosis cases and overflow flo
od areas, during 2008. Leptospirosis was diagnosed using the microscopic aggluti
nation test (MAT), the gold standard for animal and human leptospirosis diagnosi
s. <b>RESULTS: </b>Dogs mainly reacted to Autumnalis (34.2%) and Tarassovi (23.7
%) serovars, while in humans, predominance of Tarassovi serovars occurred in the
 cases registered. The occurrence of these serovars could be related to an infec
tion source common to both species, or dogs could be the infection source for hu
mans. The Eastern Sanitary District showed a greater number of reactive dogs. <b
>CONCLUSIONS: </b>Leptospirosis occurred in dogs and humans of the City of Uberl
andia in 2008. This often neglected disease must be prevented because represents
 a public health risk and resembles other endemic illness like dengue.#^dnd^i2#^
tm^len^kZoonosis^i2#^tm^len^kLeptospirosis^i2#^tm^len^kSeroprevalence^i2#Coorden
ação de Aperfeiçoamento de Pessoal de Nível Superior#other#28#20100830#30/08/201
0#20101116#16/11/2010#aop12-11.htm##
05053000000000637000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108121000300112049000300115158000300118
03000260012103200060014706500090015301400080016203500100017022300090018001201410
01890120145003300100041004750100044005160100038005600100047005980700120006450700
09300765083165900858085000802517085002002525085002502545085002802570083152402598
08500080412208500210413008500260415108500270417705800600420411700060426407200030
4270112000904273111001104282114000904293113001104302002001304313008008904326#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#l#4#1#article#1#
^a2011#oa#pt#br1.1#1#4.0#tab#12#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^
f6^l11#0037-8682#20110401#Sorovares de Leptospira spp. predominantes em exames s
orológicos de caninos e humanos no município de Uberlândia, Estado de Minas Gera
is^lpt#Predominant Leptospira spp. serovars in serological diagnosis of canines 
and humans in the City of Uberlândia, State of Minas Gerais, Brazil^len#^rND^1A0
1^nJacqueline Ribeiro de^sCastro#^rND^1A02^nSandra Renata Sampaio^sSalaberry#^rN
D^1A02^nMariana Assunção de^sSouza#^rND^1A02^nAnna Monteiro Correia^sLima-Ribeir
o#^iA01^1Universidade Federal de Uberlândia^2Faculdade de Medicina Veterinária^3
Programa de Pós-Graduação^cUberlândia^sMG#^iA02^1Universidade Federal de Uberlân
dia^2Faculdade de Medicina Veterinária^cUberlândia^sMG#^lpt^aINTRODUÇÃO: O objet
ivo desta pesquisa foi verificar a ocorrência dos principais sorovares de Leptos
pira spp. em cães domésticos e humanos, notificados no ano de 2008, bem como os 
principais fatores de riscos em uma abordagem geográfica relacionados à doença n
o município de Uberlândia, Estado de Minas Gerais, Brasil. MÉTODOS: Foram examin
adas 268 amostras de soro sanguíneo de cães de diferentes bairros pertencentes a
os distritos sanitários norte, sul, leste, oeste e central deste município, colh
idas durante a campanha de vacinação antirrábica animal, em agosto de 2008. Foi 
realizada uma abordagem geográfica do município e avaliada a localização de área
s periféricas, aterro sanitário, coleta de lixo, notificação de roedores, casos 
de leptospirose humana e áreas de alagamento decorrente de enchentes, durante o 
ano de 2008. A leptospirose foi diagnosticada pela técnica de soroaglutinação mi
croscópica (SAM), padrão-ouro para diagnóstico da leptospirose animal e humana. 
RESULTADOS: Os cães reagiram principalmente aos sorovares Autumnalis (34,2 por c
ento) e Tarassovi (23,7 por cento), sendo este, também detectado em humanos em 2
008. A ocorrência destes sorovares pode estar relacionada com uma fonte de infec
ção comum as duas espécies, ou a hipótese de que o cão possa ser a fonte de infe
cção para o ser humano. O distrito sanitário leste apresentou um maior número de
 cães reagentes. CONCLUSÕES: A leptospirose ocorreu nos cães e humanos no municí
pio de Uberlândia no ano de 2008. Esta doença muitas vezes negligenciada deve se
r prevenida por representar risco à saúde pública e se parecer com outras doença
s também endêmicas como a dengue.#^dnd^i1#^tm^lpt^kZoonose^i1#^tm^lpt^kLeptospir
ose^i1#^tm^lpt^kSoroprevalência^i1#^len^aINTRODUCTION:This study aimed to verify
 the occurrence of the principal Leptospira spp. serovars in domestic dogs and h
umans, notified in 2008, and the main risk factors in a geographic approach to t
he disease in the City of Uberlândia, State of Minas Gerais, Brazil. METHODS: Ca
nine blood serum samples (n=268) from different districts, belonging to the Nort
hern, Southern, Eastern, Western and Central Sanitary Districts of Uberlandia, w
ere collected during an animal vaccination campaign against rabies, in August 20
08. A geographic approach to the city was conducted, including evaluation of loc
ations in peripheral areas, waste landfills, garbage collection, rodent notifica
tion, human leptospirosis cases and overflow flood areas, during 2008. Leptospir
osis was diagnosed using the microscopic agglutination test (MAT), the gold stan
dard for animal and human leptospirosis diagnosis. RESULTS: Dogs mainly reacted 
to Autumnalis (34.2 percent) and Tarassovi (23.7 percent) serovars, while in hum
ans, predominance of Tarassovi serovars occurred in the cases registered. The oc
currence of these serovars could be related to an infection source common to bot
h species, or dogs could be the infection source for humans. The Eastern Sanitar
y District showed a greater number of reactive dogs. CONCLUSIONS: Leptospirosis 
occurred in dogs and humans of the City of Uberlandia in 2008. This often neglec
ted disease must be prevented because represents a public health risk and resemb
les other endemic illness like dengue.#^dnd^i2#^tm^len^kZoonosis^i2#^tm^len^kLep
tospirosis^i2#^tm^len^kSeroprevalence^i2#Coordenação de Aperfeiçoamento de Pesso
al de Nível Superior#other#28#20100830#30/08/2010#20101116#16/11/2010#aop12-11.h
tm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-868220
11005000012##
00516000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704027200085002001300357#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#5#1#article#182#<p><a name
="enda"></a><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b>Sorov
ares de <i>Leptospira</i> spp. predominantes em exames sorol&oacute;gicos de can
inos e humanos no munic&iacute;pio de Uberl&acirc;ndia, Estado de Minas Gerais</
b></font></p>     ^cY#aop12-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#6#2#article#182#<p>&nbsp;<
/p>     ^cY#aop12-11.htm##
00488000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704024400085002001300329#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#7#3#article#182#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Predominant <i>Leptospir
a</i> spp. serovars in serological diagnosis of canines and humans in the City o
f Uberl&acirc;ndia, State of Minas Gerais, Brazil </b></font></p>     ^cY#aop12-
11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#8#4#article#182#<p>&nbsp;<
/p>     ^cY#aop12-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#9#5#article#182#<p>&nbsp;<
/p>     ^cY#aop12-11.htm##
00525000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704028000086002001300366#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#10#6#article#182#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Jacqueline Ribeiro de C
astro<sup>I</sup>; Sandra Renata Sampaio Salaberry<sup>II</sup>; Mariana Assun&c
cedil;&atilde;o de Souza<sup>II</sup>; Anna Monteiro Correia Lima-Ribeiro<sup>II
I</sup></b></font></p>     ^cY#aop12-11.htm##
00480000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704023500086002001300321#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#11#7#article#182#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Programa de P&
oacute;s-Gradua&ccedil;&atilde;o, Faculdade de Medicina Veterin&aacute;ria, Univ
ersidade Federal de Uberl&acirc;ndia, Uberl&acirc;ndia, MG    ^cY#aop12-11.htm##
00377000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013200086002001300218#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#12#8#article#182#<br>   <s
up>II</sup>Faculdade de Medicina Veterin&aacute;ria, Universidade Federal de Ube
rl&acirc;ndia, Uberl&acirc;ndia, MG    ^cY#aop12-11.htm##
00462000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704021700086002001300303#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#13#9#article#182#<br>   <s
up>III</sup>Disciplina de Doen&ccedil;as Bacterianas dos Animais Dom&eacute;stic
os, Faculdade de Medicina Veterin&aacute;ria, Universidade Federal de Uberl&acir
c;ndia, Uberl&acirc;ndia, MG</font></p>     ^cY#aop12-11.htm##
00378000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013200087002001300219#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#14#10#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#endb">Endereço 
para correspondência</a></font></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#15#11#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#16#12#article#182#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop12-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#17#13#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop12-11.htm##
00717000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047100087002001300558#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#18#14#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b> O objetivo desta pesquisa foi verificar a ocorr&ecirc;ncia dos principa
is sorovares de <i>Leptospira</i> spp. em c&atilde;es dom&eacute;sticos e humano
s, notificados no ano de 2008, bem como os principais fatores de riscos em uma a
bordagem geogr&aacute;fica relacionados &agrave; doen&ccedil;a no munic&iacute;p
io de Uberl&acirc;ndia, Estado de Minas Gerais, Brasil.    ^cY#aop12-11.htm##
01097000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704085100087002001300938#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#19#15#article#182#<br>   <
b>M&Eacute;TODOS: </b> Foram examinadas 268 amostras de soro sangu&iacute;neo de
 c&atilde;es de diferentes bairros pertencentes aos distritos sanit&aacute;rios 
norte, sul, leste, oeste e central deste munic&iacute;pio, colhidas durante a ca
mpanha de vacina&ccedil;&atilde;o antirr&aacute;bica animal, em agosto de 2008. 
Foi realizada uma abordagem geogr&aacute;fica do munic&iacute;pio e avaliada a l
ocaliza&ccedil;&atilde;o de &aacute;reas perif&eacute;ricas, aterro sanit&aacute
;rio, coleta de lixo, notifica&ccedil;&atilde;o de roedores, casos de leptospiro
se humana e &aacute;reas de alagamento decorrente de enchentes, durante o ano de
 2008. A leptospirose foi diagnosticada pela t&eacute;cnica de soroaglutina&cced
il;&atilde;o microsc&oacute;pica (SAM), padr&atilde;o-ouro para diagn&oacute;sti
co da leptospirose animal e humana.    ^cY#aop12-11.htm##
00757000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051100087002001300598#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#20#16#article#182#<br>   <
b>RESULTADOS: </b> Os c&atilde;es reagiram principalmente aos sorovares Autumnal
is (34,2%) e Tarassovi (23,7%), sendo este, tamb&eacute;m detectado em humanos e
m 2008. A ocorr&ecirc;ncia destes sorovares pode estar relacionada com uma fonte
 de infec&ccedil;&atilde;o comum as duas esp&eacute;cies, ou a hip&oacute;tese d
e que o c&atilde;o possa ser a fonte de infec&ccedil;&atilde;o para o ser humano
. O distrito sanit&aacute;rio leste apresentou um maior n&uacute;mero de c&atild
e;es reagentes.    ^cY#aop12-11.htm##
00612000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036600087002001300453#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#21#17#article#182#<br>   <
b>CONCLUS&Otilde;ES: </b> A leptospirose ocorreu nos c&atilde;es e humanos no mu
nic&iacute;pio de Uberl&acirc;ndia no ano de 2008. Esta doen&ccedil;a muitas vez
es negligenciada deve ser prevenida por representar risco &agrave; sa&uacute;de 
p&uacute;blica e se parecer com outras doen&ccedil;as tamb&eacute;m end&ecirc;mi
cas como a dengue.</font></p>     ^cY#aop12-11.htm##
00420000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017400087002001300261#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#22#18#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves:</b> Z
oonose. Leptospirose. Soropreval&ecirc;ncia.</font></p> <hr size="1" noshade>   
  ^cY#aop12-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#23#19#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop12-11.htm##
00604000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035800087002001300445#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#24#20#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b>This 
study aimed to verify the occurrence of the principal <i>Leptospira</i> spp. ser
ovars in domestic dogs and humans, notified in 2008, and the main risk factors i
n a geographic approach to the disease in the City of Uberl&acirc;ndia, State of
 Minas Gerais, Brazil.    ^cY#aop12-11.htm##
00889000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064300087002001300730#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#25#21#article#182#<br>   <
b>METHODS: </b>Canine blood serum samples (n=268) from different districts, belo
nging to the Northern, Southern, Eastern, Western and Central Sanitary Districts
 of Uberlandia, were collected during an animal vaccination campaign against rab
ies, in August 2008. A geographic approach to the city was conducted, including 
evaluation of locations in peripheral areas, waste landfills, garbage collection
, rodent notification, human leptospirosis cases and overflow flood areas, durin
g 2008. Leptospirosis was diagnosed using the microscopic agglutination test (MA
T), the gold standard for animal and human leptospirosis diagnosis.    ^cY#aop12
-11.htm##
00655000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040900087002001300496#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#26#22#article#182#<br>   <
b>RESULTS: </b>Dogs mainly reacted to Autumnalis (34.2%) and Tarassovi (23.7%) s
erovars, while in humans, predominance of Tarassovi serovars occurred in the cas
es registered. The occurrence of these serovars could be related to an infection
 source common to both species, or dogs could be the infection source for humans
. The Eastern Sanitary District showed a greater number of reactive dogs.    ^cY
#aop12-11.htm##
00506000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026000087002001300347#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#27#23#article#182#<br>   <
b>CONCLUSIONS: </b>Leptospirosis occurred in dogs and humans of the City of  Ube
rlandia in 2008. This often neglected disease must be prevented because represen
ts a public health risk and resembles other endemic illness like dengue.</font><
/p>     ^cY#aop12-11.htm##
00408000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704016200087002001300249#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#28#24#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Zoonosis
. Leptospirosis. Seroprevalence.</font></p> <hr size="1" noshade>     ^cY#aop12-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#29#25#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#30#26#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011400087002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#31#27#article#182#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O</b></font></p>     ^cY#aop12-11.htm##
01080000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704083400087002001300921#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#32#28#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A leptospirose &eacute; u
ma doen&ccedil;a infectocontagiosa de distribui&ccedil;&atilde;o mundial, caract
erizada por ser uma zoonose que acomete animais dom&eacute;sticos, silvestres e 
a esp&eacute;cie humana<sup>1</sup>. O rato de esgoto (<i>Rattus novergicus</i>)
 e os c&atilde;es s&atilde;o os principais reservat&oacute;rios da leptospirose 
no ambiente urbano<sup>2</sup>, portanto, sendo importantes na transmiss&atilde;
o da doen&ccedil;a para a esp&eacute;cie humana. Esta doen&ccedil;a &eacute; mai
s comum em &aacute;reas pr&oacute;ximas &agrave;s favelas<sup>3</sup>, pois norm
almente nestes locais h&aacute; falta de saneamento b&aacute;sico levando uma ma
ior exposi&ccedil;&atilde;o das popula&ccedil;&otilde;es humana e canina aos roe
dores.</font></p>     ^cY#aop12-11.htm##
00829000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058300087002001300670#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#33#29#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Melhorias nas condi&ccedi
l;&otilde;es de moradia, com instala&ccedil;&atilde;o de redes de esgoto, drenag
em de &aacute;reas alagadas e um sistema de coleta de lixo eficiente s&atilde;o 
importantes medidas a serem adotadas para diminui&ccedil;&atilde;o da leptospiro
se na popula&ccedil;&atilde;o humana<sup>4</sup>. A vacina&ccedil;&atilde;o dos 
animais suscept&iacute;veis mostra-se como uma forma bastante eficiente para o c
ontrole da doen&ccedil;a nos mesmos e, consequentemente, em seres humanos. </fon
t></p>     ^cY#aop12-11.htm##
00834000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058800087002001300675#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#34#30#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A doen&ccedil;a tem maior
 preval&ecirc;ncia nas regi&otilde;es de clima tropical, quente e &uacute;mido e
 em locais de pobres condi&ccedil;&otilde;es sanit&aacute;rias<sup>5</sup>. No B
rasil, a zoonose &eacute; end&ecirc;mica, com a maior parte dos casos ocorrendo 
nas &eacute;pocas de maior precipita&ccedil;&atilde;o pluviom&eacute;trica. No p
a&iacute;s, a manuten&ccedil;&atilde;o do agente no meio &eacute; favorecida pel
a vasta popula&ccedil;&atilde;o de roedores e pelo clima tropical &uacute;mido. 
</font></p>     ^cY#aop12-11.htm##
00623000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037700087002001300464#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#35#31#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os sorovares mais prevale
ntes em pesquisa que determinou a situa&ccedil;&atilde;o da leptospirose canina 
no Brasil foram Canicola, Copenhageni, Icterohaemorrhagiae seguido pelo Autumnal
is<sup>6</sup>. A m&eacute;dia das preval&ecirc;ncias encontradas em todo pa&iac
ute;s<sup>7</sup> foi de 26%.</font></p>     ^cY#aop12-11.htm##
00755000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050900087002001300596#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#36#32#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os roedores s&atilde;o co
nsiderados os principais reservat&oacute;rios da infec&ccedil;&atilde;o. Cogita-
se que os sorovares presentes nos roedores em um determinado local s&atilde;o se
melhantes aos presentes em c&atilde;es que vivem nesse mesmo ambiente, fato este
 que foi discutido em pesquisa realizada em Trinidade na &Iacute;ndia<sup>8</sup
> a qual apontou o sorovar Copenhageni predominante em ambas as esp&eacute;cies.
 </font></p>     ^cY#aop12-11.htm##
00774000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052800087002001300615#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#37#33#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Import&acirc;ncia especia
l deve ser conferida &agrave; esp&eacute;cie <i>Rattus norvegicus</i>, conhecida
 como ratazana de esgotos, principal esp&eacute;cie transmissora em centros urba
nos. Sua prolifera&ccedil;&atilde;o &eacute; verificada em grandes cidades, onde
 as redes pluviais e de esgoto n&atilde;o recebem tratamento adequado e, com fre
qu&ecirc;ncia, se conectam possibilitando maior contamina&ccedil;&atilde;o ambie
ntal<sup>9,10</sup>.</font></p>     ^cY#aop12-11.htm##
00749000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050300087002001300590#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#38#34#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">O c&atilde;o tem papel im
portante na transmiss&atilde;o da doen&ccedil;a ao homem, por manter a leptospir
a por longo per&iacute;odo nos rins, podendo elimin&aacute;-la na urina sem apre
sentar sinais cl&iacute;nicos ou ap&oacute;s obter melhora cl&iacute;nica. Esse 
fato se torna mais agravante devido aos h&aacute;bitos dom&eacute;sticos desses 
animais e sua estreita rela&ccedil;&atilde;o com os humanos<sup>5,11</sup>.</fon
t></p>     ^cY#aop12-11.htm##
00655000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040900087002001300496#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#39#35#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">C&atilde;es s&atilde;o bo
as sentinelas para detectar a presen&ccedil;a de leptospirose no ambiente<sup>12
</sup> e s&atilde;o fatores chave para o entendimento da epidemiologia da doen&c
cedil;a, sendo importante o diagn&oacute;stico e tratamento dos animais doentes 
a fim de evitar a infec&ccedil;&atilde;o humana<sup>13</sup>.</font></p>     ^cY
#aop12-11.htm##
00898000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704065200087002001300739#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#40#36#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A incid&ecirc;ncia da lep
tospirose humana tem crescido em pa&iacute;ses da Am&eacute;rica Latina associad
a aos desastres naturais e ao crescimento desordenado das cidades<sup>14</sup>. 
No Brasil, em 2008, de acordo com o Minist&eacute;rio da Sa&uacute;de foram regi
strados 3.306 casos, sendo 949 na regi&atilde;o sudeste e 63 no Estado de Minas 
Gerais. Segundo a Vigil&acirc;ncia Epidemiol&oacute;gica da Prefeitura Municipal
 de Uberl&acirc;ndia, no ano de 2008, foram registrados no munic&iacute;pio 11 c
asos suspeitos e dois casos confirmados de leptospirose humana. </font></p>     
^cY#aop12-11.htm##
00711000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046500087002001300552#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#41#37#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A presente pesquisa objet
ivou investigar a ocorr&ecirc;ncia dos principais sorovares de <i>Leptospira</i>
 spp. em c&atilde;es dom&eacute;sticos e humanos notificados no ano de 2008, bem
 como os principais fatores de riscos em uma abordagem geogr&aacute;fica e epide
miol&oacute;gica relacionados &agrave; doen&ccedil;a no munic&iacute;pio de Uber
l&acirc;ndia, Estado de Minas Gerais.</font></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#42#38#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#43#39#article#182#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODOS</b></fo
nt></p>     ^cY#aop12-11.htm##
00734000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048800087002001300575#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#44#40#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A pesquisa foi realizada 
no munic&iacute;pio de Uberl&acirc;ndia situado no Tri&acirc;ngulo Mineiro, Esta
do de Minas Gerais, Brasil, limitado pelas coordenadas geogr&aacute;ficas 18º 30
' e 19º 30' de latitude sul e 47º 50' e 48º 50' de longitude oeste com uma &aacu
te;rea de 4115,09km<sup>2</sup>. Apresenta clima tropical com pluviosidade anual
 de 1.500mm e temperatura m&eacute;dia de 22ºC<sup>15</sup>.</font></p>     ^cY#
aop12-11.htm##
00693000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044700087002001300534#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#45#41#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">O experimento foi conduzi
do durante a 26ª Campanha de Vacina&ccedil;&atilde;o Antirr&aacute;bica Animal, 
etapa urbana, em agosto de 2008. O dimensionamento da amostra foi determinado co
m base na preval&ecirc;ncia esperada de 26%, a qual corresponde &agrave; preval&
ecirc;ncia m&eacute;dia da leptospirose canina no Brasil<sup>7</sup>, totalizand
o 268 c&atilde;es. </font></p>     ^cY#aop12-11.htm##
00747000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050100087002001300588#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#46#42#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A colheita de sangue dos 
c&atilde;es foi realizada em 60, dos 300 postos fixos de vacina&ccedil;&atilde;o
 distribu&iacute;dos nos cinco distritos sanit&aacute;rios do munic&iacute;pio: 
central, norte, leste, oeste e sul. Ap&oacute;s pr&eacute;via vacina&ccedil;&ati
lde;o antirr&aacute;bica e autoriza&ccedil;&atilde;o dos propriet&aacute;rios, f
oram selecionados aleatoriamente cinco c&atilde;es por posto da campanha.</font>
</p>     ^cY#aop12-11.htm##
01122000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704087600087002001300963#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#47#43#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Para realiza&ccedil;&atil
de;o do exame sorol&oacute;gico de leptospirose foram colhidos 5mL de sangue por
 meio da veia cef&aacute;lica acess&oacute;ria, com seringas de 5mL e agulha 25x
7 est&eacute;reis, ap&oacute;s antissepsia pr&eacute;via com &aacute;lcool. As a
mostras foram acondicionadas em tubos sem anticoagulante para extra&ccedil;&atil
de;o do soro e mantidas refrigeradas  (2 a 8ºC). O material foi transportado ao 
Laborat&oacute;rio de Doen&ccedil;as Infectocontagiosas da Faculdade de Medicina
 Veterin&aacute;ria da Universidade Federal de Uberl&acirc;ndia (FAMEV-UFU) e ce
ntrifugado a 2.500rpm, durante 5min. Em seguida, as amostras de soro foram acond
icionadas em microtubos de polietileno de fundo c&ocirc;nico e congeladas a -20º
C at&eacute; a realiza&ccedil;&atilde;o da SAM. </font></p>     ^cY#aop12-11.htm
##
00835000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058900087002001300676#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#48#44#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As an&aacute;lises sorol&
oacute;gicas foram processadas por meio do teste de soroaglutina&ccedil;&atilde;
o microsc&oacute;pica (SAM)<sup>3,16</sup>, padr&atilde;o ouro no diagn&oacute;s
tico da leptospirose humana e animal, padronizado pelo Minist&eacute;rio da Sa&u
acute;de, com uma cole&ccedil;&atilde;o de 12 ant&iacute;genos vivos que inclu&i
acute;ram os sorovares Autumnalis, Australis, Bataviae, Bratislava, Canicola, Gr
ippotyphosa, Hardjo, Hebdomadis, Icterohaemorrhagiae, Pomona, Tarassovi e Wolffi
.</font></p>     ^cY#aop12-11.htm##
00963000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071700087002001300804#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#49#45#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os ant&iacute;genos foram
 preparados a partir de matrizes mantidas Laborat&oacute;rio de Doen&ccedil;as I
nfectocontagiosas da UFU, repicadas semanalmente em meio de cultura EMJH (Difco&
reg;), enriquecido com 10% de soro de coelho, mantido em estufa a 30ºC e utiliza
dos pr&oacute;ximo ao terceiro dia de incuba&ccedil;&atilde;o, livre de contamin
a&ccedil;&atilde;o e de autoaglutina&ccedil;&atilde;o. Para determina&ccedil;&at
ilde;o dos c&atilde;es sororreagentes, foi utilizada a dilui&ccedil;&atilde;o de
 1:100, considerando-se amostras reagentes, as quais apresentaram aglutina&ccedi
l;&atilde;o igual ou superior a 50%<sup>16</sup>.</font></p>     ^cY#aop12-11.ht
m##
01080000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704083400087002001300921#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#50#46#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Casos de leptospirose hum
ana foram determinados a partir de coleta de dados oficiais junto aos registros 
da Vigil&acirc;ncia Epidemiol&oacute;gica da Prefeitura Municipal (Vigep) de Ube
rl&acirc;ndia (PMU), registros de exames humanos de SAM realizados no Laborat&oa
cute;rio de Doen&ccedil;as Infectocontagiosas da Faculdade de Medicina Veterin&a
acute;ria da Universidade Federal de Uberl&acirc;ndia, Estado de Minas Gerais, e
 laborat&oacute;rios da rede particular do munic&iacute;pio pesquisado. Por se t
ratar de um estudo em c&atilde;es assintom&aacute;ticos, domiciliados e, possive
lmente portadores cr&ocirc;nicos, foram considerados os casos humanos confirmado
s no ano anterior (2007) e posterior (2009) a realiza&ccedil;&atilde;o desta pes
quisa.</font></p>     ^cY#aop12-11.htm##
00881000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063500087002001300722#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#51#47#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">De acordo com a Vigep da 
PMU seguindo as normas do Minist&eacute;rio da Sa&uacute;de<sup>16</sup> foram c
onsiderados casos suspeitos todos aqueles que tiveram suspeita cl&iacute;nica da
 doen&ccedil;a e amostras de soro enviadas para a realiza&ccedil;&atilde;o da SA
M. Ap&oacute;s a realiza&ccedil;&atilde;o do exame sorol&oacute;gico foram class
ificados como negativo os casos n&atilde;o reagentes ao SAM e positivos todos aq
ueles se mostraram reagentes na SAM, exame sorol&oacute;gico padr&atilde;o na co
nfirma&ccedil;&atilde;o da leptospirose humana.</font></p>     ^cY#aop12-11.htm#
#
01030000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704078400087002001300871#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#52#48#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Foi realizada uma abordag
em geogr&aacute;fica do munic&iacute;pio com coleta de dados dos arquivos da PMU
 do Banco de dados Integrados de 2008, Vigil&acirc;ncia Epidemiol&oacute;gica e 
Centro de Controle de Zoonoses (CCZ). Avaliou-se por distrito sanit&aacute;rio o
 saneamento ambiental com rela&ccedil;&atilde;o &agrave; localiza&ccedil;&atilde
;o de &aacute;reas perif&eacute;ricas com baixa infraestrutura, aterro sanit&aac
ute;rio, coleta de lixo, notifica&ccedil;&atilde;o de roedores e &aacute;reas de
 alagamento decorrente de enchentes durante o ano de 2008. Estes dados foram cor
relacionados com os distritos sanit&aacute;rios que apresentaram c&atilde;es rea
gentes contra <i>Leptospira</i> spp.</font></p>     ^cY#aop12-11.htm##
00377000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013100087002001300218#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#53#49#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Considera&ccedil;&otil
de;es &eacute;ticas</b></font></p>     ^cY#aop12-11.htm##
00528000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028200087002001300369#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#54#50#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">O experimento foi conduzi
do de acordo com normas e aprova&ccedil;&atilde;o (015/08) do Comit&ecirc; de &E
acute;tica na Utiliza&ccedil;&atilde;o de Animais da Universidade Federal de Ube
rl&acirc;ndia.</font></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#55#51#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#56#52#article#182#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font><
/p>     ^cY#aop12-11.htm##
00771000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052500087002001300612#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#57#53#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Das 268 amostras de soro 
sangu&iacute;neo analisadas, 76 apresentaram reagentes &agrave; SAM, obtendo-se 
uma ocorr&ecirc;ncia de 28,4%. Os sorovares de maior frequ&ecirc;ncia foram o Au
tumnalis (34,2%), Tarassovi (23,7%) seguido pela sorovariedade Canicola (17,1%) 
e Grippotyphosa (14,5%), demonstrados na <b><a href="#tab1">Tabela 1</a></b>. N&
atilde;o foram detectados c&atilde;es sororreagentes aos sorovares Hebdomadis, B
ataviae e Hardjo.</font></p>     ^cY#aop12-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#58#54#article#182#<p><a na
me="tab1"></a></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#59#55#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#60#56#article#182#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop12-11tab01.jpg"></p>     ^
cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#61#57#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00602000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035600087002001300443#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#62#58#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Dos c&atilde;es sororreag
entes, 15 (19,7%) apresentaram anticorpos para mais de um sorovar de <i>Leptospi
ra </i>spp.(<b><a href="#tab2">Tabela 2</a></b>). Nesses casos de coaglutina&cce
dil;&atilde;o, considerou-se reagente a sorovariedade de maior titula&ccedil;&at
ilde;o. </font></p>     ^cY#aop12-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#63#59#article#182#<p><a na
me="tab2"></a></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#64#60#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#65#61#article#182#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop12-11tab02.jpg"></p>     ^
cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#66#62#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00498000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025200087002001300339#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#67#63#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">O distrito sanit&aacute;r
io leste (35%) apresentou um maior percentual de c&atilde;es reagentes seguido p
elo sul (26%), oeste (22%), norte (16%) e central com apenas 1%.</font></p>     
^cY#aop12-11.htm##
00765000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051900087002001300606#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#68#64#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">De acordo com os dados re
gistrados pelo CCZ da PMU, no ano de 2008, o maior n&uacute;mero de notifica&cce
dil;&otilde;es de ocorr&ecirc;ncia de roedores e solicita&ccedil;&atilde;o de se
rvi&ccedil;o de controle foi identificado no distrito sanit&aacute;rio Norte, se
guido pelo leste (<b><a href="#tab3">Tabela 3</a></b>), no qual se verificou um 
maior n&uacute;mero de c&atilde;es que apresentaram anticorpos anti-<i>Leptospir
a</i> spp. </font></p>     ^cY#aop12-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#69#65#article#182#<p><a na
me="tab3"></a></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#70#66#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#71#67#article#182#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop12-11tab03.jpg"></p>     ^
cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#72#68#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00533000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028700087002001300374#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#73#69#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os resultados e registros
 de notifica&ccedil;&atilde;o de casos humanos e sorovares ocorridos de 2007 a 2
009 encontram-se descritos nas <b><a href="#tab4">Tabelas 4</a> </b>e<b> <a href
="#tab5">5</a></b>.</font></p>     ^cY#aop12-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#74#70#article#182#<p><a na
me="tab4"></a></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#75#71#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#76#72#article#182#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop12-11tab04.jpg"></p>     ^
cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#77#73#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#78#74#article#182#<p><a na
me="tab5"></a></p>     ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#79#75#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#80#76#article#182#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop12-11tab05.jpg"></p>     ^
cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#81#77#article#182#<p>&nbsp
;</p>     ^cY#aop12-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010600087002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#82#78#article#182#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></
font></p>     ^cY#aop12-11.htm##
00592000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704034600087002001300433#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#83#79#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A ocorr&ecirc;ncia da doe
n&ccedil;a neste percentual elevado em c&atilde;es demonstra que a leptospirose 
&eacute; uma doen&ccedil;a comum e provavelmente subestimada devido &agrave; gra
nde quantidade de animais assintom&aacute;ticos, embora cronicamente afetados.</
font></p>     ^cY#aop12-11.htm##
00551000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030500087002001300392#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#84#80#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os casos de coaglutina&cc
edil;&atilde;o podem ser explicados devido exposi&ccedil;&atilde;o a mais de um 
sorovar, &agrave; diversidade de reservat&oacute;rios e ambientes aos quais os a
nimais se exp&otilde;em<sup>17</sup>.</font></p>     ^cY#aop12-11.htm##
00676000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043000087002001300517#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#85#81#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Em estudo realizado em Be
lo Horizonte, MG<sup>3</sup>, a preval&ecirc;ncia encontrada foi de 13,1% em c&a
tilde;es recolhidos pelo Centro de Controle de Zoonoses oriundos de domic&iacute
;lios e c&atilde;es errantes. J&aacute; em Patos, PB<sup>1</sup>, encontraram um
a soropreval&ecirc;ncia de 20%, no entanto, avaliaram apenas c&atilde;es errante
s.</font></p>     ^cY#aop12-11.htm##
00862000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061600087002001300703#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#86#82#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Comparando os resultados 
da presente investiga&ccedil;&atilde;o com outras conduzidas em diferentes cidad
es do pa&iacute;s, verifica-se que o percentual de c&atilde;es reagentes encontr
ados (28,4%) foi superior ao encontrado no munic&iacute;pio de Campina Grande<su
p>11</sup>, PB (21,4%) e em Botucatu<sup>18</sup>, SP (17,9%). Estas pesquisas t
amb&eacute;m foram realizadas durante a campanha de vacina&ccedil;&atilde;o anti
rr&aacute;bica com sele&ccedil;&atilde;o aleat&oacute;ria dos animais pertencent
es a diferentes localidades.</font></p>     ^cY#aop12-11.htm##
00613000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036700087002001300454#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#87#83#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Em Pelotas, RS<sup>19</su
p> e Londrina, PR<sup>20</sup>, encontraram preval&ecirc;ncias superiores, 34,8%
 e 30,5%, respectivamente. Isto, possivelmente, se deve ao fato dos autores tere
m utilizados em suas pesquisas amostras de c&atilde;es com suspeita cl&iacute;ni
ca de leptospirose.</font></p>     ^cY#aop12-11.htm##
00814000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056800087002001300655#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#88#84#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A maior incid&ecirc;ncia 
do sorovar Autumnalis (34,2%) tamb&eacute;m foi identificada em outros estudos<s
up>1,21</sup> os quais apresentaram 20% e 22,2%, respectivamente, de c&atilde;es
 sororreagentes frente a esta sorovariedade. O aparecimento de sorovares incomun
s pode ser explicado pelo fato do compartilhamento do ambiente por diferentes es
p&eacute;cies animais, o que pode promover a associa&ccedil;&atilde;o e adapta&c
cedil;&atilde;o de agentes a novos hospedeiros<sup>21</sup>.</font></p>     ^cY#
aop12-11.htm##
00975000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072900087002001300816#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#89#85#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Observou-se baixa ocorr&e
circ;ncia da doen&ccedil;a na zona central do munic&iacute;pio, o que pode estar
 relacionada com maior efetividade no saneamento b&aacute;sico, com coleta de li
xo di&aacute;ria e tratamento de &aacute;gua e esgoto em sua total extens&atilde
;o por ser considerada parte nobre do munic&iacute;pio. Os c&atilde;es do distri
to sanit&aacute;rio leste apresentaram um maior n&uacute;mero de c&atilde;es rea
gentes na SAM. Neste distrito, concentram-se alguns bairros com d&eacute;ficit e
strutural e baixo &iacute;ndice de urbaniza&ccedil;&atilde;o, tendo um elevado n
&uacute;mero de terrenos baldios e setor de ch&aacute;caras. </font></p>     ^cY
#aop12-11.htm##
00926000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068000087002001300767#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#90#86#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A leptospirose detectada 
em humanos de Belo Horizonte, MG, ocorreu principalmente nas &aacute;reas de bol
s&otilde;es de pobreza, com grande densidade populacional e car&ecirc;ncia de in
fra-estrutura<sup>22</sup>. Na distribui&ccedil;&atilde;o espacial, a doen&ccedi
l;a esteve presente em maior percentual em &aacute;reas com maior concentra&cced
il;&atilde;o de redes fluviais. Dentre os indiv&iacute;duos avaliados, 12% tiver
am contato com a &aacute;gua ou animais contaminados, demonstrando assim, a impo
rt&acirc;ncia do c&atilde;o na cadeia epidemiol&oacute;gica da doen&ccedil;a na 
zona urbana.</font></p>     ^cY#aop12-11.htm##
01061000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081500087002001300902#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#91#87#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">De acordo com a Defesa Ci
vil da PMU, MG, as &aacute;reas de emerg&ecirc;ncia pluviom&eacute;tricas est&at
ilde;o distribu&iacute;das por todas as bacias de c&oacute;rregos e rio que pass
am pelo munic&iacute;pio. No ano de 2008, houve registros de emerg&ecirc;ncias p
luviom&eacute;tricas com precipita&ccedil;&otilde;es elevadas em locais como Av.
 Governador Rondon Pacheco, Av. Minervina C&acirc;ndida e Av. Get&uacute;lio Var
gas. No entanto, estas s&atilde;o vias urbanas que ligam os principais pontos de
 Uberl&acirc;ndia, atravessam o munic&iacute;pio e geograficamente pertencem a v
&aacute;rios bairros e a mais de um distrito sanit&aacute;rio, n&atilde;o sendo 
poss&iacute;vel correlacionar com os casos de leptospirose canina. </font></p>  
   ^cY#aop12-11.htm##
00770000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052400087002001300611#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#92#88#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Alguns locais se destacar
am nesta avalia&ccedil;&atilde;o, como o bairro Morumbi localizado no distrito s
anit&aacute;rio leste de maior ocorr&ecirc;ncia de c&atilde;es reagentes. Este b
airro foi alagado em 2008 diversas vezes no per&iacute;odo chuvoso em situa&cced
il;&atilde;o cr&iacute;tica havendo a necessidade de implementar rotas alternati
vas para acesso ao bairro at&eacute; regulariza&ccedil;&atilde;o do n&iacute;vel
 de &aacute;gua.</font></p>     ^cY#aop12-11.htm##
00620000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037400087002001300461#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#93#89#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A ocorr&ecirc;ncia de enc
hentes &eacute; considerada um fator de risco para a leptospirose canina e human
a, pois durante as &eacute;pocas chuvosas ocorre maior facilidade de dissemina&c
cedil;&atilde;o do agente, eliminado pela urina de roedores e outros reservat&oa
cute;rios<sup>11,23</sup>.</font></p>     ^cY#aop12-11.htm##
00705000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045900087002001300546#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#94#90#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A presen&ccedil;a de &aac
ute;reas alagadi&ccedil;as pr&oacute;ximas &agrave;s resid&ecirc;ncias &eacute; 
considerada um fator de risco para a leptospirose canina<sup>20</sup>. &Eacute; 
importante limitar o acesso dos c&atilde;es a &aacute;reas pantanosas, lamacenta
s, lagos e &aacute;reas alagadi&ccedil;as como medida de preven&ccedil;&atilde;o
 da doen&ccedil;a<sup>6</sup>. </font></p>     ^cY#aop12-11.htm##
00876000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063000087002001300717#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#95#91#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Foi observado tamb&eacute
;m que a regi&atilde;o central teve um menor n&uacute;mero de registros de notif
ica&ccedil;&otilde;es de presen&ccedil;a de roedores e foi o distrito com um men
or percentual de c&atilde;es reagentes contra <i>Leptospira</i> spp. enquanto, o
s distritos sanit&aacute;rios norte e leste (<b><a href="#tab3">Tabela 3</a></b>
) apresentaram um maior n&uacute;mero de notifica&ccedil;&otilde;es de roedores,
 sendo que este se verificou um maior n&uacute;mero de c&atilde;es que apresenta
ram anticorpos anti-<i>Leptospira</i> spp.</font></p>     ^cY#aop12-11.htm##
00758000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051200087002001300599#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#96#92#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Os roedores s&atilde;o co
nsiderados hospedeiros de manuten&ccedil;&atilde;o de diversos sorovares e contr
ibuem para a contamina&ccedil;&atilde;o ambiental permitindo assim a poss&iacute
;vel infec&ccedil;&atilde;o do c&atilde;o e do ser humano. O contato dos c&atild
e;es com roedores constitui um fator de risco, uma vez que, a presen&ccedil;a de
 ratos est&aacute; intimamente ligada ao aparecimento da doen&ccedil;a<sup>24</s
up>.</font></p>     ^cY#aop12-11.htm##
00765000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051900087002001300606#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#97#93#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A coleta de lixo no munic
&iacute;pio de Uberl&acirc;ndia tem sido realizada diariamente no distrito sanit
&aacute;rio central e tr&ecirc;s vezes por semana nos demais distritos. O aterro
 sanit&aacute;rio localiza-se no setor norte e neste verificou-se um maior n&uac
ute;mero de notifica&ccedil;&otilde;es de roedores, enquanto, no central observo
u-se um menor registro de roedores e de c&atilde;es reagentes contra <i>Leptospi
ra</i> spp.</font></p>     ^cY#aop12-11.htm##
00493000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704024700087002001300334#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#98#94#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A incid&ecirc;ncia da lep
tospirose humana tem elevado na Am&eacute;rica Latina devido ao crescimento deso
rdenado das cidades e aos desastres naturais<sup>14</sup>. </font></p>     ^cY#a
op12-11.htm##
01191000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704094500087002001301032#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#99#95#article#182#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">De acordo com dados da Vi
gil&acirc;ncia Epidemiol&oacute;gica da Prefeitura Municipal de Uberl&acirc;ndia
, no ano de 2008, foram notificados apenas dois casos confirmados de leptospiros
e humana, sendo um proveniente da &aacute;rea rural e outro provindo do distrito
 sanit&aacute;rio oeste da zona urbana do munic&iacute;pio. Estes dados podem es
tar aqu&eacute;m da realidade devido &agrave; falta de confirma&ccedil;&atilde;o
, e notifica&ccedil;&atilde;o dos casos humanos. Acredita-se ainda, que a semelh
an&ccedil;a entre a sintomatologia da leptospirose humana e outras doen&ccedil;a
s tropicais como a dengue, possa explicar a discrep&acirc;ncia entre os dados re
gistrados em c&atilde;es e seres humanos nessa pesquisa. Em algumas &eacute;poca
s do ano de 2008 a dengue se apresentou de forma epid&ecirc;mica neste munic&iac
ute;pio de acordo com dados da Vigep.</font></p>     ^cY#aop12-11.htm##
00485000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704023800088002001300326#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#100#96#article#182#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">A rapidez que a cl&iacut
e;nica exige do profissional de posto de sa&uacute;de pode levar ao negligenciam
ento no correto diagn&oacute;stico de leptospirose.</font></p>     ^cY#aop12-11.
htm##
00987000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704074000088002001300828#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#101#97#article#182#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">Tal fato pode ser susten
tado pela avalia&ccedil;&atilde;o feita nos registros do Laborat&oacute;rio de D
oen&ccedil;as Infectocontagiosas da UFU e de laborat&oacute;rios particulares. E
m um levantamento realizado de exames sorol&oacute;gicos de SAM de leptospirose 
humana, realizados nos &uacute;ltimos tr&ecirc;s anos (2007 a 2009), ao serem co
nfrontados com os dados oficiais de notifica&ccedil;&atilde;o (Vigep), verificou
-se um n&uacute;mero maior de casos registrados confirmados de pacientes provind
os do munic&iacute;pio de Uberl&acirc;ndia, MG, neste mesmo per&iacute;odo, conf
orme <b><a href="#tab4">Tabelas 4</a> </b>e<b> <a href="#tab5">5</a></b>.</font>
</p>     ^cY#aop12-11.htm##
01242000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704099500088002001301083#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#102#98#article#182#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">No ano de 2008, foram id
entificados nos exames sorol&oacute;gicos humanos, pacientes positivos para lept
ospirose, reagentes a v&aacute;rios sorovares, incluindo o sorovar Tarassovi (<b
><a href="#tab4">Tabelas 4</a> </b>e<b> <a href="#tab5">5</a></b>), o qual foi o
 segundo sorovar mais prevalente na popula&ccedil;&atilde;o canina avaliada. A o
corr&ecirc;ncia deste sorovar pode estar relacionada com uma fonte de infec&cced
il;&atilde;o comum as duas esp&eacute;cies. Discute-se a hip&oacute;tese de que 
o c&atilde;o possa ser a fonte de infec&ccedil;&atilde;o para o ser humano. Entr
e os animais dom&eacute;sticos, em ambiente urbano, a principal fonte de infec&c
cedil;&atilde;o da leptospirose humana s&atilde;o os c&atilde;es. Esses animais 
vivem em contato direto com os seres humanos e podem eliminar leptospiras vivas 
pela urina durante meses, mesmo sem apresentar nenhum sinal cl&iacute;nico<sup>2
5</sup>.</font></p>     ^cY#aop12-11.htm##
01457000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704121000088002001301298#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#103#99#article#182#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">H&aacute; ind&iacute;cio
s que o c&atilde;o tem potencial de ser hospedeiro de manuten&ccedil;&atilde;o p
ara a esp&eacute;cie humana, mediante a realiza&ccedil;&atilde;o do primeiro est
udo<sup>26</sup> que explorou a detec&ccedil;&atilde;o molecular do sorovar Wolf
fii em ambos hospedeiros humanos e animais (c&atilde;es e ovinos) e determinaram
 que o fragmento amplificado foi 100% semelhante nas esp&eacute;cies estudadas e
videnciando que estes animais hospedeiros inclusive a esp&eacute;cie canina pode
m ter o sorovar Wolffii circulando e sendo transmitido ao ser humano. Por&eacute
;m, diferentemente da pesquisa realizada na Argentina<sup>27</sup> que determino
u as caracter&iacute;sticas cl&iacute;nicas e os fatores de risco para a leptosp
irose humana e n&atilde;o encontrou uma correla&ccedil;&atilde;o significativa d
a ocorr&ecirc;ncia da doen&ccedil;a em humanos com a presen&ccedil;a de c&atilde
;es. No entanto, apontou como vari&aacute;veis significantes, idade maior que 30
 anos, ocupa&ccedil;&atilde;o no setor rural, contato com &aacute;gua de superf&
iacute;cie contaminada e contato com inunda&ccedil;&otilde;es. </font></p>     ^
cY#aop12-11.htm##
00581000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704033300089002001300422#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#104#100#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">As &aacute;reas de maio
r risco de leptospirose em c&atilde;es na Cidade de Belo Horizonte, MG, coincidi
ram com as regi&otilde;es de vila, favelas e bairros da periferia, os quais poss
u&iacute;am defici&ecirc;ncia de saneamento ambiental<sup>3</sup>. </font></p>  
   ^cY#aop12-11.htm##
00923000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704067500089002001300764#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#105#101#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">As &aacute;reas perif&e
acute;ricas de Uberl&acirc;ndia localizam-se na regi&atilde;o leste do munic&iac
ute;pio, consideradas &aacute;reas de invas&atilde;o e que, atualmente, se emanc
iparam como bairros, como Dom Almir, Prosperidade, Joana Darc e S&atilde;o Franc
isco, no entorno do bairro Morumbi, e apresentam caracter&iacute;sticas de assen
tamentos urbanos com loteamentos irregulares, condi&ccedil;&otilde;es insalubres
 com infraestrutura prec&aacute;ria, falta de saneamento e urbaniza&ccedil;&atil
de;o inadequada, o que ocasiona grandes impactos para a sa&uacute;de humana<sup>
28</sup>.</font></p>     ^cY#aop12-11.htm##
00865000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704061700089002001300706#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#106#102#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">No presente estudo, o d
istrito sanit&aacute;rio leste tamb&eacute;m foi o que apresentou maior percentu
al de c&atilde;es reagentes contra <i>Leptospira</i> spp. Neste local, observara
m-se, em maiores propor&ccedil;&otilde;es, conglomerados de &aacute;reas perif&e
acute;ricas e bairros com d&eacute;ficits infraestruturais, com defici&ecirc;nci
a no saneamento b&aacute;sico de &aacute;gua e esgoto. O bairro Tibery localizad
o neste distrito apresentou seis c&atilde;es reagentes, sendo o bairro com maior
 ocorr&ecirc;ncia deste estudo.</font></p>     ^cY#aop12-11.htm##
00896000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704064800089002001300737#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#107#103#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Vale salientar que os c
&atilde;es deste estudo eram domiciliados e n&atilde;o apresentavam sintomatolog
ia cl&iacute;nica da doen&ccedil;a e que provavelmente albergavam a bact&eacute;
ria de forma assintom&aacute;tica, servindo como reservat&oacute;rios da doen&cc
edil;a, podendo infectar o ser humano e manter a cadeia epidemiol&oacute;gica do
 agente. Fatos importantes sob o ponto de vista epidemiol&oacute;gico, pois atua
lmente o c&atilde;o de estima&ccedil;&atilde;o j&aacute; representa um membro de
 grande n&uacute;mero de fam&iacute;lias do Brasil e do mundo.</font></p>     ^c
Y#aop12-11.htm##
00924000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704067600089002001300765#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#108#104#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Uma ocorr&ecirc;ncia de
 28,4% de c&atilde;es reagentes foi detectada em c&atilde;es domiciliados do mun
ic&iacute;pio de Uberl&acirc;ndia, MG. Os sorovares mais frequentes nos c&atilde
;es foram o Autumnalis (34,2%) seguido por Tarassovi (23,7%), sendo este, tamb&e
acute;m detectado em humanos em 2008. O distrito sanit&aacute;rio leste apresent
ou em maior n&uacute;mero de c&atilde;es regentes contra <i>Leptospira</i> spp. 
Novos estudos com maior casu&iacute;stica de casos humanos devem ser realizados 
para determinar a correla&ccedil;&atilde;o existente entre a leptospirose canina
 e humana.</font></p>     ^cY#aop12-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#109#105#article#182#<p>&nb
sp;</p>     ^cY#aop12-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010400089002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#110#106#article#182#<p><fo
nt size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>AGRADECIMENTOS</b></
font></p>     ^cY#aop12-11.htm##
00653000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704040500089002001300494#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#111#107#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">A todos da Prefeitura M
unicipal e ao Centro de Controle de Zoonoses de Uberl&acirc;ndia, MG que gentilm
ente nos receberam e forneceram dados essenciais e aos t&eacute;cnicos do Labora
t&oacute;rio de Doen&ccedil;as Infecto-contagiosas da Faculdade de Medicina Vete
rin&aacute;ria da Universidade Federal de Uberl&acirc;ndia.</font></p>     ^cY#a
op12-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#112#108#article#182#<p>&nb
sp;</p>     ^cY#aop12-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704011100089002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#113#109#article#182#<p><fo
nt size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLITO DE INTERESS
E</b></font></p>     ^cY#aop12-11.htm##
00434000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018600089002001300275#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#114#110#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Os autores declaram n&a
tilde;o haver nenhum tipo de conflito de interesse no desenvolvimento do estudo.
</font></p>     ^cY#aop12-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#115#111#article#182#<p>&nb
sp;</p>     ^cY#aop12-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010800089002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#116#112#article#182#<p><fo
nt size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>SUPORTE FINANCEIRO</
b></font></p>     ^cY#aop12-11.htm##
00427000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704017900089002001300268#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#117#113#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Coordena&ccedil;&atilde
;o de Aperfei&ccedil;oamento de Pessoal de N&iacute;vel Superior (CAPES).</font>
</p>     ^cY#aop12-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#118#114#article#182#<p>&nb
sp;</p>     ^cY#aop12-11.htm##
00355000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010700089002001300196#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#119#115#article#182#<p><fo
nt size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b
></font></p>     ^cY#aop12-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704031600091002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#120#116#articl
e#182#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1.	Batist
a CSA, Azevedo SS, Alves CJ, Vasconcellos AS, Morais M, Clementino IJ, et al. So
ropreval&ecirc;ncia de leptospirose em c&atilde;es errantes da cidade de Patos, 
 Estado da Para&iacute;ba, Brasil. Braz J Vet Res Anim Sci 2004; 41:131-136.    
^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#121#117#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704023800091002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#122#118#articl
e#182#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2.	Ribeir
o MG, Beloni SN, Langoni H, Silva AV. Leptospirose canina. Boletim T&eacute;cnic
o. Campinas: Departamento T&eacute;cnico Fort Dodge Sa&uacute;de Animal; 2003.  
  ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#123#119#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00592000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704033000091002001300421#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#124#120#articl
e#182#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3.	Magalh
&atilde;es DF, Silva J&Aacute;, Moreira EC, Wilke VML, Haddad JPA, Meneses JNC. 
Preval&ecirc;ncia de aglutininas anti-<i>Leptospira interrogans</i> em c&atilde;
es de Belo Horizonte, Minas Gerais, 2001 a 2002. Arq Bras Med Vet Zootec 2006; 5
8:167-174.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#125#121#article#182#</font
></p>     ^cY#aop12-11.htm##
00640000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704037800091002001300469#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#126#122#articl
e#182#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4.	Jaszcz
erski DCFC. Cin&eacute;tica da resposta imune humoral em c&atilde;es imunizados 
com <i>Leptospira interrogans </i>sorovares icterohaemorragiae, canicola, pomona
 e grippotyphosa. &#91;Disserta&ccedil;&atilde;o Mestrado&#93;. &#91;Curitiba (P
R)&#93;: Universidade Federal do Paran&aacute;; 2005. 82p.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#127#123#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00454000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704019200091002001300283#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#128#124#articl
e#182#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5.	Brown 
K, Prescott J. Leptospirosis in the family dogs: a public health perspective. Ca
n Med Assoc J 2008; 178:399-401.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#129#125#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00454000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704019200091002001300283#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#130#126#articl
e#182#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6.	Mello 
LPP, Manhoso FFR. Aspectos epidemiol&oacute;gicos da leptospirose canina no Bras
il. Unimar Cienc 2007; 16:27-32.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#131#127#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00435000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704017300091002001300264#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#132#128#articl
e#182#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7.	Boecha
t JUD, Machado JP. Preval&ecirc;ncia da leptospirose canina no Brasil. Vet Ser 2
004; 1:40-47.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#133#129#article#182#</font
></p>     ^cY#aop12-11.htm##
00498000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704023600091002001300327#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#134#130#articl
e#182#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8.	Suepau
l SM, Carrington CVF, Campbell M, Borde G,  Adesiyun AA. Serovars of <i>Leptospi
ra </i>isolated from dogs and rodents. Epidemiol Infect 2010; 138:1059-1070.    
^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#135#131#article#182#</font
></p>     ^cY#aop12-11.htm##
00641000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704037900091002001300470#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#136#132#articl
e#182#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9.	Possas
 CA. Urbaniza&ccedil;&atilde;o, ecologia e emerg&ecirc;ncia de formas graves da 
leptospirose: an&aacute;lise comparativa de dados secund&aacute;rios nacionais. 
Rio de Janeiro: Anais do evento comemorativo do centen&aacute;rio do Instituto O
swaldo Cruz e da Funda&ccedil;&atilde;o Oswaldo Cruz; 2000.    ^cY#aop12-11.htm#
#
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#137#133#article#182#</font
></p>     ^cY#aop12-11.htm##
00553000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029000092002001300382#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#138#134#articl
e#182#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10.	Sark
ar V, Nascimento SF, Barbosa R, Martins R, Nuevo H, Kalafanos I, et al. Populati
on-Based Case-control investigation of risk factors for leptospirosis during in 
Urban Epidemic. Am J Trop Med Hyg 2002; 66:605-610.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#139#135#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031500092002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#140#136#articl
e#182#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11.	Bati
sta CSA, Alves CJ, Azevedo SS, Vasconcellos AS, Morais ZM, Clememtino IJ, et al.
 Soropreval&ecirc;ncia e fatores de risco para a leptospirose em c&atilde;es de 
   Campina Grande, Para&iacute;ba. Arq Bras Med Vet Zootec 2005; 57:179-185.    
^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#141#137#article#182#</font
></p>     ^cY#aop12-11.htm##
00576000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031300092002001300405#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#142#138#articl
e#182#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12.	Ghne
im GS, Viers JH, Chomel BB, Kass PH, Descollonges DA, Johnson ML. Use of a case-
control study and geographic information systems to determine environmental and 
demographic risk factors for canine leptospirosis. Vet Res 2007; 38:37-50.    ^c
Y#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#143#139#article#182#</font
></p>     ^cY#aop12-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031500092002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#144#140#articl
e#182#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13.	Oliv
eira ST. Leptospirose canina: dados cl&iacute;nicos, laboratoriais e terap&ecirc
;uticos em c&atilde;es naturalmente infectados. &#91;Tese Doutorado&#93;. &#91;P
orto Alegre (RS)&#93;: Universidade Federal do Rio Grande do Sul; 2010. 89p.    
^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#145#141#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00454000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019100092002001300283#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#146#142#articl
e#182#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14.	Oliv
eira DSC, Guimar&atilde;es MJB, Medeiros Z. Modelo produtivo para a leptospirose
. Rev Patol Trop 2009; 38:17-26.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#147#143#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024900092002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#148#144#articl
e#182#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15.	Brit
o J, Prudente TD. Mapeamento do uso da terra e cobertura vegetal do munic&iacute
;pio de Uberl&acirc;ndia-MG, utilizando imagens ccd/cbers2. Cam Geogr    2005; 1
3:144-153.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#149#145#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00629000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036600092002001300458#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#150#146#articl
e#182#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16.	Mini
st&eacute;rio da Sa&uacute;de. Manual de Leptospirose. 2ª ed. rev. Bras&iacute;l
ia: Funda&ccedil;&atilde;o Nacional de Sa&uacute;de. Centro Nacional de Epidemio
logia. Coordena&ccedil;&atilde;o de Controle de Zoonoses e Animais Pe&ccedil;onh
entos. Programa Nacional de Leptospirose; 1995.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#151#147#article#182#</font
></p>     ^cY#aop12-11.htm##
00503000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024000092002001300332#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#152#148#articl
e#182#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17.	Barw
ick RS, Mohammed HO, Mcdonough PL, White ME. Epidemiologic features of equine<i>
 Leptospira interrogans </i>of human significance. Prev Vet Med 1998; 36:153-165
.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#153#149#article#182#</font
></p>     ^cY#aop12-11.htm##
00631000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036800092002001300460#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#154#150#articl
e#182#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18.	Silv
a WB, Sim&otilde;es LB, Lopes ALS, Padovani CR, Langoni H, Modolo JR. Avalia&cce
dil;&atilde;o de fatores de risco de c&atilde;es sororeagentes &agrave; <i>Lepto
spira </i>sppesuadistribui&ccedil;&atilde;oespacial, em &aacute;rea territorial 
urbana. Braz J Vet Res Anim Sci 2006; 43:783-792.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#155#151#article#182#</font
></p>     ^cY#aop12-11.htm##
00601000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033800092002001300430#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#156#152#articl
e#182#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19.	&Aac
ute;vila MO, Furtado LRI, Teixeira MM, Rosado RLI, Martins LFS, Brod CS. Aglutin
inas anti-leptosp&iacute;ricas em c&atilde;es na &aacute;rea de influencia do Ce
ntro de Controle de Zoonoses, Pelotas, RS, Brasil, no ano de 1995. Cienc Rural 1
998; 28:   107-110.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#157#153#article#182#</font
></p>     ^cY#aop12-11.htm##
00549000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028600092002001300378#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#158#154#articl
e#182#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20.	Quer
ino AMV, Delbem ACB, Oliveira RC, Silva FG, Muller EE, Freire RL, et al. Fatores
 de risco associados &agrave; leptospirose em c&atilde;es do munic&iacute;pio de
 Londrina-PR. Semin Cienc Agrar 2003; 24:27-34.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#159#155#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00664000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704040100092002001300493#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#160#156#articl
e#182#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21.	Agui
ar DM, Cavalcante GT, Marvulo MFV, Silva JCR, Pinter A, Vanconcellos SA,    et a
l. Fatores de risco associados &agrave; ocorr&ecirc;ncia de anticorpos anti-<i>L
eptospira</i> spp. Em c&atilde;es do munic&iacute;pio de Monte Negro, Rond&ocirc
;nia, Amaz&ocirc;nia Ocidental Brasileira. Arq Bras Med Vet Zootec 2007; 59:70-7
6.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#161#157#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00579000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031600092002001300408#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#162#158#articl
e#182#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22.	Figu
eiredo CM, Mour&atilde;o AC, Oliveira MAA, Alves WR, Ooteman MC, Chamone CB, et 
al. Leptospirose humana no munic&iacute;pio de Belo Horizonte, Minas Gerais, Bra
sil: uma abordagem geogr&aacute;fica. Rev Soc Bras Med Trop 2001; 34:331-338.   
 ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#163#159#article#182#</font
></p>     ^cY#aop12-11.htm##
00669000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704040600092002001300498#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#164#160#articl
e#182#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23.	Masc
olli R, Pinheiro SR, Vasconcellos AS, Ferreira F, Morais ZM, Pinto CO, et al. In
qu&eacute;rito sorol&oacute;gico para leptospirose em c&atilde;es do munic&iacut
e;pio de Santana de Para&iacute;ba, S&atilde;o Paulo, utilizando a campanha de v
acina&ccedil;&atilde;o anti-r&aacute;bica do ano de 1999. Arq Inst Biol 2002; 69
:25-32.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#165#161#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00599000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033600092002001300428#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#166#162#articl
e#182#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24.	Lope
s ALS, Silva WB, Padovani CR, Langoni H, Modolo JR. Frequ&ecirc;ncia sorol&oacut
e;gica antileptosp&iacute;rica em c&atilde;es: sua correla&ccedil;&atilde;o com 
roedores e fatores ambientais, em &aacute;rea territorial urbana. Arq Inst Biol 
2005; 72:289-296.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#167#163#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00444000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018100092002001300273#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#168#164#articl
e#182#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25.	Fain
e S, Adler B, Bolin C, Perolat P. <i>Leptospira</i> and leptospirosis. 2ª ed. Me
lbourne: MedSci; 1999.    ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#169#165#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00559000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029600092002001300388#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#170#166#articl
e#182#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26.	Zake
ri S, Khorami N, Ganji ZF, Sepahian N, Malmasi AA, Gouya MM, et al. <i>Leptospir
a wolffii</i>, a potential new pathogenic <i>Leptospira</i> species detected in 
human, sheep and dog. Infect Genet Evol 2010; 10:273-277.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#171#167#article#182#</font
></p>     ^cY#aop12-11.htm##
00534000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027100092002001300363#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#172#168#articl
e#182#27#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27.	Vana
sco NB, Schmeling MF, Lottersberger J, Costa F, Ko AI, Tarabla HD.    Clinical c
haracteristics and risk factors of human leptospirosis in Argentina (1999-2005).
 Acta Tropica 2008; 107:255-258.    ^cY#aop12-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#173#169#article#182#</font
></p>     ^cY#aop12-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023700092002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#174#170#articl
e#182#28#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28.	Rami
res JCL, Santos MAF. Exclus&atilde;o social em Uberl&acirc;ndia: algumas reflex&
otilde;es a partir do bairro Dom Almir e seu entorno. Cam Geogr 2001; 2:73-87.  
  ^cY#aop12-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#175#171#article#182# </fon
t></p>     ^cY#aop12-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#176#172#article#182#<p>&nb
sp;</p>     ^cY#aop12-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#177#173#article#182#<p>&nb
sp;</p>     ^cY#aop12-11.htm##
00471000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704022300089002001300312#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#178#174#article#182#<p><a 
name="endb"></a><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a h
ref="#enda"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a><b
> Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#aop12-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#179#175#article#182#<br>  
 Ms. Jacqueline Ribeiro de Castro    ^cY#aop12-11.htm##
00314000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006600089002001300155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#180#176#article#182#<br>  
 Lab. de Doen&ccedil;as Infectocontagiosas/FAMEV/UFU    ^cY#aop12-11.htm##
00320000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007200089002001300161#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#181#177#article#182#<br>  
 Av. Cear&aacute; s/nº, Bloco 2D, Sala 33, Campus Umuarama    ^cY#aop12-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004600089002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#182#178#article#182#<br>  
 38400-902 Uberl&acirc;ndia, MG     ^cY#aop12-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005700089002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#183#179#article#182#<br>  
 Tel: 55 34 3218-2231; Fax: 55 34 3218-2612    ^cY#aop12-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009900089002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#184#180#article#182#<br>  
 e-mail: <a href="mailto:jack_ufu@yahoo.com.br">jack_ufu@yahoo.com.br</a></font>
</p>     ^cY#aop12-11.htm##
00371000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704012300089002001300212#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#185#181#article#182#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Recebido para publica&c
cedil;&atilde;o em 30/08/2010    ^cY#aop12-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#p#186#182#article#182#<br>  
 Aceito em 16/11/2010</font></p>     ^cY#aop12-11.htm##
00705000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100018001070100
01600125010002300141010001600164010002100180810000600201012009900207030002400306
71000020033006500090033206400050034103100030034601400080034986500090035700200130
0366#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#187#1#
article#28#1#^rND^sBatista^nCSA#^rND^sAzevedo^nSS#^rND^sAlves^nCJ#^rND^sVasconce
llos^nAS#^rND^sMorais^nM#^rND^sClementino^nIJ#et al#Soroprevalência de leptospir
ose em cães errantes da cidade de Patos, Estado da Paraíba, Brasil^lpt#Braz J Ve
t Res Anim Sci#2#20040000#2004#41#131-136#20110000#aop12-11.htm##
00564000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160018000880160017001060160
01700123016001600140018002400156025001600180066000900196062004500205065000900250
064000500259865000900264002001300273#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop12-11.htm#S#c#188#2#article#28#2#^rND^sRibeiro^nMG#^rND^sBeloni^nSN#
^rND^sLangoni^nH#^rND^sSilva^nAV#Leptospirose canina^lpt#Boletim Técnico#Campina
s#Departamento Técnico Fort Dodge Saúde Animal#20030000#2003#20110000#aop12-11.h
tm##
00695000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100016001080100
01800124010001700142010001800159010001900177012011200196030002400308710000200332
065000900334064000500343031000300348014000800351865000900359002001300368#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#189#3#article#28#3
#^rND^sMagalhães^nDF#^rND^sSilva^nJÁ#^rND^sMoreira^nEC#^rND^sWilke^nVML#^rND^sHa
ddad^nJPA#^rND^sMeneses^nJNC#Prevalência de aglutininas anti-Leptospira interrog
ans em cães de Belo Horizonte, Minas Gerais, 2001 a 2002^lpt#Arq Bras Med Vet Zo
otec#2#20060000#2006#58#167-174#20110000#aop12-11.htm##
00606000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160024000880180148001120510
00900260046001300269062003100282065000900313064000500322020000300327865000900330
002001300339#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#
c#190#4#article#28#4#^rND^sJaszczerski^nDCFC#Cinética da resposta imune humoral 
em cães imunizados com Leptospira interrogans sorovares icterohaemorragiae, cani
cola, pomona e grippotyphosa^lpt#Mestrado#Curitiba^ePR#Universidade Federal do P
araná#20050000#2005#82#20110000#aop12-11.htm##
00555000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100018001030120
06600121030001600187065000900203064000500212031000400217014000800221865000900229
002001300238035001000251801001600261#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop12-11.htm#S#c#191#5#article#28#5#^rND^sBrown^nK#^rND^sPrescott^nJ#Le
ptospirosis in the family dogs: a public health perspective^len#Can Med Assoc J#
20080000#2008#178#399-401#20110000#aop12-11.htm#0008-4409#Can Med Assoc J##
00512000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100019001050120
06200124030001300186710000200199065000900201064000500210031000300215014000600218
865000900224002001300233#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
12-11.htm#S#c#192#6#article#28#6#^rND^sMello^nLPP#^rND^sManhoso^nFFR#Aspectos ep
idemiológicos da leptospirose canina no Brasil^lpt#Unimar Cienc#2#20070000#2007#
16#27-32#20110000#aop12-11.htm##
00494000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100018001070120
04900125030000800174710000200182065000900184064000500193031000200198014000600200
865000900206002001300215#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
12-11.htm#S#c#193#7#article#28#7#^rND^sBoechat^nJUD#^rND^sMachado^nJP#Prevalênci
a da leptospirose canina no Brasil^lpt#Vet Ser#2#20040000#2004#1#40-47#20110000#
aop12-11.htm##
00646000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100022001060100
01800128010001500146010001900161012005800180030001700238065000900255064000500264
031000400269014001000273865000900283002001300292035001000305801001700315#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#194#8#article#28#8
#^rND^sSuepaul^nSM#^rND^sCarrington^nCVF#^rND^sCampbell^nM#^rND^sBorde^nG#^rND^s
Adesiyun^nAA#Serovars of Leptospira isolated from dogs and rodents^len#Epidemiol
 Infect#20100000#2010#138#1059-1070#20110000#aop12-11.htm#0950-2688#Epidemiol In
fect##
00606000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160017000880180124001050660
01500229025009600244065000900340064000500349865000900354002001300363#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#195#9#article#28#9#^rN
D^sPossas^nCA#Urbanização, ecologia e emergência de formas graves da leptospiros
e: análise comparativa de dados secundários nacionais^lpt#Rio de Janeiro#Anais d
o evento comemorativo do centenário do Instituto Oswaldo Cruz e da Fundação Oswa
ldo Cruz#20000000#2000#20110000#aop12-11.htm##
00739000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100021001060100
01700127010001700144010001500161010001900176810000600195012010700201030001800308
06500090032606400050033503100030034001400080034386500090035100200130036003500100
0373801001800383#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.ht
m#S#c#196#10#article#28#10#^rND^sSarkar^nV#^rND^sNascimento^nSF#^rND^sBarbosa^nR
#^rND^sMartins^nR#^rND^sNuevo^nH#^rND^sKalafanos^nI#et al#Population-Based Case-
control investigation of risk factors for leptospirosis during in Urban Epidemic
^len#Am J Trop Med Hyg#20020000#2002#66#605-610#20110000#aop12-11.htm#0002-9637#
Am J Trop Med Hyg##
00703000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
01800125010002300143010001700166010002100183810000600204012009400210030002400304
71000020032806500090033006400050033903100030034401400080034786500090035500200130
0364#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#197#11
#article#28#11#^rND^sBatista^nCSA#^rND^sAlves^nCJ#^rND^sAzevedo^nSS#^rND^sVascon
cellos^nAS#^rND^sMorais^nZM#^rND^sClememtino^nIJ#et al#Soroprevalência e fatores
 de risco para a leptospirose em cães de Campina Grande, Paraíba^lpt#Arq Bras Me
d Vet Zootec#2#20050000#2005#57#179-185#20110000#aop12-11.htm##
00741000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01700123010001500140010002300155010001800178012014800196030000800344065000900352
06400050036103100030036601400060036986500090037500200130038403500100039780100080
0407#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#198#12
#article#28#12#^rND^sGhneim^nGS#^rND^sViers^nJH#^rND^sChomel^nBB#^rND^sKass^nPH#
^rND^sDescollonges^nDA#^rND^sJohnson^nML#Use of a case-control study and geograp
hic information systems to determine environmental and demographic risk factors 
for canine leptospirosis^len#Vet Res#20070000#2007#38#37-50#20110000#aop12-11.ht
m#0928-4249#Vet Res##
00573000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160019000900180102001090510
01000211046001700221062004200238065000900280064000500289020000300294865000900297
002001300306#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#
c#199#13#article#28#13#^rND^sOliveira^nST#Leptospirose canina: dados clínicos, l
aboratoriais e terapêuticos em cães naturalmente infectados^lpt#Doutorado#Porto 
Alegre^eRS#Universidade Federal do Rio Grande do Sul#20100000#2010#89#20110000#a
op12-11.htm##
00565000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100021001100100
01800131012004100149030001500190065000900205064000500214031000300219014000600222
865000900228002001300237035001000250801001500260#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop12-11.htm#S#c#200#14#article#28#14#^rND^sOliveira^nDSC#^
rND^sGuimarães^nMJB#^rND^sMedeiros^nZ#Modelo produtivo para a leptospirose^lpt#R
ev Patol Trop#20090000#2009#38#17-26#20110000#aop12-11.htm#0301-0406#Rev Patol T
rop##
00561000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100019001050120
11200124030001000236710000200246065000900248064000500257031000300262014000800265
865000900273002001300282#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
12-11.htm#S#c#201#15#article#28#15#^rND^sBrito^nJ#^rND^sPrudente^nTD#Mapeamento 
do uso da terra e cobertura vegetal do município de Uberlândia-MG, utilizando im
agens ccd/cbers2^lpt#Cam Geogr#2#20050000#2005#13#144-153#20110000#aop12-11.htm#
#
00614000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170020000900180027001100630
00200137066000900139062002700148062003300175062005800208062003400266065000900300
064000500309865000900314002001300323#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop12-11.htm#S#c#202#16#article#28#16#Ministério da Saúde#Manual de Lep
tospirose^lpt#2#Brasília#Fundação Nacional de Saúde#Centro Nacional de Epidemiol
ogia#Coordenação de Controle de Zoonoses e Animais Peçonhentos#Programa Nacional
 de Leptospirose#19950000#1995#20110000#aop12-11.htm##
00630000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100019001080100
02000127010001600147012008200163030001300245065000900258064000500267031000300272
014000800275865000900283002001300292035001000305801001300315#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#203#17#article#28#17#^rND^sBar
wick^nRS#^rND^sMohammed^nHO#^rND^sMcdonough^nPL#^rND^sWhite^nME#Epidemiologic fe
atures of equine Leptospira interrogans of human significance^len#Prev Vet Med#1
9980000#1998#36#153-165#20110000#aop12-11.htm#0167-5877#Prev Vet Med##
00705000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01700123010001900140010001700159010001700176012012500193030002400318710000200342
065000900344064000500353031000300358014000800361865000900369002001300378#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#204#18#article#28#
18#^rND^sSilva^nWB#^rND^sSimões^nLB#^rND^sLopes^nALS#^rND^sPadovani^nCR#^rND^sLa
ngoni^nH#^rND^sModolo^nJR#Avaliação de fatores de risco de cães sororeagentes à 
Leptospira sppesuadistribuiçãoespacial, em área territorial urbana^lpt#Braz J Ve
t Res Anim Sci#2#20060000#2006#43#783-792#20110000#aop12-11.htm##
00707000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01900125010001800144010001900162010001500181012013600196030001200332710000200344
065000900346064000500355031000300360014000800363865000900371002001300380#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#205#19#article#28#
19#^rND^sÁvila^nMO#^rND^sFurtado^nLRI#^rND^sTeixeira^nMM#^rND^sRosado^nRLI#^rND^
sMartins^nLFS#^rND^sBrod^nCS#Aglutininas anti-leptospíricas em cães na área de i
nfluencia do Centro de Controle de Zoonoses, Pelotas, RS, Brasil, no ano de 1995
^lpt#Cienc Rural#2#19980000#1998#28#107-110#20110000#aop12-11.htm##
00676000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090100
01900127010001600146010001700162010001700179810000600196012008300202030001800285
71000020030306500090030506400050031403100030031901400060032286500090032800200130
0337#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#206#20
#article#28#20#^rND^sQuerino^nAMV#^rND^sDelbem^nACB#^rND^sOliveira^nRC#^rND^sSil
va^nFG#^rND^sMuller^nEE#^rND^sFreire^nRL#et al#Fatores de risco associados à lep
tospirose em cães do município de Londrina-PR^lpt#Semin Cienc Agrar#2#20030000#2
003#24#27-34#20110000#aop12-11.htm##
00763000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100021001070100
01900128010001700147010001600164010002300180810000600203012015700209030002400366
71000020039006500090039206400050040103100030040601400060040986500090041500200130
0424#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#207#21
#article#28#21#^rND^sAguiar^nDM#^rND^sCavalcante^nGT#^rND^sMarvulo^nMFV#^rND^sSi
lva^nJCR#^rND^sPinter^nA#^rND^sVanconcellos^nSA#et al#Fatores de risco associado
s à ocorrência de anticorpos anti-Leptospira spp: Em cães do município de Monte 
Negro, Rondônia, Amazônia Ocidental Brasileira^lpt#Arq Bras Med Vet Zootec#2#200
70000#2007#59#70-76#20110000#aop12-11.htm##
00748000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100017001110100
02000128010001600148010001800164010001800182810000600200012010300206030002200309
06500090033106400050034003100030034501400080034886500090035600200130036503500100
0378801002200388#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.ht
m#S#c#208#22#article#28#22#^rND^sFigueiredo^nCM#^rND^sMourão^nAC#^rND^sOliveira^
nMAA#^rND^sAlves^nWR#^rND^sOoteman^nMC#^rND^sChamone^nCB#et al#Leptospirose huma
na no município de Belo Horizonte, Minas Gerais, Brasil: uma abordagem geográfic
a^lpt#Rev Soc Bras Med Trop#20010000#2001#34#331-338#20110000#aop12-11.htm#0037-
8682#Rev Soc Bras Med Trop##
00754000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100019001080100
02300127010001800150010001700168010001600185810000600201012016000207030001400367
71000020038106500090038306400050039203100030039701400060040086500090040600200130
0415#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#209#23
#article#28#23#^rND^sMascolli^nR#^rND^sPinheiro^nSR#^rND^sVasconcellos^nAS#^rND^
sFerreira^nF#^rND^sMorais^nZM#^rND^sPinto^nCO#et al#Inquérito sorológico para le
ptospirose em cães do município de Santana de Paraíba, São Paulo, utilizando a c
ampanha de vacinação anti-rábica do ano de 1999^lpt#Arq Inst Biol#2#20020000#200
2#69#25-32#20110000#aop12-11.htm##
00670000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01900123010001700142010001700159012012900176030001400305710000200319065000900321
064000500330031000300335014000800338865000900346002001300355#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#210#24#article#28#24#^rND^sLop
es^nALS#^rND^sSilva^nWB#^rND^sPadovani^nCR#^rND^sLangoni^nH#^rND^sModolo^nJR#Fre
quência sorológica antileptospírica em cães: sua correlação com roedores e fator
es ambientais, em área territorial urbana^lpt#Arq Inst Biol#2#20050000#2005#72#2
89-296#20110000#aop12-11.htm##
00518000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160015000900160015001050160
01500120016001700135018003300152063000200185066001000187062000700197065000900204
064000500213865000900218002001300227#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop12-11.htm#S#c#211#25#article#28#25#^rND^sFaine^nS#^rND^sAdler^nB#^rN
D^sBolin^nC#^rND^sPerolat^nP#Leptospira and leptospirosis^len#2#Melbourne#MedSci
#19990000#1999#20110000#aop12-11.htm##
00693000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01600123010001800139010001800157010001600175810000600191012010300197030001800300
71000020031806500090032006400050032903100030033401400080033786500090034500200130
0354#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#212#26
#article#28#26#^rND^sZakeri^nS#^rND^sKhorami^nN#^rND^sGanji^nZF#^rND^sSepahian^n
N#^rND^sMalmasi^nAA#^rND^sGouya^nMM#et al#Leptospira wolffii, a potential new pa
thogenic Leptospira species detected in human, sheep and dog^len#Infect Genet Ev
ol#2#20100000#2010#10#273-277#20110000#aop12-11.htm##
00701000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100020001080100
02300128010001500151010001300166010001800179012009400197030001300291065000900304
06400050031303100040031801400080032286500090033000200130033903500100035280100130
0362#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop12-11.htm#S#c#213#27
#article#28#27#^rND^sVanasco^nNB#^rND^sSchmeling^nMF#^rND^sLottersberger^nJ#^rND
^sCosta^nF#^rND^sKo^nAI#^rND^sTarabla^nHD#Clinical characteristics and risk fact
ors of human leptospirosis in Argentina (1999-2005)^len#Acta Tropica#20080000#20
08#107#255-258#20110000#aop12-11.htm#0001-706X#Acta Tropica##
00545000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090120
09600127030001000223710000200233065000900235064000500244031000200249014000600251
865000900257002001300266#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
12-11.htm#S#c#214#28#article#28#28#^rND^sRamires^nJCL#^rND^sSantos^nMAF#Exclusão
 social em Uberlândia: algumas reflexões a partir do bairro Dom Almir e seu ento
rno^lpt#Cam Geogr#2#20010000#2001#2#73-87#20110000#aop12-11.htm##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#o#1#
1#article#1#20110325#103649#aop13-11.htm#162##
04125000000000649000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400090016103500100017022300090018001201520
01890120148003410100037004890100026005260100051005520100039006030700084006420700
08600726070007500812083098600887085000801873085002101881085003301902085003501935
08500260197008312920199608500080328808500210329608500350331708500350335208500260
33871170006034130720003034191120009034221110011034311140009034421130011034510020
01303462#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#h#2#
1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#15#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead
#20110000#^f12^l16#0037-8682#20110401#Occurrence and the susceptibility to antim
icrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary ho
spital in southern Brazil^len#Ocorrência e perfil de sensibilidade a antimicrobi
anos em Pseudomonas aeruginosa e Acinetobacter sp. em um hospital terciário, no 
sul do Brasil^lpt#^rND^1A01^nGabriele Mariani^sMachado#^rND^1A02^nAldalise^sLago
#^rND^1A02 A03^nSérgio Roberto Riccardi^sFuentefria#^rND^1A02 A03^nDaiane Bopp^s
Fuentefria#Universidade de Passo Fundo^iA01^1Instituto de Ciências Biológicas^cP
asso Fundo^sRS#Hospital São Vicente de Paulo^iA02^1Laboratório de Análises Clíni
cas^cPasso Fundo^sRS#Laboratório SANI^iA03^1Serviço de Análises Especializadas^c
Passo Fundo^sRS#^len^aINTRODUCTION: The main mechanism of emerging resistance in
 Pseudomonas aeruginosa and Acinetobacter sp. isolates is the production of meta
llo-&#946;-lactamases (M&#946;Ls). M&#946;Ls are enzymes capable of hydrolyzing 
cephalosporins, penicillins and carbapenems, but not monobactams (aztreonam), wh
ich are often used as antimicrobial therapy to treat nosocomial infections. METH
ODS: An observational descriptive and retrospective study was designed to assess
 the frequency of M&#946;Ls among strains of P. aeruginosa and Acinetobacter sp.
 obtained from a tertiary hospital in southern Brazil. RESULTS: M&#946;L product
ion was observed in 77.6% (n = 173/223) for P. aeruginosa isolates and 22.4% (n 
= 50/223) of Acinetobacter sp. isolates. The Acinetobacter sp. isolates showed 9
2.8% sensitivity to amikacin and P. aeruginosa isolates showed 58.9% sensitivity
 to aztreonam. CONCLUSIONS: The M&#946;L indices determined confirm the global c
oncern with this mechanism of resistance.#^dnd^i1#^tm^len^kM&#946;L^i1#^tm^len^k
Bacterial resistance^i1#^tm^len^kPseudomonas aeruginosa^i1#^tm^len^kAcinetobacte
r^i1#^lpt^aINTRODUÇÃO: O principal mecanismo de resistência entre isolados de Ps
eudomonas aeruginosa e Acinetobacter sp. é a produção de metalo-&#946;-lactamase
s (M&#946;Ls). As M&#946;Ls são enzimas capazes de hidrolisar cefalosporinas, pe
nicilinas e carbapenêmicos, mas não monobactâmicos (aztreonam) antibióticos que 
se encontram entre as principais opções terapêuticas para o tratamento de infecç
ões causadas por bactérias não fermentadoras de glicose. MÉTODOS: Um estudo obse
rvacional, transversal, descritivo e retrospectivo foi desenvolvido para avaliar
 a frequência e o perfil de susceptibilidade cepas de P. aeruginosa e Acinetobac
ter sp. produtoras de M&#946;Ls isoladas no Hospital São Vicente de Paulo, Passo
 Fundo, Brasil. RESULTADOS: A produção de M&#946;Ls foi observada em 77,6% (n = 
173/223) dos isolados de P. aeruginosa e em 22,4% (n = 50/223) dos isolados de A
cinetobacter sp. Dentre as cepas produtoras de M&#946;L, a maioria apresentou ma
is de 90% de resistência a seis antimicrobianos dos 12 testados, enfatizando a r
esistência a ceftazidima, gentamicina, aztreonam, piperaciclina/tazobactam, cefe
pime, ciprofloxacina, meropenem e tobramicina. CONCLUSÕES: Os índices de M&#946;
L encontrados confirmam a preocupação mundial com a disseminação desse mecanismo
 de resistência.#^dnd^i2#^tm^lpt^kM&#946;L^i2#^tm^lpt^kResistência bacteriana^i2
#^tm^lpt^kPseudomonas aeruginosa^i2#^tm^lpt^kAcinetobacter^i2#other#21#20100912#
12/09/2010#20101108#08/11/2010#aop13-11.htm##
04349000000000649000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400090016103500100017022300090018001201730
01890120169003620100037005310100026005680100051005940100039006450700084006840700
08600768070007500854083107000929085000801999085002102007085003302028085004202061
08500330210308313620213608500080349808500210350608500350352708500420356208500330
36041170006036370720003036431120009036461110011036551140009036661130011036750020
01303686#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#f#3#
1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#15#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead
#20110000#^f12^l16#0037-8682#20110401#<b>Occurrence and the susceptibility to an
timicrobial agents in <i>Pseudomonas aeruginosa </i>and<i> Acinetobacter </i>sp.
 at a tertiary hospital in southern Brazil</b>^len#<b>Ocorrência e perfil de sen
sibilidade a antimicrobianos em <i>Pseudomonas aeruginosa </i>e <i>Acinetobacter
 </i>sp. em um hospital terciário, no sul do Brasil</b>^lpt#^rND^1A01^nGabriele 
Mariani^sMachado#^rND^1A02^nAldalise^sLago#^rND^1A02 A03^nSérgio Roberto Riccard
i^sFuentefria#^rND^1A02 A03^nDaiane Bopp^sFuentefria#Universidade de Passo Fundo
^iA01^1Instituto de Ciências Biológicas^cPasso Fundo^sRS#Hospital São Vicente de
 Paulo^iA02^1Laboratório de Análises Clínicas^cPasso Fundo^sRS#Laboratório SANI^
iA03^1Serviço de Análises Especializadas^cPasso Fundo^sRS#^len^a<b>INTRODUCTION:
</b> The main mechanism of emerging resistance in <i>Pseudomonas aeruginosa</i> 
and <i>Acinetobacter</i> sp. isolates is the production of metallo-&#946;-lactam
ases (M&#946;Ls). M&#946;Ls are enzymes capable of hydrolyzing cephalosporins, p
enicillins and carbapenems, but not monobactams (aztreonam), which are often use
d as antimicrobial therapy to treat nosocomial infections. <b>METHODS: </b>An ob
servational descriptive and retrospective study was designed to assess the frequ
ency of M&#946;Ls among strains of <i>P. aeruginosa</i> and <i>Acinetobacter</i>
 sp. obtained from a tertiary hospital in southern Brazil. <b>RESULTS: </b>M&#94
6;L production was observed in 77.6% (n = 173/223) for <i>P. aeruginosa</i> isol
ates and 22.4% (n = 50/223) of <i>Acinetobacter</i> sp. isolates. The <i>Acineto
bacter </i>sp. isolates showed 92.8% sensitivity to amikacin and <i>P. aeruginos
a</i> isolates showed 58.9% sensitivity to aztreonam. <b>CONCLUSIONS: </b>The M&
#946;L indices determined confirm the global concern with this mechanism of resi
stance.#^dnd^i1#^tm^len^kM&#946;L^i1#^tm^len^kBacterial resistance^i1#^tm^len^k<
i>Pseudomonas aeruginosa</i>^i1#^tm^len^k<i>Acinetobacter</i>^i1#^lpt^a<b>INTROD
UÇÃO: </b>O principal mecanismo de resistência entre isolados de <i>Pseudomonas 
aeruginosa </i>e <i>Acinetobacter</i> sp. é a produção de metalo-&#946;-lactamas
es (M&#946;Ls). As M&#946;Ls são enzimas capazes de hidrolisar cefalosporinas, p
enicilinas e carbapenêmicos, mas não monobactâmicos (aztreonam) antibióticos que
 se encontram entre as principais opções terapêuticas para o tratamento de infec
ções causadas por bactérias não fermentadoras de glicose. <b>MÉTODOS: </b>Um est
udo observacional, transversal, descritivo e retrospectivo foi desenvolvido para
 avaliar a frequência e o perfil de susceptibilidade cepas de <i>P. aeruginosa <
/i>e <i>Acinetobacter </i>sp. produtoras de M&#946;Ls isoladas no Hospital São V
icente de Paulo, Passo Fundo, Brasil. <b>RESULTADOS: </b>A produção de M&#946;Ls
 foi observada em 77,6% (n = 173/223) dos isolados de <i>P. aeruginosa</i> e em 
22,4% (n = 50/223) dos isolados de <i>Acinetobacter</i> sp. Dentre as cepas prod
utoras de M&#946;L, a maioria apresentou mais de 90% de resistência a seis antim
icrobianos dos 12 testados, enfatizando a resistência a ceftazidima, gentamicina
, aztreonam, piperaciclina/tazobactam, cefepime, ciprofloxacina, meropenem e tob
ramicina. <b>CONCLUSÕES: </b>Os índices de M&#946;L encontrados confirmam a preo
cupação mundial com a disseminação desse mecanismo de resistência.#^dnd^i2#^tm^l
pt^kM&#946;L^i2#^tm^lpt^kResistência bacteriana^i2#^tm^lpt^k<i>Pseudomonas aerug
inosa</i>^i2#^tm^lpt^k<i>Acinetobacter</i>^i2#other#21#20100912#12/09/2010#20101
108#08/11/2010#aop13-11.htm##
04305000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000500108038000400113121000300117049000300120
15800030012303000260012603200060015206500090015801400090016703500100017622300090
01860120152001950120148003470100037004950100026005320100051005580100039006090700
08600648070008800734070007700822083101400899085000801913085002101921085003301942
08500350197508500260201008313190203608500080335508500210336308500350338408500350
34190850026034541170006034800720003034861120009034891110011034981140009035091130
01103518002001303529008008903542#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop13-11.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab#15#nd#nd#R
ev. Soc. Bras. Med. Trop#ahead#20110000#^f12^l16#0037-8682#20110401#Occurrence a
nd the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acin
etobacter sp. at a tertiary hospital in southern Brazil^len#Ocorrência e perfil 
de sensibilidade a antimicrobianos em Pseudomonas aeruginosa e Acinetobacter sp.
 em um hospital terciário, no sul do Brasil^lpt#^rND^1A01^nGabriele Mariani^sMac
hado#^rND^1A02^nAldalise^sLago#^rND^1A02 A03^nSérgio Roberto Riccardi^sFuentefri
a#^rND^1A02 A03^nDaiane Bopp^sFuentefria#^iA01^1Universidade de Passo Fundo^2Ins
tituto de Ciências Biológicas^cPasso Fundo^sRS#^iA02^1Hospital São Vicente de Pa
ulo^2Laboratório de Análises Clínicas^cPasso Fundo^sRS#^iA03^1Laboratório SANI^2
Serviço de Análises Especializadas^cPasso Fundo^sRS#^len^aINTRODUCTION: The main
 mechanism of emerging resistance in Pseudomonas aeruginosa and Acinetobacter sp
. isolates is the production of metallo-&#946;-lactamases (M&#946;Ls). M&#946;Ls
 are enzymes capable of hydrolyzing cephalosporins, penicillins and carbapenems,
 but not monobactams (aztreonam), which are often used as antimicrobial therapy 
to treat nosocomial infections. METHODS: An observational descriptive and retros
pective study was designed to assess the frequency of M&#946;Ls among strains of
 P. aeruginosa and Acinetobacter sp. obtained from a tertiary hospital in southe
rn Brazil. RESULTS: M&#946;L production was observed in 77.6 percent (n = 173/22
3) for P. aeruginosa isolates and 22.4 percent (n = 50/223) of Acinetobacter sp.
 isolates. The Acinetobacter sp. isolates showed 92.8 percent sensitivity to ami
kacin and P. aeruginosa isolates showed 58.9 percent sensitivity to aztreonam. C
ONCLUSIONS: The M&#946;L indices determined confirm the global concern with this
 mechanism of resistance.#^dnd^i1#^tm^len^kM&#946;L^i1#^tm^len^kBacterial resist
ance^i1#^tm^len^kPseudomonas aeruginosa^i1#^tm^len^kAcinetobacter^i1#^lpt^aINTRO
DUÇÃO: O principal mecanismo de resistência entre isolados de Pseudomonas aerugi
nosa e Acinetobacter sp. é a produção de metalo-&#946;-lactamases (M&#946;Ls). A
s M&#946;Ls são enzimas capazes de hidrolisar cefalosporinas, penicilinas e carb
apenêmicos, mas não monobactâmicos (aztreonam) antibióticos que se encontram ent
re as principais opções terapêuticas para o tratamento de infecções causadas por
 bactérias não fermentadoras de glicose. MÉTODOS: Um estudo observacional, trans
versal, descritivo e retrospectivo foi desenvolvido para avaliar a frequência e 
o perfil de susceptibilidade cepas de P. aeruginosa e Acinetobacter sp. produtor
as de M&#946;Ls isoladas no Hospital São Vicente de Paulo, Passo Fundo, Brasil. 
RESULTADOS: A produção de M&#946;Ls foi observada em 77,6 por cento (n = 173/223
) dos isolados de P. aeruginosa e em 22,4 por cento (n = 50/223) dos isolados de
 Acinetobacter sp. Dentre as cepas produtoras de M&#946;L, a maioria apresentou 
mais de 90 por cento de resistência a seis antimicrobianos dos 12 testados, enfa
tizando a resistência a ceftazidima, gentamicina, aztreonam, piperaciclina/tazob
actam, cefepime, ciprofloxacina, meropenem e tobramicina. CONCLUSÕES: Os índices
 de M&#946;L encontrados confirmam a preocupação mundial com a disseminação dess
e mecanismo de resistência.#^dnd^i2#^tm^lpt^kM&#946;L^i2#^tm^lpt^kResistência ba
cteriana^i2#^tm^lpt^kPseudomonas aeruginosa^i2#^tm^lpt^kAcinetobacter^i2#other#2
1#20100912#12/09/2010#20101108#08/11/2010#aop13-11.htm#Internet^ihttp://www.scie
lo.br/scielo.php?script=sci_arttext&pid=S0037-86822011005000015##
00514000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704027000085002001300355#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#5#1#article#137#<p><a name
="enda"></a><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b>Occur
rence and the susceptibility to antimicrobial agents in <i>Pseudomonas aeruginos
a </i>and<i> Acinetobacter </i>sp. at a tertiary hospital in southern Brazil</b>
</font></p>     ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#6#2#article#137#<p>&nbsp;<
/p>     ^cY#aop13-11.htm##
00504000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704026000085002001300345#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#7#3#article#137#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Ocorr&ecirc;ncia e perfi
l de sensibilidade a antimicrobianos em <i>Pseudomonas aeruginosa </i>e <i>Acine
tobacter </i>sp. em um hospital terci&aacute;rio, no sul do Brasil</b></font></p
>     ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#8#4#article#137#<p>&nbsp;<
/p>     ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#9#5#article#137#<p>&nbsp;<
/p>     ^cY#aop13-11.htm##
00500000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704025500086002001300341#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#10#6#article#137#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Gabriele Mariani Machad
o<sup>I</sup>; Aldalise Lago<sup>II</sup>; S&eacute;rgio Roberto Riccardi Fuente
fria<sup>II,III</sup>; Daiane Bopp Fuentefria<sup>II,III</sup></b></font></p>   
  ^cY#aop13-11.htm##
00419000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704017400086002001300260#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#11#7#article#137#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Instituto de C
i&ecirc;ncias Biol&oacute;gicas, Universidade de Passo Fundo, Passo Fundo, RS   
 ^cY#aop13-11.htm##
00381000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013600086002001300222#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#12#8#article#137#<br>   <s
up>II</sup>Laborat&oacute;rio de An&aacute;lises Cl&iacute;nicas, Hospital S&ati
lde;o Vicente de Paulo, Passo Fundo, RS    ^cY#aop13-11.htm##
00376000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704013100086002001300217#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#13#9#article#137#<br>   <s
up>III</sup>Servi&ccedil;o de An&aacute;lises Especializadas, Laborat&oacute;rio
 SANI, Passo Fundo, RS</font></p>     ^cY#aop13-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011300087002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#14#10#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#endb">Address t
o</a></font></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#15#11#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#16#12#article#137#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop13-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#17#13#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop13-11.htm##
00912000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704066600087002001300753#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#18#14#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b> The 
main mechanism of emerging resistance in <i>Pseudomonas aeruginosa</i> and <i>Ac
inetobacter</i> sp. isolates is the production of metallo-</font>&#946;<font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif">-lactamases (M</font>&#946;<f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls). M</font>&#946;<fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls are enzymes capable 
of hydrolyzing cephalosporins, penicillins and carbapenems, but not monobactams 
(aztreonam), which are often used as antimicrobial therapy to treat nosocomial i
nfections.    ^cY#aop13-11.htm##
00568000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032200087002001300409#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#19#15#article#137#<br>   <
b>METHODS: </b> An observational descriptive and retrospective study was designe
d to assess the frequency of M</font>&#946;<font size="2" face="Verdana, Arial, 
Helvetica, sans-serif">Ls among strains of <i>P. aeruginosa</i> and <i>Acinetoba
cter</i> sp. obtained from a tertiary hospital in southern Brazil.    ^cY#aop13-
11.htm##
00644000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039800087002001300485#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#20#16#article#137#<br>   <
b>RESULTS: </b> M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sa
ns-serif">L production was observed in 77.6%  (n = 173/223) for <i>P. aeruginosa
</i> isolates and 22.4% (n = 50/223) of <i>Acinetobacter</i> sp. isolates. The <
i>Acinetobacter </i>sp. isolates showed 92.8% sensitivity to amikacin and <i>P. 
aeruginosa</i> isolates showed 58.9% sensitivity to aztreonam.    ^cY#aop13-11.h
tm##
00454000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020800087002001300295#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#21#17#article#137#<br>   <
b>CONCLUSIONS: </b> The M</font>&#946;<font size="2" face="Verdana, Arial, Helve
tica, sans-serif">L indices determined confirm the global concern with this mech
anism of resistance.</font></p>     ^cY#aop13-11.htm##
00513000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026700087002001300354#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#22#18#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> M</font>
&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L. Bacterial r
esistance. <i>Pseudomonas aeruginosa. Acinetobacter</i>. </font></p> <hr size="1
" noshade>     ^cY#aop13-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#23#19#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop13-11.htm##
01107000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704086100087002001300948#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#24#20#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b> O principal mecanismo de resist&ecirc;ncia entre isolados de <i>Pseudom
onas aeruginosa </i>e <i>Acinetobacter</i> sp. &eacute; a produ&ccedil;&atilde;o
 de metalo-</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-ser
if">-lactamases (M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, s
ans-serif">Ls). As M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica,
 sans-serif">Ls s&atilde;o enzimas capazes de hidrolisar cefalosporinas, penicil
inas e carbapen&ecirc;micos, mas n&atilde;o monobact&acirc;micos (aztreonam) ant
ibi&oacute;ticos que se encontram entre as principais op&ccedil;&otilde;es terap
&ecirc;uticas para o tratamento de infec&ccedil;&otilde;es causadas por bact&eac
ute;rias n&atilde;o fermentadoras de glicose.    ^cY#aop13-11.htm##
00647000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040100087002001300488#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#25#21#article#137#<br>   <
b>M&Eacute;TODOS: </b>Um estudo observacional, transversal, descritivo e retrosp
ectivo foi desenvolvido para avaliar a frequ&ecirc;ncia e o perfil de susceptibi
lidade cepas de <i>P. aeruginosa </i>e <i>Acinetobacter </i>sp. produtoras de M<
/font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls isola
das no Hospital S&atilde;o Vicente de Paulo, Passo Fundo, Brasil.    ^cY#aop13-1
1.htm##
00873000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062700087002001300714#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#26#22#article#137#<br>   <
b>RESULTADOS: </b> A produ&ccedil;&atilde;o de M</font>&#946;<font size="2" face
="Verdana, Arial, Helvetica, sans-serif">Ls foi observada em 77,6% (n = 173/223)
 dos isolados de <i>P. aeruginosa</i> e em 22,4% (n = 50/223) dos isolados de <i
>Acinetobacter</i> sp. Dentre as cepas produtoras de M</font>&#946;<font size="2
" face="Verdana, Arial, Helvetica, sans-serif">L, a maioria apresentou mais de 9
0% de resist&ecirc;ncia a seis antimicrobianos dos 12 testados, enfatizando a re
sist&ecirc;ncia a ceftazidima, gentamicina, aztreonam, piperaciclina/tazobactam,
 cefepime, ciprofloxacina, meropenem e tobramicina.    ^cY#aop13-11.htm##
00525000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027900087002001300366#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#27#23#article#137#<br>   <
b>CONCLUS&Otilde;ES: </b> Os &iacute;ndices de M</font>&#946;<font size="2" face
="Verdana, Arial, Helvetica, sans-serif">L encontrados confirmam a preocupa&cced
il;&atilde;o mundial com a dissemina&ccedil;&atilde;o desse mecanismo de resist&
ecirc;ncia.</font></p>     ^cY#aop13-11.htm##
00527000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028100087002001300368#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#28#24#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves: </b>M
</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L. Resi
st&ecirc;ncia bacteriana. <i>Pseudomonas aeruginosa. Acinetobacter.</i></font></
p> <hr size="1" noshade>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#29#25#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#30#26#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#31#27#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop13-11.htm##
00722000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047600087002001300563#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#32#28#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Hospital infections are a
 major concern for public health agencies and the internal committees of hospita
l infection control. Coco-bacilli and Gram-negative bacteria, such as <i>Pseudom
onas aeruginosa</i> and <i>Acinetobacter</i> sp. respectively, are extremely imp
ortant pathogens that cause serious infections in different parts of the human b
ody and may lead to patient death<sup>1-3</sup>.</font></p>     ^cY#aop13-11.htm
##
00788000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054200087002001300629#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#33#29#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In the last decade, parti
cularly in <i>P. aeruginosa</i>, enzymes were identified that promote hydrolysis
 of cephalosporins, penicillins and carbapenems but not monobactams, such as azt
reonam, which are called arbapenamases or metallo-</font>&#946;<font size="2" fa
ce="Verdana, Arial, Helvetica, sans-serif">-lactamases (M</font>&#946;<font size
="2" face="Verdana, Arial, Helvetica, sans-serif">Ls) and confer resistance to t
hese antimicrobial<sup>4,5</sup>. </font></p>     ^cY#aop13-11.htm##
01116000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704087000087002001300957#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#34#30#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The first reports of <i>P
. aeruginosa</i> isolates producing M</font>&#946;<font size="2" face="Verdana, 
Arial, Helvetica, sans-serif">Ls in Japan occurred in 1991, since then Europe, A
sia and America have also recorded such events<sup>6</sup>. In Brazil, the gene 
is prevalent <i>bla </i><sub>SPM-1</sub>, originally isolated in S&atilde;o Paul
o<sup>7</sup>. Currently, the increase in the number of isolates of <i>P. aerugi
nosa</i> with <i>bla</i> genes in intensive care units (ICUs) is a cause of seri
ous concern<sup>8</sup>. Risk factors for nosocomial infections in this environm
ent include exposure to highly invasive practices, such as mechanical ventilatio
n, urinary catheters, intra-arterial and intravenous catheters and the use of an
tibiotics in large quantities<sup>9</sup>.</font></p>     ^cY#aop13-11.htm##
00862000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061600087002001300703#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#35#31#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">All metallo-</font>&#946;
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">-lactamases (M</font
>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls) hydrolyze
 imipenem, but this ability varies considerably and the rate of hydrolysis may o
r may not be correlated with the level of bacterial resistance to carbapenems. T
hese enzymes are inhibited by EDTA (ethylenediaminetetraacetic acid) and other c
helators of divalent cations and is thus correlated with its mechanism of action
<sup>1</sup><sup>0,11</sup>.</font></p>     ^cY#aop13-11.htm##
00628000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038200087002001300469#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#36#32#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This study was conducted 
in order to extend current knowledge regarding the incidence and susceptibility 
profiles of M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-s
erif">L-producing<i> P. aeruginosa </i>and<i> Acinetobacter</i> in a tertiary ho
spital in Passo Fundo, RS, Brazil.</font></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#37#33#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#38#34#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>
     ^cY#aop13-11.htm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010800087002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#39#35#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Place of the study</b>
</font></p>     ^cY#aop13-11.htm##
00685000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043900087002001300526#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#40#36#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This study was conducted 
at the Laboratory of Clinical Analysis of S&atilde;o Vicente de Paulo Hospital (
<i>Hospital S&atilde;o Vicente de Paulo</i>, HSVP) in Passo Fundo, State of Rio 
Grande do Sul, Brazil. The hospital has approximately 590 beds and 60 beds for s
upport in a constructed area of 50,000m<sup>2</sup>, with about 28,000 admission
s per year.</font></p>     ^cY#aop13-11.htm##
00368000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704012200087002001300209#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#41#37#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Study design and data 
collection</b></font></p>     ^cY#aop13-11.htm##
01143000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089700087002001300984#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#42#38#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A retrospective cross-sec
tional observational study was conducted that included patients at the HSVP and 
bacterial cultures tests performed from June to December 2008. The data collecte
d were complied on a spreadsheet where the following information was recorded: n
ame, age, sex, hospital ward, number of laboratory records for the patient, type
 of biological material, underlying disease, culture results, susceptibility to 
antimicrobials and use of antibiotics before and after treatment. The data of pa
tients with positive cultures for M</font>&#946;<font size="2" face="Verdana, Ar
ial, Helvetica, sans-serif">L-producing or nonproducing <i>P. aeruginosa </i>and
<i> Acinetobacter</i> sp. were compared. For ethical reasons, the name of the pa
tient was noted to only to prevent replication and was not disclosed.</font></p>
     ^cY#aop13-11.htm##
00653000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040700087002001300494#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#43#39#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Data collection was perfo
rmed by the internal system of HSVP computers in the Laboratory of Clinical Anal
ysis using Mylab for Windows; this system is used to disclose the results of pat
ients to medical assistants and in the Program Requirements and Medical Patients
, where the outcome of hospitalized patients is registered.</font></p>     ^cY#a
op13-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010100087002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#44#40#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Definitions</b></font>
</p>     ^cY#aop13-11.htm##
01318000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704107200087002001301159#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#45#41#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The bacterial isolates we
re identified by classic morphological and biochemical tests, such as Gram stain
, cytochrome oxidase, motility, TSI and pyoverdin production. The profile of ant
imicrobial susceptibility was determined by the disk-fusion method, in accordanc
e with the standards of the Clinical Laboratory Standards Institute (CLSI), usin
g the following agents: 30&#181;g of ceftazidime (CAZ), 10mg of gentamicin (GEN)
, 110&#181;g of piperacillin/tazobactam (PIT), 30&#181;g of amikacin (AMI), 30&#
181;g of aztreonam (ATM), 30&#181;g of cefepime (CPM), 5&#181;g of ciprofloxacin
 (CIP), 10mg of meropenem (MER), 10mg of tobramycin (TOB), 20&#181;g of ampicill
in/sulbactam (SBA), 30&#181;g of ceftriaxone (CRO) and 15&#181;g of tigecycline 
(TGC). The phenotypic screening for the M</font>&#946;<font size="2" face="Verda
na, Arial, Helvetica, sans-serif">L production was performed by combined disk us
ing imipenem (10ug) as the substrate and EDTA (750mcg) as an inhibitor<sup>12</s
up>.</font></p>     ^cY#aop13-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#46#42#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Statistical analysis</
b></font></p>     ^cY#aop13-11.htm##
01070000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704082400087002001300911#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#47#43#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The percentage of strains
 producing M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-se
rif">L was calculated among cultures positive for pathogens. The data of the pos
itive cultures and M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica,
 sans-serif">L-producing strains were compared with the type of biological sampl
e, the profile of antimicrobial susceptibility and demographics, such as sex, ho
spital and age. Comparative analysis between the presence of M</font>&#946;<font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls and the different trai
ts was performed by tthe Fisher exact test and Chi square test (</font>&#967;<fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>2</sup> test).</fo
nt></p>     ^cY#aop13-11.htm##
00777000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053100087002001300618#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#48#44#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Qualitative categorical v
ariables, such as the presence or absence of M</font>&#946;<font size="2" face="
Verdana, Arial, Helvetica, sans-serif">Ls, type of biological sample, the hospit
al and patient sex were compared using univariate (<i>Mantel-Haenszel common odd
s ratio estimate</i>) and calculation of odds ratios (ORs) with 95% confidence i
nterval (95%CI), using SPSS (version 11.0), where p &lt; 0.05 was considered sta
tistically significant.</font></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#49#45#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#50#46#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>
     ^cY#aop13-11.htm##
00855000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060900087002001300696#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#51#47#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A total of 7,849 cultures
 were analyzed during the study period. The percentage of positive cultures for 
pathogens was 2.8% (n = 223/7849) for <i>P. aeruginosa</i> and <i>Acinetobacter 
s</i>p. Among these, 77.6% (n = 173/223) were identified as <i>P. aeruginosa</i>
 and 22.4% (n = 50/223) were <i>Acinetobacter</i> sp. The screening test for M</
font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls was po
sitive in 17.4% of isolates of <i>P. aeruginosa</i> and 6.3% of isolates of <i>A
cinetobacter </i>sp. </font></p>     ^cY#aop13-11.htm##
00696000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045000087002001300537#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#52#48#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The M</font>&#946;<font s
ize="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing isolates were r
ecovered mainly from samples of tracheal aspirate (n = 19/223, 8.5%), urine (n =
 10/2,234, 48%), tracheal secretion (n = 7/223, 3.1%) and sputum (n = 6/223, 2.6
%); however, the type of sample was not statistically significant for either of 
the pathogens studied.</font></p>     ^cY#aop13-11.htm##
00819000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057300087002001300660#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#53#49#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Other types of biological
 samples, such as cultures of catheters, drains, bronchial washings, secretions 
and cerebrospinal fluid samples, occurred less frequently. Among the 53 M</font>
&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing is
olates, 11 patients were female and 42 were male, although differences between s
exes was only significant for isolates of <i>P. aeruginosa</i> (p = 0.034), with
 an <i>odds ratio</i> of 2.361 (95%CI, 0.987 to 5,649) for males.</font></p>    
 ^cY#aop13-11.htm##
02130000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704188400087002001301971#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#54#50#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A variation in rates of p
ositive cultures for M</font>&#946;<font size="2" face="Verdana, Arial, Helvetic
a, sans-serif">L-producing<i> P. aeruginosa</i> and <i>Acinetobacter </i>sp. was
 observed for different hospital sectors, with the highest rate of production of
 M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls oc
curring in the central intensive care unit (ICU-C) with 21 isolates (n = 21/53, 
39.6%), followed by the centre for critical care nursing (CCCN) with 17 infected
 patients (n = 17/53, 31.1%) and station 7 (S07) with seven cases (n = 7/53, 13.
2%). A significant difference in the presence of M</font>&#946;<font size="2" fa
ce="Verdana, Arial, Helvetica, sans-serif">L-producing<i> Acinetobacter</i> sp. 
(p = 0.13) was only observed for the ICU. For this sector, the odds ratio was 4.
051 (95%CI, 1.343 to 13.213). The age group with the highest rate of M</font>&#9
46;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L production was 
over 60 years-old (n = 28/53, 52.8%), followed by the range from 25 to 60 years-
old (n = 15/53, 28.3%), from 12 to 25 years-old (n = 9/53, 16.9%) and up to 5 ye
ars-old (n = 1/53, 1.8%). Not one M</font>&#946;<font size="2" face="Verdana, Ar
ial, Helvetica, sans-serif">L producer was recovered from patients aged 5 to 12 
years-old (<b><a href="#tab1">Table 1</a></b>), although age showed no significa
nt difference (p = 0.564). The underlying diseases that manifested most often in
 relation to the presence of M</font>&#946;<font size="2" face="Verdana, Arial, 
Helvetica, sans-serif">Ls were the respiratory system, including pneumonia and b
ronchopneumonia, respiratory failure, chronic obstructive pulmonary disease and 
pulmonary embolism, and liver diseases, such as cirrhosis, renal and neurologica
l complications.</font></p>     ^cY#aop13-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#55#51#article#137#<p><a na
me="tab1"></a></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#56#52#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#57#53#article#137#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop13-11tab01.jpg"></p>     ^
cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#58#54#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
01641000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704139500087002001301482#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#59#55#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Comparing the isolates of
 M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-pro
ducing <i>Acinetobacter s</i>p. with the nonproducing strains, the former presen
t much greater resistance to the antimicrobial agents evaluated. Among the M</fo
nt>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing
 strains, most isolates showed over 90% of antimicrobial resistance to six of th
e 12 drugs tested, particularly to ceftazidime, gentamicin, aztreonam, piperacil
lin/tazobactam, cefepime, ciprofloxacin, meropenem and tobramycin (<b><a href="#
fig1">Figure 1</a></b>). Only 7.1% of the M</font>&#946;<font size="2" face="Ver
dana, Arial, Helvetica, sans-serif">L-producing isolates presented resistance to
 amikacin and tigecycline, while 28.5% of these isolates were resistant to ampic
illin/sulbactam, providing the only therapeutic options for these cases. Meropen
em, which has a high resistance rate and is used as standard treatment in cases 
of <i>Acinetobacter </i>sp. cannot be used in cases of M</font>&#946;<font size=
"2" face="Verdana, Arial, Helvetica, sans-serif">L production, because resistanc
e is superior to 90%, but in cases of M</font>&#946;<font size="2" face="Verdana
, Arial, Helvetica, sans-serif">L-nonproducing strains, it is the antibiotic of 
choice.</font></p>     ^cY#aop13-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#60#56#article#137#<p><a na
me="fig1"></a></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#61#57#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#62#58#article#137#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop13-11fig01.jpg"></p>     ^
cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#63#59#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00824000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057800087002001300665#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#64#60#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In M</font>&#946;<font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">L-nonproducing strains of <i
>Acinetobacter</i> sp. the levels of antibiotic resistance were lower, with 34% 
of isolates resistant to ceftazidime, 42% to gentamicin, 26% to piperacillin/taz
obactam, 24% to amikacin, 38% to aztreonam, 34% to cefepime, 42% to ciprofloxaci
n, 48% to tobramycin, 16% to ampicillin/sulbactam, 26% to ceftriaxone and only 2
% to tigecycline and meropenem (<b><a href="#fig1">Figure 1</a></b>). </font></p
>     ^cY#aop13-11.htm##
00831000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058500087002001300672#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#65#61#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The M</font>&#946;<font s
ize="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing strains of <i>P
. aeruginosa</i> show greater resistance to the antibiotics tested than the nonp
roducing strains. However, M</font>&#946;<font size="2" face="Verdana, Arial, He
lvetica, sans-serif">L-producing strains present strength of more than 80% to on
ly two antibiotics, ampicillin/sulbactam and meropenem, and resistance above 60%
 for six of the 10 antibiotics tested (<b><a href="#fig2">Figure 2</a></b>). </f
ont></p>     ^cY#aop13-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#66#62#article#137#<p><a na
me="fig2"></a></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#67#63#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#68#64#article#137#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop13-11fig02.jpg"></p>     ^
cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#69#65#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00785000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053900087002001300626#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#70#66#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Among the M</font>&#946;<
font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-nonproducing isolat
es of<i> P. aeruginosa</i>, resistance levels were much lower. The highest rates
 of resistance were observed against ampicillin/sulbactam (75.3%), followed by t
obramycin (28.3%), gentamicin and ciprofloxacin (both 27.6%), amikacin (20.8%), 
aztreonam (17.9%), cefepime (16.4%), ceftazidime (12.6%), piperacillin/tazobacta
m (10.4%) and meropenem (3.7%).</font></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#71#67#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#72#68#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font><
/p>     ^cY#aop13-11.htm##
01451000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704120500087002001301292#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#73#69#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The frequency of M</font>
&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">Ls among isola
tes of <i>P. aruginosa</i> in this study was 17.4%. In a study conducted at the 
same institution, Graf et al<sup>9</sup> detemined a rate of 10.8% of producers 
with phenotypes of resistance genes among isolates of <i>P. aeruginosa</i> in a 
period of three months. Sader et al<sup>5</sup> verified a frequency of 19.7% fo
r M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-pr
oducing isolates at a hospital in S&atilde;o Paulo. Rates ranging from 70% of is
olates resistant to carbapenems were reported by Gaspareto et al<sup>13</sup> in
 Porto Alegre, in a two-year study. The high frequency of M</font>&#946;<font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">Ls verified emphasizes the i
mportance of phenotypically investigating the presence of M</font>&#946;<font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">Ls in routine laboratory tes
ts, since the enzymes are located in mobile genetic structures that can spread b
etween bacterial strains and lead to epidemic outbreaks. </font></p>     ^cY#aop
13-11.htm##
00683000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043700087002001300524#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#74#70#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In this work, M</font>&#9
46;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing <i>Ac
inetobacter </i>sp. represented 6.3% of the samples identified. Similar rates ar
e reported by the Mystic Program Brazil 2003, where 8.8% of bacterial isolates c
ausing infections in ICUs were multidrug-resistant <i>Acinetobacter </i>sp.<sup>
14</sup>.</font></p>     ^cY#aop13-11.htm##
01282000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704103600087002001301123#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#75#71#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Bacterial resistance to t
he antibiotics tested was consistent with several previous studies involving bot
h pathogens. In M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sa
ns-serif">L-producing <i>P. aeruginosa</i>, resistance exceeded 60% in six of th
e 11 antibiotics tested. The lowest resistance was observed against aztreonam, w
hich can be used as a treatment option. For <i>Acinetobacter </i>sp. the lowest 
rates of resistance were observed against amikacin, tigecycline and sulbactam/am
picillin, making these the therapeutic options. The sensitivity profile of M</fo
nt>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing
 isolates of <i>Acinetobacter</i> sp. indicates the possible presence of other a
ssociated </font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-seri
f">-lactamase type oxacillinase (<i>bla</i><sub>OXA23</sub>), similar to the epi
demic clone disseminated in Brazil<sup>15</sup>.</font></p>     ^cY#aop13-11.htm
##
01469000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704122300087002001301310#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#76#72#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">A significant increase in
 resistance to antibiotics was observed for these pathogens compared to M</font>
&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-nonproducing
 isolates. For <i>Acinetobacter</i> sp. even aztreonam shows diminished treatmen
t effectiveness in pathogens producing this enzyme, probably due to the presence
 of other resistance genes, including those capable of hydrolyzing monobactams, 
such as extended spectrum </font>&#946;<font size="2" face="Verdana, Arial, Helv
etica, sans-serif">-lactamases (ESBLs). Reis et al<sup>16 </sup>reported that in
 some Brazilian hospitals, rates of carbapenem resistance increased approximatel
y 12% for isolates of <i>Acinetobacter </i> sp. The profile of the <i>Acinetobac
ter </i> sp. strains could be the type of enzymes associated with <i>bla</i><sub
>OXA-23</sub>. Dalla-Costa et al<sup>15 </sup>observed this strain in two hospit
als in Curitiba, together with <i>P. aeruginosa</i>, and observed their similari
ty to M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">
L-producers due to carbapenem resistance and high sensitivity to aztreonam.</fon
t></p>     ^cY#aop13-11.htm##
01142000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089600087002001300983#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#77#73#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The high rate of resistan
ce to most antibiotics tested indicates that the selection of resistant strains 
may be occurring and that the use of potent antibiotics may be contributing to t
his selection. Reis et al<sup>17</sup> identified a strain of <i>Acinetobacter <
/i>sp. resistant even to polymyxin B, a worrying fact, since this is an extremel
y powerful drug and is often used as a last choice for the treatment of pan-resi
stant strains of <i>Acinetobacter </i>sp. According to Reis et al<sup>17</sup>, 
use of polymyxin B may have played a role in the selection of resistant strains,
 arguing against the theory of clonal spread. Furthermore, two isolates showed a
n identical genetic pattern, which raises the possibility of transmission of str
ains occurring between patients and the ability to create epidemics.</font></p> 
    ^cY#aop13-11.htm##
01416000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704117000087002001301257#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#78#74#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">High rates of resistance 
observed in inpatient units, such as ICU-C, CCCN and Post 7, is probably related
 to the severity of cases among these patients, since these units are for hospit
alized patients with more severe illnesses and greater susceptibility. M</font>&
#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L production oc
curred mainly in samples from the respiratory tract, stressing that both pathoge
ns are important colonizers of artificial respiration and in patients with nosoc
omial pneumonia; another important risk factor is diabetes mellitus, which cause
s insulin resistance. Lautenbach et al<sup>18</sup> reported that 44.6% of <i>P.
 aeruginosa</i> isolates were from respiratory tract samples. In nosocomial samp
les from Porto Alegre, Pulcinelli et al<sup>16</sup> verified a rate of 70.7% in
 lower respiratory tract isolates of <i>P. aeruginosa</i>. In 2008, Carneiro et 
al<sup>19</sup> reported that in a hospital in Londrina, Parana, the incidence o
f patients with ventilator-associated pneumonia was 25.2% for <i>Acinetobacter <
/i> sp.<sup>19</sup>. </font></p>     ^cY#aop13-11.htm##
00909000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704066300087002001300750#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#79#75#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">According to the Manual o
f the Department of Infection Control, from 2009, of the HVSP, in-hospital preca
utions must be taken to prevent the spread of multidrug-resistant strains, which
 included contact precautions for patients colonized and/or infected, the use of
 aprons with long sleeves and appropriate use of procedure gloves and hand hygie
ne with antiseptic and water or alcohol gel before and after attending such pati
ents, individual use of thermometers, stethoscopes and sphygmomanometers, indivi
dual, or preferably fourth cohort control within the hospital<sup>20</sup>.</fon
t></p>     ^cY#aop13-11.htm##
01690000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704144400087002001301531#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#80#76#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">M</font>&#946;<font size=
"2" face="Verdana, Arial, Helvetica, sans-serif">L rates (17.4% of <i>P. aerugin
osa</i> isolates and 6.3% of <i>Acinetobacter</i> sp. isolates) verified among t
he HVSP isolates were similar to those of other Brazilian institutions. Detectio
n of M</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L
 production in routine laboratory exams provides the foundation and assists in t
he selection of the appropriate antimicrobial therapy. With the spread of M</fon
t>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L-producing 
strains in hospitals around the world, knowledge regarding the prevalence of M</
font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">L product
ion is essential to develop policies for empirical therapy in high risk units, w
here rates of infection by these microorganisms are high. Surveillance, combined
 with monitoring and daily review of cultures in the microbiology laboratory and
 the use of antimicrobials, are effective measures to identify outbreaks in time
 to carry out measures to optimize and intervene in the conduct adopted in the v
arious hospital sectors<sup>21</sup>. Thus, the rates of M</font>&#946;<font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif">Ls verified confirm the conce
rn of the global emergency of this resistance mechanism.</font></p>     ^cY#aop1
3-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#81#77#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#82#78#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop13-11.htm##
00603000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035700087002001300444#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#83#79#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors would like to
 thank the Clinical Laboratory and the Committee on Infection Control at the S&a
tilde;o Vicente de Paulo Hospital for allowing them to develop this study. The a
uthors are also grateful to Dr. Gilberto Barbosa da Luz for his review of the ma
nuscript.</font></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#84#80#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#85#81#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop13-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#86#82#article#137#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors declare that 
there is no conflict of interest.</font></p>     ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#87#83#article#137#<p>&nbsp
;</p>     ^cY#aop13-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#88#84#article#137#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop13-11.htm##
00634000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704037400089002001300463#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#89#85#article#
137#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Gales AC
, Menezes LC, Silbert S, Sader HS. Dissemination in distinct Brazilian regions o
f an epidemic carbapenem-resistant <i>Pseudomonas aeruginosa </i>producing SPM m
etallo-</font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">
-lactamase. J Antimicrob Chemother 2003; 52:699-702.    ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#90#86#article#137#</font><
/p>     ^cY#aop13-11.htm##
00555000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029500089002001300384#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#91#87#article#
137#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Gales AC
, Tognim MC, Reis AO, Jones RN, Sader HS. Emergence of an IMP-like metallo-enzym
e in an <i>Acinetobacter baumannii </i>clinical strain from a Brazilian teaching
 hospital. Diagn Microbiol Infect Dis 2003; 45:77-79.    ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#92#88#article#137#</font><
/p>     ^cY#aop13-11.htm##
00524000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026400089002001300353#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#93#89#article#
137#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Mendes R
E, Castanheira M, Pignatari ACC, Gales AC. Metalo-</font>&#946;<font size="2" fa
ce="Verdana, Arial, Helvetica, sans-serif">-lactamases. J Bras Patol Med Laborat
orial2006; 42:103-113.    ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#94#90#article#137#</font><
/p>     ^cY#aop13-11.htm##
00630000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704037000089002001300459#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#95#91#article#
137#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Castanhe
ira M, Toleman MA, Jones, RN, Schimidt FJ, Walsh TR.Molecular characterization o
f a beta-lactamase gene, <i>bla</i>GIM-1, encoding a new subclass of metallo-</f
ont>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">-lactamase
. Antimicrob Agents Chemother2004; 48:4654-4661.    ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#96#92#article#137#</font><
/p>     ^cY#aop13-11.htm##
00630000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704037000089002001300459#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#97#93#article#
137#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Sader HS
, Reis AO, Silbert S, Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-</
font>&#946;<font size="2" face="Verdana, Arial, Helvetica, sans-serif">-lactamas
es produced by carbapenem-resistant <i>Pseudomonas aeruginosa </i>in a Brazilian
 hospital. Clin Microbiol Infect 2004; 11:73-76.    ^cY#aop13-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#98#94#article#137#</font><
/p>     ^cY#aop13-11.htm##
00674000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704041400089002001300503#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#99#95#article#
137#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Lauretti
 L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, et al. Cloning
 and characterization of blaVIM, a new integron-borne Metallo-</font>&#946;<font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">-Lactamse gene from a <i>
Pseudomonas aeruginosa </i>clinical isolate. Antimicrob Agents Chemother 1999; 4
3:1584-1590.    ^cY#aop13-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#100#96#article#137#</font>
</p>     ^cY#aop13-11.htm##
00676000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704041500090002001300505#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#101#97#article
#137#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Lee K, 
Lim YS, Young D, Yum JH, Chong Y. Evaluation of the Hodge Test and the Imipenem-
EDTA Double-Disk Synergy Test for Differentiating Metallo-</font>&#946;<font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif">-Lactamase-Producing Isolates
 of <i>Pseudomonas </i>spp. and <i>Acinetobacter </i>spp. J Clin Microbiol 2003;
 43:4623-4629.    ^cY#aop13-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#102#98#article#137#</font>
</p>     ^cY#aop13-11.htm##
00634000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704037300090002001300463#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#103#99#article
#137#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Loureir
o MM, Moraes BA, Mendon&ccedil;a VLF, Quadra MRR, Pinheiro GS, Asensi MD. <i>Pse
udomonas aeruginosa</i>: Study of antibiotic resistance and molecular typing in 
hospital infection cases in a neonatal intensive care unit from Rio de Janeiro c
ity, Brazil. Mem Inst Oswaldo Cruz 2002; 97:387-394.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#104#100#article#137#</font
></p>     ^cY#aop13-11.htm##
00654000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704039200091002001300483#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#105#101#articl
e#137#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Gr&aum
l;f T, Fuentefria DB, Cor&ccedil;&atilde;o G. Ocorr&ecirc;ncia de cepas de <i>Ps
eudomonas aeruginosa </i>multirresistentes produtoras de Metalo-</font>&#946;<fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">-Lactamase <i>bla</i>SP
M-1 em amostras cl&iacute;nicas. Rev Soc Bras Med Trop 2008; 41:306-308.    ^cY#
aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#106#102#article#137#</font
></p>     ^cY#aop13-11.htm##
00656000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704039300092002001300485#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#107#103#articl
e#137#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Youn
g D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method fo
r differentiation of Metallo-</font>&#946;<font size="2" face="Verdana, Arial, H
elvetica, sans-serif">-Lactamase-producing clinical isolates of <i>Pseudomonas <
/i>spp. and <i>Acinetobacter </i>spp. Clin Infect Dis 2002; 10: 3798-3801.    ^c
Y#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#108#104#article#137#</font
></p>     ^cY#aop13-11.htm##
00541000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027800092002001300370#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#109#105#articl
e#137#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Wals
h TR, Toleman MA, Poirel, L, Nordmann P. Metallo-</font>&#946;<font size="2" fac
e="Verdana, Arial, Helvetica, sans-serif">-Lactamases: the Quiet before the Stor
m? Clin Microbiol Rev 2005; 18:306-325.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#110#106#article#137#</font
></p>     ^cY#aop13-11.htm##
00608000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034500092002001300437#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#111#107#articl
e#137#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Tole
man MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, et al. Molecular 
characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin Amer
ica: report from the SENTRY antimicrobial surveillance programme. J Antimicrob C
hemother 2002; 37:673-679.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#112#108#article#137#</font
></p>     ^cY#aop13-11.htm##
00697000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704043400092002001300526#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#113#109#articl
e#137#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Gasp
areto PB, Martins AF, Zavascki AP, Barth AL. Occurrence of <i>bla</i>SPM-1 and <
i>bla</i>IMP-1 genes of metalo-</font>&#946;<font size="2" face="Verdana, Arial,
 Helvetica, sans-serif">-lactamases in clinical isolates of <i>Pseudomonas aerug
inosa </i>from three universitary hospitals in the city of Porto Alegre, Brazil.
 Braz J Microbiol 2007; 38:108-109.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#114#110#article#137#</font
></p>     ^cY#aop13-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031500092002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#115#111#articl
e#137#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Kiff
er C, Hsiung A, Oplustiul C, Sampaio J, Sakayami E, Turner P, et al. Mystic Braz
il Group. Antimicrobial susceptibility of gram-negative bacteria in Brazilian ho
spitals: the MYSTIC program Brazil 2003. Braz J Infect Dis 2005; 9: 216-224.    
^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#116#112#article#137#</font
></p>     ^cY#aop13-11.htm##
00572000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030900092002001300401#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#117#113#articl
e#137#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Dall
a-Costa LM, Coelho JM, Souza HAPHM, Castro MES, Stier CJN, Bragagnolo KL, et al.
 Outbreak of Carbapenem-Resistant <i>Acinetobacter baumannii </i>Producing the O
XA-23 Enzyme in Curitiba, Brazil. J Clin Microbiol 2003; 41:3403-3406.    ^cY#ao
p13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#118#114#article#137#</font
></p>     ^cY#aop13-11.htm##
00658000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704039500092002001300487#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#119#115#articl
e#137#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Pulc
inelli RSR, Saucedo EM, Pereira R, Pilonetto M, Aquino ARC, Santos RCV. Detec&cc
edil;&atilde;o de metalo-</font>&#946;<font size="2" face="Verdana, Arial, Helve
tica, sans-serif">-lacmatases em amostras de <i>Pseudomonas aeruginosa</i> isola
das em Porto Alegre, Rio Grande do Sul. Rev Bras Anal Clin2009; 41: 197-199.    
^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#120#116#article#137#</font
></p>     ^cY#aop13-11.htm##
00493000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023000092002001300322#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#121#117#articl
e#137#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Reis
 AO, Luz DAM, Tognin MCB, Sader HS, Gales AC. Polymyxin-Resistant <i>Acinetobact
er </i>spp. Isolates: What Is Next? Emerg Infect Dis2003; 9: 1025-1027.    ^cY#a
op13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#122#118#article#137#</font
></p>     ^cY#aop13-11.htm##
00611000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034800092002001300440#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#123#119#articl
e#137#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Laut
enbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem Re
sistance Among <i>Pseudomonas aeruginosa </i>Isolates: Risk Factors for Infectio
n and Impact of Resistance on Clinical and Economic Outcomes. Infect Control Hos
p Epidemiol 2006; 27:893-900.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#124#120#article#137#</font
></p>     ^cY#aop13-11.htm##
00526000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026300092002001300355#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#125#121#articl
e#137#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Carn
eiro M, Saridakis HO. Pneumonia associada &agrave; ventila&ccedil;&atilde;o mec&
acirc;nica por <i>Acinetobacter baumannii </i>resistente a carbapenem. Rev Panam
 Infectol2008; 10:28-33.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#126#122#article#137#</font
></p>     ^cY#aop13-11.htm##
00508000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024500092002001300337#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#127#123#articl
e#137#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Barb
osa GL, Schlichting D, Oliveira DR, De Paula NN. Manual do Servi&ccedil;o de Con
trole de Infec&ccedil;&atilde;o Hospitalar. Hospital S&atilde;o Vicente de Paulo
;2009.    ^cY#aop13-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#128#124#article#137#</font
></p>     ^cY#aop13-11.htm##
00515000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025200092002001300344#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#129#125#articl
e#137#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Podn
os YD, Cinat ME, Wilson SE, Cooke J, Gornick W, Thrupp LD. Eradication of multi-
drug resistant <i>Acinetobacter </i>from an intensive care unit. Surg Infect 200
1; 2:297-301.    ^cY#aop13-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#130#126#article#137# </fon
t></p>     ^cY#aop13-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#131#127#article#137#<p>&nb
sp;</p>     ^cY#aop13-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#132#128#article#137#<p>&nb
sp;</p>     ^cY#aop13-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704019200089002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#133#129#article#137#<p><a 
name="endb"></a><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a h
ref="#enda"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a><b
> Address to:</b>     ^cY#aop13-11.htm##
00289000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004100089002001300130#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#134#130#article#137#<br>  
 Drª Daiane Bopp Fuentefria    ^cY#aop13-11.htm##
00323000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007500089002001300164#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#135#131#article#137#<br>  
 Serv. An&aacute;lises Especializadas/Laborat&oacute;rio SANI    ^cY#aop13-11.ht
m##
00291000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004300089002001300132#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#136#132#article#137#<br>  
 Av. Brasil Oeste 888, Centro    ^cY#aop13-11.htm##
00296000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004800089002001300137#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#137#133#article#137#<br>  
 99010-001 Passo Fundo, RS, Brasil    ^cY#aop13-11.htm##
00289000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004100089002001300130#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#138#134#article#137#<br>  
 Phone/fax: 55 54 3312-2000    ^cY#aop13-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#139#135#article#137#<br>  
 e-mail: <a href="mailto:dfuente@tpo.com.br">dfuente@tpo.com.br</a></font></p>  
   ^cY#aop13-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#140#136#article#137#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 12/09/2010 
   ^cY#aop13-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#p#141#137#article#137#<br>  
 Accepted in 08/11/2010</font></p>     ^cY#aop13-11.htm##
00706000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100018001040100
01700122010001600139012014600155030002300301065000900324064000500333031000300338
014000800341865000900349002001300358035001000371801002300381#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#142#1#article#21#1#^rND^sGales
^nAC#^rND^sMenezes^nLC#^rND^sSilbert^nS#^rND^sSader^nHS#Dissemination in distinc
t Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa p
roducing SPM metallo-&#946;-lactamase^len#J Antimicrob Chemother#20030000#2003#5
2#699-702#20110000#aop13-11.htm#0305-7453#J Antimicrob Chemother##
00716000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100017001040100
01500121010001600136010001600152012012500168030002700293065000900320064000500329
031000300334014000600337865000900343002001300352035001000365801002700375#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#143#2#article#21#2
#^rND^sGales^nAC#^rND^sTognim^nMC#^rND^sReis^nAO#^rND^sJones^nRN#^rND^sSader^nHS
#Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical 
strain from a Brazilian teaching hospital^len#Diagn Microbiol Infect Dis#2003000
0#2003#45#77-79#20110000#aop13-11.htm#0732-8893#Diagn Microbiol Infect Dis##
00561000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100021001050100
02100126010001600147012002900163030003000192710000200222065000900224064000500233
031000300238014000800241865000900249002001300258#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop13-11.htm#S#c#144#3#article#21#3#^rND^sMendes^nRE#^rND^s
Castanheira^nM#^rND^sPignatari^nACC#^rND^sGales^nAC#Metalo-&#946;-lactamases^lpt
#J Bras Patol Med Laboratorial#2#20060000#2006#42#103-113#20110000#aop13-11.htm#
#
00726000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100018001090100
01600127010001900143010001600162012011900178030002800297065000900325064000500334
031000300339014001000342865000900352002001300361035001000374801002800384#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#145#4#article#21#4
#^rND^sCastanheira^nM#^rND^sToleman^nMA#^rND^sJones^nRN#^rND^sSchimidt^nFJ#^rND^
sWalsh^nTR#Molecular characterization of a beta-lactamase gene, blaGIM-1, encodi
ng a new subclass of metallo-&#946;-lactamase^len#Antimicrob Agents Chemother#20
040000#2004#48#4654-4661#20110000#aop13-11.htm#0066-4804#Antimicrob Agents Chemo
ther##
00659000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100015001040100
01700119010001600136012014800152030002200300710000200322065000900324064000500333
031000300338014000600341865000900347002001300356#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop13-11.htm#S#c#146#5#article#21#5#^rND^sSader^nHS#^rND^sR
eis^nAO#^rND^sSilbert^nS#^rND^sGales^nAC#IMPs, VIMs and SPMs: the diversity of m
etallo-&#946;-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa
 in a Brazilian hospital^len#Clin Microbiol Infect#2#20040000#2004#11#73-76#2011
0000#aop13-11.htm##
00798000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100017001060100
01900123010001900142010002000161010001700181810000600198012014100204030002800345
06500090037306400050038203100030038701400100039086500090040000200130040903500100
0422801002800432#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.ht
m#S#c#147#6#article#21#6#^rND^sLauretti^nL#^rND^sRiccio^nML#^rND^sMazzariol^nA#^
rND^sCornaglia^nG#^rND^sAmicosante^nG#^rND^sFontana^nR#et al#Cloning and charact
erization of blaVIM, a new integron-borne Metallo-&#946;-Lactamse gene from a Ps
eudomonas aeruginosa clinical isolate^len#Antimicrob Agents Chemother#19990000#1
999#43#1584-1590#20110000#aop13-11.htm#0066-4804#Antimicrob Agents Chemother##
00752000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100013000880100014001010100
01500115010001400130010001500144012018600159030001700345065000900362064000500371
031000300376014001000379865000900389002001300398035001000411801001700421#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#148#7#article#21#7
#^rND^sLee^nK#^rND^sLim^nYS#^rND^sYoung^nD#^rND^sYum^nJH#^rND^sChong^nY#Evaluati
on of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differen
tiating Metallo-&#946;-Lactamase-Producing Isolates of Pseudomonas spp. and Acin
etobacter spp^len#J Clin Microbiol#20030000#2003#43#4623-4629#20110000#aop13-11.
htm#0095-1137#J Clin Microbiol##
00800000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100017001070100
02000124010001800144010001900162010001700181012017500198030002200373065000900395
06400050040403100030040901400080041286500090042000200130042903500100044280100220
0452#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#149#8#
article#21#8#^rND^sLoureiro^nMM#^rND^sMoraes^nBA#^rND^sMendonça^nVLF#^rND^sQuadr
a^nMRR#^rND^sPinheiro^nGS#^rND^sAsensi^nMD#Pseudomonas aeruginosa: Study of anti
biotic resistance and molecular typing in hospital infection cases in a neonatal
 intensive care unit from Rio de Janeiro city, Brazil^len#Mem Inst Oswaldo Cruz#
20020000#2002#97#387-394#20110000#aop13-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00666000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100014000880100021001020100
01600123012013600139030002200275065000900297064000500306031000300311014000800314
865000900322002001300331035001000344801002200354#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop13-11.htm#S#c#150#9#article#21#9#^rND^sGräf^nT#^rND^sFue
ntefria^nDB#^rND^sCorção^nG#Ocorrência de cepas de Pseudomonas aeruginosa multir
resistentes produtoras de Metalo-&#946;-Lactamase blaSPM-1 em amostras clínicas^
lpt#Rev Soc Bras Med Trop#20080000#2008#41#306-308#20110000#aop13-11.htm#0037-86
82#Rev Soc Bras Med Trop##
00747000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100013001050100
01400118010001500132010002000147010001500167012014800182030001600330065000900346
06400050035503100030036001400100036386500090037300200130038203500100039580100160
0405#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#151#10
#article#21#10#^rND^sYoung^nD#^rND^sLee^nK#^rND^sYum^nJH#^rND^sShin^nHB#^rND^sRo
ssolini^nGM#^rND^sChong^nY#Imipenem-EDTA disk method for differentiation of Meta
llo-&#946;-Lactamase-producing clinical isolates of Pseudomonas spp. and Acineto
bacter spp^len#Clin Infect Dis#20020000#2002#10#3798-3801#20110000#aop13-11.htm#
1058-4838#Clin Infect Dis##
00614000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01600124010001800140012005900158030001900217065000900236064000500245031000300250
014000800253865000900261002001300270035001000283801001900293#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#152#11#article#21#11#^rND^sWal
sh^nTR#^rND^sToleman^nMA#^rND^sPoirel^nL#^rND^sNordmann^nP#Metallo-&#946;-Lactam
ases: the Quiet before the Storm?^len#Clin Microbiol Rev#20050000#2005#18#306-32
5#20110000#aop13-11.htm#0893-8512#Clin Microbiol Rev##
00799000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100015001080100
01700123010001600140010002100156010001600177810000600193012015900199030002300358
06500090038106400050039003100030039501400080039886500090040600200130041503500100
0428801002300438#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.ht
m#S#c#153#12#article#21#12#^rND^sToleman^nMA#^rND^sSimm^nAM#^rND^sMurphy^nTA#^rN
D^sGales^nAC#^rND^sBiedenbach^nDJ#^rND^sJones^nRN#et al#Molecular characterizati
on of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report fr
om the SENTRY antimicrobial surveillance programme^len#J Antimicrob Chemother#20
020000#2002#37#673-679#20110000#aop13-11.htm#0305-7453#J Antimicrob Chemother##
00710000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100018001100100
01900128010001600147012019100163030001700354710000200371065000900373064000500382
031000300387014000800390865000900398002001300407#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop13-11.htm#S#c#154#13#article#21#13#^rND^sGaspareto^nPB#^
rND^sMartins^nAF#^rND^sZavascki^nAP#^rND^sBarth^nAL#Occurrence of blaSPM-1 and b
laIMP-1 genes of metalo-&#946;-lactamases in clinical isolates of Pseudomonas ae
ruginosa from three universitary hospitals in the city of Porto Alegre, Brazil^l
en#Braz J Microbiol#2#20070000#2007#38#108-109#20110000#aop13-11.htm##
00704000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060100
01900122010001700141010001800158010001600176810000600192012011400198030001800312
71000020033006500090033206400050034103100020034601400080034886500090035600200130
0365#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#155#14
#article#21#14#^rND^sKiffer^nC#^rND^sHsiung^nA#^rND^sOplustiul^nC#^rND^sSampaio^
nJ#^rND^sSakayami^nE#^rND^sTurner^nP#et al#Antimicrobial susceptibility of gram-
negative bacteria in Brazilian hospitals: the MYSTIC program Brazil 2003^len#Bra
z J Infect Dis#2#20050000#2005#9#216-224#20110000#aop13-11.htm##
00750000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100017001120100
01900129010001800148010001700166010002100183810000600204012010900210030001700319
06500090033606400050034503100030035001400100035386500090036300200130037203500100
0385801001700395#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.ht
m#S#c#156#15#article#21#15#^rND^sDalla-Costa^nLM#^rND^sCoelho^nJM#^rND^sSouza^nH
APHM#^rND^sCastro^nMES#^rND^sStier^nCJN#^rND^sBragagnolo^nKL#et al#Outbreak of C
arbapenem-Resistant Acinetobacter baumannii Producing the OXA-23 Enzyme in Curit
iba, Brazil^len#J Clin Microbiol#20030000#2003#41#3403-3406#20110000#aop13-11.ht
m#0095-1137#J Clin Microbiol##
00707000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01700130010001900147010001800166010001800184012012300202030001900325710000200344
065000900346064000500355031000300360014000800363865000900371002001300380#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#157#16#article#21#
16#^rND^sPulcinelli^nRSR#^rND^sSaucedo^nEM#^rND^sPereira^nR#^rND^sPilonetto^nM#^
rND^sAquino^nARC#^rND^sSantos^nRCV#Detecção de metalo-&#946;-lacmatases em amost
ras de Pseudomonas aeruginosa isoladas em Porto Alegre, Rio Grande do Sul^lpt#Re
v Bras Anal Clin#2#20090000#2009#41#197-199#20110000#aop13-11.htm##
00643000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100015001050100
01800120010001600138010001600154012006700170030001700237065000900254064000500263
031000200268014001000270865000900280002001300289035001000302801001700312#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#158#17#article#21#
17#^rND^sReis^nAO#^rND^sLuz^nDAM#^rND^sTognin^nMCB#^rND^sSader^nHS#^rND^sGales^n
AC#Polymyxin-Resistant Acinetobacter spp. Isolates: What Is Next?^len#Emerg Infe
ct Dis#20030000#2003#9#1025-1027#20110000#aop13-11.htm#1080-6040#Emerg Infect Di
s##
00791000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100017001100100
01900127010001700146010001800163010001800181012014900199030003000348065000900378
06400050038703100030039201400080039586500090040300200130041203500100042580100300
0435#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#159#18
#article#21#18#^rND^sLautenbach^nE#^rND^sWeiner^nMG#^rND^sNachamkin^nI#^rND^sBil
ker^nWB#^rND^sSheridan^nA#^rND^sFishman^nNO#Imipenem Resistance Among Pseudomona
s aeruginosa Isolates: Risk Factors for Infection and Impact of Resistance on Cl
inical and Economic Outcomes^len#Infect Control Hosp Epidemiol#20060000#2006#27#
893-900#20110000#aop13-11.htm#0899-823X#Infect Control Hosp Epidemiol##
00558000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100020001080120
09800128030001900226710000200245065000900247064000500256031000300261014000600264
865000900270002001300279#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
13-11.htm#S#c#160#19#article#21#19#^rND^sCarneiro^nM#^rND^sSaridakis^nHO#Pneumon
ia associada à ventilação mecânica por Acinetobacter baumannii resistente a carb
apenem^lpt#Rev Panam Infectol#2#20080000#2008#10#28-33#20110000#aop13-11.htm##
00544000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900160021001080160
01900129016001900148018005700167062003000224065000900254064000500263865000900268
002001300277#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#
c#161#20#article#21#20#^rND^sBarbosa^nGL#^rND^sSchlichting^nD#^rND^sOliveira^nDR
#^rND^sDe Paula^nNN#Manual do Serviço de Controle de Infecção Hospitalar^lpt#Hos
pital São Vicente de Paulo#20090000#2009#20110000#aop13-11.htm##
00645000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01700123010001500140010001700155010001700172012008200189030001200271710000200283
065000900285064000500294031000200299014000800301865000900309002001300318#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop13-11.htm#S#c#162#21#article#21#
21#^rND^sPodnos^nYD#^rND^sCinat^nME#^rND^sWilson^nSE#^rND^sCooke^nJ#^rND^sGornic
k^nW#^rND^sThrupp^nLD#Eradication of multi-drug resistant Acinetobacter from an 
intensive care unit^len#Surg Infect#2#20010000#2001#2#297-301#20110000#aop13-11.
htm##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#o#1#
1#article#1#20110325#164624#aop14-11.htm#394##
05079000000000649000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400090016103500100017022300090018001201710
01890120167003600100043005270700087005700700065006570831700007220850008024220850
02202430085003502452085002002487085001702507085001802524085001902542083166802561
08500080422908500200423708500340425708500210429108500170431208500180432908500190
43471170006043660720004043721120009043761110011043851140009043961130011044050020
01304416#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#h#2#
1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#14#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead
#20110000#^f17^l27#0037-8682#20110401#How effective is dog culling in controllin
g zoonotic visceral leishmaniasis?A critical evaluation of the science, politics
 and ethics behind this public health policy^len#Quanto é efetivo o abate de cãe
s para o controle do calazar zoonótico? Uma avaliação crítica da ciência, políti
ca e ética por trás desta política de saúde pública^lpt#^rND^1A01 A02^nCarlos He
nrique Nery^sCosta#Universidade Federal do Piauí^iA01^1Departamento de Medicina 
Comunitária^cTeresina^sPI#Instituto de Doenças Tropicais Natan Portella^iA02^cTe
resina^sPI#^len^aINTRODUCTION: Zoonotic kala-azar, a lethal disease caused by pr
otozoa of the genus Leishmania is considered out of control in parts of the worl
d, particularly in Brazil, where transmission has spread to cities throughout mo
st of the territory and mortality presents an increasing trend. Although a highl
y debatable measure, the Brazilian government regularly culls seropositive dogs 
to control the disease. Since control is failing, critical analysis concerning t
he actions focused on the canine reservoir was conducted. METHODS: In a review o
f the literature, a historical perspective focusing mainly on comparisons betwee
n the successful Chinese and Soviet strategies and the Brazilian approach is pre
sented. In addition, analyses of the principal studies regarding the role of dog
s as risk factors to humans and of the main intervention studies regarding the e
fficacy of the dog killing strategy were undertaken. Brazilian political reactio
n to a recently published systematic review that concluded that the dog culling 
program lacked efficiency and its effect on public policy were also reviewed. RE
SULTS: No firm evidence of the risk conferred by the presence of dogs to humans 
was verified; on the contrary, a lack of scientific support for the policy of ki
lling dogs was confirmed. A bias for distorting scientific data towards maintain
ing the policy of culling animals was observed. CONCLUSIONS: Since there is no e
vidence that dog culling diminishes visceral leishmaniasis transmission, it shou
ld be abandoned as a control measure. Ethical considerations have been raised re
garding distorting scientific results and the killing of animals despite minimal
 or absent scientific evidence#^dnd^i1#^tm^len^kKala-azar^i1#^tm^len^kVisceral l
eishmaniasis^i1#^tm^len^kControl^i1#^tm^len^kDogs^i1#^tm^len^kChina^i1#^tm^len^k
Brazil^i1#^lpt^aINTRODUÇÃO: O calazar zoonótico, uma doença fatal causada por pr
otozoários do gênero Leishmania, é considerada fora de controle, particularmente
 no Brasil, onde se urbaniza e a letalidade aumenta. Apesar de ser uma medida mu
ito controversa, o governo brasileiro abate cães soropositivos regularmente para
 controlar a doença. Assim, diante da falha do controle, foi efetuada uma anális
e crítica das ações para o controle do reservatório canino. MÉTODOS: Em uma revi
são da literatura, foi feita uma abordagem histórica focalizada principalmente n
a comparação das bem sucedidas tentativas chinesas e soviéticas de controlar a d
oença. Também foi efetuada uma análise dos principais estudos acerca do papel de
 cães como fatores de risco para humanos e dos principais ensaios de intervenção
 acerca da eliminação destes animais. A reação política do Brasil a uma revisão 
sistemática recentemente publicada que concluiu pela ineficácia do programa de e
liminação de cães e os seus efeitos nas políticas públicas são revisadas. RESULT
ADOS: Não foram encontradas evidências firmes do risco conferido por cães para o
s seres humanos. Além disto, foi confirmada a falta de apoio científico à políti
ca de eliminação de cães. Foi notada uma tendência para distorção dos dados cien
tíficos para o suporte da política de eliminação dos animais. CONCLUSÕES: Uma ve
z que não existem evidências de que o abate de cães diminui a transmissão de lei
shmaniose visceral, este programa deve ser abandonado como estratégia de control
e. São levantadas as implicações éticas acerca da distorção da ciência e sobre a
 eliminação de animais na ausência de mínima ou nenhuma evidência científica.#^d
nd^i2#^tm^lpt^kCalazar^i2#^tm^lpt^kLeishmaniose visceral^i2#^tm^lpt^kControle^i2
#^tm^lpt^kCães^i2#^tm^lpt^kChina^i2#^tm^lpt^kBrasil^i2#other#101#20100514#14/05/
2010#20101129#29/11/2010#aop14-11.htm##
05184000000000649000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400090016103500100017022300090018001201850
01890120188003740100043005620700087006050700065006920831735007570850008024920850
02202500085003502522085002002557085001702577085001802594085001902612083170302631
08500080433408500200434208500340436208500210439608500170441708500180443408500190
44521170006044710720004044771120009044811110011044901140009045011130011045100020
01304521#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#f#3#
1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#14#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead
#20110000#^f17^l27#0037-8682#20110401#<b>How effective is dog culling in control
ling zoonotic visceral leishmaniasis?</b><b>A critical evaluation of the science
, politics and ethics behind this public health policy</b>^len#<b>Quanto é efeti
vo o abate de cães para o controle do calazar zoonótico?</b><b> </b><b>Uma avali
ação crítica da ciência, política e ética por trás desta política de saúde públi
ca</b>^lpt#^rND^1A01 A02^nCarlos Henrique Nery^sCosta#Universidade Federal do Pi
auí^iA01^1Departamento de Medicina Comunitária^cTeresina^sPI#Instituto de Doença
s Tropicais Natan Portella^iA02^cTeresina^sPI#^len^a<b>INTRODUCTION:</b> Zoonoti
c kala-azar, a lethal disease caused by protozoa of the genus <i>Leishmania</i> 
is considered out of control in parts of the world, particularly in Brazil, wher
e transmission has spread to cities throughout most of the territory and mortali
ty presents an increasing trend. Although a highly debatable measure, the Brazil
ian government regularly culls seropositive dogs to control the disease. Since c
ontrol is failing, critical analysis concerning the actions focused on the canin
e reservoir was conducted. <b>METHODS: </b>In a review of the literature, a hist
orical perspective focusing mainly on comparisons between the successful Chinese
 and Soviet strategies and the Brazilian approach is presented. In addition, ana
lyses of the principal studies regarding the role of dogs as risk factors to hum
ans and of the main intervention studies regarding the efficacy of the dog killi
ng strategy were undertaken. Brazilian political reaction to a recently publishe
d systematic review that concluded that the dog culling program lacked efficienc
y and its effect on public policy were also reviewed. <b>RESULTS: </b>No firm ev
idence of the risk conferred by the presence of dogs to humans was verified; on 
the contrary, a lack of scientific support for the policy of killing dogs was co
nfirmed. A bias for distorting scientific data towards maintaining the policy of
 culling animals was observed. <b>CONCLUSIONS: </b>Since there is no evidence th
at dog culling diminishes visceral leishmaniasis transmission, it should be aban
doned as a control measure. Ethical considerations have been raised regarding di
storting scientific results and the killing of animals despite minimal or absent
 scientific evidence#^dnd^i1#^tm^len^kKala-azar^i1#^tm^len^kVisceral leishmanias
is^i1#^tm^len^kControl^i1#^tm^len^kDogs^i1#^tm^len^kChina^i1#^tm^len^kBrazil^i1#
^lpt^a<b>INTRODUÇÃO: </b>O calazar zoonótico, uma doença fatal causada por proto
zoários do gênero <i>Leishmania</i>, é considerada fora de controle, particularm
ente no Brasil, onde se urbaniza e a letalidade aumenta. Apesar de ser uma medid
a muito controversa, o governo brasileiro abate cães soropositivos regularmente 
para controlar a doença. Assim, diante da falha do controle, foi efetuada uma an
álise crítica das ações para o controle do reservatório canino. <b>MÉTODOS: </b>
Em uma revisão da literatura, foi feita uma abordagem histórica focalizada princ
ipalmente na comparação das bem sucedidas tentativas chinesas e soviéticas de co
ntrolar a doença. Também foi efetuada uma análise dos principais estudos acerca 
do papel de cães como fatores de risco para humanos e dos principais ensaios de 
intervenção acerca da eliminação destes animais. A reação política do Brasil a u
ma revisão sistemática recentemente publicada que concluiu pela ineficácia do pr
ograma de eliminação de cães e os seus efeitos nas políticas públicas são revisa
das. <b>RESULTADOS: </b>Não foram encontradas evidências firmes do risco conferi
do por cães para os seres humanos. Além disto, foi confirmada a falta de apoio c
ientífico à política de eliminação de cães. Foi notada uma tendência para distor
ção dos dados científicos para o suporte da política de eliminação dos animais. 
<b>CONCLUSÕES: </b>Uma vez que não existem evidências de que o abate de cães dim
inui a transmissão de leishmaniose visceral, este programa deve ser abandonado c
omo estratégia de controle. São levantadas as implicações éticas acerca da disto
rção da ciência e sobre a eliminação de animais na ausência de mínima ou nenhuma
 evidência científica.#^dnd^i2#^tm^lpt^kCalazar^i2#^tm^lpt^kLeishmaniose viscera
l^i2#^tm^lpt^kControle^i2#^tm^lpt^kCães^i2#^tm^lpt^kChina^i2#^tm^lpt^kBrasil^i2#
other#101#20100514#14/05/2010#20101129#29/11/2010#aop14-11.htm##
05202000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000500108038000400113121000300117049000300120
15800030012303000260012603200060015206500090015801400090016703500100017622300090
01860120171001950120167003660100043005330700089005760700067006650831700007320850
00802432085002202440085003502462085002002497085001702517085001802534085001902552
08316680257108500080423908500200424708500340426708500210430108500170432208500180
43390850019043571170006043760720004043821120009043861110011043951140009044061130
01104415002001304426008008904439#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop14-11.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1#4.0#ilus#tab#14#nd#nd#R
ev. Soc. Bras. Med. Trop#ahead#20110000#^f17^l27#0037-8682#20110401#How effectiv
e is dog culling in controlling zoonotic visceral leishmaniasis?A critical evalu
ation of the science, politics and ethics behind this public health policy^len#Q
uanto é efetivo o abate de cães para o controle do calazar zoonótico? Uma avalia
ção crítica da ciência, política e ética por trás desta política de saúde públic
a^lpt#^rND^1A01 A02^nCarlos Henrique Nery^sCosta#^iA01^1Universidade Federal do 
Piauí^2Departamento de Medicina Comunitária^cTeresina^sPI#^iA02^1Instituto de Do
enças Tropicais Natan Portella^cTeresina^sPI#^len^aINTRODUCTION: Zoonotic kala-a
zar, a lethal disease caused by protozoa of the genus Leishmania is considered o
ut of control in parts of the world, particularly in Brazil, where transmission 
has spread to cities throughout most of the territory and mortality presents an 
increasing trend. Although a highly debatable measure, the Brazilian government 
regularly culls seropositive dogs to control the disease. Since control is faili
ng, critical analysis concerning the actions focused on the canine reservoir was
 conducted. METHODS: In a review of the literature, a historical perspective foc
using mainly on comparisons between the successful Chinese and Soviet strategies
 and the Brazilian approach is presented. In addition, analyses of the principal
 studies regarding the role of dogs as risk factors to humans and of the main in
tervention studies regarding the efficacy of the dog killing strategy were under
taken. Brazilian political reaction to a recently published systematic review th
at concluded that the dog culling program lacked efficiency and its effect on pu
blic policy were also reviewed. RESULTS: No firm evidence of the risk conferred 
by the presence of dogs to humans was verified; on the contrary, a lack of scien
tific support for the policy of killing dogs was confirmed. A bias for distortin
g scientific data towards maintaining the policy of culling animals was observed
. CONCLUSIONS: Since there is no evidence that dog culling diminishes visceral l
eishmaniasis transmission, it should be abandoned as a control measure. Ethical 
considerations have been raised regarding distorting scientific results and the 
killing of animals despite minimal or absent scientific evidence#^dnd^i1#^tm^len
^kKala-azar^i1#^tm^len^kVisceral leishmaniasis^i1#^tm^len^kControl^i1#^tm^len^kD
ogs^i1#^tm^len^kChina^i1#^tm^len^kBrazil^i1#^lpt^aINTRODUÇÃO: O calazar zoonótic
o, uma doença fatal causada por protozoários do gênero Leishmania, é considerada
 fora de controle, particularmente no Brasil, onde se urbaniza e a letalidade au
menta. Apesar de ser uma medida muito controversa, o governo brasileiro abate cã
es soropositivos regularmente para controlar a doença. Assim, diante da falha do
 controle, foi efetuada uma análise crítica das ações para o controle do reserva
tório canino. MÉTODOS: Em uma revisão da literatura, foi feita uma abordagem his
tórica focalizada principalmente na comparação das bem sucedidas tentativas chin
esas e soviéticas de controlar a doença. Também foi efetuada uma análise dos pri
ncipais estudos acerca do papel de cães como fatores de risco para humanos e dos
 principais ensaios de intervenção acerca da eliminação destes animais. A reação
 política do Brasil a uma revisão sistemática recentemente publicada que conclui
u pela ineficácia do programa de eliminação de cães e os seus efeitos nas políti
cas públicas são revisadas. RESULTADOS: Não foram encontradas evidências firmes 
do risco conferido por cães para os seres humanos. Além disto, foi confirmada a 
falta de apoio científico à política de eliminação de cães. Foi notada uma tendê
ncia para distorção dos dados científicos para o suporte da política de eliminaç
ão dos animais. CONCLUSÕES: Uma vez que não existem evidências de que o abate de
 cães diminui a transmissão de leishmaniose visceral, este programa deve ser aba
ndonado como estratégia de controle. São levantadas as implicações éticas acerca
 da distorção da ciência e sobre a eliminação de animais na ausência de mínima o
u nenhuma evidência científica.#^dnd^i2#^tm^lpt^kCalazar^i2#^tm^lpt^kLeishmanios
e visceral^i2#^tm^lpt^kControle^i2#^tm^lpt^kCães^i2#^tm^lpt^kChina^i2#^tm^lpt^kB
rasil^i2#other#101#20100514#14/05/2010#20101129#29/11/2010#aop14-11.htm#Internet
^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011005000014
##
00520000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704027600085002001300361#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#5#1#article#289#<p><a name
="enda"></a><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b>How e
ffective is dog culling in controlling zoonotic visceral leishmaniasis? A critic
al evaluation of the science, politics and ethics behind this public health poli
cy</b></font></p>     ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#6#2#article#289#<p>&nbsp;<
/p>     ^cY#aop14-11.htm##
00586000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704034200085002001300427#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#7#3#article#289#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Quanto &eacute; efetivo 
o abate de c&atilde;es para o controle do calazar zoon&oacute;tico? Uma avalia&c
cedil;&atilde;o cr&iacute;tica da ci&ecirc;ncia, pol&iacute;tica e &eacute;tica 
por tr&aacute;s desta pol&iacute;tica de sa&uacute;de p&uacute;blica</b></font><
/p>     ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#8#4#article#289#<p>&nbsp;<
/p>     ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#9#5#article#289#<p>&nbsp;<
/p>     ^cY#aop14-11.htm##
00361000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011600086002001300202#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#10#6#article#289#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Carlos Henrique Nery Co
sta</b></font></p>     ^cY#aop14-11.htm##
00491000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704024600086002001300332#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#11#7#article#289#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif">Departamento de Medicina C
omunit&aacute;ria, Universidade Federal do Piau&iacute;, Teresina, PI. Instituto
 de Doen&ccedil;as Tropicais Natan Portella, Teresina, PI</font></p>     ^cY#aop
14-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011300086002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#12#8#article#289#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#endb">Address to
</a></font></p>     ^cY#aop14-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704002200086002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#13#9#article#289#<p>&nbsp;
</p>     ^cY#aop14-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#14#10#article#289#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop14-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#15#11#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop14-11.htm##
00851000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060500087002001300692#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#16#12#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b> Zoon
otic kala-azar, a lethal disease caused by protozoa of the genus <i>Leishmania</
i> is considered out of control in parts of the world, particularly in Brazil, w
here transmission has spread to cities throughout most of the territory and mort
ality presents an increasing trend. Although a highly debatable measure, the Bra
zilian government regularly culls seropositive dogs to control the disease. Sinc
e control is failing, critical analysis concerning the actions focused on the ca
nine reservoir was conducted.    ^cY#aop14-11.htm##
00847000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060100087002001300688#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#17#13#article#289#<br>   <
b>METHODS: </b>In a review of the literature, a historical perspective focusing 
mainly on comparisons between the successful Chinese and Soviet strategies and t
he Brazilian approach is presented. In addition, analyses of the principal studi
es regarding the role of dogs as risk factors to humans and of the main interven
tion studies regarding the efficacy of the dog killing strategy were undertaken.
 Brazilian political reaction to a recently published systematic review that con
cluded that the dog culling program lacked efficiency and its effect on public p
olicy were also reviewed.    ^cY#aop14-11.htm##
00558000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031200087002001300399#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#18#14#article#289#<br>   <
b>RESULTS: </b> No firm evidence of the risk conferred by the presence of dogs t
o humans was verified; on the contrary, a lack of scientific support for the pol
icy of killing dogs was confirmed. A bias for distorting scientific data towards
 maintaining the policy of culling animals was observed.    ^cY#aop14-11.htm##
00584000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704033800087002001300425#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#19#15#article#289#<br>   <
b>CONCLUSIONS: </b> Since there is no evidence that dog culling diminishes visce
ral leishmaniasis transmission, it should be abandoned as a control measure. Eth
ical considerations have been raised regarding distorting scientific results and
 the killing of animals despite minimal or absent scientific evidence </font></p
>     ^cY#aop14-11.htm##
00432000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018600087002001300273#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#20#16#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Kala-aza
r. Visceral leishmaniasis. Control. Dogs. China. Brazil.</font></p> <hr size="1"
 noshade>     ^cY#aop14-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#21#17#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop14-11.htm##
00871000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062500087002001300712#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#22#18#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O: </b>O calazar zoon&oacute;tico, uma doen&ccedil;a fatal causada por protozo&
aacute;rios do g&ecirc;nero <i>Leishmania</i>, &eacute; considerada fora de cont
role, particularmente no Brasil, onde se urbaniza e a letalidade aumenta. Apesar
 de ser uma medida muito controversa, o governo brasileiro abate c&atilde;es sor
opositivos regularmente para controlar a doen&ccedil;a. Assim, diante da falha d
o controle, foi efetuada uma an&aacute;lise cr&iacute;tica das a&ccedil;&otilde;
es para o controle do reservat&oacute;rio canino.    ^cY#aop14-11.htm##
01023000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704077700087002001300864#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#23#19#article#289#<br>   <
b>M&Eacute;TODOS: </b>Em uma revis&atilde;o da literatura, foi feita uma abordag
em hist&oacute;rica focalizada principalmente na compara&ccedil;&atilde;o das be
m sucedidas tentativas chinesas e sovi&eacute;ticas de controlar a doen&ccedil;a
. Tamb&eacute;m foi efetuada uma an&aacute;lise dos principais estudos acerca do
 papel de c&atilde;es como fatores de risco para humanos e dos principais ensaio
s de interven&ccedil;&atilde;o acerca da elimina&ccedil;&atilde;o destes animais
. A rea&ccedil;&atilde;o pol&iacute;tica do Brasil a uma revis&atilde;o sistem&a
acute;tica recentemente publicada que concluiu pela inefic&aacute;cia do program
a de elimina&ccedil;&atilde;o de c&atilde;es e os seus efeitos nas pol&iacute;ti
cas p&uacute;blicas s&atilde;o revisadas.    ^cY#aop14-11.htm##
00692000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044600087002001300533#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#24#20#article#289#<br>   <
b>RESULTADOS: </b>N&atilde;o foram encontradas evid&ecirc;ncias firmes do risco 
conferido por c&atilde;es para os seres humanos. Al&eacute;m disto, foi confirma
da a falta de apoio cient&iacute;fico &agrave; pol&iacute;tica de elimina&ccedil
;&atilde;o de c&atilde;es. Foi notada uma tend&ecirc;ncia para distor&ccedil;&at
ilde;o dos dados cient&iacute;ficos para o suporte da pol&iacute;tica de elimina
&ccedil;&atilde;o dos animais.    ^cY#aop14-11.htm##
00745000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049900087002001300586#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#25#21#article#289#<br>   <
b>CONCLUS&Otilde;ES: </b> Uma vez que n&atilde;o existem evid&ecirc;ncias de que
 o abate de c&atilde;es diminui a transmiss&atilde;o de leishmaniose visceral, e
ste programa deve ser abandonado como estrat&eacute;gia de controle. S&atilde;o 
levantadas as implica&ccedil;&otilde;es &eacute;ticas acerca da distor&ccedil;&a
tilde;o da ci&ecirc;ncia e sobre a elimina&ccedil;&atilde;o de animais na aus&ec
irc;ncia de m&iacute;nima ou nenhuma evid&ecirc;ncia cient&iacute;fica.</font></
p>     ^cY#aop14-11.htm##
00444000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019800087002001300285#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#26#22#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves:</b> C
alazar. Leishmaniose visceral. Controle. C&atilde;es. China. Brasil.</font></p> 
<hr size="1" noshade>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#27#23#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#28#24#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#29#25#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop14-11.htm##
02790000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704254400087002001302631#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#30#26#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Kala-azar, or visceral le
ishmaniasis, is a curious disease with peculiar geographical distribution. In th
e Indian subcontinent, where most of the cases in the world have occurred, the d
isease occupies a very limited area to the northeast, affecting certain district
s of Bihar State, India, Bangladesh and Nepal<sup>1</sup>. In these places, the 
disease is exclusively anthroponotic; i.e., is only transmitted between people. 
The predominant transmission among humans is also observed in East Africa, mainl
y in Kenya, Sudan, Uganda and Ethiopia. It was also anthroponotic in the plains 
of eastern China, but was extinguished from the lowlands in the 1950s<sup>2</sup
>. In the rest of the world, particularly in the highlands of China, Central Asi
a, the Middle East, Transcaucasia, the Mediterranean, South and Central America,
 it is a zoonosis; i.e., it is transmitted between animals and, secondarily, to 
people. The main known reservoirs are domestic dogs, coyotes and foxes, although
 other mammals may be involved in transmission<sup>3</sup>. The agents of the an
throponotic and zoonotic diseases are different but very similar. They are proto
zoa of the species <i>Leishmania donovani</i> and <i>L. infantum</i>, respective
ly, which appear to have genetically diverged a million years ago in Central Asi
a<sup>4</sup>. American parasites are often referred to as <i>L. chagasi</i>, bu
t they are genetically identical to <i>L. infantum</i>, and have probably been i
ntroduced on many different occasions by European settlers<sup>5,6</sup>; howeve
r, it is possible that indigenous populations may also exist. They are transmitt
ed by species of sand flies that breed in decomposing solid organic matter and b
elong to several species of the genus <i>Phlebotomus</i> (in the Old World) and 
<i>Lutzomyia</i> (in the Americas). The geographical distribution of the vector 
species determines the geographical distribution of the disease, so that the fac
tors that limit it should be the same as those that guide the distribution of th
e disease<sup>3</sup>. Despite the ecological differences, the disease is very s
imilar in different regions: fatal if untreated, characterized by prolonged feve
r, weight loss, anemia, bleeding, enlarged liver and spleen and accompanied by b
acterial infections that are often severe<sup>7</sup>. It has been estimated tha
t at least 59,000 people die annually of the disease around the world, particula
rly in India and Sudan<sup>8</sup>. </font></p>     ^cY#aop14-11.htm##
01559000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704131300087002001301400#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#31#27#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Much has been opined on t
he elimination of domestic dogs to control zoonotic visceral leishmaniasis, but 
few studies have actually assessed the efficiency of such a measure. A recently 
published systematic review of strategies for controlling the disease summarizes
 these studies and indicates directions that this cruel policy should take<sup>9
</sup>. Since there are some indications that despite this systematic review, ac
tions involving dog killing will continue, I decided to specifically review this
 strategy. The literature review was restricted to research and programs whose e
ffects are related only to people. The author conducted a PubMed search with com
binations of the following keywords: visceral leishmaniasis, kala-azar, control,
 dogs, history, and the name of countries and continents where the disease is en
demic. Except for a historic description, only studies with control groups and w
ith a statistical analysis were used to evaluate the role of dogs and the effect
 of control measures. This work also quotes previously identified theses and con
ference abstracts and several references that were identified in the texts exami
ned. I only consulted references that were in English, French, Spanish or Portug
uese.</font></p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#32#28#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00357000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011100087002001300198#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#33#29#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>HISTORICAL BACKGROUND<
/b></font></p>     ^cY#aop14-11.htm##
00345000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009900087002001300186#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#34#30#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Old World</b></font></
p>     ^cY#aop14-11.htm##
01236000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704099000087002001301077#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#35#31#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The first proposal concer
ning a program to eliminate dogs in order to control leishmaniasis appears to ha
ve come from Adler &amp; Tchernomoretz<sup>10</sup>. Since the authors were unab
le to cure dogs in Palestine when using pentavalent antimony or aromatic diamidi
ne, they suggested that the removal of dogs to other places or their elimination
 would be viable alternatives for control. It was probably these remarks that tr
iggered control operations through the elimination of dogs. This concept was lat
er emphasized by Hoare in his prestigious review of 1962<sup>11</sup>. In the 19
50s, two extensive programs of disease control began in China and in the Central
 Asian republics of the then Soviet Union, given the broad distribution of the d
isease and its high incidence. These programs were implemented under the aegis o
f socialist policies and under the mantle of revolutionary and centralized state
s.</font></p>     ^cY#aop14-11.htm##
01767000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704152100087002001301608#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#36#32#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Although no precise figur
es exist, the situation in China was the worst and really desolating. It is assu
med that there were a staggering 500 to 600 thousand people with the disease in 
1951<sup>12</sup>, with the very high prevalence of 3 to 5 individuals per thous
and inhabitants, including the capital Beijing<sup>13</sup>. Moreover, access to
 treatment was very difficult for the majority of patients<sup>14</sup>, which s
uggests that kala-azar killed Chinese patients by the thousands. The disease was
 distributed in 16 of the 33 administrative areas, all north of the Yangzi River
, with three distinct ecological patterns: a) the main type, responsible for the
 vast majority of cases, was anthroponotic, located mainly in the crowded easter
n plains in river valleys, the transmission of which was soon interrupted; b) zo
onotic, associated with the presence of infected dogs, located in mountainous ar
eas of the northeast, north and northwest; c) presumably zoonotic, but with no k
nown animal reservoir, in the extreme northwest desert region (<b><a href="/img/
revistas/rsbmt/2011nahead/aop14-11fig01m.jpg">Figure 1</a></b>)<sup>2, 12, 13, 1
5, 16</sup>. The main vector of the disease, both in the plains and the mountain
s, has always been <i>Ph. chinensis</i>, which is more endophilic, but in the de
sert, <i>Ph. longiductus </i>and<i> Ph. alexandri</i> still prevail, which are e
xophilic and more difficult to control<sup>17</sup>. </font></p>     ^cY#aop14-1
1.htm##
01151000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090500087002001300992#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#37#33#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In these diverse areas, t
he force of transmission could be estimated by age and delayed type hypersensiti
vity (DTH). Thus, in the plains, the mean age was greater, similar to Indian kal
a-azar, while in the mountains and the desert, most of the patients consisted of
 young children<sup>12,13,18,19</sup>, which indicates a lower strength of trans
mission in the plains. Interestingly, in the desert, no infected dogs were ident
ified, while most of the population presented reactivity to the Montenegro test 
(unlike in the areas of canine zoonosis in the mountains)<sup>16</sup>, which su
ggests that the greater strength of the infection in zoonotic regions than in th
e plains is not due to the presence of dogs, but the result of a still poorly un
derstood process, perhaps related to vector feeding preferences<sup>15</sup>.</f
ont></p>     ^cY#aop14-11.htm##
01445000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704119900087002001301286#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#38#34#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Given the hypothesis that
 the Chinese anthroponosis would be similar to Indian kala-azar caused by <i>L. 
donovani</i> and that the Chinese zoonotic visceral leishmaniasis would have <i>
L. infantum</i> as the etiological agent<sup>15</sup>, a careful genotypic analy
sis of isolates of <i>Leishmania</i> in different regions was conducted. This an
alysis highlighted the heterogeneity of the isolates, but showed that <i>L. dono
vani</i> predominated in the eastern plains and that <i>L. infantum </i>was conc
entrated in the mountain areas of Beijing and Gansu, although some <i>L. infantu
m</i> isolates were identified in the plains and isolates of <i>L. donovani</i> 
also came from the mountains, including one from a dog. In the northwestern dese
rt, strains of both species were isolated<sup>20</sup>. Thus, although a spatial
 correspondence between environment and the species of <i>Leishmania</i> has bee
n shown, the coexistence of different species in these areas has also been demon
strated. These biological and ecological variations have incurred enormous conse
quences regarding control efforts<sup>21,22</sup>. </font></p>     ^cY#aop14-11.
htm##
01846000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704160000087002001301687#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#39#35#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Immediately after the com
munists took power in 1949, two major steps were taken to reduce the impact of t
he disease in a dramatic way that embodied the revolutionary spirit: mass treatm
ent of the sick and control of vectors<sup>15</sup>. In relation to mass treatme
nt, Chinese laboratories began manufacturing pentavalent antimony<sup>14</sup>, 
Central Anti-kala-zar Stations were established and over a thousand anti-kala-az
ar units attended by hundreds of specially trained personnel helped the doctors<
sup>2,14</sup>. With this structure, 150 to 200 thousand people were treated fro
m 1951 to 1953 alone<sup>14,18</sup>. Another priority was given to combating th
e vectors, which began in 1951, since <i>P. chinensis </i>was an easy target sin
ce at Chinese latitudes, it has only one or two generations per year and lands o
n walls after feeding. The country started to produce the organochlorine insecti
cidesdichlorodiphenyltrichloroethane (DDT) and gammexane and experiments were co
nducted that showed their efficiency and prolonged residual effect. DDT became w
idely used inside and outside houses, and in outhouses and was applied in all ho
useholds of densely populated villages<sup>14,15</sup>. Although the application
 was on a large scale, the precise extent of its use in the critical years of th
e 1950s is not mentioned<sup>2</sup>. Since the 80s, DDT and gammexane have no l
onger been used and have been replaced by pyrethroids, today restricted to areas
 of zoonotic visceral leishmaniasis<sup>16,23</sup>.</font></p>     ^cY#aop14-11
.htm##
01670000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704142400087002001301511#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#40#36#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The program for the dispo
sal of dogs in China was as even more difficult to assess than the use of insect
icides, since it is not known precisely where and to what extent it was applied,
 perhaps due to the large variation in the prevalence of canine infection by <i>
Leishmania</i> in the country (from zero or minimal in the plains and desert to 
7% in mountainous areas)<sup>2,12,19</sup>. This heterogeneity led to different 
interpretations concerning the efficiency of eliminating dogs, because some auth
ors have relegated the core of the success of the control simply to the mass tre
atment and tothe use of insecticides<sup>14,24,25</sup>, while others attributed
 a relevant role to the elimination of dogs in areas of zoonotic visceral leishm
aniasis<sup>2,13,18</sup>. One fact worth noting is that the elimination of the 
animals was not performed using any definitive selection method, but indiscrimin
ately, killing any dog in sight in endemic areas<sup>24</sup>. To provide some i
dea of the magnitude of this program, it was estimated that the killing would on
ly be efficient if it eliminated at least 3/4 of all dogs in an area, whether or
 not evidence of leishmaniasis was available<sup>16</sup>. However, despite the 
fact that an enormous number of dogs were sacrificed, transmission among dogs re
sumed four years later<sup>23</sup>.</font></p>     ^cY#aop14-11.htm##
01243000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704099700087002001301084#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#41#37#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The huge Chinese efforts 
were rewarded in spectacular fashion, because by 1958, transmission was already 
entirely interrupted in areas of anthroponotic leishmaniasis<sup>15,19</sup>, an
d this finally became a reality in the 1970s<sup>26</sup>, accompanied by reduct
ion to near-extinction of <i>P. chinensis</i> from the plains<sup>24</sup>, maki
ng leishmaniasis a relatively rare disease in China<sup>13</sup>. The annual inc
idence dropped to around 200-300 cases, restricted to mountainous regions of the
 north and northwest, where exophilic vector populations continued<sup>16, 24</s
up>. After the initial success, complete elimination of kala-azar in the country
 was predicted to occur by the 1960s<sup>19</sup>, but in the 1980s, an increase
 in the number of cases occurred<sup>23</sup>, attributed to the dismantling of 
the anti-kala-azar network during the Cultural Revolution of 1966 to 1976<sup>2,
12</sup>.</font></p>     ^cY#aop14-11.htm##
02369000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704212300087002001302210#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#42#38#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">It is not easy to specula
te regarding the effectiveness of the Chinese control program, with its many nua
nces. A good explanation for the great success in the plains may have been the l
ow force of transmission in those areas, and the dense population, where control
 was evidently easier and more noticeable. In contrast, in the northwest areas, 
the high force of infection and more dispersed populations did not enabled such 
an abrupt drop in the incidence of number of cases, as verified in the lowlands.
 A great deal can be learned from the striking differences between the success o
f control in the anthroponotic and zoonotic areas seen in the truly gigantic Chi
nese control program. Obviously, the control of the anthroponosis cannot be attr
ibuted to the elimination of dogs, which leads to the conclusion that the transm
ission of anthroponotic leishmaniasis in China can only be attributed to mass tr
eatment and the use of DDT and gammexane. The real reason for the success of the
 Chinese control of anthroponotic leishmaniasis seems to have been the use of or
ganochlorine pesticides that eradicated <i>P. chinensis,</i> the main vector in 
the lowlands. This first lesson should remain. However, the question of what the
 effect was of the elimination of dogs in the areas of a zoonosis continues. Apa
rt from two studies that showed a reduction in the number of human cases followi
ng mass removal of dogs and treatment of people<sup>16</sup>, the simultaneous u
se of organochlorine insecticides in the areas of zoonotic visceral leishmaniasi
s prevents any definitive conclusion regarding the relative effectiveness of the
 disposal of dogs. The maintenance of transmission in the highlands demonstrates
 that the use of organochlorine insecticides did not have the same success in co
ntrolling zoonotic visceral leishmaniasis as it did with the anthroponotic disea
se. However, in spite of the overall success of the Chinese program, what the re
sults most clearly indicate is how difficult it is to control zoonotic visceral 
leishmaniasis. </font></p>     ^cY#aop14-11.htm##
01206000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704096000087002001301047#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#43#39#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The experiences of the co
ntrol strategies for leishmaniasis used in the Transcaucasian and Central Asian 
Republics of the former Soviet Union are helpful, since they provide information
 that is very relevant today. In these areas, the disease is only caused by <i>L
. infantum</i> and affects people and dogs<sup>22,27</sup>. It was an urban dise
ase and affected towns and cities, such as Tbilisi (in Georgia), Yerevan, (Armen
ia), Kyzylorda (Kazakhstan), and Tashkent and Samarkand (Uzbekistan)<sup>28</sup
>. The vectors were <i>P. chinensis</i>, which was extinguished, and <i>P. longi
ductus</i> and <i>P. sminov</i><sup>22</sup>. Of particular interest was the sit
uation in <i>oblast</i> Kyzylorda, where the proportion of sick children under t
wo years of age reached 92.9%, showing a huge force of infection, similar to the
 desert regions of northwestern China<sup>21</sup>. </font></p>     ^cY#aop14-11
.htm##
01583000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704133700087002001301424#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#44#40#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In these countries, inter
vention was also a combination of traditional methods: the detection and treatme
nt of human cases and disposal of dogs, but the main success was achieved only a
fter DDT use for treatment of dwellings in a radius of 500 meters from the micro
focus, and in some places, streets and city blocks<sup>22</sup>. Since these mea
sures were implemented, visceral leishmaniasis has also become scarce in the are
a of the Soviet Union, except in Kyzylorda<sup>22</sup>. In this administrative 
region, an interruption in transmission occurred in the capital, but there was n
o response to the control actions in the countryside and no reduction in the num
ber of cases in the region. Although dogs are found naturally infected, a cycle 
involving coyotes has been verified, which may help to explain the difficulty in
 controlling the disease. Nevertheless, the main reason for continued transmissi
on in this <i>oblast</i> seems to have been the scant use of DDT<sup>21</sup>, w
hich was subsequently banned in the Soviet Union in 1970<sup>29</sup>. The contr
ol failure in this area indicates that, like China, the interruption of transmis
sion in <i>L. infantum</i> foci with a high force transmission may not be possib
le, even with the use of DDT.</font></p>     ^cY#aop14-11.htm##
01578000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704133200087002001301419#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#45#41#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The experience of the Ind
ian subcontinent reveals the astonishing impact that the control of malaria with
 DDT had on the control of leishmaniasis. In the region of Bihar, India, and in 
Bangladesh and Nepal, the disease presented epidemic cycles until the end of the
 1940s. In 1953, the national program for malaria control began with the use of 
DDT, reaching its apex in 1958, which led to the disappearance of the vector <i>
P. argentipes</i> from the interior of houses. Thus, leishmaniasis disappeared a
nd also became rare in India. However, with the end of the Global Malaria Eradic
ation Campaign in 1971, resurgence of the infection was observed, which reached 
its zenith in 1977, probably affecting a million people, with a fatality rate of
 about 7%<sup>30,31</sup>. Currently, India has been implementing the use of DDT
 in the State of Bihar since 1971, but control has not been achieved<sup>32</sup
>, even though the country plans to eradicate the disease by 2015<sup>33</sup>. 
Some current studies have compared the effectiveness of residual spraying of ins
ecticides with mosquito nets impregnated with long-term insecticides and with en
vironmental modification, and the best results have been with indoor residual sp
raying<sup>34,35</sup>. </font></p>     ^cY#aop14-11.htm##
00345000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009900087002001300186#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#46#42#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>New World</b></font></
p>     ^cY#aop14-11.htm##
02314000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704206800087002001302155#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#47#43#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In the New World, some lo
cal experiences in Brazil are also relevant to assessing the effectiveness of el
iminating infected dogs as a control measure. In this country, the disease is ca
used by <i>L. chagasi</i> (= <i>L. infantum</i>), with dogs, foxes, other specie
s of mammals and people as vertebrate reservoirs, and is transmitted by the <i>L
utzomyia longipalpis</i> sand fly, which presents both exophilic and endophilic 
habits. It was a disease of the semi-arid regions where control efforts have bee
n conducted since the 1950s. Despite this, transmission in smaller cities had al
ready been registered. The present phenomenon of large scale urbanization starte
d in 1981, when epidemics hit Teresina and then S&atilde;o Luis, in the mid-nort
h, spread throughout the country to the west and south, affecting several states
, including S&atilde;o Paulo and Rio Grande do Sul, and larger cities, such as B
elo Horizonte and the capital, Brasilia (<b><a href="/img/revistas/rsbmt/2011nah
ead/aop14-11fig02m.jpg">Figure 2</a></b>). Moreover, the total number of cases i
n the country nearly doubled despite all efforts of control<sup>36,37</sup>. The
 annual cumulative incidence rate increased more discretely, but the mortality r
ate rose significantly despite medical advances and the development of specific 
guidelines for the most serious presentation of this disease<sup>38,39</sup>. Re
cently, urban outbreaks have begun to occur in neighboring Argentina<sup>40</sup
>. The situation of leishmaniasis in Brazil is the opposite to that of China, be
cause after nearly 30 years of trying to control the disease, that country had a
bout 10 times fewer cases than China had in 1950 and currently has 10 times more
 than China now has. This difference is probably due to the successful control o
f the vast number of cases of anthroponotic visceral leishmaniasis in China, whe
reas Brazil has tried to control the emergent process of urbanization by priorit
izing the selective elimination of dogs.</font></p>     ^cY#aop14-11.htm##
01470000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704122400087002001301311#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#48#44#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The control of leishmania
sis in Brazil began in the State of Cear&aacute;, in the semi-arid northeast, in
 1953, and just as in China and the Soviet Union, this was based on the treatmen
t of people, the use of DDT and the elimination of dogs. The difference between 
these countries is that, in Brazil, only dogs with reactive serology were elimin
ated<sup>41</sup>. In 1953, only one reagent dog was killed, but in 1954 and 195
5, the number rose to 42 and was higher than 2,000 in 1960. No analysis of the e
ffect of removing dogs was conducted, but in 14 counties sprayed with DDT, a 58.
2% reduction in the incidence of human cases (765 cases before and 320 after) oc
curred, against an increase of 11.9% in 14 municipalities where only dog culling
 was carried out (89 cases before and 101 after) (<b><a href="#fig3">Figure 3</a
></b>)<sup>42</sup>. Unfortunately, the use of DDT was discontinued in the 1960s
<sup>41</sup>. In any case, DDT proved capable of reducing the incidence of zoon
otic visceral leishmaniasis, although the results were a lot less effective than
 those verified for anthroponotic visceral leishmaniasis in China and India.</fo
nt></p>     ^cY#aop14-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#49#45#article#289#<p><a na
me="fig3"></a></p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#50#46#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#51#47#article#289#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop14-11fig03.jpg"></p>     ^
cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#52#48#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
01111000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704086500087002001300952#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#53#49#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The only control experien
ce that was a definite long-term success in Brazil occurred in the late 1960s in
 the Rio Doce valley, Minas Gerais, in the southeast region. The classical measu
res were used, including the application of DDT, for about 10 years. Beforehand,
 up to 40% of dogs were seropositive. The incidence fell from 169 cases in 1965 
to zero in 1978 and in subsequent years<sup>43</sup>. However, despite the conti
nuity of the program, but with the help of pyrethroids instead of DDT, infection
 among dogs is reemerging<sup>44</sup>. Another successful experience in Brazil 
occurred in a small outbreak in Rio de Janeiro, between 1979 and 1985<sup>45</su
p>, where they used organochlorines, followed by pyrethroids. However, there was
 no interruption of the transmission.</font></p>     ^cY#aop14-11.htm##
01474000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704122800087002001301315#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#54#50#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The application of contro
l measures on a large scale in Brazil was secondary to the epidemic outbreaks th
at started the process of urbanization and expansion of the disease in the early
 1980s in the state of Piau&iacute;. Similarly to India, actions against other d
iseases had some repercussion on leishmaniasis, since limited spraying with DDT 
for malaria seems to have protected against the intense transmission of leishman
iasis (in the outbreak of 1981-1986). Furthermore, in those municipalities with 
extensive spraying with gammexane for Chagas' disease, the incidence of leishman
iasis was the lowest<sup>46</sup>. However, gammexanewasnever used for leishmani
asis and the indoor use of DDT for this disease was minimal. Instead, the use of
 organophosphates and later, ultra-low volume pyrethroids, was predominant<sup>4
1</sup>. Aside from the observations in the 1950s, there has never been a contro
lled study of the use of insecticides for leishmaniasis by <i>L. chagasi</i> any
where in the world. Nowadays, Brazil is the only nation with a large-scale progr
am of systematic elimination of dogs to control zoonotic visceral leishmaniasis.
</font></p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#55#51#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#56#52#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>THE IMPORTANCE OF DOG 
INFECTION FOR HUMAN KALA-AZAR</b></font></p>     ^cY#aop14-11.htm##
01654000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704140800087002001301495#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#57#53#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Neither the role of dogs 
in the transmission of <i>L. infantum</i> to humans, nor the benefits of disposi
ng of dogs have ever achieved consensus in the literature<sup>15,47,48</sup>. Ho
wever, the evidence suggests that infections in humans and dogs are interdepende
nt, although transmission between dogs may be independent of the presence of san
d flies and not associated with human infection<sup>49</sup>. As a general rule,
 where transmission of <i>L. infantum</i> among humans occurs, it also occurs am
ong dogs<sup>19,23,50</sup>. In one study, the highest prevalence of infection a
mong dogs was not associated with the highest incidence among humans<sup>51</sup
>, but in two other studies in Brazil and in a third in Iran, this association w
as shown<sup>52-54</sup>. These discordant results demonstrate that the associat
ion between human and canine infections is not strong and suggest that the infec
tions between the two hosts may have distinct dynamics, with a more complex rela
tionship than previously thought. The existence of a sylvatic host transmitting 
the disease to both humans and dogs, as observed in Central Asia, cannot be disc
arded. In Brazil, this common source may well originate from the outskirts of ci
ties, as indicated by the association of the human disease with peri-urban veget
ation<sup>55</sup>. </font></p>     ^cY#aop14-11.htm##
02107000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704186100087002001301948#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#58#54#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">An indirect way of analyz
ing the dependence between the infection in humans and the infection in dogs is 
to assess the presence of dogs as a risk factor for humans. Even thou, the resul
ts are also inconsistent (<b><a href="/img/revistas/rsbmt/2011nahead/aop14-11tab
01m.jpg">Table 1</a></b>). Five cross-sectional studies suggest that dogs are ri
sk factors. Two of them, in the Old World, show that both the number of dogs and
 the rate between dogs and humans increase the risk of seropositivity in childre
n<sup>52,56</sup>. Another study, involving multi-level analysis, showed that th
e presence of dogs may increase the risk of clinical manifestation<sup>54</sup>,
 while another showed that the presence of dogs (and poultry) increases the risk
 of seroconversion<sup>57</sup>. Yet another study showed that the time that a d
og remains in a home increases the risk of skin reactivity to <i>Leishmania</i><
sup>58</sup>. However, longitudinal studies revealed borderline or conflicting r
esults. Two case-control studies showed no significant association between the p
resence of dogs and the disease among people<sup>59,60</sup>, although the risk 
of the disease was slightly higher among those domestic groups that lived with d
ogs. Another cohort study showed a contradictory association, depending on wheth
er the outcome was measured using skin reaction or serology<sup>61</sup>, while 
yet another reported no association between the presence of dogs and the develop
ment of the disease in people<sup>62</sup>. These fairly ambiguous results sugge
st that studies that can measure the proportion of the flow of parasites to huma
ns from a canine source have yet to be developed<sup>63</sup>. In order to achie
ve this, it is essential to conduct specifically designed cohort studies.</font>
</p>     ^cY#aop14-11.htm##
01915000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704166900087002001301756#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#59#55#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">While it is intuitive to 
believe that dogs are significant reservoirs because they are more competent at 
infecting sand flies than people<sup>47, 63-68</sup>, other parameters that depe
nd on the vectors (vectorial capacity) are much more significant for the basic r
eproductive number of the disease (e.g., the number of secondary cases emerging 
from an infectious case) and, therefore, for the incrimination of reservoirs. Fo
r example, some observations and mathematical models show that the importance of
 a reservoir is regulated not only by its competence in infecting vectors, but a
lso by the parameters that measure a) the degree of exposure of vertebrate hosts
 to vectors and b) the vector daily mortality. Both parameters have a nonlinear 
(quadratic and exponential) effect on the transmission of the disease<sup>69,70<
/sup>. This means that small efforts aimed at controlling vectors can have stron
g results concerning the transmission of the disease. In contrast, since the com
petence of the vertebrate reservoirs at infecting the vectors has a merely linea
r effect on transmission, proportionally much greater efforts are needed to cont
rol the reservoirs, thus demonstrating why the strategy of removing reservoirs i
s less efficient than controlling vectors. Indeed, Dye<sup>71</sup> and Burattin
i<sup>72</sup> modeled the impact of different strategies on the transmission of
 leishmaniasis and showed that the elimination of vertebrate reservoirs is much 
less efficient than vaccines, nutritional interventions or the use of insecticid
es (<b><a href="#fig3">Figure 3</a></b>).</font></p>     ^cY#aop14-11.htm##
03610000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704336400087002001303451#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#60#56#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">These theoretical uncerta
inties have led to the need for tests to assess the effect of removing dogs on t
he transmission of kala-azar to humans. Four intervention trials were conducted 
in Brazil (<b><a href="/img/revistas/rsbmt/2011nahead/aop14-11tab02m.jpg">Table 
2</a></b>). To some extent, all of them evaluated the effect of selective elimin
ation of seroreactive dogs. The outcome of the first of these trials was serocon
version of humans, conducted in two rural areas. No difference between the areas
 of intervention and control (20% vs. 22% and 26% vs. 27% respectively) were ver
ified after periods of 6-months and 1-year<sup>73</sup>. The second study compar
ed the effect of the elimination program with the incidence of pediatric cases i
n two urban districts and showed that the annual incidence was lower in the inte
rvention areas than in the control areas (5/1,000 vs. 20/1,000), but due to seve
ral factors, the authors could not attribute the protective effect to the elimin
ation of dogs<sup>74</sup>. Another study expanded the sample size and used rand
om allocation of interventions and factorial design to evaluate seroconversion. 
The study area consisted of 34 plots measuring about 200 x 200m in one neighborh
ood, where the interventions took place in the internal 100 x 100m area, leaving
 a buffer of 200m between each intervention area. Due to the ethical considerati
ons, all houses were sprayed indoors with a synthesis pyrethroid, included those
 within the buffer area. Thus, the following additional interventions were compa
red, and were randomly assigned as: a) spraying in residential outhouses; b) sel
ective removal of seroreactive dogs; c) spraying in residential outhouses and se
lective removal of seroreactive dogs; d) no other intervention apart from indoor
 spraying. After six months to one year of intervention, the incidence in the ar
ea where the removal of dogs was conducted with indoor spraying (but not outdoor
 spraying) fell from 46% to 16.1%. However, this effect of eliminating dogs disa
ppeared (40% to 37.9%) in the area where removal of dogs was conducted with simu
ltaneous indoor and outdoor spraying. No reduction also occurred when only addit
ional outdoor spraying was conducted. The three main problems in this study were
 the large proportion of non intervention-buffer areas (which corresponded to 75
% of the study area), the loss of up to 46% of the studied population and the al
location of an indoor spraying fund, which hindered the assessment of the effect
 of elimination of dogs in the absence of insecticide use<sup>75</sup>. An addit
ional study compared the strategies of: a) no intervention, b) spraying with pyr
ethroid insecticide, and c) area under the combination of insecticide spraying a
nd screening with the elimination of seropositive dogs, in three districts of Fe
ira de Santana in Bahia State. After a year, the seroconversion incidence densit
ies were, respectively, 3.02, 2.86 and 1.65 per 100 children-years. The differen
ces were not statistically significant to distinguish the effect on transmission
<sup>76</sup>. Although all the studies presented significant problems, it seems
 that there is a dubious, tenuous and evanescent trend of additional protection 
by removing dogs, but far less than the theory predicts.</font></p>     ^cY#aop1
4-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#61#57#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00384000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013800087002001300225#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#62#58#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICTS BETWEEN SCIE
NCE AND CONTROL PROGRAMMES</b></font></p>     ^cY#aop14-11.htm##
02722000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704247600087002001302563#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#63#59#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Science and public policy
 do not always agree or go hand in hand. Incorporation of scientific knowledge i
nto policy depends on political, economical and ethical issues, the grade of sci
entific evidence and agreement between scientists and even on the corporative in
terests of decision-makers<sup>77</sup>. Due to the worsening of the situation o
f zoonotic kala-azar in Brazil and the lack of scientific consensus, choosing th
e best health policy for the control of the disease has been prone to disregardi
ng or misinterpreting the available science. Moreover, the strategy of killing d
ogs is hampered for numerous reasons, such as the low accuracy of the methods in
 assessing the infectivity of dogs, the intensity of efforts needed to remove th
e dogs, the replacement of animals<sup>48</sup> or simple refusal of owners to h
and over their valuable and cherished creatures. Knowing these difficulties, the
 Pan American Health Organization (PAHO) commissioned a systematic review to eva
luate programs aimed at the control of kala-azar. The conclusion was that "<i>in
 spite of all these limitations, the relevant number of reports could be reviewe
d in detail, showing no strong evidence for a significant impact on VL transmiss
ion for any of the interventions reviewed. Canine culling seems to be the least 
acceptable intervention at community level for obvious reasons and has low effic
iency due to the high replacement rate of eliminated dogs with susceptible puppi
es and other cultural obstacles</i>"<sup>9</sup>. This last evaluation, despite 
the limitations of the studies analyzed, finally showed that the hypothesis of A
dler and Tchernomoretz has no empirical support. The review was then presented t
o a panel of consultants as part of the "<i>Project for the establishment of a r
egional cooperative research agenda in the field of neglected diseases</i>" conv
ened by PAHO, the World Health Organization (WHO), TDR and BIREME for a consensu
s meeting, which was also attended by representatives of health ministries of La
tin American countries with leishmaniasis transmission. The meeting was held in 
September 21-22, 2009, in Foz do Igua&ccedil;u, Parana, Brazil, and agreed with 
the systematic reviews conclusions that programs of systematic killing of dogs t
o control kala-azar lacked evidence in the literature as related to the protecti
on of humans (PAHO, a still unpublished report).</font></p>     ^cY#aop14-11.htm
##
02647000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704240100087002001302488#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#64#60#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In order to clarify the p
rocess of constructing guidelines for controlling neglected diseases, the linkin
g of scientific evidence to the maintenance of the dog killing programs to contr
ol kala-azar will be discussed in the following paragraphs. On the following day
, also in Foz do Igua&ccedil;u, a meeting was held by the chiefs of programs for
 visceral leishmaniasis control of the Southern Cone (Meeting regarding Surveill
ance, Prevention and Control of Visceral Leishmaniasis in the Southern Cone of S
outh America) and they decided to recommend the culling of infected dogs, allege
dly supported by the participants of the previous research agenda meeting, despi
te the fact that a position paper had not written or approved, and in clear oppo
sition to the findings of the systematic review<sup>78</sup>. About 10 days afte
r the panel convened by the PAHO, the Ministry of Health of Brazil consulted a f
orum of experts to assess the ban on the treatment of dogs that had been determi
ned by the Health Ministry in 2008<sup>79</sup>. Members of the Forum reaffirmed
 the ban, also in plain disagreement with the conclusions of the systematic revi
ew. The prohibition was based on the agreement that a) the infected dogs must be
 the source of <i>L. infantum</i> for humans and other dogs, b) any treatment wo
uld be inefficient in reducing infectivity, c) could also lead to drug resistanc
e and d) hinder the cooperation of the population with the program of systematic
 elimination of animals. This reaffirmation is a more extreme measure than syste
matic elimination, because it prevents all attempts to rescue the infected anima
ls that are identified in routine screenings and whose owners try to save them w
ith treatment, even with no scientific evidence that killing them will protect p
eople. Currently, a legal measure for strengthening the policy of killing of all
 seropositive animals is being developed by the Ministry of Health and the Brazi
lian Legal Advisory and Consulting Office (Parecer/CODELEGIS/CONJUR/GABIN/MS/LP 
N 1243/2009). Furthermore, far more extreme measures of reservoir control can be
 predicted due to the recent movements towards destroying pups and endangered wi
ld canines. Therefore, it is clear that the Brazilian government will not take i
nto account the conclusions of the systematic review.</font></p>     ^cY#aop14-1
1.htm##
02294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704204800087002001302135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#65#61#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">There are serious problem
s concerning the validity of the conclusions of this forum of dog treatment cons
ulted by the Ministry of Health of Brazil, since it pursued no international rec
ommended norms for elaborating guidelines<sup>80-83</sup>and the following neutr
ality issues were incurred: a) the participants were selected through criteria t
hat were not made public; b) there was bias in the convening of the components, 
because it was already public knowledge that a large number of the participants 
were in favor of canine elimination and potential participants who were known to
 profess an opposing opinion were not invited, which led to bias in the spectrum
 of opinions; c) there was no expert in development of guidelines among the memb
ers of the forum and some of the participants had no expertise in epidemiology a
nd leishmaniasis control (despite being distinguished scientists), which are fun
damental requirements for the development of guidelines<sup>81</sup>; and d) the
 decisions were not preceded by a systematic review, as the brief literature tha
tawas consulted did not follow the rules of this type of evaluation of evidence<
sup>80</sup>, the only systematic review available<sup>9</sup> was not cited and
 the forum omitted publications with results that could lead to different conclu
sions, according to the citations mentioned in <b><a href="/img/revistas/rsbmt/2
011nahead/aop14-11tab01m.jpg">Table 1</a></b>. This suggests that participants d
id not have access to the systematic review and to what went on in Foz do Iguacu
, despite the presence of members of the Ministry of Health and the PAHO at both
 meetings. Thus, by not using international recommendations for the construction
 of systematic reviews and the development of guidelines, the case for banning t
he treatment of dogs to control leishmaniasis in Brazil reveals a systematic los
s of scientific neutrality for the recommendation of a highly debatable health m
easure<sup>83</sup>.</font></p>     ^cY#aop14-11.htm##
01704000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704145800087002001301545#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#66#62#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">There are numerous reason
s for ignoring the science that is oriented towards health policy<sup>77</sup>, 
and some seem plausible in this case. One would be the fragility of knowledge co
ncerning the control of leishmaniasis, as revealed in the systematic review<sup>
9</sup>. Another is the territorial expansion of the disease and increase in inc
idence and mortality<sup>36,37</sup>, which generates expectations and pressures
 on decision makers. Third, the lack of alternatives with recognized effects reg
arding zoonotic visceral leishmaniasis, which, in the face of political pressure
 may push the decision-makers to take irrational attitudes. A fourth possibility
 would be conflicts of interest. Even without considering possible lobbies and r
esearch groups interested in vaccines and tests for the diagnosis of dogs or of 
collars with pesticides, other undefined factors, such as traditions or past rec
ommendations based on control measures used in other programs, such as rabies, m
ay be influencing decision makers negatively and leading to resistance to change
s in the policy for the control of visceral leishmaniasis. This could be created
 by the perceived threat of innovations, because changes in the decisions taken 
could possibly be interpreted as past mistakes and may have implications in rela
tion to the prestige of the institutions and within the institutions. </font></p
>     ^cY#aop14-11.htm##
01522000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704127600087002001301363#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#67#63#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Formal recommendations fo
r the elaboration of further guidelines regarding other subjects of the diseases
 caused by <i>Leishmania</i> and many other tropical diseases are also are in us
e in Brazil<sup>39,84-88</sup>, which would seem to confirm the widespread natur
e of distorting scientific evidence. In any case, perhaps the most important fac
tor that has led to noncompliance with the formality of adherence to scientific 
evidence appears to have been a lack of institutional culture for fostering scie
ntific integrity. This system of evaluating scientific evidence for public polic
y is governed by the promotion of systematic reviews and by the development and 
adoption of formal guidelines<sup>77</sup>. If this climate of integrity had alr
eady been established, it is unlikely the science would have been misinterpreted
. Lastly, the loss of neutrality during the interpretation of the scientific inf
ormation that occurred within the State itself was probably facilitated by the f
act that zoonotic visceral leishmaniasis is a neglected disease that affects the
 least expressive part of the population and whose control and research depend a
lmost entirely on the bureaucracy of the State. </font></p>     ^cY#aop14-11.htm
##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#68#64#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010100087002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#69#65#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUSIONS</b></font>
</p>     ^cY#aop14-11.htm##
01681000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704143500087002001301522#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#70#66#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Beside the three strategi
es used, the treatment patients, the use of indoor residual insecticides and the
 elimination of dogs, three other strategies for the control of zoonotic viscera
l leishmaniasis have been assessed. In Iran, a trial took place involving contro
l by impregnating dog collars with deltamethrin in nine control villages and nin
e intervention villages paired by the prevalence of previous seropositivity and 
immunity was measured after one year of observation. A 43% reduction in the inci
dence of the infection (measured using serology) was determined, but the reducti
on in the incidence of DTH was not significant<sup>52</sup>. In Sudan, a vaccine
 against leishmaniasis was tested that consisted of autoclaved <i>L. major </i>p
lus BCG, which was compared with BCG. Protection only occurred in 6%, but the gr
oup that began to present DTH presented a lower incidence of the disease<sup>89<
/sup>. Finally, the effect of mosquito nets impregnated with insecticide is curr
ently under assessment in India<sup>90</sup>. Excellent reviews regarding the us
e of insecticides and vaccines for leishmaniasis have been published<sup>91-94</
sup> and should be consulted. Therefore, there are promising efficient alternati
ves for the control of leishmaniasis besides the traditional measures that widen
 the horizon of the fight against this disease.</font></p>     ^cY#aop14-11.htm#
#
02283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704203700087002001302124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#71#67#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Since the zoonotic kala-a
zar is now a threat to other South American countries, the decision over what to
 do based on the conclusions of the systematic review has become urgent and impe
rative. Given that there is no hard evidence on how much dogs contribute towards
 human infection, or on the effect of insecticides, particularly organochlorines
, and there are no analyses of the operational obstacles to control measures use
d in large-scale urban environments, and since the biological, social or ecologi
cal events that led to urbanization and the spread of leishmaniasis are absolute
ly unknown<sup>36</sup>, investment in research that addresses these problems mu
st be a priority. Finding vaccines seems to be an immediate challenge. A recent 
international symposium identified the priorities for advancing the development 
of vaccines and this allows agencies to develop a view of crucial investments in
 the sector (Working Group on Research Priorities for Development of Leishmanias
is Vaccines: PLoS Neglected Tropical Diseases, in press). As a final point, the 
resumption of economic growth in emerging economies that are endemic with kala-a
zar, puts pressure on nations like Brazil, India and Iran to take on responsibil
ities of science and technology and to promote serious investments in the develo
pment of vaccines of a quality adequate for use in humans. Despite the great con
troversy surrounding the use of DDT, because of its persistence in the environme
nt and toxicity<sup>29,95,96</sup>, tests should be urgently conducted concernin
g its application to control urban kala-azar. Until then, the most that can be d
one would be a gradual, scheduled and monitored demobilization of the eliminatio
n of dogs, accompanied by extensive independent testing and evaluation of differ
ent strategies for spraying and other alternatives, such as the effect of vaccin
es already licensed for dogs, or collars and mosquito nets impregnated with inse
cticides.</font></p>     ^cY#aop14-11.htm##
01364000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704111800087002001301205#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#72#68#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Tropical and developing c
ountries should also take advantage of this lesson given by the systematic revie
w<sup>9</sup> on the control measures for leishmaniasis and its political conseq
uences. They should seek the best available scientific knowledge, based on the b
est evidence, to obtain the best public health programs. Indeed, article 43 of t
he International Health Regulations<sup>97</sup>, of which Brazil and many endem
ic countries in neglected diseases are signatories, require scientific evidence 
for policy development aimed at public health in one of its clauses. Moreover, t
he World Health Organization, like many other organizations, provides guidelines
 for the development of consensus<sup>98</sup>. Thus, the stimulus for policies 
aimed at promoting integrity<sup>99</sup> is an easily achievable goal and essen
tial for the formation of scientifically neutral environments. Therefore, the le
sson of zoonotic kala-azar can be useful for a quality review of current recomme
ndations for public health in different countries.</font></p>     ^cY#aop14-11.h
tm##
01356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704111000087002001301197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#73#69#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The awakening of the cons
ervationist movement and the rights of minorities, coupled with the recognition 
of complex feelings among mammals has substantially changed the moral relationsh
ip between human beings and animals<sup>100, 101</sup>. Within this change in th
e ethics of relationships with other living beings, dogs are one of the most soc
iable and affectionate species and cannot be regarded as morally irrelevant bein
gs that can be disposed of without causing irrefutable harm to humans. Thus, pro
gressively more accurate and sensitive human values imply the requirement of rep
utable and firm scientific justification in order to be morally valid, which has
 never been the case with any program for the disposal of dogs for the control o
f leishmaniasis. Finally, some good may come from the confused knowledge and dec
isions of the past, since the thousands of dogs needlessly sacrificed may at lea
st serve to encourage a revolution in scientific quality and in the ethics of he
alth policies aimed at neglected diseases.</font></p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#74#70#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#75#71#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop14-11.htm##
00430000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018400087002001300271#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#76#72#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The author is grateful to
 Dr. Dorcas Costa and Dr. Isabel Santos for kindly reviewing the manuscript.</fo
nt></p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#77#73#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#78#74#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop14-11.htm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010800087002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#79#75#article#289#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The author owns two dogs.
</font></p>     ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#80#76#article#289#<p>&nbsp
;</p>     ^cY#aop14-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#81#77#article#289#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop14-11.htm##
00494000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704023400089002001300323#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#82#78#article#
289#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1.	Joshi A,
 Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, et al.  Can visceral lei
shmaniasis be eliminated from Asia? J Vector Borne Dis 2008; 45:105-111.    ^cY#
aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#83#79#article#289#</font><
/p>     ^cY#aop14-11.htm##
00435000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704017500089002001300264#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#84#80#article#
289#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2.	Zhi-Biao
 X. Present situation of visceral leishmaniasis in China. Parasitol    Today 198
9; 5:224-228.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#85#81#article#289#</font><
/p>     ^cY#aop14-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020800089002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#86#82#article#
289#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3.	Committe
e of experts on leishmaniasis. Control of the leishmaniases. Geneva: World Healt
h Organization. Technical Report Series; 1993.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#87#83#article#289#</font><
/p>     ^cY#aop14-11.htm##
00575000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704031500089002001300404#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#88#84#article#
289#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4.	Lukes J,
 Mauricio IL, Schonian G, Dujardin JC, Soteriadou K, Dedet JP, et al.  Evolution
ary and geographical history of the <i>Leishmania donovani</i> complex with a re
vision of current taxonomy. Proc Natl Acad Sci U S A 2007; 104:9375-9380.    ^cY
#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#89#85#article#289#</font><
/p>     ^cY#aop14-11.htm##
00523000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026300089002001300352#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#90#86#article#
289#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5.	Mauricio
 IL, Gaunt MW, Stothard JR, Miles MA. Glycoprotein 63 (gp63) genes show gene con
version and reveal the evolution of Old World <i>Leishmania</i>.    Int J Parasi
tol 2007; 37:565-576.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#91#87#article#289#</font><
/p>     ^cY#aop14-11.htm##
00450000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704019000089002001300279#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#92#88#article#
289#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6.	Mauricio
 IL, Stothard JR, Miles MA. The strange case of <i>Leishmania chagasi</i>. Paras
itol Today 2000; 16:188-189.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#93#89#article#289#</font><
/p>     ^cY#aop14-11.htm##
00389000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704012900089002001300218#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#94#90#article#
289#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7.	Herwaldt
 BL. Leishmaniasis. Lancet 1999; 354:1191-1199.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#95#91#article#289#</font><
/p>     ^cY#aop14-11.htm##
00451000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704019100089002001300280#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#96#92#article#
289#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8.	Desjeux 
P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol
 Infect Dis 2004; 27:305-318.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#97#93#article#289#</font><
/p>     ^cY#aop14-11.htm##
00465000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020500089002001300294#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#98#94#article#
289#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9.	Romero G
A, Boelaert M. Control of visceral leishmaniasis in Latin America:    a systemat
ic review. PLoS Negl Trop Dis 2010; 4:e584.    ^cY#aop14-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#99#95#article#289#</font><
/p>     ^cY#aop14-11.htm##
00458000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704019600091002001300287#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#100#96#article
#289#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10.	Adler
 S, Tchernomoretz I. Failure to cure natural canine visceral leishmaniasis. Ann 
Trop Med Parasitol 1946; 40:320-325.    ^cY#aop14-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#101#97#article#289#</font>
</p>     ^cY#aop14-11.htm##
00440000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704017800091002001300269#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#102#98#article
#289#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11.	Hoare
 A. Reservoir hosts and natural foci of human protozoal infections. Acta Tropica
 1962; 19:281-317.    ^cY#aop14-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#103#99#article#289#</font>
</p>     ^cY#aop14-11.htm##
00439000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017600092002001300268#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#104#100#articl
e#289#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12.	Leng
 YJ. A review of kala-azar in China from 1949 to 1959. Trans R Soc Trop Med Hyg 
1982; 76:531-537.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#105#101#article#289#</font
></p>     ^cY#aop14-11.htm##
00516000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025300092002001300345#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#106#102#articl
e#289#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13.	Zhon
g HL, Zhang NZ. Studies on leishmaniasis in China. Historical background, epidem
iology, clinical aspects, legislature and control program. Chin Med J (Engl) 198
6; 99:281-300.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#107#103#article#289#</font
></p>     ^cY#aop14-11.htm##
00489000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022600092002001300318#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#108#104#articl
e#289#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14.	Lu C
, Chung H, Ling C, Wu C, Wang C, Chiang Y. New China's achievements in the treat
ment and prevention of kala-azar. Chin Med J (Engl) 1955; 78:91-99.    ^cY#aop14
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#109#105#article#289#</font
></p>     ^cY#aop14-11.htm##
00415000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704015200092002001300244#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#110#106#articl
e#289#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15.	Wang
 CT, Wu CC. Studies on kala-azar in new China. Chin Med J 1959; 78:55-71.    ^cY
#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#111#107#article#289#</font
></p>     ^cY#aop14-11.htm##
00466000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020300092002001300295#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#112#108#articl
e#289#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16.	Guan
 LR, Shen WX. Recent advances in visceral leishmaniasis in China. Southeast Asia
n J Trop Med Public Health 1991; 22:291-298.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#113#109#article#289#</font
></p>     ^cY#aop14-11.htm##
00526000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026300092002001300355#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#114#110#articl
e#289#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17.	Zhan
g LM, Leng YJ. Eighty-year research of phlebotomine sandflies (Diptera: Psychodi
dae) in China (1915-1995). II. Phlebotomine vectors of leishmaniasis in China. P
arasite 1997; 4:299-306.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#115#111#article#289#</font
></p>     ^cY#aop14-11.htm##
00435000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017200092002001300264#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#116#112#articl
e#289#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18.	Chun
g H-L. A r&eacute;sum&eacute; of kala-azar work in China. Chin Med J (Engl) 1953
; 71:421-464.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#117#113#article#289#</font
></p>     ^cY#aop14-11.htm##
00437000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017400092002001300266#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#118#114#articl
e#289#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19.	Wu C
. Some achievements on the study of kala-azar in New China. Chin Med J (Engl) 19
58; 77:307-309.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#119#115#article#289#</font
></p>     ^cY#aop14-11.htm##
00548000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028500092002001300377#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#120#116#articl
e#289#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20.	Lu H
G, Zhong L, Guan LR, Qu JQ, Hu XS, Chai JJ, et al.  Separation of Chinese <i>Lei
shmania</i> isolates into five genotypes by kinetoplast and chromosomal DNA hete
rogeneity. Am J Trop Med Hyg 1994; 50:763-770.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#121#117#article#289#</font
></p>     ^cY#aop14-11.htm##
00529000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026600092002001300358#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#122#118#articl
e#289#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21.	Lyse
nko A, Lubova V. Epidemiology and geography of visceral leishmanisis in the URSS
.  Colloque Internationaux du CNRS nº 239; 1977; Paris: &Eacute;cologie de leish
manioses; 1977. p. 253-256.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#123#119#article#289#</font
></p>     ^cY#aop14-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024900092002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#124#120#articl
e#289#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22.	Kell
ina OI. Problem and current lines in investigations on the epidemiology of leish
maniasis and its control in the U.S.S.R. Bull Soc Pathol Exot Filiales.  1981; 7
4:306-318.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#125#121#article#289#</font
></p>     ^cY#aop14-11.htm##
00445000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018200092002001300274#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#126#122#articl
e#289#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23.	Guan
 LR. Current status of kala-azar and vector control in China. Bull World Health 
Organ 1991; 69:595-601.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#127#123#article#289#</font
></p>     ^cY#aop14-11.htm##
00450000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018700092002001300279#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#128#124#articl
e#289#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24.	Mao 
SB. Control of parasitic diseases in China: achievements and prospects. Chin Med
 J (Engl) 1987; 100:445-453.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#129#125#article#289#</font
></p>     ^cY#aop14-11.htm##
00450000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018700092002001300279#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#130#126#articl
e#289#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25.	Yu S
. Control of parasitic diseases in China. Current status and prospects. Chin Med
 J (Engl) 1996; 109:259-265.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#131#127#article#289#</font
></p>     ^cY#aop14-11.htm##
00482000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021900092002001300311#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#132#128#articl
e#289#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26.	Bao 
Y, Wang ST, Shao QF. A further study of LDT and IFAT tests in evaluating the con
trol of kala-azar in China. J Trop Med Hyg 1994; 97:357-361.    ^cY#aop14-11.htm
##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#133#129#article#289#</font
></p>     ^cY#aop14-11.htm##
00572000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030900092002001300401#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#134#130#articl
e#289#27#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27.	Alam
 MZ, Haralambous C, Kuhls K, Gouzelou E, Sgouras D, Soteriadou K,  et al.  The p
araphyletic composition of <i>Leishmania donovani</i> zymodeme  MON-37 revealed 
by multilocus microsatellite typing. Microbes Infect 2009; 11:707-715.    ^cY#ao
p14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#135#131#article#289#</font
></p>     ^cY#aop14-11.htm##
00439000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017600092002001300268#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#136#132#articl
e#289#28#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28.	Lyse
nko AJ. Distribution of leishmaniasis in the Old World. Bull World Health Organ 
1971; 44:515-520.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#137#133#article#289#</font
></p>     ^cY#aop14-11.htm##
00487000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022400092002001300316#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#138#134#articl
e#289#29#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29.	Turu
sov V, Rakitsky V, Tomatis L. Dichlorodiphenyltrichloroethane (DDT): ubiquity, p
ersistence, and risks. Environ Health Perspect 2002; 110:125-128.    ^cY#aop14-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#139#135#article#289#</font
></p>     ^cY#aop14-11.htm##
00406000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704014300092002001300235#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#140#136#articl
e#289#30#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30.	Sen 
Gupta P. Return of kala-azar. J Indian Med Assoc 1975; 65:89-90.    ^cY#aop14-11
.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#141#137#article#289#</font
></p>     ^cY#aop14-11.htm##
00423000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016000092002001300252#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#142#138#articl
e#289#31#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">31.	Thak
ur CP, Kumar M, Pathak PK. Kala-azar hits again. J Trop Med Hyg 1981; 84:271-276
.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#143#139#article#289#</font
></p>     ^cY#aop14-11.htm##
00509000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024600092002001300338#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#144#140#articl
e#289#32#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">32.	Kuma
r V, Kesari S, Kumar AJ, Dinesh DS, Ranjan A, Prasad M, et al.  Vector density a
nd the control of kala-azar in Bihar, India. Mem Inst Oswaldo Cruz 2009; 104:101
9-1022.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#145#141#article#289#</font
></p>     ^cY#aop14-11.htm##
00453000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019000092002001300282#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#146#142#articl
e#289#33#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">33.	Dhil
lon GP, Sharma SN, Nair B. Kala-azar elimination programme in India.  J Indian M
ed Assoc 2008; 106:664,666-668.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#147#143#article#289#</font
></p>     ^cY#aop14-11.htm##
00627000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036400092002001300456#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#148#144#articl
e#289#34#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">34.	Josh
i AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, et al.  Chemical and env
ironmental vector control as a contribution to the elimination of visceral leish
maniasis on the Indian subcontinent: cluster randomized controlled trials in Ban
gladesh, India and Nepal. BMC Med 2009; 7:54.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#149#145#article#289#</font
></p>     ^cY#aop14-11.htm##
00548000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028500092002001300377#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#150#146#articl
e#289#35#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">35.	Bern
 C, Courtenay O, Alvar J. Of cattle, sand flies and men: a systematic review of 
risk factor analyses for South Asian visceral leishmaniasis and implications for
 elimination. PLoS Negl Trop Dis 2010; 4:e599.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#151#147#article#289#</font
></p>     ^cY#aop14-11.htm##
00476000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021300092002001300305#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#152#148#articl
e#289#36#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">36.	Cost
a CH. Characterization and speculations on the urbanization of visceral leishman
iasis in Brazil. Cad Saude Publica 2008; 24:2959-2963.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#153#149#article#289#</font
></p>     ^cY#aop14-11.htm##
00475000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021200092002001300304#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#154#150#articl
e#289#37#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">37.	Bern
 C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributab
le to leishmaniasis. PLoS Negl Trop Dis 2008; 2:e313.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#155#151#article#289#</font
></p>     ^cY#aop14-11.htm##
00753000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704049000092002001300582#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#156#152#articl
e#289#38#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">38.	Mini
st&eacute;rio da Sa&uacute;de. S&eacute;rie hist&oacute;rica de &oacute;bitos e 
casos de doen&ccedil;as de notifica&ccedil;&atilde;o compuls&oacute;ria no Brasi
l (1980-2005). Bras&iacute;lia: Minist&eacute;rio da Sa&uacute;de. Secretaria de
 Vigil&acirc;ncia em Sa&uacute;de. Departamento de Vigil&acirc;ncia Epidemiol&oa
cute;gica. Coordena&ccedil;&atilde;o Geral de Vigil&acirc;ncia Epidemiol&oacute;
gica; 2006.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#157#153#article#289#</font
></p>     ^cY#aop14-11.htm##
00616000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035300092002001300445#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#158#154#articl
e#289#39#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">39.	Comm
ittee of experts on primary healthcare (Brasil). Manual de Vigil&acirc;ncia e Co
ntrole da Leishmaniose Visceral: Minist&eacute;rio da Sa&uacute;de. Bras&iacute;
lia: Secretaria de Vigil&acirc;ncia em Sa&uacute;de. Departamento de Vigil&acirc
;ncia Epidemiol&oacute;gica; 2004.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#159#155#article#289#</font
></p>     ^cY#aop14-11.htm##
00503000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024000092002001300332#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#160#156#articl
e#289#40#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">40.	Salo
mon O, Sinagra A, Nevot M, Barberian G, Paulin P, Estevez J, et al.     First vi
sceral leishmaniasis focus in Argentina. Mem Inst Oswaldo Cruz 2008; 103:109-111
.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#161#157#article#289#</font
></p>     ^cY#aop14-11.htm##
00434000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017100092002001300263#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#162#158#articl
e#289#41#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">41.	Lace
rda MM. The Brazilian leishmaniasis control program. Mem Inst Oswaldo Cruz 1994;
 89:489-495.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#163#159#article#289#</font
></p>     ^cY#aop14-11.htm##
00440000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017700092002001300269#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#164#160#articl
e#289#42#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">42.	Alen
car J. Profilaxia do calazar no Cear&aacute;, Brasil. Rev Inst Med Trop Sao Paul
o 1961; 3:175-180.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#165#161#article#289#</font
></p>     ^cY#aop14-11.htm##
00540000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027700092002001300369#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#166#162#articl
e#289#43#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">43.	Maga
lhaes PA, Mayrink W, Costa CA, Melo MN, Dias M, Batista SM, et al.  Calazar na z
ona do Rio Doce-Minas Gerais. Resultados de medidas profil&aacute;ticas. Rev Ins
t Med Trop Sao Paulo 1980; 22:197-202.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#167#163#article#289#</font
></p>     ^cY#aop14-11.htm##
00619000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035600092002001300448#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#168#164#articl
e#289#44#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">44.	Mala
quias LCC, Romualdo RC, do Anjos Jr JB, Giunchetti RC, Correa-Oliveira R, Reis A
B. Serological screening confirms the re-emergence of canine leishmaniosis in ur
ban and rural areas in Governador Valadares, Vale do Rio Doce, Minas Gerais, Bra
zil. Parasitol Res 2007; 100:233-239.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#169#165#article#289#</font
></p>     ^cY#aop14-11.htm##
00552000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028900092002001300381#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#170#166#articl
e#289#45#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">45.	Marz
ochi MC, Fagundes A, Andrade MV, Souza MB, Madeira MF, Mouta-Confort E, et al.  
Visceral leishmaniasis in Rio de Janeiro, Brazil: eco-epidemiological aspects an
d control. Rev Soc Bras Med Trop 2009; 42:570-580.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#171#167#article#289#</font
></p>     ^cY#aop14-11.htm##
00488000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022500092002001300317#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#172#168#articl
e#289#46#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">46.	Cost
a CHN, Pereira HF, Araujo MV. Epidemia de leishmaniose visceral no Estado do Pia
u&iacute;, Brasil (1980-1986). Rev Saude Publica 1990; 24:361-372.    ^cY#aop14-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#173#169#article#289#</font
></p>     ^cY#aop14-11.htm##
00480000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021700092002001300309#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#174#170#articl
e#289#47#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">47.	Dean
e LM, Deane MP. Visceral leishmaniasis in Brazil: geographical distribution and 
transmission. Rev Inst Med Trop Sao Paulo 1962; 4:198-212.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#175#171#article#289#</font
></p>     ^cY#aop14-11.htm##
00466000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020300092002001300295#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#176#172#articl
e#289#48#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">48.	Cost
a CH, Vieira JB. Changes in the control program of visceral leishmaniasis in Bra
zil. Rev Soc Bras Med Trop 2001; 34:223-228.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#177#173#article#289#</font
></p>     ^cY#aop14-11.htm##
00515000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025200092002001300344#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#178#174#articl
e#289#49#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">49.	Scha
ntz PM, Steurer FJ, Duprey ZH, Kurpel KP, Barr SC, Jackson JE, et al.  Autochtho
nous visceral leishmaniasis in dogs in North America. J Am Vet Med Assoc 2005; 2
26:1316-1322.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#179#175#article#289#</font
></p>     ^cY#aop14-11.htm##
00581000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031800092002001300410#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#180#176#articl
e#289#50#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">50.	Marg
onari C, Freitas CR, Ribeiro RC, Moura AC, Timbo M, Gripp AH, et al.  Epidemiolo
gy of visceral leishmaniasis through spatial analysis, in Belo Horizonte municip
ality, state of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2006;    101:31-38. 
   ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#181#177#article#289#</font
></p>     ^cY#aop14-11.htm##
00495000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023200092002001300324#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#182#178#articl
e#289#51#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">51.	Cost
a C, Moura M, Pereira F. Fatores de risco urbanos para a ocorr&ecirc;ncia de lei
shmaniose visceral.  Rev Soc Bras Med Trop 1995; 28(supl I):7</font></p>     ^cY
#aop14-11.htm##
00559000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029600092002001300388#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#183#179#articl
e#289#52#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">52.	Gavg
ani AS, Hodjati MH, Mohite H, Davies CR. Effect of insecticide-impregnated dog c
ollars on incidence of zoonotic visceral leishmaniasis in Iranian children: a ma
tched-cluster randomised trial. Lancet 2002; 360:374-379.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#184#180#article#289#</font
></p>     ^cY#aop14-11.htm##
00545000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028200092002001300374#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#185#181#articl
e#289#53#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">53.	Oliv
eira CD, Assuncao RM, Reis IA, Proietti FA. Spatial distribution of human and ca
nine visceral leishmaniasis in Belo Horizonte, Minas Gerais State, Brasil, 1994-
1997. Cad Saude Publica 2001; 17:1231-1239.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#186#182#article#289#</font
></p>     ^cY#aop14-11.htm##
00521000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025800092002001300350#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#187#183#articl
e#289#54#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">54.	Wern
eck GL, Costa CH, Walker AM, David JR, Wand M, Maguire JH. Multilevel modelling 
of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol Infect
 2007; 135:195-201.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#188#184#article#289#</font
></p>     ^cY#aop14-11.htm##
00507000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024400092002001300336#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#189#185#articl
e#289#55#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">55.	Wern
eck GL, Costa CH, Walker AM, David JR, Wand M, Maguire JH. The urban spread of v
isceral leishmaniasis: clues from spatial analysis. Epidemiology    2002; 13:364
-367.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#190#186#article#289#</font
></p>     ^cY#aop14-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024800092002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#191#187#articl
e#289#56#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">56.	Kotk
at A, el-Daly S, el-Daaw A, Barakat R. Immunological investigation of visceral l
eishmaniasis among school children in Alexandria. J Egypt Soc Parasitol 1986; 16
:449-456.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#192#188#article#289#</font
></p>     ^cY#aop14-11.htm##
00550000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028700092002001300379#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#193#189#articl
e#289#57#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">57.	More
no EC, Melo MN, Genaro O, Lambertucci JR, Serufo JC, Andrade AS, et al.  Risk fa
ctors for <i>Leishmania chagasi</i> infection in an urban area of    Minas Gerai
s State. Rev Soc Bras Med Trop 2005; 38:456-463.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#194#190#article#289#</font
></p>     ^cY#aop14-11.htm##
00496000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023300092002001300325#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#195#191#articl
e#289#58#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">58.	Gouv
ea MV, Werneck GL, Costa CH, Amorim Carvalho FA. Factors associated to Montenegr
o skin test positivity in Teresina, Brazil. Acta Trop 2007;    104:99-107.    ^c
Y#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#196#192#article#289#</font
></p>     ^cY#aop14-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026900092002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#197#193#articl
e#289#59#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">59.	Navi
n TR, Sierra M, Custodio R, Steurer F, Porter CH, Ruebush TK,    2<sup>nd</sup> 
Epidemiologic study of visceral leishmaniasis in Honduras, 1975-1983.    Am J Tr
op Med Hyg 1985; 34:1069-1075.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#198#194#article#289#</font
></p>     ^cY#aop14-11.htm##
00529000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026600092002001300358#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#199#195#articl
e#289#60#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">60.	Cost
a CH, Pereira HF, Pereira FC, Tavares JP, Araujo MV, Goncalves MJ. Is the househ
old dog a risk factor for American visceral leishmaniasis in Brazil? Trans R Soc
 Trop Med Hyg 1999; 93:464.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#200#196#article#289#</font
></p>     ^cY#aop14-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026900092002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#201#197#articl
e#289#61#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">61.	Cald
as AJ, Costa JM, Silva AA, Vinhas V, Barral A. Risk factors associated with asym
ptomatic infection by <i>Leishmania chagasi</i> in north-east Brazil. Trans R So
c Trop Med Hyg 2002; 96:21-28.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#202#198#article#289#</font
></p>     ^cY#aop14-11.htm##
00680000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704041700092002001300509#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#203#199#articl
e#289#62#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">62.	Nasc
imento MDSB. Epidemiologia da leishmaniose visceral na Ilha de S&atilde;o Luis, 
Maranh&atilde;o, Brasil: an&aacute;lise da din&acirc;mica de transmiss&atilde;o 
e dos fatores de risco relacionados ao desenvolvimento da doen&ccedil;a. &#91;Do
ctor in Medicine&#93;. &#91;S&atilde;o Paulo&#93;: Universidade Federal de S&ati
lde;o Paulo; 1996.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#204#200#article#289#</font
></p>     ^cY#aop14-11.htm##
00475000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021200092002001300304#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#205#201#articl
e#289#63#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">63.	Quin
nell RJ, Courtenay O. Transmission, reservoir hosts and control of zoonotic visc
eral leishmaniasis. Parasitology 2009; 136:1915-1934.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#206#202#article#289#</font
></p>     ^cY#aop14-11.htm##
00445000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018200092002001300274#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#207#203#articl
e#289#64#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">64.	Adle
r S, Theodor O. Transmission of disease agents by phlebotomine sand flies. Annua
l Rev Ent. 1957; 2:203.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#208#204#article#289#</font
></p>     ^cY#aop14-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024800092002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#209#205#articl
e#289#65#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">65.	Sher
lock IA, Sherlock V. S&ocirc;bre a infec&ccedil;&atilde;o experimental de <i>Phl
ebotomus longipalpis</i> pela <i>Leishmania donovani</i>. Rev Bras Biol 1961; 21
:409-418.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#210#206#article#289#</font
></p>     ^cY#aop14-11.htm##
00571000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030800092002001300400#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#211#207#articl
e#289#66#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">66.	Moli
na R, Amela C, Nieto J, San-Andres M, Gonzalez F, Castillo JA, et al.  Infectivi
ty of dogs naturally infected with <i>Leishmania infantum</i> to colonized <i>Ph
lebotomus perniciosus</i>. Trans R Soc Trop Med Hyg 1994; 88:491-493.    ^cY#aop
14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#212#208#article#289#</font
></p>     ^cY#aop14-11.htm##
00603000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034000092002001300432#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#213#209#articl
e#289#67#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">67.	Mich
alsky EM, Rocha MF, Rocha Lima AC, Franca-Silva JC, Pires MQ,    Oliveira FS, et
 al.  Infectivity of seropositive dogs, showing different clinical forms of leis
hmaniasis, to <i>Lutzomyia longipalpis</i> phlebotomine sand flies.    Vet Paras
itol 2007; 147:67-76.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#214#210#article#289#</font
></p>     ^cY#aop14-11.htm##
00515000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025200092002001300344#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#215#211#articl
e#289#68#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">68.	Cost
a CH, Gomes RB, Silva MR, Garcez LM, Ramos PK, Santos RS, et al.  Competence of 
the human host as a reservoir for <i>Leishmania chagasi</i>. J Infect Dis 2000; 
182:997-1000.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#216#212#article#289#</font
></p>     ^cY#aop14-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020500092002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#217#213#articl
e#289#69#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">69.	Roge
rs DJ. The dynamics of vector-transmitted diseases in human communities. Philos 
Trans R Soc Lond B Biol Sci 1988; 321:513-539.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#218#214#article#289#</font
></p>     ^cY#aop14-11.htm##
00546000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028300092002001300375#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#219#215#articl
e#289#70#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">70.	Math
er T, Wilson M, Moore S, Ribeiro J, Spielman A. Comparing the relative potential
 of rodents as reservoirs of the Lyme disease spirochete    (<i>Borrelia burgdor
feri</i>). Am J Epidemiol 1989; 130:143-150.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#220#216#article#289#</font
></p>     ^cY#aop14-11.htm##
00425000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016200092002001300254#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#221#217#articl
e#289#71#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">71.	Dye 
C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996; 55:125-1
30.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#222#218#article#289#</font
></p>     ^cY#aop14-11.htm##
00514000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025100092002001300343#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#223#219#articl
e#289#72#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">72.	Bura
ttini M, Coutinho F, Lopez L, Massad E. Modelling the dynamics of leishmaniasis 
considering human, animal host and vector populations. J Biological Systems 1998
; 4:337-356.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#224#220#article#289#</font
></p>     ^cY#aop14-11.htm##
00550000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028700092002001300379#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#225#221#articl
e#289#73#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">73.	Diet
ze R, Barros GB, Teixeira L, Harris J, Michelson K, Falqueto A, et al.  Effect o
f eliminating seropositive canines on the transmission of visceral leishmaniasis
 in Brazil. Clin Infect Dis. 1997; 25:1240-1242.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#226#222#article#289#</font
></p>     ^cY#aop14-11.htm##
00583000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032000092002001300412#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#227#223#articl
e#289#74#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">74.	Ashf
ord DA, David JR, Freire M, David R, Sherlock I, Eulalio MC, et al.  Studies on 
control of visceral leishmaniasis: impact of dog control on canine and human vis
ceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg 1998; 59:53-57
.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#228#224#article#289#</font
></p>     ^cY#aop14-11.htm##
00518000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025500092002001300347#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#229#225#articl
e#289#75#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">75.	Cost
a CH, Tapety CM, Werneck GL. Controle da leishmaniose visceral em meio urbano: e
studo de interven&ccedil;&atilde;o randomizado fatorial. Rev Soc Bras Med Trop 2
007; 40:415-419.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#230#226#article#289#</font
></p>     ^cY#aop14-11.htm##
00618000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035500092002001300447#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#231#227#articl
e#289#76#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">76.	Souz
a V, Bisinoto T, Juli&atilde;o F, Lima A, Neves R. Communitary assay for assessm
ent of effectiveness of strategies for prevention and control of human visceral 
leishmaniasis in the municipality of Feira de Santana, State of Bahia, Brazil. E
pidemiol Serv Saude 2008; 17:97-106.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#232#228#article#289#</font
></p>     ^cY#aop14-11.htm##
00494000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023100092002001300323#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#233#229#articl
e#289#77#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">77.	McGa
rity TO, Wagner WE. Bending Science: how special interests corrupt public health
 research. 1<sup>st</sup> ed. Cambridge: Harvard University Press; 2008.    ^cY#
aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#234#230#article#289#</font
></p>     ^cY#aop14-11.htm##
00848000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704058500092002001300677#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#235#231#articl
e#289#78#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">78.	Orga
nizaci&oacute;n Panamericana de la Salud. Organizaci&oacute;n Mundial de la Salu
d.  Encuentro sobre vigilancia, prevenci&oacute;n y control de leishmaniasis vis
ceral (LV) en el Cono Sur de Sudam&eacute;rica. Foz do Iguaz&uacute;, Brasil. 20
09 - &#91;cited  2010  Nov  21&#93; Available from: <a href="http://new.paho.org
/panaftosa/index.php?option=com_docman&amp;task=doc_download&amp;gid=79/" target
="_blank">http://new.paho.org/panaftosa/index.php?option=com_docman&amp;task=doc
_download&amp;gid=79/</a>.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#236#232#article#289#</font
></p>     ^cY#aop14-11.htm##
00557000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029400092002001300386#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#237#233#articl
e#289#79#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">79.	Comm
ittee of experts on leishmaniasis.  II Forum de discuss&atilde;o sobre o tratame
nto da leishmaniose visceral canina. Brasilia: Minist&eacute;rio da Sa&uacute;de
. Secretaria de Vigil&acirc;ncia em Sa&uacute;de; 2009.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#238#234#article#289#</font
></p>     ^cY#aop14-11.htm##
00529000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026600092002001300358#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#239#235#articl
e#289#80#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">80.	Manc
hikanti L. Evidence-based medicine, systematic reviews, and guidelines in interv
entional pain management, part I: introduction and general considerations. Pain 
Physician 2008; 11:161-186.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#240#236#article#289#</font
></p>     ^cY#aop14-11.htm##
00504000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024100092002001300333#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#241#237#articl
e#289#81#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">81.	Schu
nemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guide
line development: 1. Guidelines for guidelines. Health Res Policy Syst 2006; 4:1
3.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#242#238#article#289#</font
></p>     ^cY#aop14-11.htm##
00521000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025800092002001300350#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#243#239#articl
e#289#82#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">82.	Fret
heim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guide
line development: 3. Group composition and consultation process. Health Res Poli
cy Syst 2006; 4:15.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#244#240#article#289#</font
></p>     ^cY#aop14-11.htm##
00479000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021600092002001300308#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#245#241#articl
e#289#83#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">83.	Diam
ond GA, Denton TA. Alternative perspectives on the biased foundations of medical
 technology assessment. Ann Intern Med 1993; 118:455-464.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#246#242#article#289#</font
></p>     ^cY#aop14-11.htm##
00604000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034100092002001300433#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#247#243#articl
e#289#84#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">84.	Comm
ittee of experts on dengue. Dengue: diagn&oacute;stico e manejo cl&iacute;nico -
 adulto e crian&ccedil;a. 3ª ed. Bras&iacute;lia: Diretoria T&eacute;cnica de Ge
st&atilde;o. Secretaria de Vigil&acirc;ncia em Sa&uacute;de.  Minist&eacute;rio 
da Sa&uacute;de; 2007.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#248#244#article#289#</font
></p>     ^cY#aop14-11.htm##
00698000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704043500092002001300527#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#249#245#articl
e#289#85#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">85.	Comm
ittee  of experts on leishmaniasis, Committee of experts on HIV infection and Ai
ds. Recomenda&ccedil;&otilde;es para diagn&oacute;stico, tratamento e acompanham
ento da co-infec&ccedil;&atilde;o <i>Leishmania</i>-HIV. Bras&iacute;lia: Progra
ma Nacional de DST e Aids. Secretaria de Vigil&acirc;ncia em Sa&uacute;de.  Mini
st&eacute;rio da Sa&uacute;de; 2004.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#250#246#article#289#</font
></p>     ^cY#aop14-11.htm##
00669000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704040600092002001300498#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#251#247#articl
e#289#86#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">86.	Comm
ittee of experts on primary health care. Vigil&acirc;ncia em sa&uacute;de: dengu
e, esquistossomose, hansen&iacute;ase, mal&aacute;ria, tracoma e tuberculose. 2ª
 ed. Bras&iacute;lia: Secretaria de Aten&ccedil;&atilde;o a Sa&uacute;de. Depart
amento de Aten&ccedil;&atilde;o B&aacute;sica. Minist&eacute;rio da Sa&uacute;de
; 2008.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#252#248#article#289#</font
></p>     ^cY#aop14-11.htm##
00697000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704043400092002001300526#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#253#249#articl
e#289#87#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">87.	Comm
ittee of experts on tegumentar leishmaniasis. Leishmaniose Visceral Grave: Norma
s e Condutas. 1<sup>st</sup> ed. Bras&iacute;lia: Coordena&ccedil;&atilde;o Gera
l de Vigil&acirc;ncia Epidemiol&oacute;gica. Departamento de Vigil&acirc;ncia Ep
idemiol&oacute;gica. Secretaria de Vigil&acirc;ncia em Sa&uacute;de. Minist&eacu
te;rio da Sa&uacute;de; 2006. p.51.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#254#250#article#289#</font
></p>     ^cY#aop14-11.htm##
00528000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026500092002001300357#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#255#251#articl
e#289#88#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">88.	Comm
ittee of experts on tegumentar leishmaniasis. Manual de vigil&acirc;ncia da leis
hmaniose tegumentar americana. 2ª ed. Bras&iacute;lia: Editora do Minist&eacute;
rio da Sa&uacute;de; 2010.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#256#252#article#289#</font
></p>     ^cY#aop14-11.htm##
00586000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032300092002001300415#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#257#253#articl
e#289#89#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">89.	Khal
il EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, et al.  Autocla
ved <i>Leishmania major</i> vaccine for prevention of visceral leishmaniasis: a 
randomised, double-blind, BCG-controlled trial in Sudan. Lancet 2000; 356:1565-1
569.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#258#254#article#289#</font
></p>     ^cY#aop14-11.htm##
00576000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031300092002001300405#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#259#255#articl
e#289#90#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">90.	Pica
do A, Das ML, Kumar V, Kesari S, Dinesh DS, Roy L, et al.  Effect of village-wid
e use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in Ind
ia and Nepal: a cluster randomized trial. PLoS Negl Trop Dis 2010; 4:e587.    ^c
Y#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#260#256#article#289#</font
></p>     ^cY#aop14-11.htm##
00426000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016300092002001300255#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#261#257#articl
e#289#91#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">91.	Alex
ander B, Maroli M. Control of phlebotomine sandflies. Med Vet Entomol 2003; 17:1
-18.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#262#258#article#289#</font
></p>     ^cY#aop14-11.htm##
00442000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017900092002001300271#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#263#259#articl
e#289#92#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">92.	Pala
tnik-de-Sousa C. Vaccines for leishmaniasis in the fore coming 25 years. Vaccine
 2008; 26:1709-1724.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#264#260#article#289#</font
></p>     ^cY#aop14-11.htm##
00504000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024100092002001300333#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#265#261#articl
e#289#93#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">93.	Kham
esipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine can
didates for development: a global overview. Indian J Med Res    2006; 123:423-43
8.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#266#262#article#289#</font
></p>     ^cY#aop14-11.htm##
00460000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019700092002001300289#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#267#263#articl
e#289#94#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">94.	Kedz
ierski L, Zhu Y, Handman E. <i>Leishmania</i> vaccines: progress and problems. P
arasitology. 2006; 133(suppl):S87-112.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#268#264#article#289#</font
></p>     ^cY#aop14-11.htm##
00459000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019600092002001300288#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#269#265#articl
e#289#95#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">95.	Roga
n WJ, Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroet
hane (DDT). Lancet 2005; 366:763-773.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#270#266#article#289#</font
></p>     ^cY#aop14-11.htm##
00491000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022800092002001300320#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#271#267#articl
e#289#96#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">96.	Guim
araes RM, Asmus CI, Meyer A. DDT reintroduction for malaria control: the cost-be
nefit debate for public health. Cad Saude Publica 2007; 23:2835-2844.    ^cY#aop
14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#272#268#article#289#</font
></p>     ^cY#aop14-11.htm##
00583000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032000092002001300412#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#273#269#articl
e#289#97#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">97.	Data
 WLC-i-P. International Health Regulation.  2005 - &#91;cited April 3 2010&#93;.
 Available from: <a href="http://whqlibdoc.who.int/HQ/2003/EIP_GPE_EQC_2003_1.pd
f/" target="_blank">http://whqlibdoc.who.int/HQ/2003/EIP_GPE_EQC_2003_1.pdf/</a>
.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#274#270#article#289#</font
></p>     ^cY#aop14-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022100092002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#275#271#articl
e#289#98#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">98.	Worl
d Health Organization. Global Programme on Evidence for Health Policy. Guideline
s for WHO guidelines. Geneva: World Health Organization; 2003.    ^cY#aop14-11.h
tm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#276#272#article#289#</font
></p>     ^cY#aop14-11.htm##
00542000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027900092002001300371#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#277#273#articl
e#289#99#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">99.	Comm
ittee on Assessing Integrity in Research Environments. Integrity in scientific r
esearch: creating an environment that promotes responsible conduct. Washington (
DC): The National Academies Press; 2002.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#278#274#article#289#</font
></p>     ^cY#aop14-11.htm##
00598000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000400089704033400093002001300427#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#279#275#articl
e#289#100#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">100.	Th
e moral status of animals. Stanford Encyclopedia of Philosophy  2003 -  &#91;cit
ed Feb 21<sup>th</sup> 2010&#93;. Available from: <a href="http://plato.stanford
.edu/entries/moral-animal/" target="_blank">http://plato.stanford.edu/entries/mo
ral-animal/</a>.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#280#276#article#289#</font
></p>     ^cY#aop14-11.htm##
00425000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000400089704016100093002001300254#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#281#277#articl
e#289#101#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">101.	Em
ery NJ, Clayton NS. Comparative social cognition. Annu Rev Psychol 2009; 60:87-1
13.    ^cY#aop14-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#282#278#article#289#</font
></p>     ^cY#aop14-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#283#279#article#289#<p>&nb
sp;</p>     ^cY#aop14-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#284#280#article#289#<p>&nb
sp;</p>     ^cY#aop14-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704019200089002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#285#281#article#289#<p><a 
name="endb"></a><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a h
ref="#enda"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a><b
> Address to:</b>     ^cY#aop14-11.htm##
00293000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004500089002001300134#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#286#282#article#289#<br>  
 Dr. Carlos Henrique Nery Costa    ^cY#aop14-11.htm##
00315000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006700089002001300156#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#287#283#article#289#<br>  
 Instituto de Doen&ccedil;as Tropicais Natan Portella    ^cY#aop14-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#288#284#article#289#<br>  
 Rua Artur de Vasconcelos 151-Sul    ^cY#aop14-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004400089002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#289#285#article#289#<br>  
 64049-750 Teresina,PI, Brasil    ^cY#aop14-11.htm##
00307000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005900089002001300148#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#290#286#article#289#<br>  
 Phone: 55 86 3237-1075; Fax: 55 86 3221-2424    ^cY#aop14-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009900089002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#291#287#article#289#<br>  
 e-mail: <a href="mailto:chncosta@gmail.com.br">chncosta@gmail.com.br</a></font>
</p>     ^cY#aop14-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#292#288#article#289#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 14/05/2010 
   ^cY#aop14-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#p#293#289#article#289#<br>  
 Accepted in 29/11/2010</font></p>     ^cY#aop14-11.htm##
00645000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100015000890100017001040100
02100121010001600142010001600158010001500174810000600189012005600195030001900251
71000020027006500090027206400050028103100030028601400080028986500090029700200130
0306#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#294#1#
article#101#1#^rND^sJoshi^nA#^rND^sNarain^nJP#^rND^sPrasittisuk^nC#^rND^sBhatia^
nR#^rND^sHashim^nG#^rND^sJorge^nA#et al#Can visceral leishmaniasis be eliminated
 from Asia?^len#J Vector Borne Dis#2#20080000#2008#45#105-111#20110000#aop14-11.
htm##
00518000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100018000890120057001070300
01600164065000900180064000500189031000200194014000800196865000900204002001300213
035001000226801001600236#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#295#2#article#101#2#^rND^sZhi-Biao^nX#Present situation of viscera
l leishmaniasis in China^len#Parasitol Today#19890000#1989#5#224-228#20110000#ao
p14-11.htm#0169-4758#Parasitol Today##
00495000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870170038000890180033001270660
00700160062002600167025002400193065000900217064000500226865000900231002001300240
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#296#3#arti
cle#101#3#Committee of experts on leishmaniasis#Control of the leishmaniases^len
#Geneva#World Health Organization#Technical Report Series#19930000#1993#20110000
#aop14-11.htm##
00763000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100015000890100019001040100
01800123010001900141010002000160010001600180810000600196012011300202030002500315
06500090034006400050034903100040035401400100035886500090036800200130037703500100
0390801002500400#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#297#4#article#101#4#^rND^sLukes^nJ#^rND^sMauricio^nIL#^rND^sSchonian^nG#^r
ND^sDujardin^nJC#^rND^sSoteriadou^nK#^rND^sDedet^nJP#et al#Evolutionary and geog
raphical history of the Leishmania donovani complex with a revision of current t
axonomy^len#Proc Natl Acad Sci U S A#20070000#2007#104#9375-9380#20110000#aop14-
11.htm#0027-8424#Proc Natl Acad Sci U S A##
00653000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100019000890100016001080100
01900124010001600143012010300159030001600262065000900278064000500287031000300292
014000800295865000900303002001300312035001000325801001600335#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#298#5#article#101#5#^rND^sMaur
icio^nIL#^rND^sGaunt^nMW#^rND^sStothard^nJR#^rND^sMiles^nMA#Glycoprotein 63 (gp6
3) genes show gene conversion and reveal the evolution of Old World Leishmania^l
en#Int J Parasitol#20070000#2007#37#565-576#20110000#aop14-11.htm#0020-7519#Int 
J Parasitol##
00565000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100019000890100019001080100
01600127012004300143030001600186065000900202064000500211031000300216014000800219
865000900227002001300236035001000249801001600259#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#299#6#article#101#6#^rND^sMauricio^nIL#^rN
D^sStothard^nJR#^rND^sMiles^nMA#The strange case of Leishmania chagasi^len#Paras
itol Today#20000000#2000#16#188-189#20110000#aop14-11.htm#0169-4758#Parasitol To
day##
00466000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100019000890120018001080300
00700126065000900133064000500142031000400147014001000151865000900161002001300170
035001000183801000700193#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#300#7#article#101#7#^rND^sHerwaldt^nBL#Leishmaniasis^len#Lancet#19
990000#1999#354#1191-1199#20110000#aop14-11.htm#0099-5355#Lancet##
00555000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100017000890120058001060300
03400164065000900198064000500207031000300212014000800215865000900223002001300232
035001000245801003400255#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#301#8#article#101#8#^rND^sDesjeux^nP#Leishmaniasis: current situat
ion and new perspectives^len#Comp Immunol Microbiol Infect Dis#20040000#2004#27#
305-318#20110000#aop14-11.htm#0147-9571#Comp Immunol Microbiol Infect Dis##
00530000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080004000831180002000870100017000890100018001060120
07600124030001900200710000200219065000900221064000500230031000200235020000500237
865000900242002001300251#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#302#9#article#101#9#^rND^sRomero^nGA#^rND^sBoelaert^nM#Control of 
visceral leishmaniasis in Latin America: a systematic review^len#PLoS Negl Trop 
Dis#2#20100000#2010#4#e584#20110000#aop14-11.htm##
00568000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100023001060120
05800129030002300187065000900210064000500219031000300224014000800227865000900235
002001300244035001000257801002300267#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#303#10#article#101#10#^rND^sAdler^nS#^rND^sTchernomore
tz^nI#Failure to cure natural canine visceral leishmaniasis^len#Ann Trop Med Par
asitol#19460000#1946#40#320-325#20110000#aop14-11.htm#0003-4983#Ann Trop Med Par
asitol##
00522000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910120067001060300
01300173065000900186064000500195031000300200014000800203865000900211002001300220
035001000233801001300243#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#304#11#article#101#11#^rND^sHoare^nA#Reservoir hosts and natural f
oci of human protozoal infections^len#Acta Tropica#19620000#1962#19#281-317#2011
0000#aop14-11.htm#0001-706X#Acta Tropica##
00532000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910120053001060300
02500159065000900184064000500193031000300198014000800201865000900209002001300218
035001000231801002500241#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#305#12#article#101#12#^rND^sLeng^nYJ#A review of kala-azar in Chin
a from 1949 to 1959^len#Trans R Soc Trop Med Hyg#19820000#1982#76#531-537#201100
00#aop14-11.htm#0035-9203#Trans R Soc Trop Med Hyg##
00620000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100016001070120
12600123030001800249065000900267064000500276031000300281014000800284865000900292
002001300301035001000314801001800324#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#306#13#article#101#13#^rND^sZhong^nHL#^rND^sZhang^nNZ#
Studies on leishmaniasis in China: Historical background, epidemiology, clinical
 aspects, legislature and control program^len#Chin Med J (Engl)#19860000#1986#99
#281-300#20110000#aop14-11.htm#0366-6999#Chin Med J (Engl)##
00665000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100012000910100015001030100
01400118010001200132010001400144010001600158012007400174030001800248065000900266
06400050027503100030028001400060028386500090028900200130029803500100031180100180
0321#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#307#14
#article#101#14#^rND^sLu^nC#^rND^sChung^nH#^rND^sLing^nC#^rND^sWu^nC#^rND^sWang^
nC#^rND^sChiang^nY#New China's achievements in the treatment and prevention of k
ala-azar^len#Chin Med J (Engl)#19550000#1955#78#91-99#20110000#aop14-11.htm#0366
-6999#Chin Med J (Engl)##
00512000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100013001060120
03800119030001100157065000900168064000500177031000300182014000600185865000900191
002001300200035001000213801001100223#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#308#15#article#101#15#^rND^sWang^nCT#^rND^sWu^nCC#Stud
ies on kala-azar in new China^len#Chin Med J#19590000#1959#78#55-71#20110000#aop
14-11.htm#0366-6999#Chin Med J##
00593000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100015001060120
05500121030004100176065000900217064000500226031000300231014000800234865000900242
002001300251035001000264801004100274#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#309#16#article#101#16#^rND^sGuan^nLR#^rND^sShen^nWX#Re
cent advances in visceral leishmaniasis in China^len#Southeast Asian J Trop Med 
Public Health#19910000#1991#22#291-298#20110000#aop14-11.htm#0038-3619#Southeast
 Asian J Trop Med Public Health##
00621000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100015001070120
14700122030000900269065000900278064000500287031000200292014000800294865000900302
002001300311035001000324801000900334#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#310#17#article#101#17#^rND^sZhang^nLM#^rND^sLeng^nYJ#E
ighty-year research of phlebotomine sandflies (Diptera: Psychodidae) in China (1
915-1995): II. Phlebotomine vectors of leishmaniasis in China^len#Parasite#19970
000#1997#4#299-306#20110000#aop14-11.htm#1252-607X#Parasite##
00507000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910120040001080300
01800148065000900166064000500175031000300180014000800183865000900191002001300200
035001000213801001800223#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#311#18#article#101#18#^rND^sChung^nH-L#A résumé of kala-azar work 
in China^len#Chin Med J (Engl)#19530000#1953#71#421-464#20110000#aop14-11.htm#03
66-6999#Chin Med J (Engl)##
00523000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100012000910120061001030300
01800164065000900182064000500191031000300196014000800199865000900207002001300216
035001000229801001800239#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#312#19#article#101#19#^rND^sWu^nC#Some achievements on the study o
f kala-azar in New China^len#Chin Med J (Engl)#19580000#1958#77#307-309#20110000
#aop14-11.htm#0366-6999#Chin Med J (Engl)##
00727000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100013000910100015001040100
01500119010001300134010001300147010001500160810000600175012011500181030001800296
06500090031406400050032303100030032801400080033186500090033900200130034803500100
0361801001800371#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#313#20#article#101#20#^rND^sLu^nHG#^rND^sZhong^nL#^rND^sGuan^nLR#^rND^sQu^
nJQ#^rND^sHu^nXS#^rND^sChai^nJJ#et al#Separation of Chinese Leishmania isolates 
into five genotypes by kinetoplast and chromosomal DNA heterogeneity^len#Am J Tr
op Med Hyg#19940000#1994#50#763-770#20110000#aop14-11.htm#0002-9637#Am J Trop Me
d Hyg##
00562000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880160017000910160016001080180
10800124065000900232064000500241066000600246061002600252014000800278865000900286
002001300295#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#
c#314#21#article#101#21#^rND^sLysenko^nA#^rND^sLubova^nV#Epidemiology and geogra
phy of visceral leishmanisis in the URSS: Colloque Internationaux du CNRS nº 239
^len#19770000#1977#Paris#Écologie de leishmanioses#253-256#20110000#aop14-11.htm
##
00608000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910120116001090300
03000225065000900255064000500264031000300269014000800272865000900280002001300289
035001000302801003000312#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#315#22#article#101#22#^rND^sKellina^nOI#Problem and current lines 
in investigations on the epidemiology of leishmaniasis and its control in the U.
S.S.R^len#Bull Soc Pathol Exot Filiales#19810000#1981#74#306-318#20110000#aop14-
11.htm#0037-9085#Bull Soc Pathol Exot Filiales##
00537000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910120060001060300
02400166065000900190064000500199031000300204014000800207865000900215002001300224
035001000237801002400247#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#316#23#article#101#23#^rND^sGuan^nLR#Current status of kala-azar a
nd vector control in China^len#Bull World Health Organ#19910000#1991#69#595-601#
20110000#aop14-11.htm#0042-9686#Bull World Health Organ##
00536000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100014000910120071001050300
01800176065000900194064000500203031000400208014000800212865000900220002001300229
035001000242801001800252#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#317#24#article#101#24#^rND^sMao^nSB#Control of parasitic diseases 
in China: achievements and prospects^len#Chin Med J (Engl)#19870000#1987#100#445
-453#20110000#aop14-11.htm#0366-6999#Chin Med J (Engl)##
00536000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100012000910120073001030300
01800176065000900194064000500203031000400208014000800212865000900220002001300229
035001000242801001800252#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#318#25#article#101#25#^rND^sYu^nS#Control of parasitic diseases in
 China: Current status and prospects^len#Chin Med J (Engl)#19960000#1996#109#259
-265#20110000#aop14-11.htm#0366-6999#Chin Med J (Engl)##
00601000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100013000910100015001040100
01500119012009000134030001500224065000900239064000500248031000300253014000800256
865000900264002001300273035001000286801001500296#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#319#26#article#101#26#^rND^sBao^nY#^rND^sW
ang^nST#^rND^sShao^nQF#A further study of LDT and IFAT tests in evaluating the c
ontrol of kala-azar in China^len#J Trop Med Hyg#19940000#1994#97#357-361#2011000
0#aop14-11.htm#0022-5304#J Trop Med Hyg##
00711000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100021001060100
01500127010001800142010001700160010002000177810000600197012011700203030001600320
71000020033606500090033806400050034703100030035201400080035586500090036300200130
0372#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#320#27
#article#101#27#^rND^sAlam^nMZ#^rND^sHaralambous^nC#^rND^sKuhls^nK#^rND^sGouzelo
u^nE#^rND^sSgouras^nD#^rND^sSoteriadou^nK#et al#The paraphyletic composition of 
Leishmania donovani zymodeme MON-37 revealed by multilocus microsatellite typing
^len#Microbes Infect#2#20090000#2009#11#707-715#20110000#aop14-11.htm##
00531000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910120051001090300
02400160065000900184064000500193031000300198014000800201865000900209002001300218
035001000231801002400241#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#321#28#article#101#28#^rND^sLysenko^nAJ#Distribution of leishmania
sis in the Old World^len#Bull World Health Organ#19710000#1971#44#515-520#201100
00#aop14-11.htm#0042-9686#Bull World Health Organ##
00615000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100018001080100
01700126012007600143030002400219065000900243064000500252031000400257014000800261
865000900269002001300278035001000291801002400301#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#322#29#article#101#29#^rND^sTurusov^nV#^rN
D^sRakitsky^nV#^rND^sTomatis^nL#Dichlorodiphenyltrichloroethane (DDT): ubiquity,
 persistence, and risks^len#Environ Health Perspect#20020000#2002#110#125-128#20
110000#aop14-11.htm#0091-6765#Environ Health Perspect##
00493000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910120024001100300
01900134065000900153064000500162031000300167014000600170865000900176002001300185
035001000198801001900208#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#323#30#article#101#30#^rND^sSen Gupta^nP#Return of kala-azar^len#J
 Indian Med Assoc#19750000#1975#65#89-90#20110000#aop14-11.htm#0019-5847#J India
n Med Assoc##
00542000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100015001080100
01700123012002500140030001500165065000900180064000500189031000300194014000800197
865000900205002001300214035001000227801001500237#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#324#31#article#101#31#^rND^sThakur^nCP#^rN
D^sKumar^nM#^rND^sPathak^nPK#Kala-azar hits again^len#J Trop Med Hyg#19810000#19
81#84#271-276#20110000#aop14-11.htm#0022-5304#J Trop Med Hyg##
00699000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100016001060100
01600122010001700138010001600155010001600171810000600187012006400193030002200257
06500090027906400050028803100040029301400100029786500090030700200130031603500100
0329801002200339#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#325#32#article#101#32#^rND^sKumar^nV#^rND^sKesari^nS#^rND^sKumar^nAJ#^rND^
sDinesh^nDS#^rND^sRanjan^nA#^rND^sPrasad^nM#et al#Vector density and the control
 of kala-azar in Bihar, India^len#Mem Inst Oswaldo Cruz#20090000#2009#104#1019-1
022#20110000#aop14-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00575000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100017001090100
01400126012004500140030001900185065000900204064000500213031000400218014001200222
865000900234002001300243035001000256801001900266#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#326#33#article#101#33#^rND^sDhillon^nGP#^r
ND^sSharma^nSN#^rND^sNair^nB#Kala-azar elimination programme in India^len#J Indi
an Med Assoc#20080000#2008#106#664,666-668#20110000#aop14-11.htm#0019-5847#J Ind
ian Med Assoc##
00775000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100014001070100
01600121010001900137010001600156010001500172810000600187012020500193030000800398
71000020040606500090040806400050041703100020042202000030042486500090042700200130
0436#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#327#34
#article#101#34#^rND^sJoshi^nAB#^rND^sDas^nML#^rND^sAkhter^nS#^rND^sChowdhury^nR
#^rND^sMondal^nD#^rND^sKumar^nV#et al#Chemical and environmental vector control 
as a contribution to the elimination of visceral leishmaniasis on the Indian sub
continent: cluster randomized controlled trials in Bangladesh, India and Nepal^l
en#BMC Med#2#20090000#2009#7#54#20110000#aop14-11.htm##
00632000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100014000910100019001050100
01500124012015100139030001900290710000200309065000900311064000500320031000200325
020000500327865000900332002001300341#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#328#35#article#101#35#^rND^sBern^nC#^rND^sCourtenay^nO
#^rND^sAlvar^nJ#Of cattle, sand flies and men: a systematic review of risk facto
r analyses for South Asian visceral leishmaniasis and implications for eliminati
on^len#PLoS Negl Trop Dis#2#20100000#2010#4#e599#20110000#aop14-11.htm##
00562000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910120094001070300
01800201065000900219064000500228031000300233014001000236865000900246002001300255
035001000268801001800278#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#329#36#article#101#36#^rND^sCosta^nCH#Characterization and specula
tions on the urbanization of visceral leishmaniasis in Brazil^len#Cad Saude Publ
ica#20080000#2008#24#2959-2963#20110000#aop14-11.htm#0102-311X#Cad Saude Publica
##
00559000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100014000910100018001050100
01500123012007900138030001900217710000200236065000900238064000500247031000200252
020000500254865000900259002001300268#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#330#37#article#101#37#^rND^sBern^nC#^rND^sMaguire^nJH#
^rND^sAlvar^nJ#Complexities of assessing the disease burden attributable to leis
hmaniasis^len#PLoS Negl Trop Dis#2#20080000#2008#2#e313#20110000#aop14-11.htm##
00630000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170020000910180098001110660
00900209062014600218065000900364064000500373865000900378002001300387#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#331#38#article#101#38#
Ministério da Saúde#Série histórica de óbitos e casos de doenças de notificação 
compulsória no Brasil (1980-2005)^lpt#Brasília#Ministério da Saúde. Secretaria d
e Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Coordenação Ge
ral de Vigilância Epidemiológica#20060000#2006#20110000#aop14-11.htm##
00576000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170051000910180082001420660
00900224062007700233065000900310064000500319865000900324002001300333#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#332#39#article#101#39#
Brasil^dCommittee of experts on primary healthcare#Manual de Vigilância e Contro
le da Leishmaniose Visceral: Ministério da Saúde^lpt#Brasília#Secretaria de Vigi
lância em Saúde. Departamento de Vigilância Epidemiológica#20040000#2004#2011000
0#aop14-11.htm##
00690000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100017001080100
01500125010001900140010001600159010001700175810000600192012005200198030002200250
06500090027206400050028103100040028601400080029086500090029800200130030703500100
0320801002200330#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#333#40#article#101#40#^rND^sSalomon^nO#^rND^sSinagra^nA#^rND^sNevot^nM#^rN
D^sBarberian^nG#^rND^sPaulin^nP#^rND^sEstevez^nJ#et al#First visceral leishmania
sis focus in Argentina^len#Mem Inst Oswaldo Cruz#20080000#2008#103#109-111#20110
000#aop14-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00524000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910120048001090300
02200157065000900179064000500188031000300193014000800196865000900204002001300213
035001000226801002200236#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#334#41#article#101#41#^rND^sLacerda^nMM#The Brazilian leishmaniasi
s control program^len#Mem Inst Oswaldo Cruz#19940000#1994#89#489-495#20110000#ao
p14-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00529000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910120043001080300
02800151065000900179064000500188031000200193014000800195865000900203002001300212
035001000225801002800235#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#335#42#article#101#42#^rND^sAlencar^nJ#Profilaxia do calazar no Ce
ará, Brasil^lpt#Rev Inst Med Trop Sao Paulo#19610000#1961#3#175-180#20110000#aop
14-11.htm#0036-4665#Rev Inst Med Trop Sao Paulo##
00729000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100020000910100017001110100
01600128010001500144010001400159010001800173810000600191012008100197030002800278
06500090030606400050031503100030032001400080032386500090033100200130034003500100
0353801002800363#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#336#43#article#101#43#^rND^sMagalhaes^nPA#^rND^sMayrink^nW#^rND^sCosta^nCA
#^rND^sMelo^nMN#^rND^sDias^nM#^rND^sBatista^nSM#et al#Calazar na zona do Rio Doc
e-Minas Gerais: Resultados de medidas profiláticas^lpt#Rev Inst Med Trop Sao Pau
lo#19800000#1980#22#197-202#20110000#aop14-11.htm#0036-4665#Rev Inst Med Trop Sa
o Paulo##
00791000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100021000910100019001120100
02200131010002100153010002500174010001500199012016500214030001400379065000900393
06400050040203100040040701400080041186500090041900200130042803500100044180100140
0451#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#337#44
#article#101#44#^rND^sMalaquias^nLCC#^rND^sRomualdo^nRC#^rND^sdo Anjos Jr^nJB#^r
ND^sGiunchetti^nRC#^rND^sCorrea-Oliveira^nR#^rND^sReis^nAB#Serological screening
 confirms the re-emergence of canine leishmaniosis in urban and rural areas in G
overnador Valadares, Vale do Rio Doce, Minas Gerais, Brazil^len#Parasitol Res#20
070000#2007#100#233-239#20110000#aop14-11.htm#0044-3255#Parasitol Res##
00742000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100018001100100
01800128010001600146010001800162010002300180810000600203012009400209030002200303
06500090032506400050033403100030033901400080034286500090035000200130035903500100
0372801002200382#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#338#45#article#101#45#^rND^sMarzochi^nMC#^rND^sFagundes^nA#^rND^sAndrade^n
MV#^rND^sSouza^nMB#^rND^sMadeira^nMF#^rND^sMouta-Confort^nE#et al#Visceral leish
maniasis in Rio de Janeiro, Brazil: eco-epidemiological aspects and control^len#
Rev Soc Bras Med Trop#20090000#2009#42#570-580#20110000#aop14-11.htm#0037-8682#R
ev Soc Bras Med Trop##
00603000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100018001080100
01700126012007700143030001800220065000900238064000500247031000300252014000800255
865000900263002001300272035001000285801001800295#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#339#46#article#101#46#^rND^sCosta^nCHN#^rN
D^sPereira^nHF#^rND^sAraujo^nMV#Epidemia de leishmaniose visceral no Estado do P
iauí, Brasil (1980-1986)^lpt#Rev Saude Publica#19900000#1990#24#361-372#20110000
#aop14-11.htm#0034-8910#Rev Saude Publica##
00594000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100016001070120
08100123030002800204065000900232064000500241031000200246014000800248865000900256
002001300265035001000278801002800288#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#340#47#article#101#47#^rND^sDeane^nLM#^rND^sDeane^nMP#
Visceral leishmaniasis in Brazil: geographical distribution and transmission^len
#Rev Inst Med Trop Sao Paulo#19620000#1962#4#198-212#20110000#aop14-11.htm#0036-
4665#Rev Inst Med Trop Sao Paulo##
00574000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100017001070120
07100124030002200195065000900217064000500226031000300231014000800234865000900242
002001300251035001000264801002200274#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#341#48#article#101#48#^rND^sCosta^nCH#^rND^sVieira^nJB
#Changes in the control program of visceral leishmaniasis in Brazil^len#Rev Soc 
Bras Med Trop#20010000#2001#34#223-228#20110000#aop14-11.htm#0037-8682#Rev Soc B
ras Med Trop##
00702000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100018001090100
01700127010001700144010001500161010001800176810000600194012006600200030001900266
06500090028506400050029402000040029901400100030386500090031300200130032203500100
0335801001900345#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#342#49#article#101#49#^rND^sSchantz^nPM#^rND^sSteurer^nFJ#^rND^sDuprey^nZH
#^rND^sKurpel^nKP#^rND^sBarr^nSC#^rND^sJackson^nJE#et al#Autochthonous visceral 
leishmaniasis in dogs in North America^len#J Am Vet Med Assoc#20050000#2005#226#
1316-1322#20110000#aop14-11.htm#0003-1488#J Am Vet Med Assoc##
00768000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100018001100100
01800128010001600146010001500162010001600177810000600193012013100199030002200330
06500090035206400050036103100040036601400060037086500090037600200130038503500100
0398801002200408#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#343#50#article#101#50#^rND^sMargonari^nC#^rND^sFreitas^nCR#^rND^sRibeiro^n
RC#^rND^sMoura^nAC#^rND^sTimbo^nM#^rND^sGripp^nAH#et al#Epidemiology of visceral
 leishmaniasis through spatial analysis, in Belo Horizonte municipality, state o
f Minas Gerais, Brazil^len#Mem Inst Oswaldo Cruz#20060000#2006#101#31-38#2011000
0#aop14-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00611000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100015001060100
01700121012007200138030002200210065000900232064000500241031000300246032000400249
020000200253865000900255002001300264035001000277801002200287#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#344#51#article#101#51#^rND^sCo
sta^nC#^rND^sMoura^nM#^rND^sPereira^nF#Fatores de risco urbanos para a ocorrênci
a de leishmaniose visceral^lpt#Rev Soc Bras Med Trop#19950000#1995#28#^sI#7#2011
0000#aop14-11.htm#0037-8682#Rev Soc Bras Med Trop##
00688000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100018001090100
01600127010001700143012015400160030000700314065000900321064000500330031000400335
014000800339865000900347002001300356035001000369801000700379#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#345#52#article#101#52#^rND^sGa
vgani^nAS#^rND^sHodjati^nMH#^rND^sMohite^nH#^rND^sDavies^nCR#Effect of insectici
de-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Ir
anian children: a matched-cluster randomised trial^len#Lancet#20020000#2002#360#
374-379#20110000#aop14-11.htm#0099-5355#Lancet##
00685000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100019001100100
01500129010001900144012012500163030001800288065000900306064000500315031000300320
014001000323865000900333002001300342035001000355801001800365#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#346#53#article#101#53#^rND^sOl
iveira^nCD#^rND^sAssuncao^nRM#^rND^sReis^nIA#^rND^sProietti^nFA#Spatial distribu
tion of human and canine visceral leishmaniasis in Belo Horizonte, Minas Gerais 
State, Brasil, 1994-1997^len#Cad Saude Publica#20010000#2001#17#1231-1239#201100
00#aop14-11.htm#0102-311X#Cad Saude Publica##
00696000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100016001090100
01700125010001600142010001400158010001800172012008800190030001700278065000900295
06400050030403100040030901400080031386500090032100200130033003500100034380100170
0353#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#347#54
#article#101#54#^rND^sWerneck^nGL#^rND^sCosta^nCH#^rND^sWalker^nAM#^rND^sDavid^n
JR#^rND^sWand^nM#^rND^sMaguire^nJH#Multilevel modelling of the incidence of visc
eral leishmaniasis in Teresina, Brazil^len#Epidemiol Infect#20070000#2007#135#19
5-201#20110000#aop14-11.htm#0950-2688#Epidemiol Infect##
00675000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100016001090100
01700125010001600142010001400158010001800172012007600190030001300266065000900279
06400050028803100030029301400080029686500090030400200130031303500100032680100130
0336#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#348#55
#article#101#55#^rND^sWerneck^nGL#^rND^sCosta^nCH#^rND^sWalker^nAM#^rND^sDavid^n
JR#^rND^sWand^nM#^rND^sMaguire^nJH#The urban spread of visceral leishmaniasis: c
lues from spatial analysis^len#Epidemiology#20020000#2002#13#364-367#20110000#ao
p14-11.htm#1044-3983#EPIDEMIOLOGY##
00655000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100017001070100
01700124010001700141012009400158030002200252065000900274064000500283031000300288
014000800291865000900299002001300308035001000321801002200331#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#349#56#article#101#56#^rND^sKo
tkat^nA#^rND^sel-Daly^nS#^rND^sel-Daaw^nA#^rND^sBarakat^nR#Immunological investi
gation of visceral leishmaniasis among school children in Alexandria^len#J Egypt
 Soc Parasitol#19860000#1986#16#449-456#20110000#aop14-11.htm#0253-5890#J Egypt 
Soc Parasitol##
00730000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100015001080100
01600123010002200139010001700161010001800178810000600196012008900202030002200291
06500090031306400050032203100030032701400080033086500090033800200130034703500100
0360801002200370#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#350#57#article#101#57#^rND^sMoreno^nEC#^rND^sMelo^nMN#^rND^sGenaro^nO#^rND
^sLambertucci^nJR#^rND^sSerufo^nJC#^rND^sAndrade^nAS#et al#Risk factors for Leis
hmania chagasi infection in an urban area of Minas Gerais State^len#Rev Soc Bras
 Med Trop#20050000#2005#38#456-463#20110000#aop14-11.htm#0037-8682#Rev Soc Bras 
Med Trop##
00625000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100018001080100
01600126010002600142012007800168030001000246065000900256064000500265031000400270
014000700274865000900281002001300290035001000303801001000313#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#351#58#article#101#58#^rND^sGo
uvea^nMV#^rND^sWerneck^nGL#^rND^sCosta^nCH#^rND^sAmorim Carvalho^nFA#Factors ass
ociated to Montenegro skin test positivity in Teresina, Brazil^len#Acta Trop#200
70000#2007#104#99-107#20110000#aop14-11.htm#0001-706X#Acta Trop##
00691000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100016001070100
01800123010001700141010001700158010001800175012007700193030001800270065000900288
06400050029703100030030201400100030586500090031500200130032403500100033780100180
0347#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#352#59
#article#101#59#^rND^sNavin^nTR#^rND^sSierra^nM#^rND^sCustodio^nR#^rND^sSteurer^
nF#^rND^sPorter^nCH#^rND^sRuebush^nTK#2nd Epidemiologic study of visceral leishm
aniasis in Honduras, 1975-1983^len#Am J Trop Med Hyg#19850000#1985#34#1069-1075#
20110000#aop14-11.htm#0002-9637#Am J Trop Med Hyg##
00713000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100018001070100
01800125010001800143010001700161010002000178012008600198030002500284065000900309
06400050031803100030032302000040032686500090033000200130033903500100035280100250
0362#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#353#60
#article#101#60#^rND^sCosta^nCH#^rND^sPereira^nHF#^rND^sPereira^nFC#^rND^sTavare
s^nJP#^rND^sAraujo^nMV#^rND^sGoncalves^nMJ#Is the household dog a risk factor fo
r American visceral leishmaniasis in Brazil?^len#Trans R Soc Trop Med Hyg#199900
00#1999#93#464#20110000#aop14-11.htm#0035-9203#Trans R Soc Trop Med Hyg##
00690000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100016001080100
01600124010001600140010001600156012009900172030002500271065000900296064000500305
031000300310014000600313865000900319002001300328035001000341801002500351#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#354#61#article#101
#61#^rND^sCaldas^nAJ#^rND^sCosta^nJM#^rND^sSilva^nAA#^rND^sVinhas^nV#^rND^sBarra
l^nA#Risk factors associated with asymptomatic infection by Leishmania chagasi i
n north-east Brazil^len#Trans R Soc Trop Med Hyg#20020000#2002#96#21-28#20110000
#aop14-11.htm#0035-9203#Trans R Soc Trop Med Hyg##
00637000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880160023000910180182001140610
01900296066001000315062003400325065000900359064000500368865000900373002001300382
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#355#62#art
icle#101#62#^rND^sNascimento^nMDSB#Epidemiologia da leishmaniose visceral na Ilh
a de São Luis, Maranhão, Brasil: análise da dinâmica de transmissão e dos fatore
s de risco relacionados ao desenvolvimento da doença^len#Doctor in Medicine#São 
Paulo#Universidade Federal de São Paulo#19960000#1996#20110000#aop14-11.htm##
00574000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100019001100120
08100129030001300210065000900223064000500232020000400237014001000241865000900251
002001300260035001000273801001300283#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#356#63#article#101#63#^rND^sQuinnell^nRJ#^rND^sCourten
ay^nO#Transmission, reservoir hosts and control of zoonotic visceral leishmanias
is^len#Parasitology#20090000#2009#136#1915-1934#20110000#aop14-11.htm#0031-1820#
Parasitology##
00510000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100017001060120
06200123030001500185710000200200065000900202064000500211031000200216020000400218
865000900222002001300231#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#357#64#article#101#64#^rND^sAdler^nS#^rND^sTheodor^nO#Transmission
 of disease agents by phlebotomine sand flies^len#Annual Rev Ent#2#19570000#1957
#2#203#20110000#aop14-11.htm##
00577000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100018001100120
08600128030001400214065000900228064000500237031000300242014000800245865000900253
002001300262035001000275801001400285#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#358#65#article#101#65#^rND^sSherlock^nIA#^rND^sSherloc
k^nV#Sôbre a infecção experimental de Phlebotomus longipalpis pela Leishmania do
novani^lpt#Rev Bras Biol#19610000#1961#21#409-418#20110000#aop14-11.htm#0034-710
8#Rev Bras Biol##
00750000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100015001070100
01500122010002000137010001800157010001900175810000600194012010500200030002500305
06500090033006400050033903100030034401400080034786500090035500200130036403500100
0377801002500387#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#359#66#article#101#66#^rND^sMolina^nR#^rND^sAmela^nC#^rND^sNieto^nJ#^rND^s
San-Andres^nM#^rND^sGonzalez^nF#^rND^sCastillo^nJA#et al#Infectivity of dogs nat
urally infected with Leishmania infantum to colonized Phlebotomus perniciosus^le
n#Trans R Soc Trop Med Hyg#19940000#1994#88#491-493#20110000#aop14-11.htm#0035-9
203#Trans R Soc Trop Med Hyg##
00772000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100020000910100016001110100
02100127010002300148010001600171010001900187810000600206012013800212030001400350
06500090036406400050037303100040037801400060038286500090038800200130039703500100
0410801001400420#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#360#67#article#101#67#^rND^sMichalsky^nEM#^rND^sRocha^nMF#^rND^sRocha Lima
^nAC#^rND^sFranca-Silva^nJC#^rND^sPires^nMQ#^rND^sOliveira^nFS#et al#Infectivity
 of seropositive dogs, showing different clinical forms of leishmaniasis, to Lut
zomyia longipalpis phlebotomine sand flies^len#Vet Parasitol#20070000#2007#147#6
7-76#20110000#aop14-11.htm#0304-4017#Vet Parasitol##
00689000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100016001070100
01600123010001700139010001600156010001700172810000600189012007100195030001300266
06500090027906400050028803100040029301400090029786500090030600200130031503500100
0328801001300338#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#361#68#article#101#68#^rND^sCosta^nCH#^rND^sGomes^nRB#^rND^sSilva^nMR#^rND
^sGarcez^nLM#^rND^sRamos^nPK#^rND^sSantos^nRS#et al#Competence of the human host
 as a reservoir for Leishmania chagasi^len#J Infect Dis#20000000#2000#182#997-10
00#20110000#aop14-11.htm#0022-1899#J Infect Dis##
00571000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910120069001080300
03500177065000900212064000500221031000400226014000800230865000900238002001300247
035001000260801003500270#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#362#69#article#101#69#^rND^sRogers^nDJ#The dynamics of vector-tran
smitted diseases in human communities^len#Philos Trans R Soc Lond B Biol Sci#198
80000#1988#321#513-539#20110000#aop14-11.htm#0962-8436#Philos Trans R Soc Lond B
 Biol Sci##
00691000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100016001070100
01500123010001700138010001800155012011600173030001500289065000900304064000500313
031000400318014000800322865000900330002001300339035001000352801001500362#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#363#70#article#101
#70#^rND^sMather^nT#^rND^sWilson^nM#^rND^sMoore^nS#^rND^sRibeiro^nJ#^rND^sSpielm
an^nA#Comparing the relative potential of rodents as reservoirs of the Lyme dise
ase spirochete (Borrelia burgdorferi)^len#Am J Epidemiol#19890000#1989#130#143-1
50#20110000#aop14-11.htm#0002-9262#Am J Epidemiol##
00511000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100013000910120048001040300
01800152065000900170064000500179031000300184014000800187865000900195002001300204
035001000217801001800227#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#364#71#article#101#71#^rND^sDye^nC#The logic of visceral leishmani
asis control^len#Am J Trop Med Hyg#19960000#1996#55#125-130#20110000#aop14-11.ht
m#0002-9637#Am J Trop Med Hyg##
00616000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100018001100100
01500128010001600143012009800159030002100257710000200278065000900280064000500289
031000200294014000800296865000900304002001300313#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#365#72#article#101#72#^rND^sBurattini^nM#^
rND^sCoutinho^nF#^rND^sLopez^nL#^rND^sMassad^nE#Modelling the dynamics of leishm
aniasis considering human, animal host and vector populations^len#J Biological S
ystems#2#19980000#1998#4#337-356#20110000#aop14-11.htm##
00733000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100017001070100
01800124010001600142010001900158010001800177810000600195012010300201030001600304
06500090032006400050032903100030033401400100033786500090034700200130035603500100
0369801001600379#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#366#73#article#101#73#^rND^sDietze^nR#^rND^sBarros^nGB#^rND^sTeixeira^nL#^
rND^sHarris^nJ#^rND^sMichelson^nK#^rND^sFalqueto^nA#et al#Effect of eliminating 
seropositive canines on the transmission of visceral leishmaniasis in Brazil^len
#Clin Infect Dis#19970000#1997#25#1240-1242#20110000#aop14-11.htm#1058-4838#Clin
 Infect Dis##
00769000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100016001090100
01600125010001500141010001800156010001800174810000600192012014200198030001800340
06500090035806400050036703100030037201400060037586500090038100200130039003500100
0403801001800413#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#367#74#article#101#74#^rND^sAshford^nDA#^rND^sDavid^nJR#^rND^sFreire^nM#^r
ND^sDavid^nR#^rND^sSherlock^nI#^rND^sEulalio^nMC#et al#Studies on control of vis
ceral leishmaniasis: impact of dog control on canine and human visceral leishman
iasis in Jacobina, Bahia, Brazil^len#Am J Trop Med Hyg#19980000#1998#59#53-57#20
110000#aop14-11.htm#0002-9637#Am J Trop Med Hyg##
00630000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100017001070100
01800124012009700142030002200239065000900261064000500270031000300275014000800278
865000900286002001300295035001000308801002200318#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#368#75#article#101#75#^rND^sCosta^nCH#^rND
^sTapety^nCM#^rND^sWerneck^nGL#Controle da leishmaniose visceral em meio urbano:
 estudo de intervenção randomizado fatorial^lpt#Rev Soc Bras Med Trop#20070000#2
007#40#415-419#20110000#aop14-11.htm#0037-8682#Rev Soc Bras Med Trop##
00731000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100015000910100018001060100
01600124010001400140010001500154012019100169030002100360710000200381065000900383
064000500392031000300397014000700400865000900407002001300416#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#369#76#article#101#76#^rND^sSo
uza^nV#^rND^sBisinoto^nT#^rND^sJulião^nF#^rND^sLima^nA#^rND^sNeves^nR#Communitar
y assay for assessment of effectiveness of strategies for prevention and control
 of human visceral leishmaniasis in the municipality of Feira de Santana, State 
of Bahia, Brazil^len#Epidemiol Serv Saude#2#20080000#2008#17#97-106#20110000#aop
14-11.htm##
00528000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880160019000910160017001100180
07400127063000200201066001000203062002500213065000900238064000500247865000900252
002001300261#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#
c#370#77#article#101#77#^rND^sMcGarity^nTO#^rND^sWagner^nWE#Bending Science: how
 special interests corrupt public health research^len#1#Cambridge#Harvard Univer
sity Press#20080000#2008#20110000#aop14-11.htm##
00706000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170072000910180113001630660
01400276067000700290065000900297064000500306110000900311109001200320037008600332
865000900418002001300427#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#371#78#article#101#78#Organización Mundial de la Salud^dOrganizaci
ón Panamericana de la Salud#Encuentro sobre vigilancia, prevención y control de 
leishmaniasis visceral (LV) en el Cono Sur de Sudamérica^les#Foz do Iguazú#Brasi
l#20090000#2009#20101121#2010 Nov 21#http://new.paho.org/panaftosa/index.php?opt
ion=com_docman& task=doc_download& gid=79/#20110000#aop14-11.htm##
00547000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170038000910180077001290660
00900206062002000215062003400235065000900269064000500278865000900283002001300292
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#372#79#art
icle#101#79#Committee of experts on leishmaniasis#II Forum de discussão sobre o 
tratamento da leishmaniose visceral canina^lpt#Brasilia#Ministério da Saúde#Secr
etaria de Vigilância em Saúde#20090000#2009#20110000#aop14-11.htm##
00577000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100021000910120147001120300
01500259710000200274065000900276064000500285031000300290014000800293865000900301
002001300310#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#
c#373#80#article#101#80#^rND^sManchikanti^nL#Evidence-based medicine, systematic
 reviews, and guidelines in interventional pain management, part I: introduction
 and general considerations^len#Pain Physician#2#20080000#2008#11#161-186#201100
00#aop14-11.htm##
00588000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100021000910100018001120100
01600130012009800146030002300244710000200267065000900269064000500278031000200283
020000300285865000900288002001300297#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#374#81#article#101#81#^rND^sSchunemann^nHJ#^rND^sFreth
eim^nA#^rND^sOxman^nAD#Improving the use of research evidence in guideline devel
opment: 1. Guidelines for guidelines^len#Health Res Policy Syst#2#20060000#2006#
4#13#20110000#aop14-11.htm##
00605000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100021001090100
01600130012011500146030002300261710000200284065000900286064000500295031000200300
020000300302865000900305002001300314#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#375#82#article#101#82#^rND^sFretheim^nA#^rND^sSchunema
nn^nHJ#^rND^sOxman^nAD#Improving the use of research evidence in guideline devel
opment: 3. Group composition and consultation process^len#Health Res Policy Syst
#2#20060000#2006#4#15#20110000#aop14-11.htm##
00580000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100018000910100017001090120
08800126030001500214065000900229064000500238031000400243014000800247865000900255
002001300264035001000277801001500287#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#376#83#article#101#83#^rND^sDiamond^nGA#^rND^sDenton^n
TA#Alternative perspectives on the biased foundations of medical technology asse
ssment^len#Ann Intern Med#19930000#1993#118#455-464#20110000#aop14-11.htm#0003-4
819#Ann Intern Med##
00566000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170031000910180060001220630
00200182066000900184062002800193062005500221065000900276064000500285865000900290
002001300299#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#
c#377#84#article#101#84#Committee of experts on dengue#Dengue: diagnóstico e man
ejo clínico - adulto e criança^lpt#3#Brasília#Diretoria Técnica de Gestão#Secret
aria de Vigilância em Saúde. Ministério da Saúde#20070000#2007#20110000#aop14-11
.htm##
00656000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170038000910170047001290180
09400176066000900270062003200279062005500311065000900366064000500375865000900380
002001300389#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#
c#378#85#article#101#85#Committee of experts on leishmaniasis#Committee of exper
ts on HIV infection and Aids#Recomendações para diagnóstico, tratamento e acompa
nhamento da co-infecção Leishmania-HIV^lpt#Brasília#Programa Nacional de DST e A
ids#Secretaria de Vigilância em Saúde. Ministério da Saúde#20040000#2004#2011000
0#aop14-11.htm##
00600000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170044000910180093001350630
00200228066000900230062008300239065000900322064000500331865000900336002001300345
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#379#86#art
icle#101#86#Committee of experts on primary health care#Vigilância em saúde: den
gue, esquistossomose, hanseníase, malária, tracoma e tuberculose^lpt#2#Brasília#
Secretaria de Atenção a Saúde. Departamento de Atenção Básica. Ministério da Saú
de#20080000#2008#20110000#aop14-11.htm##
00641000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170049000910180051001400630
00200191066000900193062014600202065000900348064000500357031000300362865000900365
002001300374#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#
c#380#87#article#101#87#Committee of experts on tegumentar leishmaniasis#Leishma
niose Visceral Grave: Normas e Condutas^lpt#1#Brasília#Coordenação Geral de Vigi
lância Epidemiológica. Departamento de Vigilância Epidemiológica. Secretaria de 
Vigilância em Saúde. Ministério da Saúde#20060000#2006#51#20110000#aop14-11.htm#
#
00522000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170049000910180062001400630
00200202066000900204062003100213065000900244064000500253865000900258002001300267
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#381#88#art
icle#101#88#Committee of experts on tegumentar leishmaniasis#Manual de vigilânci
a da leishmaniose tegumentar americana^lpt#2#Brasília#Editora do Ministério da S
aúde#20100000#2010#20110000#aop14-11.htm##
00754000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100017000910100020001080100
01900128010001800147010001700165010001400182810000600196012014000202030000700342
06500090034906400050035803100040036301400100036786500090037700200130038603500100
0399801000700409#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.ht
m#S#c#382#89#article#101#89#^rND^sKhalil^nEA#^rND^sEl Hassan^nAM#^rND^sZijlstra^
nEE#^rND^sMukhtar^nMM#^rND^sGhalib^nHW#^rND^sMusa^nB#et al#Autoclaved Leishmania
 major vaccine for prevention of visceral leishmaniasis: a randomised, double-bl
ind, BCG-controlled trial in Sudan^len#Lancet#20000000#2000#356#1565-1569#201100
00#aop14-11.htm#0099-5355#Lancet##
00724000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100014001070100
01500121010001600136010001700152010001300169810000600182012014600188030001900334
71000020035306500090035506400050036403100020036902000050037186500090037600200130
0385#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#383#90
#article#101#90#^rND^sPicado^nA#^rND^sDas^nML#^rND^sKumar^nV#^rND^sKesari^nS#^rN
D^sDinesh^nDS#^rND^sRoy^nL#et al#Effect of village-wide use of long-lasting inse
cticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster ra
ndomized trial^len#PLoS Negl Trop Dis#2#20100000#2010#4#e587#20110000#aop14-11.h
tm##
00528000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100019000910100016001100120
03800126030001600164065000900180064000500189031000300194014000500197865000900202
002001300211035001000224801001600234#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#384#91#article#101#91#^rND^sAlexander^nB#^rND^sMaroli^
nM#Control of phlebotomine sandflies^len#Med Vet Entomol#20030000#2003#17#1-18#2
0110000#aop14-11.htm#0269-283X#Med Vet Entomol##
00518000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100027000910120059001180300
00800177065000900185064000500194031000300199014001000202865000900212002001300221
035001000234801000800244#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
14-11.htm#S#c#385#92#article#101#92#^rND^sPalatnik-de-Sousa^nC#Vaccines for leis
hmaniasis in the fore coming 25 years^len#Vaccine#20080000#2008#26#1709-1724#201
10000#aop14-11.htm#0264-410X#Vaccine##
00658000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100021000910100016001120100
01700128010001700145010001800162012007200180030001700252065000900269064000500278
031000400283014000800287865000900295002001300304035001000317801001700327#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#386#93#article#101
#93#^rND^sKhamesipour^nA#^rND^sRafati^nS#^rND^sDavoudi^nN#^rND^sMaboudi^nF#^rND^
sModabber^nF#Leishmaniasis vaccine candidates for development: a global overview
^len#Indian J Med Res#20060000#2006#123#423-438#20110000#aop14-11.htm#0971-5916#
Indian J Med Res##
00582000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100020000910100013001110100
01700124012004700141030001300188065000900201064000500210031000400215032000800219
014000800227865000900235002001300244035001000257801001300267#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#387#94#article#101#94#^rND^sKe
dzierski^nL#^rND^sZhu^nY#^rND^sHandman^nE#Leishmania vaccines: progress and prob
lems^len#Parasitology#20060000#2006#133#^ssuppl#S87-112#20110000#aop14-11.htm#00
31-1820#Parasitology##
00552000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100016000910100014001070120
08100121030000700202065000900209064000500218031000400223014000800227865000900235
002001300244035001000257801000700267#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#388#95#article#101#95#^rND^sRogan^nWJ#^rND^sChen^nA#He
alth risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT)^len#L
ancet#20050000#2005#366#763-773#20110000#aop14-11.htm#0099-5355#Lancet##
00613000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880100020000910100016001110100
01500127012008600142030001800228065000900246064000500255031000300260014001000263
865000900273002001300282035001000295801001800305#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop14-11.htm#S#c#389#96#article#101#96#^rND^sGuimaraes^nRM#
^rND^sAsmus^nCI#^rND^sMeyer^nA#DDT reintroduction for malaria control: the cost-
benefit debate for public health^len#Cad Saude Publica#20070000#2007#23#2835-284
4#20110000#aop14-11.htm#0102-311X#Cad Saude Publica##
00497000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170013000910180036001040650
00900140064000500149110000900154109001300163037005700176865000900233002001300242
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#390#97#art
icle#101#97#Data WLC-i-P#International Health Regulation^len#20050000#2005#20100
403#April 3 2010#http://whqlibdoc.who.int/HQ/2003/EIP_GPE_EQC_2003_1.pdf/#201100
00#aop14-11.htm##
00498000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170074000910180034001650660
00700199062002600206065000900232064000500241865000900246002001300255#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#391#98#article#101#98#
World Health Organization^dGlobal Programme on Evidence for Health Policy#Guidel
ines for WHO guidelines^len#Geneva#World Health Organization#20030000#2003#20110
000#aop14-11.htm##
00555000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080004000841180003000880170058000910180096001490660
01500245062002900260065000900289064000500298865000900303002001300312#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#392#99#article#101#99#
Committee on Assessing Integrity in Research Environments#Integrity in scientifi
c research: creating an environment that promotes responsible conduct^len#Washin
gton^eDC#The National Academies Press#20020000#2002#20110000#aop14-11.htm##
00510000000000241000450000400110000070200540001170500020006570600020006770000040
00697010004000737090008000777080004000851180004000890180032000930250036001250650
00900161064000500170110000900175109001400184037004800198865000900246002001300255
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop14-11.htm#S#c#393#100#ar
ticle#101#100#The moral status of animals^len#Stanford Encyclopedia of Philosoph
y#20030000#2003#20100221#Feb 21th 2010#http://plato.stanford.edu/entries/moral-a
nimal/#20110000#aop14-11.htm##
00528000000000277000450000400110000070200540001170500020006570600020006770000040
00697010004000737090008000777080004000851180004000890100016000930100018001090120
03300127030001700160065000900177064000500186031000300191014000700194865000900201
002001300210035001000223801001700233#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop14-11.htm#S#c#394#101#article#101#101#^rND^sEmery^nNJ#^rND^sClayton^
nNS#Comparative social cognition^len#Annu Rev Psychol#20090000#2009#60#87-113#20
110000#aop14-11.htm#0066-4308#Annu Rev Psychol##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#o#1#
1#article#1#20110325#103701#aop15-11.htm#219##
04438000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400090015603500100016522300090017501200780018401200800
02620100042003420100042003840100032004260100046004580100036005040100036005400100
03100576070012200607083132000729085000802049085001902057085002402076085002302100
08500270212308500190215008314130216908500080358208500180359008500230360808500240
36310850028036550850019036831170006037020720003037081120009037111110011037201140
00903731113001103740002001303751#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop15-11.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#TAB#11#nd#nd#Rev. Soc. Bra
s. Med. Trop.#ahead#20110000#^f28^l33#0037-8682#20110401#Rabies diagnosis and se
rology in bats from the State of São Paulo, Brazil^len#Diagnóstico e sorologia d
e raiva em morcegos do Estado de São Paulo, Brasil^lpt#^rND^1A01^nMarilene Ferna
ndes de^sAlmeida#^rND^1A01^nLuzia Fátima Alves^sMartorelli#^rND^1A01^nMiriam Mar
tos^sSodré#^rND^1A01^nAna Paula Arruda Geraldes^sKataoka#^rND^1A01^nAdriana Ruck
ert da^sRosa#^rND^1A01^nMaria Lucia de^sOliveira#^rND^1A01^nElizabeth^sAmatuzzi#
Prefeitura da Cidade de São Paulo^iA01^1Coordenação de Vigilância em Saúde^2Cent
ro de Controle de Zoonoses^cSão Paulo^sSP#^len^aINTRODUCTION: Bats are one of th
e most important reservoirs and vectors of the rabies virus in the world. METHOD
S: From 1988 to 2003, the Zoonosis Control Center in São Paulo City performed ra
bies diagnosis on 5,670 bats by direct immunofluorescent test and mouse inoculat
ion test. Blood samples were collected from 1,618 bats and the sera were analyze
d using the rapid fluorescent focus inhibition test to confirm rabies antibodies
. RESULTS: Forty-four (0.8%) bats were positive for rabies. The prevalence of ra
bies antibodies was 5.9% using 0.5IU/ml as a cutoff. Insectivorous bats (69.8%) 
and bats of the species Molossus molossus (51.8%) constituted the majority of th
e sample; however, the highest prevalence of antibodies were observed in Glossop
haga soricina (14/133), Histiotus velatus (16/60), Desmodus rotundus (8/66), Art
ibeus lituratus (5/54), Nyctinomops macrotis (3/23), Tadarida brasiliensis (3/48
), Carollia perspicillata (3/9), Eumops auripendulus (2/30), Nyctinomops laticau
datus (2/16), Sturnira lilium (2/17) and Eumops perotis (1/13). The prevalence o
f rabies antibodies was analyzed by species, food preference and sex. CONCLUSION
S: The expressive levels of antibodies associated with the low virus positivity 
verified in these bats indicate that rabies virus circulates actively among them
.#^dnd^i1#^tm^len^kRabies^i1#^tm^len^kChiropteran^i1#^tm^len^kDiagnostic^i1#^tm^
len^kSeroprevalence^i1#^tm^len^kBrazil^i1#^lpt^aINTRODUÇÃO: Morcegos são um dos 
mais importantes reservatórios e vetores do vírus da raiva no mundo. MÉTODOS: No
 período entre 1998 e 2003, o Centro de Controle de Zoonoses da Cidade de São Pa
ulo realizou o diagnóstico de raiva em 5.670 morcegos utilizando as técnicas de 
imunofluorescência direta e inoculação intracerebral em camundongos. Sangue foi 
coletado de 1.618 espécimes para pesquisa de anticorpos pela técnica de inibição
 de foco de fluorescência rápida. RESULTADOS: Quarenta e quatro (0,8%) morcegos 
foram positivos para raiva. A prevalência de anticorpos foi de 5,9% usando 0,5UI
/ml como ponto de corte. Os morcegos de hábito alimentar insetívoro (69,8%) e os
 morcegos da espécie Molossus molossus (51,8%) representaram a maioria da amostr
a. Entretanto, as mais altas prevalências de anticorpos foram observadas nos mor
cegos Glossophaga soricina (14/133), Histiotus velatus (16/60), Desmodus rotundu
s (8/66), Artibeus lituratus (5/54), Nyctinomops macrotis (3/23), Tadarida brasi
liensis (3/48), Carollia perspicillata (3/9), Eumops auripendulus (2/30), Nyctin
omops laticaudatus (2/16), Sturnira lilium (2/17) e Eumops perotis (1/13). A pre
valência de anticorpos foi analisada por espécie, hábito alimentar e sexo. CONCL
USÕES: O expressivo nível de anticorpos associado à baixa positividade para o ví
rus da raiva entre os morcegos estudados indica que o vírus circula ativamente e
ntre morcegos.#^dnd^i2#^tm^lpt^kRaiva^i2#^tm^lpt^kQuiróptero^i2#^tm^lpt^kDiagnós
tico^i2#^tm^lpt^kSoroprevalência^i2#^tm^lpt^kBrasil^i2#other#40#20100614#14/06/2
010#20101104#04/11/2010#aop15-11.htm##
04676000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400090015603500100016522300090017501200850018401200870
02690100042003560100042003980100032004400100046004720100036005180100036005540100
03100590070012200621083143200743085000802175085001902183085002402202085002302226
08500270224908500190227608315250229508500080382008500180382808500230384608500240
38690850028038930850019039211170006039400720003039461120009039491110011039581140
00903969113001103978002001303989#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop15-11.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#TAB#11#nd#nd#Rev. Soc. Bra
s. Med. Trop.#ahead#20110000#^f28^l33#0037-8682#20110401#<b>Rabies diagnosis and
 serology in bats from the State of São Paulo, Brazil</b>^len#<b>Diagnóstico e s
orologia de raiva em morcegos do Estado de São Paulo, Brasil</b>^lpt#^rND^1A01^n
Marilene Fernandes de^sAlmeida#^rND^1A01^nLuzia Fátima Alves^sMartorelli#^rND^1A
01^nMiriam Martos^sSodré#^rND^1A01^nAna Paula Arruda Geraldes^sKataoka#^rND^1A01
^nAdriana Ruckert da^sRosa#^rND^1A01^nMaria Lucia de^sOliveira#^rND^1A01^nElizab
eth^sAmatuzzi#Prefeitura da Cidade de São Paulo^iA01^1Coordenação de Vigilância 
em Saúde^2Centro de Controle de Zoonoses^cSão Paulo^sSP#^len^a<b>INTRODUCTION:</
b> Bats are one of the most important reservoirs and vectors of the rabies virus
 in the world. <b>METHODS:</b> From 1988 to 2003, the Zoonosis Control Center in
 São Paulo City performed rabies diagnosis on 5,670 bats by direct immunofluores
cent test and mouse inoculation test. Blood samples were collected from 1,618 ba
ts and the sera were analyzed using the rapid fluorescent focus inhibition test 
to confirm rabies antibodies. <b>RESULTS:</b> Forty-four (0.8%) bats were positi
ve for rabies. The prevalence of rabies antibodies was 5.9% using 0.5IU/ml as a 
cutoff. Insectivorous bats (69.8%) and bats of the species <i>Molossus molossus<
/i> (51.8%) constituted the majority of the sample; however, the highest prevale
nce of antibodies were observed in <i>Glossophaga soricina</i> (14/133),<i> Hist
iotus velatus</i> (16/60), <i>Desmodus rotundus</i> (8/66), <i>Artibeus lituratu
s</i> (5/54<i>), Nyctinomops macrotis</i> (3/23), <i>Tadarida brasiliensis</i> (
3/48), <i>Carollia perspicillata</i> (3/9), <i>Eumops auripendulus</i> (2/30), <
i>Nyctinomops laticaudatus</i> (2/16), <i>Sturnira lilium</i> (2/17) and<i> Eumo
ps perotis</i> (1/13). The prevalence of rabies antibodies was analyzed by speci
es, food preference and sex. <b>CONCLUSIONS:</b> The expressive levels of antibo
dies associated with the low virus positivity verified in these bats indicate th
at rabies virus circulates actively among them.#^dnd^i1#^tm^len^kRabies^i1#^tm^l
en^kChiropteran^i1#^tm^len^kDiagnostic^i1#^tm^len^kSeroprevalence^i1#^tm^len^kBr
azil^i1#^lpt^a<b>INTRODUÇÃO:</b> Morcegos são um dos mais importantes reservatór
ios e vetores do vírus da raiva no mundo. <b>MÉTODOS: </b>No período entre 1998 
e 2003, o Centro de Controle de Zoonoses da Cidade de São Paulo realizou o diagn
óstico de raiva em 5.670 morcegos utilizando as técnicas de imunofluorescência d
ireta e inoculação intracerebral em camundongos. Sangue foi coletado de 1.618 es
pécimes para pesquisa de anticorpos pela técnica de inibição de foco de fluoresc
ência rápida. <b>RESULTADOS:</b> Quarenta e quatro (0,8%) morcegos foram positiv
os para raiva. A prevalência de anticorpos foi de 5,9% usando 0,5UI/ml como pont
o de corte. Os morcegos de hábito alimentar insetívoro (69,8%) e os morcegos da 
espécie <i>Molossus molossus </i>(51,8%) representaram a maioria da amostra. Ent
retanto, as mais altas prevalências de anticorpos foram observadas nos morcegos 
<i>Glossophaga soricina</i> (14/133),<i> Histiotus velatus</i> (16/60), <i>Desmo
dus rotundus</i> (8/66), <i>Artibeus lituratus</i> (5/54<i>), Nyctinomops macrot
is</i> (3/23), <i>Tadarida brasiliensis</i> (3/48), <i>Carollia perspicillata</i
> (3/9), <i>Eumops auripendulus</i> (2/30), <i>Nyctinomops laticaudatus</i> (2/1
6), <i>Sturnira lilium</i> (2/17) e<i> Eumops perotis</i> (1/13). A prevalência 
de anticorpos foi analisada por espécie, hábito alimentar e sexo. <b>CONCLUSÕES:
 </b>O expressivo nível de anticorpos associado à baixa positividade para o víru
s da raiva entre os morcegos estudados indica que o vírus circula ativamente ent
re morcegos.#^dnd^i2#^tm^lpt^kRaiva^i2#^tm^lpt^kQuiróptero^i2#^tm^lpt^kDiagnósti
co^i2#^tm^lpt^kSoroprevalência^i2#^tm^lpt^kBrasil^i2#other#40#20100614#14/06/201
0#20101104#04/11/2010#aop15-11.htm##
04623000000000697000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108121000300112049000300115158000300118
03000260012103200060014706500090015301400090016203500100017122300090018101200780
01900120080002680100042003480100042003900100032004320100046004640100036005100100
03600546010003100582070012400613083134800737085000802085085001902093085002402112
08500230213608500270215908500190218608314490220508500080365408500180366208500230
36800850024037030850028037270850019037551170006037740720003037801120009037831110
01103792114000903803113001103812002001303823008008903836#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop15-11.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1
#4.0#tab#11#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f28^l33#0037-8682#20
110401#Rabies diagnosis and serology in bats from the State of São Paulo, Brazil
^len#Diagnóstico e sorologia de raiva em morcegos do Estado de São Paulo, Brasil
^lpt#^rND^1A01^nMarilene Fernandes de^sAlmeida#^rND^1A01^nLuzia Fátima Alves^sMa
rtorelli#^rND^1A01^nMiriam Martos^sSodré#^rND^1A01^nAna Paula Arruda Geraldes^sK
ataoka#^rND^1A01^nAdriana Ruckert da^sRosa#^rND^1A01^nMaria Lucia de^sOliveira#^
rND^1A01^nElizabeth^sAmatuzzi#^iA01^1Prefeitura da Cidade de São Paulo^2Coordena
ção de Vigilância em Saúde^3Centro de Controle de Zoonoses^cSão Paulo^sSP#^len^a
INTRODUCTION: Bats are one of the most important reservoirs and vectors of the r
abies virus in the world. METHODS: From 1988 to 2003, the Zoonosis Control Cente
r in São Paulo City performed rabies diagnosis on 5,670 bats by direct immunoflu
orescent test and mouse inoculation test. Blood samples were collected from 1,61
8 bats and the sera were analyzed using the rapid fluorescent focus inhibition t
est to confirm rabies antibodies. RESULTS: Forty-four (0.8 percent) bats were po
sitive for rabies. The prevalence of rabies antibodies was 5.9 percent using 0.5
IU/ml as a cutoff. Insectivorous bats (69.8 percent) and bats of the species Mol
ossus molossus (51.8 percent) constituted the majority of the sample; however, t
he highest prevalence of antibodies were observed in Glossophaga soricina (14/13
3), Histiotus velatus (16/60), Desmodus rotundus (8/66), Artibeus lituratus (5/5
4), Nyctinomops macrotis (3/23), Tadarida brasiliensis (3/48), Carollia perspici
llata (3/9), Eumops auripendulus (2/30), Nyctinomops laticaudatus (2/16), Sturni
ra lilium (2/17) and Eumops perotis (1/13). The prevalence of rabies antibodies 
was analyzed by species, food preference and sex. CONCLUSIONS: The expressive le
vels of antibodies associated with the low virus positivity verified in these ba
ts indicate that rabies virus circulates actively among them.#^dnd^i1#^tm^len^kR
abies^i1#^tm^len^kChiropteran^i1#^tm^len^kDiagnostic^i1#^tm^len^kSeroprevalence^
i1#^tm^len^kBrazil^i1#^lpt^aINTRODUÇÃO: Morcegos são um dos mais importantes res
ervatórios e vetores do vírus da raiva no mundo. MÉTODOS: No período entre 1998 
e 2003, o Centro de Controle de Zoonoses da Cidade de São Paulo realizou o diagn
óstico de raiva em 5.670 morcegos utilizando as técnicas de imunofluorescência d
ireta e inoculação intracerebral em camundongos. Sangue foi coletado de 1.618 es
pécimes para pesquisa de anticorpos pela técnica de inibição de foco de fluoresc
ência rápida. RESULTADOS: Quarenta e quatro (0,8 por cento) morcegos foram posit
ivos para raiva. A prevalência de anticorpos foi de 5,9 por cento usando 0,5UI/m
l como ponto de corte. Os morcegos de hábito alimentar insetívoro (69,8 por cent
o) e os morcegos da espécie Molossus molossus (51,8 por cento) representaram a m
aioria da amostra. Entretanto, as mais altas prevalências de anticorpos foram ob
servadas nos morcegos Glossophaga soricina (14/133), Histiotus velatus (16/60), 
Desmodus rotundus (8/66), Artibeus lituratus (5/54), Nyctinomops macrotis (3/23)
, Tadarida brasiliensis (3/48), Carollia perspicillata (3/9), Eumops auripendulu
s (2/30), Nyctinomops laticaudatus (2/16), Sturnira lilium (2/17) e Eumops perot
is (1/13). A prevalência de anticorpos foi analisada por espécie, hábito aliment
ar e sexo. CONCLUSÕES: O expressivo nível de anticorpos associado à baixa positi
vidade para o vírus da raiva entre os morcegos estudados indica que o vírus circ
ula ativamente entre morcegos.#^dnd^i2#^tm^lpt^kRaiva^i2#^tm^lpt^kQuiróptero^i2#
^tm^lpt^kDiagnóstico^i2#^tm^lpt^kSoroprevalência^i2#^tm^lpt^kBrasil^i2#other#40#
20100614#14/06/2010#20101104#04/11/2010#aop15-11.htm#Internet^ihttp://www.scielo
.br/scielo.php?script=sci_arttext&pid=S0037-86822011005000011##
00433000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704018900085002001300274#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#5#1#article#175#<p><a name
="enda"></a><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><b>Rabie
s diagnosis and serology in bats from the State of S&atilde;o Paulo, Brazil</b><
/font></p>     ^cY#aop15-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#6#2#article#175#<p>&nbsp;<
/p>     ^cY#aop15-11.htm##
00423000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704017900085002001300264#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#7#3#article#175#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Diagn&oacute;stico e sor
ologia de raiva em morcegos do Estado de S&atilde;o Paulo, Brasil</b></font></p>
     ^cY#aop15-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#8#4#article#175#<p>&nbsp;<
/p>     ^cY#aop15-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#9#5#article#175#<p>&nbsp;<
/p>     ^cY#aop15-11.htm##
00535000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704029000086002001300376#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#10#6#article#175#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Marilene Fernandes de A
lmeida; Luzia F&aacute;tima Alves Martorelli; Miriam Martos Sodr&eacute;; Ana Pa
ula Arruda Geraldes Kataoka; Adriana Ruckert da Rosa; Maria Lucia de Oliveira; E
lizabeth Amatuzzi</b></font></p>     ^cY#aop15-11.htm##
00486000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704024100086002001300327#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#11#7#article#175#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif">Centro de Controle de Zoon
oses, Coordena&ccedil;&atilde;o de Vigil&acirc;ncia em Sa&uacute;de, Prefeitura 
da Cidade de  S&atilde;o Paulo, S&atilde;o Paulo, SP</font></p>     ^cY#aop15-11
.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011300086002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#12#8#article#175#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#endb">Address to
</a></font></p>     ^cY#aop15-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704002200086002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#13#9#article#175#<p>&nbsp;
</p>     ^cY#aop15-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#14#10#article#175#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop15-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#15#11#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop15-11.htm##
00430000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018400087002001300271#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#16#12#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION:</b> Bats
 are one of the most important reservoirs and vectors of the rabies virus in the
 world.     ^cY#aop15-11.htm##
00603000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035700087002001300444#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#17#13#article#175#<br>   <
b>METHODS:</b> From 1988 to 2003, the Zoonosis Control Center in S&atilde;o Paul
o City performed rabies diagnosis on 5,670 bats by direct immunofluorescent test
 and mouse inoculation test. Blood samples were collected from 1,618 bats and th
e sera were analyzed using the rapid fluorescent focus inhibition test to confir
m rabies antibodies.     ^cY#aop15-11.htm##
01061000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081500087002001300902#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#18#14#article#175#<br>   <
b>RESULTS:</b> Forty-four (0.8%) bats were positive for rabies. The prevalence o
f rabies antibodies was 5.9% using 0.5IU/ml as a cutoff. Insectivorous bats (69.
8%) and bats of the species <i>Molossus molossus</i> (51.8%) constituted the maj
ority of the sample; however, the highest prevalence of antibodies were observed
 in <i>Glossophaga soricina</i> (14/133),<i> Histiotus velatus</i> (16/60), <i>D
esmodus rotundus</i> (8/66), <i>Artibeus lituratus</i> (5/54<i>),  Nyctinomops m
acrotis</i> (3/23), <i>Tadarida brasiliensis</i> (3/48), <i>Carollia perspicilla
ta</i> (3/9), <i>Eumops auripendulus</i> (2/30), <i>Nyctinomops laticaudatus</i>
 (2/16), <i>Sturnira lilium</i> (2/17) and<i> Eumops perotis</i> (1/13). The pre
valence of rabies antibodies was analyzed by species, food preference and sex.  
   ^cY#aop15-11.htm##
00451000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020500087002001300292#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#19#15#article#175#<br>   <
b>CONCLUSIONS:</b> The expressive levels of antibodies associated with the low v
irus positivity verified in these bats indicate that rabies virus circulates act
ively among them.</font></p>     ^cY#aop15-11.htm##
00424000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017800087002001300265#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#20#16#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Rabies. 
Chiropteran. Diagnostic. Seroprevalence. Brazil.</font></p> <hr size="1" noshade
>     ^cY#aop15-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#21#17#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop15-11.htm##
00459000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021300087002001300300#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#22#18#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O:</b> Morcegos s&atilde;o um dos mais importantes reservat&oacute;rios e vetor
es do v&iacute;rus da raiva no mundo.    ^cY#aop15-11.htm##
00730000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048400087002001300571#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#23#19#article#175#<br>   <
b>M&Eacute;TODOS: </b> No per&iacute;odo entre 1998 e 2003, o Centro de Controle
 de Zoonoses da Cidade de S&atilde;o Paulo realizou o diagn&oacute;stico de raiv
a em 5.670 morcegos utilizando as t&eacute;cnicas de imunofluoresc&ecirc;ncia di
reta e inocula&ccedil;&atilde;o intracerebral em camundongos. Sangue foi coletad
o de 1.618 esp&eacute;cimes para pesquisa de anticorpos pela t&eacute;cnica de i
nibi&ccedil;&atilde;o de foco de fluoresc&ecirc;ncia r&aacute;pida.     ^cY#aop1
5-11.htm##
01166000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704092000087002001301007#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#24#20#article#175#<br>   <
b>RESULTADOS:</b> Quarenta e quatro (0,8%) morcegos foram positivos para raiva. 
A preval&ecirc;ncia de anticorpos foi de 5,9% usando 0,5UI/ml como ponto de cort
e. Os morcegos de h&aacute;bito alimentar inset&iacute;voro (69,8%) e os morcego
s da esp&eacute;cie <i>Molossus molossus </i>(51,8%) representaram a maioria da 
amostra. Entretanto, as mais altas preval&ecirc;ncias de anticorpos foram observ
adas nos morcegos <i>Glossophaga soricina</i> (14/133),<i> Histiotus velatus</i>
 (16/60), <i>Desmodus rotundus</i> (8/66), <i>Artibeus lituratus</i> (5/54<i>), 
 Nyctinomops macrotis</i> (3/23), <i>Tadarida brasiliensis</i> (3/48), <i>Caroll
ia perspicillata</i> (3/9), <i>Eumops auripendulus</i> (2/30), <i>Nyctinomops la
ticaudatus</i> (2/16), <i>Sturnira lilium</i> (2/17) e<i> Eumops perotis</i> (1/
13). A preval&ecirc;ncia de anticorpos foi analisada por esp&eacute;cie, h&aacut
e;bito alimentar e sexo.    ^cY#aop15-11.htm##
00496000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025000087002001300337#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#25#21#article#175#<br>   <
b>CONCLUS&Otilde;ES: </b> O expressivo n&iacute;vel de anticorpos associado &agr
ave; baixa positividade para o v&iacute;rus da raiva entre os morcegos estudados
 indica que o v&iacute;rus circula ativamente entre morcegos. </font></p>     ^c
Y#aop15-11.htm##
00451000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020500087002001300292#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#26#22#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves:</b> R
aiva. Quir&oacute;ptero. Diagn&oacute;stico. Soropreval&ecirc;ncia. Brasil.</fon
t></p> <hr size="1" noshade>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#27#23#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#28#24#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#29#25#article#175#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop15-11.htm##
00742000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049600087002001300583#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#30#26#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In recent decades, there 
have been frequent case reports of rabies in bats, which are one of the main vir
us reservoirs in many countries around the world<sup>1</sup>. Several reports ha
ve confirmed the rabies virus in both hematophagous and nonhematophagous bats; t
he former are responsible for rabies outbreaks in Latin America<sup>2</sup> and 
the latter for sporadic rabies transmission to humans<sup>3,4</sup>.</font></p> 
    ^cY#aop15-11.htm##
00729000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048300087002001300570#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#31#27#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Data from the Pan-America
n Health Organization (PAHO)<sup>5</sup> revealed 678 reported cases of bat-tran
smitted human rabies in Latin America from 1990 to 2010. Considering only the 24
0 human cases transmitted by bats during the period 1996-2010, 74% were transmit
ted by hematophagous bats, 6.7% by nonhematophagous bats and in 19.6%, identific
ation of the species was not registered<sup>2,5</sup>. </font></p>     ^cY#aop15
-11.htm##
00674000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042800087002001300515#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#32#28#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In Brazil, between 2001 a
nd 2010, 1,305 cases of rabies in bats were notified, 815 (62.5%) involving nonh
ematophagous bats, 303 (23.2%) in hematophagous bats and in 187 (14.3%) bats, id
entification of the species was not confirmed<sup>5</sup>. The rabies virus has 
already been isolated in 41 of the 172 species that live in Brazil<sup>6</sup>. 
</font></p>     ^cY#aop15-11.htm##
00554000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030800087002001300395#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#33#29#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The purpose of this work 
was to report the diagnosis of rabies in bats conducted from 1988 to 2003 on sam
ples collected in the State of S&atilde;o Paulo, Brazil and serology for rabies 
antibodies performed from 1992 to 2003. </font></p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#34#30#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#35#31#article#175#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>
     ^cY#aop15-11.htm##
00765000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051900087002001300606#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#36#32#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">From 1988 to 2003, the ra
bies laboratory of the S&atilde;o Paulo Zoonosis Control Center (CCZ-SP) receive
d 5,834 bats for rabies diagnosis from citizens and other zoonosis centers in th
e State of S&atilde;o Paulo. Among these, 164 bats were unsuitable for diagnosis
 (autolysis, alcohol, etc). Diagnosis was performed on the brain of 5,670 bats b
y fluorescent antibody test (FAT)<sup>7</sup> and mouse inoculation test (MIT)<s
up>8</sup>.</font></p>     ^cY#aop15-11.htm##
00871000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062500087002001300712#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#37#33#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Of the total number of re
ceived bats, 1,618 were alive. After weighting, the bats were anesthetized with 
ketamine hydrochloride (Ketamina&#63194;), which was injected into the pectoral 
muscle, considering weight and volume. Blood was collected by cardiac punction o
f the bats and the sera were analyzed for rabies virus neutralizing antibody (VN
A) using the rapid fluorescent focus inhibition test (RFFIT)<sup>9</sup>. The cu
toff point was 0.5IU/ML. Euthanasia of the bats was performed in a CO<sub>2</sub
> chamber following blood collection.</font></p>     ^cY#aop15-11.htm##
00466000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022000087002001300307#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#38#34#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Statistical analysis was 
performed using the uncorrected Chi square test, contained in the software Epi-I
nfo 6.0 (CDC, Atlanta, GA, USA).</font></p>     ^cY#aop15-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#39#35#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Ethical considerations
</b></font></p>     ^cY#aop15-11.htm##
00572000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032600087002001300413#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#40#36#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The Scientific Committee 
of the CCZ-SP authorized all the proceedings performed in this work. The capture
 of bats was authorized by a Brazilian institution responsible for wild animal c
are (<i>Instituto Brasileiro do Meio Ambiente</i>, IBAMA).</font></p>     ^cY#ao
p15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#41#37#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#42#38#article#175#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>
     ^cY#aop15-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010600087002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#43#39#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Rabies diagnosis</b></
font></p>     ^cY#aop15-11.htm##
00644000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039800087002001300485#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#44#40#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Forty-four (0.8%) bats we
re positive for rabies by FAT and MIT tests among the 5,670 samples analyzed, 45
.5% of these were from City of S&atilde;o Paulo and 54.5% from another seven cit
ies in the State of S&atilde;o Paulo. The incubation period for MIT ranged from 
6 to 29 days (<b><a href="#tab1">Table 1</a></b>).</font></p>     ^cY#aop15-11.h
tm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#45#41#article#175#<p><a na
me="tab1"></a></p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#46#42#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#47#43#article#175#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop15-11tab01.jpg"></p>     ^
cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#48#44#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00750000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050400087002001300591#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#49#45#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Regarding the circumstanc
es of the location of the 44 positive bats, 24 were captured inside houses or co
mmercial buildings, ten were collected on the ground, three specimens were captu
re in fruit trees, three bats were captured by mist nets on farms (two <i>Desmod
us rotundus </i>and one<i> Carollia perspicillata</i>) and one specimen was capt
ured by children during flight. In three cases, this data was not available.</fo
nt></p>     ^cY#aop15-11.htm##
00674000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042800087002001300515#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#50#46#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The rabies-positive bats 
belonged to three families and 14 species: Vespertilionidae family (19 bats from
 six species), Molossidae family (16 bats from four species) and Phyllostomidae 
family (nine bats from four species). Sixteen were males and 28 were females. Ra
bies positivity year-by-year is presented in <b><a href="#tab1">Table 1</a></b>.
</font></p>     ^cY#aop15-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#51#47#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Rabies serology</b></f
ont></p>     ^cY#aop15-11.htm##
00658000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041200087002001300499#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#52#48#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Virus neutralizing antibo
dy prevalence was 5.9% in the RFFIT test (96 sera samples). Prevalence according
 year and food preference of bats is presented in <b><a href="#tab2">Table 2</a>
</b>. Among the 96 reagent sera, only three bats were positive for FAT and MIT t
echniques (three bats of the species <i>H. velatus</i> in 2002).</font></p>     
^cY#aop15-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#53#49#article#175#<p><a na
me="tab2"></a></p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#54#50#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#55#51#article#175#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop15-11tab02.jpg"></p>     ^
cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#56#52#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00499000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025300087002001300340#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#57#53#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Among the 1,618 bats subm
itted to rabies serology, 65.8% of them were captured in the City of S&atilde;o 
Paulo and 34.2% in other cities in the State of S&atilde;o Paulo.</font></p>    
 ^cY#aop15-11.htm##
00732000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048600087002001300573#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#58#54#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Predominance of insectivo
rous bats (69.8%) was observed every year throughout the period. Phytophagous (n
ectarivorous and frugivorous) represented 18% and hematophagous bats represented
 4.2%. Thirty species of bats were identified and the insectivorous bat <i>Molos
sus molossus </i>(51.8%) was predominant. Rabies antibody prevalence according s
pecies is presented in <b><a href="#tab3">Table 3</a></b>.</font></p>     ^cY#ao
p15-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#59#55#article#175#<p><a na
me="tab3"></a></p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#60#56#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00337000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009100087002001300178#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#61#57#article#175#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop15-11tab03.jpg"></p>     ^
cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#62#58#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00716000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047000087002001300557#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#63#59#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Distribution according se
x confirmed 62 out of 896 females and 34 out of 559 males with rabies antibody t
iters. For 163 specimens this information was not available. Throughout the enti
re period, the number of females was higher than males; however, this difference
 was not significant (<i>x<sup>2</sup> </i>= 0.39;  p = 0.05). Seroprevalence wa
s 6.9% among females and 6.1% among males.</font></p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#64#60#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#65#61#article#175#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font><
/p>     ^cY#aop15-11.htm##
00890000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064400087002001300731#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#66#62#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The conditions of big cit
ies seem appropriate for the permanence of bats, given the lack of predators, la
rge quantities of food and adequate shelters. These factors are common in urban 
ecosystems. In this work, insectivorous bats from Molossidae and Vespertilionida
e families represented the majority of the sample. This was expected, because ur
ban ecosystems, like the City of S&atilde;o Paulo, are especially favorable to i
nsectivorous bats due to the large population of insects attracted to this type 
of environment by street lamp illumination<sup>10</sup>.</font></p>     ^cY#aop1
5-11.htm##
00608000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036200087002001300449#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#67#63#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In the majority of the 44
 positives cases, bats were found in the morning, inside houses or commercial bu
ildings or on the ground. Eighteen per cent of the bats captured in yards or bui
ldings in South Carolina (USA) in the period 1970-1990, were positive for rabies
<sup>11</sup>.</font></p>     ^cY#aop15-11.htm##
00927000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068100087002001300768#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#68#64#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">In disagreement with Hest
er et al<sup>12</sup>, who reported that rabies prevalence in solitary species s
ubmitted for rabies diagnosis in the USA and Canada is consistently greater than
 in colonial species, even though the largest number of rabies cases were determ
ined in the colonial bat <i>Eptesicus fuscus</i>,in this work, only six of the r
abies-positive bats were from solitary species. In our sample, prevalence seems 
be more directly related to species habit in urban areas, which use cramped loca
ls as shelter with intense body contact among individuals, than solitary or colo
nial species.</font></p>     ^cY#aop15-11.htm##
00954000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704070800087002001300795#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#69#65#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">It is likely that some of
 the bats detected as rabies-positive were sent for rabies diagnosis and species
 identification because the people who found them had some knowledge concerning 
the potential risk involving bats and rabies transmission. Bats collected by the
 public are often sick or injured and therefore represent a biased subpopulation
 of bats more likely to be infected with rabies, such that rabies prevalence ten
ds to be higher<sup>11,13,14</sup>. In studies where presumed healthy bats captu
red during flight were screened for the rabies virus, prevalence is consistently
 reported as less than 2%<sup>12</sup>. </font></p>     ^cY#aop15-11.htm##
01033000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704078700087002001300874#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#70#66#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Every day the CCZ-SP rece
ives complaints from citizens in relation to bats, citing the noise, the smell o
f urine and excrement they produce or simply their presence. The population has 
been oriented continually not to handle these animals and to communicate with th
e health authorities when a bat is found in an atypical situation, such as flyin
g during the day, paralyzed or moribund, incapable of flying or exposed to sunli
ght. At the CCZ-SP, information regarding rabies and bats has been publicized fo
r more than 20 years, but to the public, the ecological role of these animals re
mains largely unknown and public opinion concerning them is generally based on p
rejudice, fear and erroneous concepts. </font></p>     ^cY#aop15-11.htm##
00863000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061700087002001300704#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#71#67#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The prevalence of the rab
ies virus observed in this study (0.8%) may not be representative of the reality
 of the bat population in urban areas, because the majority of the bats were rec
eived due to citizens' complaints (passive surveillance). However, other reports
 in the State of S&atilde;o Paulo showed similar prevalence in bats: 1.2% in the
 northwestern region from 1993 to 2007<sup>15</sup>, 1.3% in the northern and no
rthwestern areas from 1997 to 2002<sup>16</sup> and 1.6 in the western region fr
om 1996 to 2003<sup>17</sup>.</font></p>     ^cY#aop15-11.htm##
00855000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060900087002001300696#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#72#68#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">While in other regions of
 the State of S&atilde;o Paulo, the most common species confirmed with rabies we
re the frugivorous bat <i>A. lituratus</i> and the insectivorous bats <i>M. nigr
icans</i><sup>15,16</sup>, in this work, four species predominated: <i>T. brasil
ienses</i> (19.2%) <i>H. velatus</i> (15.9%), <i>N. macrotis</i> (13.6%) and <i>
A. lituratus</i> (13.6%), while <i>M. nigricans</i> represented 9.1%. Regarding 
<i>H. velatus</i>, five of the six positive cases were found in one colony in 20
01/2002<sup>18</sup>.</font></p>     ^cY#aop15-11.htm##
00824000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057800087002001300665#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#73#69#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">An increase in the number
 of bats forwarded for diagnosis in this laboratory has been observed since 1989
 and this could be the outcome of an increase in the bat population in urban are
as due to the degradation of their natural areas, as well as the publicizing and
 divulgation of positive rabies cases. The increase in the number of cases of ra
bies-positive bats registered mostly reflects the increasing interest concerning
 the disease than any real increase in disease incidence<sup>19</sup>.</font></p
>     ^cY#aop15-11.htm##
00781000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704053500087002001300622#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#74#70#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Rabies infections of bats
 can occur during interspecies interaction, possibly by sharing shelters. In nat
ure, bites among bats, the main mechanism of rabies transmission, are frequently
 observed; although rabies virus in bats involves a variety of transmission and 
maintenance mechanisms in addition to biting: aerosols<sup>20</sup>, drinking mi
lk infected with rabies virus<sup>21</sup>, transplacental transfer and prenatal
 infection<sup>13,22</sup>.</font></p>     ^cY#aop15-11.htm##
00796000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055000087002001300637#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#75#71#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Low rabies virus prevalen
ce in bats associated with higher rabies antibody prevalence has been reported i
n the literature. Few studies exist concerning rabies seroprevalence in bats and
 in these studies the prevalence has shown extensive differences in the results,
 between 2.2% and 80%. The presence of rabies antibodies has been detected by di
fferent serological techniques in numerous bats species, collected in their habi
tats or in urban shelters<sup>23-27</sup>.</font></p>     ^cY#aop15-11.htm##
00973000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072700087002001300814#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#76#72#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Price &amp; Everard<sup>2
3</sup> observed seroprevalence of 8.6% in 439 sera samples. The highest prevale
nce (29.4%) was observed in <i>Artibeus planirostris</i> (formerly <i>A. jamaice
nsis</i>). Steece &amp; Altenbach<sup>13</sup> reported antibodies in 514 of 750
 sera of <i>Tadarida brasiliensis</i>. Aghomo et al<sup>24</sup> verified rabies
 antibodies in five out of 50 frugivorous bats <i>Eidolon helvum </i>(10%) from 
Nigeria, Africa. Jiang et al<sup>26</sup> tested for rabies antibodies in sera f
rom 685 bats of eight species from China and the total seroprevalence was 2.2%, 
2.3% for frugivorous bats and 1.8% for insectivorous bats. </font></p>     ^cY#a
op15-11.htm##
00845000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059900087002001300686#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#77#73#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Shankar et al<sup>28</sup
> detected VNA in five (14.3%) out of 35 insectivorous bats <i>Eptesicus fuscus<
/i> and Salas-Rojas et al<sup>25</sup> examined 151 sera from nonhematophagous b
ats of 16 species and the seroprevalence determined was 37%. VNA were determined
 in 12 nonhematophagous bat species. The three species with the largest sample s
ize and prevalence were <i>Artibeus planirostris</i> (formerly named <i>A. jamai
censis</i>) (14/34), <i>Sturnira lilium</i> (14/37) and <i>Glossophaga soricina<
/i> (8/20).</font></p>     ^cY#aop15-11.htm##
00738000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049200087002001300579#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#78#74#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The high prevalence of ra
bies antibodies observed in this study in insectivorous bats <i>Histiotus velatu
s</i> is related to one colony of 42 bats, in which five rabies-positive cases w
ere detected (12%). Thirty-eight sera were collected and 16 presented antibody t
iters above 0.5IU/ml. Elevated seropositivity with high titers, like that observ
ed in this colony, demonstrates a recent outbreak<sup>18</sup>. </font></p>     
^cY#aop15-11.htm##
01203000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704095700087002001301044#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#79#75#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Regarding <i>C. perspicil
lata</i> and <i>G. soricina</i>, the presence of rabies antibodies could be rela
ted to the fact that these species share shelters with <i>D. rotundus</i>, a spe
cies frequently involved in rabies cases in Brazil; however, each species has th
eir own niche inside the shelter with no interspecies relation. <i>A. lituratus<
/i> are colonial frugivorous bats that show aggressive behavior. At the CCZ-SP, 
these bats are frequently observed with visible scars on the wings compatible wi
th bites, the main mechanism for rabies virus transmission. Bats <i>Nyctinomops 
laticaudatus,Nyctinomops macrotis</i> and <i>Tadarida brasiliensis</i> are colon
ial species that use cramped locations as shelters in urban areas, with intense 
body contact among individuals; this fact could also be associated with rabies v
irus transmission and the presence of antibodies.</font></p>     ^cY#aop15-11.ht
m##
00729000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048300087002001300570#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#80#76#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The high prevalence of ra
bies antibodies in bats and other wild animals associated with low prevalence of
 rabies virus has been explained in different ways: exposure to rabies virus sho
rtly after birth<sup>13</sup>; subclinical or asymptomatic infections<sup>13,29,
30</sup>; sublethal infection<sup>31-33</sup>; carrier state<sup>34</sup>; and l
atent virus activated by stress<sup>30-31,35,36</sup>. </font></p>     ^cY#aop15
-11.htm##
01009000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704076300087002001300850#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#81#77#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Turmelle et al<sup>27</su
p> investigated whether roost type (natural or artificial) was a significant pre
dictor of rabies seroprevalence in insectivorous bats <i>Tadarida brasiliensis</
i>. They expected lower immune competence from bats in artificial roosts because
 of the perceived stresses associated with anthropogenic disturbances. However, 
while roost type alone was not a significant predictor of rabies seroprevalence,
 seasonal fluctuations in seroprevalence were affected by roost type. Increased 
seroprevalence after parturition in cave colonies, related to an influx of susce
ptible young, was also observed, as well as more uniform seroprevalence in artif
icial colonies.</font></p>     ^cY#aop15-11.htm##
00990000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704074400087002001300831#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#82#78#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Regarding the influence o
f stress, as measured by the maintenance of the rabies virus in bat colonies of 
<i>Desmodus rotundus</i>, Dimitrov et al<sup>37</sup> investigated its effects b
y analysing its influence on population densities and immunological profile of t
he colonies. The conclusion was that an accidental stressful event can be easily
 overcome by the population, while a persistent vertical immunodepression due to
 stress factors can have a devastating impact on the colony, even if it occurs a
t relatively low rates, and that seasonal stress factors affect population dynam
ics, but do not significantly alter the immunological profile of the colony.</fo
nt></p>     ^cY#aop15-11.htm##
00808000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056200087002001300649#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#83#79#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Shankar et al<sup>28</sup
> observed seroconversion in four bats during the period of captivity and conclu
ded that fatal rabies virus infections may not be common among bats despite esta
blished stable infection cycles via bites, while immunity may be acquired throug
h recurrent exposure to rabies virus during close contact between individuals. I
ntraspecies spread of rabies may cause acute disease in some bats, while in othe
rs an abortive infection may result in seroconversion.</font></p>     ^cY#aop15-
11.htm##
01147000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090100087002001300988#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#84#80#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The predominance of femal
es over males observed in this study was also reported by Burnett<sup>38</sup> a
nd Childs et al<sup>39</sup>. However, this difference regarding sex was not obs
erved by others authors<sup>12,15,16</sup>. In some species, females live in mat
ernity colonies segregated from the males. This fact suggests that females are m
ore easily captured in relation to males, who live in small groups or in various
 shelters and locations or are segregated from the colony by dominant males. Mor
eover, due to pregnancy and pups, females become heavier and, consequently, are 
easier to capture in the shelter. On the other hand, males fight viciously for a
ccess to the top of hierarchy in the colony or for preferred roosting females<su
p>40</sup>, which would provide the opportunity for rabies transmission. </font>
</p>     ^cY#aop15-11.htm##
00972000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072600087002001300813#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#85#81#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The expressive levels of 
antibodies verified in these bats indicate that rabies virus circulates actively
 among them, causing continuous viral challenge and, as a consequence, many of t
hem are protected from the disease and rabies virus prevalence is low. The exist
ence of rabid bats in areas where rabies has not been notified represents a pote
ntial risk of rabies infection for humans and domestic animals, especially when 
these bats are found inside houses or commercial buildings, as reported in this 
paper. However, biologists and health authorities need to ensure that this risk 
does not endanger conservation efforts for these mammals. </font></p>     ^cY#ao
p15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#86#82#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#87#83#article#175#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop15-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#88#84#article#175#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors declare that 
there is no conflict of interest.</font></p>     ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#89#85#article#175#<p>&nbsp
;</p>     ^cY#aop15-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#90#86#article#175#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop15-11.htm##
00585000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704032500089002001300414#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#91#87#article#
175#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1.	Velasco-
Villa A, Orciari LA, Ju&aacute;rez-Islas V, G&oacute;mez-Sierra M, Padilla-Medin
a I, Flisser A, et al. Molecular diversity of rabies viruses associated with bat
s in Mexico and other countries of the Americas.J Clin Microbiol2006; 44:1697-17
10.    ^cY#aop15-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#92#88#article#175# </font>
</p>     ^cY#aop15-11.htm##
00543000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704028300089002001300372#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#93#89#article#
175#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2.	Schneide
r MC, Romijn PC, Uieda W, Tamayo H, da Silva DF, Belotto A, et al. Rabies transm
itted by vampire bats to humans: An emerging zoonotic disease in Latin America? 
Rev Panam Salud Publica 2009; 25:260-269.    ^cY#aop15-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002100087002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#94#90#article#175# </font>
</p>     ^cY#aop15-11.htm##
00504000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024400089002001300333#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#95#91#article#
175#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3.	Messenge
r SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic ca
ses of rabies in humans in the United States. Clin Infect Dis    2002; 35:738-74
7.    ^cY#aop15-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#96#92#article#175#</font><
/p>     ^cY#aop15-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704025100089002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#97#93#article#
175#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4.	Favi M, 
Mattos CA, Yung V, Chala E, L&oacute;pez LR, Mattos CC. First Case of Human Rabi
es in Chile Caused by an Insectivorous Bat Virus Variant. Emerg Infect Dis 2002;
 8:79-81.    ^cY#aop15-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#98#94#article#175#</font><
/p>     ^cY#aop15-11.htm##
00684000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704042400089002001300513#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#99#95#article#
175#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5.	Pan-Amer
ican Health Organization. World Health Organization &#91;Internet&#93;. Database
 2009. &#91;cited 2010 oct 13&#93; Available from <a href="http://siepi.panaftos
a.org.br/anuais.aspx" target="_blank">http://siepi.panaftosa.org.br/anuais.aspx<
/a> and <a href="http://sirvera.panaftosa.org.br" target="_blank">http://sirvera
.panaftosa.org.br</a>.    ^cY#aop15-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#100#96#article#175#</font>
</p>     ^cY#aop15-11.htm##
00474000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704021300090002001300303#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#101#97#article
#175#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6.	Sodr&ea
cute; MM, Gama AR, Almeida MF. Updated List of bat species positive for rabies i
n Brazil. Rev Inst Med Trop Sao Paulo 2010;52:75-81.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002100088002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#102#98#article#175# </font
></p>     ^cY#aop15-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704025000090002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#103#99#article
#175#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7.	Dean DJ
, Abelseth MK, Atanasiu P. The fluorescent antibody test. <i>In:</i> Meslin FX, 
Kaplan MM, Koprowisk H, editors. Geneva: Laboratory techniques in rabies; 1996. 
p. 80-87.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#104#100#article#175#</font
></p>     ^cY#aop15-11.htm##
00488000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704022600091002001300317#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#105#101#articl
e#175#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8.	Koprow
isk H. The mouse inoculation test. <i>In</i>: Meslin FX, Kaplan MM, Koprowisk H,
 editors. Geneva: Laboratory techniques in rabies; 1996. p. 88-96.    ^cY#aop15-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#106#102#article#175#</font
></p>     ^cY#aop15-11.htm##
00463000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704020100091002001300292#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#107#103#articl
e#175#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9.	Smith 
JS, Yager PA, Baer GM. A Rapid Reproducible test for determining rabies neutrali
zing antibody. Bull WHO 1973; 48:535-541.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#108#104#article#175#</font
></p>     ^cY#aop15-11.htm##
00456000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019300092002001300285#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#109#105#articl
e#175#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10.	Ryde
ll J, Racey PA. Street lamps and the feeding ecology of insectivorous bats. Symp
 Zool Soc London 1995; 67:291-307.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#110#106#article#175#</font
></p>     ^cY#aop15-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020500092002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#111#107#articl
e#175#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11.	Park
er EK, Dowda H, Redden SE, Tolson MW, Turner N, Kemick W. Bat rabies in South Ca
rolina, 1970-90. J Wildl Dis 1999; 35:557-563.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#112#108#article#175#</font
></p>     ^cY#aop15-11.htm##
00427000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016400092002001300256#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#113#109#articl
e#175#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12.	Hest
er LC, Best TL, Hudson MK. Rabies in Bats from Alabama. J Wildl Dis 2007; 43:291
-299.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#114#110#article#175#</font
></p>     ^cY#aop15-11.htm##
00529000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026600092002001300358#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#115#111#articl
e#175#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13.	Stee
ce RS, Altenbach JS. Prevalence of rabies specific antibodies in the Mexican fre
e-tailed bat (<i>Tadarida brasiliensis mexicana</i>) at Lava cave, New Mexico. J
 Wildl Dis1989; 25:490-496.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#116#112#article#175#</font
></p>     ^cY#aop15-11.htm##
00571000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030800092002001300400#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#117#113#articl
e#175#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14.	Lies
ener AL, Smith KE, Davis RD, Bender JB, Danila RN, Neitzel DF, et al. Circumstan
ces of bat encounters and knowledge of rabies among Minnesota residents submitti
ng bats for rabies testing. Vector Borne Zoonotic Dis2006; 6:208-215.    ^cY#aop
15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#118#114#article#175#</font
></p>     ^cY#aop15-11.htm##
00556000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029300092002001300385#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#119#115#articl
e#175#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15.	Quei
roz LH, Carvalho C, Buso DS, Ferrari CIL, Pedro WA. Perfil epidemiol&oacute;gico
 da raiva na regi&atilde;o Noroeste do Estado de S&atilde;o Paulo no per&iacute;
odo de 1993 a 2007.Rev Soc Bras Med Trop2009; 42:9-14.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#120#116#article#175#</font
></p>     ^cY#aop15-11.htm##
00548000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704030000089002001300389#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#121#117#article#175#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">16.	Cunha ESM, Silva LH
Q, Lara MCCSH, Nassas AFCN, Albas A, Sodr&eacute; MM, et al.Bat rabies in the no
rth-northwestern regions of the State of S&atilde;o Paulo, Brazil: 1997-2002. Re
v Saude Publica2006; 40:1082-1086.</font></p>     ^cY#aop15-11.htm##
00497000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023400092002001300326#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#122#118#articl
e#175#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17.	Alba
s A, Zoccolaro PT, Rosa TZ, Cunha ESM. Laboratory diagnosis of rabies in the wes
t region of S&atilde;o Paulo state. Rev Soc Bras Med Trop 2005; 38:493-495.    ^
cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#123#119#article#175#</font
></p>     ^cY#aop15-11.htm##
00569000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030600092002001300398#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#124#120#articl
e#175#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18.	Mart
orelli LFA, Almeida MF, Durigon EL.  Rabies in a bat colony of <i>Histiotus vela
tus</i>, S&atilde;o Paulo City, Brazil. XIII International Meeting on Research A
dvances and Rabies Control in the Americas. Mexico; 2002. p. 60-61.    ^cY#aop15
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#125#121#article#175#</font
></p>     ^cY#aop15-11.htm##
00444000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018100092002001300273#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#126#122#articl
e#175#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19.	Stee
ce RS, Erickson TJ, Siem RA. Chiropteran rabies in Minnesota: 1976-1980. J Wildl
 Dis 1982; 18:487-489.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#127#123#article#175#</font
></p>     ^cY#aop15-11.htm##
00430000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016700092002001300259#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#128#124#articl
e#175#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20.	Cons
tantine DG. Rabies transmission by air in bat caves. Public Health Rep 1967; 82:
867-888.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#129#125#article#175#</font
></p>     ^cY#aop15-11.htm##
00461000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704019800092002001300290#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#130#126#articl
e#175#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21.	Cons
tantine DG, Tierkel ES, Kleckner MD, Hawkine DM. Rabies in New Mexico caverns ba
ts. Public Health Rep 1968; 83:303-316.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#131#127#article#175#</font
></p>     ^cY#aop15-11.htm##
00510000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024700092002001300339#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#132#128#articl
e#175#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22.	Stee
ce RS, Calisher CH. Evidence for prenatal transfer of rabies virus in the Mexica
n free-tailed bat (<i>Tadarida brasiliensis mexicana</i>). J Wildl Dis 1989; 25:
329-334.    ^cY#aop15-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#133#129#article#175# </fon
t></p>     ^cY#aop15-11.htm##
00449000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018600092002001300278#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#134#130#articl
e#175#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23.	Pric
e JL, Everard COR. Rabies virus and antibody in bats in Grenada and Trinidad. J 
Wildl Dis 1977; 13:131-134.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#135#131#article#175#</font
></p>     ^cY#aop15-11.htm##
00519000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025600092002001300348#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#136#132#articl
e#175#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24.	Agho
mo HO, Ako-Nai AK, Oduye OO, Tomori O, Rupprecht CE. Detection    of rabies viru
s antibodies in fruit bats (<i>Eidolon helvum</i>) from Nigeria.    J Wildl Dis 
1990; 26:258-261.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#137#133#article#175#</font
></p>     ^cY#aop15-11.htm##
00604000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034100092002001300433#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#138#134#articl
e#175#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25.	Sala
s-Rojas M, Sanchez-Hernandez C, Romero-Almara ML, Schnellc GD, Schmida RK, Aguil
ar-Setien A. Prevalence of rabies and LPM paramyxovirus antibody in non-hematoph
agous bats captured in the Central Pacific coast of Mexico. Trans R Soc Trop Med
 Hyg 2004; 98:577-584.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#139#135#article#175#</font
></p>     ^cY#aop15-11.htm##
00552000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028900092002001300381#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#140#136#articl
e#175#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26.	Jian
g Y, Wang L, Lu Z, Xuan Z, Han X, Xia X, et al.  Seroprevalence of Rabies Virus 
Antibodies in Bats from Southern China. Vector Borne Zoonotic Dis 2009; Publishe
d online: 3 June 2009; doi: 10.1089=vbz.2008.0212.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#141#137#article#175#</font
></p>     ^cY#aop15-11.htm##
00593000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033000092002001300422#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#142#138#articl
e#175#27#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27.	Turm
elle AS, Allen LC, Jackson FR, Kunz TH, Rupprecht CE.  Ecology of Rabies Virus E
xposure in Colonies of Brazilian Free-Tailed Bats (<i>Tadarida brasiliensis</i>)
 at Natural and Man-Made Roosts in Texas. Vector Borne Zoonotic Dis March 2010, 
10:165-175.    ^cY#aop15-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#143#139#article#175# </fon
t></p>     ^cY#aop15-11.htm##
00503000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024000092002001300332#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#144#140#articl
e#175#28#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28.	Shan
kar V, Bowen RA, Davis AD, Rupprecht CE, Shea T. Rabies in a Captive Colony of B
ig Brown Bats (<i>Eptesicus fuscus</i>). J Wildl Dis 2004; 40:403-413</font></p>
     ^cY#aop15-11.htm##
00510000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024700092002001300339#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#145#141#articl
e#175#29#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29.	Hill
 RE, Beran GW, Clark WR. Demonstration of rabies virus-specific antibody in the 
sera of free-ranging Iowa raccoons (<i>Procyon lotor</i>). J Wildl Dis 1992; 28:
377-385.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#146#142#article#175#</font
></p>     ^cY#aop15-11.htm##
00537000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027400092002001300366#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#147#143#articl
e#175#30#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30.	Gree
nwood RJ, Newton WE, Pearson GL, Schamber GJ. Population and movement characteri
stics of radio-collared striped skunks in North Dakota during an epizootic of ra
bies. J Wildl Dis 1997; 33:226-241.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#148#144#article#175#</font
></p>     ^cY#aop15-11.htm##
00465000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020200092002001300294#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#149#145#articl
e#175#31#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">31.	Mcle
an RG. Raccoon rabies. <i>In</i>: Baer GM, editor. The natural history of rabies
. New York: Academic Press; 1975. p. 53-77.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#150#146#article#175#</font
></p>     ^cY#aop15-11.htm##
00482000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021900092002001300311#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#151#147#articl
e#175#32#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">32.	Ever
ard COR, Baer GM, Alls ME, Moore SA. Rabies serum neutralizing antibody in mongo
oses from Grenada. Trans R Soc Trop Med Hyg1981; 75:654-666.    ^cY#aop15-11.htm
##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#152#148#article#175#</font
></p>     ^cY#aop15-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023700092002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#153#149#articl
e#175#33#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">33.	Gasc
oyne SC, Laurenson MK, Lelo S, Bomer M. Rabies in African Wild    Dogs (<i>Lycao
n pictus</i>) in the Serengeti Region, Tanzania. J Wildl Dis 1993; 29:396-402.  
  ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#154#150#article#175#</font
></p>     ^cY#aop15-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026900092002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#155#151#articl
e#175#34#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">34.	East
 ML, Hofer H, Cox JH, Wulle U, Wiik H, Pitra C. Regular exposure to rabies virus
 and lack of symptomatic disease in Serengeti spotted hyenas. Proc Natl    Acad 
Sci USA, 2001; 98:15026-15031.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#156#152#article#175#</font
></p>     ^cY#aop15-11.htm##
00500000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023700092002001300329#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#157#153#articl
e#175#35#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">35.	Zump
t IF. Factors influencing rabies outbreaks: the age and breeding cycle of the ye
llow mongoose, <i>Cynictis penicillata. </i>J S Afr Vet Assoc 1969;40:319-322.  
  ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#158#154#article#175#</font
></p>     ^cY#aop15-11.htm##
00434000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017100092002001300263#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#159#155#articl
e#175#36#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">36.	Ball
ard WB, Krausman PR. Occurrence of rabies in wolves of Alaska. J Wildl Dis 1997;
 33:242-245.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#160#156#article#175#</font
></p>     ^cY#aop15-11.htm##
00588000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032500092002001300417#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#161#157#articl
e#175#37#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">37.	Dimi
trov DT, Hallam TG, McCracken GF, editors. Modeling the effects of stresses on d
ynamics of bat rabies. Proceeding of the second IASTED International Conference 
Environmental Modeling and Simulation. St. Thomas: US Virgin Islands; 2006. p.11
7-112.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#162#158#article#175#</font
></p>     ^cY#aop15-11.htm##
00415000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704015200092002001300244#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#163#159#articl
e#175#38#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">38.	Burn
ett CD. Bat Rabies in Illinois: 1965 to 1986. J Wildl Dis 1989; 25:10-19.    ^cY
#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#164#160#article#175#</font
></p>     ^cY#aop15-11.htm##
00466000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020300092002001300295#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#165#161#articl
e#175#39#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">39.	Chil
ds JE, Trimarchi CV, Krebs JW. The epidemiology of bat rabies in New York State,
 1988-92. Epidemiol. Infect1994; 113:51-511.    ^cY#aop15-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#166#162#article#175#</font
></p>     ^cY#aop15-11.htm##
00440000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704017700092002001300269#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#167#163#articl
e#175#40#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">40.	Wilk
inson GS. The social organization of the common vampire bat. Behav Ecol Sociobio
l1985; 17:123-134.    ^cY#aop15-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002100089002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#168#164#article#175# </fon
t></p>     ^cY#aop15-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#169#165#article#175#<p>&nb
sp;</p>     ^cY#aop15-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#170#166#article#175#<p>&nb
sp;</p>     ^cY#aop15-11.htm##
00440000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704019200089002001300281#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#171#167#article#175#<p><a 
name="endb"></a><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a h
ref="#enda"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a><b
> Address to:</b>     ^cY#aop15-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#172#168#article#175#<br>  
 Dra. Marilene Fernandes de Almeida    ^cY#aop15-11.htm##
00304000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005600089002001300145#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#173#169#article#175#<br>  
 CCZ/COVISA/Prefeitura de S&atilde;o Paulo    ^cY#aop15-11.htm##
00299000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005100089002001300140#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#174#170#article#175#<br>  
 Rua Santa Eul&aacute;lia 86, Santana    ^cY#aop15-11.htm##
00301000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005300089002001300142#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#175#171#article#175#<br>  
 02031-020 S&atilde;o Paulo, SP, Brasil    ^cY#aop15-11.htm##
00306000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005800089002001300147#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#176#172#article#175#<br>  
 Phone: 55 11 2251-2666; Fax 55 11 2251-2249    ^cY#aop15-11.htm##
00435000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018700089002001300276#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#177#173#article#175#<br>  
 e-mail: <a href="mailto:marilene@prefeitura.sp.gov.br">marilene@prefeitura.sp.g
ov.br</a>; <a href="mailto:lenefalmeida@hotmail.com">lenefalmeida@hotmail.com</a
></font></p>     ^cY#aop15-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#178#174#article#175#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 14/06/2010 
   ^cY#aop15-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#p#179#175#article#175#<br>  
 Accepted in 04/11/2010</font></p>     ^cY#aop15-11.htm##
00760000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100023000880100018001110100
02200129010002200151010002400173010001700197810000600214012010900220030001700329
06500090034606400050035503100030036001400100036386500090037300200130038203500100
0395801001700405#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.ht
m#S#c#180#1#article#40#1#^rND^sVelasco-Villa^nA#^rND^sOrciari^nLA#^rND^sJuárez-I
slas^nV#^rND^sGómez-Sierra^nM#^rND^sPadilla-Medina^nI#^rND^sFlisser^nA#et al#Mol
ecular diversity of rabies viruses associated with bats in Mexico and other coun
tries of the Americas^len#J Clin Microbiol#20060000#2006#44#1697-1710#20110000#a
op15-11.htm#0095-1137#J Clin Microbiol##
00738000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100017001080100
01500125010001600140010001900156010001700175810000600192012009700198030002400295
06500090031906400050032803100030033301400080033686500090034400200130035303500100
0366801002400376#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.ht
m#S#c#181#2#article#40#2#^rND^sSchneider^nMC#^rND^sRomijn^nPC#^rND^sUieda^nW#^rN
D^sTamayo^nH#^rND^sda Silva^nDF#^rND^sBelotto^nA#et al#Rabies transmitted by vam
pire bats to humans: An emerging zoonotic disease in Latin America?^len#Rev Pana
m Salud Publica#20090000#2009#25#260-269#20110000#aop15-11.htm#1020-4989#Rev Pan
am Salud Publica##
00622000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100016001080100
02000124012009900144030001600243065000900259064000500268031000300273014000800276
865000900284002001300293035001000306801001600316#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop15-11.htm#S#c#182#3#article#40#3#^rND^sMessenger^nSL#^rN
D^sSmith^nJS#^rND^sRupprecht^nCE#Emerging epidemiology of bat-associated cryptic
 cases of rabies in humans in the United States^len#Clin Infect Dis#20020000#200
2#35#738-747#20110000#aop15-11.htm#1058-4838#Clin Infect Dis##
00680000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100014000880100017001020100
01400119010001500133010001600148010001700164012008500181030001700266065000900283
06400050029203100020029701400060029986500090030500200130031403500100032780100170
0337#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#183#4#
article#40#4#^rND^sFavi^nM#^rND^sMattos^nCA#^rND^sYung^nV#^rND^sChala^nE#^rND^sL
ópez^nLR#^rND^sMattos^nCC#First Case of Human Rabies in Chile Caused by an Insec
tivorous Bat Virus Variant^len#Emerg Infect Dis#20020000#2002#8#79-81#20110000#a
op15-11.htm#1080-6040#Emerg Infect Dis##
00545000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170033000880170026001210610
00900147018001800156110000900174109001200183037004200195037003200237865000900269
002001300278#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#
c#184#5#article#40#5#Pan-American Health Organization#World Health Organization#
Internet#Database 2009^len#20101013#2010 oct 13#http://siepi.panaftosa.org.br/an
uais.aspx#http://sirvera.panaftosa.org.br#20110000#aop15-11.htm##
00567000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100015001040100
01800119012006200137030002800199065000900227064000500236865000900241002001300250
035001000263801002800273#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#185#6#article#40#6#^rND^sSodré^nMM#^rND^sGama^nAR#^rND^sAlmeida^nM
F#Updated List of bat species positive for rabies in Brazil^len#Rev Inst Med Tro
p Sao Paulo#20010000#2010#20110000#aop15-11.htm#0036-4665#Rev Inst Med Trop Sao 
Paulo##
00610000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100019001030100
01800122012003400140016001700174016001700191016001900208066000700227062003200234
065000900266064000500275014000600280865000900286002001300295#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#186#7#article#40#7#^rND^sDean^
nDJ#^rND^sAbelseth^nMK#^rND^sAtanasiu^nP#The fluorescent antibody test^len#^rED^
sMeslin^nFX#^rED^sKaplan^nMM#^rED^sKoprowisk^nH#Geneva#Laboratory techniques in 
rabies#19960000#1996#80-87#20110000#aop15-11.htm##
00550000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880120031001070160
01700138016001700155016001900172066000700191062003200198065000900230064000500239
014000600244865000900250002001300259#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop15-11.htm#S#c#187#8#article#40#8#^rND^sKoprowisk^nH#The mouse inocul
ation test^len#^rED^sMeslin^nFX#^rED^sKaplan^nMM#^rED^sKoprowisk^nH#Geneva#Labor
atory techniques in rabies#19960000#1996#88-96#20110000#aop15-11.htm##
00575000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100016001040100
01500120012007500135030000900210065000900219064000500228031000300233014000800236
865000900244002001300253035001000266801000900276#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop15-11.htm#S#c#188#9#article#40#9#^rND^sSmith^nJS#^rND^sY
ager^nPA#^rND^sBaer^nGM#A Rapid Reproducible test for determining rabies neutral
izing antibody^len#Bull WHO#19730000#1973#48#535-541#20110000#aop15-11.htm#0042-
9686#Bull WHO##
00521000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060120
06300122030002100185710000200206065000900208064000500217031000300222014000800225
865000900233002001300242#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#189#10#article#40#10#^rND^sRydell^nJ#^rND^sRacey^nPA#Street lamps 
and the feeding ecology of insectivorous bats^len#Symp Zool Soc London#2#1995000
0#1995#67#291-307#20110000#aop15-11.htm##
00637000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100015001070100
01700122010001700139010001600156010001600172012004200188030001200230065000900242
06400050025103100030025601400080025986500090026700200130027603500100028980100120
0299#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#190#11
#article#40#11#^rND^sParker^nEK#^rND^sDowda^nH#^rND^sRedden^nSE#^rND^sTolson^nMW
#^rND^sTurner^nN#^rND^sKemick^nW#Bat rabies in South Carolina, 1970-90^len#J Wil
dl Dis#19990000#1999#35#557-563#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00542000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100015001070100
01700122012003200139030001200171065000900183064000500192031000300197014000800200
865000900208002001300217035001000230801001200240#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop15-11.htm#S#c#191#12#article#40#12#^rND^sHester^nLC#^rND
^sBest^nTL#^rND^sHudson^nMK#Rabies in Bats from Alabama^len#J Wildl Dis#20070000
#2007#43#291-299#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00620000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100020001070120
13400127030001200261065000900273064000500282031000300287014000800290865000900298
002001300307035001000320801001200330#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop15-11.htm#S#c#192#13#article#40#13#^rND^sSteece^nRS#^rND^sAltenbach^
nJS#Prevalence of rabies specific antibodies in the Mexican free-tailed bat (Tad
arida brasiliensis mexicana) at Lava cave, New Mexico^len#J Wildl Dis#19890000#1
989#25#490-496#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00720000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
01600125010001700141010001700158010001800175810000600193012012100199030002600320
71000020034606500090034806400050035703100020036201400080036486500090037200200130
0381#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#193#14
#article#40#14#^rND^sLiesener^nAL#^rND^sSmith^nKE#^rND^sDavis^nRD#^rND^sBender^n
JB#^rND^sDanila^nRN#^rND^sNeitzel^nDF#et al#Circumstances of bat encounters and 
knowledge of rabies among Minnesota residents submitting bats for rabies testing
^len#Vector Borne Zoonotic Dis#2#20060000#2006#6#208-215#20110000#aop15-11.htm##
00691000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
01500126010001900141010001600160012010300176030002200279065000900301064000500310
031000300315014000500318865000900323002001300332035001000345801002200355#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#194#15#article#40#
15#^rND^sQueiroz^nLH#^rND^sCarvalho^nC#^rND^sBuso^nDS#^rND^sFerrari^nCIL#^rND^sP
edro^nWA#Perfil epidemiológico da raiva na região Noroeste do Estado de São Paul
o no período de 1993 a 2007^lpt#Rev Soc Bras Med Trop#20090000#2009#42#9-14#2011
0000#aop15-11.htm#0037-8682#Rev Soc Bras Med Trop##
00725000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100017001070100
01800124010001900142010001500161010001600176810000600192012009400198030001800292
06500090031006400050031903100030032401400100032786500090033700200130034603500100
0359801001800369#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.ht
m#S#c#195#16#article#40#16#^rND^sCunha^nESM#^rND^sSilva^nLHQ#^rND^sLara^nMCCSH#^
rND^sNassas^nAFCN#^rND^sAlbas^nA#^rND^sSodré^nMM#et al#Bat rabies in the north-n
orthwestern regions of the State of São Paulo, Brazil: 1997-2002^len#Rev Saude P
ublica#20060000#2006#40#1082-1086#20110000#aop15-11.htm#0034-8910#Rev Saude Publ
ica##
00633000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100020001050100
01500125010001700140012007300157030002200230065000900252064000500261031000300266
014000800269865000900277002001300286035001000299801002200309#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#196#17#article#40#17#^rND^sAlb
as^nA#^rND^sZoccolaro^nPT#^rND^sRosa^nTZ#^rND^sCunha^nESM#Laboratory diagnosis o
f rabies in the west region of São Paulo state^len#Rev Soc Bras Med Trop#2005000
0#2005#38#493-495#20110000#aop15-11.htm#0037-8682#Rev Soc Bras Med Trop##
00634000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160022000900160018001120160
01800130018007200148053009000220056001000310055001200320054000800332014000600340
865000900346002001300355#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#197#18#article#40#18#^rND^sMartorelli^nLFA#^rND^sAlmeida^nMF#^rND^
sDurigon^nEL#Rabies in a bat colony of Histiotus velatus, São Paulo City, Brazil
^len#International Meeting on Research Advances and Rabies Control in the Americ
as^nXIII^i1^i1#Mexico^i1#20020000^i1#2002^i1#60-61#20110000#aop15-11.htm##
00559000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070100
01500126012004700141030001200188065000900200064000500209031000300214014000800217
865000900225002001300234035001000247801001200257#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop15-11.htm#S#c#198#19#article#40#19#^rND^sSteece^nRS#^rND
^sErickson^nTJ#^rND^sSiem^nRA#Chiropteran rabies in Minnesota: 1976-1980^len#J W
ildl Dis#19820000#1982#18#487-489#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00515000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900120044001120300
01800156065000900174064000500183031000300188014000800191865000900199002001300208
035001000221801001800231#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#199#20#article#40#20#^rND^sConstantine^nDG#Rabies transmission by 
air in bat caves^len#Public Health Rep#19670000#1967#82#867-888#20110000#aop15-1
1.htm#0033-3549#Public health rep##
00600000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01900130010001800149012003800167030001800205065000900223064000500232031000300237
014000800240865000900248002001300257035001000270801001800280#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#200#21#article#40#21#^rND^sCon
stantine^nDG#^rND^sTierkel^nES#^rND^sKleckner^nMD#^rND^sHawkine^nDM#Rabies in Ne
w Mexico caverns bats^len#Public Health Rep#19680000#1968#83#303-316#20110000#ao
p15-11.htm#0033-3549#Public health rep##
00600000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070120
11500126030001200241065000900253064000500262031000300267014000800270865000900278
002001300287035001000300801001200310#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop15-11.htm#S#c#201#22#article#40#22#^rND^sSteece^nRS#^rND^sCalisher^n
CH#Evidence for prenatal transfer of rabies virus in the Mexican free-tailed bat
 (Tadarida brasiliensis mexicana)^len#J Wildl Dis#19890000#1989#25#329-334#20110
000#aop15-11.htm#0090-3558#J Wildl Dis##
00546000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060120
06200125030001200187065000900199064000500208031000300213014000800216865000900224
002001300233035001000246801001200256#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop15-11.htm#S#c#202#23#article#40#23#^rND^sPrice^nJL#^rND^sEverard^nCO
R#Rabies virus and antibody in bats in Grenada and Trinidad^len#J Wildl Dis#1977
0000#1977#13#131-134#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00657000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01600125010001600141010002000157012008500177030001200262065000900274064000500283
031000300288014000800291865000900299002001300308035001000321801001200331#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#203#24#article#40#
24#^rND^sAghomo^nHO#^rND^sAko-Nai^nAK#^rND^sOduye^nOO#^rND^sTomori^nO#^rND^sRupp
recht^nCE#Detection of rabies virus antibodies in fruit bats (Eidolon helvum) fr
om Nigeria^len#J Wildl Dis#19900000#1990#26#258-261#20110000#aop15-11.htm#0090-3
558#J Wildl Dis##
00786000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100027001110100
02400138010001900162010001800181010002400199012013000223030002500353065000900378
06400050038703100030039201400080039586500090040300200130041203500100042580100250
0435#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#204#25
#article#40#25#^rND^sSalas-Rojas^nM#^rND^sSanchez-Hernandez^nC#^rND^sRomero-Alma
ra^nML#^rND^sSchnellc^nGD#^rND^sSchmida^nRK#^rND^sAguilar-Setien^nA#Prevalence o
f rabies and LPM paramyxovirus antibody in non-hematophagous bats captured in th
e Central Pacific coast of Mexico^len#Trans R Soc Trop Med Hyg#20040000#2004#98#
577-584#20110000#aop15-11.htm#0035-9203#Trans R Soc Trop Med Hyg##
00696000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100014001050100
01200119010001400131010001300145010001300158810000600171012007400177030002600251
71000020027706500090027906400050028806500090029306400120030223700220031486500090
0336002001300345#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.ht
m#S#c#205#26#article#40#26#^rND^sJiang^nY#^rND^sWang^nL#^rND^sLu^nZ#^rND^sXuan^n
Z#^rND^sHan^nX#^rND^sXia^nX#et al#Seroprevalence of Rabies Virus Antibodies in B
ats from Southern China^len#Vector Borne Zoonotic Dis#2#20090000#2009#20090603#3
 June 2009#10.1089=vbz.2008.0212#20110000#aop15-11.htm##
00704000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100016001090100
01800125010001500143010002000158012014300178030003200321710000200353065000900355
064000500364031000300369014000800372865000900380002001300389#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#206#27#article#40#27#^rND^sTur
melle^nAS#^rND^sAllen^nLC#^rND^sJackson^nFR#^rND^sKunz^nTH#^rND^sRupprecht^nCE#E
cology of Rabies Virus Exposure in Colonies of Brazilian Free-Tailed Bats (Tadar
ida brasiliensis) at Natural and Man-Made Roosts in Texas^len#Vector Borne Zoono
tic Dis March#2#20100000#2010#10#165-175#20110000#aop15-11.htm##
00636000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01600123010002000139010001400159012006800173030001200241065000900253064000500262
031000300267014000800270865000900278002001300287035001000300801001200310#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#207#28#article#40#
28#^rND^sShankar^nV#^rND^sBowen^nRA#^rND^sDavis^nAD#^rND^sRupprecht^nCE#^rND^sSh
ea^nT#Rabies in a Captive Colony of Big Brown Bats (Eptesicus fuscus)^len#J Wild
l Dis#20040000#2004#40#403-413#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00618000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100016001050100
01600121012011000137030001200247065000900259064000500268031000300273014000800276
865000900284002001300293035001000306801001200316#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop15-11.htm#S#c#208#29#article#40#29#^rND^sHill^nRE#^rND^s
Beran^nGW#^rND^sClark^nWR#Demonstration of rabies virus-specific antibody in the
 sera of free-ranging Iowa raccoons (Procyon lotor)^len#J Wildl Dis#19920000#199
2#28#377-385#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00670000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100017001100100
01800127010001900145012012300164030001200287065000900299064000500308031000300313
014000800316865000900324002001300333035001000346801001200356#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#209#30#article#40#30#^rND^sGre
enwood^nRJ#^rND^sNewton^nWE#^rND^sPearson^nGL#^rND^sSchamber^nGJ#Population and 
movement characteristics of radio-collared striped skunks in North Dakota during
 an epizootic of rabies^len#J Wildl Dis#19970000#1997#33#226-241#20110000#aop15-
11.htm#0090-3558#J Wildl Dis##
00507000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900120019001070160
01500126018003400141066000900175062001500184065000900199064000500208014000600213
865000900219002001300228#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#210#31#article#40#31#^rND^sMclean^nRG#Raccoon rabies^len#^rED^sBae
r^nGM#The natural history of rabies^len#New York#Academic Press#19750000#1975#53
-77#20110000#aop15-11.htm##
00629000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100015001090100
01500124010001600139012006500155030002500220065000900245064000500254031000300259
014000800262865000900270002001300279035001000292801002500302#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#211#32#article#40#32#^rND^sEve
rard^nCOR#^rND^sBaer^nGM#^rND^sAlls^nME#^rND^sMoore^nSA#Rabies serum neutralizin
g antibody in mongooses from Grenada^len#Trans R Soc Trop Med Hyg#19810000#1981#
75#654-666#20110000#aop15-11.htm#0035-9203#Trans R Soc Trop Med Hyg##
00623000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100020001090100
01400129010001500143012008200158030001200240065000900252064000500261031000300266
014000800269865000900277002001300286035001000299801001200309#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop15-11.htm#S#c#212#33#article#40#33#^rND^sGas
coyne^nSC#^rND^sLaurenson^nMK#^rND^sLelo^nS#^rND^sBomer^nM#Rabies in African Wil
d Dogs (Lycaon pictus) in the Serengeti Region, Tanzania^len#J Wildl Dis#1993000
0#1993#29#396-402#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00716000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100015001050100
01400120010001500134010001400149010001500163012009700178030001900275067000400294
06500090029806400050030703100030031201400120031586500090032700200130033603500100
0349801001900359#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop15-11.ht
m#S#c#213#34#article#40#34#^rND^sEast^nML#^rND^sHofer^nH#^rND^sCox^nJH#^rND^sWul
le^nU#^rND^sWiik^nH#^rND^sPitra^nC#Regular exposure to rabies virus and lack of 
symptomatic disease in Serengeti spotted hyenas^len#Proc Natl Acad Sci#USA#20010
000#2001#98#15026-15031#20110000#aop15-11.htm#0027-8424#Proc Natl Acad Sci##
00579000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900120114001060300
01800220065000900238064000500247031000300252014000800255865000900263002001300272
035001000285801001800295#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#214#35#article#40#35#^rND^sZumpt^nIF#Factors influencing rabies ou
tbreaks: the age and breeding cycle of the yellow mongoose, Cynictis penicillata
^len#J S Afr Vet Assoc#19690000#1969#40#319-322#20110000#aop15-11.htm#0301-0732#
J S Afr Vet Assoc##
00531000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100019001080120
04500127030001200172065000900184064000500193031000300198014000800201865000900209
002001300218035001000231801001200241#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop15-11.htm#S#c#215#36#article#40#36#^rND^sBallard^nWB#^rND^sKrausman^
nPR#Occurrence of rabies in wolves of Alaska^len#J Wildl Dis#19970000#1997#33#24
2-245#20110000#aop15-11.htm#0090-3558#J Wildl Dis##
00644000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160019000900160017001090160
02000126018006300146053008400209066001100293062001800304065000900322064000500331
014000800336865000900344002001300353#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop15-11.htm#S#c#216#37#article#40#37#^rED^sDimitrov^nDT#^rED^sHallam^n
TG#^rED^sMcCracken^nGF#Modeling the effects of stresses on dynamics of bat rabie
s^len#IASTED International Conference Environmental Modeling and Simulation^nsec
ond^i1^i1#St. Thomas#US Virgin Islands#20060000#2006#117-112#20110000#aop15-11.h
tm##
00494000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900120041001080300
01200149065000900161064000500170031000300175014000600178865000900184002001300193
035001000206801001200216#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#217#38#article#40#38#^rND^sBurnett^nCD#Bat Rabies in Illinois: 196
5 to 1986^len#J Wildl Dis#19890000#1989#25#10-19#20110000#aop15-11.htm#0090-3558
#J Wildl Dis##
00588000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100020001070100
01600127012006200143030001800205065000900223064000500232031000400237014000700241
865000900248002001300257035001000270801001800280#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop15-11.htm#S#c#218#39#article#40#39#^rND^sChilds^nJE#^rND
^sTrimarchi^nCV#^rND^sKrebs^nJW#The epidemiology of bat rabies in New York State
, 1988-92^len#Epidemiol. Infect#19940000#1994#113#51-511#20110000#aop15-11.htm#0
950-2688#Epidemiol. infect##
00529000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900120054001100300
02100164065000900185064000500194031000300199014000800202865000900210002001300219
035001000232801002100242#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
15-11.htm#S#c#219#40#article#40#40#^rND^sWilkinson^nGS#The social organization o
f the common vampire bat^len#Behav Ecol Sociobiol#19850000#1985#17#123-134#20110
000#aop15-11.htm#0340-5443#Behav Ecol Sociobiol##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#o#1#
1#article#1#20110328#093856#aop08-11.htm#174##
04180000000000601000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201210
01860120112003070100038004190100029004570100037004860700144005230700146006670831
22000813085000802033085002702041085003102068085002302099085003502122085002102157
08312390217808500080341708500240342508500310344908500230348008500320350308500210
3535117000603556072000303562002001303565#2011nahead#V:\SciELO\serial\rsbmt\2011n
ahead\markup\aop08-11.htm#S#h#2#1#article#1#oa#en#br1.1#1#4.0#MAP#TAB#06#nd#nd#R
ev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110401#Prevalence of
 Mansonella ozzardi among riverine communities in the municipality of Lábrea, St
ate of Amazonas, Brazil^len#Prevalências de Mansonella ozzardi entre comunidades
 ribeirinhas do município de Lábrea, Estado do Amazonas^lpt#^rND^1A01^nJansen Fe
rnandes^sMedeiros#^rND^1A02^nVictor^sPy-Daniel#^rND^1A02^nUlysses Carvalho^sBarb
osa#Universidade do Estado do Amazonas^iA01^1Instituto Nacional de Pesquisas da 
Amazônia^2Coordenação de Pesquisas em Ciências da Saúde^cManaus^sAM#Instituto Na
cional de Pesquisas da Amazônia^iA02^1Núcleo de Pesquisas em Ciências Humanas e 
Sociais^2Laboratório de EtnoEpidemiologia^cManaus^sAM#^len^aINTRODUCTION: Estima
te the prevalence of Mansonella ozzardi infection and calculate the parasitic in
fection rate (PIR) in simuliid black flies in the municipality of Lábrea, State 
of Amazonas, Brazil. METHODS: Prevalence was measured using the thick blood smea
r method collected from the fingers and was related to age, sex and occupation. 
Simuliidae were collected with a suction apparatus, then stained with hematoxyli
n and dissected to verify the PIR. RESULTS: The average prevalence rate of M. oz
zardi among the 694 individuals examined was 20.7%. Infection was higher in men 
(27.6%) than in women (14.3%) (p < 0.001) and occurred in most age groups, with 
the highest prevalence in the following age groups: 38-47 (40%), 48-57 (53.1%) a
nd &gt;58 (60.5%). The highest prevalence rates were observed in the retired (64
%), followed by farm workers (47.1%). Infection by M. ozzardi was only identifie
d in Cerqueirellum amazonicum (Simuliidae) with a PIR of 0.6%. CONCLUSIONS: This
 study showed a high prevalence of M. ozzardi in the riverine communities of Láb
rea due to the lack of policies regarding the treatment of microfilaremic indivi
duals in the region and an abundance of competent vectors for M. ozzardi.#^dnd^i
1#^tm^len^kMansonelliasis^i1#^tm^len^kMansonella ozzardi^i1#^tm^len^kSimuliidae^
i1#^tm^len^kMunicipality of Lábrea^i1#^tm^len^kAmazonas^i1#^lpt^aINTRODUÇÃO: Est
imar as prevalências de Mansonella ozzardi, e calcular a taxa de infecção parasi
tária nos simulídeos no município de Lábrea, Estado do Amazonas. MÉTODOS: As pre
valências foram obtidas através do método de gota espessa a partir do sangue col
etado da polpa digital e foram relacionadas com a idade, sexo e ocupação. Os sim
ulídeos foram coletados com capturador de sucção, posteriormente foram corados c
om hematoxilina e dissecados para se obter a taxa de infecção parasitária. RESUL
TADOS: A prevalência de M. ozzardi entre as 694 pessoas examinadas foi de 20,7%.
 A infecção foi maior nos homens (27,6%) do que nas mulheres (14,3%) (p < 0,001)
 e ocorreu na maioria das faixas etárias com maiores prevalências nos indivíduos
 entre 38-47 (40%), 48-57 (53,1%) e &gt;58 (60,5%) anos. As maiores prevalências
 foram observadas nos aposentados (64%) e agricultores (47,1%). Somente Cerqueir
ellum amazonicum (Simuliidae) foi encontrado infectado com M. ozzardi com uma ta
xa de infecção parasitária de 0,6%. CONCLUSÕES: Este trabalho mostra elevadas pr
evalências de M. ozzardi nas comunidades ribeirinhas de Lábrea devido à ausência
 de políticas de tratamento dos microfilarêmicos na região e a abundância de vet
ores competentes.#^dnd^i2#^tm^lpt^kMansonelose^i2#^tm^lpt^kMansonella ozzardi^i2
#^tm^lpt^kSimuliidae^i2#^tm^lpt^kMunicípio de Lábrea^i2#^tm^lpt^kAmazonas^i2#oth
er#27#aop08-11.htm##
04375000000000601000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201350
01860120126003210100038004470100029004850100037005140700144005510700146006950831
29300841085000802134085002702142085003802169085003002207085003502237085002102272
08313050229308500080359808500240360608500380363008500300366808500320369808500210
3730117000603751072000303757002001303760#2011nahead#V:\SciELO\serial\rsbmt\2011n
ahead\markup\aop08-11.htm#S#f#3#1#article#1#oa#en#br1.1#1#4.0#MAP#TAB#06#nd#nd#R
ev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110401#<b>Prevalence
 of <i>Mansonella ozzardi </i>among riverine communities in the municipality of 
Lábrea, State of Amazonas, Brazil</b>^len#<b>Prevalências de <i>Mansonella ozzar
di </i>entre comunidades ribeirinhas do município de Lábrea, Estado do Amazonas<
/b>^lpt#^rND^1A01^nJansen Fernandes^sMedeiros#^rND^1A02^nVictor^sPy-Daniel#^rND^
1A02^nUlysses Carvalho^sBarbosa#Universidade do Estado do Amazonas^iA01^1Institu
to Nacional de Pesquisas da Amazônia^2Coordenação de Pesquisas em Ciências da Sa
úde^cManaus^sAM#Instituto Nacional de Pesquisas da Amazônia^iA02^1Núcleo de Pesq
uisas em Ciências Humanas e Sociais^2Laboratório de EtnoEpidemiologia^cManaus^sA
M#^len^a<b>INTRODUCTION: </b>Estimate the prevalence of <i>Mansonella ozzardi </
i>infection and calculate the parasitic infection rate (PIR) in simuliid black f
lies in the municipality of Lábrea, State of Amazonas, Brazil. <b>METHODS: </b>P
revalence was measured using the thick blood smear method collected from the fin
gers and was related to age, sex and occupation. Simuliidae were collected with 
a suction apparatus, then stained with hematoxylin and dissected to verify the P
IR. <b>RESULTS: </b>The average prevalence rate of <i>M. ozzardi </i>among the 6
94 individuals examined was 20.7%. Infection was higher in men (27.6%) than in w
omen (14.3%) (p &lt; 0.001) and occurred in most age groups, with the highest pr
evalence in the following age groups: 38-47 (40%), 48-57 (53.1%) and &gt;58 (60.
5%). The highest prevalence rates were observed in the retired (64%), followed b
y farm workers (47.1%). Infection by <i>M. ozzardi </i>was only identified in <i
>Cerqueirellum amazonicum </i>(Simuliidae) with a PIR of 0.6%. <b>CONCLUSIONS: <
/b>This study showed a high prevalence of <i>M. ozzardi </i>in the riverine comm
unities of Lábrea due to the lack of policies regarding the treatment of microfi
laremic individuals in the region and an abundance of competent vectors for <i>M
. ozzardi</i>.#^dnd^i1#^tm^len^kMansonelliasis^i1#^tm^len^k<i>Mansonella ozzardi
</i>^i1#^tm^len^k<i>Simuliidae</i>^i1#^tm^len^kMunicipality of Lábrea^i1#^tm^len
^kAmazonas^i1#^lpt^a<b>INTRODUÇÃO:</b> Estimar as prevalências de <i>Mansonella 
ozzardi</i>, e calcular a taxa de infecção parasitária nos simulídeos no municíp
io de Lábrea, Estado do Amazonas. <b>MÉTODOS: </b>As prevalências foram obtidas 
através do método de gota espessa a partir do sangue coletado da polpa digital e
 foram relacionadas com a idade, sexo e ocupação. Os simulídeos foram coletados 
com capturador de sucção, posteriormente foram corados com hematoxilina e dissec
ados para se obter a taxa de infecção parasitária. <b>RESULTADOS: </b>A prevalên
cia de <i>M. ozzardi </i>entre as 694 pessoas examinadas foi de 20,7%. A infecçã
o foi maior nos homens (27,6%) do que nas mulheres (14,3%) (p &lt; 0,001) e ocor
reu na maioria das faixas etárias com maiores prevalências nos indivíduos entre 
38-47 (40%), 48-57 (53,1%) e &gt;58 (60,5%) anos. As maiores prevalências foram 
observadas nos aposentados (64%) e agricultores (47,1%). Somente <i>Cerqueirellu
m amazonicum </i>(Simuliidae) foi encontrado infectado com <i>M. ozzardi </i>com
 uma taxa de infecção parasitária de 0,6%. <b>CONCLUSÕES: </b>Este trabalho most
ra elevadas prevalências de <i>M. ozzardi</i> nas comunidades ribeirinhas de Láb
rea devido à ausência de políticas de tratamento dos microfilarêmicos na região 
e a abundância de vetores competentes.#^dnd^i2#^tm^lpt^kMansonelose^i2#^tm^lpt^k
<i>Mansonella ozzardi</i>^i2#^tm^lpt^k<i>Simuliidae</i>^i2#^tm^lpt^kMunicípio de
 Lábrea^i2#^tm^lpt^kAmazonas^i2#other#27#aop08-11.htm##
04447000000000625000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120121001920120112003130100038004250100029004630100037004920700146005290700
14800675083128300823085000802106085002702114085003102141085002302172085003502195
08500210223008313200225108500080357108500240357908500310360308500230363408500320
3657085002103689117000603710072000303716002001303719008008903732#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#l#4#1#article#1#^a2011#oa#en
#br1.1#1#4.0#map#tab#06#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f0^l0#00
37-8682#20110401#Prevalence of Mansonella ozzardi among riverine communities in 
the municipality of Lábrea, State of Amazonas, Brazil^len#Prevalências de Manson
ella ozzardi entre comunidades ribeirinhas do município de Lábrea, Estado do Ama
zonas^lpt#^rND^1A01^nJansen Fernandes^sMedeiros#^rND^1A02^nVictor^sPy-Daniel#^rN
D^1A02^nUlysses Carvalho^sBarbosa#^iA01^1Universidade do Estado do Amazonas^2Ins
tituto Nacional de Pesquisas da Amazônia^3Coordenação de Pesquisas em Ciências d
a Saúde^cManaus^sAM#^iA02^1Instituto Nacional de Pesquisas da Amazônia^2Núcleo d
e Pesquisas em Ciências Humanas e Sociais^3Laboratório de EtnoEpidemiologia^cMan
aus^sAM#^len^aINTRODUCTION: Estimate the prevalence of Mansonella ozzardi infect
ion and calculate the parasitic infection rate (PIR) in simuliid black flies in 
the municipality of Lábrea, State of Amazonas, Brazil. METHODS: Prevalence was m
easured using the thick blood smear method collected from the fingers and was re
lated to age, sex and occupation. Simuliidae were collected with a suction appar
atus, then stained with hematoxylin and dissected to verify the PIR. RESULTS: Th
e average prevalence rate of M. ozzardi among the 694 individuals examined was 2
0.7 percent. Infection was higher in men (27.6 percent) than in women (14.3 perc
ent) (p < 0.001) and occurred in most age groups, with the highest prevalence in
 the following age groups: 38-47 (40 percent), 48-57 (53.1 percent) and &gt;58 (
60.5 percent). The highest prevalence rates were observed in the retired (64 per
cent), followed by farm workers (47.1 percent). Infection by M. ozzardi was only
 identified in Cerqueirellum amazonicum (Simuliidae) with a PIR of 0.6 percent. 
CONCLUSIONS: This study showed a high prevalence of M. ozzardi in the riverine c
ommunities of Lábrea due to the lack of policies regarding the treatment of micr
ofilaremic individuals in the region and an abundance of competent vectors for M
. ozzardi.#^dnd^i1#^tm^len^kMansonelliasis^i1#^tm^len^kMansonella ozzardi^i1#^tm
^len^kSimuliidae^i1#^tm^len^kMunicipality of Lábrea^i1#^tm^len^kAmazonas^i1#^lpt
^aINTRODUÇÃO: Estimar as prevalências de Mansonella ozzardi, e calcular a taxa d
e infecção parasitária nos simulídeos no município de Lábrea, Estado do Amazonas
. MÉTODOS: As prevalências foram obtidas através do método de gota espessa a par
tir do sangue coletado da polpa digital e foram relacionadas com a idade, sexo e
 ocupação. Os simulídeos foram coletados com capturador de sucção, posteriorment
e foram corados com hematoxilina e dissecados para se obter a taxa de infecção p
arasitária. RESULTADOS: A prevalência de M. ozzardi entre as 694 pessoas examina
das foi de 20,7 por cento. A infecção foi maior nos homens (27,6 por cento) do q
ue nas mulheres (14,3 por cento) (p < 0,001) e ocorreu na maioria das faixas etá
rias com maiores prevalências nos indivíduos entre 38-47 (40 por cento), 48-57 (
53,1 por cento) e &gt;58 (60,5 por cento) anos. As maiores prevalências foram ob
servadas nos aposentados (64 por cento) e agricultores (47,1 por cento). Somente
 Cerqueirellum amazonicum (Simuliidae) foi encontrado infectado com M. ozzardi c
om uma taxa de infecção parasitária de 0,6 por cento. CONCLUSÕES: Este trabalho 
mostra elevadas prevalências de M. ozzardi nas comunidades ribeirinhas de Lábrea
 devido à ausência de políticas de tratamento dos microfilarêmicos na região e a
 abundância de vetores competentes.#^dnd^i2#^tm^lpt^kMansonelose^i2#^tm^lpt^kMan
sonella ozzardi^i2#^tm^lpt^kSimuliidae^i2#^tm^lpt^kMunicípio de Lábrea^i2#^tm^lp
t^kAmazonas^i2#other#27#aop08-11.htm#Internet^ihttp://www.scielo.br/scielo.php?s
cript=sci_arttext&pid=S0037-86822011005000006##
00485000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704024100085002001300326#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#5#1#article#143#<p><font s
ize="4" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota_1"></a><b>Pre
valence of <i>Mansonella ozzardi </i>among riverine communities in the municipal
ity of L&aacute;brea, State of Amazonas, Brazil</b></font></p>     ^cY#aop08-11.
htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#6#2#article#143#<p>&nbsp;<
/p>     ^cY#aop08-11.htm##
00468000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704022400085002001300309#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#7#3#article#143#<p><font s
ize="3" face="Verdana, Arial, Helvetica, sans-serif"><b>Preval&ecirc;ncias de <i
>Mansonella ozzardi </i>entre comunidades ribeirinhas do munic&iacute;pio de L&a
acute;brea, Estado do Amazonas</b></font></p>     ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#8#4#article#143#<p>&nbsp;<
/p>     ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#9#5#article#143#<p>&nbsp;<
/p>     ^cY#aop08-11.htm##
00442000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704019700086002001300283#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#10#6#article#143#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Jansen Fernandes Medeir
os<sup>I</sup>; Victor Py-Daniel<sup>II</sup>; Ulysses Carvalho Barbosa<sup>II</
sup></b></font></p>     ^cY#aop08-11.htm##
00499000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704025400086002001300340#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#11#7#article#143#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Coordena&ccedi
l;&atilde;o de Pesquisas em Ci&ecirc;ncias da Sa&uacute;de, Instituto Nacional d
e Pesquisas da Amaz&ocirc;nia, Universidade do Estado do Amazonas, Manaus, AM   
 ^cY#aop08-11.htm##
00451000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704020600086002001300292#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#12#8#article#143#<br>   <s
up>II</sup>Laborat&oacute;rio de EtnoEpidemiologia, N&uacute;cleo de Pesquisas e
m Ci&ecirc;ncias Humanas e Sociais, Instituto Nacional de Pesquisas da Amaz&ocir
c;nia, Manaus, AM</font></p>     ^cY#aop08-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011400086002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#13#9#article#143#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#nota1">Address t
o</a></font></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#14#10#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#15#11#article#143#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop08-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#16#12#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p
>     ^cY#aop08-11.htm##
00538000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704029200087002001300379#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#17#13#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION: </b>Esti
mate the prevalence of <i>Mansonella ozzardi </i>infection and calculate the par
asitic infection rate (PIR) in simuliid black flies in the municipality of L&aac
ute;brea, State of Amazonas, Brazil.    ^cY#aop08-11.htm##
00521000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027500087002001300362#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#18#14#article#143#<br>   <
b>METHODS: </b>Prevalence was measured using the thick blood smear method collec
ted from the fingers and was related to age, sex and occupation. Simuliidae were
 collected with a suction apparatus, then stained with hematoxylin and dissected
 to verify the PIR.    ^cY#aop08-11.htm##
00802000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055600087002001300643#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#19#15#article#143#<br>   <
b>RESULTS: </b>The average prevalence rate of <i>M. ozzardi </i>among the 694 in
dividuals examined was 20.7%. Infection was higher in men (27.6%) than in women 
(14.3%) (p &lt; 0.001) and occurred in most age groups, with the highest prevale
nce in the following age groups: 38-47    (40%), 48-57 (53.1%) and &gt;58 (60.5%
). The highest prevalence rates were observed in the retired (64%), followed by 
farm workers (47.1%). Infection by <i>M. ozzardi </i>was only identified in <i>C
erqueirellum amazonicum </i>(Simuliidae) with a PIR of 0.6%.    ^cY#aop08-11.htm
##
00551000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030500087002001300392#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#20#16#article#143#<br>   <
b>CONCLUSIONS: </b>This study showed a high prevalence of <i>M. ozzardi </i>in t
he riverine communities of L&aacute;brea due to the lack of policies regarding t
he treatment of microfilaremic individuals in the region and an abundance of com
petent vectors for <i>M. ozzardi</i>.</font></p>     ^cY#aop08-11.htm##
00463000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021700087002001300304#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#21#17#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Mansonel
liasis. <i>Mansonella ozzardi. Simuliidae</i>. Municipality of L&aacute;brea. Am
azonas.</font></p> <hr size="1" noshade>     ^cY#aop08-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#22#18#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p> 
    ^cY#aop08-11.htm##
00552000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704030600087002001300393#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#23#19#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde
;O:</b> Estimar as preval&ecirc;ncias de <i>Mansonella ozzardi</i>, e calcular a
 taxa de infec&ccedil;&atilde;o parasit&aacute;ria nos simul&iacute;deos no muni
c&iacute;pio de L&aacute;brea, Estado do Amazonas.    ^cY#aop08-11.htm##
00683000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043700087002001300524#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#24#20#article#143#<br>   <
b>M&Eacute;TODOS: </b>As preval&ecirc;ncias foram obtidas atrav&eacute;s do m&ea
cute;todo de gota espessa a partir do sangue coletado da    polpa digital e fora
m relacionadas com a idade, sexo e ocupa&ccedil;&atilde;o. Os simul&iacute;deos 
foram coletados com capturador de suc&ccedil;&atilde;o, posteriormente foram cor
ados com hematoxilina e dissecados para se obter a taxa de infec&ccedil;&atilde;
o parasit&aacute;ria.    ^cY#aop08-11.htm##
00882000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063600087002001300723#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#25#21#article#143#<br>   <
b>RESULTADOS: </b>A preval&ecirc;ncia de <i>M. ozzardi </i>entre as 694 pessoas 
examinadas foi de 20,7%. A infec&ccedil;&atilde;o foi maior nos homens (27,6%) d
o que nas mulheres (14,3%) (p &lt; 0,001) e ocorreu na maioria das faixas et&aac
ute;rias com maiores preval&ecirc;ncias    nos indiv&iacute;duos entre 38-47 (40
%), 48-57 (53,1%) e &gt;58 (60,5%) anos. As maiores preval&ecirc;ncias foram obs
ervadas nos aposentados (64%) e agricultores (47,1%). Somente <i>Cerqueirellum a
mazonicum </i>(Simuliidae) foi encontrado infectado com <i>M. ozzardi </i>com um
a taxa de infec&ccedil;&atilde;o parasit&aacute;ria de 0,6%.    ^cY#aop08-11.htm
##
00567000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032100087002001300408#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#26#22#article#143#<br>   <
b>CONCLUS&Otilde;ES: </b>Este trabalho mostra elevadas preval&ecirc;ncias de <i>
M. ozzardi</i> nas comunidades ribeirinhas de L&aacute;brea devido &agrave; aus&
ecirc;ncia de pol&iacute;ticas de tratamento dos microfilar&ecirc;micos na regi&
atilde;o e a abund&acirc;ncia de vetores competentes.</font></p>     ^cY#aop08-1
1.htm##
00471000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022500087002001300312#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#27#23#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chaves: </b>M
ansonelose. <i>Mansonella ozzardi. Simuliidae</i>. Munic&iacute;pio de L&aacute;
brea. Amazonas.</font></p> <hr size="1" noshade>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#28#24#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#29#25#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#30#26#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font
></p>     ^cY#aop08-11.htm##
00724000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047800087002001300565#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#31#27#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><i>Mansonella ozzardi </i
>is a human filarial parasite that is distributed in parts of Central and South 
America and some Caribbean islands. Adult worms have rarely been captured, but a
ppear to live in the mesentery and peritoneal cavity, while the microfilariae ci
rculate mainly in the blood. They are transmitted by Diptera insects of the fami
lies Ceratopogonidae and Simuliidae<sup>1,2</sup>.</font></p>     ^cY#aop08-11.h
tm##
00889000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064300087002001300730#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#32#28#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The pathogenicity of <i>M
. ozzardi </i>remains unclear. Some reports have associated the presence of fila
rial worm with clinical manifestation, such as fever, coldness in the legs, join
t pain and headaches<sup>3</sup>, but the frequency of these manifestations in e
ndemic areas has not been studied. In some situations the presence of fever and 
chills appears similar to malaria, but unlike malaria, the symptoms of <i>M. ozz
ardi </i>do not have specific schedules, can occur during the day and cause dama
ge to individuals in their daily functions<sup>4</sup>.</font></p>     ^cY#aop08
-11.htm##
01001000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704075500087002001300842#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#33#29#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The microfilariae of <i>M
. ozzardi </i>were detected in Brazil in the 1940s and 1950s<sup>5,6</sup>. Even
 though endemic areas had already been identified during this period in the Stat
e of Amazonas, along the Solim&otilde;es, Purus and Negro Rivers and their tribu
taries<sup>7</sup>, at least one study predicted the neglect of this filarial di
sease<sup>8</sup>. In the municipality of L&aacute;brea, State of Amazonas, Braz
il, studies between 1940s and 1980s reported prevalence rates varying from 0.4% 
to 4.4%<sup>7,9</sup>, while more recent studies have shown that prevalence cont
inues increasing, reaching 30.2% among people living along the Ituxi river<sup>4
</sup>.</font></p>     ^cY#aop08-11.htm##
00960000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071400087002001300801#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#34#30#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">As a part of our group's 
long-term study on the prevalence and distribution of filarial infection of huma
ns in Brazil, a survey was conducted to determine the current status of <i>M. oz
zardi </i>on the Purus river, in L&aacute;brea. Thus, the study aimed to obtain 
data on human infection by <i>M. ozzardi </i>through comparison of prevalence ra
tes between sexes and examine the relations between filarial infection and age a
nd professional occupation. Identification of the simuliid species involved in t
he transmission of <i>M. ozzardi </i>and estimation of the parasitic infection r
ate (PIR) of these vectors was also performed.</font></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#35#31#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#36#32#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>
     ^cY#aop08-11.htm##
00676000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043000087002001300517#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#37#33#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This work was conducted i
n riverine communities on the Purus river in the municipality of L&aacute;brea (
07º15S/64º51'W), State of Amazonas, Brazil (<b><a href="#fig1">Figure 1</a></b>)
. This municipality, with a population of 38,451 inhabitants, 80% of whom reside
 in urban areas<sup>10</sup>,is located in the southwest of the State of Amazona
s.</font></p>     ^cY#aop08-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#38#34#article#143#<p><a na
me="fig1"></a></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#39#35#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#40#36#article#143#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop08-11_fig01.jpg"></p>     
^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#41#37#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
01463000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704121700087002001301304#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#42#38#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The study was conducted i
n 23 communities selected at random along the Purus River: 1: <i>Vila Ded&eacute
;</i>, 2: <i>Santa F&eacute;, </i>3: <i>Erm&iacute;dia</i>, 4: <i>Tamacuru</i>, 
5: <i>Escrit&oacute;rio</i>, 6: <i>Bela Rosa</i>, 7: <i>Realeza</i>, 8: <i>Praia
 da Gaivota</i>, 9: <i>V&aacute;rzea Grande</i>, 10: <i>Luzit&acirc;nea</i>, 11:
 <i>Santa Cruz</i>, 12: <i>Cachoeira do Hil&aacute;rio</i>, 13: <i>Santa Vit&oac
ute;ria</i>, 14: <i>Asim&atilde;</i>, 15: <i>Remanso do Itana&atilde;</i>, 16: <
i>Cacau</i>, 17: <i>Porongaba</i>, 18: <i>Nova Morada</i>, 19: <i>Santa Eug&ecir
c;nia</i>, 20: <i>S&atilde;o Ger&ocirc;nimo</i>, 21: <i>Nazar&eacute;</i>, 22: <
i>Mucuripe</i>, and 23: <i>Passe&aacute;</i>), as presented in <b><a href="#fig1
">Figure 1</a></b>. The populations mainly practice subsistence farming (fishing
 and some vegetable and fruit farming, including cassava and bananas) and raisin
g animals (cows, pigs and chickens) on a small scale. The average yearly rainfal
l in L&aacute;brea fluctuates between 2,400 and 2,600mm. The temperature usually
 ranges between 24 and 26ºC and relative humidity between 85 and 95%.</font></p>
     ^cY#aop08-11.htm##
01090000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704084400087002001300931#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#43#39#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The population in the rur
al areas in L&aacute;brea is approximately 7,690 (20% of the total population)<s
up>10</sup>. The sample size was determined by assuming an expected prevalence o
f <i>M. ozzardi </i>of 30.2%<sup>4 </sup>with an error of 12% and confidence int
erval of 95%. The population density is low, such that at least 20% in the commu
nities was examined. The study was conducted in communities through convenience 
samples. Individuals that were present at the moment of study and informed of th
e purpose and scope of the study were invited to participate. A total of 694 ind
ividuals between 2 and 88 years-old (mean = 22.9±17.6) were examined by Rapid Ep
idemiological Mapping for microfilariae (mf) of <i>M. ozzardi</i> in April 2006 
and August 2007.</font></p>     ^cY#aop08-11.htm##
00707000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046100087002001300548#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#44#40#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Estimation of <i>M. ozzar
di </i>prevalence was performed using thick blood smears obtained by digital pun
ctures. Two drops of blood (about 60&#181;l) were collected from each individual
 and placed on a slide. After air-drying, the blood was dehemoglobinized, staine
d with Giemsa, placed under a microscope for identification of the species of mi
crofilariae present<sup>11</sup>.</font></p>     ^cY#aop08-11.htm##
01006000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704076000087002001300847#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#45#41#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The evaluation of prevale
nce took into account the following data: sex; age group, 2-9, 10-18, 19-27, 28-
37, 38-47, 48-57, 58-67 and <u>&gt;</u> 68 years-old; occupation, farm worker, h
ousewife, student, teacher, retiree (man <u>&gt;</u> 65 and women <u>&gt;</u> 60
 years-old) and those with not occupation (&lt;5 years-old)<sup>12</sup>. Preval
ences between the sexes were compared by the x<sup>2 </sup>test and the differen
ces between age groups were compared using the maximum likelihood Chi square G-t
est. Differences in microfilaremia between the sexes were assessed by the Mann W
hitney U test and microfilaremiae counts and age were analyzed using Spearman's 
correlation.</font></p>     ^cY#aop08-11.htm##
01076000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704083000087002001300917#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#46#42#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Simuliidae were caught in
 the communities by a rapid entomological assessment technique using manual suct
ion collectors. The flies were identified in the laboratory, stained with acid h
ematoxylin and dissected. The simuliidae collected were dissected into three par
ts (head, thorax, and abdomen) using a stylet, under a stereoscopic microscope<s
up>13</sup>. When filarial worms were detected, they were identified and quantif
ied regarding developmental stage (L<sub>1</sub>, L<sub>2</sub>, or L<sub>3</sub
>)<sup>14</sup>. The parasitic infection rate (PIR) was calculated by the number
 of females infected with stage L<sub>1</sub>, L<sub>2 </sub>and/or L<sub>3 </su
b><i>M. ozzardi </i>divided by the number of females dissected, multiplied by 10
0.</font></p>     ^cY#aop08-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#47#43#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Ethical considerations
</b></font></p>     ^cY#aop08-11.htm##
00692000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044600087002001300533#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#48#44#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This study was approved b
y the Research Ethics Committee of the National Institute of Amazonian Research 
(<i>Instituto Nacional de Pesquisas da Amaz&ocirc;nia</i>, INPA), Manaus, Amazon
as, Brazil, under process no. 043/2005. Free, informed consent was obtained from
 all adult participants during meetings with the community and from parents in t
he case of minors.</font></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#49#45#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#50#46#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>
     ^cY#aop08-11.htm##
00560000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031400087002001300401#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#51#47#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Of the 694 individuals ex
amined, 144 (20.7%) were <i>M. ozzardi </i>positive, with prevalence that varied
 from 8.4% to 62.5% in different communities (<b><a href="/img/revistas/rsbmt/20
11nahead/aop08-11_tab01.jpg">Table 1</a></b>).</font></p>     ^cY#aop08-11.htm##
01155000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090900087002001300996#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#52#48#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The distribution of indiv
iduals with <i>M. ozzardi </i>according to sex and age is presented in <b><a hre
f="#tab2">Table 2</a></b>. Men exhibited significantly higher prevalence than wo
men (27.6% vs 14.3%; Chi square p &lt; 0.001). The lowest prevalence was observe
d in the group of individuals between 2 and 9 years-old (4.9%). The percentage o
f microfilaremic individuals increased linearly with age (r = 0.96, p &lt; 0.001
; Spearman's correlation), with the highest indices of infection in individuals 
over 58 years of age (men = 66.7% and women = 55%). With the exception of indivi
duals between 2 and 9 years of age, in all the other age groups, men presented h
igher prevalence than women, with significant differences verified for the age g
roups 19-27, 28-37 and 38-47 (p &lt; 0.001) (<b><a href="#tab2">Table 2</a></b>)
.</font></p>     ^cY#aop08-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#53#49#article#143#<p><a na
me="tab2"></a></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#54#50#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#55#51#article#143#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop08-11_tab02.jpg"></p>     
^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#56#52#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00560000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031400087002001300401#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#57#53#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Regarding occupation, ret
irees showed the highest prevalence (64%) followed by farm workers (47.4%). Infe
ction was least prevalent in children under 5 (no occupation - 3.8%) and student
s (8.9%) (<b><a href="#tab3">Table 3</a></b>).</font></p>     ^cY#aop08-11.htm##
00281000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003500087002001300122#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#58#54#article#143#<p><a na
me="tab3"></a></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#59#55#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00338000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009200087002001300179#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#60#56#article#143#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/aop08-11_tab03.jpg"></p>     
^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#61#57#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00617000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037100087002001300458#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#62#58#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Microfilaremia was higher
 in men than in women, but this difference was not significant (32.01 vs 19.36 m
f/40&#181;l blood; Mann Whitney p = 0.27); while the highest concentrations were
 verified in retirees and farm workers (<b><a href="#tab3">Table 3</a></b>). Ove
rall microfilaremia was</font></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#63#59#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#64#60#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font><
/p>     ^cY#aop08-11.htm##
00813000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056700087002001300654#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#65#61#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This work confirms that <
i>M. ozzardi </i>prevalence has increased in L&aacute;brea: currently registerin
g 20.7%, which represents a 41.5-fold increase in relation to that reported by L
acerda &amp; Rachou (0.4%)<sup>7 </sup>in 1956 and 4.7-fold in relation to that 
reported by Shelley (4.4%)<sup>9 </sup>in 1975. This increase also was observed 
on the Ituxi River<sup>4</sup>, where a 5.1-fold increase was verified in relati
on to that reported by Tavares (5.9%)<sup>15</sup> in 1981.</font></p>     ^cY#a
op08-11.htm##
01149000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704090300087002001300990#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#66#62#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The present results show 
that prevalence increases linearly with age, a result that is in agreement with 
other studies<sup>12,15-18</sup>. Older individuals with greater exposure to ope
n air contract the infection with greater regularity, whereas younger individual
s whose daily agenda includes closer proximity to home and school are apparently
 less exposed. The greater exposure to the vectors explains the higher infection
 rates in men than in women, also confirmed in other studies<sup>12,17,19</sup>.
 In certain age groups (19-27, 28-37, 38-47), men showed much higher prevalence 
than women, possibly explained as a by-product of different occupations. Whereas
 men have greater exposure to vectors due to their daily activities, women are l
ess exposed as they typically maintain day-to-day activities close to home.</fon
t></p>     ^cY#aop08-11.htm##
00880000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063400087002001300721#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#67#63#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Observation verified that
 among men and women over the age of 48, the rates of prevalence of infection we
re very similar. Some evidence exists that during the in individuals 50 years-ol
d or over, prevalence for <i>M. ozzardi </i>in both sexes becomes virtually the 
same<sup>18</sup>. The similarity in prevalence rates between older men and wome
n could be an artifact of the changing daily habits of men with age, as they ten
d to live a more sedentary lives, similar to the daily routine of women, thus fa
rther removed from direct exposure to vectors.</font></p>     ^cY#aop08-11.htm##
01582000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704133600087002001301423#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#68#64#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The microfilariae load wa
s highest among those aged over 38 years-old. These observations indicate that t
he high microfilaremia level determined in those over 40 is probably due to a co
ntinuum of overlapping infections. These findings are in agreement with observat
ions reported in Bolivia, where the microfilaria loads using the finger prick me
thod were lowest in children and increased with age (&gt; 100mf/20&#181;l blood 
observed in people &gt;44 years-old)<sup>18</sup>. Monkeys were used as experime
ntal hosts to monitor the microfilaremia of <i>M. ozzardi</i>. After a mean prep
atent period of 163 days, microfilaremia increased, peaking at around 20 weeks, 
and then decreased, stabilizing at low levels for up to 48 weeks<sup>20</sup>. M
icrofilariae density was significantly higher in males. These results are simila
r to those verified among inhabitants of Colombia, based on a Knott&acute;s samp
le (mf/ml)<sup>21 </sup>and also in studies with <i>Wuchereria bancrofti </i>usi
ng polycarbonate membrane filtration in Brazil<sup>22</sup>. It should be noted,
 however, that mf-counts are highly variable between smears from an individual d
ue to variations in blood sampling time<sup>23 </sup>and short-term variation in
 mf density<sup>23-25</sup>.</font></p>     ^cY#aop08-11.htm##
00977000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704073100087002001300818#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#69#65#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The highest prevalence wa
s determined in retirees, suggesting that these individuals could have suffered 
a continuous succession of overlapping infections that remained untreated during
 their lifetime. Farm workers represent the second most microfilaremic group, ag
ain confirming that individuals working in agricultural fields, in contact with 
the forest environment, or along river margins, are more exposed to simuliidae a
nd therefore present greater prevalence of infection than other occupations. Mos
t epidemiological studies of <i>M. ozzardi </i>report that individuals who work 
in the open air show higher prevalence rates<sup>9,12,26</sup>.</font></p>     ^
cY#aop08-11.htm##
01129000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704088300087002001300970#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#70#66#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This study verified that 
<i>C. amazonicum </i>is the vector of <i>M. ozzardi </i>in communities of L&aacu
te;brea situated along the Purus River, confirming the reports of other research
ers<sup>27</sup>. The PIR (0.6%) and number of L<sub>1</sub>, L<sub>2 </sub>and 
L<sub>3 </sub>larvae were low. A low PIR (0.9%) was previously determined in sim
uliidae captured along the Purus river, in the municipality of L&aacute;brea<sup
>27</sup>. It is possible that PIR vary during the year in relation to numerous 
factors, including microfilarial density and the degree of exposure of inhabitan
ts to vectors. However, to understand the dynamics in the transmission of <i>M. 
ozzardi </i>along the Purus river, studies should be conducted over extended tim
e intervals and include both the dry and rainy seasons.</font></p>     ^cY#aop08
-11.htm##
00813000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056700087002001300654#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#71#67#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">This study reports a stro
ng temporal increase in prevalence rates over time in the region of L&aacute;bre
a. However, a long-term policy of treatment for microfilaremic individuals in th
e region remains inaccessible, while the policies that do exist are short lived 
and local, a strategy which fails to attend the majority affected by <i>M. ozzar
di</i>. This is most likely the principal reason why the prevalence of <i>Manson
ella ozzardi</i> has continued to grow for several decades.</font></p>     ^cY#a
op08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#72#68#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#73#69#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop08-11.htm##
00470000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022400087002001300311#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#74#70#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors would like to
 thank the Funda&ccedil;&atilde;o Nacional de Sa&uacute;de in the municipality o
f Pauini for the logistical support.</font></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#75#71#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011000087002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#76#72#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLICT OF INTEREST</
b></font></p>     ^cY#aop08-11.htm##
00387000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014100087002001300228#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#77#73#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">The authors declare that 
there is no conflict of interest.</font></p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#78#74#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#79#75#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>FINANCIAL SUPPORT</b><
/font></p>     ^cY#aop08-11.htm##
00426000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018000087002001300267#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#80#76#article#143#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">Funda&ccedil;&atilde;o de
 Amparo &agrave; Pesquisa do Estado do Amazonas (FAPEAM; Proc. 2205/05).</font><
/p>     ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#81#77#article#143#<p>&nbsp
;</p>     ^cY#aop08-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#82#78#article#143#<p><font
 size="3" face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font><
/p>     ^cY#aop08-11.htm##
00432000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704017200089002001300261#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#83#79#article#
143#1#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Cerqueir
a NL. Sobre a transmiss&atilde;o da <i>Mansonella ozzardi</i>. J Bras Med 1959; 
1:885-914.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#84#80#article#143#</font><
/p>     ^cY#aop08-11.htm##
00505000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024500089002001300334#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#85#81#article#
143#2#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Shelley 
AJ, Shelley A. Further evidence for the transmission of <i>Mansonella ozzardi </
i>by <i>Simulium amazonicum</i> in Brazil. Ann Trop Med Parasitol 1976; 70:213-2
17.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#86#82#article#143#</font><
/p>     ^cY#aop08-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704025100089002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#87#83#article#
143#3#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Batista 
D, Oliveira WR, Rabello VD. Estudo da patogenicidade da <i>Mansonella ozzardi </
i>e da sintomatologia da mansonelose. Rev Inst Med Trop S&atilde;o Paulo 1960; 2
:281-289.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#88#84#article#143#</font><
/p>     ^cY#aop08-11.htm##
00577000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704031700089002001300406#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#89#85#article#
143#4#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Medeiros
 JF, Py-Daniel V, Barbosa UC, Ogawa GM. Current profile of <i>Mansonella ozzardi
 </i>(Nematoda: Onchocercidae) in communities along the Ituxi river, L&aacute;br
ea municipality, Amazonas, Brazil. Mem Inst Oswaldo Cruz 2008; 103:409-411.    ^
cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#90#86#article#143#</font><
/p>     ^cY#aop08-11.htm##
00470000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021000089002001300299#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#91#87#article#
143#5#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Deane MP
. Sobre a incid&ecirc;ncia de fil&aacute;rias humanas em Manaus, Estado do Amazo
nas. Rev Serv Esp Saude Publica 1949; 2:849-858.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#92#88#article#143#</font><
/p>     ^cY#aop08-11.htm##
00522000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026200089002001300351#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#93#89#article#
143#6#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Deane L,
 Rachou RG, Lacerda NB, Martins JB. Alguns dados relativos &agrave; preval&ecirc
;ncia de <i>Mansonella ozzardi </i>no Brasil. Rev Bras Malariol Doen&ccedil;as T
rop 1954; 6:219-224.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#94#90#article#143#</font><
/p>     ^cY#aop08-11.htm##
00532000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704027200089002001300361#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#95#91#article#
143#7#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Lacerda 
NB, Rachou RG. Filarioses humanas nas sedes municipais do estado do Amazonas e t
errit&oacute;rios do Acre, Guapor&eacute; e Rio Branco. Rev Bras Malariol Doen&c
cedil;as Trop 1956; 8:437-442.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#96#92#article#143#</font><
/p>     ^cY#aop08-11.htm##
00435000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704017500089002001300264#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#97#93#article#
143#8#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Moraes M
AP. Contribui&ccedil;&atilde;o ao estudo da mansonelose do Amazonas. O Hosp 1958
; 54:887-892.    ^cY#aop08-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#98#94#article#143#</font><
/p>     ^cY#aop08-11.htm##
00527000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026700089002001300356#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#99#95#article#
143#9#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Shelley 
AJ. A preliminary survey of the prevalence of <i>Mansonella ozzardi </i>in some 
rural communities on the river Purus, state of Amazonas, Brazil. Ann Trop Med Pa
rasitol 1975; 69:407-412.    ^cY#aop08-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#100#96#article#143#</font>
</p>     ^cY#aop08-11.htm##
00602000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704034000091002001300431#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#101#97#article
#143#10#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Insti
tuto Brasileiro de Geografia e Estat&iacute;stica &#91;Internet&#93;. Rio de Jan
eiro: Censo 2008 - Popula&ccedil;&atilde;o e Domic&iacute;lios 2008 - &#91;2010 
march 3&#93;. Available from: <a href="http://www.ibge.gov.br" target="_blank">w
ww.ibge.gov.br</a>/.    ^cY#aop08-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#102#98#article#143#</font>
</p>     ^cY#aop08-11.htm##
00558000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704029600091002001300387#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#103#99#article
#143#11#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Post 
RJ, Adams ZA, Shelley AJ, Maia-Herzog M, Luna-Dias APA, Coscar&oacute;n S. The m
orphological discrimination of microfilariae of <i>Onchocerca volvulus </i>from 
<i>Mansonella ozzardi</i>. Parasitology 2003; 127:21-27.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#104#100#article#143#</font
></p>     ^cY#aop08-11.htm##
00555000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029200092002001300384#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#105#101#articl
e#143#12#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Mede
iros JF, Py-Daniel V, Barbosa UC, Izzo TJ. <i>Mansonella ozzardi </i>in Brazil: 
prevalence of infection in riverine communities in the Purus region, in the stat
e of Amazonas. Mem Inst Oswaldo Cruz 2009; 104:74-80.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#106#102#article#143#</font
></p>     ^cY#aop08-11.htm##
00561000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029800092002001300390#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#107#103#articl
e#143#13#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Mede
iros JF, Py-Daniel V, Barbosa UC, Farias ES. Epidemiological studies of <i>Manso
nella ozzardi </i>(Nematoda, Onchocercidae) in indigenous communities of Pauini 
municipality, Amazonas, Brazil. Acta Amaz 2007; 37:241-246.    ^cY#aop08-11.htm#
#
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#108#104#article#143#</font
></p>     ^cY#aop08-11.htm##
00621000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035800092002001300450#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#109#105#articl
e#143#14#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Yaza
rbal L, Bas&aacute;&ntilde;ez MG, Ram&iacute;rez-P&eacute;rez J, Ram&iacute;rez 
A, Botto C, Yazarbal A. Experimental and natural infection of <i>Simulium sanche
zi </i>by <i>Mansonella ozzardi </i>in the middle Orinoco region of Venezuela. T
rans R Soc Trop Med Hyg 1985; 79:29-33.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#110#106#article#143#</font
></p>     ^cY#aop08-11.htm##
00521000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025800092002001300350#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#111#107#articl
e#143#15#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Tava
res AM. Estudo da infec&ccedil;&atilde;o por <i>Mansonella ozzardi</i>. &#91;Dis
serta&ccedil;&atilde;o&#93;. &#91;Bras&iacute;lia&#93;: Universidade de Bras&iac
ute;lia; 1981.122p.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#112#108#article#143#</font
></p>     ^cY#aop08-11.htm##
00675000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704041200092002001300504#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#113#109#articl
e#143#16#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Lawr
ence ND, Erdtmann B, Peet JW, Nunes de Mello JA, Hearl GR, James V, et al. Estud
os epidemiol&oacute;gicos entre popula&ccedil;&otilde;es ind&iacute;genas da Ama
z&ocirc;nia. II. Preval&ecirc;ncia da microfilaremia de <i>M. ozzardi: </i>Compa
ra&ccedil;&atilde;o de dois m&eacute;todos de diagn&oacute;stico. Acta Amaz 1980
; 10:763-769.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#114#110#article#143#</font
></p>     ^cY#aop08-11.htm##
00577000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031400092002001300406#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#115#111#articl
e#143#17#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Koze
k WJ, D'Alessandro A, Suva J, Navarrete S. Filariasis in Colombia: Prevalence of
 mansonellosis in the teenage and adult population of the Colombian bank of the 
Amazon River, Comisaria del Amazonas. Am J Trop Med Hyg 1982; 31:1131-1136.    ^
cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#116#112#article#143#</font
></p>     ^cY#aop08-11.htm##
00556000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029300092002001300385#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#117#113#articl
e#143#18#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Bart
oloni A, Cancrini G, Bartelesi F, Marcolin D, Roselli M, Arce CC, et al. <i>Mans
onella ozzardi </i>infection in Bolivia: prevalence and clinical association in 
the Chacon region. Am J Trop Med Hyg 1999; 61:830-833.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#118#114#article#143#</font
></p>     ^cY#aop08-11.htm##
00588000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032500092002001300417#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#119#115#articl
e#143#19#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Mede
iros JF, Py-Daniel V, Barbosa UC, Ogawa GM. Ocorr&ecirc;ncia da <i>Mansonella oz
zardi </i>(Nematoda, Onchocercidae) em comunidades ribeirinhas do rio Purus, Mun
ic&iacute;pio de Boca do Acre, Amazonas, Brasil. Cad Saude Publica 2009; 25:1421
-1426.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#120#116#article#143#</font
></p>     ^cY#aop08-11.htm##
00505000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024200092002001300334#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#121#117#articl
e#143#20#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Orih
el TC, Eberhard ML, Lowrie Jr RC. <i>Mansonella ozzardi</i>: the course of the p
atency in experimentally infected patas monkeys. Trop Med Parasitol 1993; 44:49-
54.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#122#118#article#143#</font
></p>     ^cY#aop08-11.htm##
00610000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704034700092002001300439#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#123#119#articl
e#143#21#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Koze
k WJ, Palma G, Henao A, Garcia H, Hoyos M. Filariasis in Colombia: Prevalence an
d distribution of <i>Mansonella ozzardi </i>and <i>Mansonella </i>(=Dipetalonema
) <i>perstans </i>infections in the Comisar&iacute;a del Guain&iacute;a. Am J Tr
op Med Hyg 1983; 32:379-384.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#124#120#article#143#</font
></p>     ^cY#aop08-11.htm##
00574000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031100092002001300403#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#125#121#articl
e#143#22#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Roch
a EMM, Fontes G, Brito AC, Silva TRC, Medeiros Z, Antunes CMF. Filariose bancrof
tiana em &aacute;reas urbanas do Estado de Alagoas, nordeste do Brasil: estudo e
m popula&ccedil;&atilde;o geral. Rev Soc Bras Med Trop 2000; 33:545-551.    ^cY#
aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#126#122#article#143#</font
></p>     ^cY#aop08-11.htm##
00545000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028200092002001300374#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#127#123#articl
e#143#23#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Simo
nsen PE, Niemann L, Meyrowitsch DW. <i>Wuchereria bancrofti </i>in Tanzania: mic
rofilarial periodicity and effect of blood sampling time on microfilarial intens
ities. Trop Med Int Health 1997; 2:153-158.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#128#124#article#143#</font
></p>     ^cY#aop08-11.htm##
00618000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035500092002001300447#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#129#125#articl
e#143#24#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Drey
er G, Pimentael A, Medeiros Z, Beliz F, Moura I, Coutinho A, et al. Studies on t
he periodicity and intravascular distribution of <i>Wuchereria bancrofti </i>mic
rofilariae in paired samples of capillary and venous blood from Recife, Brazil. 
Trop Med Int Health 1996; 1:264-272.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#130#126#article#143#</font
></p>     ^cY#aop08-11.htm##
00507000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024400092002001300336#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#131#127#articl
e#143#25#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Pich
on G, Riviere F, Thirel R, Chebret M, Tetuanui A, Toudic A. Fluctuations affecti
ng the measurement of microfilaremia. Bull Soc Pathol Exot Filiales 1981; 74:525
-532.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#132#128#article#143#</font
></p>     ^cY#aop08-11.htm##
00478000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021500092002001300307#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#133#129#articl
e#143#26#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Bati
sta D, Cerqueira NL, Moraes MAP. Epidemiologia da mansonelose em localidade do i
nterior do Amazonas. Rev Assoc Med Bras 1960; 6:176-184.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#134#130#article#143#</font
></p>     ^cY#aop08-11.htm##
00591000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032800092002001300420#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#135#131#articl
e#143#27#<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. Shel
ley AJ, Coscar&oacute;n S. Simuliid blackflies (Diptera: Simuliidae) and Ceratop
ogonid midges (Diptera: Ceratopogonidae) as vectors of <i>Mansonella ozzardi </i
>(Nematoda: Onchocercidae) in Northern Argentina. Mem Inst Oswaldo Cruz 2001; 96
:451-458.    ^cY#aop08-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#136#132#article#143#</font
></p>     ^cY#aop08-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#137#133#article#143#<p>&nb
sp;</p>     ^cY#aop08-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#138#134#article#143#<p>&nb
sp;</p>     ^cY#aop08-11.htm##
00442000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704019400089002001300283#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#139#135#article#143#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif"><a name="nota1"></a><a 
href="#nota_1"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a
> <b>Address to:</b>    ^cY#aop08-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004400089002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#140#136#article#143#<br>  
 Dr. Jansen Fernandes Medeiros    ^cY#aop08-11.htm##
00272000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002400089002001300113#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#141#137#article#143#<br>  
 CPCS/INPA    ^cY#aop08-11.htm##
00327000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007900089002001300168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#142#138#article#143#<br>  
 Caixa Postal 478. Av. Andr&eacute; Ara&uacute;jo 2936,    Aleixo    ^cY#aop08-1
1.htm##
00291000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004300089002001300132#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#143#139#article#143#<br>  
 69060-001 Manaus, AM, Brasil    ^cY#aop08-11.htm##
00285000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003700089002001300126#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#144#140#article#143#<br>  
 Phone: 55 92 3643-3288    ^cY#aop08-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#145#141#article#143#<br>  
 e-mail: <a href="mailto:jmedeiro@gmail.com">jmedeiro@gmail.com</a></font></p>  
   ^cY#aop08-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#146#142#article#143#<p><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif">Received in 03/03/2010 
   ^cY#aop08-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#p#147#143#article#143#<br>  
 Accepted in 03/11/2010</font></p>     ^cY#aop08-11.htm##
00498000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880120046001080300
01100154065000900165064000500174031000200179014000800181865000900189002001300198
035001000211801001100221#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
08-11.htm#S#c#148#1#article#27#1#^rND^sCerqueira^nNL#Sobre a transmissão da Mans
onella ozzardi^lpt#J Bras Med#19590000#1959#1#885-914#20110000#aop08-11.htm#0047
-2077#J Bras Med##
00601000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100017001060120
09700123030002300220065000900243064000500252031000300257014000800260865000900268
002001300277035001000290801002300300#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop08-11.htm#S#c#149#2#article#27#2#^rND^sShelley^nAJ#^rND^sShelley^nA#
Further evidence for the transmission of Mansonella ozzardi by Simulium amazonic
um in Brazil^len#Ann Trop Med Parasitol#19760000#1976#70#213-217#20110000#aop08-
11.htm#0003-4983#Ann Trop Med Parasitol##
00630000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100019001050100
01800124012008600142030002800228065000900256064000500265031000200270014000800272
865000900280002001300289035001000302801002800312#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop08-11.htm#S#c#150#3#article#27#3#^rND^sBatista^nD#^rND^s
Oliveira^nWR#^rND^sRabello^nVD#Estudo da patogenicidade da Mansonella ozzardi e 
da sintomatologia da mansonelose^lpt#Rev Inst Med Trop São Paulo#19600000#1960#2
#281-289#20110000#aop08-11.htm#0036-4665#Rev Inst Med Trop São Paulo##
00708000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100019001070100
01800126010001600144012014400160030002200304065000900326064000500335031000400340
014000800344865000900352002001300361035001000374801002200384#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#151#4#article#27#4#^rND^sMedei
ros^nJF#^rND^sPy-Daniel^nV#^rND^sBarbosa^nUC#^rND^sOgawa^nGM#Current profile of 
Mansonella ozzardi (Nematoda: Onchocercidae) in communities along the Ituxi rive
r, Lábrea municipality, Amazonas, Brazil^len#Mem Inst Oswaldo Cruz#20080000#2008
#103#409-411#20110000#aop08-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00506000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120073001040300
02700177710000200204065000900206064000500215031000200220014000800222865000900230
002001300239#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#
c#152#5#article#27#5#^rND^sDeane^nMP#Sobre a incidência de filárias humanas em M
anaus, Estado do Amazonas^lpt#Rev Serv Esp Saude Publica#2#19490000#1949#2#849-8
58#20110000#aop08-11.htm##
00598000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100017001030100
01800120010001800138012007300156030003100229710000200260065000900262064000500271
031000200276014000800278865000900286002001300295#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop08-11.htm#S#c#153#6#article#27#6#^rND^sDeane^nL#^rND^sRa
chou^nRG#^rND^sLacerda^nNB#^rND^sMartins^nJB#Alguns dados relativos à prevalênci
a de Mansonella ozzardi no Brasil^lpt#Rev Bras Malariol Doenças Trop#2#19540000#
1954#6#219-224#20110000#aop08-11.htm##
00578000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100017001060120
11000123030003100233710000200264065000900266064000500275031000200280014000800282
865000900290002001300299#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
08-11.htm#S#c#154#7#article#27#7#^rND^sLacerda^nNB#^rND^sRachou^nRG#Filarioses h
umanas nas sedes municipais do estado do Amazonas e territórios do Acre, Guaporé
 e Rio Branco^lpt#Rev Bras Malariol Doenças Trop#2#19560000#1956#8#437-442#20110
000#aop08-11.htm##
00470000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880120054001060300
00700160710000200167065000900169064000500178031000300183014000800186865000900194
002001300203#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#
c#155#8#article#27#8#^rND^sMoraes^nMAP#Contribuição ao estudo da mansonelose do 
Amazonas^lpt#O Hosp#2#19580000#1958#54#887-892#20110000#aop08-11.htm##
00612000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880120137001060300
02300243065000900266064000500275031000300280014000800283865000900291002001300300
035001000313801002300323#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
08-11.htm#S#c#156#9#article#27#9#^rND^sShelley^nAJ#A preliminary survey of the p
revalence of Mansonella ozzardi in some rural communities on the river Purus, st
ate of Amazonas, Brazil^len#Ann Trop Med Parasitol#19750000#1975#69#407-412#2011
0000#aop08-11.htm#0003-4983#Ann Trop Med Parasitol##
00488000000000229000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170048000900660015001380180
04400153065000900197064001300206037001700219865000900236002001300245#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#157#10#article#27#10#I
nstituto Brasileiro de Geografia e Estatística#Rio de Janeiro#Censo 2008: Popula
ção e Domicílios 2008^lpt#20100303#2010 march 3#www.ibge.gov.br/#20110000#aop08-
11.htm##
00708000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100016001050100
01800121010002100139010002100160010001800181012010100199030001300300065000900313
06400050032203100040032701400060033186500090033700200130034603500100035980100130
0369#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#158#11
#article#27#11#^rND^sPost^nRJ#^rND^sAdams^nZA#^rND^sShelley^nAJ#^rND^sMaia-Herzo
g^nM#^rND^sLuna-Dias^nAPA#^rND^sCoscarón^nS#The morphological discrimination of 
microfilariae of Onchocerca volvulus from Mansonella ozzardi^len#Parasitology#20
030000#2003#127#21-27#20110000#aop08-11.htm#0031-1820#Parasitology##
00691000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
01800128010001500146012012800161030002200289065000900311064000500320031000400325
014000600329865000900335002001300344035001000357801002200367#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#159#12#article#27#12#^rND^sMed
eiros^nJF#^rND^sPy-Daniel^nV#^rND^sBarbosa^nUC#^rND^sIzzo^nTJ#Mansonella ozzardi
 in Brazil: prevalence of infection in riverine communities in the Purus region,
 in the state of Amazonas^len#Mem Inst Oswaldo Cruz#20090000#2009#104#74-80#2011
0000#aop08-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00685000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
01800128010001700146012014300163030001000306065000900316064000500325031000300330
014000800333865000900341002001300350035001000363801001000373#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#160#13#article#27#13#^rND^sMed
eiros^nJF#^rND^sPy-Daniel^nV#^rND^sBarbosa^nUC#^rND^sFarias^nES#Epidemiological 
studies of Mansonella ozzardi (Nematoda, Onchocercidae) in indigenous communitie
s of Pauini municipality, Amazonas, Brazil^len#Acta Amaz#20070000#2007#37#241-24
6#20110000#aop08-11.htm#0044-5967#Acta amaz##
00754000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080100
02300126010001700149010001500166010001800181012012400199030002500323065000900348
06400050035703100030036201400060036586500090037100200130038003500100039380100250
0403#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#161#14
#article#27#14#^rND^sYazarbal^nL#^rND^sBasáñez^nMG#^rND^sRamírez-Pérez^nJ#^rND^s
Ramírez^nA#^rND^sBotto^nC#^rND^sYazarbal^nA#Experimental and natural infection o
f Simulium sanchezi by Mansonella ozzardi in the middle Orinoco region of Venezu
ela^len#Trans R Soc Trop Med Hyg#19850000#1985#79#29-33#20110000#aop08-11.htm#00
35-9203#Trans R Soc Trop Med Hyg##
00494000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900180046001080510
01200154046000900166050002500175045000900200044000500209020000400214865000900218
002001300227#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#
c#162#15#article#27#15#^rND^sTavares^nAM#Estudo da infecção por Mansonella ozzar
di^lpt#Dissertação#Brasília#Universidade de Brasília#19810000#1981#122#20110000#
aop08-11.htm##
00778000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090100
01500127010002500142010001600167010001500183810000600198012015900204030001000363
06500090037306400050038203100030038701400080039086500090039800200130040703500100
0420801001000430#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.ht
m#S#c#163#16#article#27#16#^rND^sLawrence^nND#^rND^sErdtmann^nB#^rND^sPeet^nJW#^
rND^sNunes de Mello^nJA#^rND^sHearl^nGR#^rND^sJames^nV#et al#Estudos epidemiológ
icos entre populações indígenas da Amazônia. II. Prevalência da microfilaremia d
e M. ozzardi: Comparação de dois métodos de diagnóstico^lpt#Acta Amaz#19800000#1
980#10#763-769#20110000#aop08-11.htm#0044-5967#Acta amaz##
00716000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100022001060100
01400128010001900142012015800161030001800319065000900337064000500346031000300351
014001000354865000900364002001300373035001000386801001800396#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#164#17#article#27#17#^rND^sKoz
ek^nWJ#^rND^sD'Alessandro^nA#^rND^sSuva^nJ#^rND^sNavarrete^nS#Filariasis in Colo
mbia: Prevalence of mansonellosis in the teenage and adult population of the Col
ombian bank of the Amazon River, Comisaria del Amazonas^lpt#Am J Trop Med Hyg#19
820000#1982#31#1131-1136#20110000#aop08-11.htm#0002-9637#Am J Trop Med Hyg##
00735000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090100
01900127010001800146010001700164010001500181810000600196012010200202030001800304
06500090032206400050033103100030033601400080033986500090034700200130035603500100
0369801001800379#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.ht
m#S#c#165#18#article#27#18#^rND^sBartoloni^nA#^rND^sCancrini^nG#^rND^sBartelesi^
nF#^rND^sMarcolin^nD#^rND^sRoselli^nM#^rND^sArce^nCC#et al#Mansonella ozzardi in
fection in Bolivia: prevalence and clinical association in the Chacon region^len
#Am J Trop Med Hyg#19990000#1999#61#830-833#20110000#aop08-11.htm#0002-9637#Am J
 Trop Med Hyg##
00707000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
01800128010001600146012014800162030001800310065000900328064000500337031000300342
014001000345865000900355002001300364035001000377801001800387#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#166#19#article#27#19#^rND^sMed
eiros^nJF#^rND^sPy-Daniel^nV#^rND^sBarbosa^nUC#^rND^sOgawa^nGM#Ocorrência da Man
sonella ozzardi (Nematoda, Onchocercidae) em comunidades ribeirinhas do rio Puru
s, Município de Boca do Acre, Amazonas, Brasil^len#Cad Saude Publica#20090000#20
09#25#1421-1426#20110000#aop08-11.htm#0102-311X#Cad Saude Publica##
00620000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100019001070100
02000126012009100146030001900237065000900256064000500265031000300270014000600273
865000900279002001300288035001000301801001900311#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop08-11.htm#S#c#167#20#article#27#20#^rND^sOrihel^nTC#^rND
^sEberhard^nML#^rND^sLowrie Jr^nRC#Mansonella ozzardi: the course of the patency
 in experimentally infected patas monkeys^len#Trop Med Parasitol#19930000#1993#4
4#49-54#20110000#aop08-11.htm#0177-2392#Trop Med Parasitol##
00732000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060100
01500121010001600136010001500152012015800167030001800325065000900343064000500352
031000300357014000800360865000900368002001300377035001000390801001800400#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#168#21#article#27#
21#^rND^sKozek^nWJ#^rND^sPalma^nG#^rND^sHenao^nA#^rND^sGarcia^nH#^rND^sHoyos^nM#
Filariasis in Colombia: Prevalence and distribution of Mansonella ozzardi and Ma
nsonella (=Dipetalonema) perstans infections in the Comisaría del Guainía^len#Am
 J Trop Med Hyg#19830000#1983#32#379-384#20110000#aop08-11.htm#0002-9637#Am J Tr
op Med Hyg##
00732000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01600123010001700139010001800156010001900174012011200193030002200305065000900327
06400050033603100030034101400080034486500090035200200130036103500100037480100220
0384#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#169#22
#article#27#22#^rND^sRocha^nEMM#^rND^sFontes^nG#^rND^sBrito^nAC#^rND^sSilva^nTRC
#^rND^sMedeiros^nZ#^rND^sAntunes^nCMF#Filariose bancroftiana em áreas urbanas do
 Estado de Alagoas, nordeste do Brasil: estudo em população geral^lpt#Rev Soc Br
as Med Trop#20000000#2000#33#545-551#20110000#aop08-11.htm#0037-8682#Rev Soc Bra
s Med Trop##
00661000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100017001090100
02200126012012700148030002000275065000900295064000500304031000200309014000800311
865000900319002001300328035001000341801002000351#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop08-11.htm#S#c#170#23#article#27#23#^rND^sSimonsen^nPE#^r
ND^sNiemann^nL#^rND^sMeyrowitsch^nDW#Wuchereria bancrofti in Tanzania: microfila
rial periodicity and effect of blood sampling time on microfilarial intensities^
len#Trop Med Int Health#19970000#1997#2#153-158#20110000#aop08-11.htm#1360-2276#
Trop Med Int Health##
00799000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01800125010001500143010001500158010001800173810000600191012016800197030002000365
06500090038506400050039403100020039901400080040186500090040900200130041803500100
0431801002000441#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.ht
m#S#c#171#24#article#27#24#^rND^sDreyer^nG#^rND^sPimentael^nA#^rND^sMedeiros^nZ#
^rND^sBeliz^nF#^rND^sMoura^nI#^rND^sCoutinho^nA#et al#Studies on the periodicity
 and intravascular distribution of Wuchereria bancrofti microfilariae in paired 
samples of capillary and venous blood from Recife, Brazil^len#Trop Med Int Healt
h#19960000#1996#1#264-272#20110000#aop08-11.htm#1360-2276#Trop Med Int Health##
00694000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01600123010001700139010001800156010001600174012006100190030003000251065000900281
06400050029003100030029501400080029886500090030600200130031503500100032880100300
0338#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop08-11.htm#S#c#172#25
#article#27#25#^rND^sPichon^nG#^rND^sRiviere^nF#^rND^sThirel^nR#^rND^sChebret^nM
#^rND^sTetuanui^nA#^rND^sToudic^nA#Fluctuations affecting the measurement of mic
rofilaremia^len#Bull Soc Pathol Exot Filiales#19810000#1981#74#525-532#20110000#
aop08-11.htm#0037-9085#Bull Soc Pathol Exot Filiales##
00600000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100020001070100
01800127012007100145030001900216065000900235064000500244031000200249014000800251
865000900259002001300268035001000281801001900291#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop08-11.htm#S#c#173#26#article#27#26#^rND^sBatista^nD#^rND
^sCerqueira^nNL#^rND^sMoraes^nMAP#Epidemiologia da mansonelose em localidade do 
interior do Amazonas^lpt#Rev Assoc Med Bras#19600000#1960#6#176-184#20110000#aop
08-11.htm#0004-5241#Rev Assoc Med Bras##
00684000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100018001080120
17900126030002200305065000900327064000500336031000300341014000800344865000900352
002001300361035001000374801002200384#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop08-11.htm#S#c#174#27#article#27#27#^rND^sShelley^nAJ#^rND^sCoscarón^
nS#Simuliid blackflies (Diptera: Simuliidae) and Ceratopogonid midges (Diptera: 
Ceratopogonidae) as vectors of Mansonella ozzardi (Nematoda: Onchocercidae) in N
orthern Argentina^len#Mem Inst Oswaldo Cruz#20010000#2001#96#451-458#20110000#ao
p08-11.htm#0074-0276#Mem Inst Oswaldo Cruz##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#o#1#
1#article#1#20110411#104859#aop16-11.htm#125##
04628000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301201100018201201380
02920100035004300100032004650100037004970100045005340700085005790700085006640831
45300749085000802202085002902210085002802239085003302267083149102300085000803791
08500270379908500290382608500350385505800620389011700060395207200030395811200090
3961111001103970114000903981113001103990002001304001#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop16-11.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#TAB#20
#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#Assoc
iação entre dissinergia miocárdica e arritmia ventricular na forma indeterminada
 da doença de Chagas^lpt#Association between left ventricular wall motion abnorm
alities and ventricular arrhythmia in the indeterminate form of Chagas disease^l
en#^rND^1A01 A02^nMárcio Lins^sBarros#^rND^1A01 A02^nAntônio^sRibeiro#^rND^1A01 
A02^nMaria do Carmo^sNunes#^rND^1A01 A02^nManoel Otávio da Costa^sRocha#Universi
dade Federal de Minas Gerais^iA01^1Hospital das Clínicas^cBelo Horizonte^sMG#Uni
versidade Federal de Minas Gerais^iA02^1Faculdade de Medicina^cBelo Horizonte^sM
G#^lpt^aINTRODUÇÃO: Pacientes na forma indeterminada da doença de Chagas (FIDC) 
podem apresentar anormalidades contráteis segmentares, com evidências de pior pr
ognóstico comparativamente a pacientes com estudo ecocardiográfico normal. O obj
etivo deste estudo foi de avaliar a associação entre a presença de anormalidade 
contrátil segmentar e a presença de distúrbios do ritmo cardíaco na FIDC. MÉTODO
S: Foram estudados 38 pacientes na FIDC, sendo 26 pacientes sem anormalidade con
trátil e 12 com presença de distúrbio contrátil ao estudo ecocardiográfico. Todo
s os pacientes foram submetidos a um estudo ecocardiográfico completo, incluindo
 o Doppler tecidual, bem como à monitorização eletrocardiográfica de 24h (Holter
). RESULTADOS: Entre as diversas variáveis estudadas, foram encontradas diferenç
as significativas entre os dois grupos em relação à fração de ejeção (p < 0,001)
, dimensão sistólica do ventrículo esquerdo (p = 0,029) e tempo de contração iso
volumétrica (p < 0,05) medidos pela ecocardiografia e Doppler tecidual, bem como
 extrassistolia ventricular isolada (p = 0,016) e em pares (p = 0,003) pela aval
iação pelo Holter. CONCLUSÕES: Pacientes na FIDC que apresentam anormalidades co
ntráteis quando avaliados pela ecocardiografia apresentam episódios mais frequen
tes de extrassistolia ventricular, traduzindo um maior dano morfofuncional e elé
trico do coração, quando comparados a pacientes que apresentem estudo ecocardiog
ráfico normal.#^dnd^i1#^tm^lpt^kDoença de Chagas^i1#^tm^lpt^kEcocardiografia^i1#
^tm^lpt^kArritmia ventricular^i1#^len^aINTRODUCTION: Chagas' disease can lead to
 severe and potentially lethal damage of cardiac function. Thus, the identificat
ion of cardiac abnormalities in patients presenting the indeterminate form (IF) 
can be important for risk stratification. This paper aimed to demonstrate whethe
r IF chagasic patients who presented wall motion abnormalities showed functional
 and electric disturbances compared to patients with normal echocardiogram and D
oppler studies. METHODS: Thirty eight patients with the IF were studied, includi
ng 26 chagasic patients with normal electrocardiographic, radiological and echoc
ardiographic exams and 12 chagasic patients showing segmental wall motion abnorm
alities in the echocardiographic exam. All the patients were submitted to comple
te echocardiogram and Doppler study, including tissue Doppler imaging (TDI) and 
Holter 24h monitoring. RESULTS: Among the variables evaluated, significant diffe
rences among the two groups were verified in relation to: the ejection fraction 
(p < 0.001); left ventricular systolic dimension (p = 0.029); isovolumic contrac
tion time, measured by TDI in the basal segments of the left ventricle (p < 0.05
); and the presence of isolated (p = 0.0005) and paired ventricular extrasystole
s (p = 0.003), in the Holter monitoring. CONCLUSIONS: The indeterminate form of 
Chagas' disease can present cardiac wall motion abnormality, demonstrating funct
ional and electric damage compared to chagasic patients with normal echocardiogr
am.#^dnd^i2#^tm^len^kChagas disease^i2#^tm^len^kEchocardiography^i2#^tm^len^kVen
tricular arrhythmia^i2#Conselho Nacional de Desenvolvimento Científico e Tecnoló
gico#other#14#20091226#26/12/2009#20101126#26/11/2010#aop16-11.htm##
04724000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301201170018201201450
02990100035004440100032004790100037005110100045005480700085005930700085006780831
49400763085000802257085002902265085002802294085003302322083153202355085000803887
08500270389508500290392208500350395105800620398611700060404807200030405411200090
4057111001104066114000904077113001104086002001304097#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop16-11.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#TAB#20
#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#<b>As
sociação entre dissinergia miocárdica e arritmia ventricular na forma indetermin
ada da doença de Chagas</b>^lpt#<b>Association between left ventricular wall mot
ion abnormalities and ventricular arrhythmia in the indeterminate form of Chagas
 disease</b>^len#^rND^1A01 A02^nMárcio Lins^sBarros#^rND^1A01 A02^nAntônio^sRibe
iro#^rND^1A01 A02^nMaria do Carmo^sNunes#^rND^1A01 A02^nManoel Otávio da Costa^s
Rocha#Universidade Federal de Minas Gerais^iA01^1Hospital das Clínicas^cBelo Hor
izonte^sMG#Universidade Federal de Minas Gerais^iA02^1Faculdade de Medicina^cBel
o Horizonte^sMG#^lpt^a<b>INTRODUÇÃO:</b> Pacientes na forma indeterminada da doe
nça de Chagas (FIDC) podem apresentar anormalidades contráteis segmentares, com 
evidências de pior prognóstico comparativamente a pacientes com estudo ecocardio
gráfico normal. O objetivo deste estudo foi de avaliar a associação entre a pres
ença de anormalidade contrátil segmentar e a presença de distúrbios do ritmo car
díaco na FIDC. <b>MÉTODOS: </b>Foram estudados 38 pacientes na FIDC, sendo 26 pa
cientes sem anormalidade contrátil e 12 com presença de distúrbio contrátil ao e
studo ecocardiográfico. Todos os pacientes foram submetidos a um estudo ecocardi
ográfico completo, incluindo o Doppler tecidual, bem como à monitorização eletro
cardiográfica de 24h (Holter). <b>RESULTADOS:</b> Entre as diversas variáveis es
tudadas, foram encontradas diferenças significativas entre os dois grupos em rel
ação à fração de ejeção (p <u>&lt;</u> 0,001), dimensão sistólica do ventrículo 
esquerdo (p = 0,029) e tempo de contração isovolumétrica (p &lt; 0,05) medidos p
ela ecocardiografia e Doppler tecidual, bem como extrassistolia ventricular isol
ada (p = 0,016) e em pares (p = 0,003) pela avaliação pelo Holter. <b>CONCLUSÕES
: </b>Pacientes na FIDC que apresentam anormalidades contráteis quando avaliados
 pela ecocardiografia apresentam episódios mais frequentes de extrassistolia ven
tricular, traduzindo um maior dano morfofuncional e elétrico do coração, quando 
comparados a pacientes que apresentem estudo ecocardiográfico normal.#^dnd^i1#^t
m^lpt^kDoença de Chagas^i1#^tm^lpt^kEcocardiografia^i1#^tm^lpt^kArritmia ventric
ular^i1#^len^a<b>INTRODUCTION:</b> Chagas' disease can lead to severe and potent
ially lethal damage of cardiac function. Thus, the identification of cardiac abn
ormalities in patients presenting the indeterminate form (IF) can be important f
or risk stratification. This paper aimed to demonstrate whether IF chagasic pati
ents who presented wall motion abnormalities showed functional and electric dist
urbances compared to patients with normal echocardiogram and Doppler studies. <b
>METHODS: </b>Thirty eight patients with the IF were studied, including 26 chaga
sic patients with normal electrocardiographic, radiological and echocardiographi
c exams and 12 chagasic patients showing segmental wall motion abnormalities in 
the echocardiographic exam. All the patients were submitted to complete echocard
iogram and Doppler study, including tissue Doppler imaging (TDI) and Holter 24h 
monitoring. <b>RESULTS:</b> Among the variables evaluated, significant differenc
es among the two groups were verified in relation to: the ejection fraction (p <
u>&lt;</u> 0.001); left ventricular systolic dimension (p = 0.029); isovolumic c
ontraction time, measured by TDI in the basal segments of the left ventricle (p 
&lt; 0.05); and the presence of isolated (p = 0.0005) and paired ventricular ext
rasystoles (p = 0.003), in the Holter monitoring. <b>CONCLUSIONS: </b>The indete
rminate form of Chagas' disease can present cardiac wall motion abnormality, dem
onstrating functional and electric damage compared to chagasic patients with nor
mal echocardiogram.#^dnd^i2#^tm^len^kChagas disease^i2#^tm^len^kEchocardiography
^i2#^tm^len^kVentricular arrhythmia^i2#Conselho Nacional de Desenvolvimento Cien
tífico e Tecnológico#other#14#20091226#26/12/2009#20101126#26/11/2010#aop16-11.h
tm##
04751000000000637000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108121000300112049000300115158000300118
03000260012103200060014706500090015301400070016203500100016922300090017901201100
01880120138002980100035004360100032004710100037005030100045005400700087005850700
08700672083145300759085000802212085002902220085002802249085003302277083149102310
08500080380108500270380908500290383608500350386505800620390011700060396207200030
3968112000903971111001103980114000903991113001104000002001304011008008904024#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#l#4#1#article#1#
^a2011#oa#pt#br1.1#1#4.0#tab#20#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^
f0^l0#0037-8682#20110415#Associação entre dissinergia miocárdica e arritmia vent
ricular na forma indeterminada da doença de Chagas^lpt#Association between left 
ventricular wall motion abnormalities and ventricular arrhythmia in the indeterm
inate form of Chagas disease^len#^rND^1A01 A02^nMárcio Lins^sBarros#^rND^1A01 A0
2^nAntônio^sRibeiro#^rND^1A01 A02^nMaria do Carmo^sNunes#^rND^1A01 A02^nManoel O
távio da Costa^sRocha#^iA01^1Universidade Federal de Minas Gerais^2Hospital das 
Clínicas^cBelo Horizonte^sMG#^iA02^1Universidade Federal de Minas Gerais^2Faculd
ade de Medicina^cBelo Horizonte^sMG#^lpt^aINTRODUÇÃO: Pacientes na forma indeter
minada da doença de Chagas (FIDC) podem apresentar anormalidades contráteis segm
entares, com evidências de pior prognóstico comparativamente a pacientes com est
udo ecocardiográfico normal. O objetivo deste estudo foi de avaliar a associação
 entre a presença de anormalidade contrátil segmentar e a presença de distúrbios
 do ritmo cardíaco na FIDC. MÉTODOS: Foram estudados 38 pacientes na FIDC, sendo
 26 pacientes sem anormalidade contrátil e 12 com presença de distúrbio contráti
l ao estudo ecocardiográfico. Todos os pacientes foram submetidos a um estudo ec
ocardiográfico completo, incluindo o Doppler tecidual, bem como à monitorização 
eletrocardiográfica de 24h (Holter). RESULTADOS: Entre as diversas variáveis est
udadas, foram encontradas diferenças significativas entre os dois grupos em rela
ção à fração de ejeção (p < 0,001), dimensão sistólica do ventrículo esquerdo (p
 = 0,029) e tempo de contração isovolumétrica (p < 0,05) medidos pela ecocardiog
rafia e Doppler tecidual, bem como extrassistolia ventricular isolada (p = 0,016
) e em pares (p = 0,003) pela avaliação pelo Holter. CONCLUSÕES: Pacientes na FI
DC que apresentam anormalidades contráteis quando avaliados pela ecocardiografia
 apresentam episódios mais frequentes de extrassistolia ventricular, traduzindo 
um maior dano morfofuncional e elétrico do coração, quando comparados a paciente
s que apresentem estudo ecocardiográfico normal.#^dnd^i1#^tm^lpt^kDoença de Chag
as^i1#^tm^lpt^kEcocardiografia^i1#^tm^lpt^kArritmia ventricular^i1#^len^aINTRODU
CTION: Chagas' disease can lead to severe and potentially lethal damage of cardi
ac function. Thus, the identification of cardiac abnormalities in patients prese
nting the indeterminate form (IF) can be important for risk stratification. This
 paper aimed to demonstrate whether IF chagasic patients who presented wall moti
on abnormalities showed functional and electric disturbances compared to patient
s with normal echocardiogram and Doppler studies. METHODS: Thirty eight patients
 with the IF were studied, including 26 chagasic patients with normal electrocar
diographic, radiological and echocardiographic exams and 12 chagasic patients sh
owing segmental wall motion abnormalities in the echocardiographic exam. All the
 patients were submitted to complete echocardiogram and Doppler study, including
 tissue Doppler imaging (TDI) and Holter 24h monitoring. RESULTS: Among the vari
ables evaluated, significant differences among the two groups were verified in r
elation to: the ejection fraction (p < 0.001); left ventricular systolic dimensi
on (p = 0.029); isovolumic contraction time, measured by TDI in the basal segmen
ts of the left ventricle (p < 0.05); and the presence of isolated (p = 0.0005) a
nd paired ventricular extrasystoles (p = 0.003), in the Holter monitoring. CONCL
USIONS: The indeterminate form of Chagas' disease can present cardiac wall motio
n abnormality, demonstrating functional and electric damage compared to chagasic
 patients with normal echocardiogram.#^dnd^i2#^tm^len^kChagas disease^i2#^tm^len
^kEchocardiography^i2#^tm^len^kVentricular arrhythmia^i2#Conselho Nacional de De
senvolvimento Científico e Tecnológico#other#14#20091226#26/12/2009#20101126#26/
11/2010#aop16-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttex
t&pid=S0037-86822011005000020##
00491000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704024700085002001300332#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#5#1#article#107#<p><a name
="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Associ
a&ccedil;&atilde;o    entre dissinergia mioc&aacute;rdica e arritmia ventricular
 na forma indeterminada    da doen&ccedil;a de Chagas</b></font></p>     ^cY#aop
16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#6#2#article#107#<p>&nbsp;<
/p>     ^cY#aop16-11.htm##
00473000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704022900085002001300314#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#7#3#article#107#<p><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Association    between l
eft ventricular wall motion abnormalities and ventricular arrhythmia    in the i
ndeterminate form of Chagas disease</b></font></p>     ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#8#4#article#107#<p>&nbsp;<
/p>     ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#9#5#article#107#<p>&nbsp;<
/p>     ^cY#aop16-11.htm##
00512000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704026700086002001300353#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#10#6#article#107#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>M&aacute;rcio    Lins B
arros<sup>I, II</sup>; Ant&ocirc;nio Ribeiro<sup>I, II</sup>; Maria do    Carmo 
Nunes<sup>I, II</sup>; Manoel Ot&aacute;vio da Costa Rocha<sup>I, II</sup></b></
font></p>     ^cY#aop16-11.htm##
00417000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704017200086002001300258#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#11#7#article#107#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Hospital    da
s Cl&iacute;nicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG    ^
cY#aop16-11.htm##
00454000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704020900086002001300295#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#12#8#article#107#<br>   <s
up>II</sup>Programa de P&oacute;s-Gradua&ccedil;&atilde;o em Infectologia    e M
edicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais,  
  Belo Horizonte, MG</font></p>     ^cY#aop16-11.htm##
00393000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704014800086002001300234#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#13#9#article#107#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Endere&cce
dil;o    para correspond&ecirc;ncia</a></font></p>     ^cY#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#14#10#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#15#11#article#107#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop16-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#16#12#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p> 
    ^cY#aop16-11.htm##
00825000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704057900087002001300666#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#17#13#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODU&Ccedil;&Atilde
;O:</b>    Pacientes na forma indeterminada da doen&ccedil;a de Chagas (FIDC) po
dem apresentar    anormalidades contr&aacute;teis segmentares, com evid&ecirc;nc
ias de pior progn&oacute;stico    comparativamente a pacientes com estudo ecocar
diogr&aacute;fico normal. O objetivo    deste estudo foi de avaliar a associa&cc
edil;&atilde;o entre a presen&ccedil;a    de anormalidade contr&aacute;til segme
ntar e a presen&ccedil;a de dist&uacute;rbios    do ritmo card&iacute;aco na FID
C.     ^cY#aop16-11.htm##
00688000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044200087002001300529#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#18#14#article#107#<br>   <
b>M&Eacute;TODOS: </b>Foram estudados 38 pacientes na FIDC, sendo 26 pacientes  
  sem anormalidade contr&aacute;til e 12 com presen&ccedil;a de dist&uacute;rbio
    contr&aacute;til ao estudo ecocardiogr&aacute;fico. Todos os pacientes foram
    submetidos a um estudo ecocardiogr&aacute;fico completo, incluindo o Doppler
    tecidual, bem como &agrave; monitoriza&ccedil;&atilde;o eletrocardiogr&aacut
e;fica    de 24h (Holter).    ^cY#aop16-11.htm##
00837000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059100087002001300678#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#19#15#article#107#<br>   <
b>RESULTADOS:</b> Entre as diversas vari&aacute;veis estudadas, foram encontrada
s    diferen&ccedil;as significativas entre os dois grupos em rela&ccedil;&atild
e;o    &agrave; fra&ccedil;&atilde;o de eje&ccedil;&atilde;o (p <u>&lt;</u> 0,00
1),    dimens&atilde;o sist&oacute;lica do ventr&iacute;culo esquerdo (p = 0,029
) e    tempo de contra&ccedil;&atilde;o isovolum&eacute;trica (p &lt; 0,05) medi
dos    pela ecocardiografia e Doppler tecidual, bem como extrassistolia ventricu
lar    isolada (p = 0,016) e em pares (p = 0,003) pela avalia&ccedil;&atilde;o p
elo    Holter.     ^cY#aop16-11.htm##
00656000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041000087002001300497#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#20#16#article#107#<br>   <
b>CONCLUS&Otilde;ES: </b>Pacientes na FIDC que apresentam anormalidades contr&aa
cute;teis    quando avaliados pela ecocardiografia apresentam epis&oacute;dios m
ais frequentes    de extrassistolia ventricular, traduzindo um maior dano morfof
uncional e el&eacute;trico    do cora&ccedil;&atilde;o, quando comparados a paci
entes que apresentem estudo    ecocardiogr&aacute;fico normal.</font></p>     ^c
Y#aop16-11.htm##
00441000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019500087002001300282#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#21#17#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palavras-chaves:</b>  
  Doen&ccedil;a de Chagas. Ecocardiografia. Arritmia ventricular.</font></p> <hr
 size="1" noshade>     ^cY#aop16-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#22#18#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p
>     ^cY#aop16-11.htm##
00799000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055300087002001300640#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#23#19#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODUCTION:</b>    C
hagas' disease can lead to severe and potentially lethal damage of cardiac    fu
nction. Thus, the identification of cardiac abnormalities in patients presenting
    the indeterminate form (IF) can be important for risk stratification. This p
aper    aimed to demonstrate whether IF chagasic patients who presented wall mot
ion    abnormalities showed functional and electric disturbances compared to pat
ients    with normal echocardiogram and Doppler studies.     ^cY#aop16-11.htm##
00690000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044400087002001300531#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#24#20#article#107#<br>   <
b>METHODS: </b>Thirty eight patients with the IF were studied, including 26    c
hagasic patients with normal electrocardiographic, radiological and echocardiogr
aphic    exams and 12 chagasic patients showing segmental wall motion abnormalit
ies in    the echocardiographic exam. All the patients were submitted to complet
e echocardiogram    and Doppler study, including tissue Doppler imaging (TDI) an
d Holter 24h monitoring.        ^cY#aop16-11.htm##
00714000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046800087002001300555#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#25#21#article#107#<br>   <
b>RESULTS:</b> Among the variables evaluated, significant differences among    t
he two groups were verified in relation to: the ejection fraction (p <u>&lt;</u>
    0.001); left ventricular systolic dimension (p = 0.029); isovolumic contract
ion    time, measured by TDI in the basal segments of the left ventricle (p &lt;
 0.05);    and the presence of isolated (p = 0.0005) and paired ventricular extr
asystoles    (p = 0.003), in the Holter monitoring.     ^cY#aop16-11.htm##
00488000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704024200087002001300329#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#26#22#article#107#<br>   <
b>CONCLUSIONS: </b>The indeterminate form of Chagas' disease can present cardiac
    wall motion abnormality, demonstrating functional and electric damage compar
ed    to chagasic patients with normal echocardiogram.</font></p>     ^cY#aop16-
11.htm##
00428000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018200087002001300269#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#27#23#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords:</b>    Chaga
s disease. Echocardiography. Ventricular arrhythmia.</font></p> <hr size="1" nos
hade>     ^cY#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#28#24#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#29#25#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00361000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011500087002001300202#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#30#26#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"> <b>INTRODU&Ccedil;&Atild
e;O</b></font></p>     ^cY#aop16-11.htm##
01817000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704157100087002001301658#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#31#27#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A doen&ccedil;a    de Cha
gas representa uma das principais causas de morbimortalidade na Am&eacute;rica  
  Latina, com grande impacto socioecon&ocirc;mico gerado pelo acometimento de   
 expressivo contingente populacional, especialmente, na faixa mais produtiva    
da vida<sup>1</sup>. Aproximadamente, metade destes pacientes n&atilde;o apresen
ta    sinais cl&iacute;nicos, eletrocardiogr&aacute;ficos e radiol&oacute;gicos 
de    envolvimento card&iacute;aco, embora parte n&atilde;o desprez&iacute;vel d
esta    popula&ccedil;&atilde;o desenvolva cardiopatia ao longo dos anos<sup>2</
sup>.    Embora esses pacientes n&atilde;o demonstrem redu&ccedil;&atilde;o sign
ificativa    da fun&ccedil;&atilde;o sist&oacute;lica global ventricular, estudo
s pr&eacute;vios    t&ecirc;m demonstrado evid&ecirc;ncia de anormalidade contr&
aacute;til segmentar    em indiv&iacute;duos na forma indeterminada da doen&cced
il;a de Chagas (FIDC),    com evid&ecirc;ncia de progn&oacute;stico desfavor&aac
ute;vel comparativamente    a pacientes que n&atilde;o apresentem dissinergia ve
ntricular<sup>3</sup>. O    objetivo deste trabalho foi de estudar, comparativam
ente, atrav&eacute;s da    ecocardiografia e da monitoriza&ccedil;&atilde;o elet
rocardiogr&aacute;fica    de 24h (Holter), o comportamento morfofuncional e el&e
acute;trico card&iacute;aco    em pacientes na forma indeterminada da doen&ccedi
l;a de Chagas que apresentem    ou n&atilde;o dist&uacute;rbios da contratilidad
e ventricular esquerda.</font></p>     ^cY#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#32#28#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#33#29#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>M&Eacute;TODOS</b></fo
nt></p>     ^cY#aop16-11.htm##
02049000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704180300087002001301890#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#34#30#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Foram selecionados    38 
pacientes, em um estudo transversal e com coleta prospectiva de dados, sendo    
18 do sexo feminino e 20 do masculino, selecionados em dois grupos: 0-chag&aacut
e;sicos    na FIDC e com ecocardiograma normal (26 pacientes) e 1-chag&aacute;si
cos na    FIDC e com anormalidade contr&aacute;til ventricular esquerda (12 paci
entes).    Todos os pacientes foram selecionados no Centro de treinamento e Refe
r&ecirc;ncia    em Doen&ccedil;as Infecciosas e Parasit&aacute;rias (CTR-DIP) da
 Universidade    Federal de Minas Gerais (UFMG) ap&oacute;s esclarecimento indiv
idual sobre os    objetivos da investiga&ccedil;&atilde;o e consentimento escrit
o, p&oacute;s    informado. Para a realiza&ccedil;&atilde;o do recrutamento, os 
pacientes foram    inicialmente submetidos &agrave; anamnese e exame f&iacute;si
co padronizados,    eletrocardiograma, radiografia de t&oacute;rax e exames labo
ratoriais (hemograma    completo, dosagem bioqu&iacute;mica de creatinina, ur&ea
cute;ia, glicemia de    jejum, pot&aacute;ssio e s&oacute;dio, dosagem de TSH e 
exames sorol&oacute;gicos    para infec&ccedil;&atilde;o pelo <i>Trypanosoma cru
zi</i> por pelo menos tr&ecirc;s    m&eacute;todos diferentes), radiologia do es
&ocirc;fago e c&oacute;lons. Foram    considerados chag&aacute;sicos com a forma
 indeterminada, aqueles pacientes    que apresentaram positividade sorol&oacute;
gica para <i>Trypanosoma cruzi</i>    atrav&eacute;s de pelo menos duas entre t&
eacute;cnicas diferentes (rea&ccedil;&atilde;o    de imunofluoresc&ecirc;ncia in
direta, hemaglutina&ccedil;&atilde;o indireta    e ELISA), al&eacute;m de aprese
ntar ECG, radiografia do t&oacute;rax e radiologia    do es&ocirc;fago e c&oacut
e;lons normais.</font></p>     ^cY#aop16-11.htm##
01535000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704128900087002001301376#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#35#31#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Foram considerados    cri
t&eacute;rios de exclus&atilde;o: hipertens&atilde;o arterial sist&ecirc;mica,  
  definida como press&atilde;o arterial medida durante o exame f&iacute;sico <u>
&gt;</u>    160/95; hist&oacute;ria sugestiva de insufici&ecirc;ncia coronariana
; epis&oacute;dio    pr&eacute;vio sugestivo de doen&ccedil;a reum&aacute;tica; 
diabetes <i>mellitus</i>    ou intoler&acirc;ncia &agrave; glicose, conforme def
inido pelo <i>National Diabetes    Data Group; d</i>isfun&ccedil;&atilde;o tireo
idiana, manifesta por n&iacute;veis    anormais de horm&ocirc;nio estimulante da
 tire&oacute;ide (TSH) e da tiroxina    (T4) livre; insufici&ecirc;ncia renal, d
efinida por aumento dos n&iacute;veis    de creatinina e ur&eacute;ia; doen&cced
il;a pulmonar obstrutiva cr&ocirc;nica,    a partir de dados cl&iacute;nicos, ra
diol&oacute;gicos e eletrocardiogr&aacute;ficos    sugestivos; dist&uacute;rbios
 hidroeletrol&iacute;ticos, a partir das dosagens    de s&oacute;dio e pot&aacut
e;ssio; anemia significativa, definida como hemoglobina    abaixo de 10g/dl; alc
oolismo, definido como consumo m&eacute;dio semanal de    420g de etanol; gravid
ez; impossibilidade de realiza&ccedil;&atilde;o do protocolo.</font></p>     ^cY
#aop16-11.htm##
01939000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704169300087002001301780#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#36#32#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os pacientes foram    sub
metidos a ecodopplercardiograma com mapeamento de fluxo em cores, utilizando    
aparelho ATL HDI 5.000 (Bothell, Washington, USA), para obten&ccedil;&atilde;o  
  dos diversos &iacute;ndices de fun&ccedil;&atilde;o sistodiast&oacute;lica enu
merados    a seguir: dimens&otilde;es diast&oacute;lica e sist&oacute;lica finai
s do ventr&iacute;culo    esquerdo e di&acirc;metro do &aacute;trio esquerdo; ob
ten&ccedil;&atilde;o da    fra&ccedil;&atilde;o de eje&ccedil;&atilde;o pelo m&e
acute;todo de Simpson,    a partir de <i>software</i> fornecido pelo aparelho. P
ara an&aacute;lise da    fun&ccedil;&atilde;o diast&oacute;lica, foi utilizado o
 Doppler pulsado do fluxo    transmitral (ondas E, A, rela&ccedil;&atilde;o E/A 
e tempo de desacelera&ccedil;&atilde;o-    TD) e da via de sa&iacute;da do ventr
&iacute;culo esquerdo (tempo de relaxamento    isovolum&eacute;trico- TRIV). O D
oppler tissular foi obtido utilizando a janela    apical nos cortes apical 4 c&a
circ;maras, apical 2 c&acirc;maras e apical longo    para avalia&ccedil;&atilde;
o das paredes septal, lateral, inferior, anterior    e posterior, posicionando-s
e o volume amostra do cursor Doppler ao n&iacute;vel    das por&ccedil;&otilde;e
s basal, m&eacute;dio e apical das referidas paredes    a fim de se determinar a
s velocidades de contra&ccedil;&atilde;o, medindo-se    a velocidade de pico sis
t&oacute;lica, al&eacute;m da estimativa do tempo de    contra&ccedil;&atilde;o 
isovolum&eacute;trica regional (TCIVr), medindo-se o    intervalo entre a onda Q
 do eletrocardiograma e o in&iacute;cio da onda sist&oacute;lica.</font></p>    
 ^cY#aop16-11.htm##
01434000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704118800087002001301275#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#37#33#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A monitoriza&ccedil;&atil
de;o    eletrocardiogr&aacute;fica de 24h foi realizada utilizando um sistema de
 grava&ccedil;&atilde;o    port&aacute;til de tr&ecirc;s canais (Dynamis, Cardio
s, S&atilde;o Paulo, Brazil).    Os pacientes foram estimulados a desenvolverem 
suas atividades normais durante    o per&iacute;odo de grava&ccedil;&atilde;o. A
s grava&ccedil;&otilde;es foram    analisadas no sistema <i>Burdick/DMI Hospital
 Holter System</i> (Spacelabs Burdick,    Deerfield, WI, USA) por uma t&eacute;c
nica semiautom&aacute;tica, com frequ&ecirc;ncia    de amostragem de 200Hz. Os t
ra&ccedil;ados foram revistos por especialista experiente    (ALPR), que realizo
u a codifica&ccedil;&atilde;o dos batimentos ect&oacute;picos    e a exclus&atil
de;o de artefatos, gerando relat&oacute;rio consubstanciado.    Foram avaliadas,
 especificamente neste estudo, as frequ&ecirc;ncias card&iacute;acas    m&eacute
;dia, m&iacute;nima e m&aacute;xima, o n&uacute;mero de extra-s&iacute;stoles   
 totais, n&uacute;mero de pares e n&uacute;mero de epis&oacute;dios de taquicard
ia    ventricular n&atilde;o sustentada.</font></p>     ^cY#aop16-11.htm##
01516000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704127000087002001301357#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#38#34#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os dados cl&iacute;nicos 
   e gerados pelos procedimentos foram analisados utilizando o pacote estat&iacu
te;stico    SPSS vers&atilde;o 16 para ambiente <i>Windows</i>. Inicialmente, fo
i realizada    a estat&iacute;stica descritiva das vari&aacute;veis escolhidas, 
obtendo-se    a distribui&ccedil;&atilde;o de frequ&ecirc;ncia absoluta e relati
va das vari&aacute;veis    qualitativas e a m&eacute;dia e desvio padr&atilde;o 
ou mediana e intervalo    interquartil das vari&aacute;veis quantitativas cont&i
acute;nuas, dependendo    da distribui&ccedil;&atilde;o, se normal ou n&atilde;o
. A seguir, comparam-se    as propor&ccedil;&otilde;es, m&eacute;dias e medianas
 das vari&aacute;veis independentes    e dependentes dos grupos, atrav&eacute;s 
de testes estat&iacute;sticos apropriados,    como o qui-quadrado, para vari&aac
ute;veis qualitativas, e os testes <i>t</i>    de <i>Student</i> e Mann-Whitney,
 para vari&aacute;veis quantitativas, com distribui&ccedil;&atilde;o    normal o
u n&atilde;o-normal, respectivamente. Em todos os testes, utilizou-se    a proba
bilidade de signific&acirc;ncia p &lt; 0,05 como necess&aacute;rio para    rejei
&ccedil;&atilde;o da hip&oacute;tese nula.</font></p>     ^cY#aop16-11.htm##
00380000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013400087002001300221#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#39#35#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Considera&ccedil;&otil
de;es    &eacute;ticas</b></font></p>     ^cY#aop16-11.htm##
00656000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041000087002001300497#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#40#36#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Este estudo foi    aprova
do pelo Comit&ecirc; de &Eacute;tica em Pesquisa da UFMG, sendo consideradas    
as recomenda&ccedil;&otilde;es da Organiza&ccedil;&atilde;o Mundial de Sa&uacute
;de    e da Declara&ccedil;&atilde;o de Helsinque de 2000, no sentido de se salv
aguardarem    os direitos e o bem estar das pessoas estudadas.</font></p>     ^c
Y#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#41#37#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#42#38#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>RESULTADOS</b></font><
/p>     ^cY#aop16-11.htm##
01492000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704124600087002001301333#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#43#39#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os resultados dos    par&
acirc;metros gerais obtidos dos ecocardiogramas realizados nos dois grupos    es
t&atilde;o sumariados na <b><a href="#t1">Tabela 1</a></b>. Dentre estas vari&aa
cute;veis,    observa-se diferen&ccedil;a estatisticamente significativa rela&cc
edil;&atilde;o    &agrave; fra&ccedil;&atilde;o de eje&ccedil;&atilde;o (p <u>&l
t;</u> 0,001)    e dimens&atilde;o sist&oacute;lica do ventr&iacute;culo esquerd
o (p = 0,029).    Dentre os pacientes analisados, com a ecocardiografia, 28,7% a
presentaram altera&ccedil;&atilde;o    da contratilidade segmentar, com predomin
&acirc;ncia pelo acometimento do &aacute;pex    ventricular (76,1%), sendo encon
trado, nesta regi&atilde;o, aneurisma de pequena    dimens&atilde;o, em tr&ecirc
;s (6,5%) pacientes. A an&aacute;lise pelo Doppler    tecidual n&atilde;o demons
trou diferen&ccedil;a significativa em rela&ccedil;&atilde;o    &agrave;s veloci
dades sist&oacute;lica e diast&oacute;lica, com diferen&ccedil;a    estatisticam
ente significativa, em rela&ccedil;&atilde;o ao TCIV avaliado nos    segmentos b
asais, de todas as paredes, excetuando-se a parede lateral <b>(<a href="#t2">Tab
ela    2</a>)</b>.</font></p>     ^cY#aop16-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#44#40#article#107#<p align
="center"><a name="t1"></a></p>     ^cY#aop16-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#45#41#article#107#<p align
="center">&nbsp;</p>     ^cY#aop16-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#46#42#article#107#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/16t01.jpg"></p>     ^cY#aop16
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#47#43#article#107#<p align
="center">&nbsp;</p>     ^cY#aop16-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#48#44#article#107#<p align
="center"><a name="t2"></a></p>     ^cY#aop16-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#49#45#article#107#<p align
="center">&nbsp;</p>     ^cY#aop16-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#50#46#article#107#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/16t02.jpg"></p>     ^cY#aop16
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#51#47#article#107#<p align
="center">&nbsp;</p>     ^cY#aop16-11.htm##
00673000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042700087002001300514#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#52#48#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A <b><a href="#t3">Tabela
    3</a></b> demonstra dados relacionados com o Holter entre os dois grupos. En
tre    as vari&aacute;veis estudadas, foi observado um maior n&uacute;mero de ex
trassistolia    ventricular isolada e pareada, denotando um maior dist&uacute;rb
io el&eacute;trico    em pacientes chag&aacute;sicos com dissinergia segmentar.<
/font></p>     ^cY#aop16-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#53#49#article#107#<p align
="center"><a name="t3"></a></p>     ^cY#aop16-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#54#50#article#107#<p align
="center">&nbsp;</p>     ^cY#aop16-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#55#51#article#107#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/16t03.jpg"></p>     ^cY#aop16
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#56#52#article#107#<p align
="center">&nbsp;</p>     ^cY#aop16-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010600087002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#57#53#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>DISCUSS&Atilde;O</b></
font></p>     ^cY#aop16-11.htm##
01962000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704171600087002001301803#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#58#54#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A doen&ccedil;a    de Cha
gas &eacute; causada pelo protozo&aacute;rio <i>Trypanosoma cruzi</i>    e repre
senta uma das principais causas de morte em diversos pa&iacute;ses da    Am&eacu
te;rica Latina<sup>1</sup>. O cora&ccedil;&atilde;o &eacute; o &oacute;rg&atilde
;o    mais frequente e severamente acometido, podendo determinar a morte por arr
itmia,    insufici&ecirc;ncia card&iacute;aca ou por fen&ocirc;menos tromboemb&o
acute;licos.    Cerca de 50% dos pacientes infectados encontram-se na forma cr&o
circ;nica indeterminada    e embora a caracter&iacute;stica principal destes pac
ientes seja a aus&ecirc;ncia    de anormalidades cl&iacute;nicas, eletrocardiogr
&aacute;ficas e radiol&oacute;gicas    significativas, tem-se observado altera&c
cedil;&otilde;es morfofuncionais card&iacute;acas    quando se utilizam m&eacute
;todos complementares mais sofisticados. Embora v&aacute;rios    estudos longitu
dinais tenham demonstrado o bom progn&oacute;stico dos pacientes    na forma ind
eterminada, cerca de 2 a 5% destes evoluem anualmente para uma das    outras for
mas cr&ocirc;nicas sendo que, dentro de cinco a 10 anos, 30% destes    pacientes
 evoluem para cardiopatia cr&ocirc;nica<sup>2</sup>. Al&eacute;m disso,    tem-s
e relatado a presen&ccedil;a de morte s&uacute;bita em chag&aacute;sicos    como
 a primeira manifesta&ccedil;&atilde;o cl&iacute;nica da doen&ccedil;a<sup>4,5</
sup>.    Sternick cols demonstraram recentemente a possibilidade da ocorr&ecirc;
ncia    de morte s&uacute;bita em chag&aacute;sicos com eletrocardiograma normal
 e fra&ccedil;&atilde;o    de eje&ccedil;&atilde;o normal ao ecocardiograma<sup>
6</sup>.</font></p>     ^cY#aop16-11.htm##
01616000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704137000087002001301457#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#59#55#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">No grupo que apresentou  
  anormalidades contr&aacute;teis segmentares, observou-se sinais de comprometim
ento    ventricular global, como foi demonstrado pela maior dimens&atilde;o sist
&oacute;lica    ventricular e menor fra&ccedil;&atilde;o de eje&ccedil;&atilde;o
 quando comparados    aos pacientes com contratilidade normal. Viotti cols, em u
m estudo envolvendo    849 pacientes com cardiopatia chag&aacute;sica cr&ocirc;n
ica, e acompanhados    por cerca de 9,9 anos, demonstraram que piora cl&iacute;n
ica, dimens&atilde;o    sist&oacute;lica ventricular esquerda e fra&ccedil;&atil
de;o de eje&ccedil;&atilde;o    foram os &uacute;nicos preditores de mortalidade
<sup>7</sup>. Pacientes classificados    na FIDC, mas apresentando altera&ccedil
;&atilde;o contr&aacute;til segmentar    ao ecocardigrama, apresentam sinais de 
diminui&ccedil;&atilde;o global da contratilidade    ventricular esquerda. Al&ea
cute;m disso, independente da classifica&ccedil;&atilde;o    cl&iacute;nica, pac
ientes com altera&ccedil;&atilde;o contr&aacute;til ao ecocardiograma    demonst
ram sinais de depress&atilde;o maior da contratilidade mioc&aacute;rdica,    qua
ndo comparados com pacientes que apresentam apenas dist&uacute;rbios isolados   
 da condu&ccedil;&atilde;o el&eacute;trica ao ECG<sup>8</sup>.</font></p>     ^c
Y#aop16-11.htm##
01416000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704117000087002001301257#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#60#56#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Pazin-Filho cols    avali
aram o valor progn&oacute;stico de anormalidades contr&aacute;teis segmentares  
  em 59 pacientes com diferentes formas cl&iacute;nicas da doen&ccedil;a de Chag
as,    demonstrando a ocorr&ecirc;ncia de deterioriza&ccedil;&atilde;o da fun&cc
edil;&atilde;o    card&iacute;aca global em 71,4% dos pacientes com dissinergia 
segmentar em compara&ccedil;&atilde;o    com 22,2% (p &lt; 0,005) naqueles pacie
ntes com fun&ccedil;&atilde;o contr&aacute;til    segmentar normal<sup>9</sup>. 
Rassi cols demonstraram, ap&oacute;s an&aacute;lise    multivariada, a relev&aci
rc;ncia progn&oacute;stica dos achados de anormalidade    contr&aacute;til segme
ntar ou global pela ecocardiografia, como preditores de    risco de morte por ca
usas cardiovasculares e morte s&uacute;bita (<i>hazard    ratio</i> de 2,46; p =
 0,008). Embora os autores n&atilde;o tenham feito men&ccedil;&atilde;o    da FI
DC, os dados refletem a import&acirc;ncia progn&oacute;stica da identifica&ccedi
l;&atilde;o    de anormalidade contr&aacute;til segmentar em pacientes chag&aacu
te;sicos<sup>10</sup>.</font></p>     ^cY#aop16-11.htm##
00832000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058600087002001300673#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#61#57#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">O Doppler tecidual    dem
onstrou um comprometimento da contratilidade longitudinal em quase todas    as p
aredes avaliadas, mesmo quando o ecocardiograma mostrasse uma predomin&acirc;nci
a    de envolvimento apical, denotando um maior dano mioc&aacute;rdico neste gru
po    de pacientes. Estudos pr&eacute;vios publicados pelo nosso grupo t&ecirc;m
 demonstrado    a superioridade desta t&eacute;cnica no diagn&oacute;stico de an
ormalidades    funcionais precoces na doen&ccedil;a de Chagas<sup>11-13</sup>.</
font></p>     ^cY#aop16-11.htm##
01093000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704084700087002001300934#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#62#58#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A arritmia ventricular   
 representa um aspecto predominante na doen&ccedil;a de Chagas. A exist&ecirc;nc
ia    de arritmia ventricular na FIDC tem sido extensivamente demonstrada, suger
indo-se    que sua presen&ccedil;a esteja relacionada a pior progn&oacute;stico<
sup>2,5,6</sup>.    O presente estudo demonstrou a exist&ecirc;ncia de associa&c
cedil;&atilde;o    entre anormalidade contr&aacute;til e arritmia ventricular na
 FIDC, indicando    que estes pacientes possam representar subgrupo com maior en
volvimento card&iacute;aco,    e sendo a presen&ccedil;a de anormalidade contr&a
acute;til segmentar um substrato    anat&ocirc;mico para o surgimento de um foco
 arr&iacute;tmico, mesmo em um cora&ccedil;&atilde;o    com fun&ccedil;&atilde;o
 global preservada.</font></p>     ^cY#aop16-11.htm##
01716000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704147000087002001301557#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#63#59#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Nossos dados est&atilde;o
    em concord&acirc;ncia com os relatados por Pedrosa cols, que estudaram 71 pa
cientes    divididos em quatro grupos de acordo com o comprometimento mioc&aacut
e;rdico,    sendo que o grupo IA representava pacientes com ECG e ecocardiograma
 normais;    o grupo IB continha pacientes com ECG normal e altera&ccedil;&otild
e;es contr&aacute;teis    ao ecocardiograma; o grupo II com ECG e Eco anormais e
 grupo III com ECG e ECO    anormais e sinais de insufici&ecirc;ncia card&iacute
;aca. O Holter demonstrou    que cerca de 56% dos pacientes do grupo IA n&atilde
;o apresentaram arritmias    ventriculares. No grupo IB, 37,5% n&atilde;o aprese
ntaram arritmias ventriculares    e 25% apresentaram arritmias ventriculares pol
im&oacute;rficas frequentes ao    Holter. Em rela&ccedil;&atilde;o a pares de ex
trass&iacute;stoles ventriculares    (EV), tamb&eacute;m se observou aumento de 
sua incid&ecirc;ncia com a piora    do grau de les&atilde;o mioc&aacute;rdica. N
enhum paciente do grupo IA apresentou    pares de EV ao Holter, sendo que a inci
d&ecirc;ncia dessa arritmia no grupo    IB foi de 12,5%, demonstrando o aumento 
da incid&ecirc;ncia de arritmia ventricular    quando se avan&ccedil;a o grau de
 comprometimento mioc&aacute;rdico. Presen&ccedil;a    de taquicardia ventricula
r n&atilde;o sustentada foi encontrada apenas nos grupos    II e III<sup>14</sup
>.</font></p>     ^cY#aop16-11.htm##
01720000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704147400087002001301561#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#64#60#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Concluindo, pacientes    
chag&aacute;sicos na forma indeterminada, que apresentam dist&uacute;rbio contr&
aacute;til    segmentar &agrave; ecocardiografia, podem apresentar frequ&ecirc;n
cia maior    de arritmia ventricular ao Holter, denotando sinais de um maior com
prometimento    mioc&aacute;rdico e el&eacute;trico do cora&ccedil;&atilde;o. A 
despeito da    heterogeneidade do desempenho card&iacute;aco de pacientes chag&a
acute;sicos    com a forma indeterminada, quando avaliados por m&eacute;todos pr
oped&ecirc;uticos    mais sens&iacute;veis, o conceito desta forma continua v&aa
cute;lido e &uacute;til    pelo menos em termos coletivos e epidemiol&oacute;gic
os. Contudo, pacientes    na forma indeterminada podem apresentar altera&ccedil;
&otilde;es morfol&oacute;gicas    e funcionais com potencial significado progn&o
acute;stico, sugerindo que apresentem    comportamento diferenciado em rela&cced
il;&atilde;o &agrave;queles pacientes    que n&atilde;o apresentaram qualquer al
tera&ccedil;&atilde;o morfofuncional    card&iacute;aca, mesmo quando submetidos
 &agrave; extensa avalia&ccedil;&atilde;o.    O significado progn&oacute;stico e
 as implica&ccedil;&otilde;es terap&ecirc;uticas    da exist&ecirc;ncia dessas a
ltera&ccedil;&otilde;es morfol&oacute;gicas e funcionais,    na forma indetermin
ada da doen&ccedil;a de Chagas, devem ser melhor avaliados    em estudos prospec
tivos.</font></p>     ^cY#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#65#61#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011400087002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#66#62#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>CONFLITO DE    INTERES
SE</b></font></p>     ^cY#aop16-11.htm##
00438000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019200087002001300279#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#67#63#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os autores declaram    n&
atilde;o haver nenhum tipo de conflito de interesse no desenvolvimento do    est
udo.</font></p>     ^cY#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#68#64#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00354000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010800087002001300195#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#69#65#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>SUPORTE FINANCEIRO</b>
</font></p>     ^cY#aop16-11.htm##
00415000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704016900087002001300256#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#70#66#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Conselho Nacional    de D
esenvolvimento Cient&iacute;fico e Tecnol&oacute;gico (CNPq).</font></p>     ^cY
#aop16-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#71#67#article#107#<p>&nbsp
;</p>     ^cY#aop16-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#72#68#article#107#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>REFER&Ecirc;NCIAS</b><
/font></p>     ^cY#aop16-11.htm##
00567000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030700089002001300396#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#73#69#article#
107#1#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Schmunis
 GA.    American Trypanosomiasis as a public health problem. <i>In:</i> Pan Amer
ican    Health Organization, editor. Chagas' disease and the nervous system. Was
hington    (DC): Pan American Health Organization; 1994. p. 3-29.    ^cY#aop16-1
1.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#74#70#article#107#</font><
/p>     ^cY#aop16-11.htm##
00536000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704027600089002001300365#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#75#71#article#
107#2#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Ribeiro 
ALP,    Rocha MOC. Forma indeterminada da doen&ccedil;a de Chagas: considera&cce
dil;&otilde;es    acerca do diagn&oacute;stico e do progn&oacute;stico. Rev Soc 
Bras Med Trop    1998; 31:301-314.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#76#72#article#107#</font><
/p>     ^cY#aop16-11.htm##
00585000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704032500089002001300414#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#77#73#article#
107#3#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Ortiz J,
 Barreto    AC, Matsumoto AY, Monaco CA, Ianni B, Marotta RH, et al. Altera&cced
il;&atilde;o    contr&aacute;til segmentar na forma indeterminada da doen&ccedil
;a de Chagas.    Estudo ecocardiogr&aacute;fico. Arq Bras Cardiol 1987; 49:217-2
20.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#78#74#article#107#</font><
/p>     ^cY#aop16-11.htm##
00538000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704027800089002001300367#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#79#75#article#
107#4#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Bestetti
 RB,    Freitas OC, Muccillo G, Oliveira JS. Clinical and morphological characte
ristics    associated with sudden cardiac death in patients with Chagas' disease
. Eur Heart    J 1993; 14:1610-1614.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#80#76#article#107#</font><
/p>     ^cY#aop16-11.htm##
00501000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024100089002001300330#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#81#77#article#
107#5#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Barreto 
AC,    Belloti G, Sosa E, Grupi C, Mady C, Ianni BM, et al. Arritmias e a forma 
indeterminada    da doen&ccedil;a de Chagas. Arq Bras Cardiol 1986; 47:197-199. 
   ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#82#78#article#107#</font><
/p>     ^cY#aop16-11.htm##
00578000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704031800089002001300407#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#83#79#article#
107#6#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Sternick
 EB,    Martinelli M, Sampaio RC, Gerken LM, Teixeira RA, Scarpelli R, et al. Su
dden    Cardiac Death in Patients with Chagas Heart Disease and Preserved Left V
entricular    Function<i>.</i> J Cardiovasc Electrophysiol 2006; 17:113-116.    
^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#84#80#article#107#</font><
/p>     ^cY#aop16-11.htm##
00558000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029800089002001300387#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#85#81#article#
107#7#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Viotti R
J, Vigliano    C, Laucella S, Lococo B, Petti M, Bertocchi G, et al. Value of ec
hocardiography    for diagnosis and prognosis of chronic Chagas disease cardiomy
opathy without    heart failure. Heart 2004; 90:655-660.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#86#82#article#107#</font><
/p>     ^cY#aop16-11.htm##
00581000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704032100089002001300410#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#87#83#article#
107#8#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Almeida-
Filho    OC, Maciel BC, Schmidt A, Pazin-Filho A, Marin-Neto JA. Minor segmental
 dyssynergy    reflects extensive myocardial damage and global left ventricle dy
sfunction in    chronic Chagas disease. J Am Soc Echocardiogr 2002; 15:610-616. 
   ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#88#84#article#107#</font><
/p>     ^cY#aop16-11.htm##
00587000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704032700089002001300416#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#89#85#article#
107#9#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Pazin-Fi
lho    A, Romano MM, Almeida-Filho OC, Furuta MS, Viviani LF, Schmidt A, et al. 
Minor    segmental wall motion abnormalities detected in patients with Chagas' d
isease    have adverse prognostic implications. Braz J Med Biol Res 2006; 39:483
-487.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#90#86#article#107#</font><
/p>     ^cY#aop16-11.htm##
00536000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704027500090002001300365#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#91#87#article#
107#10#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Rassi 
Jr A,    Rassi A, Little WC, Xavier SC, Rassi SG, Rassi AG, et al. Development a
nd validation    of a risk score for predicting death in Chagas' heart disease. 
N Engl J Med    2006; 355:799-808.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#92#88#article#107#</font><
/p>     ^cY#aop16-11.htm##
00564000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704030300090002001300393#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#93#89#article#
107#11#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Barros
 MV,    Rocha MO, Ribeiro AL, Machado FS. Doppler tissue imaging to evaluate ear
ly myocardium    damage in patients with undetermined form of Chagas' disease an
d normal echocardiogram.    Echocardiography 2001; 18:131-136.    ^cY#aop16-11.h
tm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#94#90#article#107#</font><
/p>     ^cY#aop16-11.htm##
00490000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704022900090002001300319#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#95#91#article#
107#12#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Barros
 MV,    Ribeiro AL, Machado FS, Rocha MO. Doppler tissue imaging to assess systo
lic    function in Chagas' disease. Arq Bras Cardiol 2003; 80:36-35.    ^cY#aop1
6-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#96#92#article#107#</font><
/p>     ^cY#aop16-11.htm##
00534000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704027300090002001300363#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#97#93#article#
107#13#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Barros
 MV,    Machado FS, Ribeiro AL, Costa-Rocha MO. Detection of early right ventric
ular    dysfunction in Chagas disease using Doppler tissue imaging. J Am Soc Ech
ocardiogr    2002; 15:1197-1201.    ^cY#aop16-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#98#94#article#107#</font><
/p>     ^cY#aop16-11.htm##
00595000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704033400090002001300424#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#99#95#article#
107#14#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Pedros
a RC,    Campos MC. Teste ergom&eacute;trico e o Holter de 24 horas na detec&cce
dil;&atilde;o    de arritmias ventriculares complexas em diferentes est&aacute;d
ios da cardiopatia    chag&aacute;sica cr&ocirc;nica. Rev Soc Bras Med Trop 2004
; 37:376-383.    ^cY#aop16-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#100#96#article#107#</font>
</p>     ^cY#aop16-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002200088002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#101#97#article#107#<p>&nbs
p;</p>     ^cY#aop16-11.htm##
00269000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002200088002001300110#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#102#98#article#107#<p>&nbs
p;</p>     ^cY#aop16-11.htm##
00468000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704022100088002001300309#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#103#99#article#107#<p><fon
t face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><a
 href="#top"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a> 
   Endere&ccedil;o para correspond&ecirc;ncia:    ^cY#aop16-11.htm##
00312000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704006400089002001300153#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#104#100#article#107#<br>  
 </b>Dr. M&aacute;rcio Vin&iacute;cius Lins Barros    ^cY#aop16-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#105#101#article#107#<br>  
 HC/UFMG    ^cY#aop16-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005700089002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#106#102#article#107#<br>  
 Rua Carangola 57/1201, Santo Ant&ocirc;nio    ^cY#aop16-11.htm##
00292000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004400089002001300133#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#107#103#article#107#<br>  
 30330-240, Belo Horizonte, MG    ^cY#aop16-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003500089002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#108#104#article#107#<br>  
 Tel: 55 31 3292-2207    ^cY#aop16-11.htm##
00355000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010700089002001300196#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#109#105#article#107#<br>  
 e-mail: <a href="mailto:marciovlbarros@uol.com.br">marciovlbarros@uol.com.br</a
></font></p>     ^cY#aop16-11.htm##
00375000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704012700089002001300216#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#110#106#article#107#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">Recebido para publica&c
cedil;&atilde;o    em 26/12/2009.    ^cY#aop16-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#p#111#107#article#107#<br>  
 Aceito em 26/11/2010</font></p>     ^cY#aop16-11.htm##
00594000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880120056001070170
03300163018004300196066001500239062003300254065000900287064000500296014000500301
865000900306002001300315#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
16-11.htm#S#c#112#1#article#14#1#^rND^sSchmunis^nGA#American Trypanosomiasis as 
a public health problem^len#Pan American Health Organization#Chagas' disease and
 the nervous system^len#Washington^eDC#Pan American Health Organization#19940000
#1994#3-29#20110000#aop16-11.htm##
00601000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100017001070120
09800124030002200222065000900244064000500253031000300258014000800261865000900269
002001300278035001000291801002200301#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop16-11.htm#S#c#113#2#article#14#2#^rND^sRibeiro^nALP#^rND^sRocha^nMOC
#Forma indeterminada da doença de Chagas: considerações acerca do diagnóstico e 
do prognóstico^lpt#Rev Soc Bras Med Trop#19980000#1998#31#301-314#20110000#aop16
-11.htm#0037-8682#Rev Soc Bras Med Trop##
00728000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100018001030100
02000121010001700141010001500158010001800173810000600191012010200197030001700299
06500090031606400050032503100030033001400080033386500090034100200130035003500100
0363801001700373#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.ht
m#S#c#114#3#article#14#3#^rND^sOrtiz^nJ#^rND^sBarreto^nAC#^rND^sMatsumoto^nAY#^r
ND^sMonaco^nCA#^rND^sIanni^nB#^rND^sMarotta^nRH#et al#Alteração contrátil segmen
tar na forma indeterminada da doença de Chagas: Estudo ecocardiográfico^lpt#Arq 
Bras Cardiol#19870000#1987#49#217-220#20110000#aop16-11.htm#0066-782X#Arq Bras C
ardiol##
00664000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100018001070100
01800125010001900143012011700162030001200279065000900291064000500300031000300305
014001000308865000900318002001300327035001000340801001200350#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#c#115#4#article#14#4#^rND^sBeste
tti^nRB#^rND^sFreitas^nOC#^rND^sMuccillo^nG#^rND^sOliveira^nJS#Clinical and morp
hological characteristics associated with sudden cardiac death in patients with 
Chagas' disease^len#Eur Heart J#19930000#1993#14#1610-1614#20110000#aop16-11.htm
#0195-668X#Eur Heart J##
00675000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100017001060100
01400123010001500137010001400152010001600166810000600182012005800188030001700246
06500090026306400050027203100030027701400080028086500090028800200130029703500100
0310801001700320#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.ht
m#S#c#116#5#article#14#5#^rND^sBarreto^nAC#^rND^sBelloti^nG#^rND^sSosa^nE#^rND^s
Grupi^nC#^rND^sMady^nC#^rND^sIanni^nBM#et al#Arritmias e a forma indeterminada d
a doença de Chagas^lpt#Arq Bras Cardiol#19860000#1986#47#197-199#20110000#aop16-
11.htm#0066-782X#Arq Bras Cardiol##
00760000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100020001070100
01800127010001700145010001900162010001900181810000600200012010300206030002800309
06500090033706400050034603100030035101400080035486500090036200200130037103500100
0384801002800394#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.ht
m#S#c#117#6#article#14#6#^rND^sSternick^nEB#^rND^sMartinelli^nM#^rND^sSampaio^nR
C#^rND^sGerken^nLM#^rND^sTeixeira^nRA#^rND^sScarpelli^nR#et al#Sudden Cardiac De
ath in Patients with Chagas Heart Disease and Preserved Left Ventricular Functio
n^len#J Cardiovasc Electrophysiol#20060000#2006#17#113-116#20110000#aop16-11.htm
#1045-3873#J Cardiovasc Electrophysiol##
00725000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100018001050100
01800123010001600141010001500157010001900172810000600191012012100197030000600318
06500090032406400050033303100030033801400080034186500090034900200130035803500100
0371801000600381#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.ht
m#S#c#118#7#article#14#7#^rND^sViotti^nRJ#^rND^sVigliano^nC#^rND^sLaucella^nS#^r
ND^sLococo^nB#^rND^sPetti^nM#^rND^sBertocchi^nG#et al#Value of echocardiography 
for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without hea
rt failure^len#Heart#20040000#2004#90#655-660#20110000#aop16-11.htm#1355-6037#He
art##
00735000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100024000880100017001120100
01700129010002100146010002100167012013200188030002200320065000900342064000500351
031000300356014000800359865000900367002001300376035001000389801002200399#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#c#119#8#article#14#8
#^rND^sAlmeida-Filho^nOC#^rND^sMaciel^nBC#^rND^sSchmidt^nA#^rND^sPazin-Filho^nA#
^rND^sMarin-Neto^nJA#Minor segmental dyssynergy reflects extensive myocardial da
mage and global left ventricle dysfunction in chronic Chagas disease^len#J Am So
c Echocardiogr#20020000#2002#15#610-616#20110000#aop16-11.htm#0894-7317#J Am Soc
 Echocardiogr##
00768000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100017001090100
02400126010001700150010001800167010001700185810000600202012012500208030002000333
06500090035306400050036203100030036701400080037086500090037800200130038703500100
0400801002000410#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.ht
m#S#c#120#9#article#14#9#^rND^sPazin-Filho^nA#^rND^sRomano^nMM#^rND^sAlmeida-Fil
ho^nOC#^rND^sFuruta^nMS#^rND^sViviani^nLF#^rND^sSchmidt^nA#et al#Minor segmental
 wall motion abnormalities detected in patients with Chagas' disease have advers
e prognostic implications^len#Braz J Med Biol Res#20060000#2006#39#483-487#20110
000#aop16-11.htm#0100-879X#Braz J Med Biol Res##
00710000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100015001080100
01700123010001700140010001600157010001600173810000600189012009300195030001300288
06500090030106400050031003100040031501400080031986500090032700200130033603500100
0349801001300359#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop16-11.ht
m#S#c#121#10#article#14#10#^rND^sRassi Jr^nA#^rND^sRassi^nA#^rND^sLittle^nWC#^rN
D^sXavier^nSC#^rND^sRassi^nSG#^rND^sRassi^nAG#et al#Development and validation o
f a risk score for predicting death in Chagas' heart disease^len#N Engl J Med#20
060000#2006#355#799-808#20110000#aop16-11.htm#0028-4793#N Engl J Med##
00695000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01800123010001800141012014300159030001700302065000900319064000500328031000300333
014000800336865000900344002001300353035001000366801001700376#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#c#122#11#article#14#11#^rND^sBar
ros^nMV#^rND^sRocha^nMO#^rND^sRibeiro^nAL#^rND^sMachado^nFS#Doppler tissue imagi
ng to evaluate early myocardium damage in patients with undetermined form of Cha
gas' disease and normal echocardiogram^len#Echocardiography#20010000#2001#18#131
-136#20110000#aop16-11.htm#0263-5453#ECHOCARDIOGRAPHY##
00624000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01800125010001600143012007400159030001700233065000900250064000500259031000300264
014000600267865000900273002001300282035001000295801001700305#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#c#123#12#article#14#12#^rND^sBar
ros^nMV#^rND^sRibeiro^nAL#^rND^sMachado^nFS#^rND^sRocha^nMO#Doppler tissue imagi
ng to assess systolic function in Chagas' disease^len#Arq Bras Cardiol#20030000#
2003#80#36-35#20110000#aop16-11.htm#0066-782X#Arq Bras Cardiol##
00670000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01800125010002200143012010000165030002200265065000900287064000500296031000300301
014001000304865000900314002001300323035001000336801002200346#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop16-11.htm#S#c#124#13#article#14#13#^rND^sBar
ros^nMV#^rND^sMachado^nFS#^rND^sRibeiro^nAL#^rND^sCosta-Rocha^nMO#Detection of e
arly right ventricular dysfunction in Chagas disease using Doppler tissue imagin
g^len#J Am Soc Echocardiogr#20020000#2002#15#1197-1201#20110000#aop16-11.htm#089
4-7317#J Am Soc Echocardiogr##
00654000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080120
15000125030002200275065000900297064000500306031000300311014000800314865000900322
002001300331035001000344801002200354#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop16-11.htm#S#c#125#14#article#14#14#^rND^sPedrosa^nRC#^rND^sCampos^nM
C#Teste ergométrico e o Holter de 24 horas na detecção de arritmias ventriculare
s complexas em diferentes estádios da cardiopatia chagásica crônica^lpt#Rev Soc 
Bras Med Trop#20040000#2004#37#376-383#20110000#aop16-11.htm#0037-8682#Rev Soc B
ras Med Trop##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#o#1#
1#article#1#20110411#104901#aop17-11.htm#151##
04843000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400070016103500100016822300090017801201710
01870120164003580100036005220100049005580100037006070100032006440100030006760100
05200706010003200758010003700790070011800827070015600945070010901101070011001210
07001260132008312160144608500080266208500190267008500230268908500230271208500340
27350831272027690850008040410850018040490850023040670850024040900850033041141170
00604147072000304153002001304156#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop17-11.htm#S#h#2#1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#18#nd#nd#Rev. Soc
. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#First report of rabi
es infection in bats, Molossus molossus, Molossops neglectus and Myotis riparius
 in the city of São Paulo, State of São Paulo, southeastern Brazil^len#Primeiro 
relato de infecção de vírus da raiva em morcegos, Molossus molossus, Molossops n
eglectus e Myotis riparius na cidade de São Paulo, Estado de São Paulo^lpt#^rND^
1A01^nAdriana Ruckert da^sRosa#^rND^1A02^nAna Paula de Arruda Geraldes^sKataoka#
^rND^1A03^nSilvana Regina^sFavoretto#^rND^1A01^nMiriam Martos^sSodré#^rND^1A02^n
José Trezza^sNetto#^rND^1A04 A05^nAngélica Cristine de Almeida^sCampos#^rND^1A05
^nEdison Luiz^sDurigon#^rND^nLuzia Fátima Alves^sMartorelli#Prefeitura Municipal
 da Cidade de São Paulo^iA01^1Centro de Controle de Zoonoses^2Setor de Quirópter
os^cSão Paulo^sSP#Prefeitura Municipal da Cidade de São Paulo^iA02^1Centro de Co
ntrole de Zoonoses^2Laboratório de Zoonoses e Doenças Transmitidas por Vetores^c
São Paulo^sSP#Secretaria Estadual da Saúde^iA03^1Instituto Pasteur de São Paulo^
2Laboratório de Diagnóstico^cSão Paulo^sSP#Universidade de São Paulo^iA04^1Insti
tuto de Ciências Biomédicas^2Núcleo de Pesquisas em Raiva^cSão Paulo^sSP#Univers
idade de São Paulo^iA05^1Instituto de Ciências Biomédicas^2Laboratório de Virolo
gia Clínica e Molecular^cSão Paulo^sSP#^len^aINTRODUCTION: This paper presents t
he first report of rabies in three bat species, Molossus molossus, Molossops neg
lectus and Myotis riparius in the city of São Paulo, Brazil. METHODS: Bats were 
diagnosed as positive for rabies using the fluorescent antibody test and mouse i
noculation test. The isolates were characterized antigenically using a panel of 
eight monoclonal antibodies. The samples were also genetically analyzed by parti
al sequencing of the portion of nucleoprotein gene between positions 1157 and 14
45nt. RESULTS: Analysis of the results verified that the sample isolated from th
e species M. molossus presented antigenic variant 6, while the other two samples
 showed a different profile from that established in the panel, one not previous
ly reported in the literature. The results of genetic analysis revealed that the
 M. molossus sample segregated with Lasiurus sp. isolates, M. neglectus segregat
ed with a subgroup of Eptesicus furinalis isolates and the Myotis riparius sampl
e segregated with Myotis sp. isolates. CONCLUSIONS: The cases reported in this p
aper emphasize the need for clarification of the circumstances in which cases of
 rabies in wildlife occur, principally in urban areas.#^dnd^i1#^tm^len^kRabies^i
1#^tm^len^kChiroptera^i1#^tm^len^kUrban area^i1#^tm^len^kPhylogenetic analysis^i
1#^lpt^aINTRODUÇÃO: Esse trabalho apresenta o primeiro registro de raiva em três
 espécies de morcegos: Molossus molossus, Molossops neglectus e Myotis riparius 
na Cidade de São Paulo, Brasil. MÉTODOS: Os morcegos foram diagnosticados como p
ositivos para raiva usando as técnicas padrão de imunofluorescência direta e o t
este de inoculação em camundongo. Os isolados foram caracterizados antigenicamen
te usando um painel de oito anticorpos monoclonais (CDC/Atlanta/USA). As amostra
s também foram analisadas geneticamente por sequenciamento parcial do gene da nu
cleoproteína entre as posições 1157 e 1445nt. RESULTADOS: O resultado das anális
es mostrou que as amostras isoladas da espécie M. molossus apresentou variante a
ntigênica 6, enquanto as outras duas amostras mostraram um perfil diferente daqu
ele estabelecido no painel e ainda não registrado em literatura. Os resultados d
a analise genética revelaram que a amostra de M. molossus segrega com isolados d
e Lasiurus sp., M. neglectus segrega com o isolado do subgrupo de Eptesicus furi
nalis e uma amostra de M. riparius segrega com isolados de Myotis sp. CONCLUSÕES
: Os casos relatados neste estudo enfatizam a necessidade do esclarecimento da o
corrência de casos de raiva em morcegos, principalmente em áreas urbanas.#^dnd^i
2#^tm^lpt^kRaiva^i2#^tm^lpt^kChiroptera^i2#^tm^lpt^kÁrea urbana^i2#^tm^lpt^kAnál
ise filogenética^i2#other#19#aop17-11.htm##
05102000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000500101038000400106121000300110049000300113158000300116
03000270011903200060014606500090015201400070016103500100016822300090017801201990
01870120192003860100036005780100049006140100037006630100032007000100030007320100
05200762010003200814010003700846070011800883070015601001070010901157070011001266
07001260137608313210150208500080282308500190283108500230285008500230287308500340
28960831370029300850008043000850018043080850023043260850024043490850033043731170
00604406072000304412002001304415#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop17-11.htm#S#f#3#1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#18#nd#nd#Rev. Soc
. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#<b>First report of r
abies infection in bats, <i>Molossus molossus</i>, <i>Molossops neglectus</i> an
d <i>Myotis riparius</i> in the city of São Paulo, State of São Paulo, southeast
ern Brazil</b>^len#<b>Primeiro relato de infecção de vírus da raiva em morcegos,
 <i>Molossus molossus</i>, <i>Molossops neglectus</i> e <i>Myotis riparius</i> n
a cidade de São Paulo, Estado de São Paulo</b>^lpt#^rND^1A01^nAdriana Ruckert da
^sRosa#^rND^1A02^nAna Paula de Arruda Geraldes^sKataoka#^rND^1A03^nSilvana Regin
a^sFavoretto#^rND^1A01^nMiriam Martos^sSodré#^rND^1A02^nJosé Trezza^sNetto#^rND^
1A04 A05^nAngélica Cristine de Almeida^sCampos#^rND^1A05^nEdison Luiz^sDurigon#^
rND^nLuzia Fátima Alves^sMartorelli#Prefeitura Municipal da Cidade de São Paulo^
iA01^1Centro de Controle de Zoonoses^2Setor de Quirópteros^cSão Paulo^sSP#Prefei
tura Municipal da Cidade de São Paulo^iA02^1Centro de Controle de Zoonoses^2Labo
ratório de Zoonoses e Doenças Transmitidas por Vetores^cSão Paulo^sSP#Secretaria
 Estadual da Saúde^iA03^1Instituto Pasteur de São Paulo^2Laboratório de Diagnóst
ico^cSão Paulo^sSP#Universidade de São Paulo^iA04^1Instituto de Ciências Biomédi
cas^2Núcleo de Pesquisas em Raiva^cSão Paulo^sSP#Universidade de São Paulo^iA05^
1Instituto de Ciências Biomédicas^2Laboratório de Virologia Clínica e Molecular^
cSão Paulo^sSP#^len^a<b>INTRODUCTION:</b> This paper presents the first report o
f rabies in three bat species<b>,</b> <i>Molossus molossus</i>, <i>Molossops neg
lectus</i> and <i>Myotis riparius</i> in the city of São Paulo, Brazil. <b>METHO
DS: </b>Bats were diagnosed as positive for rabies using the fluorescent antibod
y test and mouse inoculation test. The isolates were characterized antigenically
 using a panel of eight monoclonal antibodies. The samples were also genetically
 analyzed by partial sequencing of the portion of nucleoprotein gene between pos
itions 1157 and 1445nt. <b>RESULTS: </b>Analysis of the results verified that th
e sample isolated from the species <i>M. molossus</i> presented antigenic varian
t 6, while the other two samples showed a different profile from that establishe
d in the panel, one not previously reported in the literature. The results of ge
netic analysis revealed that the <i>M. molossus</i> sample segregated with <i>La
siurus</i> sp. isolates, <i>M. neglectus</i> segregated with a subgroup of <i>Ep
tesicus furinalis</i> isolates and the <i>Myotis riparius</i> sample segregated 
with <i>Myotis</i> sp. isolates. <b>CONCLUSIONS: </b>The cases reported in this 
paper emphasize the need for clarification of the circumstances in which cases o
f rabies in wildlife occur, principally in urban areas.#^dnd^i1#^tm^len^kRabies^
i1#^tm^len^kChiroptera^i1#^tm^len^kUrban area^i1#^tm^len^kPhylogenetic analysis^
i1#^lpt^a<b>INTRODUÇÃO:</b> Esse trabalho apresenta o primeiro registro de raiva
 em três espécies de morcegos: <i>Molossus molossus</i>, <i>Molossops neglectus<
/i> e <i>Myotis riparius</i> na Cidade de São Paulo, Brasil. <b>MÉTODOS: </b>Os 
morcegos foram diagnosticados como positivos para raiva usando as técnicas padrã
o de imunofluorescência direta e o teste de inoculação em camundongo. Os isolado
s foram caracterizados antigenicamente usando um painel de oito anticorpos monoc
lonais (CDC/Atlanta/USA). As amostras também foram analisadas geneticamente por 
sequenciamento parcial do gene da nucleoproteína entre as posições 1157 e 1445nt
. <b>RESULTADOS: </b>O resultado das análises mostrou que as amostras isoladas d
a espécie <i>M. molossus</i> apresentou variante antigênica 6, enquanto as outra
s duas amostras mostraram um perfil diferente daquele estabelecido no painel e a
inda não registrado em literatura. Os resultados da analise genética revelaram q
ue a amostra de <i>M. molossus</i> segrega com isolados de <i>Lasiurus</i> sp., 
<i>M. neglectus</i> segrega com o isolado do subgrupo de <i>Eptesicus furinalis<
/i> e uma amostra de <i>M. riparius</i> segrega com isolados de <i>Myotis</i> sp
. <b>CONCLUSÕES: </b>Os casos relatados neste estudo enfatizam a necessidade do 
esclarecimento da ocorrência de casos de raiva em morcegos, principalmente em ár
eas urbanas.#^dnd^i2#^tm^lpt^kRaiva^i2#^tm^lpt^kChiroptera^i2#^tm^lpt^kÁrea urba
na^i2#^tm^lpt^kAnálise filogenética^i2#other#19#aop17-11.htm##
04972000000000697000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000500108038000400113121000300117049000300120
15800030012303000260012603200060015206500090015801400070016703500100017422300090
01840120171001930120164003640100036005280100049005640100037006130100032006500100
03000682010005200712010003200764010003700796070012000833070015800953070011101111
07001120122207001280133408312160146208500080267808500190268608500230270508500230
27280850034027510831272027850850008040570850018040650850023040830850024041060850
03304130117000604163072000304169002001304172008008904185#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop17-11.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1
#4.0#ilus#tab#18#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8682
#20110415#First report of rabies infection in bats, Molossus molossus, Molossops
 neglectus and Myotis riparius in the city of São Paulo, State of São Paulo, sou
theastern Brazil^len#Primeiro relato de infecção de vírus da raiva em morcegos, 
Molossus molossus, Molossops neglectus e Myotis riparius na cidade de São Paulo,
 Estado de São Paulo^lpt#^rND^1A01^nAdriana Ruckert da^sRosa#^rND^1A02^nAna Paul
a de Arruda Geraldes^sKataoka#^rND^1A03^nSilvana Regina^sFavoretto#^rND^1A01^nMi
riam Martos^sSodré#^rND^1A02^nJosé Trezza^sNetto#^rND^1A04 A05^nAngélica Cristin
e de Almeida^sCampos#^rND^1A05^nEdison Luiz^sDurigon#^rND^nLuzia Fátima Alves^sM
artorelli#^iA01^1Prefeitura Municipal da Cidade de São Paulo^2Centro de Controle
 de Zoonoses^3Setor de Quirópteros^cSão Paulo^sSP#^iA02^1Prefeitura Municipal da
 Cidade de São Paulo^2Centro de Controle de Zoonoses^3Laboratório de Zoonoses e 
Doenças Transmitidas por Vetores^cSão Paulo^sSP#^iA03^1Secretaria Estadual da Sa
úde^2Instituto Pasteur de São Paulo^3Laboratório de Diagnóstico^cSão Paulo^sSP#^
iA04^1Universidade de São Paulo^2Instituto de Ciências Biomédicas^3Núcleo de Pes
quisas em Raiva^cSão Paulo^sSP#^iA05^1Universidade de São Paulo^2Instituto de Ci
ências Biomédicas^3Laboratório de Virologia Clínica e Molecular^cSão Paulo^sSP#^
len^aINTRODUCTION: This paper presents the first report of rabies in three bat s
pecies, Molossus molossus, Molossops neglectus and Myotis riparius in the city o
f São Paulo, Brazil. METHODS: Bats were diagnosed as positive for rabies using t
he fluorescent antibody test and mouse inoculation test. The isolates were chara
cterized antigenically using a panel of eight monoclonal antibodies. The samples
 were also genetically analyzed by partial sequencing of the portion of nucleopr
otein gene between positions 1157 and 1445nt. RESULTS: Analysis of the results v
erified that the sample isolated from the species M. molossus presented antigeni
c variant 6, while the other two samples showed a different profile from that es
tablished in the panel, one not previously reported in the literature. The resul
ts of genetic analysis revealed that the M. molossus sample segregated with Lasi
urus sp. isolates, M. neglectus segregated with a subgroup of Eptesicus furinali
s isolates and the Myotis riparius sample segregated with Myotis sp. isolates. C
ONCLUSIONS: The cases reported in this paper emphasize the need for clarificatio
n of the circumstances in which cases of rabies in wildlife occur, principally i
n urban areas.#^dnd^i1#^tm^len^kRabies^i1#^tm^len^kChiroptera^i1#^tm^len^kUrban 
area^i1#^tm^len^kPhylogenetic analysis^i1#^lpt^aINTRODUÇÃO: Esse trabalho aprese
nta o primeiro registro de raiva em três espécies de morcegos: Molossus molossus
, Molossops neglectus e Myotis riparius na Cidade de São Paulo, Brasil. MÉTODOS:
 Os morcegos foram diagnosticados como positivos para raiva usando as técnicas p
adrão de imunofluorescência direta e o teste de inoculação em camundongo. Os iso
lados foram caracterizados antigenicamente usando um painel de oito anticorpos m
onoclonais (CDC/Atlanta/USA). As amostras também foram analisadas geneticamente 
por sequenciamento parcial do gene da nucleoproteína entre as posições 1157 e 14
45nt. RESULTADOS: O resultado das análises mostrou que as amostras isoladas da e
spécie M. molossus apresentou variante antigênica 6, enquanto as outras duas amo
stras mostraram um perfil diferente daquele estabelecido no painel e ainda não r
egistrado em literatura. Os resultados da analise genética revelaram que a amost
ra de M. molossus segrega com isolados de Lasiurus sp., M. neglectus segrega com
 o isolado do subgrupo de Eptesicus furinalis e uma amostra de M. riparius segre
ga com isolados de Myotis sp. CONCLUSÕES: Os casos relatados neste estudo enfati
zam a necessidade do esclarecimento da ocorrência de casos de raiva em morcegos,
 principalmente em áreas urbanas.#^dnd^i2#^tm^lpt^kRaiva^i2#^tm^lpt^kChiroptera^
i2#^tm^lpt^kÁrea urbana^i2#^tm^lpt^kAnálise filogenética^i2#other#19#aop17-11.ht
m#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-8682201
1005000018##
00563000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704031900085002001300404#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#5#1#article#128#<p><a name
="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>First 
   report of rabies infection in bats, <i>Molossus molossus</i>, <i>Molossops ne
glectus</i>    and <i>Myotis riparius</i> in the city of S&atilde;o Paulo, State
 of S&atilde;o    Paulo, southeastern Brazil</b> </font></p>     ^cY#aop17-11.ht
m##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#6#2#article#128#<p>&nbsp;<
/p>     ^cY#aop17-11.htm##
00558000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704031400085002001300399#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#7#3#article#128#<p><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Primeiro relato    de in
fec&ccedil;&atilde;o de v&iacute;rus da raiva em morcegos, <i>Molossus    moloss
us</i>, <i>Molossops neglectus</i> e <i>Myotis riparius</i> na cidade    de S&at
ilde;o Paulo, Estado de S&atilde;o Paulo</b></font></p>     ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#8#4#article#128#<p>&nbsp;<
/p>     ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#9#5#article#128#<p>&nbsp;<
/p>     ^cY#aop17-11.htm##
00696000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704045100086002001300537#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#10#6#article#128#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Adriana Ruckert    da R
osa<sup>I</sup>; Ana Paula de Arruda Geraldes Kataoka<sup>II</sup>; Silvana    R
egina Favoretto<sup>III</sup>; Miriam Martos Sodr&eacute;<sup>I</sup>; Jos&eacut
e;    Trezza Netto<sup>II</sup>; Ang&eacute;lica Cristine de Almeida Campos<sup>
IV,    V</sup>; Edison Luiz Durigon<sup>V</sup>; Luzia F&aacute;tima Alves Marto
relli<sup>II</sup></b></font></p>     ^cY#aop17-11.htm##
00467000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704022200086002001300308#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#11#7#article#128#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Setor    de Qu
ir&oacute;pteros, Centro de Controle de Zoonoses, Prefeitura Municipal    da Cid
ade de S&atilde;o Paulo, S&atilde;o Paulo, SP    ^cY#aop17-11.htm##
00457000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704021200086002001300298#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#12#8#article#128#<br>   <s
up>II</sup>Laborat&oacute;rio de Zoonoses e Doen&ccedil;as Transmitidas por    V
etores, Centro de Controle de Zoonoses, Prefeitura Municipal da Cidade de S&atil
de;o    Paulo, S&atilde;o Paulo, SP    ^cY#aop17-11.htm##
00415000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704017000086002001300256#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#13#9#article#128#<br>   <s
up>III</sup>Laborat&oacute;rio de Diagn&oacute;stico, Instituto Pasteur de    S&
atilde;o Paulo, Secretaria Estadual da Sa&uacute;de, S&atilde;o Paulo, SP    ^cY
#aop17-11.htm##
00418000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017200087002001300259#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#14#10#article#128#<br>   <
sup>IV</sup>N&uacute;cleo de Pesquisas em Raiva, Instituto de Ci&ecirc;ncias    
Biom&eacute;dicas, da Universidade de S&atilde;o Paulo, S&atilde;o Paulo, SP    
^cY#aop17-11.htm##
00452000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020600087002001300293#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#15#11#article#128#<br>   <
sup>V</sup>Laborat&oacute;rio de Virologia Cl&iacute;nica e Molecular, Instituto
    de Ci&ecirc;ncias Biom&eacute;dicas, Universidade de S&atilde;o Paulo, S&ati
lde;o    Paulo, SP</font></p>     ^cY#aop17-11.htm##
00363000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011700087002001300204#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#16#12#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Address  
  to </a></font></p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#17#13#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#18#14#article#128#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop17-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#19#15#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p
>     ^cY#aop17-11.htm##
00544000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704029800087002001300385#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#20#16#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODUCTION:</b>    T
his paper presents the first report of rabies in three bat species<b>,</b>    <i
>Molossus molossus</i>, <i>Molossops neglectus</i> and <i>Myotis riparius</i>   
 in the city of S&atilde;o Paulo, Brazil.     ^cY#aop17-11.htm##
00625000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037900087002001300466#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#21#17#article#128#<br>   <
b>METHODS: </b>Bats were diagnosed as positive for rabies using the fluorescent 
   antibody test and mouse inoculation test. The isolates were characterized ant
igenically    using a panel of eight monoclonal antibodies. The samples were als
o genetically    analyzed by partial sequencing of the portion of nucleoprotein 
gene between    positions 1157 and 1445nt.     ^cY#aop17-11.htm##
00851000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060500087002001300692#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#22#18#article#128#<br>   <
b>RESULTS: </b>Analysis of the results verified that the sample isolated from   
 the species <i>M. molossus</i> presented antigenic variant 6, while the other  
  two samples showed a different profile from that established in the panel, one
    not previously reported in the literature. The results of genetic analysis r
evealed    that the <i>M. molossus</i> sample segregated with <i>Lasiurus</i> sp
. isolates,    <i>M. neglectus</i> segregated with a subgroup of <i>Eptesicus fu
rinalis</i>    isolates and the <i>Myotis riparius</i> sample segregated with <i
>Myotis</i>    sp. isolates.     ^cY#aop17-11.htm##
00461000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021500087002001300302#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#23#19#article#128#<br>   <
b>CONCLUSIONS: </b>The cases reported in this paper emphasize the need for    cl
arification of the circumstances in which cases of rabies in wildlife occur,    
principally in urban areas.</font></p>     ^cY#aop17-11.htm##
00432000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018600087002001300273#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#24#20#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords:</b>    Rabie
s. Chiroptera. Urban area<i>.</i> Phylogenetic analysis.</font></p> <hr size="1"
 noshade>     ^cY#aop17-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#25#21#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p> 
    ^cY#aop17-11.htm##
00572000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704032600087002001300413#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#26#22#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODU&Ccedil;&Atilde
;O:</b>    Esse trabalho apresenta o primeiro registro de raiva em tr&ecirc;s es
p&eacute;cies    de morcegos: <i>Molossus molossus</i>, <i>Molossops neglectus</
i> e <i>Myotis    riparius</i> na Cidade de S&atilde;o Paulo, Brasil.     ^cY#ao
p17-11.htm##
00769000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052300087002001300610#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#27#23#article#128#<br>   <
b>M&Eacute;TODOS: </b>Os morcegos foram diagnosticados como positivos para    ra
iva usando as t&eacute;cnicas padr&atilde;o de imunofluoresc&ecirc;ncia direta  
  e o teste de inocula&ccedil;&atilde;o em camundongo. Os isolados foram caracte
rizados    antigenicamente usando um painel de oito anticorpos monoclonais (CDC/
Atlanta/USA).    As amostras tamb&eacute;m foram analisadas geneticamente por se
quenciamento    parcial do gene da nucleoprote&iacute;na entre as posi&ccedil;&o
tilde;es 1157    e 1445nt.     ^cY#aop17-11.htm##
00875000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062900087002001300716#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#28#24#article#128#<br>   <
b>RESULTADOS: </b>O resultado das an&aacute;lises mostrou que as amostras isolad
as    da esp&eacute;cie <i>M. molossus</i> apresentou variante antig&ecirc;nica 
6,    enquanto as outras duas amostras mostraram um perfil diferente daquele est
abelecido    no painel e ainda n&atilde;o registrado em literatura. Os resultado
s da analise    gen&eacute;tica revelaram que a amostra de <i>M. molossus</i> se
grega com isolados    de <i>Lasiurus</i> sp., <i>M. neglectus</i> segrega com o 
isolado do subgrupo    de <i>Eptesicus furinalis</i> e uma amostra de <i>M. ripa
rius</i> segrega com    isolados de <i>Myotis</i> sp.    ^cY#aop17-11.htm##
00469000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022300087002001300310#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#29#25#article#128#<br>   <
b>CONCLUS&Otilde;ES: </b>Os casos relatados neste estudo enfatizam a necessidade
    do esclarecimento da ocorr&ecirc;ncia de casos de raiva em morcegos, princip
almente    em &aacute;reas urbanas.</font></p>     ^cY#aop17-11.htm##
00452000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020600087002001300293#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#30#26#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palavras-chaves:</b>  
  Raiva. Chiroptera. &Aacute;rea urbana. An&aacute;lise filogen&eacute;tica.</fo
nt></p> <hr size="1" noshade>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#31#27#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#32#28#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#33#29#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>INTRODUCTION</b></font
></p>     ^cY#aop17-11.htm##
00880000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704063400087002001300721#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#34#30#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The territorial    expans
ion of the human population, deforestation and construction of projects    (road
s, dams, mineral extraction and others) have contributed to the displacement    
of bats to the cities. The urban ecosystem provides many forms of shelter and   
 food for the bat population. With the absence of a satisfactory number of preda
tors,    some species of bats, particularly those that are more generalist, i.e.
, species    with less specificity regarding food preferences and habitats, have
 been taking    advantage of these changes1,2.</font></p>     ^cY#aop17-11.htm##
00646000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040000087002001300487#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#35#31#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Insectivorous bats    hav
e proven to be more versatile among the different species of bats in the    colo
nization of cities and are therefore considered highly anthropophilic3.    Insec
ts attracted by street lighting, widely distributed in the urban environment,   
 are the source of food for these species of bat2,4.</font></p>     ^cY#aop17-11
.htm##
00691000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044500087002001300532#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#36#32#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The city of S&atilde;o   
 Paulo registered the presence of about 40 bats species with different feeding  
  habits, of which 62% belong to the family Molossidae, 20% are Phyllostomidae  
  and 8% are Vespertilionidae5. However, as in most Brazilian cities, about 70% 
   of specimens forwarded for rabies diagnoses in this city have insectivorous  
  feeding habits.</font></p>     ^cY#aop17-11.htm##
00740000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049400087002001300581#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#37#33#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Insectivorous bats    can
 gather in colonies of tens to hundreds of individuals in the urban area    of S
&atilde;o Paulo: roosting in roofs (86.3%); small spaces between buildings,    s
uch as expansion joints (8.7%); window-blinds (3.8%); hollow cinder blocks    (0
.9%) and garages (0.3%). Bats exploring refuges in houses, as reported above,   
 increases the opportunity for contact with humans and their pets.</font></p>   
  ^cY#aop17-11.htm##
00840000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059400087002001300681#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#38#34#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Bats have been    studied
 as a possible natural reservoir and/or for transmitting pathogens, including   
 the rabies virus6,7. In the northern region of Brazil, hematophagous bats are  
  the main reservoirs of rabies virus in the wild cycle. In urban areas, this   
 virus has been isolated mainly from insectivorous and frugivorous bats8-12.    
However, up to now, no human rabies cases have been registered in Brazil resulti
ng    from aggression by these bats involving viral variants related to these sp
ecies.</font></p>     ^cY#aop17-11.htm##
00629000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038300087002001300470#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#39#35#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In the city of    S&atild
e;o Paulo, rabies has been controlled. The last case of rabies in humans    occu
rred in 1981 and in pets in 198313. However, the rabies virus is still circulati
ng    in the bat populations, with an average of two to four bats diagnosed as i
nfected    with the virus per year.</font></p>     ^cY#aop17-11.htm##
00711000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046500087002001300552#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#40#36#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">During the period    from
 1988 to 2009, 46 cases of rabies were reported involving 12 species of    bats 
in the city. Almost all of these cases involved insectivorous bats14, 23    belo
nging to the Molossidae family, 21 to Vespertilionidae and two to the Phyllostom
idae    family; one frugivorous (<i>Artibeus lituratus</i>) and one nectarivorou
s (<i>Glossophaga    soricina</i>)14.</font></p>     ^cY#aop17-11.htm##
00757000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051100087002001300598#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#41#37#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Studies of Brazilian    s
amples of rabies virus isolated from different bat species, characterized by    
the technique of monoclonal antibodies using a panel from the CDC (Centers for  
  Disease Control and Prevention, Atlanta, GA, USA) and gene sequencing, have   
 proven the existence of numerous species involved in the maintenance and transm
ission    of rabies virus in nature, serving as reservoirs and transmitters7,12,
15.</font></p>     ^cY#aop17-11.htm##
00875000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062900087002001300716#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#42#38#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">This study reported    th
e first occurrence of rabies in three bat species, two belonging to the Molossid
ae    family (<i>Molossus molossus</i> and <i>Molossops neglectus</i>) and one t
o    the Vespertilionidae family (<i>Myotis riparius</i>). Although <i>M</i>. <i
>molossus</i>    has already been diagnosed as positive for rabies in several ot
her cities and    states in the country, this is the first report in the city of
 S&atilde;o Paulo.    For the other two species, this work presents the first re
ported occurrence    of rabies in Brazil.</font></p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#43#39#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#44#40#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>METHODS</b></font></p>
     ^cY#aop17-11.htm##
00610000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036400087002001300451#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#45#41#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Samples of the    rabies 
virus characterized in this study were obtained from bats captured on    three o
ccasions by the Center for Zoonosis Control of the city of S&atilde;o    Paulo (
<i>Centro de Controle de Zoonoses</i>, CCZ-SP) in response to complaints    from
 the population.</font></p>     ^cY#aop17-11.htm##
00472000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022600087002001300313#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#46#42#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In all the events,    the
 bats were diagnosed as positive for rabies using the fluorescent antibody    te
st16 and the mouse inoculation test17.</font></p>     ^cY#aop17-11.htm##
00576000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704033000087002001300417#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#47#43#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In order to characterize 
   the isolates, these were submitted to antigenic typing using a panel of eight
    monoclonal antibodies provided by the CDC, Atlanta, USA, for the characteriz
ation    of rabies virus isolated in Latin American samples18.</font></p>     ^c
Y#aop17-11.htm##
00798000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055200087002001300639#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#48#44#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The samples were    also 
genetically analyzed by partial sequencing (289nt) of the portion of the    carb
oxyl-terminal of the nucleoprotein gene between positions 1157 and 1445nt.    A 
phylogenetic tree was constructed using the Neighbor-Joining method (NJ) with   
 Kimura MEGA, version 4. A comparison of samples with the same sequence of prote
ins    was conducted based on the database available in GenBank. The bootstrap v
alues    were calculated for 1,000 replicas.</font></p>     ^cY#aop17-11.htm##
00358000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011200087002001300199#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#49#45#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Ethical considerations
</b></font></p>     ^cY#aop17-11.htm##
00436000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019000087002001300277#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#50#46#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The primary reference    
regarding euthanasia of animals is the AVMA Guidelines on Euthanasia, June 20071
9.</font></p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#51#47#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#52#48#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>RESULTS</b></font></p>
     ^cY#aop17-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010100087002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#53#49#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>First event</b></font>
</p>     ^cY#aop17-11.htm##
00868000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062200087002001300709#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#54#50#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In April 2005,    a bat w
as found hanging on the wall of a residence in the western zone of the    city. 
Two teenagers decided to raise it as a pet. In addition to the teenagers,    thr
ee adult people came into contact with the bat, though none of them were    bitt
en. After two days with no success in feeding the bat, the CCZ-SP was notified  
  to rescue it. It was an adult female of the <i>Molossops neglectus</i> species
.    As required in the Rabies Control Program Protocol, all the people involved
    received antirabies treatment.</font></p>     ^cY#aop17-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#55#51#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Second event</b></font
></p>     ^cY#aop17-11.htm##
00595000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704034900087002001300436#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#56#52#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In October 2005,    the C
CZ-SP was called to capture a bat fallen in the yard of a residential home    in
 the northwestern zone of the city. The bat, an adult male of <i>Myotis riparius
</i>,    was still alive. No known contact with people or other animals occurred
.</font></p>     ^cY#aop17-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010100087002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#57#53#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Third event</b></font>
</p>     ^cY#aop17-11.htm##
00713000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046700087002001300554#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#58#54#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In March 2008,    a bat t
hat entered a 2<sup>nd</sup> floor apartment located in the northwestern    zone
 of the city was removed by CCZ-SP. The bat, an adult male of <i>Molossus    mol
ossus</i>, was caught by the family's dog, a female who was nursing and had    b
een previously vaccinated. The same was taken to the veterinarian and received  
  a booster vaccination against rabies.</font></p>     ^cY#aop17-11.htm##
00650000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040400087002001300491#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#59#55#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Antigenic characteriza
tion<b>:</b></i>    the reaction patterns observed in bats samples with the 8 pr
e-established reactivity    patterns that characterize rabies virus variants in 
animals involved with rabies    virus maintenance and transmission in Latin Amer
ica are reported in <b><a href="#t1">Table    1</a></b>.</font></p>     ^cY#aop1
7-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#60#56#article#128#<p align
="center"><a name="t1"></a></p>     ^cY#aop17-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#61#57#article#128#<p align
="center">&nbsp;</p>     ^cY#aop17-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#62#58#article#128#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/17t01.jpg"></p>     ^cY#aop17
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#63#59#article#128#<p align
="center">&nbsp;</p>     ^cY#aop17-11.htm##
00680000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043400087002001300521#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#64#60#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Genetic characterizati
on<b>:</b></i>    the results of the genetic analysis revealed that the isolates
 segregated with    other isolates from insectivorous bats in Brazil and other c
ountries from the    Americas, resulting in independent clades with high bootstr
ap values (<b><a href="/img/revistas/rsbmt/2011nahead/17f01.jpg">Figure    1</a>
</b>).</font></p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#65#61#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#66#62#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>DISCUSSION</b></font><
/p>     ^cY#aop17-11.htm##
00699000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045300087002001300540#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#67#63#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Of the bats diagnosed    
as positive for rabies in the city of S&atilde;o Paulo from 1988 to 2009, 38    
(82.6%) were found or captured in atypical circumstances and at unusual times,  
  such as on the ground, inside residences and hanging in buildings, including  
  the three positive cases reported in this paper and 8 (17.4%) were captured   
 while roosting in roofs.</font></p>     ^cY#aop17-11.htm##
00520000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027400087002001300361#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#68#64#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Bats of the Molossidae   
 family are the most predominant in urban areas in Brazil and a number of its   
 species are those most frequently reported inside houses or having invading    
homes.</font></p>     ^cY#aop17-11.htm##
00751000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050500087002001300592#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#69#65#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Although <i>M.    molossu
s</i> is one of the most abundant bats in the city of S&atilde;o Paulo,    repre
senting 40% of the bats collected from 1988 to 2009<sup>14</sup>, only    in Mar
ch 2008 was the first occurrence of the disease registered in this species.    T
his fact demonstrates that rabies virus circulates at a low level among this    
species, which has a positivity of approximately 0.06% (1711/1) in this city.</f
ont></p>     ^cY#aop17-11.htm##
00619000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037300087002001300460#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#70#66#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">For <i>Molossops    negle
ctus</i> (Molossidae) and <i>Myotis riparius</i> (Vespertilionidae), species    
that have low population densities and few registered captures in the State    o
r city of S&atilde;o Paulo, this is the first occurrence of a positive diagnosis
    for rabies in Brazil.</font></p>     ^cY#aop17-11.htm##
00646000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040000087002001300487#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#71#67#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In urban areas,    bats u
se shelters in numerous buildings, indicating high human synanthropy.    Althoug
h the possibility of accidents involving bats, humans, dogs and cats    exists, 
the risk can be considered low, since positivity for rabies in bats    is less t
han 1% in the city of S&atilde;o Paulo<sup>14</sup>.</font></p>     ^cY#aop17-11
.htm##
00797000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055100087002001300638#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#72#68#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Of the 46 bats    diagnos
ed as positive in this city over the past 21 years, 23.9% came into direct    co
ntact with people and 13.0% with domestic animals. In these circumstances,    al
l the individuals were instructed to seek immediate medical attention and    the
 animals were forwarded for veterinary medical consultation. Moreover, the    ac
tions and guidelines recommended in the State Program of Rabies Control for    t
he State of S&atilde;o Paulo were followed.</font></p>     ^cY#aop17-11.htm##
00619000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037300087002001300460#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#73#69#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Given the events    outli
ned here, the facts emphasize the importance of health agencies in orientating  
  the public not to directly handle bats, especially when found in atypical situ
ations,    and highlight the importance of maintaining the vaccination of domest
ic animals    up to date.</font></p>     ^cY#aop17-11.htm##
00738000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704049200087002001300579#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#74#70#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Regarding antigenic    ch
aracterization, analysis of the results verified that the sample isolated    fro
m the species <i>M. molossus</i> presented antigenic variant 6, associated    wi
th the insectivorous bat <i>Lasiurus cinereus</i>. The other two samples showed 
   a different profile from those established in the panel, one not previously  
  reported in the literature (<b><a href="#t1">Table 1</a></b>).</font></p>     
^cY#aop17-11.htm##
02041000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704179500087002001301882#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#75#71#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The sample from    <i>M. 
molossus</i> segregated with <i>Lasiurus</i> sp. isolates, bats that are    also
 insectivorous. Although these two species have the same feeding habits,    they
 roost in different shelters in the city of S&atilde;o Paulo. <i>M. molossus</i>
    roosts in the roofs of buildings and forms medium to large colonies, unlike 
   <i>Lasiurus</i> sp., which roosts alone or forms small colonies, usually in  
  palm trees. The <i>M. neglectus</i> sample segregated with a subgroup of <i>Ep
tesicus    furinalis</i> isolates. This group (<i>E. furinalis</i>) consisted of
 five specimens    from the same colony collected in the city of Jundia&iacute;,
 about 60km from    the origin of the sample (DQ631835 and DQ6318356). The two s
pecies that form    this clade are insectivorous bats. The sample of <i>Myotis r
iparius</i> segregated    with samples of <i>Myotis</i> sp., isolated in Argenti
na (<b><a href="/img/revistas/rsbmt/2011nahead/17f01.jpg">Figure    1</a></b>). 
The cases reported in this paper emphasize the need for clarification    of the 
circumstances in which cases of rabies in wildlife occur, principally    in urba
n areas. This is important to continue to expand current knowledge concerning   
 the rabies potential of bats in the epidemiological rabies cycle and, consequen
tly,    to establish appropriate measures for the management and control of this
 population,    including considering their behavior and biology. Moreover, it i
s important    to respond to the population's general lack of knowledge by provi
ding guidance    concerning prevention, health promotion for humans and domestic
 animals and    inform the public regarding the real benefits and risks involvin
g bats.</font></p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#76#72#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#77#73#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop17-11.htm##
00656000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041000087002001300497#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#78#74#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The following people    p
rovided field assistance capturing bats, laboratorial diagnosis or database    a
ssistance: Jo&atilde;o do Esp&iacute;rito Santo Netto, Antonio Duarte, S&ocirc;n
ia    Bortolete, Gilberto Molgado, Maria de Lourdes S. Silva and Maria Lucia de 
Oliveira;    the authors are grateful for their contributions.</font></p>     ^c
Y#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#79#75#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011300087002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#80#76#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>CONFLICT OF    INTERES
T</b></font></p>     ^cY#aop17-11.htm##
00390000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014400087002001300231#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#81#77#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors declare    th
at there is no conflict of interest.</font></p>     ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#82#78#article#128#<p>&nbsp
;</p>     ^cY#aop17-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#83#79#article#128#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>REFERENCES</b></font><
/p>     ^cY#aop17-11.htm##
00398000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704013800089002001300227#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#84#80#article#
128#1#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Fenton M
B. Bats.    New York: Facts on File Incorporation; 1992.    ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#85#81#article#128#</font><
/p>     ^cY#aop17-11.htm##
00540000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704028000089002001300369#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#86#82#article#
128#2#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Bredt A,
 Silva    DM. Morcegos em &aacute;reas urbanas e rurais: manual de manejo e cont
role.    Bras&iacute;lia: Funda&ccedil;&atilde;o Nacional de Sa&uacute;de. Minis
t&eacute;rio    da Sa&uacute;de; 1996.    ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#87#83#article#128#</font><
/p>     ^cY#aop17-11.htm##
00568000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030800089002001300397#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#88#84#article#
128#3#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Taddei V
A, Vizotto    LD, Sazima I. Uma nova esp&eacute;cie de <i>Lonchophylla</i> do Br
asil e chave    para identifica&ccedil;&atilde;o das esp&eacute;cies do g&ecirc;
nero (Chiroptera,    Phyllostomidae). Cienc Cult 1983; 35:625-629.    ^cY#aop17-
11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#89#85#article#128#</font><
/p>     ^cY#aop17-11.htm##
00506000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024600089002001300335#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#90#86#article#
128#4#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Rydell J
, Racey    PA. Street lamps and the feeding ecology of insectivorous bats. Paper
 presented    at: Symposium the Zoological Society of London; 1995; London, Engl
and.    ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#91#87#article#128#</font><
/p>     ^cY#aop17-11.htm##
00640000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704038000089002001300469#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#92#88#article#
128#5#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Martorel
li LFA,    Almeida MF, Kataoka APAG, Gama AR, Sodr&eacute; MM, Trezza-Neto J, et
 al. Full-length    sequence of rabies virus from insectivorous bats, S&atilde;o
 Paulo City, Brazil.    Paper presented at: XX International Conference on Rabie
s in the Americas. Abstract    Book; 2009; Quebec, Canada.    ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#93#89#article#128#</font><
/p>     ^cY#aop17-11.htm##
00529000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704026900089002001300358#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#94#90#article#
128#6#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Brand&at
ilde;o    PE, Scheffer K, Villarreal LY, Achkar S, Oliveira RN, Fahl WO, et al. 
Coronavirus    detected in the vampire bat <i>Desmodus rotundus</i>. Braz J Infe
ct Dis 2008;    12:466-468.    ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#95#91#article#128#</font><
/p>     ^cY#aop17-11.htm##
00574000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704031400089002001300403#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#96#92#article#
128#7#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Favorett
o SR,    Carrieri ML, Cunha EMS, Aguiar EAC, Silva LHQ, Sodr&eacute; MM, et al<i
>.</i>    Antigenic typing of Brazilian rabies virus samples isolated from anima
ls and    humans, 1989-2000. Rev Inst Med Trop Sao Paulo 2002; 44:91-95.    ^cY#
aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#97#93#article#128#</font><
/p>     ^cY#aop17-11.htm##
00530000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704027000089002001300359#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#98#94#article#
128#8#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Langoni 
H, Lima    K, Menozzi BD, Silva RC. Rabies in the big fruit-eating bat <i>Artibe
us lituratus</i>    from Botucatu, Southeastern Brazil. J Venom Anim Toxins Incl
 Trop Dis 2005;    11:84-87.    ^cY#aop17-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#99#95#article#128#</font><
/p>     ^cY#aop17-11.htm##
00559000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704029800090002001300388#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#100#96#article
#128#9#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Cunha E
MS, Silva    LHQ, Lara MCCSH, Nassas AFCN, Albas A, Sodr&eacute; MM, et al. Bat 
rabies in    the north-northwestern regions of the state of S&atilde;o Paulo, Br
azil: 1997-2002.    Rev Saude Publica 2006; 40:1082-1086.    ^cY#aop17-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#101#97#article#128#</font>
</p>     ^cY#aop17-11.htm##
00541000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704027900091002001300370#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#102#98#article
#128#10#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Schef
fer KC,    Carrieri ML, Albas A, Santos HCP, Kotait I, Ito FH. Rabies virus in n
aturally    infected bats in the state of S&atilde;o Paulo, Southeastern Brazil.
 Rev Saude    Publica 2007; 41:389-395.    ^cY#aop17-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#103#99#article#128#</font>
</p>     ^cY#aop17-11.htm##
00601000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033800092002001300430#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#104#100#articl
e#128#11#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Silv
a MV, Xavier    SM, Moreira WC, Santos BCP, Esberard CEL. V&iacute;rus r&aacute;
bico em morcego    <i>Nyctinomops laticaudatus</i> na cidade do Rio de Janeiro, 
RJ: isolamento,    titula&ccedil;&atilde;o e epidemiologia. Rev Soc Bras Med Tro
p 2007; 40:479-481.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#105#101#article#128#</font
></p>     ^cY#aop17-11.htm##
00582000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031900092002001300411#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#106#102#articl
e#128#12#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Cast
ilho JG,    Canello FM, Scheffer KC, Achkar SM, Carrieri ML, Kotait I. Antigenic
 and genetic    characterization of the first rabies virus isolated from the bat
 <i>Eumops perotis</i>    in Brazil. Rev Inst Med Trop Sao Paulo 2008; 50:95-99.
    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#107#103#article#128#</font
></p>     ^cY#aop17-11.htm##
00558000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029500092002001300387#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#108#104#articl
e#128#13#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Ramo
s PM, Ramos    OS. Acidentes humanos com macacos em rela&ccedil;&atilde;o a trat
amentos profil&aacute;ticos    para a raiva, no munic&iacute;pio de S&atilde;o P
aulo, Brasil. Rev Soc Bras    Med Trop 2002; 35:575-577.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#109#105#article#128#</font
></p>     ^cY#aop17-11.htm##
00600000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033700092002001300429#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#110#106#articl
e#128#14#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Kata
oka APAG,    Martorelli LFA, Almeida MF, Gama AR, Sodr&eacute; MM, Amatuzi E, et
 al. Bats    rabies virus in S&atilde;o Paulo City, Brazil, from 1988 to 2009. P
aper presented    at: XX International Conference on Rabies in the Americas; 200
9; Quebec, Canada.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#111#107#article#128#</font
></p>     ^cY#aop17-11.htm##
00613000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035000092002001300442#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#112#108#articl
e#128#15#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15. Alba
s A, Souza    EAN, Louren&ccedil;o RA, Favoretto SR, Sodr&eacute; MM. Antigen pr
ofile of rabies    virus isolated from different species of non-hematophagous ba
ts in the region    of Presidente Prudente, State of S&atilde;o Paulo. Rev Soc B
ras Med Trop 2009;    42:15-17.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#113#109#article#128#</font
></p>     ^cY#aop17-11.htm##
00549000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028600092002001300378#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#114#110#articl
e#128#16#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16. Dean
 DJ, Abelseth    MK, Atanasiu P. The fluorescent antibody test. <i>In:</i> Mesli
n FX, Kaplan    MM, Koprowisk H, editors. Laboratory techniques in rabies. 4th e
d. Genebra:    World Health Organization; 1996.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#115#111#article#128#</font
></p>     ^cY#aop17-11.htm##
00525000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704026200092002001300354#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#116#112#articl
e#128#17#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Kopr
owisk H.    The mouse inoculation test. <i>In:</i> Meslin FX, Kaplan MM, Koprowi
sk H, editors.    Laboratory techniques in rabies. 4th ed. Genebra: World Health
 Organization;    1996.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#117#113#article#128#</font
></p>     ^cY#aop17-11.htm##
00554000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704029100092002001300383#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#118#114#articl
e#128#18#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18. Pan-
American    Health Organization. Los Anticuerpos Monoclonales en la Caracterizac
i&oacute;n    y Vigilancia de los Virus de la Rabia en Am&eacute;rica Latina y e
l Caribe.    Pan Am J Public Health 2000; 8:214-217.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#119#115#article#128#</font
></p>     ^cY#aop17-11.htm##
00689000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704042600092002001300518#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#120#116#articl
e#128#19#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19. Amer
ican Veterinary    Medical Association. AVMA Guidelines on Euthanasia. Formerly 
Report of the AVMA    Panel on Euthanasia. Washington: American Veterinary Medic
al Association; 2007.    Available from: <a href="http://www.avma.org/issues/ani
mal_welfare/euthanasia.pdf/" target="_blank">http://www.avma.org/issues/animal_w
elfare/euthanasia.pdf/</a>.    ^cY#aop17-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#121#117#article#128#</font
></p>     ^cY#aop17-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#122#118#article#128#<p>&nb
sp;</p>     ^cY#aop17-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#123#119#article#128#<p>&nb
sp;</p>     ^cY#aop17-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018900089002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#124#120#article#128#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><
a href="#top"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a>
    Address to:    ^cY#aop17-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#125#121#article#128#<br>  
 </b>Dra. Adriana Ruckert da Rosa    ^cY#aop17-11.htm##
00305000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005700089002001300146#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#126#122#article#128#<br>  
 Setor Quir&oacute;pteros/CCZ/Prefeitura-SP    ^cY#aop17-11.htm##
00299000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005100089002001300140#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#127#123#article#128#<br>  
 Rua Santa Eul&aacute;lia 86, Santana    ^cY#aop17-11.htm##
00302000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005400089002001300143#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#128#124#article#128#<br>  
 02031-020, S&atilde;o Paulo, SP, Brasil    ^cY#aop17-11.htm##
00285000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003700089002001300126#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#129#125#article#128#<br>  
 Phone: 55 11 2221-3345    ^cY#aop17-11.htm##
00356000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010800089002001300197#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#130#126#article#128#<br>  
 e-mail:<a href="mailto:arosa@prefeitura.sp.gov.br">arosa@prefeitura.sp.gov.br</
a></font></p>     ^cY#aop17-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#131#127#article#128#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">Received in __/__/____ 
   ^cY#aop17-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#p#132#128#article#128#<br>  
 Accepted in __/__/____</font></p>     ^cY#aop17-11.htm##
00417000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160017000880180009001050660
00900114062002800123065000900151064000500160865000900165002001300174#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#133#1#article#19#1#^rN
D^sFenton^nMB#Bats^lpt#New York#Facts on File Incorporation#19920000#1992#201100
00#aop17-11.htm##
00533000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160015000880160016001030180
06800119066000900187062002700196062002000223065000900243064000500252865000900257
002001300266#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#
c#134#2#article#19#2#^rND^sBredt^nA#^rND^sSilva^nDM#Morcegos em áreas urbanas e 
rurais: manual de manejo e controle^lpt#Brasília#Fundação Nacional de Saúde#Mini
stério da Saúde#19960000#1996#20110000#aop17-11.htm##
00634000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100018001050100
01600123012012600139030001100265065000900276064000500285031000300290014000800293
865000900301002001300310035001000323801001100333#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop17-11.htm#S#c#135#3#article#19#3#^rND^sTaddei^nVA#^rND^s
Vizotto^nLD#^rND^sSazima^nI#Uma nova espécie de Lonchophylla do Brasil e chave p
ara identificação das espécies do gênero (Chiroptera, Phyllostomidae)^lpt#Cienc 
Cult#19830000#1983#35#625-629#20110000#aop17-11.htm#0009-6725#Cienc Cult##
00476000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160016000880160016001040180
06300120065000900183064000500192066000700197067000800204865000900212002001300221
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#136#4#arti
cle#19#4#^rND^sRydell^nJ#^rND^sRacey^nPA#Street lamps and the feeding ecology of
 insectivorous bats^len#19950000#1995#London#England#20110000#aop17-11.htm##
00726000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160022000880160018001100160
02000128016001500148016001600163016002100179810000600200018008900206053006100295
055001200356054000800368066000700376067000700383865000900390002001300399#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#137#5#article#19#5
#^rND^sMartorelli^nLFA#^rND^sAlmeida^nMF#^rND^sKataoka^nAPAG#^rND^sGama^nAR#^rND
^sSodré^nMM#^rND^sTrezza-Neto^nJ#et al#Full-length sequence of rabies virus from
 insectivorous bats, São Paulo City, Brazil^len#International Conference on Rabi
es in the Americas^nXX^i1^i1#20090000^i1#2009^i1#Quebec#Canada#20110000#aop17-11
.htm##
00656000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100018000880100018001060100
02100124010001600145010001900161010001500180810000600195012006200201030001800263
71000020028106500090028306400050029203100030029701400080030086500090030800200130
0317#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#138#6#
article#19#6#^rND^sBrandão^nPE#^rND^sScheffer^nK#^rND^sVillarreal^nLY#^rND^sAchk
ar^nS#^rND^sOliveira^nRN#^rND^sFahl^nWO#et al#Coronavirus detected in the vampir
e bat Desmodus rotundus^len#Braz J Infect Dis#2#20080000#2008#12#466-468#2011000
0#aop17-11.htm##
00749000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100019001080100
01700127010001800144010001700162010001600179810000600195012009900201030002800300
06500090032806400050033703100030034201400060034586500090035100200130036003500100
0373801002800383#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.ht
m#S#c#139#7#article#19#7#^rND^sFavoretto^nSR#^rND^sCarrieri^nML#^rND^sCunha^nEMS
#^rND^sAguiar^nEAC#^rND^sSilva^nLHQ#^rND^sSodré^nMM#et al#Antigenic typing of Br
azilian rabies virus samples isolated from animals and humans, 1989-2000^len#Rev
 Inst Med Trop Sao Paulo#20020000#2002#44#91-95#20110000#aop17-11.htm#0036-4665#
Rev Inst Med Trop Sao Paulo##
00617000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100014001050100
01800119010001600137012009300153030003400246710000200280065000900282064000500291
031000300296014000600299865000900305002001300314#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop17-11.htm#S#c#140#8#article#19#8#^rND^sLangoni^nH#^rND^s
Lima^nK#^rND^sMenozzi^nBD#^rND^sSilva^nRC#Rabies in the big fruit-eating bat Art
ibeus lituratus from Botucatu, Southeastern Brazil^len#J Venom Anim Toxins Incl 
Trop Dis#2#20050000#2005#11#84-87#20110000#aop17-11.htm##
00723000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100017001050100
01800122010001900140010001500159010001600174810000600190012009400196030001800290
06500090030806400050031703100030032201400100032586500090033500200130034403500100
0357801001800367#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.ht
m#S#c#141#9#article#19#9#^rND^sCunha^nEMS#^rND^sSilva^nLHQ#^rND^sLara^nMCCSH#^rN
D^sNassas^nAFCN#^rND^sAlbas^nA#^rND^sSodré^nMM#et al#Bat rabies in the north-nor
thwestern regions of the state of São Paulo, Brazil: 1997-2002^len#Rev Saude Pub
lica#20060000#2006#40#1082-1086#20110000#aop17-11.htm#0034-8910#Rev Saude Public
a##
00701000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
01500128010001800143010001600161010001400177012009100191030001800282065000900300
06400050030903100030031401400080031786500090032500200130033403500100034780100180
0357#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#142#10
#article#19#10#^rND^sScheffer^nKC#^rND^sCarrieri^nML#^rND^sAlbas^nA#^rND^sSantos
^nHCP#^rND^sKotait^nI#^rND^sIto^nFH#Rabies virus in naturally infected bats in t
he state of São Paulo, Southeastern Brazil^len#Rev Saude Publica#20070000#2007#4
1#389-395#20110000#aop17-11.htm#0034-8910#Rev Saude Publica##
00718000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01800123010001800141010002000159012012400179030002200303065000900325064000500334
031000300339014000800342865000900350002001300359035001000372801002200382#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#143#11#article#19#
11#^rND^sSilva^nMV#^rND^sXavier^nSM#^rND^sMoreira^nWC#^rND^sSantos^nBCP#^rND^sEs
berard^nCEL#Vírus rábico em morcego Nyctinomops laticaudatus na cidade do Rio de
 Janeiro, RJ: isolamento, titulação e epidemiologia^lpt#Rev Soc Bras Med Trop#20
070000#2007#40#479-481#20110000#aop17-11.htm#0037-8682#Rev Soc Bras Med Trop##
00751000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100018001090100
01900127010001700146010001900163010001600182012011600198030002800314065000900342
06400050035103100030035601400060035986500090036500200130037403500100038780100280
0397#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#144#12
#article#19#12#^rND^sCastilho^nJG#^rND^sCanello^nFM#^rND^sScheffer^nKC#^rND^sAch
kar^nSM#^rND^sCarrieri^nML#^rND^sKotait^nI#Antigenic and genetic characterizatio
n of the first rabies virus isolated from the bat Eumops perotis in Brazil^len#R
ev Inst Med Trop Sao Paulo#20080000#2008#50#95-99#20110000#aop17-11.htm#0036-466
5#Rev Inst Med Trop Sao Paulo##
00621000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100016001060120
12000122030002200242065000900264064000500273031000300278014000800281865000900289
002001300298035001000311801002200321#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop17-11.htm#S#c#145#13#article#19#13#^rND^sRamos^nPM#^rND^sRamos^nOS#A
cidentes humanos com macacos em relação a tratamentos profiláticos para a raiva,
 no município de São Paulo, Brasil^lpt#Rev Soc Bras Med Trop#20020000#2002#35#57
5-577#20110000#aop17-11.htm#0037-8682#Rev Soc Bras Med Trop##
00708000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160020000900160022001100160
01800132016001500150016001600165016001700181810000600198018006700204053006100271
055001200332054000800344056001000352057001000362865000900372002001300381#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#146#14#article#19#
14#^rND^sKataoka^nAPAG#^rND^sMartorelli^nLFA#^rND^sAlmeida^nMF#^rND^sGama^nAR#^r
ND^sSodré^nMM#^rND^sAmatuzi^nE#et al#Bats rabies virus in São Paulo City, Brazil
, from 1988 to 2009^len#International Conference on Rabies in the Americas^nXX^i
1^i1#20090000^i1#2009^i1#Quebec^i1#Canada^i1#20110000#aop17-11.htm##
00741000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100017001050100
01900122010002000141010001600161012015100177030002200328065000900350064000500359
031000300364014000600367865000900373002001300382035001000395801002200405#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#147#15#article#19#
15#^rND^sAlbas^nA#^rND^sSouza^nEAN#^rND^sLourenço^nRA#^rND^sFavoretto^nSR#^rND^s
Sodré^nMM#Antigen profile of rabies virus isolated from different species of non
-hematophagous bats in the region of Presidente Prudente, State of São Paulo^len
#Rev Soc Bras Med Trop#20090000#2009#42#15-17#20110000#aop17-11.htm#0037-8682#Re
v Soc Bras Med Trop##
00651000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100019001050100
01800124012003400142016001700176016001700193016001900210018003600229063000200265
066000800267062002600275065000900301064000500310865000900315002001300324#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#148#16#article#19#
16#^rND^sDean^nDJ#^rND^sAbelseth^nMK#^rND^sAtanasiu^nP#The fluorescent antibody 
test^len#^rND^sMeslin^nFX#^rND^sKaplan^nMM#^rND^sKoprowisk^nH#Laboratory techniq
ues in rabies^len#4#Genebra#World Health Organization#19960000#1996#20110000#aop
17-11.htm##
00591000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900120031001090160
01700140016001700157016001900174018003600193063000200229066000800231062002600239
065000900265064000500274865000900279002001300288#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop17-11.htm#S#c#149#17#article#19#17#^rND^sKoprowisk^nH#Th
e mouse inoculation test^len#^rED^sMeslin^nFX#^rED^sKaplan^nMM#^rED^sKoprowisk^n
H#Laboratory techniques in rabies^len#4#Genebra#World Health Organization#199600
00#1996#20110000#aop17-11.htm##
00571000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870110033000900120123001230300
02300246710000200269065000900271064000500280031000200285014000800287865000900295
002001300304#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#
c#150#18#article#19#18#Pan-American Health Organization#Los Anticuerpos Monoclon
ales en la Caracterización y Vigilancia de los Virus de la Rabia en América Lati
na y el Caribe^les#Pan Am J Public Health#2#20000000#2000#8#214-217#20110000#aop
17-11.htm##
00551000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170040000900180034001300660
01100164062004000175065000900215064000500224037005800229865000900287002001300296
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop17-11.htm#S#c#151#19#art
icle#19#19#American Veterinary Medical Association#AVMA Guidelines on Euthanasia
^len#Washington#American Veterinary Medical Association#20070000#2007#http://www
.avma.org/issues/animal_welfare/euthanasia.pdf/#20110000#aop17-11.htm##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#o#1#
1#article#1#20110411#104904#aop18-11.htm#200##
05133000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301201200018201201110
03020100038004130100035004510100032004860100062005180100041005800100040006210100
04200661010003400703070010100737070009600838070010900934070009301043083144501136
08500080258108500400258908500220262908500250265108316230267608500080429908500400
43070850024043470850026043711170006043970720003044031120009044061110011044151140
00904426113001104435002001304446#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop18-11.htm#S#h#2#1#article#1#oa#en#br1.1#1#4.0#TAB#17#nd#nd#Rev. Soc. Bra
s. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#Occurrence and risk facto
rs associated with infection by Toxoplasma gondii in goats in the State of Alago
as, Brazil^len#Ocorrência e fatores de risco associados à infecção por Toxoplasm
a gondii em caprinos do Estado de Alagoas^lpt#^rND^1A01^nGiulliano Aires^sAnderl
ini#^rND^1A02^nRinaldo Aparecido^sMota#^rND^1A03^nEduardo Bento^sFaria#^rND^1A02
^nErika Fernanda Torres Samico Fernandes^sCavalcanti#^rND^1A01^nRômulo Menna Bar
reto^sValença#^rND^1A04^nJosé Wilton^sPinheiro Júnior#^rND^nPedro Paulo Feitosa 
de^sAlbuquerque#^rND^nOrestes Luiz de^sSouza Neto#Centro de Estudos Superiores d
e Maceió^iA01^1Faculdade de Ciências Biológicas e da Saúde^cMaceió^sAL#Universid
ade Federal Rural de Pernambuco^iA02^1Departamento de Medicina Veterinária^cReci
fe^sPE#Universidade Federal Rural de Pernambuco^iA03^1Programa de Pós Graduação 
em Medicina Veterinária^cRecife^sPE#Universidade Federal Rural de Pernambuco^iA0
4^1Unidade Acadêmica de Garanhuns^cGaranhuns^sPE#^len^aINTRODUCTION: Goats are c
onsidered very susceptible to infection by Toxoplasma gondii and when this occur
s during pregnancy, it may cause fetal death with subsequent fetal resorption, a
bortion, mummification, stillborn or the birth of weak goats. The objective of t
his work was to determine the occurrence of and identify risk factors for T. gon
dii infection in goats in different mesoregions in the State of Alagoas. METHODS
: The research was conducted on 24 goat breeding farms in 10 municipalities. A t
otal of 454 blood samples were examined for anti-T. gondii antibodies by indirec
t immunofluorescence antibody test. To evaluate the risk factors of toxoplasmosi
s in goats, questionnaires were applied analyzing the farm's production system a
nd nutritional, reproductive and sanitary management. RESULTS: Disease occurrenc
e was 39% with 95.8% of farms presenting seropositive animals. Significant assoc
iations were observed for mesoregion (OR = 0.23; 95%CI = 0.09 - 0.57), age (OR =
 0.36; 95%CI = 0.20 - 0.64), semi-intensive herd management (OR = 8.70; 95%CI = 
1.87 - 40.43), access of cats to water provided for goats (OR = 3.38; 95%CI = 1.
89-6.02) and cats feeding on placental remnants (OR = 2.73; 95%CI = 1.38 - 5.40)
. CONCLUSIONS: Toxoplasma gondii infection is disseminated in the State of Alago
as and the adoption of a program that monitors infection foci is required to red
uce the risk factors identified in the present study.#^dnd^i1#^tm^len^kIndirect 
immunofluorescence^i1#^tm^len^kProtozoan^i1#^tm^len^kEpidemiology^i1#^lpt^aINTRO
DUÇÃO: Caprinos são considerados susceptíveis à infecção por Toxoplasma gondii q
ue quando ocorre durante a gestação pode causar morte fetal com subsequente reab
sorção, aborto, mumificação, natimortos ou nascimento de cabritos fracos. Objeti
vou-se com este estudo determinar a ocorrência e identificar os fatores de risco
 associados à infecção por T. gondii em caprinos nas diferentes mesorregiões do 
Estado de Alagoas. MÉTODOS: A pesquisa foi realizada em 10 municípios, sendo ana
lisadas 24 propriedades de produção caprina com aptidão mista. Foram coletadas a
mostras sanguíneas de 454 animais para realização da pesquisa de anticorpos anti
-Toxoplasma gondii através da prova sorológica de imunofluorescência indireta. P
ara o estudo dos fatores de risco, foram aplicados questionários com questões re
ferentes ao sistema de produção e manejos nutricional, reprodutivo e sanitário. 
RESULTADOS: A ocorrência encontrada foi de 39% com 95,8% das propriedades aprese
ntando animais positivos. Foi observada associação significativa para as variáve
is: mesorregião (OR = 0,23; IC 95% = 0,09 - 0,57), idade (OR = 0,36; IC 95% = 0,
20 - 0,64), sistema de criação semi-intensivo (OR = 8,70; IC 95% = 1,87 - 40,43)
, acesso dos gatos à água fornecida aos animais (OR = 3,38; IC 95% = 1,89 - 6,02
) e gatos se alimentando de restos placentários (OR = 2,73; IC 95% = 1,38 - 5,40
). CONCLUSÕES: A infecção por T. gondii está disseminada no Estado de Alagoas, s
endo necessária a realização de um programa de monitoramento dos focos da infecç
ão no Estado com objetivo de reduzir os fatores de riscos identificados no prese
nte estudo.#^dnd^i2#^tm^lpt^kImunofluorescência indireta^i2#^tm^lpt^kProtozoário
^i2#^tm^lpt^kEpidemiologia^i2#other#33#20100112#12/01/2010#20101116#16/11/2010#a
op18-11.htm##
05273000000000673000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301201340018201201250
03160100038004410100035004790100032005140100062005460100041006080100040006490100
04200689010003400731070010100765070009600866070010900962070009301071083150101164
08500080266508500400267308500220271308500250273508316790276008500080443908500400
44470850024044870850026045111170006045370720003045431120009045461110011045551140
00904566113001104575002001304586#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\ma
rkup\aop18-11.htm#S#f#3#1#article#1#oa#en#br1.1#1#4.0#TAB#17#nd#nd#Rev. Soc. Bra
s. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#<b>Occurrence and risk fa
ctors associated with infection by <i>Toxoplasma gondii</i> in goats in the Stat
e of Alagoas, Brazil</b>^len#<b>Ocorrência e fatores de risco associados à infec
ção por <i>Toxoplasma gondii</i> em caprinos do Estado de Alagoas</b>^lpt#^rND^1
A01^nGiulliano Aires^sAnderlini#^rND^1A02^nRinaldo Aparecido^sMota#^rND^1A03^nEd
uardo Bento^sFaria#^rND^1A02^nErika Fernanda Torres Samico Fernandes^sCavalcanti
#^rND^1A01^nRômulo Menna Barreto^sValença#^rND^1A04^nJosé Wilton^sPinheiro Júnio
r#^rND^nPedro Paulo Feitosa de^sAlbuquerque#^rND^nOrestes Luiz de^sSouza Neto#Ce
ntro de Estudos Superiores de Maceió^iA01^1Faculdade de Ciências Biológicas e da
 Saúde^cMaceió^sAL#Universidade Federal Rural de Pernambuco^iA02^1Departamento d
e Medicina Veterinária^cRecife^sPE#Universidade Federal Rural de Pernambuco^iA03
^1Programa de Pós Graduação em Medicina Veterinária^cRecife^sPE#Universidade Fed
eral Rural de Pernambuco^iA04^1Unidade Acadêmica de Garanhuns^cGaranhuns^sPE#^le
n^a<b>INTRODUCTION:</b> Goats are considered very susceptible to infection by <i
>Toxoplasma gondii</i> and when this occurs during pregnancy, it may cause fetal
 death with subsequent fetal resorption, abortion, mummification, stillborn or t
he birth of weak goats. The objective of this work was to determine the occurren
ce of and identify risk factors for <i>T. gondii</i> infection in goats in diffe
rent mesoregions in the State of Alagoas. <b>METHODS: </b>The research was condu
cted on 24 goat breeding farms in 10 municipalities. A total of 454 blood sample
s were examined for anti-<i>T. gondii</i> antibodies by indirect immunofluoresce
nce antibody test. To evaluate the risk factors of toxoplasmosis in goats, quest
ionnaires were applied analyzing the farm's production system and nutritional, r
eproductive and sanitary management. <b>RESULTS:</b> Disease occurrence was 39% 
with 95.8% of farms presenting seropositive animals. Significant associations we
re observed for mesoregion (OR = 0.23; 95%CI = 0.09 - 0.57), age (OR = 0.36; 95%
CI = 0.20 - 0.64), semi-intensive herd management (OR = 8.70; 95%CI = 1.87 - 40.
43), access of cats to water provided for goats (OR = 3.38; 95%CI = 1.89-6.02) a
nd cats feeding on placental remnants (OR = 2.73; 95%CI = 1.38 - 5.40). <b>CONCL
USIONS:</b> <i>Toxoplasma gondii</i> infection is disseminated in the State of A
lagoas and the adoption of a program that monitors infection foci is required to
 reduce the risk factors identified in the present study.#^dnd^i1#^tm^len^kIndir
ect immunofluorescence^i1#^tm^len^kProtozoan^i1#^tm^len^kEpidemiology^i1#^lpt^a<
b>INTRODUÇÃO:</b> Caprinos são considerados susceptíveis à infecção por <i>Toxop
lasma gondii</i> que quando ocorre durante a gestação pode causar morte fetal co
m subsequente reabsorção, aborto, mumificação, natimortos ou nascimento de cabri
tos fracos. Objetivou-se com este estudo determinar a ocorrência e identificar o
s fatores de risco associados à infecção por <i>T. gondii</i> em caprinos nas di
ferentes mesorregiões do Estado de Alagoas. <b>MÉTODOS: </b>A pesquisa foi reali
zada em 10 municípios, sendo analisadas 24 propriedades de produção caprina com 
aptidão mista. Foram coletadas amostras sanguíneas de 454 animais para realizaçã
o da pesquisa de anticorpos anti-<i>Toxoplasma gondii</i> através da prova sorol
ógica de imunofluorescência indireta. Para o estudo dos fatores de risco, foram 
aplicados questionários com questões referentes ao sistema de produção e manejos
 nutricional, reprodutivo e sanitário. <b>RESULTADOS:</b> A ocorrência encontrad
a foi de 39% com 95,8% das propriedades apresentando animais positivos. Foi obse
rvada associação significativa para as variáveis: mesorregião (OR = 0,23; IC 95%
 = 0,09 - 0,57), idade (OR = 0,36; IC 95% = 0,20 - 0,64), sistema de criação sem
i-intensivo (OR = 8,70; IC 95% = 1,87 - 40,43), acesso dos gatos à água fornecid
a aos animais (OR = 3,38; IC 95% = 1,89 - 6,02) e gatos se alimentando de restos
 placentários (OR = 2,73; IC 95% = 1,38 - 5,40). <b>CONCLUSÕES:</b> A infecção p
or <i>T. gondii</i> está disseminada no Estado de Alagoas, sendo necessária a re
alização de um programa de monitoramento dos focos da infecção no Estado com obj
etivo de reduzir os fatores de riscos identificados no presente estudo.#^dnd^i2#
^tm^lpt^kImunofluorescência indireta^i2#^tm^lpt^kProtozoário^i2#^tm^lpt^kEpidemi
ologia^i2#other#33#20100112#12/01/2010#20101116#16/11/2010#aop18-11.htm##
05372000000000697000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108121000300112049000300115158000300118
03000260012103200060014706500090015301400070016203500100016922300090017901201200
01880120111003080100038004190100035004570100032004920100062005240100041005860100
04000627010004200667010003400709070010300743070009800846070011100944070009501055
08314940115008500080264408500400265208500220269208500250271408316860273908500080
44250850040044330850024044730850026044971170006045230720003045291120009045321110
01104541114000904552113001104561002001304572008008904585#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop18-11.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1
#4.0#tab#17#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#20110000#^f0^l0#0037-8682#2011
0415#Occurrence and risk factors associated with infection by Toxoplasma gondii 
in goats in the State of Alagoas, Brazil^len#Ocorrência e fatores de risco assoc
iados à infecção por Toxoplasma gondii em caprinos do Estado de Alagoas^lpt#^rND
^1A01^nGiulliano Aires^sAnderlini#^rND^1A02^nRinaldo Aparecido^sMota#^rND^1A03^n
Eduardo Bento^sFaria#^rND^1A02^nErika Fernanda Torres Samico Fernandes^sCavalcan
ti#^rND^1A01^nRômulo Menna Barreto^sValença#^rND^1A04^nJosé Wilton^sPinheiro Jún
ior#^rND^nPedro Paulo Feitosa de^sAlbuquerque#^rND^nOrestes Luiz de^sSouza Neto#
^iA01^1Centro de Estudos Superiores de Maceió^2Faculdade de Ciências Biológicas 
e da Saúde^cMaceió^sAL#^iA02^1Universidade Federal Rural de Pernambuco^2Departam
ento de Medicina Veterinária^cRecife^sPE#^iA03^1Universidade Federal Rural de Pe
rnambuco^2Programa de Pós Graduação em Medicina Veterinária^cRecife^sPE#^iA04^1U
niversidade Federal Rural de Pernambuco^2Unidade Acadêmica de Garanhuns^cGaranhu
ns^sPE#^len^aINTRODUCTION: Goats are considered very susceptible to infection by
 Toxoplasma gondii and when this occurs during pregnancy, it may cause fetal dea
th with subsequent fetal resorption, abortion, mummification, stillborn or the b
irth of weak goats. The objective of this work was to determine the occurrence o
f and identify risk factors for T. gondii infection in goats in different mesore
gions in the State of Alagoas. METHODS: The research was conducted on 24 goat br
eeding farms in 10 municipalities. A total of 454 blood samples were examined fo
r anti-T. gondii antibodies by indirect immunofluorescence antibody test. To eva
luate the risk factors of toxoplasmosis in goats, questionnaires were applied an
alyzing the farm's production system and nutritional, reproductive and sanitary 
management. RESULTS: Disease occurrence was 39 percent with 95.8 percent of farm
s presenting seropositive animals. Significant associations were observed for me
soregion (OR = 0.23; 95 percentCI = 0.09 - 0.57), age (OR = 0.36; 95 percentCI =
 0.20 - 0.64), semi-intensive herd management (OR = 8.70; 95 percentCI = 1.87 - 
40.43), access of cats to water provided for goats (OR = 3.38; 95 percentCI = 1.
89-6.02) and cats feeding on placental remnants (OR = 2.73; 95 percentCI = 1.38 
- 5.40). CONCLUSIONS: Toxoplasma gondii infection is disseminated in the State o
f Alagoas and the adoption of a program that monitors infection foci is required
 to reduce the risk factors identified in the present study.#^dnd^i1#^tm^len^kIn
direct immunofluorescence^i1#^tm^len^kProtozoan^i1#^tm^len^kEpidemiology^i1#^lpt
^aINTRODUÇÃO: Caprinos são considerados susceptíveis à infecção por Toxoplasma g
ondii que quando ocorre durante a gestação pode causar morte fetal com subsequen
te reabsorção, aborto, mumificação, natimortos ou nascimento de cabritos fracos.
 Objetivou-se com este estudo determinar a ocorrência e identificar os fatores d
e risco associados à infecção por T. gondii em caprinos nas diferentes mesorregi
ões do Estado de Alagoas. MÉTODOS: A pesquisa foi realizada em 10 municípios, se
ndo analisadas 24 propriedades de produção caprina com aptidão mista. Foram cole
tadas amostras sanguíneas de 454 animais para realização da pesquisa de anticorp
os anti-Toxoplasma gondii através da prova sorológica de imunofluorescência indi
reta. Para o estudo dos fatores de risco, foram aplicados questionários com ques
tões referentes ao sistema de produção e manejos nutricional, reprodutivo e sani
tário. RESULTADOS: A ocorrência encontrada foi de 39 por cento com 95,8 por cent
o das propriedades apresentando animais positivos. Foi observada associação sign
ificativa para as variáveis: mesorregião (OR = 0,23; IC 95 por cento = 0,09 - 0,
57), idade (OR = 0,36; IC 95 por cento = 0,20 - 0,64), sistema de criação semi-i
ntensivo (OR = 8,70; IC 95 por cento = 1,87 - 40,43), acesso dos gatos à água fo
rnecida aos animais (OR = 3,38; IC 95 por cento = 1,89 - 6,02) e gatos se alimen
tando de restos placentários (OR = 2,73; IC 95 por cento = 1,38 - 5,40). CONCLUS
ÕES: A infecção por T. gondii está disseminada no Estado de Alagoas, sendo neces
sária a realização de um programa de monitoramento dos focos da infecção no Esta
do com objetivo de reduzir os fatores de riscos identificados no presente estudo
.#^dnd^i2#^tm^lpt^kImunofluorescência indireta^i2#^tm^lpt^kProtozoário^i2#^tm^lp
t^kEpidemiologia^i2#other#33#20100112#12/01/2010#20101116#16/11/2010#aop18-11.ht
m#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-8682201
1005000017##
00481000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704023700085002001300322#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#5#1#article#163#<p><a name
="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Occurr
ence    and risk factors associated with infection by <i>Toxoplasma gondii</i> i
n goats    in the State of Alagoas, Brazil</b> </font></p>     ^cY#aop18-11.htm#
#
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#6#2#article#163#<p>&nbsp;<
/p>     ^cY#aop18-11.htm##
00480000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704023600085002001300321#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#7#3#article#163#<p><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Ocorr&ecirc;ncia    e fa
tores de risco associados &agrave; infec&ccedil;&atilde;o por <i>Toxoplasma    g
ondii</i> em caprinos do Estado de Alagoas</b></font></p>     ^cY#aop18-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#8#4#article#163#<p>&nbsp;<
/p>     ^cY#aop18-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#9#5#article#163#<p>&nbsp;<
/p>     ^cY#aop18-11.htm##
00721000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704047600086002001300562#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#10#6#article#163#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Giulliano Aires    Ande
rlini<sup>I</sup>; Rinaldo Aparecido Mota<sup>II</sup>; Eduardo Bento Faria<sup>
III</sup>;    Erika Fernanda Torres Samico Fernandes Cavalcanti<sup>II</sup>; R&
ocirc;mulo    Menna Barreto Valen&ccedil;a<sup>I</sup>; Jos&eacute; Wilton Pinhe
iro J&uacute;nior<sup>IV</sup>;    Pedro Paulo Feitosa de Albuquerque<sup>II</su
p>; Orestes Luiz de Souza Neto<sup>II</sup></b></font></p>     ^cY#aop18-11.htm#
#
00448000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704020300086002001300289#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#11#7#article#163#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Faculdade    d
e Ci&ecirc;ncias Biol&oacute;gicas e da Sa&uacute;de, Centro de Estudos Superior
es    de Macei&oacute;, AL    ^cY#aop18-11.htm##
00373000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704012800086002001300214#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#12#8#article#163#<br>   <s
up>II</sup>Departamento de Medicina Veterin&aacute;ria, Universidade Federal    
Rural de Pernambuco, Recife, PE    ^cY#aop18-11.htm##
00408000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704016300086002001300249#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#13#9#article#163#<br>   <s
up>III</sup>Programa de P&oacute;s Gradua&ccedil;&atilde;o em Medicina Veterin&a
acute;ria,    Universidade Federal Rural de Pernambuco, Recife, PE    ^cY#aop18-
11.htm##
00382000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013600087002001300223#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#14#10#article#163#<br>   <
sup>IV</sup>Unidade Acad&ecirc;mica de Garanhuns, Universidade Federal Rural    
de Pernambuco, Garanhuns, PE</font></p>     ^cY#aop18-11.htm##
00362000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011600087002001300203#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#15#11#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Address  
  to</a></font></p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#16#12#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#17#13#article#163#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop18-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#18#14#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p
>     ^cY#aop18-11.htm##
00773000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052700087002001300614#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#19#15#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODUCTION:</b>    G
oats are considered very susceptible to infection by <i>Toxoplasma gondii</i>   
 and when this occurs during pregnancy, it may cause fetal death with subsequent
    fetal resorption, abortion, mummification, stillborn or the birth of weak go
ats.    The objective of this work was to determine the occurrence of and identi
fy risk    factors for <i>T. gondii</i> infection in goats in different mesoregi
ons in    the State of Alagoas.    ^cY#aop18-11.htm##
00668000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042200087002001300509#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#20#16#article#163#<br>   <
b>METHODS: </b>The research was conducted on 24 goat breeding farms in 10 munici
palities.    A total of 454 blood samples were examined for anti-<i>T. gondii</i
> antibodies    by indirect immunofluorescence antibody test. To evaluate the ri
sk factors of    toxoplasmosis in goats, questionnaires were applied analyzing t
he farm's production    system and nutritional, reproductive and sanitary manage
ment.     ^cY#aop18-11.htm##
00711000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046500087002001300552#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#21#17#article#163#<br>   <
b>RESULTS:</b> Disease occurrence was 39% with 95.8% of farms presenting seropos
itive    animals. Significant associations were observed for mesoregion (OR = 0.
23; 95%CI    = 0.09 - 0.57), age (OR = 0.36; 95%CI = 0.20 - 0.64), semi-intensiv
e herd management    (OR = 8.70; 95%CI = 1.87 - 40.43), access of cats to water 
provided for goats    (OR = 3.38; 95%CI = 1.89-6.02) and cats feeding on placent
al remnants (OR =    2.73; 95%CI = 1.38 - 5.40).     ^cY#aop18-11.htm##
00504000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025800087002001300345#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#22#18#article#163#<br>   <
b>CONCLUSIONS:</b> <i>Toxoplasma gondii</i> infection is disseminated in the    
State of Alagoas and the adoption of a program that monitors infection foci    i
s required to reduce the risk factors identified in the present study.</font></p
>     ^cY#aop18-11.htm##
00424000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017800087002001300265#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#23#19#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords:</b>    Indir
ect immunofluorescence. Protozoan. Epidemiology.</font></p> <hr size="1" noshade
>     ^cY#aop18-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#24#20#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p> 
    ^cY#aop18-11.htm##
00908000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704066200087002001300749#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#25#21#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODU&Ccedil;&Atilde
;O:</b>    Caprinos s&atilde;o considerados suscept&iacute;veis &agrave; infec&c
cedil;&atilde;o    por <i>Toxoplasma gondii</i> que quando ocorre durante a gest
a&ccedil;&atilde;o    pode causar morte fetal com subsequente reabsor&ccedil;&at
ilde;o, aborto, mumifica&ccedil;&atilde;o,    natimortos ou nascimento de cabrit
os fracos. Objetivou-se com este estudo determinar    a ocorr&ecirc;ncia e ident
ificar os fatores de risco associados &agrave; infec&ccedil;&atilde;o    por <i>
T. gondii</i> em caprinos nas diferentes mesorregi&otilde;es do Estado    de Ala
goas.     ^cY#aop18-11.htm##
00868000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062200087002001300709#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#26#22#article#163#<br>   <
b>M&Eacute;TODOS: </b>A pesquisa foi realizada em 10 munic&iacute;pios, sendo   
 analisadas 24 propriedades de produ&ccedil;&atilde;o caprina com aptid&atilde;o
    mista. Foram coletadas amostras sangu&iacute;neas de 454 animais para realiz
a&ccedil;&atilde;o    da pesquisa de anticorpos anti-<i>Toxoplasma gondii</i> at
rav&eacute;s da prova    sorol&oacute;gica de imunofluoresc&ecirc;ncia indireta.
 Para o estudo dos fatores    de risco, foram aplicados question&aacute;rios com
 quest&otilde;es referentes    ao sistema de produ&ccedil;&atilde;o e manejos nu
tricional, reprodutivo e sanit&aacute;rio.        ^cY#aop18-11.htm##
00838000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059200087002001300679#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#27#23#article#163#<br>   <
b>RESULTADOS:</b> A ocorr&ecirc;ncia encontrada foi de 39% com 95,8% das proprie
dades    apresentando animais positivos. Foi observada associa&ccedil;&atilde;o 
significativa    para as vari&aacute;veis: mesorregi&atilde;o (OR = 0,23; IC 95%
 = 0,09 - 0,57),    idade (OR = 0,36; IC 95% = 0,20 - 0,64), sistema de cria&cce
dil;&atilde;o semi-intensivo    (OR = 8,70; IC 95% = 1,87 - 40,43), acesso dos g
atos &agrave; &aacute;gua fornecida    aos animais (OR = 3,38; IC 95% = 1,89 - 6
,02) e gatos se alimentando de restos    placent&aacute;rios (OR = 2,73; IC 95% 
= 1,38 - 5,40).     ^cY#aop18-11.htm##
00607000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036100087002001300448#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#28#24#article#163#<br>   <
b>CONCLUS&Otilde;ES:</b> A infec&ccedil;&atilde;o por <i>T. gondii</i> est&aacut
e;    disseminada no Estado de Alagoas, sendo necess&aacute;ria a realiza&ccedil
;&atilde;o    de um programa de monitoramento dos focos da infec&ccedil;&atilde;
o no Estado    com objetivo de reduzir os fatores de riscos identificados no pre
sente estudo.</font></p>     ^cY#aop18-11.htm##
00447000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020100087002001300288#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#29#25#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palavras-chaves:</b>  
  Imunofluoresc&ecirc;ncia indireta. Protozo&aacute;rio. Epidemiologia.</font></
p> <hr size="1" noshade>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#30#26#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#31#27#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#32#28#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>INTRODUCTION</b></font
></p>     ^cY#aop18-11.htm##
00607000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036100087002001300448#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#33#29#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Toxoplasma gondii</i> 
   is the most studied coccid in the world, with more than 15,000 original resea
rch    articles and over 500 published revisions, since it is one of the most co
mmon    agents in parasitic infections of homeothermic animals, including humans
<sup>1</sup>.</font></p>     ^cY#aop18-11.htm##
00619000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037300087002001300460#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#34#30#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Among domestic    animals
, the ingestion of sporulated oocysts derived from cat feces is the most    impo
rtant infection route. Cats are considered the principal reservoir of the    cyc
le of toxoplasmosis, which is considered rare or nonexistent in environments    
without cats<sup>2</sup>.</font></p>     ^cY#aop18-11.htm##
00757000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051100087002001300598#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#35#31#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Goats are considered    v
ery susceptible to infections by <i>T. gondii</i> and when infected during    pr
egnancy, they present parasitemia in the first week postinfection and, consequen
tly,    in the second and third week, the placenta and fetus are infected, respe
ctively<sup>3</sup>.    Infection causes fetal death, with subsequent resorption
, miscarriage, mummification,    stillbirth or the birth of weak goats<sup>4</su
p>.</font></p>     ^cY#aop18-11.htm##
00640000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039400087002001300481#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#36#32#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Numerous studies    of an
ti-<i>T. gondii</i> antibody prevalence in goats have been developed in    sever
al countries, including those conducted in the United Sates<sup>5</sup>,    Vene
zuela<sup>6</sup>, Brazil<sup>7</sup>, Spain<sup>8</sup>, Ghana<sup>9</sup>,    
Uganda<sup>10</sup> and Thailand<sup>11</sup>.</font></p>     ^cY#aop18-11.htm##
00730000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048400087002001300571#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#37#33#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Data regarding    infecti
on and the prevalence of antibodies anti-<i>T. gondii</i> in research    conduct
ed in Brazil highlighted the need to include the protozoan among the    causes o
f reproductive losses in goat herds in the country<sup>12</sup>. However,    few
 countries in the world regularly monitor toxoplasmosis in different hosts,    i
ncluding humans and particularly in animals<sup>1</sup>.</font></p>     ^cY#aop1
8-11.htm##
00839000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059300087002001300680#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#38#34#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">As demonstrated    by sev
eral studies, the principal risk factors for infection by <i>T. gondii</i>    in
 goats are: sex and age, in which the principal affected group is adult females;
    the pluviometric index, high humidity and mild temperatures in the regions w
here    the herds are raised<sup>9,11</sup>; management systems<sup>13</sup>; co
mmon    feeders and drinkers for young and adult goats; the presence of cats; an
d goats    with reproductive disorders on the property in question<sup>4,14,15</
sup>.</font></p>     ^cY#aop18-11.htm##
00517000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704027100087002001300358#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#39#35#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The purpose of    this wo
rk was to determine the occurrence of infection by <i>T. gondii</i> in    goats 
in the State of Alagoas and identify the risk factors associated with    infecti
on.</font></p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#40#36#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#41#37#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>METHODS</b></font></p>
     ^cY#aop18-11.htm##
01047000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704080100087002001300888#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#42#38#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The State of Alagoas    i
s located in the macroregion of northeastern Brazil between the parallels 8º48'1
2"    and 10º30'12" south and the meridians 35º09'36" and 38º13'54" west, coveri
ng    a territorial area of 27.767,7 km&sup2; (approx. 10720 mi&sup2;), correspo
nding    to 0.3% of the national territory. Situated in the intertropical strip,
 the    state receives a large quantity of solar energy throughout the year, var
ying    from 2200 to 2600h of sunlight, which determines the hot climate, with a
nnual    temperatures around 22ºC to 28ºC<sup>16</sup>. The State of Alagoas is 
divided    into three mesoregions: East, <i>Agreste</i> and <i>Sert&atilde;o</i>
 and into    13 geographic microregions<sup>17</sup>.</font></p>     ^cY#aop18-1
1.htm##
00755000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050900087002001300596#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#43#39#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In order to calculate    
the sample size, an expected prevalence of 50% was considered, to maximize the  
  sample size, and a minimum confidence interval of 95% and statistical error   
 of 5% was established. Thus, the working sample size (n) was determined as 358 
   goats<sup>18</sup>; however, a total of 454 goats (40 males and 414 females) 
   belonging to 24 properties and from 10 municipalities were eventually studied
.</font></p>     ^cY#aop18-11.htm##
00619000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704037300087002001300460#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#44#40#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The goats were    subdivi
ded into three age groups: <u>&lt;</u> 12 months-old, 13-24 months-old    and &g
t; 24 months-old. Regarding the region of origin, the study included herds    fr
om properties located in all three Alagoas mesoregions: East, <i>Agreste</i>    
and <i>Sert&atilde;o</i>.</font></p>     ^cY#aop18-11.htm##
00614000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036800087002001300455#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#45#41#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The reaction of    indire
ct immunofluorescence (RIFI) technique was used for serological assays,    in ac
cordance the previously described method<sup>19</sup>. The serological    reacti
ons were considered positive when total fluorescence occurred at a dilution    o
f 1:64<sup>20</sup>.</font></p>     ^cY#aop18-11.htm##
01329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704108300087002001301170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#46#42#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">To study the possible    
risk factors of infection, questionnaires were applied consisting of objective  
  questions designed to elicit information regarding the breeder, general charac
teristics    regarding the property and herd, the management system, the sanitar
y situation    of the herd and reproductive management. From these data, identif
ication of    the risk factors associated with infection by <i>T. gondii</i> was
 conducted    by univariate analysis of the variables of interest using Pearson'
s Chi square    test or the Fisher exact test when necessary<sup>21</sup> and wh
en a positive    association was identified in the univariate analysis, multivar
iate analysis    was performed using the logistic regression model, considering 
the serological    status of the animal (positive or negative) for <i>T. gondii<
/i> as a dependent    variable. The SAS (Statistical Analysis System) program wa
s used to perform    the statistical calculations, with significance determined 
as p &gt; 0.05.</font></p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#47#43#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#48#44#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>RESULTS</b></font></p>
     ^cY#aop18-11.htm##
00633000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038700087002001300474#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#49#45#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"> total of 177 (39%)    of
 the 454 blood samples analyzed were positive for anti-<i>Toxoplasma gondii</i> 
   antibodies. Concerning titration, observation verified that 24 (13.6%) goats 
   presented titers of 64; 31 (17.5%), 128; 73 (41.3%), 256; 40 (22.5%), 512 and
    9 (5.1%) presented titers of 1,024.</font></p>     ^cY#aop18-11.htm##
00693000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044700087002001300534#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#50#46#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Of the 24 properties    a
nalyzed in this study, the presence of goats positive for <i>T. gondii</i>    wa
s a determined on 95.8%. In addition, of the 10 municipalities analyzed, nine   
 (90%) showed the presence of positive animals. Considering sex, predominance   
 of females was verified, which showed 40.3% (167/414) positivity against 25%   
 (10/40) for males.</font></p>     ^cY#aop18-11.htm##
00670000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704042400087002001300511#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#51#47#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The mesoregions    East a
nd <i>Agreste</i> showed high occurrences of 66.2% and 41.2%, respectively.    T
he extensive management system showed the highest prevalence (83.3%) among    se
ropositive goats; i.e., herds with more than 100 (80%) heads of goat and propert
ies    of less than 300 hectares (48.1%) <b>(<a href="#t1">Table 1</a>)</b>.</fo
nt></p>     ^cY#aop18-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#52#48#article#163#<p align
="center"><a name="t1"></a></p>     ^cY#aop18-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#53#49#article#163#<p align
="center">&nbsp;</p>     ^cY#aop18-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#54#50#article#163#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/18t01.jpg"></p>     ^cY#aop18
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#55#51#article#163#<p align
="center">&nbsp;</p>     ^cY#aop18-11.htm##
00808000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056200087002001300649#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#56#52#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Risk factors; i.e.,    wh
ether the variables sex, age, region, property size, number of animals and    re
aring system were associated or not with infection by <i>T. gondii</i>, were    
determined by univariate and multivariate analyses, as presented are in <b><a hr
ef="#t1">Tables    1</a></b> and <b><a href="#t2">2</a></b>. A significant assoc
iation was not    observed for the variable sex, despite the fact that prevalenc
e in females was    considerably higher than in males.</font></p>     ^cY#aop18-
11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#57#53#article#163#<p align
="center"><a name="t2"></a></p>     ^cY#aop18-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#58#54#article#163#<p align
="center">&nbsp;</p>     ^cY#aop18-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#59#55#article#163#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/18t02.jpg"></p>     ^cY#aop18
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#60#56#article#163#<p align
="center">&nbsp;</p>     ^cY#aop18-11.htm##
00764000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051800087002001300605#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#61#57#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">According to age    distr
ibution, high occurrence was observed among adult goats (27.6%, aged between    
13 and 24 months-old and 50.4% for age &gt; 24 months-old); however, no signific
ant    association was determined for this factor. In addition, the indices of o
ccurrence    verified in the mesoregions East (66.2%) and <i>Agreste</i> (41.2%)
 showed no    association with infection by <i>T. gondii</i> in the multivariate
 analysis.</font></p>     ^cY#aop18-11.htm##
00558000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031200087002001300399#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#62#58#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Considering property    s
ize, analysis verified that goats bred and raised in areas between 20 and 30ha  
  had significantly higher chance of being infected (OR = 3.46) compared to thos
e    living on properties larger than 200ha.</font></p>     ^cY#aop18-11.htm##
00709000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046300087002001300550#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#63#59#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Considering herd    size,
 higher occurrence was observed in herds with more than 100 (80%) heads    of go
at compared with those numbering less than 50 (48%) and between 50 and    100 (1
5.4%). In relation to rearing system, the goats maintained using semi-intensive 
   management showed a higher risk of infection by <i>T. gondii </i>(OR = 8.7)  
  compared to extensive management.</font></p>     ^cY#aop18-11.htm##
00828000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058200087002001300669#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#64#60#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The results of    the uni
variate and multivariate analyses regarding the variables water source,    feed,
 common drinkers for young and adult goats and common feeders for young    and a
dult goats are presented in <b><a href="#t2">Tables 2</a> </b>and<b> <a href="#t
3">3</a></b>.    Although univariate analysis verified significant associations 
for the variables    water source, common drinkers and common feeders for young 
and adult goats,    these were not confirmed in the multivariate analysis.</font
></p>     ^cY#aop18-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004800087002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#65#61#article#163#<p align
="center"><a name="t3"></a></p>     ^cY#aop18-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#66#62#article#163#<p align
="center">&nbsp;</p>     ^cY#aop18-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#67#63#article#163#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/18t03.jpg"></p>     ^cY#aop18
-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003700087002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#68#64#article#163#<p align
="center">&nbsp;</p>     ^cY#aop18-11.htm##
01096000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704085000087002001300937#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#69#65#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In relation to    the rep
roductive management and hygienic-sanitary variables, the presence of    goats w
ith reproductive disorders, the age at which the disorders appeared and    the k
ind of reproductive management adopted were significant in the univariate    ana
lysis <b>(<a href="/img/revistas/rsbmt/2011nahead/18t04.jpg">Table 4</a>)</b>. H
owever, only the    variable reproductive management showed a significant associ
ation in the multivariate    analysis. The adoption of a natural mating system i
ncreased the chance of infection    (OR = 6.49). Of the 24 properties, 17 (70.8%
) showed reproductive disorders,    with miscarriage being the most common probl
em observed (88.2%), followed by    retention of the placenta (5.9%) and repetit
ion of the rut (5.9%).</font></p>     ^cY#aop18-11.htm##
00689000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044300087002001300530#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#70#66#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Analysis of the    risk f
actors involving the definitive host of the agent verified that access    to wat
er provided for the goats by cats (OR = 3.38) and cats feeding on placental    r
emnants (OR = 2.73) were significant variables and associated with the risk    o
f infection by <i>T</i>. <i>gondii</i>, as demonstrated in <b><a href="#t2">Tabl
e    2</a></b>.</font></p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#71#67#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#72#68#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>DISCUSSION</b></font><
/p>     ^cY#aop18-11.htm##
01061000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704081500087002001300902#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#73#69#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The mean infection    occ
urrence (39%) determined in this study is above the national and regional    ave
rages of 29.3% and 27.6%, respectively. It is similar to that determined    in t
he municipality of Goi&acirc;nia (43.1%)<sup>22</sup>, in the microregion    of 
Londrina (30.7%)<sup>23</sup> and in the States of Bahia (28.9%)<sup>24</sup>,  
  Pernambuco (40.4%)<sup>25</sup>, Rio Grande do Norte (30.6%)<sup>13</sup> and 
   Minas Gerais (45.8%)<sup>7</sup>. These results also diverge from other works
    conducted in S&atilde;o Paulo (14.5%<sup>26</sup> and 28.7%<sup>14</sup>), U
berl&acirc;ndia    (19%)<sup>27</sup>, Bahia (16.4%)<sup>28</sup>, Para&iacute;b
a (24.5%)<sup>29</sup>    and in Cear&aacute; (25.1%)<sup>15</sup>.</font></p>  
   ^cY#aop18-11.htm##
00790000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054400087002001300631#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#74#70#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Given the geographical   
 dimensions of Brazil, significant climatic diversity can be a factor of influen
ce    in prevalence variations, as are the test used and the respective cutoff p
oint    adopted. Moreover, according to some authors<sup>14</sup>, goats maintai
ned    in suburban areas under precarious conditions of hygiene and in contact w
ith    people and their domestic animals are factors that can explain the increa
se    in seropositivity of the herd.</font></p>     ^cY#aop18-11.htm##
00702000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045600087002001300543#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#75#71#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Though not statistically 
   significant in the multivariate analysis, the higher prevalence observed in  
  females (40.4%) corroborates some studies<sup>7,10</sup>, but is in disagreeme
nt    with research in which the variable sex was a significant factor (OR = 2.9
1<sup>11</sup>    and OR = 1.73<sup>25</sup>) as a determinant of infection by <
i>T. gondii</i><sup>,</sup>.</font></p>     ^cY#aop18-11.htm##
00964000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071800087002001300805#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#76#72#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The hypothesis    that fe
males are more susceptible to infection, to severe forms of the disease    and s
how higher rates of mortality by <i>T. gondii</i> has mainly been reinforced    
in herds in forest areas that are characteristically hot and humid, which coinci
des    with the results of specific investigations<sup>9</sup>. Under controlled
 conditions    in the laboratory, a dichotomy in the susceptibility between male
s and females    is evident, revealing that physiological differences between ma
les and females,    mainly hormonal, play an important role in determining susce
ptibility to parasitic    infections<sup>30</sup>.</font></p>     ^cY#aop18-11.h
tm##
01219000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704097300087002001301060#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#77#73#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The results of    the mul
tivariate analysis demonstrate a positive association for adult goats    in rela
tion to young. Similar results were described by others, who also verified    th
at goats over one year-old presented a higher percentage of seropositivity    in
 relation to those aged less than 12 months-old<sup>11,22</sup>. Analysis    con
firmed that seropositivity was directly related to age<sup>14</sup> and the    a
ge factor was significant for the occurrence of infection by <i>T. gondii</i>   
 in goats aged over 24<sup>9</sup> and 36 months-old<sup>27</sup>. Given the    
time required to achieve subsistence goat breeding in the State of Alagoas,    i
t is probable that adult animals in the goat herds evaluated have been more    f
requently exposed to numerous predisposing factors or sources of infections    i
n the environment and, therefore, present a high infection index.</font></p>    
 ^cY#aop18-11.htm##
01519000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704127300087002001301360#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#78#74#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Although no significant  
  findings were determined in the multivariate analysis, among the mesoregions  
  studied, East and Agreste showed significant associations with infection by   
 <i>T. gondii</i> in the univariate analysis. The <i>Agreste</i> region of Alago
as    is a climatic transition zone between the East and the <i>Sert&atilde;o</i
>,    it has a semiarid climate that is considerably humid and the volume of rai
nfall    and the period of humidity is around 2.5-fold higher than the <i>Sert&a
tilde;o<sup>31</sup></i>.    This could be a relevant factor for higher rates of
 infection determined in    this study, in agreement with previous studies in th
e State of Bahia in Brazil<sup>24</sup>    and in countries like Spain<sup>8</su
p> and Thailand<sup>11</sup>, which showed    that regions of high humidity and 
milder temperatures favor higher prevalences.    However, in Africa, it would be
 a mistake to attribute differences in prevalence    to higher pluviometric indi
ces, such that attention should be focused on the    kind of soil and its vegeta
ble cover, which affect local humidity and provide    microclimates favorable to
 the maintenance of the oocysts<sup>10</sup>.</font></p>     ^cY#aop18-11.htm##
00849000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060300087002001300690#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#79#75#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In East Alagoas,    the c
limate is humid, coastal and tropical and the mean annual temperature of    arou
nd 25&deg;C, typical of the Atlantic Forest, is propitious for the maintenance  
  of oocysts of <i>T. gondii</i>, in agreement with results reported for the Sta
te    of Pernambuco<sup>25</sup>, Brazil, which has a climate similar to Alagoas
.    Most notable are comparisons between the Zona da Mata in Pernambuco and the
    East region of Alagoas, where higher indices of seropositivity were register
ed    for both.</font></p>     ^cY#aop18-11.htm##
00723000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047700087002001300564#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#80#76#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Concerning the    size of
 the properties studied, those between 30 and 200 hectares showed a significant 
   association with infection (OR = 3.46) in the multivariate analysis. In these
    kinds of properties, the goats generally pasture at greater distances, facil
itating    their contact with areas that can be frequented by domestic or wild f
eline and    contamination by sporulated oocysts.</font></p>     ^cY#aop18-11.ht
m##
01268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704102200087002001301109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#81#77#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The management    of a pr
operty oriented by animal production constitutes a fundamental role in    prophy
laxis or as potential factor regarding the dissemination of disease in    the he
rd. In this study, the semi-intensive management system proved to be a    risk f
actor that was significantly associated with infection by <i>T. gondii    </i>(O
R = 8.7). This rearing system permits contact between goats and oocysts    excre
ted in the feces of the wild or domestic felines, thus increasing the probabilit
y    of infection. Similarly, in the State of Rio Grande do Norte, it was observ
ed    that the system of extensive management (OR = 1.18) was associated with in
fection<sup>13</sup>,    also previously demonstrated in the State of Cear&aacut
e;<sup>15</sup>, particularly    in regions with poor socioeconomic conditions, 
where goat raising consists subsistence    breeding and where it is common for t
he goats to be confined overnight.</font></p>     ^cY#aop18-11.htm##
00831000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058500087002001300672#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#82#78#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The presence of    goats 
with reproductive disorders and aged between one and three years-old on    the p
roperties showed a significant association in the univariate analysis,    even t
hough this was not confirmed in the multivariate analysis. Females of    this ag
e are more susceptible and reproductive disorders in this phase become    more e
vident in the herd<sup>9,27</sup>. In most herds, fetal losses occur in    femal
es of similar age, particularly among those over three years-old<sup>4</sup>.</f
ont></p>     ^cY#aop18-11.htm##
00773000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704052700087002001300614#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#83#79#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The property variable    
regarding the adoption of a natural mating system increased the risk of infectio
n    (OR = 6.49) by <i>T. gondii</i>. Even in the light of this result, is not p
ossible    to definitively conclude that venereal transmission occurred in this 
study,    although one study involving goats experimentally infected with <i>T. 
gondii</i>    verified that males can excrete the parasite in semen for up to 52
 days<sup>33</sup>.</font></p>     ^cY#aop18-11.htm##
01266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704102000087002001301107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#84#80#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Although the mere    pres
ence of cats on the property did not constitute a risk factor in this study,    
certain characteristics associated with the habitual behavior of cats were signi
ficant,    including access to water consumed by the herd (OR = 3.38) and the fa
ct that    cats feed on the placental remnants (OR = 2.73). The presence of cats
 has been    considered a risk factor for toxoplasmosis in goats<sup>15</sup>. I
n a study    on goats in Texas, USA, nondetection of anti-<i>T. gondii</i> antib
odies was    attributed to the absence of cats on the properties of that region<
sup>33</sup>.    In other similar studies, the higher prevalences verified in go
at herds was    associated with the presence of a high density population of cat
s, pets, rodents    and humans on the properties, providing high availability of
 definitive intermediate    hosts for the parasite, thus increasing the chances 
of infection<sup>10,15,24</sup>.</font></p>     ^cY#aop18-11.htm##
00828000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704058200087002001300669#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#85#81#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The occurrence    of anti
bodies against <i>T. gondii</i> in goats in the State of Alagoas was    reported
 for the first time. Based on the risk factors identified, a state-wide    monit
oring program that focus on preventing infection is required and should    inclu
de determination of the serological status of all herds and the development    o
f educational projects emphasizing the risk factors identified in this study,   
 in order to promote better sanitary conditions for goat herds in Alagoas.</font
></p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#86#82#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011300087002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#87#83#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>CONFLICT OF    INTERES
T</b></font></p>     ^cY#aop18-11.htm##
00390000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014400087002001300231#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#88#84#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors declare    th
at there is no conflict of interest.</font></p>     ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#89#85#article#163#<p>&nbsp
;</p>     ^cY#aop18-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#90#86#article#163#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>REFERENCES</b></font><
/p>     ^cY#aop18-11.htm##
00460000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020000089002001300289#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#91#87#article#
163#1#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Tenter A
M, Heckeroth    AR, Weiss LM. <i>Toxoplasma gondii</i>: from animals to humans. 
Int J Parasitol    2000; 30:1217-1258.    ^cY#aop18-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#92#88#article#163#</font><
/p>     ^cY#aop18-11.htm##
00516000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704025600089002001300345#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#93#89#article#
163#2#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Dubey JP
, Rollor    EA, Smith K, Kwok OC, Thulliez P. Low seroprevalence of <i>Toxoplasm
a gondii</i>    in feral pigs from a remote island lacking cats. J Parasitol 199
7; 83:839-841.    ^cY#aop18-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#94#90#article#163#</font><
/p>     ^cY#aop18-11.htm##
00437000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704017700089002001300266#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#95#91#article#
163#3#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Dubey JP
. Lesions    in transplacentally induced toxoplasmosis in goats. Am J Vet Res 19
88; 49:905-909.    ^cY#aop18-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#96#92#article#163#</font><
/p>     ^cY#aop18-11.htm##
00565000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030500089002001300394#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#97#93#article#
163#4#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Engeland
 IV,    Waldeland H, Kindahl H, Ropstad E, Andresen O. Effect of <i>Toxoplasma g
ondii</i>    infection on the development of pregnancy and on endocrine foetal-p
lacental    function in the goat. Vet Parasitol 1996; 67:61-74.    ^cY#aop18-11.
htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#98#94#article#163#</font><
/p>     ^cY#aop18-11.htm##
00481000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022100089002001300310#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#99#95#article#
163#5#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Dubey JP
, Adams    DS. Prevalence of <i>Toxoplasma gondii</i> antibodies in dairy goats 
from 1982    to 1984. J Am Vet Med Assoc 1990; 196:295-296.    ^cY#aop18-11.htm#
#
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#100#96#article#163#</font>
</p>     ^cY#aop18-11.htm##
00482000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704022100090002001300311#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#101#97#article
#163#6#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Nieto S
O, Mel&eacute;ndez    RD. Seroprevalence of <i>Toxoplasma gondii</i> in goats fr
om arid zones of Venezuela.    J Parasitol 1998; 84:190-191.    ^cY#aop18-11.htm
##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#102#98#article#163#</font>
</p>     ^cY#aop18-11.htm##
00554000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704029300090002001300383#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#103#99#article
#163#7#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Carneir
o ACAV,    Carneiro M, Gouveia AMG, Guimar&atilde;es AS, Marques APR, Vilas-Boas
 LS, et    al. Seroprevalence and risk factors of caprine toxoplasmosis in Minas
 Gerais,    Brazil. Vet Parasitol 2009; 160:225-229.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#104#100#article#163#</font
></p>     ^cY#aop18-11.htm##
00491000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704022900091002001300320#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#105#101#articl
e#163#8#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Rodrig
uez-Ponce    E, Molina JM, Hern&aacute;ndez S. Seroprevalence of goat toxoplasmo
sis on Grand    Canary Island (Spain). Prev Vet Med 1995; 24:229-234.    ^cY#aop
18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#106#102#article#163#</font
></p>     ^cY#aop18-11.htm##
00525000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000200089704026300091002001300354#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#107#103#articl
e#163#9#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Van De
r Puije    WNA, Bosompem KM, Canacoo EA, Wastling JM, Akanmori BD. The prevalenc
e of anti-<i>Toxoplasma    gondii</i> antibodies in Ghanaian sheep and goats. Ac
ta Trop 2000; 76:21-26.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#108#104#article#163#</font
></p>     ^cY#aop18-11.htm##
00510000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024700092002001300339#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#109#105#articl
e#163#10#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Biss
on A, Maley    S, Rubaire-Akiiki CM, Wastling JM. The seroprevalence of antibodi
es to <i>Toxoplasma    gondii</i> in domestic goats in Uganda. Acta Trop 2000; 7
6:33-38.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#110#106#article#163#</font
></p>     ^cY#aop18-11.htm##
00574000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031100092002001300403#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#111#107#articl
e#163#11#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Jitt
apalapong    S, Sangvaranonda A, Pinyopanuwata N, Chimnoia W, Khachaeramb W, Koi
zumic S,    et al. Seroprevalence of <i>Toxoplasma gondii</i> infection in domes
tic goats    in Satun Province, Thailand. Vet Parasitol 2005; 127:17-22.    ^cY#
aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#112#108#article#163#</font
></p>     ^cY#aop18-11.htm##
00579000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031600092002001300408#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#113#109#articl
e#163#12#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Pesc
ador CA,    Oliveira EC, Pedroso PMO, Bandarra PM, Okuda LH, Corbellini LG, et a
l. Perdas    reprodutivas associadas com infec&ccedil;&atilde;o por <i>Toxoplasm
a gondii</i>    em caprinos no sul do Brasil. Pesq Vet Bras 2007; 27:167-171.   
 ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#114#110#article#163#</font
></p>     ^cY#aop18-11.htm##
00644000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704038100092002001300473#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#115#111#articl
e#163#13#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Neto
 JOA, Azevedo    SS, Gennari SM, Funada MR, Pena HFJ, Ara&uacute;jo ARCP, et al.
 Prevalence and    risk factors for anti-<i>Toxoplasma gondii</i> antibodies in 
goats of the Serid&oacute;    Oriental microregion, Rio Grande do Norte state, N
ortheast region of Brazil.    Vet Parasitol 2008; 156:329-332.    ^cY#aop18-11.h
tm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#116#112#article#163#</font
></p>     ^cY#aop18-11.htm##
00583000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704032000092002001300412#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#117#113#articl
e#163#14#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Figl
iuolo LPC,    Rodrigues AAR, Viana RB, Aguiar DM, Kasai N, Gennari SM. Prevalenc
e of anti-<i>Toxoplasma    gondii</i> and anti-<i>Neospora caninum</i> antibodie
s in goat from S&atilde;o    Paulo State, Brazil. Small Rumin Res 2004; 55:29-32
.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#118#114#article#163#</font
></p>     ^cY#aop18-11.htm##
00549000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028600092002001300378#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#119#115#articl
e#163#15#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15. Cava
lcante    ACR, Carneiro M, Gouveia AMG, Pinheiro RR, Vitor RWA. Risk factors for
 infection    by <i>Toxoplasma gondii</i> in herds of goats in Cear&aacute;, Bra
zil. Arq Bras    Med Vet Zootec 2008; 60:36-41.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#120#116#article#163#</font
></p>     ^cY#aop18-11.htm##
00539000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027600092002001300368#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#121#117#articl
e#163#16#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16. Univ
ersidade    Federal de Alagoas. Departamento de Geografia e Meio Ambiente, Atlas
 Geogr&aacute;fico    de Estado de Alagoas. Alagoas: Editora da Universidade Fed
eral de Alagoas (EDUFAL);    1994<i>.    ^cY#aop18-11.htm##
00272000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002400089002001300113#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#122#118#article#163#</i></
font></p>     ^cY#aop18-11.htm##
00686000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704042300092002001300515#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#123#119#articl
e#163#17#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Inst
ituto Brasileiro    de Geografia e Estat&iacute;stica &#91;internet&#93;. Geoci&
ecirc;ncias: &Aacute;rea    Territorial Oficial. &#91;Cited 2010 mar 3&#93; Avai
lable from: <a href="http://www.ibge.gov.br/home/geociencias/areaterritorial/pri
ncipal.shtm" target="_blank">http://www.ibge.gov.br/home/geociencias/areaterrito
rial/principal.shtm</a>.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#124#120#article#163#</font
></p>     ^cY#aop18-11.htm##
00427000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704016400092002001300256#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#125#121#articl
e#163#18#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18. Thru
sfield    MV. Epidemiologia Veterin&aacute;ria. 2nd ed. S&atilde;o Paulo: Roca; 
2004.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#126#122#article#163#</font
></p>     ^cY#aop18-11.htm##
00473000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021000092002001300302#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#127#123#articl
e#163#19#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19. Cama
rgo ME.    Introdu&ccedil;&atilde;o &agrave;s t&eacute;cnicas de imunofluoresc&e
circ;ncia.    Rev Bras Patol Clin 1974; 10:143-171.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#128#124#article#163#</font
></p>     ^cY#aop18-11.htm##
00574000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031100092002001300403#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#129#125#articl
e#163#20#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20. Garc
ia JL,    Navarro IT, Ogawa L, Oliveira RC. Soroepidemiologia da toxoplasmose em
 gatos    e c&atilde;es de propriedades rurais do munic&iacute;pio de Jaguapit&a
tilde;,    Estado do Paran&aacute;, Brazil. Cienc Rural 1999; 29:99-104.    ^cY#
aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#130#126#article#163#</font
></p>     ^cY#aop18-11.htm##
00414000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704015100092002001300243#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#131#127#articl
e#163#21#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21. Zar 
JH. Biostatistical    analysis. 4th ed. New Jersey: Prentice Hall; 1999.    ^cY#
aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#132#128#article#163#</font
></p>     ^cY#aop18-11.htm##
00551000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028800092002001300380#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#133#129#articl
e#163#22#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">22. Linh
ares GFC,    Dias MJ, Souza AM, Dias Filho FC. Anticorpos anti-<i>Toxoplasma gon
dii</i> em    caprinos no munic&iacute;pio de Goi&acirc;nia: levantamento sorol&
oacute;gico.    An Esc Agron Vet 1990; 20: 31-37.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#134#130#article#163#</font
></p>     ^cY#aop18-11.htm##
00620000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035700092002001300449#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#135#131#articl
e#163#23#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">23. Sell
a MZ, Navarro    JT, Vidotto O, Freire RL, Shida PN. Epidemiologia da toxoplasmo
se caprina: levantamento    sorol&oacute;gico do <i>Toxoplasma gondii</i> em cap
rinos leiteiros na micro    regi&atilde;o de Londrina, Paran&aacute;, Brasil. Re
v Bras Parasitol Vet 1994;    3:13-16.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#136#132#article#163#</font
></p>     ^cY#aop18-11.htm##
00574000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031100092002001300403#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#137#133#articl
e#163#24#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">24. Gond
im LFP,    Barbosa J&uacute;nior HV, Ribeiro Filho CHAH, Saeki H. Serological su
rvey of    antibodies to <i>Toxoplasma gondii</i> in goats, sheep, cattle and wa
ter buffaloes    in Bahia State, Brazil. Vet Parasitol 1999; 82:273-276.    ^cY#
aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#138#134#article#163#</font
></p>     ^cY#aop18-11.htm##
00568000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030500092002001300397#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#139#135#articl
e#163#25#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">25. Silv
a AV, Cunha    ELP, Meireles LR, Gottschalk S, Mota RA, Langoni H. Toxoplasmose 
em ovinos e    caprinos: estudo soroepidemiol&oacute;gico em duas regi&otilde;es
 do Estado    de Pernambuco, Brasil. Cienc Rural 2003; 33:115-119.    ^cY#aop18-
11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#140#136#article#163#</font
></p>     ^cY#aop18-11.htm##
00551000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704028800092002001300380#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#141#137#articl
e#163#26#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">26. Main
ardi RS,    Stachissini AVM, Langoni H, Padovani CR, Modolo JR. Soropreval&ecirc
;ncia de    <i>Toxoplasma gondii</i> em rebanhos caprinos no Estado de S&atilde;
o Paulo.    Rev Bras Parasitol Vet 2000; 9:97-99.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#142#138#article#163#</font
></p>     ^cY#aop18-11.htm##
00621000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035800092002001300450#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#143#139#articl
e#163#27#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">27. Figu
eiredo    JF, Silva DAO, Cabral DD, Mineo JR. Seroprevalence of <i>Toxoplasma go
ndii</i>    Infection in Goats by the Indirect Haemagglutination, Immunofluoresc
ence and    Immunoenzymatic Tests in the Region of Uberl&acirc;ndia, Brazil. Mem
 Inst Oswaldo    Cruz 2001; 96:687-692.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#144#140#article#163#</font
></p>     ^cY#aop18-11.htm##
00618000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704035500092002001300447#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#145#141#articl
e#163#28#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">28. Uz&e
circ;da    RS, Fern&aacute;ndez SY, Jesus EEV, Pinheiro AM, Ayres MCC, Spinola S
, et al.    Fatores relacionados &agrave; presen&ccedil;a de anticorpos IgG anti
-<i>Toxoplasma    gondii</i> em caprinos leiteiros do Estado da Bahia. Rev Bras 
Sa&uacute;de Prod    An 2004; 5:1-8.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#146#142#article#163#</font
></p>     ^cY#aop18-11.htm##
00654000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704039100092002001300483#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#147#143#articl
e#163#29#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">29. Fari
a EB, Gennari    SM, Pena HFP, Athayde ACR, Silva MLCR, Azevedo SS. Prevalence o
f anti-<i>Toxoplasma    gondii</i> and anti<i>-Neospora caninum</i> antibodies i
n goats slaughtered    in the public slaughterhouse of Patos city, Para&iacute;b
a State, Northeast    region of Brazil. Vet Parasitol 2007; 149:126-129.    ^cY#
aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#148#144#article#163#</font
></p>     ^cY#aop18-11.htm##
00476000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021300092002001300305#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#149#145#articl
e#163#30#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">30. Robe
rts CW,    Walker W, Alexander J. Sex-Associated Hormones and Immunity to Protoz
oan Parasites.    Clin Microbiol Rev 2001; 14:476-488.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#150#146#article#163#</font
></p>     ^cY#aop18-11.htm##
00645000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704038200092002001300474#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#151#147#articl
e#163#31#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">31. Di P
ace FT,    Di Pace EL. Avalia&ccedil;&atilde;o da Esta&ccedil;&atilde;o de Cresc
imento    no Sert&atilde;o, Agreste, Zona da Mata e Litoral Alagoano. Florian&oa
cute;polis    (SC): XI Congresso Brasileiro de Agrometeorologia. II Reuni&atilde
;o Latino-Americana    de Agrometeorologia; 1999. p. 1123-1128.    ^cY#aop18-11.
htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#152#148#article#163#</font
></p>     ^cY#aop18-11.htm##
00469000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704020600092002001300298#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#153#149#articl
e#163#32#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">32. Dube
y JP, Sharma    SP. Prolonged excretion of <i>Toxoplasma gondii</i> in semen of 
goats<i>.</i>    Am J Vet Res 1980; 41:794-795.    ^cY#aop18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#154#150#article#163#</font
></p>     ^cY#aop18-11.htm##
00492000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022900092002001300321#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#155#151#articl
e#163#33#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">33. Dube
y JP, Livingston    Jr CW. Sarcocystis capracanis and <i>Toxoplasma gondii</i> i
nfections in range    goats from Texas. Am J Vet Res 1986; 47:523-524.    ^cY#ao
p18-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#156#152#article#163#</font
></p>     ^cY#aop18-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#157#153#article#163#<p>&nb
sp;</p>     ^cY#aop18-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#158#154#article#163#<p>&nb
sp;</p>     ^cY#aop18-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018900089002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#159#155#article#163#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><
a href="#top"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a>
    Address to:    ^cY#aop18-11.htm##
00293000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004500089002001300134#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#160#156#article#163#<br>  
 </b>Dr. Rinaldo Aparecido Mota    ^cY#aop18-11.htm##
00302000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005400089002001300143#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#161#157#article#163#<br>  
 Deptº Medicina Veterin&aacute;ria/UFRPE    ^cY#aop18-11.htm##
00293000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004500089002001300134#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#162#158#article#163#<br>  
 Rua Dom Manuel de Medeiros s/n    ^cY#aop18-11.htm##
00291000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004300089002001300132#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#163#159#article#163#<br>  
 52171-900 Recife, PE, Brasil    ^cY#aop18-11.htm##
00307000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005900089002001300148#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#164#160#article#163#<br>  
 Phone: 55 81 3320-6425; Fax: 55 81 3320-6402    ^cY#aop18-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704010500089002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#165#161#article#163#<br>  
 e-mail: <a href="mailto:rinaldo.mota@hotmail.com">rinaldo.mota@hotmail.com</a><
/font></p>     ^cY#aop18-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#166#162#article#163#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">Received in 12/01/2010 
   ^cY#aop18-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#p#167#163#article#163#<br>  
 Accepted in 16/11/2010</font></p>     ^cY#aop18-11.htm##
00568000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100020001050100
01600125012004600141030001600187065000900203064000500212031000300217014001000220
865000900230002001300239035001000252801001600262#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop18-11.htm#S#c#168#1#article#33#1#^rND^sTenter^nAM#^rND^s
Heckeroth^nAR#^rND^sWeiss^nLM#Toxoplasma gondii: from animals to humans^lpt#Int 
J Parasitol#20000000#2000#30#1217-1258#20110000#aop18-11.htm#0020-7519#Int J Par
asitol##
00656000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100017001040100
01500121010001500136010001800151012009200169030001200261065000900273064000500282
031000300287014000800290865000900298002001300307035001000320801001200330#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#169#2#article#33#2
#^rND^sDubey^nJP#^rND^sRollor^nEA#^rND^sSmith^nK#^rND^sKwok^nOC#^rND^sThulliez^n
P#Low seroprevalence of Toxoplasma gondii in feral pigs from a remote island lac
king cats^len#J Parasitol#19970000#1997#83#839-841#20110000#aop18-11.htm#0022-33
95#J Parasitol##
00516000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120063001040300
01300167065000900180064000500189031000300194014000800197865000900205002001300214
035001000227801001300237#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
18-11.htm#S#c#170#3#article#33#3#^rND^sDubey^nJP#Lesions in transplacentally ind
uced toxoplasmosis in goats^len#Am J Vet Res#19880000#1988#49#905-909#20110000#a
op18-11.htm#0002-9645#Am J Vet Res##
00704000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100019000880100019001070100
01700126010001700143010001800160012012900178030001400307065000900321064000500330
031000300335014000600338865000900344002001300353035001000366801001400376#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#171#4#article#33#4
#^rND^sEngeland^nIV#^rND^sWaldeland^nH#^rND^sKindahl^nH#^rND^sRopstad^nE#^rND^sA
ndresen^nO#Effect of Toxoplasma gondii infection on the development of pregnancy
 and on endocrine foetal-placental function in the goat^len#Vet Parasitol#199600
00#1996#67#61-74#20110000#aop18-11.htm#0304-4017#Vet Parasitol##
00574000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100016001040120
08000120030001900200065000900219064000500228031000400233014000800237865000900245
002001300254035001000267801001900277#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop18-11.htm#S#c#172#5#article#33#5#^rND^sDubey^nJP#^rND^sAdams^nDS#Pre
valence of Toxoplasma gondii antibodies in dairy goats from 1982 to 1984^len#J A
m Vet Med Assoc#19900000#1990#196#295-296#20110000#aop18-11.htm#0003-1488#J Am V
et Med Assoc##
00560000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100019001040120
07800123030001200201065000900213064000500222031000300227014000800230865000900238
002001300247035001000260801001200270#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop18-11.htm#S#c#173#6#article#33#6#^rND^sNieto^nSO#^rND^sMeléndez^nRD#
Seroprevalence of Toxoplasma gondii in goats from arid zones of Venezuela^len#J 
Parasitol#19980000#1998#84#190-191#20110000#aop18-11.htm#0022-3395#J Parasitol##
00721000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100018001090100
01900127010002000146010001900166010002100185810000600206012008500212030001400297
06500090031106400050032003100040032501400080032986500090033700200130034603500100
0359801001400369#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.ht
m#S#c#174#7#article#33#7#^rND^sCarneiro^nACAV#^rND^sCarneiro^nM#^rND^sGouveia^nA
MG#^rND^sGuimarães^nAS#^rND^sMarques^nAPR#^rND^sVilas-Boas^nLS#et al#Seroprevale
nce and risk factors of caprine toxoplasmosis in Minas Gerais, Brazil^len#Vet Pa
rasitol#20090000#2009#160#225-229#20110000#aop18-11.htm#0304-4017#Vet Parasitol#
#
00594000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100025000880100017001130100
01900130012007200149030001300221065000900234064000500243031000300248014000800251
865000900259002001300268035001000281801001300291#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop18-11.htm#S#c#175#8#article#33#8#^rND^sRodriguez-Ponce^n
E#^rND^sMolina^nJM#^rND^sHernández^nS#Seroprevalence of goat toxoplasmosis on Gr
and Canary Island (Spain)^len#Prev Vet Med#19950000#1995#24#229-234#20110000#aop
18-11.htm#0167-5877#Prev Vet Med##
00661000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100025000880100019001130100
01800132010001900150010001900169012008400188030001000272065000900282064000500291
031000300296014000600299865000900305002001300314035001000327801001000337#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#176#9#article#33#9
#^rND^sVan Der Puije^nWNA#^rND^sBosompem^nKM#^rND^sCanacoo^nEA#^rND^sWastling^nJ
M#^rND^sAkanmori^nBD#The prevalence of anti-Toxoplasma gondii antibodies in Ghan
aian sheep and goats^len#Acta Trop#20000000#2000#76#21-26#20110000#aop18-11.htm#
0001-706X#Acta Trop##
00628000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100015001060100
02500121010001900146012008600165030001000251065000900261064000500270031000300275
014000600278865000900284002001300293035001000306801001000316#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#177#10#article#33#10#^rND^sBis
son^nA#^rND^sMaley^nS#^rND^sRubaire-Akiiki^nCM#^rND^sWastling^nJM#The seropreval
ence of antibodies to Toxoplasma gondii in domestic goats in Uganda^len#Acta Tro
p#20000000#2000#76#33-38#20110000#aop18-11.htm#0001-706X#Acta Trop##
00740000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100023000900100023001130100
02300136010001800159010002100177010001800198810000600216012009600222030001400318
06500090033206400050034103100040034601400060035086500090035600200130036503500100
0378801001400388#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.ht
m#S#c#178#11#article#33#11#^rND^sJittapalapong^nS#^rND^sSangvaranonda^nA#^rND^sP
inyopanuwata^nN#^rND^sChimnoia^nW#^rND^sKhachaeramb^nW#^rND^sKoizumic^nS#et al#S
eroprevalence of Toxoplasma gondii infection in domestic goats in Satun Province
, Thailand^len#Vet Parasitol#20050000#2005#127#17-22#20110000#aop18-11.htm#0304-
4017#Vet Parasitol##
00697000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100019001090100
01900128010001900147010001600166010002100182810000600203012009900209030001400308
71000020032206500090032406400050033303100030033801400080034186500090034900200130
0358#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#179#12
#article#33#12#^rND^sPescador^nCA#^rND^sOliveira^nEC#^rND^sPedroso^nPMO#^rND^sBa
ndarra^nPM#^rND^sOkuda^nLH#^rND^sCorbellini^nLG#et al#Perdas reprodutivas associ
adas com infecção por Toxoplasma gondii em caprinos no sul do Brasil^lpt#Pesq Ve
t Bras#2#20070000#2007#27#167-171#20110000#aop18-11.htm##
00793000000000337000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01800124010001700142010001600159010001900175810000600194012016900200030001400369
06500090038306400050039203100040039701400080040186500090040900200130041803500100
0431801001400441#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.ht
m#S#c#180#13#article#33#13#^rND^sNeto^nJOA#^rND^sAzevedo^nSS#^rND^sGennari^nSM#^
rND^sFunada^nMR#^rND^sPena^nHFJ#^rND^sAraújo^nARCP#et al#Prevalence and risk fac
tors for anti-Toxoplasma gondii antibodies in goats of the Seridó Oriental micro
region, Rio Grande do Norte state, Northeast region of Brazil^len#Vet Parasitol#
20080000#2008#156#329-332#20110000#aop18-11.htm#0304-4017#Vet Parasitol##
00690000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100021001110100
01600132010001700148010001500165010001800180012011500198030001600313710000200329
065000900331064000500340031000300345014000600348865000900354002001300363#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#181#14#article#33#
14#^rND^sFigliuolo^nLPC#^rND^sRodrigues^nAAR#^rND^sViana^nRB#^rND^sAguiar^nDM#^r
ND^sKasai^nN#^rND^sGennari^nSM#Prevalence of anti-Toxoplasma gondii and anti-Neo
spora caninum antibodies in goat from São Paulo State, Brazil^len#Small Rumin Re
s#2#20040000#2004#55#29-32#20110000#aop18-11.htm##
00645000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100022000900100018001120100
01900130010001900149010001700168012008700185030002400272710000200296065000900298
064000500307031000300312014000600315865000900321002001300330#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#182#15#article#33#15#^rND^sCav
alcante^nACR#^rND^sCarneiro^nM#^rND^sGouveia^nAMG#^rND^sPinheiro^nRR#^rND^sVitor
^nRWA#Risk factors for infection by Toxoplasma gondii in herds of goats in Ceará
, Brazil^len#Arq Bras Med Vet Zootec#2#20080000#2008#60#36-41#20110000#aop18-11.
htm##
00543000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170075000900180042001650660
00800207062004300215062000700258065000900265064000500274865000900279002001300288
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#183#16#art
icle#33#16#Universidade Federal de Alagoas^dDepartamento de Geografia e Meio Amb
iente#Atlas Geográfico de Estado de Alagoas^lpt#Alagoas#Editora da Universidade 
Federal de Alagoas#EDUFAL#19940000#1994#20110000#aop18-11.htm##
00511000000000217000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170048000900180042001381100
00900180109001100189037007100200865000900271002001300280#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#184#17#article#33#17#Instituto Bra
sileiro de Geografia e Estatística#Geociências: Área Territorial Oficial^lpt#201
00303#2010 mar 3#http://www.ibge.gov.br/home/geociencias/areaterritorial/princip
al.shtm#20110000#aop18-11.htm##
00436000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160021000900180030001110630
00200141066001000143062000500153065000900158064000500167865000900172002001300181
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#185#18#art
icle#33#18#^rND^sThrusfield^nMV#Epidemiologia Veterinária^lpt#2#São Paulo#Roca#2
0040000#2004#20110000#aop18-11.htm##
00480000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900120049001080300
02000157710000200177065000900179064000500188031000300193014000800196865000900204
002001300213#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#
c#186#19#article#33#19#^rND^sCamargo^nME#Introdução às técnicas de imunofluoresc
ência^lpt#Rev Bras Patol Clin#2#19740000#1974#10#143-171#20110000#aop18-11.htm##
00638000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
01500125010001900140012012900159030001200288710000200300065000900302064000500311
031000300316014000700319865000900326002001300335#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop18-11.htm#S#c#187#20#article#33#20#^rND^sGarcia^nJL#^rND
^sNavarro^nIT#^rND^sOgawa^nL#^rND^sOliveira^nRC#Soroepidemiologia da toxoplasmos
e em gatos e cães de propriedades rurais do município de Jaguapitã, Estado do Pa
raná, Brazil^lpt#Cienc Rural#2#19990000#1999#29#99-104#20110000#aop18-11.htm##
00437000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160014000900180028001040630
00200132066001100134062001400145065000900159064000500168865000900173002001300182
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#188#21#art
icle#33#21#^rND^sZar^nJH#Biostatistical analysis^len#4#New Jersey#Prentice Hall#
19990000#1999#20110000#aop18-11.htm##
00615000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100020000900100015001100100
01600125010002100141012009900162030001700261710000200278065000900280064000500289
031000300294014000600297865000900303002001300312#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop18-11.htm#S#c#189#22#article#33#22#^rND^sLinhares^nGFC#^
rND^sDias^nMJ#^rND^sSouza^nAM#^rND^sDias Filho^nFC#Anticorpos anti-Toxoplasma go
ndii em caprinos no município de Goiânia: levantamento sorológico^lpt#An Esc Agr
on Vet#2#19900000#1990#20#31-37#20110000#aop18-11.htm##
00699000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01700124010001700141010001600158012015400174030002300328710000200351065000900353
064000500362031000200367014000600369865000900375002001300384#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#190#23#article#33#23#^rND^sSel
la^nMZ#^rND^sNavarro^nJT#^rND^sVidotto^nO#^rND^sFreire^nRL#^rND^sShida^nPN#Epide
miologia da toxoplasmose caprina: levantamento sorológico do Toxoplasma gondii e
m caprinos leiteiros na micro região de Londrina, Paraná, Brasil^lpt#Rev Bras Pa
rasitol Vet#2#19940000#1994#3#13-16#20110000#aop18-11.htm##
00686000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100025001080100
02600133010001500159012012500174030001400299065000900313064000500322031000300327
014000800330865000900338002001300347035001000360801001400370#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#191#24#article#33#24#^rND^sGon
dim^nLFP#^rND^sBarbosa Júnior^nHV#^rND^sRibeiro Filho^nCHAH#^rND^sSaeki^nH#Serol
ogical survey of antibodies to Toxoplasma gondii in goats, sheep, cattle and wat
er buffaloes in Bahia State, Brazil^len#Vet Parasitol#19990000#1999#82#273-276#2
0110000#aop18-11.htm#0304-4017#Vet Parasitol##
00682000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060100
01900123010002000142010001500162010001700177012011300194030001200307710000200319
065000900321064000500330031000300335014000800338865000900346002001300355#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#192#25#article#33#
25#^rND^sSilva^nAV#^rND^sCunha^nELP#^rND^sMeireles^nLR#^rND^sGottschalk^nS#^rND^
sMota^nRA#^rND^sLangoni^nH#Toxoplasmose em ovinos e caprinos: estudo soroepidemi
ológico em duas regiões do Estado de Pernambuco, Brasil^lpt#Cienc Rural#2#200300
00#2003#33#115-119#20110000#aop18-11.htm##
00641000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100023001090100
01700132010001900149010001700168012008500185030002300270710000200293065000900295
064000500304031000200309014000600311865000900317002001300326#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#193#26#article#33#26#^rND^sMai
nardi^nRS#^rND^sStachissini^nAVM#^rND^sLangoni^nH#^rND^sPadovani^nCR#^rND^sModol
o^nJR#Soroprevalência de Toxoplasma gondii em rebanhos caprinos no Estado de São
 Paulo^lpt#Rev Bras Parasitol Vet#2#20000000#2000#9#97-99#20110000#aop18-11.htm#
#
00739000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100017001110100
01700128010001600145012017500161030002200336065000900358064000500367031000300372
014000800375865000900383002001300392035001000405801002200415#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#194#27#article#33#27#^rND^sFig
ueiredo^nJF#^rND^sSilva^nDAO#^rND^sCabral^nDD#^rND^sMineo^nJR#Seroprevalence of 
Toxoplasma gondii Infection in Goats by the Indirect Haemagglutination, Immunofl
uorescence and Immunoenzymatic Tests in the Region of Uberlândia, Brazil^len#Mem
 Inst Oswaldo Cruz#20010000#2001#96#687-692#20110000#aop18-11.htm#0074-0276#Mem 
Inst Oswaldo Cruz##
00713000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100020001060100
01700126010001900143010001700162010001700179810000600196012011800202030002300320
71000020034306500090034506400050035403100020035901400040036186500090036500200130
0374#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#195#28
#article#33#28#^rND^sUzêda^nRS#^rND^sFernández^nSY#^rND^sJesus^nEEV#^rND^sPinhei
ro^nAM#^rND^sAyres^nMCC#^rND^sSpinola^nS#et al#Fatores relacionados à presença d
e anticorpos IgG anti-Toxoplasma gondii em caprinos leiteiros do Estado da Bahia
^lpt#Rev Bras Saúde Prod An#2#20040000#2004#5#1-8#20110000#aop18-11.htm##
00792000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01600124010001900140010001800159010001800177012018500195030001400380065000900394
06400050040303100040040801400080041286500090042000200130042903500100044280100140
0452#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop18-11.htm#S#c#196#29
#article#33#29#^rND^sFaria^nEB#^rND^sGennari^nSM#^rND^sPena^nHFP#^rND^sAthayde^n
ACR#^rND^sSilva^nMLCR#^rND^sAzevedo^nSS#Prevalence of anti-Toxoplasma gondii and
 anti-Neospora caninum antibodies in goats slaughtered in the public slaughterho
use of Patos city, Paraíba State, Northeast region of Brazil^len#Vet Parasitol#2
0070000#2007#149#126-129#20110000#aop18-11.htm#0304-4017#Vet Parasitol##
00592000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100016001080100
01900124012006400143030001900207065000900226064000500235031000300240014000800243
865000900251002001300260035001000273801001900283#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop18-11.htm#S#c#197#30#article#33#30#^rND^sRoberts^nCW#^rN
D^sWalker^nW#^rND^sAlexander^nJ#Sex-Associated Hormones and Immunity to Protozoa
n Parasites^len#Clin Microbiol Rev#20010000#2001#14#476-488#20110000#aop18-11.ht
m#0893-8512#Clin Microbiol Rev##
00654000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900160018001080180
09200126066001800218053005100236053005500287065000900342064000500351014001000356
865000900366002001300375#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
18-11.htm#S#c#198#31#article#33#31#^rND^sDi Pace^nFT#^rND^sDi Pace^nEL#Avaliação
 da Estação de Crescimento no Sertão, Agreste, Zona da Mata e Litoral Alagoano^l
pt#Florianópolis^eSC#Congresso Brasileiro de Agrometeorologia^nXI^i1^i1#Reunião 
Latino-Americana de Agrometeorologia^nII^i1^i1#19990000#1999#1123-1128#20110000#
aop18-11.htm##
00547000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100017001060120
06300123030001300186065000900199064000500208031000300213014000800216865000900224
002001300233035001000246801001300256#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop18-11.htm#S#c#199#32#article#33#32#^rND^sDubey^nJP#^rND^sSharma^nSP#
Prolonged excretion of Toxoplasma gondii in semen of goats^len#Am J Vet Res#1980
0000#1980#41#794-795#20110000#aop18-11.htm#0002-9645#Am J Vet Res##
00577000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100024001060120
08600130030001300216065000900229064000500238031000300243014000800246865000900254
002001300263035001000276801001300286#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop18-11.htm#S#c#200#33#article#33#33#^rND^sDubey^nJP#^rND^sLivingston 
Jr^nCW#Sarcocystis capracanis and Toxoplasma gondii infections in range goats fr
om Texas^len#Am J Vet Res#19860000#1986#47#523-524#20110000#aop18-11.htm#0002-96
45#Am J Vet Res##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#o#1#
1#article#1#20110411#104906#aop19-11.htm#136##
04354000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201500
01860120168003360100042005040100036005460100028005820100029006100700102006390700
09000741083134800831085000802179085002302187085003402210085003202244083131002276
08500080358608500200359408500350361408500290364911700060367807200030368411200090
3687111001103696114000903707113001103716002001303727#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop19-11.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#GRA#TA
B#16#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#A
valiação nutricional e alimentar de pacientes portadores de hanseníase tratados 
em unidades de saúde da grande Vitória, Estado do Espírito Santo^lpt#The nutriti
onal and dieting profiles of patients diagnosed with leprosy treated in the prim
ary healthcare units of Greater Vitória, State of Espírito Santo, Brazil^len#^rN
D^1A01^nRosa Maria Natalli^sMontenegro#^rND^1A01^nMaria Del Carmen^sMolina#^rND^
1A02^nMarilda^sMoreira#^rND^1A01^nEliana^sZandonade#Universidade Federal do Espí
rito Santo^iA01^1Programa de Pós Graduação em Saúde Coletiva^cVitória^sES#Secret
aria de Saúde do Estado do Espírito Santo^iA02^1Programa de Hanseníase^cVitória^
sES#^lpt^aINTRODUÇÃO: O presente estudo investigou a hanseníase quanto à apresen
tação clínica, perfil sociodemográfico, nutricional e alimentar de pacientes dia
gnosticados nas Unidades de Saúde dos municípios da Grande Vitória, Espírito San
to, Brasil, no período de janeiro a dezembro de 2009. MÉTODOS: Foram estudados 1
52 pacientes de ambos os sexos, em início de tratamento poliquimioterápico. Fora
m coletados dados sociodemográficos, antropométricos, bioquímicos e de alimentaç
ão a partir de um questionário de frequência alimentar (QFA) validado e adaptado
. Foi calculado o índice de massa corporal (IMC) para avaliação do estado nutric
ional. RESULTADOS: O estudo mostrou que: 79 (52%) dos participantes eram do sexo
 feminino, a média de idade foi de 40,4 anos (± 16,9); 81 (53,3%) possuíam víncu
lo empregatício; a média de anos de estudo foi de 7,1 (± 4,5). Em relação à doen
ça, 79 (52%) eram multibacilares e 73 (48%) paucibacilares. O índice baciloscópi
co foi negativo em 125 (82,2%) pacientes. O excesso de peso foi identifcado em 1
1,8% e 5,3% apresentaram baixo peso. O arroz e o feijão foram os alimentos relat
ados com maior frequência de consumo, 87,3% e 88,7% respectivamente. CONCLUSÕES:
 O estudo demonstrou que ações simples, iniciadas na atenção primária à saúde, p
odem auxiliar na melhoria do acompanhamento a portadores de hanseníase.#^dnd^i1#
^tm^lpt^kHanseníase^i1#^tm^lpt^kAvaliação nutricional^i1#^tm^lpt^kAvaliação alim
entar^i1#^len^aINTRODUCTION: The present study investigated leprosy in relation 
to the clinical, sociodemographic, nutritional and dietary profiles of patients 
diagnosed at primary healthcare units in the suburbs of Greater Vitória, State o
f Espírito Santo, Brazil, from January to December 2009. METHODS: The study invo
lved 152 male and female patients initiating polychemotherapy treatment. The col
lected data included sociodemographic, anthropometric, biochemical and dietary a
spects derived from a questionnaire of eating frequency (QEF) that was validated
 and adapted for Brazilian culture. Body mass index (BMI) was calculated to eval
uate patient nutritional status. RESULTS: The study showed that: 79 (52%) of the
 participants were women, average age was 40.4 years-old (±16.9); 81 (53.3%) wer
e employed; the mean number of years of schooling was 7.1 (±4.5). Concerning the
 disease, 79 (52%) of the participants were multibacillary and 73 (48%) paucibac
illary. The bacilloscopy index was negative in 125 (82.2%) patients. Excess weig
ht was identified in 11.8% and 5.3% were underweight. Rice and beans were mentio
ned frequently, 87.3% and 88.7%, respectively. CONCLUSIONS: The study showed tha
t simple actions, initiated during primary healthcare, can help to improve the t
reatment of patients with the leprosy.#^dnd^i2#^tm^len^kLeprosy^i2#^tm^len^kNutr
itional evaluation^i2#^tm^len^kDieting profiles^i2#other#14#20100514#14/05/2010#
20101104#04/11/2010#aop19-11.htm##
04424000000000613000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101038000400105121000300109049000300112158000300115
03000270011803200060014506500090015101400070016003500100016722300090017701201570
01860120175003430100042005180100036005600100028005960100029006240700102006530700
09000755083137600845085000802221085002302229085003402252085003202286083133802318
08500080365608500200366408500350368408500290371911700060374807200030375411200090
3757111001103766114000903777113001103786002001303797#2011nahead#V:\SciELO\serial
\rsbmt\2011nahead\markup\aop19-11.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#GRA#TA
B#16#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#0037-8682#20110415#<
b>Avaliação nutricional e alimentar de pacientes portadores de hanseníase tratad
os em unidades de saúde da grande Vitória, Estado do Espírito Santo</b>^lpt#<b>T
he nutritional and dieting profiles of patients diagnosed with leprosy treated i
n the primary healthcare units of Greater Vitória, State of Espírito Santo, Braz
il</b>^len#^rND^1A01^nRosa Maria Natalli^sMontenegro#^rND^1A01^nMaria Del Carmen
^sMolina#^rND^1A02^nMarilda^sMoreira#^rND^1A01^nEliana^sZandonade#Universidade F
ederal do Espírito Santo^iA01^1Programa de Pós Graduação em Saúde Coletiva^cVitó
ria^sES#Secretaria de Saúde do Estado do Espírito Santo^iA02^1Programa de Hansen
íase^cVitória^sES#^lpt^a<b>INTRODUÇÃO:</b> O presente estudo investigou a hansen
íase quanto à apresentação clínica, perfil sociodemográfico, nutricional e alime
ntar de pacientes diagnosticados nas Unidades de Saúde dos municípios da Grande 
Vitória, Espírito Santo, Brasil, no período de janeiro a dezembro de 2009. <b>MÉ
TODOS: </b>Foram estudados 152 pacientes de ambos os sexos, em início de tratame
nto poliquimioterápico. Foram coletados dados sociodemográficos, antropométricos
, bioquímicos e de alimentação a partir de um questionário de frequência aliment
ar (QFA) validado e adaptado. Foi calculado o índice de massa corporal (IMC) par
a avaliação do estado nutricional. <b>RESULTADOS: </b>O estudo mostrou que: 79 (
52%) dos participantes eram do sexo feminino, a média de idade foi de 40,4 anos 
(± 16,9); 81 (53,3%) possuíam vínculo empregatício; a média de anos de estudo fo
i de 7,1 (± 4,5). Em relação à doença, 79 (52%) eram multibacilares e 73 (48%) p
aucibacilares. O índice baciloscópico foi negativo em 125 (82,2%) pacientes. O e
xcesso de peso foi identifcado em 11,8% e 5,3% apresentaram baixo peso. O arroz 
e o feijão foram os alimentos relatados com maior frequência de consumo, 87,3% e
 88,7% respectivamente. <b>CONCLUSÕES: </b>O estudo demonstrou que ações simples
, iniciadas na atenção primária à saúde, podem auxiliar na melhoria do acompanha
mento a portadores de hanseníase.#^dnd^i1#^tm^lpt^kHanseníase^i1#^tm^lpt^kAvalia
ção nutricional^i1#^tm^lpt^kAvaliação alimentar^i1#^len^a<b>INTRODUCTION:</b> Th
e present study investigated leprosy in relation to the clinical, sociodemograph
ic, nutritional and dietary profiles of patients diagnosed at primary healthcare
 units in the suburbs of Greater Vitória, State of Espírito Santo, Brazil, from 
January to December 2009. <b>METHODS: </b>The study involved 152 male and female
 patients initiating polychemotherapy treatment. The collected data included soc
iodemographic, anthropometric, biochemical and dietary aspects derived from a qu
estionnaire of eating frequency (QEF) that was validated and adapted for Brazili
an culture. Body mass index (BMI) was calculated to evaluate patient nutritional
 status. <b>RESULTS: </b>The study showed that: 79 (52%) of the participants wer
e women, average age was 40.4 years-old (±16.9); 81 (53.3%) were employed; the m
ean number of years of schooling was 7.1 (±4.5). Concerning the disease, 79 (52%
) of the participants were multibacillary and 73 (48%) paucibacillary. The bacil
loscopy index was negative in 125 (82.2%) patients. Excess weight was identified
 in 11.8% and 5.3% were underweight. Rice and beans were mentioned frequently, 8
7.3% and 88.7%, respectively. <b>CONCLUSIONS: </b>The study showed that simple a
ctions, initiated during primary healthcare, can help to improve the treatment o
f patients with the leprosy.#^dnd^i2#^tm^len^kLeprosy^i2#^tm^len^kNutritional ev
aluation^i2#^tm^len^kDieting profiles^i2#other#14#20100514#14/05/2010#20101104#0
4/11/2010#aop19-11.htm##
04621000000000637000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108038000400112121000300116049000300119
15800030012203000260012503200060015106500090015701400070016603500100017322300090
01830120150001920120168003420100042005100100036005520100028005880100029006160700
10400645070009200749083142900841085000802270085002302278085003402301085003202335
08313730236708500080374008500200374808500350376808500290380311700060383207200030
3838112000903841111001103850114000903861113001103870002001303881008008903894#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#l#4#1#article#1#
^a2011#oa#pt#br1.1#1#4.0#gra#tab#16#nd#nd#Rev. Soc. Bras. Med. Trop#ahead#201100
00#^f0^l0#0037-8682#20110415#Avaliação nutricional e alimentar de pacientes port
adores de hanseníase tratados em unidades de saúde da grande Vitória, Estado do 
Espírito Santo^lpt#The nutritional and dieting profiles of patients diagnosed wi
th leprosy treated in the primary healthcare units of Greater Vitória, State of 
Espírito Santo, Brazil^len#^rND^1A01^nRosa Maria Natalli^sMontenegro#^rND^1A01^n
Maria Del Carmen^sMolina#^rND^1A02^nMarilda^sMoreira#^rND^1A01^nEliana^sZandonad
e#^iA01^1Universidade Federal do Espírito Santo^2Programa de Pós Graduação em Sa
úde Coletiva^cVitória^sES#^iA02^1Secretaria de Saúde do Estado do Espírito Santo
^2Programa de Hanseníase^cVitória^sES#^lpt^aINTRODUÇÃO: O presente estudo invest
igou a hanseníase quanto à apresentação clínica, perfil sociodemográfico, nutric
ional e alimentar de pacientes diagnosticados nas Unidades de Saúde dos municípi
os da Grande Vitória, Espírito Santo, Brasil, no período de janeiro a dezembro d
e 2009. MÉTODOS: Foram estudados 152 pacientes de ambos os sexos, em início de t
ratamento poliquimioterápico. Foram coletados dados sociodemográficos, antropomé
tricos, bioquímicos e de alimentação a partir de um questionário de frequência a
limentar (QFA) validado e adaptado. Foi calculado o índice de massa corporal (IM
C) para avaliação do estado nutricional. RESULTADOS: O estudo mostrou que: 79 (5
2 por cento) dos participantes eram do sexo feminino, a média de idade foi de 40
,4 anos (± 16,9); 81 (53,3 por cento) possuíam vínculo empregatício; a média de 
anos de estudo foi de 7,1 (± 4,5). Em relação à doença, 79 (52 por cento) eram m
ultibacilares e 73 (48 por cento) paucibacilares. O índice baciloscópico foi neg
ativo em 125 (82,2 por cento) pacientes. O excesso de peso foi identifcado em 11
,8 por cento e 5,3 por cento apresentaram baixo peso. O arroz e o feijão foram o
s alimentos relatados com maior frequência de consumo, 87,3 por cento e 88,7 por
 cento respectivamente. CONCLUSÕES: O estudo demonstrou que ações simples, inici
adas na atenção primária à saúde, podem auxiliar na melhoria do acompanhamento a
 portadores de hanseníase.#^dnd^i1#^tm^lpt^kHanseníase^i1#^tm^lpt^kAvaliação nut
ricional^i1#^tm^lpt^kAvaliação alimentar^i1#^len^aINTRODUCTION: The present stud
y investigated leprosy in relation to the clinical, sociodemographic, nutritiona
l and dietary profiles of patients diagnosed at primary healthcare units in the 
suburbs of Greater Vitória, State of Espírito Santo, Brazil, from January to Dec
ember 2009. METHODS: The study involved 152 male and female patients initiating 
polychemotherapy treatment. The collected data included sociodemographic, anthro
pometric, biochemical and dietary aspects derived from a questionnaire of eating
 frequency (QEF) that was validated and adapted for Brazilian culture. Body mass
 index (BMI) was calculated to evaluate patient nutritional status. RESULTS: The
 study showed that: 79 (52 percent) of the participants were women, average age 
was 40.4 years-old (±16.9); 81 (53.3 percent) were employed; the mean number of 
years of schooling was 7.1 (±4.5). Concerning the disease, 79 (52 percent) of th
e participants were multibacillary and 73 (48 percent) paucibacillary. The bacil
loscopy index was negative in 125 (82.2 percent) patients. Excess weight was ide
ntified in 11.8 percent and 5.3 percent were underweight. Rice and beans were me
ntioned frequently, 87.3 percent and 88.7 percent, respectively. CONCLUSIONS: Th
e study showed that simple actions, initiated during primary healthcare, can hel
p to improve the treatment of patients with the leprosy.#^dnd^i2#^tm^len^kLepros
y^i2#^tm^len^kNutritional evaluation^i2#^tm^len^kDieting profiles^i2#other#14#20
100514#14/05/2010#20101104#04/11/2010#aop19-11.htm#Internet^ihttp://www.scielo.b
r/scielo.php?script=sci_arttext&pid=S0037-86822011005000016##
00549000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704030500085002001300390#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#5#1#article#118#<p><a name
="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Avalia
&ccedil;&atilde;o    nutricional e alimentar de pacientes portadores de hansen&i
acute;ase tratados    em unidades de sa&uacute;de da grande Vit&oacute;ria, Esta
do do Esp&iacute;rito    Santo</b> </font></p>     ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#6#2#article#118#<p>&nbsp;<
/p>     ^cY#aop19-11.htm##
00520000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704027600085002001300361#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#7#3#article#118#<p><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="3"><b>The nutritional    and d
ieting profiles of patients diagnosed with leprosy treated in the primary    hea
lthcare units of Greater Vit&oacute;ria, State of Esp&iacute;rito Santo,    Braz
il</b></font></p>     ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#8#4#article#118#<p>&nbsp;<
/p>     ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#9#5#article#118#<p>&nbsp;<
/p>     ^cY#aop19-11.htm##
00479000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704023400086002001300320#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#10#6#article#118#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Rosa Maria Natalli    M
ontenegro<sup>I</sup>; Maria Del Carmen Molina<sup>I;</sup> Marilda Moreira<sup>
II</sup>;    Eliana Zandonade<sup>I</sup></b></font></p>     ^cY#aop19-11.htm##
00472000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704022700086002001300313#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#11#7#article#118#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Programa    de
 P&oacute;s Gradua&ccedil;&atilde;o em Sa&uacute;de Coletiva, Universidade    Fe
deral do Esp&iacute;rito Santo, Vit&oacute;ria, ES    ^cY#aop19-11.htm##
00400000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704015500086002001300241#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#12#8#article#118#<br>   <s
up>II</sup>Programa de Hansen&iacute;ase, Secretaria de Sa&uacute;de do Estado  
  do Esp&iacute;rito Santo, Vit&oacute;ria, ES</font></p>     ^cY#aop19-11.htm##
00393000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704014800086002001300234#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#13#9#article#118#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Endere&cce
dil;o    para correspond&ecirc;ncia</a></font></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#14#10#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#15#11#article#118#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop19-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#16#12#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p> 
    ^cY#aop19-11.htm##
00714000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046800087002001300555#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#17#13#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODU&Ccedil;&Atilde
;O:</b>     O presente estudo investigou a hansen&iacute;ase quanto &agrave; apr
esenta&ccedil;&atilde;o    cl&iacute;nica, perfil sociodemogr&aacute;fico, nutri
cional e alimentar de pacientes    diagnosticados nas Unidades de Sa&uacute;de d
os munic&iacute;pios da Grande    Vit&oacute;ria, Esp&iacute;rito Santo, Brasil,
 no per&iacute;odo de janeiro    a dezembro de 2009.    ^cY#aop19-11.htm##
00726000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048000087002001300567#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#18#14#article#118#<br>   <
b>M&Eacute;TODOS:</b>  Foram estudados 152 pacientes de ambos os sexos, em in&ia
cute;cio    de tratamento poliquimioter&aacute;pico. Foram coletados dados socio
demogr&aacute;ficos,    antropom&eacute;tricos, bioqu&iacute;micos e de alimenta
&ccedil;&atilde;o a    partir de um question&aacute;rio de frequ&ecirc;ncia alim
entar (QFA) validado    e adaptado. Foi calculado o &iacute;ndice de massa corpo
ral (IMC) para avalia&ccedil;&atilde;o    do estado nutricional.    ^cY#aop19-11
.htm##
00938000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704069200087002001300779#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#19#15#article#118#<br>   <
b>RESULTADOS:</b>  O estudo mostrou que: 79 (52%) dos participantes eram do    s
exo feminino, a m&eacute;dia de idade foi de 40,4 anos (&plusmn; 16,9); 81    (5
3,3%) possu&iacute;am v&iacute;nculo empregat&iacute;cio; a m&eacute;dia de    a
nos de estudo foi de 7,1 (&plusmn; 4,5). Em rela&ccedil;&atilde;o &agrave;    do
en&ccedil;a, 79 (52%) eram multibacilares e 73 (48%) paucibacilares. O &iacute;n
dice    bacilosc&oacute;pico foi negativo em 125 (82,2%) pacientes. O excesso de
 peso    foi identifcado em 11,8% e 5,3% apresentaram baixo peso. O arroz e o fe
ij&atilde;o    foram os alimentos relatados com maior frequ&ecirc;ncia de consum
o, 87,3% e    88,7% respectivamente.    ^cY#aop19-11.htm##
00512000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704026600087002001300353#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#20#16#article#118#<br>   <
b>CONCLUS&Otilde;ES:</b>  O estudo demonstrou que a&ccedil;&otilde;es simples,  
  iniciadas na aten&ccedil;&atilde;o prim&aacute;ria &agrave; sa&uacute;de, pode
m    auxiliar na melhoria do acompanhamento a portadores de hansen&iacute;ase.</
font></p>     ^cY#aop19-11.htm##
00470000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704022400087002001300311#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#21#17#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palavras-chaves:   </b
> Hansen&iacute;ase. Avalia&ccedil;&atilde;o nutricional. Avalia&ccedil;&atilde;
o    alimentar</font></p> <hr size="1" noshade>     ^cY#aop19-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#22#18#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p
>     ^cY#aop19-11.htm##
00632000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038600087002001300473#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#23#19#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODUCTION:</b>     
The present study investigated leprosy in relation to the clinical, sociodemogra
phic,    nutritional and dietary profiles of patients diagnosed at primary healt
hcare    units in the suburbs of Greater Vit&oacute;ria, State of Esp&iacute;rit
o Santo,    Brazil, from January to December 2009.    ^cY#aop19-11.htm##
00656000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041000087002001300497#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#24#20#article#118#<br>   <
b>METHODS:</b>  The study involved 152 male and female patients initiating polyc
hemotherapy    treatment. The collected data included sociodemographic, anthropo
metric, biochemical    and dietary aspects derived from a questionnaire of eatin
g frequency (QEF) that    was validated and adapted for Brazilian culture. Body 
mass index (BMI) was calculated    to evaluate patient nutritional status.    ^c
Y#aop19-11.htm##
00794000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054800087002001300635#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#25#21#article#118#<br>   <
b>RESULTS:</b>  The study showed that: 79 (52%) of the participants were women, 
   average age was 40.4 years-old (&plusmn;16.9); 81 (53.3%) were employed; the 
   mean number of years of schooling was 7.1 (&plusmn;4.5). Concerning the disea
se,    79 (52%) of the participants were multibacillary and 73 (48%) paucibacill
ary.    The bacilloscopy index was negative in 125 (82.2%) patients. Excess weig
ht was    identified in 11.8% and 5.3% were underweight. Rice and beans were men
tioned    frequently, 87.3% and 88.7%, respectively.    ^cY#aop19-11.htm##
00435000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704018900087002001300276#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#26#22#article#118#<br>   <
b>CONCLUSIONS:</b>  The study showed that simple actions, initiated during prima
ry    healthcare, can help to improve the treatment of patients with the leprosy
.</font></p>     ^cY#aop19-11.htm##
00422000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017600087002001300263#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#27#23#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords:</b>     Lepr
osy. Nutritional evaluation. Dieting profiles.</font></p> <hr size="1" noshade> 
    ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#28#24#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#29#25#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011400087002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#30#26#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>INTRODU&Ccedil;&Atilde
;O</b></font></p>     ^cY#aop19-11.htm##
01012000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704076600087002001300853#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#31#27#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A hansen&iacute;ase,    t
amb&eacute;m conhecida como <i>lepra</i>, &eacute; uma doen&ccedil;a infecciosa 
   de evolu&ccedil;&atilde;o lenta e, no Brasil, permanece como um problema de  
  sa&uacute;de p&uacute;blica devido a sua magnitude, ao seu potencial incapacit
ante    e por acometer a popula&ccedil;&atilde;o na faixa et&aacute;ria ativa. O
 Esp&iacute;rito    Santo &eacute; um estado end&ecirc;mico para a hansen&iacute
;ase e esfor&ccedil;os    para o controle da doen&ccedil;a t&ecirc;m sido realiz
ados, com resultados positivos    como a redu&ccedil;&atilde;o do coeficiente de
 preval&ecirc;ncia de 32,6 casos    em 1991 para 3,20 casos/10.000 habitantes em
 2007<sup>1</sup>.</font></p>     ^cY#aop19-11.htm##
00840000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704059400087002001300681#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#32#28#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Atualmente, muitas    dis
cuss&otilde;es t&ecirc;m sido retomadas sobre a import&acirc;ncia da nutri&ccedi
l;&atilde;o    nos cuidados com a sa&uacute;de. Assim, a alimenta&ccedil;&atilde
;o ganha import&acirc;ncia    na preven&ccedil;&atilde;o e controle de doen&cced
il;as. No contexto da sa&uacute;de    coletiva, estas devem estar inseridas nas 
a&ccedil;&otilde;es dos direitos humanos    para a vida e asseguradas pelas pol&
iacute;ticas p&uacute;blicas de promo&ccedil;&atilde;o    da sa&uacute;de<sup>2<
/sup>.</font></p>     ^cY#aop19-11.htm##
00632000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038600087002001300473#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#33#29#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">O objetivo deste    estud
o foi caracterizar o perfil dos pacientes portadores da hansen&iacute;ase    qua
nto aos aspectos sociodemogr&aacute;ficos, nutricionais e a forma de apresenta&c
cedil;&atilde;o    da doen&ccedil;a em pacientes cadastrados nas Unidades de Sa&
uacute;de da Grande    Vit&oacute;ria.</font></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#34#30#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00350000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010400087002001300191#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#35#31#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>M&Eacute;TODOS</b></fo
nt></p>     ^cY#aop19-11.htm##
00962000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704071600087002001300803#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#36#32#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Trata-se de um    estudo 
descritivo transversal de portadores de hansen&iacute;ase em in&iacute;cio    de
 tratamento. Para o c&aacute;lculo da amostra, utilizou-se os dados de popula&cc
edil;&atilde;o    de pacientes com hansen&iacute;ase nos munic&iacute;pios da Gr
ande Vit&oacute;ria    (Vit&oacute;ria, Vila Velha, Serra e Cariacica), no ano d
e 2007, num total de    400 casos novos<sup>1</sup> com propor&ccedil;&atilde;o 
de eutr&oacute;ficos    de aproximadamente 50%. Considerando-se a precis&atilde;
o desejada de 6,5% e    o n&iacute;vel de signific&acirc;ncia de 5%, o tamanho m
&iacute;nimo de amostra    foi de 145 pacientes.</font></p>     ^cY#aop19-11.htm
##
00606000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036000087002001300447#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#37#33#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os dados foram    coletad
os nas unidades de sa&uacute;de destes munic&iacute;pios por serem unidades    c
om maior n&uacute;mero de pacientes em registro ativo e todas est&atilde;o    lo
calizadas na regi&atilde;o metropolitana da grande Vit&oacute;ria, Esp&iacute;ri
to    Santo.</font></p>     ^cY#aop19-11.htm##
00934000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704068800087002001300775#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#38#34#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">No per&iacute;odo    de j
aneiro a dezembro de 2009, foram examinados todos os pacientes virgens de    tra
tamento para a hansen&iacute;ase ou os que tivessem iniciado a poliquimioterapia
    h&aacute; um m&ecirc;s. Foram exclu&iacute;dos os pacientes coinfectados por
    tuberculose, aqueles que conhecessem serem portadores do v&iacute;rus da s&i
acute;ndrome    de imunodefici&ecirc;ncia adquirida e os pacientes com rea&ccedi
l;&otilde;es    da hansen&iacute;ase, pois as mesmas podem desencadear altera&cc
edil;&otilde;es    sist&ecirc;micas, prejudicando a avalia&ccedil;&atilde;o nutr
icional do paciente.</font></p>     ^cY#aop19-11.htm##
00849000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060300087002001300690#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#39#35#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os dados sociodemogr&aacu
te;ficos    foram obtidos por entrevista com aux&iacute;lio de um formul&aacute;
rio e os    dados sobre a doen&ccedil;a no prontu&aacute;rio cl&iacute;nico do p
aciente    e transcritos para o instrumento de coleta. Os exames hematol&oacute;
gicos (hemat&oacute;crito    e hemoglobina) foram solicitados como rotina do ser
vi&ccedil;o no momento do    diagn&oacute;stico e para an&aacute;lise destes ind
icadores foram utilizados    os valores de refer&ecirc;ncia preconizados por Por
to<sup>3</sup>.</font></p>     ^cY#aop19-11.htm##
00645000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704039900087002001300486#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#40#36#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Para a avalia&ccedil;&ati
lde;o    antropom&eacute;trica, foram coletados os seguintes dados: peso (P), es
tatura    (E), circunfer&ecirc;ncia do bra&ccedil;o (CB), dobra cut&acirc;nea tr
iciptal    (DCT) e calculada a circunfer&ecirc;ncia muscular do bra&ccedil;o (CM
B), interpretada    conforme Frisancho<sup>4</sup>.</font></p>     ^cY#aop19-11.
htm##
00665000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704041900087002001300506#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#41#37#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Para a medida de    DCT e
 CB, foi utilizado um adip&ocirc;metro adequadamente calibrado, modelo    Lange,
 e fita milimetrada, respectivamente, e obedecendo a crit&eacute;rios    univers
almente estabelecidos. Estas medidas foram analisadas isoladamente aplicando-se 
   a tabela de percentis e interpretada conforme Frisancho<sup>4</sup>.</font></
p>     ^cY#aop19-11.htm##
00649000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704040300087002001300490#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#42#38#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">O &iacute;ndice    de mas
sa corp&oacute;rea (IMC) foi calculado para a classifica&ccedil;&atilde;o    do 
estado nutricional. Foi utilizada a classifica&ccedil;&atilde;o da Organiza&cced
il;&atilde;o    Mundial de Sa&uacute;de<sup>5</sup>, para avaliar o estado nutri
cional dos adolescentes,    adultos e idosos, por sexo.</font></p>     ^cY#aop19
-11.htm##
00702000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704045600087002001300543#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#43#39#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Para avalia&ccedil;&atild
e;o    da alimenta&ccedil;&atilde;o, foi utilizado o question&aacute;rio de freq
u&ecirc;ncia    de consumo alimentar (QFA) composto de 24 itens, validado por Kr
oke cols<sup>6</sup>    adaptado por Duarte<sup>7</sup>. Os alimentos foram clas
sificados conforme as    diretrizes do Guia Alimentar para a Popula&ccedil;&atil
de;o Brasileira<sup>8</sup>.</font></p>     ^cY#aop19-11.htm##
00477000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704023100087002001300318#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#44#40#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A apresenta&ccedil;&atild
e;o    descritiva dos dados foi feita mediante an&aacute;lise estat&iacute;stica
 pelo    programa SPSS, vers&atilde;o 17.0.</font></p>     ^cY#aop19-11.htm##
00380000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704013400087002001300221#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#45#41#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Considera&ccedil;&otil
de;es    &eacute;ticas</b></font></p>     ^cY#aop19-11.htm##
00709000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046300087002001300550#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#46#42#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Esta pesquisa foi    subm
etida ao Comit&ecirc; de &Eacute;tica da Universidade Federal do Esp&iacute;rito
    Santo, obtendo parecer favor&aacute;vel (processo 013/09). Foram atendidos o
s    pressupostos &eacute;ticos de pesquisa em seres humanos e mantido o sigilo 
das    informa&ccedil;&otilde;es coletadas. Os pacientes assinaram o termo de co
nsentimento    livre e esclarecido.</font></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#47#43#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#48#44#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>RESULTADOS</b></font><
/p>     ^cY#aop19-11.htm##
00895000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704064900087002001300736#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#49#45#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Dos 152 pacientes    part
icipantes do estudo, 52% eram do sexo feminino. A idade variou de 10 a 74    ano
s, com m&eacute;dia de 40,4 anos (&plusmn; 16,9). Do total de sujeitos, 53,3%   
 possu&iacute;am v&iacute;nculo empregat&iacute;cio e, em rela&ccedil;&atilde;o 
   &agrave; renda salarial familiar, 11,2% das fam&iacute;lias recebiam menos de
    um sal&aacute;rio m&iacute;nimo; 64,3% de um a tr&ecirc;s sal&aacute;rios m&
iacute;nimos;    17,8% de tr&ecirc;s at&eacute; cinco sal&aacute;rios m&iacute;n
imos e 6,6%,    mais de cinco sal&aacute;rios m&iacute;nimos.</font></p>     ^cY
#aop19-11.htm##
00988000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704074200087002001300829#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#50#46#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Quanto &agrave;    distri
bui&ccedil;&atilde;o, segundo o munic&iacute;pio de resid&ecirc;ncia,    14,5% r
esidiam em Cariacica, 23% em Serra, 34,9% em Vila Velha, 26,3% em Vit&oacute;ria
    e 1,3% em outros munic&iacute;pios. Em rela&ccedil;&atilde;o ao n&uacute;mer
o    de c&ocirc;modos por domic&iacute;lio, constatou-se que 21,1% dos pacientes
    possu&iacute;am de um a tr&ecirc;s c&ocirc;modos na resid&ecirc;ncia, 40,8% 
   de tr&ecirc;s a cinco c&ocirc;modos e 36,8% mais de cinco c&ocirc;modos e um 
   morador de rua 0,7%. Em rela&ccedil;&atilde;o &agrave; quantidade de pessoas 
   por domic&iacute;lio, a m&eacute;dia foi de 3,7 (&plusmn; 1,8) pessoas.</font
></p>     ^cY#aop19-11.htm##
00459000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704021300087002001300300#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#51#47#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Quando avaliada    a esco
laridade, encontrou-se 11,4% analfabetos e a m&eacute;dia de anos de estudo    f
oi de 7,1 (&plusmn; 4,5).</font></p>     ^cY#aop19-11.htm##
00859000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061300087002001300700#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#52#48#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Dos avaliados,    quanto 
&agrave; classifica&ccedil;&atilde;o operacional (CO) preconizada pelo    Minist
&eacute;rio da Sa&uacute;de, para fins de tratamento, 52% eram multibacilares   
 (MB) e 48% paucibacilares (PB). Para a forma cl&iacute;nica (FC), segundo a    
classifica&ccedil;&atilde;o de Madri, encontrou-se: 9,2% da forma cl&iacute;nica
    indeterminada (MHI), 42,8% tubercul&oacute;ide (MHT), 34,2% dimorfo (MHD) e 
   13,8% virchowianos (MHV). O &iacute;ndice bacilosc&oacute;pico foi negativo  
  em 82,2% dos pacientes.</font></p>     ^cY#aop19-11.htm##
00898000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704065200087002001300739#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#53#49#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A avalia&ccedil;&atilde;o
    nutricional utilizando o m&eacute;todo do IMC (&iacute;ndice de Quetelet) de
monstrou    que entre os estudados, 48,7% foram classificados como eutr&oacute;f
icos e 5,3%    como desnutridos. No grupo de sobrepeso, o percentual foi de 34,2
% e no grupo    de obesidade 11,8%. A <b><a href="#f1">Figura 1</a></b> apresent
a os resultados    nas quatro categorias estudadas (baixo peso, eutrofismo, sobr
epeso, obesidade)    por sexo. N&atilde;o se encontrou associa&ccedil;&atilde;o 
estatisticamente    significante entre o sexo e IMC (p = 0,250).</font></p>     
^cY#aop19-11.htm##
00279000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003300087002001300120#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#54#50#article#118#<p><a na
me="f1"></a></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#55#51#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#56#52#article#118#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/19f01.jpg"></p>     ^cY#aop19
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#57#53#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00597000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035100087002001300438#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#58#54#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A <b><a href="#t1">Tabela
    1</a></b> apresenta os valores absolutos e percentuais das medidas de CB, DC
T    e CMB nas suas classifica&ccedil;&otilde;es (frequ&ecirc;ncias absolutas e 
percentuais    das classifica&ccedil;&otilde;es das vari&aacute;veis CB, DCT e C
MB)</font></p>     ^cY#aop19-11.htm##
00279000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003300087002001300120#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#59#55#article#118#<p><a na
me="t1"></a></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#60#56#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#61#57#article#118#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/19t01.jpg"></p>     ^cY#aop19
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#62#58#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00597000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704035100087002001300438#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#63#59#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A classifica&ccedil;&atil
de;o    nutricional utilizando a CB avaliou o somat&oacute;rio dos componentes &
oacute;sseo,    muscular e de gordura e detectou um percentual de desnutri&ccedi
l;&atilde;o    igual a 30,3%. A obesidade foi representada por 15,1% dos pacient
es.</font></p>     ^cY#aop19-11.htm##
00560000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031400087002001300401#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#64#60#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A classifica&ccedil;&atil
de;o    nutricional utilizando a medida da DCT demonstrou que 38,2% dos estudado
s apresentaram    excesso de gordura, enquanto pelo c&aacute;lculo da CMB, 31,6%
 apresentaram    baixo teor de massa muscular.</font></p>     ^cY#aop19-11.htm##
00580000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704033400087002001300421#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#65#61#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Em rela&ccedil;&atilde;o 
   aos exames de hemoglobina, 62,5% encontravam-se na faixa de normalidade e 4,6
    dos estudados apresentaram valor gravemente reduzido. Quanto ao hemat&oacute
;crito,    os resultados s&atilde;o 69,7% e 3,9%, respectivamente.</font></p>   
  ^cY#aop19-11.htm##
00788000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704054200087002001300629#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#66#62#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Foi aplicado o    questio
n&aacute;rio de frequ&ecirc;ncia alimentar para a amostra estudada. Dentre    o 
grupo de cereais, tub&eacute;rculos e ra&iacute;zes, observou-se que o arroz    
foi o alimento mais consumido, aparecendo no consumo di&aacute;rio de 87,3%    d
a amostra. O consumo de frutas representou apenas 41,1% e o de vegetais 57%.    
O feij&atilde;o presente na dieta de 88,1% dos estudados com consumo de uma    p
or&ccedil;&atilde;o di&aacute;ria.</font></p>     ^cY#aop19-11.htm##
00683000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704043700087002001300524#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#67#63#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">No grupo das prote&iacute
;nas,    o alimento mais representativo foi o ovo (21,9% do consumo di&aacute;ri
o). O    leite estava presente no consumo semanal de 40,4% dos estudados. Em rel
a&ccedil;&atilde;o    &agrave; ingest&atilde;o de carnes, observou-se um maior c
onsumo semanal para    o frango, com 88,7%, e em segundo lugar a carne bovina, c
om 74,8%.</font></p>     ^cY#aop19-11.htm##
00734000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048800087002001300575#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#68#64#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">As gorduras e os    a&cce
dil;&uacute;cares foram representados pelo consumo de frituras, manteiga    e ma
rgarina, com 26,5%, 30,5% e 35,8%, respectivamente, da amostra. Os a&ccedil;&uac
ute;cares    foram representados pelo consumo di&aacute;rio de 31,8% dos estudad
os. Este    grupo pode ser responsabilizado pelo excesso de gordura, em 38,2% do
s examinados,    na medida da dobra cut&acirc;nea triciptal.</font></p>     ^cY#
aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#69#65#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00352000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010600087002001300193#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#70#66#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>DISCUSS&Atilde;O</b></
font></p>     ^cY#aop19-11.htm##
01091000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704084500087002001300932#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#71#67#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Do total de entrevistados
,    nos munic&iacute;pios da grande Vit&oacute;ria, ES, o percentual de acometi
mento    pela doen&ccedil;a foi ligeiramente maior no sexo feminino, com 52% dos
 casos,    concordando com achados de estudo realizado em Bauru/SP<sup>9</sup>. 
Quanto    &agrave; faixa et&aacute;ria, observou-se um maior n&uacute;mero de di
agn&oacute;stico,    na faixa et&aacute;ria de 40 a 49 anos. Outros estudos most
ram a incid&ecirc;ncia    predominante da doen&ccedil;a, nessa faixa et&aacute;r
ia, como &eacute; o caso    de estudo de perfil cl&iacute;nico realizado no nord
este do Brasil<sup>10</sup>.    Na faixa et&aacute;ria de 10 a 19 anos, encontro
u-se 25 pacientes diagnosticados,    o que representando o percentual de 16,4% d
o total de casos.</font></p>     ^cY#aop19-11.htm##
01107000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704086100087002001300948#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#72#68#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">A baixa escolaridade    d
os pacientes analisados, que dispunham de uma m&eacute;dia de 7,1 (&plusmn;    4
,5) anos de estudos, pode refletir-se em suas possibilidades profissionais    de
 vida e emprego tendo como consequ&ecirc;ncia, para a grande maioria, os baixos 
   sal&aacute;rios. O fen&ocirc;meno da pauperiza&ccedil;&atilde;o de pacientes,
    acometidos por doen&ccedil;as infecciosas, como &eacute; o caso da hansen&ia
cute;ase,    &eacute; discutido por diversos autores<sup>11-12</sup>, que consta
tam que a    infec&ccedil;&atilde;o pelo <i>Mycobacterium leprae</i> acomete pri
oritariamente    indiv&iacute;duos que vivem em condi&ccedil;&otilde;es socioeco
n&ocirc;micas    desfavor&aacute;veis, como fatores que predisp&otilde;em ao des
envolvimento    da doen&ccedil;a.</font></p>     ^cY#aop19-11.htm##
00853000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704060700087002001300694#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#73#69#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Poucos estudos    avaliam
 estado nutricional em pessoas portadoras de hansen&iacute;ase. Em nosso    estu
do, 74 pessoas, que representam 48,7% da amostra, foram classificadas como    eu
tr&oacute;ficas, em rela&ccedil;&atilde;o &agrave; avalia&ccedil;&atilde;o    po
r IMC, resultado semelhante ao encontrado por Garcia<sup>9</sup>, enquanto    a 
avalia&ccedil;&atilde;o do estado nutricional de pacientes portadores da doen&cc
edil;a    em hospital na Argentina mostra um percentual de 23,7% de eutr&oacute;
ficos<sup>13</sup>.</font></p>     ^cY#aop19-11.htm##
00533000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704028700087002001300374#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#74#70#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Estudos do perfil    nutr
icional da popula&ccedil;&atilde;o brasileira mostram diferen&ccedil;a nos    va
lores de IMC quando relacionados com a idade e o sexo<sup>14</sup>, diferente   
 da nossa pesquisa.</font></p>     ^cY#aop19-11.htm##
01074000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704082800087002001300915#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#75#71#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Dentre os alimentos    de
 consumo di&aacute;rio encontramos o arroz, consumido pelo maior n&uacute;mero  
  de pessoas, seguido pelo feij&atilde;o. Representando o grupo das prote&iacute
;nas    de origem animal est&atilde;o o leite e os ovos. Dentre as carnes, o mai
or consumo    semanal foi de frango. O baixo consumo de prote&iacute;nas pode se
r um dos fatores    associados ao baixo teor de massa muscular, que aparecem em 
31,6% dos sujeitos    estudados na avalia&ccedil;&atilde;o da circunfer&ecirc;nc
ia muscular do bra&ccedil;o.    O consumo de verduras, legumes e frutas &eacute;
 considerado pequeno quando    comparado a quantidade destes nutrientes recomend
ada pelo Guia de Alimentar    da Popula&ccedil;&atilde;o Brasileira<sup>8</sup>.
</font></p>     ^cY#aop19-11.htm##
00758000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704051200087002001300599#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#76#72#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os entrevistados    dizem
 que apesar de apreciarem carnes e derivados do leite, n&atilde;o os consomem   
 por serem alimentos demasiadamente fora do or&ccedil;amento dom&eacute;stico.  
  Em rela&ccedil;&atilde;o aos legumes, verduras e frutas, admitem que s&atilde;
o    alimentos de melhor pre&ccedil;o. Por&eacute;m, admitem n&atilde;o utiliz&a
acute;-los    por falta de h&aacute;bito ou pela dificuldade em armazen&aacute;-
los.</font></p>     ^cY#aop19-11.htm##
00897000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704065100087002001300738#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#77#73#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Com esses dados,    &eacu
te; poss&iacute;vel tra&ccedil;ar um perfil do indiv&iacute;duo, da fam&iacute;l
ia    e da comunidade para a busca de uma pr&aacute;tica educativa eficaz, atrav
&eacute;s    do incentivo, do autocuidado, do plantio de hortas comunit&aacute;r
ias e da    utiliza&ccedil;&atilde;o de alimentos regionais, gerando, dessa form
a, um incentivo    a novas pol&iacute;ticas p&uacute;blicas que valorizem o bem 
estar, a qualidade    de vida e o bom estado nutricional que podem ser primordia
is no controle e erradica&ccedil;&atilde;o    da doen&ccedil;a.</font></p>     ^
cY#aop19-11.htm##
00560000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704031400087002001300401#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#78#74#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Com base nos resultados  
  obtidos passou-se a conhecer melhor a manifesta&ccedil;&atilde;o da doen&ccedi
l;a    e seus aspectos sociodemogr&aacute;ficos e nutricionais em pacientes dos 
munic&iacute;pios    da Grande Vit&oacute;ria.</font></p>     ^cY#aop19-11.htm##
00873000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062700087002001300714#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#79#75#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">O estudo demonstrou    qu
e a&ccedil;&otilde;es simples, como a avalia&ccedil;&atilde;o de medidas antropo
m&eacute;tricas,    c&aacute;lculo do IMC e question&aacute;rios sociodemogr&aac
ute;fico e alimentar,    podem auxiliar na melhoria do acompanhamento a portador
es de doen&ccedil;as    infecciosas, como &eacute; o caso da hansen&iacute;ase. 
Estes cuidados devem    ser iniciados na aten&ccedil;&atilde;o prim&aacute;ria &
agrave; sa&uacute;de    com profissionais da equipe de aten&ccedil;&atilde;o b&a
acute;sica devidamente    capacitados. </font></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#80#76#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00360000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011400087002001300201#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#81#77#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>CONFLITO DE    INTERES
SE</b></font></p>     ^cY#aop19-11.htm##
00438000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704019200087002001300279#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#82#78#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Os autores declaram    n&
atilde;o haver nenhum tipo de conflito de interesse no desenvolvimento do    est
udo.</font></p>     ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#83#79#article#118#<p>&nbsp
;</p>     ^cY#aop19-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#84#80#article#118#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>REFER&Ecirc;NCIAS</b><
/font></p>     ^cY#aop19-11.htm##
00637000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704037700089002001300466#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#85#81#article#
118#1#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Secretar
ia de    Sa&uacute;de do Esp&iacute;rito Santo. Ger&ecirc;ncia Epidemiol&oacute;
gica    de Vigil&acirc;ncia em Sa&uacute;de do Esp&iacute;rito Santo. Relat&oacu
te;rio    de atividades do Programa Estadual de Controle de Hansen&iacute;ase. V
it&oacute;ria,    ES: Secretaria de Sa&uacute;de; 2007.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#86#82#article#118#</font><
/p>     ^cY#aop19-11.htm##
00508000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704024800089002001300337#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#87#83#article#
118#2#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Minist&e
acute;rio    da Sa&uacute;de. Secretaria de Vigil&acirc;ncia em Sa&uacute;de. Ha
nsen&iacute;ase    no Brasil: dados e indicadores selecionados. Bras&iacute;lia;
 2009.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#88#84#article#118#</font><
/p>     ^cY#aop19-11.htm##
00477000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021700089002001300306#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#89#85#article#
118#3#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Porto CC
. Exames    Complementares. <i>In:</i> Hungria H, editor. Semiologia m&eacute;di
ca. Rio    de Janeiro: Ed. Guanabara; 2001. p. 977-978.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#90#86#article#118#</font><
/p>     ^cY#aop19-11.htm##
00468000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020800089002001300297#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#91#87#article#
118#4#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Frisanch
o AR.    New norms of upper limb fat and muscle areas for assessment of nutritio
nal status.    Amer J Clin Nutr 1981; 34:2540.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#92#88#article#118#</font><
/p>     ^cY#aop19-11.htm##
00555000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029500089002001300384#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#93#89#article#
118#5#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Organiza
&ccedil;&atilde;o    Mundial de Sa&uacute;de. Unidade guia para eliminar a hanse
n&iacute;ase como    um problema de sa&uacute;de p&uacute;blica. Genebra: Organi
za&ccedil;&atilde;o    Mundial de Sa&uacute;de; 1995.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#94#90#article#118#</font><
/p>     ^cY#aop19-11.htm##
00783000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704052300089002001300612#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#95#91#article#
118#6#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Kroke A,
 Klipstein-Grobusch    K, Voss S, M&ouml;seneder J, Thielecke F, Noack R, et al.
 Validation of a self-administered    food-frequency questionnaire administered 
in the European Prospective Investigation    into Cancer and Nutrition (EPIC) St
udy: comparison of energy, protein, and macronutrient    intakes estimated with 
the doubly labeled water, urinary nitrogen, and repeated    24-h dietary recall 
methods. Am J Clin Nutr 1999; 70:439-447.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#96#92#article#118#</font><
/p>     ^cY#aop19-11.htm##
00463000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020300089002001300292#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#97#93#article#
118#7#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Duarte A
CG.    Avalia&ccedil;&atilde;o nutricional: aspectos cl&iacute;nicos e laborator
iais.    S&atilde;o Paulo: Atheneu; 2007.    ^cY#aop19-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#98#94#article#118#</font><
/p>     ^cY#aop19-11.htm##
00563000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030300089002001300392#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#99#95#article#
118#8#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Minist&e
acute;rio    da Sa&uacute;de. Manual cl&iacute;nico de alimenta&ccedil;&atilde;o
 e nutri&ccedil;&atilde;o    na assist&ecirc;ncia a adultos infectados pelo HIV.
 Bras&iacute;lia: Minist&eacute;rio    da Sa&uacute;de; 2006.    ^cY#aop19-11.ht
m##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#100#96#article#118#</font>
</p>     ^cY#aop19-11.htm##
00592000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000200088704033100090002001300421#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#101#97#article
#118#9#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Garcia 
ICO.    Avalia&ccedil;&atilde;o nutricional e caracteriza&ccedil;&atilde;o socio
demogr&aacute;fica    de portadores de hansen&iacute;ase &#91;disserta&ccedil;&a
tilde;o&#93;. &#91;S&atilde;o    Paulo&#93;: Universidade de S&atilde;o Paulo; 2
006. 138p.    ^cY#aop19-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#102#98#article#118#</font>
</p>     ^cY#aop19-11.htm##
00715000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704045300091002001300544#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#103#99#article
#118#10#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Gomes
 CCD,    Pontes MAA, Gon&ccedil;alves HSG, Penna GO. Perfil cl&iacute;nico-epide
miol&oacute;gico    dos pacientes diagnosticados com hansen&iacute;ase em um cen
tro de refer&ecirc;ncia    na regi&atilde;o nordeste do Brasil. Investiga&ccedil
;&atilde;o Cl&iacute;nica,    Epidemiol&oacute;gica, Laboratorial e Terap&ecirc;
utica. An Bras Dermatol 2005;    80(supl 3):S283-288.    ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#104#100#article#118#</font
></p>     ^cY#aop19-11.htm##
00450000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018700092002001300279#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#105#101#articl
e#118#11#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Rufi
no Neto    A. Tuberculose e o estudo molecular da sua epidemiologia. Rev Cienc F
arm Apl    2007; 28:251-257.    ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#106#102#article#118#</font
></p>     ^cY#aop19-11.htm##
00631000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704036800092002001300460#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#107#103#articl
e#118#12#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Made
ira ES.    Os espa&ccedil;os de transmiss&atilde;o da hansen&iacute;ase: domic&i
acute;lio,    ambiente de trabalho e rela&ccedil;&otilde;es de vizinhan&ccedil;a
s &#91;disserta&ccedil;&atilde;o&#93;.    &#91;Vit&oacute;ria&#93;: Universidade
 Federal do Esp&iacute;rito Santo; 2006.    112p.    ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#108#104#article#118#</font
></p>     ^cY#aop19-11.htm##
00511000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024800092002001300340#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#109#105#articl
e#118#13#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Cani
coba M,    Feldman N, Lipovetzky S, Moyano O. Evaluaci&oacute;n del estado nutri
cional    de pacientes em um hospital con lepra en Argentina. Nutr Hosp 2007; 22
:377-381.    ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#110#106#article#118#</font
></p>     ^cY#aop19-11.htm##
00640000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704037700092002001300469#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#111#107#articl
e#118#14#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Anse
lmo MAC.    Avalia&ccedil;&atilde;o do estado nutricional de indiv&iacute;duos a
dultos sadios    de classe m&eacute;dia. Ingest&atilde;o en&eacute;rgica e prot&
eacute;ica, antropometria,    exames bioqu&iacute;micos do sangue e testes de im
unocompet&ecirc;ncia. Rev    Saude Publica 1992; 26:46-53.    ^cY#aop19-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#112#108#article#118#</font
></p>     ^cY#aop19-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#113#109#article#118#<p>&nb
sp;</p>     ^cY#aop19-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#114#110#article#118#<p>&nb
sp;</p>     ^cY#aop19-11.htm##
00469000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704022100089002001300310#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#115#111#article#118#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><
a href="#top"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a>
    Endere&ccedil;o para correspond&ecirc;ncia:    ^cY#aop19-11.htm##
00301000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005300089002001300142#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#116#112#article#118#<br>  
</b> Dra. Rosa Maria Natalli Montenegro    ^cY#aop19-11.htm##
00330000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704008200089002001300171#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#117#113#article#118#<br>  
 Rua Doutor Dido Fontes 40/201, Ed. Solar Menegatti, Jardim da Penha    ^cY#aop1
9-11.htm##
00291000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004300089002001300132#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#118#114#article#118#<br>  
 29060-280 Vit&oacute;ria, ES    ^cY#aop19-11.htm##
00283000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003500089002001300124#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#119#115#article#118#<br>  
 Tel: 55 27 8838-2221    ^cY#aop19-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009500089002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#120#116#article#118#<br>  
 e-mail: <a href="mailto:rnnegro@hotmail.com">rnnegro@hotmail.com</a></font></p>
     ^cY#aop19-11.htm##
00374000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704012600089002001300215#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#121#117#article#118#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">Recebido para publica&c
cedil;&atilde;o    em 14/05/2010    ^cY#aop19-11.htm##
00295000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004700089002001300136#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#p#122#118#article#118#<br>  
 Aceito em 04/11/2010</font></p>     ^cY#aop19-11.htm##
00565000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170104000880180075001920660
01200267062002000279065000900299064000500308865000900313002001300322#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#123#1#article#14#1#Sec
retaria de Saúde do Espírito Santo^dGerência Epidemiológica de Vigilância em Saú
de do Espírito Santo#Relatório de atividades do Programa Estadual de Controle de
 Hanseníase^lpt#Vitória^eES#Secretaria de Saúde#20070000#2007#20110000#aop19-11.
htm##
00465000000000217000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170055000880180059001430660
00900202065000900211064000500220865000900225002001300234#2011nahead#V:\SciELO\se
rial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#124#2#article#14#2#Ministério da S
aúde^dSecretaria de Vigilância em Saúde#Hanseníase no Brasil: dados e indicadore
s selecionados^lpt#Brasília#20090000#2009#20110000#aop19-11.htm##
00508000000000265000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880120026001040160
01700130018002200147066001500169062001400184065000900198064000500207014000800212
865000900220002001300229#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
19-11.htm#S#c#125#3#article#14#3#^rND^sPorto^nCC#Exames Complementares^lpt#^rND^
sHungria^nH#Semiologia médica^lpt#Rio de Janeiro#Ed. Guanabara#20010000#2001#977
-978#20110000#aop19-11.htm##
00511000000000253000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880120086001080300
01700194710000200211065000900213064000500222031000300227014000500230865000900235
002001300244#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#
c#126#4#article#14#4#^rND^sFrisancho^nAR#New norms of upper limb fat and muscle 
areas for assessment of nutritional status^len#Amer J Clin Nutr#2#19810000#1981#
34#2540#20110000#aop19-11.htm##
00498000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170029000880180078001170660
00800195062002900203065000900232064000500241865000900246002001300255#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#127#5#article#14#5#Org
anização Mundial de Saúde#Unidade guia para eliminar a hanseníase como um proble
ma de saúde pública^lpt#Genebra#Organização Mundial de Saúde#19950000#1995#20110
000#aop19-11.htm##
00948000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100028001030100
01400131010001900145010001900164010001500183810000600198012031900204030001500523
06500090053806400050054703100030055201400080055586500090056300200130057203500100
0585801001500595#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.ht
m#S#c#128#6#article#14#6#^rND^sKroke^nA#^rND^sKlipstein-Grobusch^nK#^rND^sVoss^n
S#^rND^sMöseneder^nJ#^rND^sThielecke^nF#^rND^sNoack^nR#et al#Validation of a sel
f-administered food-frequency questionnaire administered in the European Prospec
tive Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy,
 protein, and macronutrient intakes estimated with the doubly labeled water, uri
nary nitrogen, and repeated 24-h dietary recall methods^len#Am J Clin Nutr#19990
000#1999#70#439-447#20110000#aop19-11.htm#0002-9165#Am J Clin Nutr##
00451000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160018000880180061001060660
01000167062000800177065000900185064000500194865000900199002001300208#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#129#7#article#14#7#^rN
D^sDuarte^nACG#Avaliação nutricional: aspectos clínicos e laboratoriais^lpt#São 
Paulo#Atheneu#20070000#2007#20110000#aop19-11.htm##
00493000000000229000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860170020000880180090001080660
00900198062002000207065000900227064000500236865000900241002001300250#2011nahead#
V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#130#8#article#14#8#Min
istério da Saúde#Manual clínico de alimentação e nutrição na assistência a adult
os infectados pelo HIV^lpt#Brasília#Ministério da Saúde#20060000#2006#20110000#a
op19-11.htm##
00513000000000241000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860160018000880180088001060660
01000194062002600204065000900230064000500239020000500244865000900249002001300258
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#131#9#arti
cle#14#9#^rND^sGarcia^nICO#Avaliação nutricional e caracterização sociodemográfi
ca de portadores de hanseníase^lpt#São Paulo#Universidade de São Paulo#20060000#
2006#138p#20110000#aop19-11.htm##
00772000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100018001070100
02100125010001600146012020000162030001700362065000900379064000500388031000300393
032000400396014000900400865000900409002001300418035001000431801001700441#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#132#10#article#14#
10#^rND^sGomes^nCCD#^rND^sPontes^nMAA#^rND^sGonçalves^nHSG#^rND^sPenna^nGO#Perfi
l clínico-epidemiológico dos pacientes diagnosticados com hanseníase em um centr
o de referência na região nordeste do Brasil: Investigação Clínica, Epidemiológi
ca, Laboratorial e Terapêutica^lpt#An Bras Dermatol#20050000#2005#80#^s3#S283-28
8#20110000#aop19-11.htm#0365-0596#An Bras Dermatol##
00491000000000253000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900120058001110300
01900169710000200188065000900190064000500199031000300204014000800207865000900215
002001300224#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#
c#133#11#article#14#11#^rND^sRufino Neto^nA#Tuberculose e o estudo molecular da 
sua epidemiologia^lpt#Rev Cienc Farm Apl#2#20070000#2007#28#251-257#20110000#aop
19-11.htm##
00540000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870160018000900180103001080660
00800211062003900219065000900258064000500267020000400272865000900276002001300285
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#134#12#art
icle#14#12#^rND^sMadeira^nES#Os espaços de transmissão da hanseníase: domicílio,
 ambiente de trabalho e relações de vizinhanças^lpt#Vitória#Universidade Federal
 do Espírito Santo#20060000#2006#112#20110000#aop19-11.htm##
00629000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900100017001080100
02000125010001600145012008900161030001000250065000900260064000500269031000300274
014000800277865000900285002001300294035001000307801001000317#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop19-11.htm#S#c#135#13#article#14#13#^rND^sCan
icoba^nM#^rND^sFeldman^nN#^rND^sLipovetzky^nS#^rND^sMoyano^nO#Evaluación del est
ado nutricional de pacientes em um hospital con lepra en Argentina^les#Nutr Hosp
#20070000#2007#22#377-381#20110000#aop19-11.htm#0212-1611#Nutr Hosp##
00651000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900120185001090300
01800294065000900312064000500321031000300326014000600329865000900335002001300344
035001000357801001800367#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
19-11.htm#S#c#136#14#article#14#14#^rND^sAnselmo^nMAC#Avaliação do estado nutric
ional de indivíduos adultos sadios de classe média: Ingestão enérgica e protéica
, antropometria, exames bioquímicos do sangue e testes de imunocompetência^lpt#R
ev Saude Publica#19920000#1992#26#46-53#20110000#aop19-11.htm#0034-8910#Rev Saud
e Publica##
00286000000000169000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810910009000830920007000920020013000997030
00400112#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#o#1#
1#article#1#20110411#104908#aop20-11.htm#170##
05247000000000637000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301201120018201201240
02940100047004180100033004650100033004980100035005310100026005660700108005920831
76700700085000802467085003502475085004302510085002402553083182802577085000804405
08500350441308500440444808500230449205800130451505800050452806000140453311700060
4547072000304553112000904556111001104565114000904576113001104585002001304596#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#h#2#1#article#1#
oa#en#br1.1#1#4.0#TAB#19#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#
0037-8682#20110415#Antimicrobial susceptibilities of Listeria monocytogenes huma
n strains isolated from 1970 to 2008 in Brazil^len#Susceptibilidade antimicrobia
na de cepas humanas de Listeria monocytogenes isoladas no período de 1970 a 2008
 no Brasil^lpt#^rND^1A01^nCristhiane Moura Falavina dos^sReis#^rND^1A01^nAndré V
ictor^sBarbosa#^rND^1A01^nLeonardo Alves^sRusak#^rND^1A01^nDeyse Christina^sVall
im#^rND^1A01^nErnesto^sHofer#Fundação Oswaldo Cruz^iA01^1Instituto Oswaldo Cruz^
2Laboratório de Zoonoses Bacterianas^cRio de Janeiro^sRJ#^len^aINTRODUCTION: Lis
teria monocytogenes is the causative agent of listeriosis, a foodborne illness t
hat affects mainly pregnant women, the elderly and immunocompromised patients. T
he primary treatment is a combination of ampicillin with an aminoglycoside, in a
ddition to a second-choice drug represented by chloramphenicol, erythromycin, te
tracycline and rifampicin. The aim of this study was to analyze the antimicrobia
l susceptibility profile of strains isolated from human sources in the last four
 decades. METHODS: Sixty-eight strains were selected from the culture collection
 of the Laboratory of Bacterial Zoonoses/LABZOO/FIOCRUZ isolated in different re
gions of Brazil from 1970 to 2008 and primarily isolated from cerebrospinal flui
d and blood culture. Susceptibility tests to antimicrobials drugs were evaluated
 using the criteria established by Soussy using the Kirby-Bauer method and E-Tes
t strips were used to determine the minimum inhibitory concentration (MIC). RESU
LTS: Among the strains tested, serovar L4b (60.3%) was the most prevalent, follo
wed by serovar 1/2a (20.6%), 1/2b (13.2%) and the more uncommon serovars 1/2c, 3
b and 4ab (5.9%). All strains were susceptible to ampicillin, cephalothin, eryth
romycin, gentamicin, teicoplanin and vancomycin. Only one strain (1.5%) showed r
esistance to rifampin, and two (3%) were resistant to trimethoprim-sulfamethoxaz
ole. MICs with values up to 2&#956;g/ml reinforce the need for microbiological s
urveillance. CONCLUSIONS: The study demonstrated low prevalence of strains resis
tant to the antimicrobial drugs indicated in the treatment of human listeriosis.
 Monitoring antimicrobial resistance profile is still very important to determin
e adequate treatment, especially in immunocompromised patients.#^dnd^i1#^tm^len^
kListeria monocytogenes^i1#^tm^len^kAntimicrobial susceptibilities^i1#^tm^len^kL
isteriosis^i1#^lpt^aINTRODUÇÃO: Listeria monocytogenes é o agente etiológico da 
listeriose, doença de origem alimentar que acomete principalmente grávidas, paci
entes imunodeprimidos e idosos. O tratamento primário é a associação de ampicili
na a um aminoglicosídeo além de outros, em segunda escolha, representados por cl
oranfenicol, eritromicina, tetraciclina e rifampicina. O presente estudo teve co
mo objetivo analisar o perfil de susceptibilidade aos antimicrobianos de amostra
s de origem humana isoladas nas últimas quatro décadas. MÉTODOS: Foram seleciona
das 68 cepas provenientes de casos clínicos humanos ocorridos em diferentes regi
ões do país no período de 1970-2008. A susceptibilidade aos antimicrobianos test
ados foi determinada através dos critérios estabelecidos por Soussy pelo método 
de Kirby-Bauer e a concentração mínima inibitória realizada através do E-Test. R
ESULTADOS: A amostragem constituiu-se de 68 cepas, isoladas principalmente de lí
quido cefalorraquidiano, e hemocultura no período, pertencentes ao Laboratório d
e Zoonoses Bacterianas/LABZOO/Fiocruz. O sorovar L4b (60,3%) foi o mais prevalen
te, seguido do sorovar 1/2a (20,6%), 1/2b (13,2%) e aqueles mais raros represent
ados por 1/2c, 3b e 4ab (5,9%). Todas as cepas foram sensíveis à ampicilina, cef
alotina, eritromicina, gentamicina, teicoplanina e vancomicina. Apenas uma cepa 
(1,5%) apresentou resistência à rifampicina, enquanto duas (3%) foram resistente
s à associação de sulfametoxazol-trimetoprim. CONCLUSÕES: Apesar de o estudo ter
 demonstrado uma baixa prevalência de amostras resistentes aos antimicrobianos i
ndicados na terapêutica da listeriose humana, o sistema de monitoramento do perf
il de resistência antimicrobiana é de extrema importância para a orientação do t
ratamento adequado, principalmente nas infecções em pacientes imunocomprometidos
.#^dnd^i2#^tm^lpt^kListeria monocytogenes^i2#^tm^lpt^kSusceptibilidade antimicro
biana^i2#^tm^lpt^kListeriose^i2#FIOCRUZ^dIOC#CNPq#301545/2006-5#other#27#2010102
7#27/10/2010#20101215#15/12/2010#aop20-11.htm##
05418000000000637000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810710003000830400003000860010006000890420
00200095120000400097038000400101121000300105049000300108158000300111030002700114
03200060014106500090014701400070015603500100016322300090017301201260018201201380
03080100047004460100033004930100033005260100035005590100026005940700108006200831
80200728085000802530085004202538085004302580085002402623083186302647085000804510
08500420451808500440456008500230460405800130462705800050464006000730464511700060
4718072000304724112000904727111001104736114000904747113001104756002001304767#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#f#3#1#article#1#
oa#en#br1.1#1#4.0#TAB#19#nd#nd#Rev. Soc. Bras. Med. Trop.#ahead#20110000#^f0^l0#
0037-8682#20110415#<b>Antimicrobial susceptibilities of <i>Listeria monocytogene
s</i> human strains isolated from 1970 to 2008 in Brazil</b>^len#<b>Susceptibili
dade antimicrobiana de cepas humanas de <i>Listeria monocytogenes</i> isoladas n
o período de 1970 a 2008 no Brasil</b>^lpt#^rND^1A01^nCristhiane Moura Falavina 
dos^sReis#^rND^1A01^nAndré Victor^sBarbosa#^rND^1A01^nLeonardo Alves^sRusak#^rND
^1A01^nDeyse Christina^sVallim#^rND^1A01^nErnesto^sHofer#Fundação Oswaldo Cruz^i
A01^1Instituto Oswaldo Cruz^2Laboratório de Zoonoses Bacterianas^cRio de Janeiro
^sRJ#^len^a<b>INTRODUCTION:</b> <i>Listeria monocytogenes</i> is the causative a
gent of listeriosis, a foodborne illness that affects mainly pregnant women, the
 elderly and immunocompromised patients. The primary treatment is a combination 
of ampicillin with an aminoglycoside, in addition to a second-choice drug repres
ented by chloramphenicol, erythromycin, tetracycline and rifampicin. The aim of 
this study was to analyze the antimicrobial susceptibility profile of strains is
olated from human sources in the last four decades. <b>METHODS:</b> Sixty-eight 
strains were selected from the culture collection of the Laboratory of Bacterial
 Zoonoses/LABZOO/FIOCRUZ isolated in different regions of Brazil from 1970 to 20
08 and primarily isolated from cerebrospinal fluid and blood culture. Susceptibi
lity tests to antimicrobials drugs were evaluated using the criteria established
 by Soussy using the Kirby-Bauer method and E-Test strips were used to determine
 the minimum inhibitory concentration (MIC). <b>RESULTS: </b>Among the strains t
ested, serovar L4b (60.3%) was the most prevalent, followed by serovar 1/2a (20.
6%), 1/2b (13.2%) and the more uncommon serovars 1/2c, 3b and 4ab (5.9%). All st
rains were susceptible to ampicillin, cephalothin, erythromycin, gentamicin, tei
coplanin and vancomycin. Only one strain (1.5%) showed resistance to rifampin, a
nd two (3%) were resistant to trimethoprim-sulfamethoxazole. MICs with values up
 to 2&#956;g/ml reinforce the need for microbiological surveillance. <b>CONCLUSI
ONS:</b> The study demonstrated low prevalence of strains resistant to the antim
icrobial drugs indicated in the treatment of human listeriosis. Monitoring antim
icrobial resistance profile is still very important to determine adequate treatm
ent, especially in immunocompromised patients.#^dnd^i1#^tm^len^k<i>Listeria mono
cytogenes</i>^i1#^tm^len^kAntimicrobial susceptibilities^i1#^tm^len^kListeriosis
^i1#^lpt^a<b>INTRODUÇÃO:</b> <i>Listeria monocytogenes</i> é o agente etiológico
 da listeriose, doença de origem alimentar que acomete principalmente grávidas, 
pacientes imunodeprimidos e idosos. O tratamento primário é a associação de ampi
cilina a um aminoglicosídeo além de outros, em segunda escolha, representados po
r cloranfenicol, eritromicina, tetraciclina e rifampicina. O presente estudo tev
e como objetivo analisar o perfil de susceptibilidade aos antimicrobianos de amo
stras de origem humana isoladas nas últimas quatro décadas. <b>MÉTODOS: </b>Fora
m selecionadas 68 cepas provenientes de casos clínicos humanos ocorridos em dife
rentes regiões do país no período de 1970-2008. A susceptibilidade aos antimicro
bianos testados foi determinada através dos critérios estabelecidos por Soussy p
elo método de Kirby-Bauer e a concentração mínima inibitória realizada através d
o E-Test. <b>RESULTADOS: </b>A amostragem constituiu-se de 68 cepas, isoladas pr
incipalmente de líquido cefalorraquidiano, e hemocultura no período, pertencente
s ao Laboratório de Zoonoses Bacterianas/LABZOO/Fiocruz. O sorovar L4b (60,3%) f
oi o mais prevalente, seguido do sorovar 1/2a (20,6%), 1/2b (13,2%) e aqueles ma
is raros representados por 1/2c, 3b e 4ab (5,9%). Todas as cepas foram sensíveis
 à ampicilina, cefalotina, eritromicina, gentamicina, teicoplanina e vancomicina
. Apenas uma cepa (1,5%) apresentou resistência à rifampicina, enquanto duas (3%
) foram resistentes à associação de sulfametoxazol-trimetoprim. <b>CONCLUSÕES: <
/b>Apesar de o estudo ter demonstrado uma baixa prevalência de amostras resisten
tes aos antimicrobianos indicados na terapêutica da listeriose humana, o sistema
 de monitoramento do perfil de resistência antimicrobiana é de extrema importânc
ia para a orientação do tratamento adequado, principalmente nas infecções em pac
ientes imunocomprometidos.#^dnd^i2#^tm^lpt^k<i>Listeria monocytogenes</i>^i2#^tm
^lpt^kSusceptibilidade antimicrobiana^i2#^tm^lpt^kListeriose^i2#FIOCRUZ^dIOC#CNP
q#<span style='font-size: 10.0pt;font-family:Verdana'>301545/2006-5</span>#other
#27#20101027#27/10/2010#20101215#15/12/2010#aop20-11.htm##
05464000000000661000450000400110000070200540001170500020006570600020006770000020
00697010002000717090008000737080002000810640007000830710003000900400003000930010
00600096042000200102120000400104038000400108121000300112049000300115158000300118
03000260012103200060014706500090015301400070016203500100016922300090017901201120
01880120124003000100047004240100033004710100033005040100035005370100026005720700
11000598083180900708085000802517085003502525085004302560085002402603083188202627
08500080450908500350451708500440455208500230459605800130461905800050463206000140
46371170006046510720003046571120009046601110011046691140009046801130011046890020
01304700008008904713#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-1
1.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1#4.0#tab#19#nd#nd#Rev. Soc. Bras. Me
d. Trop#ahead#20110000#^f0^l0#0037-8682#20110415#Antimicrobial susceptibilities 
of Listeria monocytogenes human strains isolated from 1970 to 2008 in Brazil^len
#Susceptibilidade antimicrobiana de cepas humanas de Listeria monocytogenes isol
adas no período de 1970 a 2008 no Brasil^lpt#^rND^1A01^nCristhiane Moura Falavin
a dos^sReis#^rND^1A01^nAndré Victor^sBarbosa#^rND^1A01^nLeonardo Alves^sRusak#^r
ND^1A01^nDeyse Christina^sVallim#^rND^1A01^nErnesto^sHofer#^iA01^1Fundação Oswal
do Cruz^2Instituto Oswaldo Cruz^3Laboratório de Zoonoses Bacterianas^cRio de Jan
eiro^sRJ#^len^aINTRODUCTION: Listeria monocytogenes is the causative agent of li
steriosis, a foodborne illness that affects mainly pregnant women, the elderly a
nd immunocompromised patients. The primary treatment is a combination of ampicil
lin with an aminoglycoside, in addition to a second-choice drug represented by c
hloramphenicol, erythromycin, tetracycline and rifampicin. The aim of this study
 was to analyze the antimicrobial susceptibility profile of strains isolated fro
m human sources in the last four decades. METHODS: Sixty-eight strains were sele
cted from the culture collection of the Laboratory of Bacterial Zoonoses/LABZOO/
FIOCRUZ isolated in different regions of Brazil from 1970 to 2008 and primarily 
isolated from cerebrospinal fluid and blood culture. Susceptibility tests to ant
imicrobials drugs were evaluated using the criteria established by Soussy using 
the Kirby-Bauer method and E-Test strips were used to determine the minimum inhi
bitory concentration (MIC). RESULTS: Among the strains tested, serovar L4b (60.3
 percent) was the most prevalent, followed by serovar 1/2a (20.6 percent), 1/2b 
(13.2 percent) and the more uncommon serovars 1/2c, 3b and 4ab (5.9 percent). Al
l strains were susceptible to ampicillin, cephalothin, erythromycin, gentamicin,
 teicoplanin and vancomycin. Only one strain (1.5 percent) showed resistance to 
rifampin, and two (3 percent) were resistant to trimethoprim-sulfamethoxazole. M
ICs with values up to 2&#956;g/ml reinforce the need for microbiological surveil
lance. CONCLUSIONS: The study demonstrated low prevalence of strains resistant t
o the antimicrobial drugs indicated in the treatment of human listeriosis. Monit
oring antimicrobial resistance profile is still very important to determine adeq
uate treatment, especially in immunocompromised patients.#^dnd^i1#^tm^len^kListe
ria monocytogenes^i1#^tm^len^kAntimicrobial susceptibilities^i1#^tm^len^kListeri
osis^i1#^lpt^aINTRODUÇÃO: Listeria monocytogenes é o agente etiológico da lister
iose, doença de origem alimentar que acomete principalmente grávidas, pacientes 
imunodeprimidos e idosos. O tratamento primário é a associação de ampicilina a u
m aminoglicosídeo além de outros, em segunda escolha, representados por cloranfe
nicol, eritromicina, tetraciclina e rifampicina. O presente estudo teve como obj
etivo analisar o perfil de susceptibilidade aos antimicrobianos de amostras de o
rigem humana isoladas nas últimas quatro décadas. MÉTODOS: Foram selecionadas 68
 cepas provenientes de casos clínicos humanos ocorridos em diferentes regiões do
 país no período de 1970-2008. A susceptibilidade aos antimicrobianos testados f
oi determinada através dos critérios estabelecidos por Soussy pelo método de Kir
by-Bauer e a concentração mínima inibitória realizada através do E-Test. RESULTA
DOS: A amostragem constituiu-se de 68 cepas, isoladas principalmente de líquido 
cefalorraquidiano, e hemocultura no período, pertencentes ao Laboratório de Zoon
oses Bacterianas/LABZOO/Fiocruz. O sorovar L4b (60,3 por cento) foi o mais preva
lente, seguido do sorovar 1/2a (20,6 por cento), 1/2b (13,2 por cento) e aqueles
 mais raros representados por 1/2c, 3b e 4ab (5,9 por cento). Todas as cepas for
am sensíveis à ampicilina, cefalotina, eritromicina, gentamicina, teicoplanina e
 vancomicina. Apenas uma cepa (1,5 por cento) apresentou resistência à rifampici
na, enquanto duas (3 por cento) foram resistentes à associação de sulfametoxazol
-trimetoprim. CONCLUSÕES: Apesar de o estudo ter demonstrado uma baixa prevalênc
ia de amostras resistentes aos antimicrobianos indicados na terapêutica da liste
riose humana, o sistema de monitoramento do perfil de resistência antimicrobiana
 é de extrema importância para a orientação do tratamento adequado, principalmen
te nas infecções em pacientes imunocomprometidos.#^dnd^i2#^tm^lpt^kListeria mono
cytogenes^i2#^tm^lpt^kSusceptibilidade antimicrobiana^i2#^tm^lpt^kListeriose^i2#
FIOCRUZ^dIOC#CNPq#301545/2006-5#other#27#20101027#27/10/2010#20101215#15/12/2010
#aop20-11.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S
0037-86822011005000019##
00473000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704022900085002001300314#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#5#1#article#139#<p><a name
="top"></a><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Antimi
crobial    susceptibilities of <i>Listeria monocytogenes</i> human strains isola
ted from    1970 to 2008 in Brazil</b> </font></p>     ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#6#2#article#139#<p>&nbsp;<
/p>     ^cY#aop20-11.htm##
00473000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704022900085002001300314#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#7#3#article#139#<p><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Susceptibilidade    anti
microbiana de cepas humanas de <i>Listeria monocytogenes</i> isoladas no    per&
iacute;odo de 1970 a 2008 no Brasil</b></font></p>     ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#8#4#article#139#<p>&nbsp;<
/p>     ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000020
0069701000200071709000800073708000400081704002200085002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#9#5#article#139#<p>&nbsp;<
/p>     ^cY#aop20-11.htm##
00465000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704022000086002001300306#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#10#6#article#139#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Cristhiane Moura    Fal
avina dos Reis; Andr&eacute; Victor Barbosa; Leonardo Alves Rusak; Deyse    Chri
stina Vallim; Ernesto Hofer</b></font></p>     ^cY#aop20-11.htm##
00457000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704021200086002001300298#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#11#7#article#139#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2">Laborat&oacute;rio    de Z
oonoses Bacterianas, Instituto Oswaldo Cruz, Funda&ccedil;&atilde;o Oswaldo    C
ruz, Rio de Janeiro, RJ</font></p>     ^cY#aop20-11.htm##
00361000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704011600086002001300202#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#12#8#article#139#<p><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Address   
 to</a></font></p>     ^cY#aop20-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000200072709000800074708000400082704002200086002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#13#9#article#139#<p>&nbsp;
</p>     ^cY#aop20-11.htm##
00290000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704004400087002001300131#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#14#10#article#139#<p>&nbsp
;</p> <hr size="1" noshade>     ^cY#aop20-11.htm##
00344000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009800087002001300185#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#15#11#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p
>     ^cY#aop20-11.htm##
00859000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704061300087002001300700#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#16#12#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODUCTION:</b>     
<i>Listeria monocytogenes</i> is the causative agent of listeriosis, a foodborne
    illness that affects mainly pregnant women, the elderly and immunocompromise
d    patients. The primary treatment is a combination of ampicillin with an amin
oglycoside,    in addition to a second-choice drug represented by chloramphenico
l, erythromycin,    tetracycline and rifampicin. The aim of this study was to an
alyze the antimicrobial    susceptibility profile of strains isolated from human
 sources in the last four    decades.    ^cY#aop20-11.htm##
00749000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704050300087002001300590#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#17#13#article#139#<br>   <
b>METHODS:</b>  Sixty-eight strains were selected from the culture collection   
 of the Laboratory of Bacterial Zoonoses/LABZOO/FIOCRUZ isolated in different   
 regions of Brazil from 1970 to 2008 and primarily isolated from cerebrospinal  
  fluid and blood culture. Susceptibility tests to antimicrobials drugs were eva
luated    using the criteria established by Soussy using the Kirby-Bauer method 
and E-Test    strips were used to determine the minimum inhibitory concentration
 (MIC).    ^cY#aop20-11.htm##
00872000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704062600087002001300713#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#18#14#article#139#<br>   <
b>RESULTS:</b>  Among the strains tested, serovar L4b (60.3%) was the most preva
lent,    followed by serovar 1/2a (20.6%), 1/2b (13.2%) and the more uncommon se
rovars    1/2c, 3b and 4ab (5.9%). All strains were susceptible to ampicillin, c
ephalothin,    erythromycin, gentamicin, teicoplanin and vancomycin. Only one st
rain (1.5%)    showed resistance to rifampin, and two (3%) were resistant to tri
methoprim-sulfamethoxazole.    MICs with values up to 2</font><font size="2">&#9
56;</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">g/ml    re
inforce the need for microbiological surveillance.    ^cY#aop20-11.htm##
00580000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704033400087002001300421#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#19#15#article#139#<br>   <
b>CONCLUSIONS:</b>  The study demonstrated low prevalence of strains resistant  
  to the antimicrobial drugs indicated in the treatment of human listeriosis.   
 Monitoring antimicrobial resistance profile is still very important to determin
e    adequate treatment, especially in immunocompromised patients.</font></p>   
  ^cY#aop20-11.htm##
00446000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020000087002001300287#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#20#16#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords</b>:    <i>Li
steria monocytogenes.</i> Antimicrobial susceptibilities. Listeriosis.</font></p
> <hr size="1" noshade>     ^cY#aop20-11.htm##
00342000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009600087002001300183#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#21#17#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p> 
    ^cY#aop20-11.htm##
00969000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072300087002001300810#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#22#18#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>INTRODU&Ccedil;&Atilde
;O:</b>     <i>Listeria monocytogenes</i> &eacute; o agente etiol&oacute;gico da
 listeriose,    doen&ccedil;a de origem alimentar que acomete principalmente gr&
aacute;vidas,    pacientes imunodeprimidos e idosos. O tratamento prim&aacute;ri
o &eacute; a    associa&ccedil;&atilde;o de ampicilina a um aminoglicos&iacute;d
eo al&eacute;m    de outros, em segunda escolha, representados por cloranfenicol
, eritromicina,    tetraciclina e rifampicina. O presente estudo teve como objet
ivo analisar o    perfil de susceptibilidade aos antimicrobianos de amostras de 
origem humana    isoladas nas &uacute;ltimas quatro d&eacute;cadas.    ^cY#aop20
-11.htm##
00717000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047100087002001300558#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#23#19#article#139#<br>   <
b>M&Eacute;TODOS:</b>  Foram selecionadas 68 cepas provenientes de casos cl&iacu
te;nicos    humanos ocorridos em diferentes regi&otilde;es do pa&iacute;s no per
&iacute;odo    de 1970-2008. A susceptibilidade aos antimicrobianos testados foi
 determinada    atrav&eacute;s dos crit&eacute;rios estabelecidos por Soussy pel
o m&eacute;todo    de Kirby-Bauer e a concentra&ccedil;&atilde;o m&iacute;nima i
nibit&oacute;ria    realizada atrav&eacute;s do E-Test.    ^cY#aop20-11.htm##
00968000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704072200087002001300809#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#24#20#article#139#<br>   <
b>RESULTADOS:</b>  A amostragem constituiu-se de 68 cepas, isoladas principalmen
te    de l&iacute;quido cefalorraquidiano, e hemocultura no per&iacute;odo, pert
encentes    ao Laborat&oacute;rio de Zoonoses Bacterianas/LABZOO/Fiocruz. O soro
var L4b    (60,3%) foi o mais prevalente, seguido do sorovar 1/2a (20,6%), 1/2b 
(13,2%)    e aqueles mais raros representados por 1/2c, 3b e 4ab (5,9%). Todas a
s cepas    foram sens&iacute;veis &agrave; ampicilina, cefalotina, eritromicina,
 gentamicina,    teicoplanina e vancomicina. Apenas uma cepa (1,5%) apresentou r
esist&ecirc;ncia    &agrave; rifampicina, enquanto duas (3%) foram resistentes &
agrave; associa&ccedil;&atilde;o    de sulfametoxazol-trimetoprim.    ^cY#aop20-
11.htm##
00717000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704047100087002001300558#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#25#21#article#139#<br>   <
b>CONCLUS&Otilde;ES:</b>  Apesar de o estudo ter demonstrado uma baixa preval&ec
irc;ncia    de amostras resistentes aos antimicrobianos indicados na terap&ecirc
;utica da    listeriose humana, o sistema de monitoramento do perfil de resist&e
circ;ncia    antimicrobiana &eacute; de extrema import&acirc;ncia para a orienta
&ccedil;&atilde;o    do tratamento adequado, principalmente nas infec&ccedil;&ot
ilde;es em pacientes    imunocomprometidos.</font></p>     ^cY#aop20-11.htm##
00454000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704020800087002001300295#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#26#22#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palavras-chaves:</b>  
   <i>Listeria monocytogenes</i>. Susceptibilidade antimicrobiana. Listeriose.</
font></p> <hr size="1" noshade>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#27#23#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#28#24#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00348000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010200087002001300189#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#29#25#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>INTRODUCTION</b></font
></p>     ^cY#aop20-11.htm##
00802000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704055600087002001300643#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#30#26#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Listeria monocytogenes
</i>    is a gram positive, facultative anaerobe, intracellular bacterium and th
e etiologic    agent of human and animal listeriosis. The disease affects primar
ily pregnant    women, newborns and patients with degenerative diseases and/or i
mmunocompromised    patients, is clinically manifested as meningitis and septice
mia, has a high    mortality rate, between 20 and 30% of cases, and causes neuro
logical sequelae    in some cases<sup>1-3</sup>.</font></p>     ^cY#aop20-11.htm
##
00608000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704036200087002001300449#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#31#27#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Members of the    genus <
i>Listeria</i> are widely distributed in nature and can be detected in    the en
vironment (soil, vegetables, silage and water) and in the intestinal tract    of
 humans and animals<sup>2</sup>. The species is a significant food-borne pathoge
n<sup>4</sup>.</font></p>     ^cY#aop20-11.htm##
01429000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704118300087002001301270#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#32#28#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Listeria monocytogenes
</i>    presents uniform antimicrobial susceptibility, including drugs commonly 
used    for treating human listeriosis, such as ampicillin or in association wit
h an    aminoglycoside (e.g. gentamicin), and other second-choice antimicrobials
 represented    by chloramphenicol, erythromycin, tetracycline and rifampicin<su
p>4-6</sup>.    However, clinical strains resistant to chloramphenicol, erythrom
ycin, streptomycin,    tetracycline, vancomycin and trimethoprim have been recen
tly described<sup>4</sup>.    The widespread distribution of epidemiologically s
erotypes of <i>L. monocytogenes</i>    and their resistance to commonly used ant
ibiotics indicate a potential public    health risk. Given this situation, it is
 assumed that the system for monitoring    antimicrobial resistance profile is e
xtremely important to determine the appropriate    treatment of human listeriosi
s. Therefore, the main goal of this study was to    analyze the profile of antim
icrobial resistance in strains isolated from humans    in different regions of B
razil during the last four decades.</font></p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#33#29#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#34#30#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>METHODS</b></font></p>
     ^cY#aop20-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#35#31#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Bacterial strains</b><
/font></p>     ^cY#aop20-11.htm##
00810000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704056400087002001300651#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#36#32#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Sixty-eight strains    is
olated from 1970 to 2008 were selected, including human clinical cases occurring
    in different regions of the country. The samples belong to the collection of
    Bacteriological Culture Collection Laboratory, Bacterial Zoonoses of the Osw
aldo    Cruz Institute/LABZOO/IOC/FIOCRUZ <b>(<a href="#t1">Table 1</a>)</b>, we
re maintained    in tryptose agar semi-solid at 4&deg;C throughout the study per
iod and stored    at -20&deg;C in BHI plus 20% glycerol.</font></p>     ^cY#aop2
0-11.htm##
00279000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003300087002001300120#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#37#33#article#139#<p><a na
me="t1"></a></p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#38#34#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#39#35#article#139#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/20t01.jpg"></p>     ^cY#aop20
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#40#36#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00709000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704046300087002001300550#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#41#37#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Phenotypic identification
    was performed in accordance with methods described by Rocourt &amp; Seeliger
<sup>7</sup>.    For the identification of serogroups/serovars, the technique of
 slide agglutination    test was used, with poly and monovalent somatic and flag
ellar antisera prepared    by LABZOO, according to the technical guidance of See
liger &amp; H&ouml;hne<sup>8</sup>.</font></p>     ^cY#aop20-11.htm##
00364000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011800087002001300205#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#42#38#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Genotypic analysis    
by PCR</b></font></p>     ^cY#aop20-11.htm##
00496000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704025000087002001300337#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#43#39#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The extraction    of bact
erial chromosomal DNA was performed using the Blood &amp; Tissue Dneasy    Kit (
Qiagen), in accordance with the manufacturer's specifications.</font></p>     ^c
Y#aop20-11.htm##
00692000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704044600087002001300533#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#44#40#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">To determine the    strai
ns detected, primers targeting the 23S rRNA genes (marker of genus), <i>hly</i> 
   (marker of the species <i>L. monocytogenes</i>) and the markers D1 and D2 to 
   were used confirm the identification of serogroups/serovars, according to lit
erature<sup>9,10</sup>    (<b><a href="/img/revistas/rsbmt/2011nahead/20t02.jpg"
>Table 2</a></b>).</font></p>     ^cY#aop20-11.htm##
01501000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704125500087002001301342#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#45#41#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The amplification    reac
tions were performed in volumes of 25</font><font size="2">&#956;</font><font fa
ce="Verdana, Arial, Helvetica, sans-serif" size="2">l    with a primer concentra
tion of 50pmol/</font><font size="2">&#956;</font><font face="Verdana, Arial, He
lvetica, sans-serif" size="2">l,    1U Taq polymerase, 0.2mM of each deoxynucleo
tide triphosphate, 2.5mM MgCl<sub>2</sub>    and 50ng of DNA. For the PCR, the P
X2 thermal cycler equipment (Thermo Fisher    Scientific Inc. Waltham, MA, USA) 
was used under the following conditions (D1    + D2 primers): an initial step of
 95&deg;C for 3min followed by 25 cycles at    95&deg;C/30s, 56&deg;C/30s, 72&de
g;C/1min and a final extension at 72&deg;C    for 10min. For amplification with 
primers 23S rRNA + <i>hly</i> 95&deg;C/5min    followed by 40 cycles of 95&deg;C
/1min, 62&deg;C/1min and 72&deg;C/1min, followed    by a final extension at 72&d
eg;C for 8min. All PCR products were determined    by gel electrophoresis on 1% 
agarose 0.5 X TBE buffer and visualized under UV    light after staining with et
hidium bromide. As molecular weight markers, the    2-log DNA ladders were used 
(New England BioLabs Inc.).</font></p>     ^cY#aop20-11.htm##
00367000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704012100087002001300208#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#46#42#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Antimicrobial    susce
ptibility</b></font></p>     ^cY#aop20-11.htm##
01768000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704152200087002001301609#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#47#43#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Antimicrobial resistance 
   was analyzed using the disk diffusion method, in accordance with the CLSI<sup
>11</sup>,    and was performed with standard discs (Oxoid) indicated for infect
ions caused    by Gram-positive bacteria: ampicillin (10mg), cephalothin (30</fo
nt><font size="2">&#956;</font><font face="Verdana, Arial, Helvetica, sans-serif
" size="2">g),    chloramphenicol (30</font><font size="2">&#956;</font><font fa
ce="Verdana, Arial, Helvetica, sans-serif" size="2">g),    erythromycin (15</fon
t><font size="2">&#956;</font><font face="Verdana, Arial, Helvetica, sans-serif"
 size="2">g),    gentamicin (10mg), norfloxacin (10mg), rifampicin (5</font><fon
t size="2">&#956;</font><font face="Verdana, Arial, Helvetica, sans-serif" size=
"2">g),    sulfamethoxazole/trimethoprim (25</font><font size="2">&#956;</font><
font face="Verdana, Arial, Helvetica, sans-serif" size="2">g),    teicoplanin (3
0</font><font size="2">&#956;</font><font face="Verdana, Arial, Helvetica, sans-
serif" size="2">g),    tetracycline (30</font><font size="2">&#956;</font><font 
face="Verdana, Arial, Helvetica, sans-serif" size="2">g)    and vancomycin (30</
font><font size="2">&#956;</font><font face="Verdana, Arial, Helvetica, sans-ser
if" size="2">g).    To maintain quality control of performance and reliability o
f the results, the    standard strains of <i>Escherichia coli</i> ATCC 25922 and
 <i>Staphylococcus    aureus</i> ATCC 25923 were used.</font></p>     ^cY#aop20-
11.htm##
00727000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704048100087002001300568#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#48#44#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The size of the    inhibi
tion zone was determined according to CLSI guidelines, 2009, for <i>Staphylococc
us    spp</i><sup>11</sup>. Ampicillin and vancomycin were determined using the 
criteria    established for <i>Listeria spp</i>. by Soussy et al<sup>12</sup>. A
ccording    to their behavior before the use of antibiotics, the strains were cl
assified    as sensitive, intermediate and resistant.</font></p>     ^cY#aop20-1
1.htm##
00388000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014200087002001300229#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#49#45#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Determination    of mi
nimum inhibitory concentration</b></font></p>     ^cY#aop20-11.htm##
01210000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704096400087002001301051#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#50#46#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">After examination    of t
he susceptibility by disk diffusion method in agar, 43 strains were randomly    
selected to determine the minimum inhibitory concentration (MIC) to ampicillin  
  (0.016-256</font><font size="2">&#956;</font><font face="Verdana, Arial, Helve
tica, sans-serif" size="2">g/ml),    tetracycline (0.016-256</font><font size="2
">&#956;</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">g/ml)
    and rifampicin (0.016-256</font><font size="2">&#956;</font><font face="Verd
ana, Arial, Helvetica, sans-serif" size="2">g/ml)    by the E-test method, in ac
cordance with the manufacturer's instructions (AB    Biodisk). The MIC values we
re defined as the lowest concentration of antibiotic    able to inhibit growth a
nd the rate of change of MIC50 (where 50% of bacteria    were inhibited) and MIC
90 was calculated to specify the antimicrobial activity.</font></p>     ^cY#aop2
0-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#51#47#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00343000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704009700087002001300184#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#52#48#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>RESULTS</b></font></p>
     ^cY#aop20-11.htm##
02277000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704203100087002001302118#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#53#49#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Of the 68 strains    anal
yzed, 37 (53%) were isolated from cerebrospinal fluid (CSF), 26 (41%) were    is
olated from blood and the remaining 6% were isolated from one of the following  
  samples: placental tissue, vaginal secretion, cervical lymphadenitis and perit
oneal    fluid. The strains showed absolute consistency in the results obtained 
from    phenotypic and genotypic analyzes. Antigenic characterization of <i>L. m
onocytogenes</i>    permitted the identification of five serovars, with the high
est frequency determined    for serovar 4b (n = 41, 60.3%), followed by 1/2a (n 
= 14, 20.6%) and 1 / 2b    (n = 9, 13.2%), and the more uncommon serovars, 1/2c 
(n = 2, 2.9%), 3b (n =    1, 1.4%) and 4ab (n = 1, 1.4%). The temporal relations
 of the serotypes isolated    are shown in <b><a href="#t3">Table 3</a></b>. Cur
rently, there is no criterion    recommended by the CLSI for the interpretation 
of <i>Listeria</i> susceptibility,    except for penicillin and ampicillin break
point, hence the breakpoints recommended    for the interpretive criteria for <i
>Staphylococcus spp.</i> were applied. All    68 strains analyzed were also susc
eptible to ampicillin, gentamicin, erythromycin,    cephalothin, teicoplanin and
 vancomycin. Over the last four decades, a slight    variation in the number of 
strains showing resistance to certain antimicrobials    has been observed. In th
e 70s, only one strain of the serovar 1/2a (1.5%) was    resistant to rifampicin
 isolated from CSF, and two serovar 4b (3%) samples isolated    during the 1990s
 from blood were resistant to the association of trimethoprim-sulfamethoxazole. 
   In contrast, in the 1980s and from 2000 to 2008, no resistance observed has  
  been observed. A total of 29 (42.6%) strains have shown intermediate resistanc
e    profile for antimicrobials: chloramphenicol (7.4%), norfloxacin (27.9%), te
tracycline    (5.9%) and rifampicin (1.5%), distributed over the last four decad
es.</font></p>     ^cY#aop20-11.htm##
00279000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003300087002001300120#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#54#50#article#139#<p><a na
me="t3"></a></p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#55#51#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#56#52#article#139#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/20t03.jpg"></p>     ^cY#aop20
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#57#53#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
01002000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704075600087002001300843#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#58#54#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">All 43 strains    tested 
against antimicrobial agents (rifampicin, ampicillin and tetracycline)    using 
the E-test were sensitive. Rifampicin had the lowest MIC90 (0.25</font><font siz
e="2">&#956;</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">g
/ml),    indicating its effective activity against <i>Listeria</i>. The values f
or ampicillin    and tetracycline ranged from 0.25 to 4</font><font size="2">&#9
56;</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">g/ml    an
d showed a level of MIC90 of 2</font><font size="2">&#956;</font><font face="Ver
dana, Arial, Helvetica, sans-serif" size="2">g/ml    (<a href="#t4"><b>Table 4</
b></a>).</font></p>     ^cY#aop20-11.htm##
00279000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704003300087002001300120#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#59#55#article#139#<p><a na
me="t4"></a></p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#60#56#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00329000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704008300087002001300170#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#61#57#article#139#<p align
="center"><img src="/img/revistas/rsbmt/2011nahead/20t04.jpg"></p>     ^cY#aop20
-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#62#58#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#63#59#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>DISCUSSION</b></font><
/p>     ^cY#aop20-11.htm##
00626000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704038000087002001300467#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#64#60#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">Among the 13 serotypes   
 of <i>L. monocytogenes</i> in the literature, serovar 4b is primarily responsib
le    for most of the outbreaks in humans<sup>5,13</sup> while the serovar 1/2a 
prevails    in food and in some regions of the world where it is more common in 
human cases<sup>14-16</sup>    .</font></p>     ^cY#aop20-11.htm##
02466000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704222000087002001302307#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#65#61#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In relation to    serovar
s of <i>L. monocytogenes</i> identified in this study, a higher incidence    of 
serovar 4b (60.3%) was observed, which is in agreement with research by Hofer   
 et al<sup>17</sup> and reports dating back to the 1970s. The frequency of serov
ar    4b was also demonstrated by Hofer et al<sup>18</sup> in renal transplant r
ecipients    from the same hospital in S&atilde;o Paulo. In the same state, Leme
s-Marques    et al<sup>19</sup> observed the incidence of the same serovar in cl
inical isolates    from 1990 to 2005. Hofer et al<i><sup>20</sup></i>, performed
 phenotypic analysis    of strains of <i>L. monocytogenes</i> isolated from clin
ical material from 1969    to 2000 in different regions of the country, noting t
he higher incidence of    serotype 4b, followed by 1/2a, in agreement with the r
esults obtained in this    study. In the aforementioned study<sup>20</sup>, the 
prevalence of serotype    4b in CSF samples compared to blood isolates was also 
evident, which is consistent    with the results obtained in this work, particul
arly for the 1970s. It is important    to emphasize that all the strains tested 
were susceptible to ampicillin, which    incidentally is the principal drug of c
hoice for the treatment of listeriosis.    It association with gentamicin has al
so been indicated and used successfully    in the treatment of listeriosis, a si
tuation supported by this study, since    all strains were susceptible to gentam
icin. The discrete level of rifampicin    resistance in this study, another drug
 of choice for treatment is in agreement    with the findings of Hofer &amp; Oli
veira<sup>21</sup>, and Pore-Gluchowska    &amp; Markiewicz<sup>6</sup>, who rep
orted resistance in clinical strains from    different parts of the world. It ap
pears that virtually the same profile has    been identified over the years and 
in different countries. In relation to tetracycline,    this research highlighte
d the extreme sensitivity of the 68 strains to this    drug, contrasting with th
e emergence of clinical strains resistant to tetracycline,    related to the gen
e <i>tetM</i><sup>5,22,23</sup>.</font></p>     ^cY#aop20-11.htm##
01006000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704076000087002001300847#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#66#62#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">No resistance to    the a
ssociation of trimethoprim-sulfamethoxazole was observed, which is important    
considering its nomination as an alternative in the treatment of listeriosis,   
 primarily in patients with intolerance to penicillin<sup>5,24</sup>. The same  
  result was obtained by Lemes-Marques et al<sup>19</sup>, although reports in  
  the literature demonstrate resistance to trimethoprim<sup>25</sup>, as well   
 as the combination of trimethoprim-sulfamethoxazole<sup>26,27</sup>. MICs with 
   values up to 2</font><font size="2">&#956;</font><font face="Verdana, Arial, 
Helvetica, sans-serif" size="2">g/ml    reinforce the need for microbiological s
urveillance.</font></p>     ^cY#aop20-11.htm##
01136000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704089000087002001300977#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#67#63#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">In short, these    result
s are compatible with most tests performed in various parts of the world,    inc
luding Brazil, which showed a lower prevalence of strains resistant to antimicro
bial    therapy, indicated in cases of human listeriosis. However, the widesprea
d use    of antimicrobials in veterinary medicine, agriculture and particularly 
in animal    food production could represent selective pressure on <i>Listeria s
pp.</i> In    the environment in the future, allowing the acquisition of resista
nce mechanisms.    Therefore, to evaluate the progression of resistance, it is e
ssential to establish    a program of continuous monitoring of antimicrobial sus
ceptibility of isolates    of <i>L. monocytogenes</i> and <i>Listeria spp.</i> i
solated from human, animal,    food and environmental sources.</font></p>     ^c
Y#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#68#64#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00351000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010500087002001300192#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#69#65#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>ACKNOWLEDGMENTS</b></f
ont></p>     ^cY#aop20-11.htm##
00419000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704017300087002001300260#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#70#66#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors would    like
 to thank Evaldo Soares da Silva for his technical collaboration.</font></p>    
 ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#71#67#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00359000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704011300087002001300200#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#72#68#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>CONFLICT OF    INTERES
T</b></font></p>     ^cY#aop20-11.htm##
00390000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704014400087002001300231#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#73#69#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors declare    th
at there is no conflict of interest.</font></p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#74#70#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00353000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010700087002001300194#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#75#71#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>FINANCIAL SUPPORT</b><
/font></p>     ^cY#aop20-11.htm##
00372000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704012600087002001300213#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#76#72#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="2">IOC/FIOCRUZ, CNPq    (Pro
c. 301545/2006-5).</font></p>     ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002200087002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#77#73#article#139#<p>&nbsp
;</p>     ^cY#aop20-11.htm##
00346000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704010000087002001300187#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#78#74#article#139#<p><font
 face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>REFERENCES</b></font><
/p>     ^cY#aop20-11.htm##
00496000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704023600089002001300325#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#79#75#article#
139#1#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Mead PS,
 Slutsker    L, Dietz V, Mccaig LF, Bresee JS, Shapiro C, et al. Food-related il
lness and    death in the United States. Emerg Infect Dis 1999; 5:607-625.    ^c
Y#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#80#76#article#139#</font><
/p>     ^cY#aop20-11.htm##
00533000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704027300089002001300362#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#81#77#article#
139#2#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Hofer E,
 Hofer    CB. Listeriose. <i>In:</i> Coura JR, editor. Din&acirc;mica das Doen&c
cedil;as    Infecciosas e Parasit&aacute;rias. Vol II. Rio de Janeiro: Guanabara
 Koogan;    2005. p. 1539-1545.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#82#78#article#139#</font><
/p>     ^cY#aop20-11.htm##
00485000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704022500089002001300314#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#83#79#article#
139#3#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Cruz CD,
 Martinez    MB, Destro MT. <i>Listeria monocytogenes</i>: um agente infeccioso 
ainda pouco    conhecido no Brasil. Alim Nutr 2008; 19:195-206.    ^cY#aop20-11.
htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#84#80#article#139#</font><
/p>     ^cY#aop20-11.htm##
00545000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704028500089002001300374#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#85#81#article#
139#4#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Aureli P
, Ferrine    AM, Mannoni V, Hodzic S, Wedell-Weergaard C, Oliva B. Susceptibilit
y of <i>Listeria    monocytogenes</i> isolated from food in Italy to antibiotics
. Int J Food Microbiol    2003; 83:325-330.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#86#82#article#139#</font><
/p>     ^cY#aop20-11.htm##
00474000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704021400089002001300303#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#87#83#article#
139#5#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Charpent
ier    E, Courvalin P. Minireview. Antibiotic Resistence in <i>Listeria</i> spp.
 Antimicrob    Agents Chemother 1999; 43: 2103-2108.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#88#84#article#139#</font><
/p>     ^cY#aop20-11.htm##
00469000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704020900089002001300298#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#89#85#article#
139#6#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Poros-Gl
uchowska    J, Markiewicz Z. Antimicrobial resistance of <i>Listeria monocytogen
es</i>.    Acta Microbiol Pol 2003; 52:113-129.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#90#86#article#139#</font><
/p>     ^cY#aop20-11.htm##
00554000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704029400089002001300383#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#91#87#article#
139#7#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Rocourt 
J, Schrettenbrunner    A, Seeliger HPR. Differ&eacute;nciation biochimique des g
roupes g&eacute;nomiques    des <i>Listeria monocytogenes</i> (<i>sensu lato</i>
). Ann Microbiol (Inst Pasteur)    1983; 134A:65-71.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#92#88#article#139#</font><
/p>     ^cY#aop20-11.htm##
00543000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704028300089002001300372#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#93#89#article#
139#8#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Seeliger
 HPR,    H&ouml;hne K. Serotyping of <i>L. monocytogenes</i> and related species
. <i>In</i>:    Bergan T, Norris JR, editors. Methods in microbiology. Vol 13. L
ondon: Academic    Press; 1979. p. 31-49.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#94#90#article#139#</font><
/p>     ^cY#aop20-11.htm##
00561000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000200087704030100089002001300390#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#95#91#article#
139#9#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Hudson J
A, Lake    RJ, Savill MG, Scholes P, Mccormick RE. Rapid detection of Listeria m
onocytogenes    in ham samples using immunomagnetic separation followed by polym
erase chain    reaction. J Appl Microbiol 2001; 90:614-621.    ^cY#aop20-11.htm#
#
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#96#92#article#139#</font><
/p>     ^cY#aop20-11.htm##
00471000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704021000090002001300300#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#97#93#article#
139#10#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Boruck
 MK,    Douglas R, Call DR. <i>Listeria monocytogenes</i> serotype identificatio
n by    PCR. J Clin Microbiol 2003; 41:5537-5540.    ^cY#aop20-11.htm##
00266000000000145000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083704002000087002001300107#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#98#94#article#139#</font><
/p>     ^cY#aop20-11.htm##
00608000000000157000450000400110000070200540001170500020006570600020006770000030
0069701000300072709000800075708000400083888000300087704034700090002001300437#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#99#95#article#
139#11#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Clinic
al and    Laboratory Standards Institute. Performance Standards for Antimicrobia
l Disk    and Dilution Susceptibility Tests for Bacteria Isolated From Animals. 
Approved    Standard. 3rd ed. Wayne (PA): Clinical and Laboratory Standards Inst
itute; 2009.    M31-A3.28.    ^cY#aop20-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#100#96#article#139#</font>
</p>     ^cY#aop20-11.htm##
00639000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704037700091002001300468#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#101#97#article
#139#12#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Souss
y CJ,    Ckuzel R, Courvalin P. Comit&eacute; de I' Antibiogramme de la Soci&eac
ute;t&eacute;    Fran&ccedil;aise de Microbiologie. Definition and Determination
 of <i>in vitro</i>    Antibiotic Susceptibility Breakpoints for Bacteria in Fra
nce. Eur J Clin Microbiol    Infect Dis 1994; 13:238-246.    ^cY#aop20-11.htm##
00267000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084704002000088002001300108#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#102#98#article#139#</font>
</p>     ^cY#aop20-11.htm##
00522000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000300073709000800076708000400084888000300088704026000091002001300351#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#103#99#article
#139#13#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Gasan
ov U,    Hughes D, Hansbro PM. Methods for isolation and identification of <i>Li
steria</i>    spp. and <i>Listeria monocytogenes</i>: a review. FEMS Microbiol R
ev 2005; 29:851-875.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#104#100#article#139#</font
></p>     ^cY#aop20-11.htm##
00443000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704018000092002001300272#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#105#101#articl
e#139#14#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Jay 
JM. Prevalence    of <i>Listeria</i> spp. in meat and poultry products. Food Con
trol 1996; 7:209-214.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#106#102#article#139#</font
></p>     ^cY#aop20-11.htm##
00407000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704014400092002001300236#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#107#103#articl
e#139#15#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15. Schl
ech WF.    Overview of listeriosis. Food Control 1996; 7:183-186.    ^cY#aop20-1
1.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#108#104#article#139#</font
></p>     ^cY#aop20-11.htm##
00599000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704033600092002001300428#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#109#105#articl
e#139#16#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16. Gilb
reth SE,    Call JE, Wallace FM, Scott VN, Chen Y, Luchansky JB. Relatedness of 
<i>Listeria    monocytogenes</i> isolates recovered from selected ready-to-eat f
oods and listeriosis    patients in the United States. Appl Environ Microbiol 20
05; 71:8115-8122.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#110#106#article#139#</font
></p>     ^cY#aop20-11.htm##
00519000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025600092002001300348#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#111#107#articl
e#139#17#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Hofe
r E, Pessoa    GVA, Melles CEA. Listeriose humana. Preval&ecirc;ncia dos sorotip
os de <i>Listeria    monocytogenes</i> isolados no Brasil. Rev Inst Adolfo Lutz 
1984; 44:125-131.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#112#108#article#139#</font
></p>     ^cY#aop20-11.htm##
00482000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704021900092002001300311#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#113#109#articl
e#139#18#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18. Hofe
r CB, Melles    CEA, Hofer E. <i>Listeria monocytogenes</i> in renal transplant 
recipients.    Rev Inst Med Trop Sao Paulo 1999; 41:375-377.    ^cY#aop20-11.htm
##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#114#110#article#139#</font
></p>     ^cY#aop20-11.htm##
00580000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704031700092002001300409#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#115#111#articl
e#139#19#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19. Leme
s-Marques    EG, Cruz CD, Destro MT. Pheno - and genotypic characterization of <
i>Listeria    monocytogenes</i> clinical isolates from the southwestern region o
f the State    of S&atilde;o Paulo, Brazil. Braz J Microbiol 2007; 38:287-292.  
  ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#116#112#article#139#</font
></p>     ^cY#aop20-11.htm##
00512000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024900092002001300341#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#117#113#articl
e#139#20#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20. Hofe
r E, Reis    CMF, Hofer CB. Serovars of <i>Listeria monocytogenes</i> and relate
d species    isolated from human clinical specimens. Rev Soc Bras Med Trop 2006;
 39:32-37.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#118#114#article#139#</font
></p>     ^cY#aop20-11.htm##
00516000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704025300092002001300345#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#119#115#articl
e#139#21#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21. Hofe
r E, Oliveira    LMA. Sensibilidade antimicrobiana em amostras de <i>Listeria</i
> isoladas de    diferentes fontes e regi&otilde;es do Brasil. Rev Microbiol 198
8; 19:109-112.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#120#116#article#139#</font
></p>     ^cY#aop20-11.htm##
00572000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030900092002001300401#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#121#117#articl
e#139#22#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">22. Morv
an A, Moubareck    C, Leclereq A, Herv&eacute;-Bazin M, Bremont S, Lecuit M, et 
al. Antimicrobial    resistance of <i>Listeria monocytogenes</i> human strains i
solated in France.    Antimicrob Agentes Chemother 2010; 54:2728-2731.    ^cY#ao
p20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#122#118#article#139#</font
></p>     ^cY#aop20-11.htm##
00571000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704030800092002001300400#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#123#119#articl
e#139#23#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">23. Poya
rt-Salmeron    C, Trien-Cuot P, Carlier C, Macgowan A, McLauchlin J, Courvalin P
. Genetic basis    of tetracycline resistance in clinical isolates of <i>Listeri
a monocytogenes</i>.    Antimicrob Agents Chemother 1992; 36:463-466.    ^cY#aop
20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#124#120#article#139#</font
></p>     ^cY#aop20-11.htm##
00484000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704022100092002001300313#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#125#121#articl
e#139#24#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">24. Whit
e DG, Zhao    S, Simjee S, Wagner DD, Mcdemott PF. Antimicrobial resistance of f
oodborne pathogens.    Microbes and Infection 2002; 4:405-412.    ^cY#aop20-11.h
tm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#126#122#article#139#</font
></p>     ^cY#aop20-11.htm##
00499000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704023600092002001300328#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#127#123#articl
e#139#25#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">25. Char
pentier    E, Gerbaud G, Jacquet C, Rocourt J, Courvalin P. Incidence of antibio
tic resistance    in <i>Listeria</i> species. J Infect Dis 1995; 172:277-281.   
 ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#128#124#article#139#</font
></p>     ^cY#aop20-11.htm##
00509000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704024600092002001300338#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#129#125#articl
e#139#26#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">26. Hofe
r E, Nascimento    RS, Oliveira MA. Meningite por <i>L. monocytogenes</i>. Relat
o de casos em pacientes    do Distrito Federal. Rev Soc Bras Med Trop 1998; 31:1
73-177.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#130#126#article#139#</font
></p>     ^cY#aop20-11.htm##
00541000000000157000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085888000300089704027800092002001300370#201
1nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#131#127#articl
e#139#27#<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">27. Cat&
atilde;o    RMR, Vigolvino WA, Andrade WT, Hofer E. Meningite por <i>Listeria mo
nocytogenes</i>    em Campina Grande - Para&iacute;ba, Brasil: relato de um caso
. Rev Bras Anal    Clin 2003; 35:81-83.    ^cY#aop20-11.htm##
00268000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002000089002001300109#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#132#128#article#139#</font
></p>     ^cY#aop20-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#133#129#article#139#<p>&nb
sp;</p>     ^cY#aop20-11.htm##
00270000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704002200089002001300111#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#134#130#article#139#<p>&nb
sp;</p>     ^cY#aop20-11.htm##
00437000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704018900089002001300278#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#135#131#article#139#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><
a href="#top"><img src="/img/revistas/rsbmt/2011nahead/seta.jpg" border="0"></a>
    Address to:    ^cY#aop20-11.htm##
00294000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004600089002001300135#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#136#132#article#139#<br>  
</b> Dra. Deyse Christina Vallim    ^cY#aop20-11.htm##
00300000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005200089002001300141#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#137#133#article#139#<br>  
 Lab. Zoonoses Bacterianas/IOC/FIOCRUZ    ^cY#aop20-11.htm##
00327000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704007900089002001300168#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#138#134#article#139#<br>  
 Av. Brasil 4365, Pavilh&atilde;o Rocha Lima/sala 315, Manguinhos    ^cY#aop20-1
1.htm##
00299000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704005100089002001300140#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#139#135#article#139#<br>  
 21040-900 Rio de Janeiro, RJ, Brasil    ^cY#aop20-11.htm##
00285000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704003700089002001300126#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#140#136#article#139#<br>  
 Phone: 55 21 2270-6565    ^cY#aop20-11.htm##
00347000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009900089002001300188#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#141#137#article#139#<br>  
 e-mail: <a href="mailto:vallim@ioc.fiocruz.br">vallim@ioc.fiocruz.br</a></font>
</p>     ^cY#aop20-11.htm##
00341000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704009300089002001300182#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#142#138#article#139#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">Received in 27/10/2010 
   ^cY#aop20-11.htm##
00297000000000145000450000400110000070200540001170500020006570600020006770000040
0069701000400073709000800077708000400085704004900089002001300138#2011nahead#V:\S
ciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#p#143#139#article#139#<br>  
 Accepted in 15/12/2010</font></p>     ^cY#aop20-11.htm##
00677000000000337000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100018001030100
01500121010001700136010001700153010001700170810000600187012005600193030001700249
06500090026606400050027503100020028001400080028286500090029000200130029903500100
0312801001700322#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.ht
m#S#c#144#1#article#27#1#^rND^sMead^nPS#^rND^sSlutsker^nL#^rND^sDietz^nV#^rND^sM
ccaig^nLF#^rND^sBresee^nJS#^rND^sShapiro^nC#et al#Food-related illness and death
 in the United States^len#Emerg Infect Dis#19990000#1999#5#607-625#20110000#aop2
0-11.htm#1080-6040#Emerg Infect Dis##
00573000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100016001030120
01500119016001600134018005200150031000300202066001500205062001700220065000900237
064000500246014001000251865000900261002001300270#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#145#2#article#27#2#^rND^sHofer^nE#^rND^sHo
fer^nCB#Listeriose^lpt#^rED^sCoura^nJR#Dinâmica das Doenças Infecciosas e Parasi
tárias^lpt#II#Rio de Janeiro#Guanabara Koogan#20050000#2005#1539-1545#20110000#a
op20-11.htm##
00557000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100015000880100019001030100
01700122012008100139030001000220710000200230065000900232064000500241031000300246
014000800249865000900257002001300266#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop20-11.htm#S#c#146#3#article#27#3#^rND^sCruz^nCD#^rND^sMartinez^nMB#^
rND^sDestro^nMT#Listeria monocytogenes: um agente infeccioso ainda pouco conheci
do no Brasil^len#Alim Nutr#2#20080000#2008#19#195-206#20110000#aop20-11.htm##
00709000000000325000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100016000880100018001040100
01700122010001600139010002600155010001500181012008800196030002100284065000900305
06400050031403100030031901400080032286500090033000200130033903500100035280100210
0362#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#147#4#
article#27#4#^rND^sAureli^nP#^rND^sFerrine^nAM#^rND^sMannoni^nV#^rND^sHodzic^nS#
^rND^sWedell-Weergaard^nC#^rND^sOliva^nB#Susceptibility of Listeria monocytogene
s isolated from food in Italy to antibiotics^len#Int J Food Microbiol#20030000#2
003#83#325-330#20110000#aop20-11.htm#0168-1605#Int J Food Microbiol##
00575000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100021000880100019001090120
05400128030002800182065000900210064000500219031000300224014001000227865000900237
002001300246035001000259801002800269#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop20-11.htm#S#c#148#5#article#27#5#^rND^sCharpentier^nE#^rND^sCourvali
n^nP#Minireview: Antibiotic Resistence in Listeria spp^len#Antimicrob Agents Che
mother#19990000#1999#43#2103-2108#20110000#aop20-11.htm#0066-4804#Antimicrob Age
nts Chemother##
00562000000000277000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100026000880100020001140120
05500134030001900189065000900208064000500217031000300222014000800225865000900233
002001300242035001000255801001900265#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop20-11.htm#S#c#149#6#article#27#6#^rND^sPoros-Gluchowska^nJ#^rND^sMar
kiewicz^nZ#Antimicrobial resistance of Listeria monocytogenes^len#Acta Microbiol
 Pol#20030000#2003#52#113-129#20110000#aop20-11.htm#0001-6195#Acta Microbiol Pol
##
00651000000000289000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100026001050100
02000131012009500151030002900246065000900275064000500284031000500289014000600294
865000900300002001300309035001000322801002900332#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#150#7#article#27#7#^rND^sRocourt^nJ#^rND^s
Schrettenbrunner^nA#^rND^sSeeliger^nHPR#Differénciation biochimique des groupes 
génomiques des Listeria monocytogenes (sensu lato)^len#Ann Microbiol (Inst Paste
ur)#19830000#1983#134A#65-71#20110000#aop20-11.htm#0769-2609#Ann Microbiol (Inst
 Pasteur)##
00608000000000301000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100020000880100015001080120
05500123016001600178016001700194018002800211031000300239066000700242062001500249
065000900264064000500273014000600278865000900284002001300293#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#151#8#article#27#8#^rND^sSeeli
ger^nHPR#^rND^sHöhne^nK#Serotyping of L. monocytogenes and related species^len#^
rED^sBergan^nT#^rED^sNorris^nJR#Methods in microbiology^len#13#London#Academic P
ress#19790000#1979#31-49#20110000#aop20-11.htm##
00710000000000313000450000400110000070200540001170500020006570600020006770000040
00697010002000737090008000757080003000831180002000860100017000880100015001050100
01700120010001700137010002000154012013100174030001700305065000900322064000500331
031000300336014000800339865000900347002001300356035001000369801001700379#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#152#9#article#27#9
#^rND^sHudson^nJA#^rND^sLake^nRJ#^rND^sSavill^nMG#^rND^sScholes^nP#^rND^sMccormi
ck^nRE#Rapid detection of Listeria monocytogenes in ham samples using immunomagn
etic separation followed by polymerase chain reaction^len#J Appl Microbiol#20010
000#2001#90#614-621#20110000#aop20-11.htm#1364-5072#J Appl Microbiol##
00580000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100017001070100
01500124012005800139030001700197065000900214064000500223031000300228014001000231
865000900241002001300250035001000263801001700273#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#153#10#article#27#10#^rND^sBoruck^nMK#^rND
^sDouglas^nR#^rND^sCall^nDR#Listeria monocytogenes serotype identification by PC
R^len#J Clin Microbiol#20030000#2003#41#5537-5540#20110000#aop20-11.htm#0095-113
7#J Clin Microbiol##
00605000000000241000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870170044000900180137001340630
00200271066001000273062004400283065000900327064000500336865000900341002001300350
#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#154#11#art
icle#27#11#Clinical and Laboratory Standards Institute#Performance Standards for
 Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From
 Animals: Approved Standard^len#3#Wayne^ePA#Clinical and Laboratory Standards In
stitute#20090000#2009#20110000#aop20-11.htm##
00728000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01900123012017500142030003200317065000900349064000500358031000300363014000800366
865000900374002001300383035001000396801003200406#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#155#12#article#27#12#^rND^sSoussy^nCJ#^rND
^sCkuzel^nR#^rND^sCourvalin^nP#Comité de I' Antibiogramme de la Société Français
e de Microbiologie: Definition and Determination of in vitro Antibiotic Suscepti
bility Breakpoints for Bacteria in France^lfr#Eur J Clin Microbiol Infect Dis#19
940000#1994#13#238-246#20110000#aop20-11.htm#0722-2211#Eur J Clin Microbiol Infe
ct Dis##
00625000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100016001070100
01800123012009900141030001900240065000900259064000500268031000300273014000800276
865000900284002001300293035001000306801001900316#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#156#13#article#27#13#^rND^sGasanov^nU#^rND
^sHughes^nD#^rND^sHansbro^nPM#Methods for isolation and identification of Lister
ia spp. and Listeria monocytogenes: a review^len#FEMS Microbiol Rev#20050000#200
5#29#851-875#20110000#aop20-11.htm#0168-6445#FEMS Microbiol Rev##
00513000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100014000900120061001040300
01300165065000900178064000500187031000200192014000800194865000900202002001300211
035001000224801001300234#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
20-11.htm#S#c#157#14#article#27#14#^rND^sJay^nJM#Prevalence of Listeria spp. in 
meat and poultry products^len#Food Control#19960000#1996#7#209-214#20110000#aop2
0-11.htm#0956-7153#FOOD CONTROL##
00484000000000265000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100018000900120028001080300
01300136065000900149064000500158031000200163014000800165865000900173002001300182
035001000195801001300205#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop
20-11.htm#S#c#158#15#article#27#15#^rND^sSchlech^nWF#Overview of listeriosis^len
#Food Control#19960000#1996#7#183-186#20110000#aop20-11.htm#0956-7153#FOOD CONTR
OL##
00763000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100019000900100015001090100
01800124010001600142010001400158010002000172012014000192030002300332065000900355
06400050036403100030036901400100037286500090038200200130039103500100040480100230
0414#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#159#16
#article#27#16#^rND^sGilbreth^nSE#^rND^sCall^nJE#^rND^sWallace^nFM#^rND^sScott^n
VN#^rND^sChen^nY#^rND^sLuchansky^nJB#Relatedness of Listeria monocytogenes isola
tes recovered from selected ready-to-eat foods and listeriosis patients in the U
nited States^len#Appl Environ Microbiol#20050000#2005#71#8115-8122#20110000#aop2
0-11.htm#0099-2240#Appl Environ Microbiol##
00624000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100018001050100
01800123012009400141030002100235065000900256064000500265031000300270014000800273
865000900281002001300290035001000303801002100313#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#160#17#article#27#17#^rND^sHofer^nE#^rND^s
Pessoa^nGVA#^rND^sMelles^nCEA#Listeriose humana: Prevalência dos sorotipos de Li
steria monocytogenes isolados no Brasil^lpt#Rev Inst Adolfo Lutz#19840000#1984#4
4#125-131#20110000#aop20-11.htm#0073-9855#Rev Inst Adolfo Lutz##
00600000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100018001060100
01500124012005800139030002800197065000900225064000500234031000300239014000800242
865000900250002001300259035001000272801002800282#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#161#18#article#27#18#^rND^sHofer^nCB#^rND^
sMelles^nCEA#^rND^sHofer^nE#Listeria monocytogenes in renal transplant recipient
s^len#Rev Inst Med Trop Sao Paulo#19990000#1999#41#375-377#20110000#aop20-11.htm
#0036-4665#Rev Inst Med Trop Sao Paulo##
00640000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100024000900100015001140100
01700129012015000146030001700296710000200313065000900315064000500324031000300329
014000800332865000900340002001300349#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop20-11.htm#S#c#162#19#article#27#19#^rND^sLemes-Marques^nEG#^rND^sCru
z^nCD#^rND^sDestro^nMT#Pheno - and genotypic characterization of Listeria monocy
togenes clinical isolates from the southwestern region of the State of São Paulo
, Brazil^len#Braz J Microbiol#2#20070000#2007#38#287-292#20110000#aop20-11.htm##
00624000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100016001050100
01600121012009800137030002200235065000900257064000500266031000300271014000600274
865000900280002001300289035001000302801002200312#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#163#20#article#27#20#^rND^sHofer^nE#^rND^s
Reis^nCMF#^rND^sHofer^nCB#Serovars of Listeria monocytogenes and related species
 isolated from human clinical specimens^len#Rev Soc Bras Med Trop#20060000#2006#
39#32-37#20110000#aop20-11.htm#0037-8682#Rev Soc Bras Med Trop##
00595000000000277000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100020001050120
10700125030001400232065000900246064000500255031000300260014000800263865000900271
002001300280035001000293801001400303#2011nahead#V:\SciELO\serial\rsbmt\2011nahea
d\markup\aop20-11.htm#S#c#164#21#article#27#21#^rND^sHofer^nE#^rND^sOliveira^nLM
A#Sensibilidade antimicrobiana em amostras de Listeria isoladas de diferentes fo
ntes e regiões do Brasil^len#Rev Microbiol#19880000#1988#19#109-112#20110000#aop
20-11.htm#0001-3714#Rev Microbiol##
00697000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100019001060100
01800125010002100143010001700164010001600181810000600197012008800203030002900291
71000020032006500090032206400050033103100030033601400100033986500090034900200130
0358#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#165#22
#article#27#22#^rND^sMorvan^nA#^rND^sMoubareck^nC#^rND^sLeclereq^nA#^rND^sHervé-
Bazin^nM#^rND^sBremont^nS#^rND^sLecuit^nM#et al#Antimicrobial resistance of List
eria monocytogenes human strains isolated in France^len#Antimicrob Agentes Chemo
ther#2#20100000#2010#54#2728-2731#20110000#aop20-11.htm##
00740000000000325000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100025000900100020001150100
01700135010001800152010002000170010001900190012009200209030002800301065000900329
06400050033803100030034301400080034686500090035400200130036303500100037680100280
0386#2011nahead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#166#23
#article#27#23#^rND^sPoyart-Salmeron^nC#^rND^sTrien-Cuot^nP#^rND^sCarlier^nC#^rN
D^sMacgowan^nA#^rND^sMcLauchlin^nJ#^rND^sCourvalin^nP#Genetic basis of tetracycl
ine resistance in clinical isolates of Listeria monocytogenes^len#Antimicrob Age
nts Chemother#19920000#1992#36#463-466#20110000#aop20-11.htm#0066-4804#Antimicro
b Agents Chemother##
00597000000000301000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100016000900100014001060100
01600120010001700136010001900153012005200172030002300224710000200247065000900249
064000500258031000200263014000800265865000900273002001300282#2011nahead#V:\SciEL
O\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#167#24#article#27#24#^rND^sWhi
te^nDG#^rND^sZhao^nS#^rND^sSimjee^nS#^rND^sWagner^nDD#^rND^sMcdemott^nPF#Antimic
robial resistance of foodborne pathogens^len#Microbes and Infection#2#20020000#2
002#4#405-412#20110000#aop20-11.htm##
00638000000000313000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100021000900100017001110100
01700128010001700145010001900162012005900181030001300240065000900253064000500262
031000400267014000800271865000900279002001300288035001000301801001300311#2011nah
ead#V:\SciELO\serial\rsbmt\2011nahead\markup\aop20-11.htm#S#c#168#25#article#27#
25#^rND^sCharpentier^nE#^rND^sGerbaud^nG#^rND^sJacquet^nC#^rND^sRocourt^nJ#^rND^
sCourvalin^nP#Incidence of antibiotic resistance in Listeria species^len#J Infec
t Dis#19950000#1995#172#277-281#20110000#aop20-11.htm#0022-1899#J Infect Dis##
00621000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100015000900100021001050100
01900126012008500145030002200230065000900252064000500261031000300266014000800269
865000900277002001300286035001000299801002200309#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#169#26#article#27#26#^rND^sHofer^nE#^rND^s
Nascimento^nRS#^rND^sOliveira^nMA#Meningite por L. monocytogenes: Relato de caso
s em pacientes do Distrito Federal^lpt#Rev Soc Bras Med Trop#19980000#1998#31#17
3-177#20110000#aop20-11.htm#0037-8682#Rev Soc Bras Med Trop##
00612000000000289000450000400110000070200540001170500020006570600020006770000040
00697010003000737090008000767080003000841180003000870100017000900100020001070100
01800127010001500145012009600160030001900256710000200275065000900277064000500286
031000300291014000600294865000900300002001300309#2011nahead#V:\SciELO\serial\rsb
mt\2011nahead\markup\aop20-11.htm#S#c#170#27#article#27#27#^rND^sCatão^nRMR#^rND
^sVigolvino^nWA#^rND^sAndrade^nWT#^rND^sHofer^nE#Meningite por Listeria monocyto
genes em Campina Grande - Paraíba, Brasil: relato de um caso^lpt#Rev Bras Anal C
lin#2#20030000#2003#35#81-83#20110000#aop20-11.htm##
